<?xml version="1.0" encoding="UTF-8" ?><xml><records><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>7</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">7</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors></contributors><titles><title><style face="normal" font="default" size="100%">&lt;Gianfrancesco-2017-Evidence for a causal relat.pdf&gt;</style></title></titles><dates></dates><urls><pdf-urls><url>internal-pdf://1198723806/Gianfrancesco-2017-Evidence for a causal relat.pdf</url></pdf-urls></urls></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>45</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">45</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors></contributors><titles><title><style face="normal" font="default" size="100%">&lt;Burgess-2014-Instrumental variable analysis wi.pdf&gt;</style></title></titles><dates></dates><urls><pdf-urls><url>internal-pdf://1108201100/Burgess-2014-Instrumental variable analysis wi.pdf</url></pdf-urls></urls></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>96</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">96</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors></contributors><titles><title><style face="normal" font="default" size="100%">&lt;Hindy-2019-Cardiometabolic polygenic risk scor.pdf&gt;</style></title></titles><dates></dates><urls><pdf-urls><url>internal-pdf://1335011654/Hindy-2019-Cardiometabolic polygenic risk scor.pdf</url></pdf-urls></urls></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>104</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">104</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors></contributors><titles><title><style face="normal" font="default" size="100%">&lt;Welsh-2009-Unraveling the Directional Link bet.pdf&gt;</style></title></titles><dates></dates><urls><pdf-urls><url>internal-pdf://3620832916/Welsh-2009-Unraveling the Directional Link bet.pdf</url></pdf-urls></urls></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>135</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">135</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors></contributors><titles><title><style face="normal" font="default" size="100%">&lt;Larsson-2017-Type 2 diabetes, glucose, insulin.pdf&gt;</style></title></titles><dates></dates><urls><pdf-urls><url>internal-pdf://2696956487/Larsson-2017-Type 2 diabetes, glucose, insulin.pdf</url></pdf-urls></urls></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>137</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">137</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors></contributors><titles><title><style face="normal" font="default" size="100%">&lt;Reed-2017-Assessing the causal role of adiposi.pdf&gt;</style></title></titles><dates></dates><urls><pdf-urls><url>internal-pdf://1035027834/Reed-2017-Assessing the causal role of adiposi.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.3945/ajcn.117</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>149</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">149</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors></contributors><titles><title><style face="normal" font="default" size="100%">&lt;Fall-2013-The role of adiposity in cardiometab.pdf&gt;</style></title></titles><dates></dates><urls><pdf-urls><url>internal-pdf://3885724518/Fall-2013-The role of adiposity in cardiometab.pdf</url></pdf-urls></urls></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>80</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">80</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Abdellaoui, Abdel</style></author><author><style face="normal" font="default" size="100%">Sanchez-Roige, Sandra</style></author><author><style face="normal" font="default" size="100%">Sealock, Julia</style></author><author><style face="normal" font="default" size="100%">Treur, Jorien L.</style></author><author><style face="normal" font="default" size="100%">Dennis, Jessica</style></author><author><style face="normal" font="default" size="100%">Fontanillas, Pierre</style></author><author><style face="normal" font="default" size="100%">Elson, Sarah</style></author><author><style face="normal" font="default" size="100%">Nivard, Michel</style></author><author><style face="normal" font="default" size="100%">Fung Ip, Hill</style></author><author><style face="normal" font="default" size="100%">der Zee, Matthijs van</style></author><author><style face="normal" font="default" size="100%">Baselmans, Bart</style></author><author><style face="normal" font="default" size="100%">Hottenga, Jouke Jan</style></author><author><style face="normal" font="default" size="100%">Willemsen, Gonneke</style></author><author><style face="normal" font="default" size="100%">Mosing, Miriam</style></author><author><style face="normal" font="default" size="100%">Yu, Li</style></author><author><style face="normal" font="default" size="100%">Pedersen, Nancy L.</style></author><author><style face="normal" font="default" size="100%">Amin, Najaf</style></author><author><style face="normal" font="default" size="100%">van Duijn, Cornelia M.</style></author><author><style face="normal" font="default" size="100%">Szilagyi, Ingrid</style></author><author><style face="normal" font="default" size="100%">Tiemeier, Henning</style></author><author><style face="normal" font="default" size="100%">Neumann, Alexander</style></author><author><style face="normal" font="default" size="100%">Verweij, Karin</style></author><author><style face="normal" font="default" size="100%">Cacioppo, Stephanie</style></author><author><style face="normal" font="default" size="100%">Cacioppo, John T.</style></author><author><style face="normal" font="default" size="100%">Davis, Lea K.</style></author><author><style face="normal" font="default" size="100%">Palmer, Abraham A.</style></author><author><style face="normal" font="default" size="100%">Boomsma, Dorret I.</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><urls><pdf-urls><url>internal-pdf://1032348672/Abdellaoui-2018-Phenome-wide investigation of.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/468835</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>18</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">18</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Afzal, Shoaib</style></author><author><style face="normal" font="default" size="100%">Brøndum-Jacobsen, Peter</style></author><author><style face="normal" font="default" size="100%">Bojesen, Stig E.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, Børge G.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study</style></title><secondary-title><style face="normal" font="default" size="100%">The Lancet Diabetes &amp; Endocrinology</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">The Lancet Diabetes &amp; Endocrinology</style></full-title></periodical><pages><style face="normal" font="default" size="100%">298-306</style></pages><volume><style face="normal" font="default" size="100%">2</style></volume><number><style face="normal" font="default" size="100%">4</style></number><section><style face="normal" font="default" size="100%">298</style></section><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><isbn><style face="normal" font="default" size="100%">22138587</style></isbn><urls><pdf-urls><url>internal-pdf://0309635481/Afzal-2014-Vitamin D concentration, obesity, a.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/s2213-8587(13)70200-6</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>155</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">155</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Arafat, S.</style></author><author><style face="normal" font="default" size="100%">Minica, C. C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Biological Psychology,Vrije Universiteit,Amsterdam,the Netherlands.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Fetal Origins of Mental Disorders? An Answer Based on Mendelian Randomization</style></title><secondary-title><style face="normal" font="default" size="100%">Twin Res Hum Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Twin Res Hum Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">485-494</style></pages><volume><style face="normal" font="default" size="100%">21</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2018/12/28</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Fetal Diseases/genetics/*pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Pleiotropy</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Mental Disorders/*etiology</style></keyword><keyword><style face="normal" font="default" size="100%">*Models, Biological</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*attention deficit hyperactivity disorder</style></keyword><keyword><style face="normal" font="default" size="100%">*birth weight</style></keyword><keyword><style face="normal" font="default" size="100%">*depression</style></keyword><keyword><style face="normal" font="default" size="100%">*schizophrenia</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1832-4274 (Print)&#xD;1832-4274 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30587273</style></accession-num><abstract><style face="normal" font="default" size="100%">The Barker hypothesis states that low birth weight (BW) is associated with higher risk of adult onset diseases, including mental disorders like schizophrenia, major depressive disorder (MDD), and attention deficit hyperactivity disorder (ADHD). The main criticism of this hypothesis is that evidence for it comes from observational studies. Specifically, observational evidence does not suffice for inferring causality, because the associations might reflect the effects of confounders. Mendelian randomization (MR) - a novel method that tests causality on the basis of genetic data - creates the unprecedented opportunity to probe the causality in the association between BW and mental disorders in observation studies. We used MR and summary statistics from recent large genome-wide association studies to test whether the association between BW and MDD, schizophrenia and ADHD is causal. We employed the inverse variance weighted (IVW) method in conjunction with several other approaches that are robust to possible assumption violations. MR-Egger was used to rule out horizontal pleiotropy. IVW showed that the association between BW and MDD, schizophrenia and ADHD is not causal (all p &amp;gt; .05). The results of all the other MR methods were similar and highly consistent. MR-Egger provided no evidence for pleiotropic effects biasing the estimates of the effects of BW on MDD (intercept = -0.004, SE = 0.005, p = .372), schizophrenia (intercept = 0.003, SE = 0.01, p = .769), or ADHD (intercept = 0.009, SE = 0.01, p = .357). Based on the current evidence, we refute the Barker hypothesis concerning the fetal origins of adult mental disorders. The discrepancy between our results and the results from observational studies may be explained by the effects of confounders in the observational studies, or by the existence of a small causal effect not detected in our study due to weak instruments. Our power analyses suggested that the upper bound for a potential causal effect of BW on mental disorders would likely not exceed an odds ratio of 1.2.</style></abstract><notes><style face="normal" font="default" size="100%">Arafat, Subhi&#xD;Minica, Camelia C&#xD;eng&#xD;R01 DA018673/DA/NIDA NIH HHS/&#xD;R37 DA018673/DA/NIDA NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Twin Res Hum Genet. 2018 Dec;21(6):485-494. doi: 10.1017/thg.2018.65.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30587273</style></url></related-urls><pdf-urls><url>internal-pdf://3536639600/Arafat-2018-Fetal Origins of Mental Disorders_.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6390405</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1017/thg.2018.65</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>130</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">130</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ashar, F. N.</style></author><author><style face="normal" font="default" size="100%">Mitchell, R. N.</style></author><author><style face="normal" font="default" size="100%">Albert, C. M.</style></author><author><style face="normal" font="default" size="100%">Newton-Cheh, C.</style></author><author><style face="normal" font="default" size="100%">Brody, J. A.</style></author><author><style face="normal" font="default" size="100%">Muller-Nurasyid, M.</style></author><author><style face="normal" font="default" size="100%">Moes, A.</style></author><author><style face="normal" font="default" size="100%">Meitinger, T.</style></author><author><style face="normal" font="default" size="100%">Mak, A.</style></author><author><style face="normal" font="default" size="100%">Huikuri, H.</style></author><author><style face="normal" font="default" size="100%">Junttila, M. J.</style></author><author><style face="normal" font="default" size="100%">Goyette, P.</style></author><author><style face="normal" font="default" size="100%">Pulit, S. L.</style></author><author><style face="normal" font="default" size="100%">Pazoki, R.</style></author><author><style face="normal" font="default" size="100%">Tanck, M. W.</style></author><author><style face="normal" font="default" size="100%">Blom, M. T.</style></author><author><style face="normal" font="default" size="100%">Zhao, X.</style></author><author><style face="normal" font="default" size="100%">Havulinna, A. S.</style></author><author><style face="normal" font="default" size="100%">Jabbari, R.</style></author><author><style face="normal" font="default" size="100%">Glinge, C.</style></author><author><style face="normal" font="default" size="100%">Tragante, V.</style></author><author><style face="normal" font="default" size="100%">Escher, S. A.</style></author><author><style face="normal" font="default" size="100%">Chakravarti, A.</style></author><author><style face="normal" font="default" size="100%">Ehret, G.</style></author><author><style face="normal" font="default" size="100%">Coresh, J.</style></author><author><style face="normal" font="default" size="100%">Li, M.</style></author><author><style face="normal" font="default" size="100%">Prineas, R. J.</style></author><author><style face="normal" font="default" size="100%">Franco, O. H.</style></author><author><style face="normal" font="default" size="100%">Kwok, P. Y.</style></author><author><style face="normal" font="default" size="100%">Lumley, T.</style></author><author><style face="normal" font="default" size="100%">Dumas, F.</style></author><author><style face="normal" font="default" size="100%">McKnight, B.</style></author><author><style face="normal" font="default" size="100%">Rotter, J. I.</style></author><author><style face="normal" font="default" size="100%">Lemaitre, R. N.</style></author><author><style face="normal" font="default" size="100%">Heckbert, S. R.</style></author><author><style face="normal" font="default" size="100%">O&apos;Donnell, C. J.</style></author><author><style face="normal" font="default" size="100%">Hwang, S. J.</style></author><author><style face="normal" font="default" size="100%">Tardif, J. C.</style></author><author><style face="normal" font="default" size="100%">VanDenburgh, M.</style></author><author><style face="normal" font="default" size="100%">Uitterlinden, A. G.</style></author><author><style face="normal" font="default" size="100%">Hofman, A.</style></author><author><style face="normal" font="default" size="100%">Stricker, B. H. C.</style></author><author><style face="normal" font="default" size="100%">de Bakker, P. I. W.</style></author><author><style face="normal" font="default" size="100%">Franks, P. W.</style></author><author><style face="normal" font="default" size="100%">Jansson, J. H.</style></author><author><style face="normal" font="default" size="100%">Asselbergs, F. W.</style></author><author><style face="normal" font="default" size="100%">Halushka, M. K.</style></author><author><style face="normal" font="default" size="100%">Maleszewski, J. J.</style></author><author><style face="normal" font="default" size="100%">Tfelt-Hansen, J.</style></author><author><style face="normal" font="default" size="100%">Engstrom, T.</style></author><author><style face="normal" font="default" size="100%">Salomaa, V.</style></author><author><style face="normal" font="default" size="100%">Virmani, R.</style></author><author><style face="normal" font="default" size="100%">Kolodgie, F.</style></author><author><style face="normal" font="default" size="100%">Wilde, A. A. M.</style></author><author><style face="normal" font="default" size="100%">Tan, H. L.</style></author><author><style face="normal" font="default" size="100%">Bezzina, C. R.</style></author><author><style face="normal" font="default" size="100%">Eijgelsheim, M.</style></author><author><style face="normal" font="default" size="100%">Rioux, J. D.</style></author><author><style face="normal" font="default" size="100%">Jouven, X.</style></author><author><style face="normal" font="default" size="100%">Kaab, S.</style></author><author><style face="normal" font="default" size="100%">Psaty, B. M.</style></author><author><style face="normal" font="default" size="100%">Siscovick, D. S.</style></author><author><style face="normal" font="default" size="100%">Arking, D. E.</style></author><author><style face="normal" font="default" size="100%">Sotoodehnia, N.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins, 733 N Broadway, Baltimore, MD, USA.&#xD;Divisions of Preventive Medicine and Cardiovascular Medicine, Department of Medicine, Brigham and Women&apos;s Hospital, 900 Commonwealth Ave East, 3rd Floor, Boston, MA, USA.&#xD;Center for Human Genetic Research &amp; Cardiovascular Research Center, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, USA.&#xD;Cardiovascular Health Research Unit, Department of Medicine, University of Washington, 1730 Minor Ave, Seattle, WA, USA.&#xD;Institute of Genetic Epidemiology, Helmholtz Zentrum Munchen - German Research Center for Environmental Health, Ingolstadter Landstrasse 1, Neuherberg, Germany.&#xD;Chair of Genetic Epidemiology, Institute for Medical Informatics, Biometry and Epidemiology, Faculty of Medicine, Ludwig-Maximilians University, Marchioninistr. 15, Munich, Germany.&#xD;Department of Internal Medicine I (Cardiology), Hospital of the Ludwig-Maximilians-University, Marchioninistr. 15, Munich, Germany.&#xD;DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Biedersteiner Strasse 29, Munich, Germany.&#xD;Institute of Human Genetics, Helmholtz Zentrum Munchen - German Research Center for Environmental Health, Ingolstaedter Landstrasse 1, Neuherberg, Germany.&#xD;Institute of Human Genetics, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaninger Strasse 22, Munich, Germany.&#xD;Cardiovascular Research Institute and Institute for Human Genetics, University of California, San Francisco, 1550 4th Street, San Francisco, CA, USA.&#xD;Research Unit of Internal Medicine, University Hospital and University of Oulu, Kajaaninkatu 50, Oulu, Finland.&#xD;Montreal Heart Institute, Universite de Montreal, 5000 rue Belanger, Montreal, Quebec, Canada.&#xD;Department of Genetics, Center for Molecular Medicine, University Medical Centre Utrecht, Heidelberglaan 100, Utrecht, The Netherlands.&#xD;Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary&apos;s Hospital, Praed St, Paddington, London, UK.&#xD;Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Meibergdreef 9, AZ Amsterdam, The Netherlands.&#xD;Department of Clinical and Experimental Cardiology, Heart Center, Academic Medical Center, Meibergdreef 9, AZ Amsterdam, The Netherlands.&#xD;CVPath Institute, 19 Firstfield Road, Gaithersburg, MD, USA.&#xD;National Institute for Health and Welfare, Mannerheimintie 166, Helsinki, Finland.&#xD;Department of Cardiology, Rigshospitalet, Inge Lehmanns Vej 7, Copenhagen, Denmark.&#xD;Department of Cardiology, Division Heart &amp; Lungs, University Medical Center Utrecht, University of Utrecht, Heidelberglaan 100, Utrecht, The Netherlands.&#xD;Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, Barngatan 4, Skanes universitetssjukhus, Malmo, Sweden.&#xD;Department of Epidemiology, Johns Hopkins University, 615 N Wolfe Street, Baltimore, MD, USA.&#xD;Public Health Sciences, Wake Forest University, Medical Center Boulevard, Winston-Salem, NC, USA.&#xD;Institute of Social and Preventative Medicine, University of Bern, Mittelstrasse 43, Bern, Switzerland.&#xD;Department of Epidemiology, Erasmus MC, Dr. Molewaterplein 50, GE Rotterdam, The Netherlands.&#xD;Department of Statistics, University of Auckland, Private Bag 92014, Auckland, New Zealand.&#xD;Paris Sudden Death Expertise Center, University Paris Descartes, Sorbonne Paris Cite, INSERM U970, 56 rue Leblanc, Paris, France.&#xD;Department of Biostatistics, University of Washington, F-600, Health Sciences Building 1705 NE Pacific Street, Seattle, WA, USA.&#xD;The Institute for Translational Genomics and Population Sciences, Departments of Pediatrics and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, 1124 W. Carson Street, Torrance, CA, USA.&#xD;Cardiovascular Health Research Unit, Department of Epidemiology, University of Washington, 1959 NE Pacific St, Seattle, WA, USA.&#xD;NHLBI Framingham Heart Study, 73 Mount Wayte Avenue, Suite #2, Framingham, MA, USA.&#xD;Cardiology Section, Department of Medicine, Boston VA Healthcare System, 1400 VFW Parkway, Boston, MA, USA.&#xD;Erasmus MC University Medical Center, Department of Internal Medicine, Dr. Molewaterplein 40, CD Rotterdam, The Netherlands.&#xD;Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, The Netherlands.&#xD;Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, The Netherlands.&#xD;Department of Public Health and Clinical Medicine, Research Unit Skelleftea, Umea University, University Hospital, Building 1A, 4st, Umea, Sweden.&#xD;Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, 69-75 Chenies Mews, London, UK.&#xD;Institute of Health Informatics, University College London, 222 Euston Road London, UK.&#xD;Department of Pathology, Division of Cardiovascular Pathology, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross Rm 632B, Baltimore, MD, USA.&#xD;Department of Laboratory Medicine &amp; Pathology, Mayo Clinic, 3050 Superior Drive, Rochester, MN, USA.&#xD;Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen, Inge Lehmanns Vej 7, Copenhagen, Denmark.&#xD;Department of Cardiology, University of Lund, Getingevagen 4, Lund, Sweden.&#xD;Amsterdam UMC, University of Amsterdam, Heart Center; Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Meibergdreef 9, AZ, Amsterdam, The Netherlands.&#xD;Department of Nephrology, University Medical Center Groningen, Hanzeplein 1, GZ, Groningen, The Netherlands.&#xD;Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Services, University of Washington, 1730 Minor Ave, suite #1360, Seattle, WA, USA.&#xD;The New York Academy of Medicine, 1216 5th Ave, New York, New York, USA.&#xD;Cardiovascular Health Research Unit, Division of Cardiology, Departments of Medicine and Epidemiology, University of Washington, 1730 Minor Ave, Seattle, WA, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">A comprehensive evaluation of the genetic architecture of sudden cardiac arrest</style></title><secondary-title><style face="normal" font="default" size="100%">Eur Heart J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur Heart J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">3961-3969</style></pages><volume><style face="normal" font="default" size="100%">39</style></volume><number><style face="normal" font="default" size="100%">44</style></number><edition><style face="normal" font="default" size="100%">2018/09/01</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Arrhythmias, Cardiac/*genetics/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Artery Disease/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Death, Sudden, Cardiac/*etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Heart Conduction System/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Sex Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov 21</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1522-9645 (Electronic)&#xD;0195-668X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30169657</style></accession-num><abstract><style face="normal" font="default" size="100%">Aims: Sudden cardiac arrest (SCA) accounts for 10% of adult mortality in Western populations. We aim to identify potential loci associated with SCA and to identify risk factors causally associated with SCA. Methods and results: We carried out a large genome-wide association study (GWAS) for SCA (n = 3939 cases, 25 989 non-cases) to examine common variation genome-wide and in candidate arrhythmia genes. We also exploited Mendelian randomization (MR) methods using cross-trait multi-variant genetic risk score associations (GRSA) to assess causal relationships of 18 risk factors with SCA. No variants were associated with SCA at genome-wide significance, nor were common variants in candidate arrhythmia genes associated with SCA at nominal significance. Using cross-trait GRSA, we established genetic correlation between SCA and (i) coronary artery disease (CAD) and traditional CAD risk factors (blood pressure, lipids, and diabetes), (ii) height and BMI, and (iii) electrical instability traits (QT and atrial fibrillation), suggesting aetiologic roles for these traits in SCA risk. Conclusions: Our findings show that a comprehensive approach to the genetic architecture of SCA can shed light on the determinants of a complex life-threatening condition with multiple influencing factors in the general population. The results of this genetic analysis, both positive and negative findings, have implications for evaluating the genetic architecture of patients with a family history of SCA, and for efforts to prevent SCA in high-risk populations and the general community.</style></abstract><notes><style face="normal" font="default" size="100%">Ashar, Foram N&#xD;Mitchell, Rebecca N&#xD;Albert, Christine M&#xD;Newton-Cheh, Christopher&#xD;Brody, Jennifer A&#xD;Muller-Nurasyid, Martina&#xD;Moes, Anna&#xD;Meitinger, Thomas&#xD;Mak, Angel&#xD;Huikuri, Heikki&#xD;Junttila, M Juhani&#xD;Goyette, Philippe&#xD;Pulit, Sara L&#xD;Pazoki, Raha&#xD;Tanck, Michael W&#xD;Blom, Marieke T&#xD;Zhao, XiaoQing&#xD;Havulinna, Aki S&#xD;Jabbari, Reza&#xD;Glinge, Charlotte&#xD;Tragante, Vinicius&#xD;Escher, Stefan A&#xD;Chakravarti, Aravinda&#xD;Ehret, Georg&#xD;Coresh, Josef&#xD;Li, Man&#xD;Prineas, Ronald J&#xD;Franco, Oscar H&#xD;Kwok, Pui-Yan&#xD;Lumley, Thomas&#xD;Dumas, Florence&#xD;McKnight, Barbara&#xD;Rotter, Jerome I&#xD;Lemaitre, Rozenn N&#xD;Heckbert, Susan R&#xD;O&apos;Donnell, Christopher J&#xD;Hwang, Shih-Jen&#xD;Tardif, Jean-Claude&#xD;VanDenburgh, Martin&#xD;Uitterlinden, Andre G&#xD;Hofman, Albert&#xD;Stricker, Bruno H C&#xD;de Bakker, Paul I W&#xD;Franks, Paul W&#xD;Jansson, Jan-Hakan&#xD;Asselbergs, Folkert W&#xD;Halushka, Marc K&#xD;Maleszewski, Joseph J&#xD;Tfelt-Hansen, Jacob&#xD;Engstrom, Thomas&#xD;Salomaa, Veikko&#xD;Virmani, Renu&#xD;Kolodgie, Frank&#xD;Wilde, Arthur A M&#xD;Tan, Hanno L&#xD;Bezzina, Connie R&#xD;Eijgelsheim, Mark&#xD;Rioux, John D&#xD;Jouven, Xavier&#xD;Kaab, Stefan&#xD;Psaty, Bruce M&#xD;Siscovick, David S&#xD;Arking, Dan E&#xD;Sotoodehnia, Nona&#xD;eng&#xD;HHSN268201100012C/HL/NHLBI NIH HHS/&#xD;HHSN268201100010C/HL/NHLBI NIH HHS/&#xD;R01 HL105756/HL/NHLBI NIH HHS/&#xD;R01 HL046959/HL/NHLBI NIH HHS/&#xD;HHSN268201100005I/HL/NHLBI NIH HHS/&#xD;R01 HL034594/HL/NHLBI NIH HHS/&#xD;R01 HL068070/HL/NHLBI NIH HHS/&#xD;R01 HL026490/HL/NHLBI NIH HHS/&#xD;R01 HL088576/HL/NHLBI NIH HHS/&#xD;R01 CA040360/CA/NCI NIH HHS/&#xD;N01HC85081/HL/NHLBI NIH HHS/&#xD;R01 HL103612/HL/NHLBI NIH HHS/&#xD;HHSN268201100009I/HL/NHLBI NIH HHS/&#xD;T32 GM007814/GM/NIGMS NIH HHS/&#xD;R01 HL120393/HL/NHLBI NIH HHS/&#xD;UL1 RR025005/RR/NCRR NIH HHS/&#xD;P01 CA087969/CA/NCI NIH HHS/&#xD;HHSN268201100008C/HL/NHLBI NIH HHS/&#xD;U01 HL080295/HL/NHLBI NIH HHS/&#xD;HHSN268201100005G/HL/NHLBI NIH HHS/&#xD;HHSN268201100008I/HL/NHLBI NIH HHS/&#xD;R01 HL059367/HL/NHLBI NIH HHS/&#xD;U01 HL130114/HL/NHLBI NIH HHS/&#xD;HHSN268201100007C/HL/NHLBI NIH HHS/&#xD;P01 CA055075/CA/NCI NIH HHS/&#xD;HHSN268200800007C/HL/NHLBI NIH HHS/&#xD;R01 HL085251/HL/NHLBI NIH HHS/&#xD;R01 HL034595/HL/NHLBI NIH HHS/&#xD;HHSN268201100011I/HL/NHLBI NIH HHS/&#xD;HHSN268201100011C/HL/NHLBI NIH HHS/&#xD;R01 HL086694/HL/NHLBI NIH HHS/&#xD;R01 HL091244/HL/NHLBI NIH HHS/&#xD;R01 HL087652/HL/NHLBI NIH HHS/&#xD;U01 HG004402/HG/NHGRI NIH HHS/&#xD;N01HC55222/HL/NHLBI NIH HHS/&#xD;N01HC85086/HL/NHLBI NIH HHS/&#xD;R01 HL088456/HL/NHLBI NIH HHS/&#xD;P30 DK063491/DK/NIDDK NIH HHS/&#xD;HHSN268201100006C/HL/NHLBI NIH HHS/&#xD;HHSN268201200036C/HL/NHLBI NIH HHS/&#xD;HHSN268201800001C/HL/NHLBI NIH HHS/&#xD;R01 HL080467/HL/NHLBI NIH HHS/&#xD;N01HC85082/HL/NHLBI NIH HHS/&#xD;HHSN268201100009C/HL/NHLBI NIH HHS/&#xD;N01HC85083/HL/NHLBI NIH HHS/&#xD;HHSN268201100005C/HL/NHLBI NIH HHS/&#xD;N01HC25195/HL/NHLBI NIH HHS/&#xD;R01 HL035464/HL/NHLBI NIH HHS/&#xD;HHSN268201100007I/HL/NHLBI NIH HHS/&#xD;N01HC85079/HL/NHLBI NIH HHS/&#xD;R01 AG023629/AG/NIA NIH HHS/&#xD;R01 HL087641/HL/NHLBI NIH HHS/&#xD;UL1 TR001881/TR/NCATS NIH HHS/&#xD;N01HC85080/HL/NHLBI NIH HHS/&#xD;R01 CA097193/CA/NCI NIH HHS/&#xD;R01 HL054776/HL/NHLBI NIH HHS/&#xD;R56 AG023629/AG/NIA NIH HHS/&#xD;R01 CA034944/CA/NCI NIH HHS/&#xD;R01 HL091069/HL/NHLBI NIH HHS/&#xD;R01 HL111089/HL/NHLBI NIH HHS/&#xD;R01 HL116747/HL/NHLBI NIH HHS/&#xD;R01 HL111267/HL/NHLBI NIH HHS/&#xD;R01 HL092111/HL/NHLBI NIH HHS/&#xD;Meta-Analysis&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Eur Heart J. 2018 Nov 21;39(44):3961-3969. doi: 10.1093/eurheartj/ehy474.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30169657</style></url></related-urls><pdf-urls><url>internal-pdf://3085925036/Ashar-2018-A comprehensive evaluation of the g.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6247663</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/eurheartj/ehy474</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>119</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">119</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Astley, C. M.</style></author><author><style face="normal" font="default" size="100%">Todd, J. N.</style></author><author><style face="normal" font="default" size="100%">Salem, R. M.</style></author><author><style face="normal" font="default" size="100%">Vedantam, S.</style></author><author><style face="normal" font="default" size="100%">Ebbeling, C. B.</style></author><author><style face="normal" font="default" size="100%">Huang, P. L.</style></author><author><style face="normal" font="default" size="100%">Ludwig, D. S.</style></author><author><style face="normal" font="default" size="100%">Hirschhorn, J. N.</style></author><author><style face="normal" font="default" size="100%">Florez, J. C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Medicine, Division of Endocrinology, Boston Children&apos;s Hospital, Boston, MA.&#xD;Departments of Medicine and Pediatrics, Harvard Medical School, Boston, MA.&#xD;Programs in Metabolism and Medical &amp; Population Genetics, Broad Institute, Cambridge, MA.&#xD;Diabetes Unit and Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA.&#xD;Department of Family Medicine and Public Health, University of California, San Diego, CA.&#xD;Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA.&#xD;Department of Medicine, Division of Endocrinology, Boston Children&apos;s Hospital, Boston, MA; joelh@broadinstitute.org david.ludwig@childrens.harvard.edu jcflorez@mgh.harvard.edu.&#xD;Departments of Medicine and Pediatrics, Harvard Medical School, Boston, MA; joelh@broadinstitute.org david.ludwig@childrens.harvard.edu jcflorez@mgh.harvard.edu.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetic Evidence That Carbohydrate-Stimulated Insulin Secretion Leads to Obesity</style></title><secondary-title><style face="normal" font="default" size="100%">Clin Chem</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Clin Chem</style></full-title></periodical><pages><style face="normal" font="default" size="100%">192-200</style></pages><volume><style face="normal" font="default" size="100%">64</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2018/01/04</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Dietary Carbohydrates/*administration &amp; dosage</style></keyword><keyword><style face="normal" font="default" size="100%">Fasting</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Glucose/administration &amp; dosage</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin Resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin Secretion/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Models, Biological</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*genetics/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Reproducibility of Results</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1530-8561 (Electronic)&#xD;0009-9147 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29295838</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: A fundamental precept of the carbohydrate-insulin model of obesity is that insulin secretion drives weight gain. However, fasting hyperinsulinemia can also be driven by obesity-induced insulin resistance. We used genetic variation to isolate and estimate the potentially causal effect of insulin secretion on body weight. METHODS: Genetic instruments of variation of insulin secretion [assessed as insulin concentration 30 min after oral glucose (insulin-30)] were used to estimate the causal relationship between increased insulin secretion and body mass index (BMI), using bidirectional Mendelian randomization analysis of genome-wide association studies. Data sources included summary results from the largest published metaanalyses of predominantly European ancestry for insulin secretion (n = 26037) and BMI (n = 322154), as well as individual-level data from the UK Biobank (n = 138541). Data from the Cardiology and Metabolic Patient Cohort study at Massachusetts General Hospital (n = 1675) were used to validate genetic associations with insulin secretion and to test the observational association of insulin secretion and BMI. RESULTS: Higher genetically determined insulin-30 was strongly associated with higher BMI (beta = 0.098, P = 2.2 x 10(-21)), consistent with a causal role in obesity. Similar positive associations were noted in sensitivity analyses using other genetic variants as instrumental variables. By contrast, higher genetically determined BMI was not associated with insulin-30. CONCLUSIONS: Mendelian randomization analyses provide evidence for a causal relationship of glucose-stimulated insulin secretion on body weight, consistent with the carbohydrate-insulin model of obesity.</style></abstract><notes><style face="normal" font="default" size="100%">Astley, Christina M&#xD;Todd, Jennifer N&#xD;Salem, Rany M&#xD;Vedantam, Sailaja&#xD;Ebbeling, Cara B&#xD;Huang, Paul L&#xD;Ludwig, David S&#xD;Hirschhorn, Joel N&#xD;Florez, Jose C&#xD;eng&#xD;K24 DK110550/DK/NIDDK NIH HHS/&#xD;MC_QA137853/Medical Research Council/United Kingdom&#xD;R01 DK075787/DK/NIDDK NIH HHS/&#xD;K12 DK094721/DK/NIDDK NIH HHS/&#xD;K24 DK082730/DK/NIDDK NIH HHS/&#xD;R00 HL122515/HL/NHLBI NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Clin Chem. 2018 Jan;64(1):192-200. doi: 10.1373/clinchem.2017.280727.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29295838</style></url></related-urls><pdf-urls><url>internal-pdf://3025900174/Astley-2018-Genetic Evidence That Carbohydrate.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5937525</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1373/clinchem.2017.280727</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>10</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">10</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Au Yeung, S. L.</style></author><author><style face="normal" font="default" size="100%">Lin, S. L.</style></author><author><style face="normal" font="default" size="100%">Li, A. M.</style></author><author><style face="normal" font="default" size="100%">Schooling, C. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.&#xD;Department of Pediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.&#xD;City University of New York, Graduate School of Public Health and Health Policy, New York, NY, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Birth weight and risk of ischemic heart disease: A Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Sci Rep</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Sci Rep</style></full-title></periodical><pages><style face="normal" font="default" size="100%">38420</style></pages><volume><style face="normal" font="default" size="100%">6</style></volume><edition><style face="normal" font="default" size="100%">2016/12/08</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Cholesterol, HDL/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol, LDL/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Infant, Low Birth Weight</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Lipids</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Myocardial Ischemia/*genetics/metabolism/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Triglycerides/genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec 7</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2045-2322 (Electronic)&#xD;2045-2322 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27924921</style></accession-num><abstract><style face="normal" font="default" size="100%">Low birth weight is a risk factor for cardiovascular disease. However, the association could be confounded by many factors. We used Mendelian randomization to clarify the role of birth weight in ischemic heart disease (IHD) and lipids. We used all 7 single nucleotide polymorphisms (SNPs) independently contributing to birth weight at genome wide significance (p &lt; 5 x 10(-8)) in separate sample instrumental variable analysis to estimate the effect of birth weight on IHD using the CARDIoGRAMplusC4D 1000 Genomes based GWAS case (n = 60,801)-control (n = 123,504) study and on lipids using GLGC (n = 188,577). Higher genetically predicted birth weight was associated with lower risk of IHD (odds ratio (OR) 0.96 per 100 grams, 95% confidence interval (CI) 0.93 to 0.99), but the association was not robust to sensitivity analyses excluding SNPs related to height or use of weighted median methods. Genetically predicted birth weight was not associated with low density lipoprotein cholesterol or triglycerides, but was associated with lower high density lipoprotein cholesterol (-0.014 standard deviation, 95% CI -0.027 to -0.0005) and the association was more robust to the sensitivity analyses. Our study does not show strong evidence for an effect of birth weight on IHD and lipids.</style></abstract><notes><style face="normal" font="default" size="100%">Au Yeung, Shiu Lun&#xD;Lin, Shi Lin&#xD;Li, Albert Martin&#xD;Schooling, C Mary&#xD;eng&#xD;Meta-Analysis&#xD;England&#xD;Sci Rep. 2016 Dec 7;6:38420. doi: 10.1038/srep38420.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27924921</style></url></related-urls><pdf-urls><url>internal-pdf://2740368149/Au Yeung-2016-Birth weight and risk of ischemi.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5141503</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/srep38420</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>142</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">142</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Auvinen, Juha</style></author><author><style face="normal" font="default" size="100%">Tapio, Joona</style></author><author><style face="normal" font="default" size="100%">Karhunen, Ville</style></author><author><style face="normal" font="default" size="100%">Kettunen, Johannes</style></author><author><style face="normal" font="default" size="100%">Serpi, Raisa</style></author><author><style face="normal" font="default" size="100%">Dimova, Elitsa Y.</style></author><author><style face="normal" font="default" size="100%">Soininen, Pasi</style></author><author><style face="normal" font="default" size="100%">Tammelin, Tuija</style></author><author><style face="normal" font="default" size="100%">Mykkänen, Juha</style></author><author><style face="normal" font="default" size="100%">Puukka, Katri</style></author><author><style face="normal" font="default" size="100%">Kähönen, Mika</style></author><author><style face="normal" font="default" size="100%">Raitoharju, Emma</style></author><author><style face="normal" font="default" size="100%">Lehtimäki, Terho</style></author><author><style face="normal" font="default" size="100%">Ala-Korpela, Mika</style></author><author><style face="normal" font="default" size="100%">Raitakari, Olli T.</style></author><author><style face="normal" font="default" size="100%">Keinänen-Kiukaanniemi, Sirkka</style></author><author><style face="normal" font="default" size="100%">Järvelin, Marjo-Riitta</style></author><author><style face="normal" font="default" size="100%">Koivunen, Peppi</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><urls><pdf-urls><url>internal-pdf://1514954141/Auvinen-2018-Lower hemoglobin levels associate.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/472142</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>127</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">127</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bae, S. C.</style></author><author><style face="normal" font="default" size="100%">Lee, Y. H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.&#xD;Department of Rheumatology, Korea University College of Medicine, Seoul, Korea.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal association between body mass index and risk of rheumatoid arthritis: A Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Eur J Clin Invest</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur J Clin Invest</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e13076</style></pages><volume><style face="normal" font="default" size="100%">49</style></volume><number><style face="normal" font="default" size="100%">4</style></number><edition><style face="normal" font="default" size="100%">2019/02/03</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Arthritis, Rheumatoid/*etiology/genetics/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/complications/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Bmi</style></keyword><keyword><style face="normal" font="default" size="100%">mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">rheumatoid arthritis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1365-2362 (Electronic)&#xD;0014-2972 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30710354</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVE: This study aimed to examine whether body mass index (BMI) is causally associated with rheumatoid arthritis (RA). METHOD: A two-sample Mendelian randomization (MR) analysis using the inverse-variance weighted (IVW), weighted median and MR-Egger regression methods was performed. We used the publicly available summary statistics data sets of genome-wide association studies (GWAS) meta-analyses for BMI in individuals of European descent (n = 322 154; GIANT consortium) as the exposure and a GWAS for noncancer illness code self-reported: RA from the individuals included in the UK Biobank (total n = 337 159; case = 7480, control = 329 679) as the outcome. RESULTS: We selected 68 single nucleotide polymorphisms at genome-wide significance from GWASs on BMI as the instrumental variables. The IVW method showed evidence to support a causal association between BMI and RA (beta = 0.003, SE = 0.001, P = 0.033). MR-Egger regression revealed that directional pleiotropy was unlikely to be biasing the result (intercept = -3.54E-05; P = 0.736), but it showed no causal association between BMI and RA (beta = 0.004, SE = 0.004, P = 0.302). However, the weighted median approach yielded evidence of a causal association between BMI and RA (beta = 0.006, SE = 0.002, P = 0.004). Cochran&apos;s Q test and the funnel plot indicated no evidence of heterogeneity and asymmetry, indicating no directional pleiotropy. CONCLUSION: The results of MR analysis support that BMI may be causally associated with an increased risk of RA.</style></abstract><notes><style face="normal" font="default" size="100%">Bae, Sang-Cheol&#xD;Lee, Young Ho&#xD;eng&#xD;NRF-2017M3A9B4050335/National Research Foundation Singapore&#xD;Observational Study&#xD;England&#xD;Eur J Clin Invest. 2019 Apr;49(4):e13076. doi: 10.1111/eci.13076. Epub 2019 Feb 18.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30710354</style></url></related-urls><pdf-urls><url>internal-pdf://2580298854/Bae-2019-Causal association between body mass.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/eci.13076</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>116</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">116</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bao, Y.</style></author><author><style face="normal" font="default" size="100%">Clarke, P. S.</style></author><author><style face="normal" font="default" size="100%">Smart, M.</style></author><author><style face="normal" font="default" size="100%">Kumari, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute for Social and Economic Research, University of Essex, Colchester, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Assessing the robustness of sisVIVE in a Mendelian randomization study to estimate the causal effect of body mass index on income using multiple SNPs from understanding society</style></title><secondary-title><style face="normal" font="default" size="100%">Stat Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Stat Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1529-1542</style></pages><volume><style face="normal" font="default" size="100%">38</style></volume><number><style face="normal" font="default" size="100%">9</style></number><edition><style face="normal" font="default" size="100%">2018/12/20</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">*Causality</style></keyword><keyword><style face="normal" font="default" size="100%">Computer Simulation</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Income</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Models, Genetic</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">*Regression Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*MR-Egger</style></keyword><keyword><style face="normal" font="default" size="100%">*MR-Median</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*instrumental variables</style></keyword><keyword><style face="normal" font="default" size="100%">*pleiotropic bias</style></keyword><keyword><style face="normal" font="default" size="100%">*sisVIVE</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr 30</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1097-0258 (Electronic)&#xD;0277-6715 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30565280</style></accession-num><abstract><style face="normal" font="default" size="100%">The &quot;some invalid, some valid instrumental variable estimator&quot; (sisVIVE) is a lasso-based method for instrumental variables (IVs) regression of outcome on an exposure. In principle, sisVIVE is robust to some of the IVs in the analysis being invalid, in the sense of being related to the outcome variable through pathways not mediated by the exposure. In this paper, we consider the application of sisVIVE to a Mendelian randomization study in which multiple genetic variants are used as IVs to estimate the causal effect of body mass index on personal income in the presence of unobserved confounding. In addition to analyzing data from the large-scale longitudinal household survey Understanding Society, we conduct a simulation study to (a) assess the performance of sisVIVE in relation to that of competing robust methods like &quot;MR-Egger&quot; and &quot;MR-Median&quot; and (b) identify scenarios under which its absolute performance is poor. We find that sisVIVE outperforms alternative robust methods, in terms of mean-square error, across a wide range of scenarios, but that its performance is poor in absolute terms when the presence of indirect pleiotropy leads to failure of the &quot;InSIDE&quot; condition, which is not explicitly required for identification. We argue that this is because the consistency criterion for sisVIVE does not identify the true causal effect when InSIDE fails.</style></abstract><notes><style face="normal" font="default" size="100%">Bao, Yanchun&#xD;Clarke, Paul S&#xD;Smart, Melissa&#xD;Kumari, Meena&#xD;eng&#xD;G1001799/MRC_/Medical Research Council/United Kingdom&#xD;MR/N01104X/1/MRC_/Medical Research Council/United Kingdom&#xD;MR/N01104X/2/MRC_/Medical Research Council/United Kingdom&#xD;Comparative Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Stat Med. 2019 Apr 30;38(9):1529-1542. doi: 10.1002/sim.8066. Epub 2018 Dec 18.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30565280</style></url></related-urls><pdf-urls><url>internal-pdf://0544104003/Bao-2018-Assessing the robustness of sisVIVE i.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6492086</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/sim.8066</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>154</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">154</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Barning, F.</style></author><author><style face="normal" font="default" size="100%">Abarin, T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Mathematics and Statistics, Memorial University of Newfoundland, Canada.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Assessing the Causality Factors in the Association between (Abdominal) Obesity and Physical Activity among the Newfoundland Population-A Mendelian Randomization Analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Genet Epigenet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Genet Epigenet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">15-24</style></pages><volume><style face="normal" font="default" size="100%">8</style></volume><edition><style face="normal" font="default" size="100%">2016/08/02</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Fto</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">central obesity</style></keyword><keyword><style face="normal" font="default" size="100%">confounding</style></keyword><keyword><style face="normal" font="default" size="100%">instrumental variable</style></keyword><keyword><style face="normal" font="default" size="100%">physical activity</style></keyword><keyword><style face="normal" font="default" size="100%">trunk fat percentage</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year></dates><isbn><style face="normal" font="default" size="100%">1179-237X (Print)&#xD;1179-237X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27478388</style></accession-num><abstract><style face="normal" font="default" size="100%">A total of 1,263 adults from Newfoundland and Labrador were studied in the research. Body mass index (BMI) and percent trunk fat (PTF) were analyzed as biomarkers for obesity. The Mendelian randomization (MR) approach with two single-nucleotide polymorphisms in the fat-mass and obesity (FTO) gene as instruments was employed to assess the causal effect. In both genders, increasing physical activity significantly reduced BMI and PTF when adjusted for age and the FTO gene. The effect of physical activity was stronger on PTF than BMI. Direct observational analyses showed significant increase in BMI/PTF when physical activity decreased. A similar association in MR analyses was not significant. The association between physical activity and BMI/PTF could be due to reversed causality or common confounding factors. Our study provides insights into the causal contributions of obesity to physical activity in adults. Health intervention strategies to increase physical activity among adults should include some other plans such as improving diet for reducing obesity.</style></abstract><notes><style face="normal" font="default" size="100%">Barning, Frank&#xD;Abarin, Taraneh&#xD;eng&#xD;Genet Epigenet. 2016 Jul 24;8:15-24. doi: 10.4137/GEG.S38289. eCollection 2016.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27478388</style></url></related-urls><pdf-urls><url>internal-pdf://2104150895/Barning-2016-Assessing the Causality Factors i.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4959453</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.4137/GEG.S38289</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>171</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">171</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Benn, M.</style></author><author><style face="normal" font="default" size="100%">Tybjaerg-Hansen, A.</style></author><author><style face="normal" font="default" size="100%">Smith, G. D.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Clinical Biochemistry, Gentofte Hospital, Copenhagen University Hospital, Kildegardsvej 28, 2900, Gentofte, Denmark. Marianne.benn@regionh.dk.&#xD;The Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. Marianne.benn@regionh.dk.&#xD;The Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen University Hospital, Frederiksberg, Denmark. Marianne.benn@regionh.dk.&#xD;Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Marianne.benn@regionh.dk.&#xD;The Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.&#xD;Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.&#xD;The Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen University Hospital, Frederiksberg, Denmark.&#xD;Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.&#xD;MRC Integrative Epidemiology Unit (IEU) at the University of Bristol, Bristol, UK.&#xD;School of Social and Community Medicine, University of Bristol, Bristol, UK.&#xD;Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.</style></auth-address><titles><title><style face="normal" font="default" size="100%">High body mass index and cancer risk-a Mendelian randomisation study</style></title><secondary-title><style face="normal" font="default" size="100%">Eur J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">879-92</style></pages><volume><style face="normal" font="default" size="100%">31</style></volume><number><style face="normal" font="default" size="100%">9</style></number><edition><style face="normal" font="default" size="100%">2016/04/12</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Alleles</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasms/*etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*Cancer</style></keyword><keyword><style face="normal" font="default" size="100%">*Epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomisation</style></keyword><keyword><style face="normal" font="default" size="100%">*Obesity</style></keyword><keyword><style face="normal" font="default" size="100%">*Overweight</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1573-7284 (Electronic)&#xD;0393-2990 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27061578</style></accession-num><abstract><style face="normal" font="default" size="100%">High body mass index (BMI) has been associated with increased risk of some cancer. Whether these reflect causal associations is unknown. We examined this issue. Using a Mendelian randomisation approach, we studied 108,812 individuals from the general population. During a median of 4.7 years of follow-up (range 0-37), 8002 developed non-skin cancer, 3347 non-melanoma skin cancer, 1396 lung cancer, 637 other smoking related cancers, 1203 colon cancer, 159 kidney cancer, 1402 breast cancer, 1062 prostate cancer, and 2804 other cancers. Participants were genotyped for five genetic variants associated with BMI. Two Danish general population studies, the Copenhagen General Population and the Copenhagen City Heart Study. In observational analyses, overall risk of non-melanoma skin cancer was 35 % (95 % confidence interval 28-42 %) lower and risk of lung cancer 32 % (19-43 %) lower in individuals with a BMI &gt;/= 30 versus 18.5-24.9 kg/m(2). Corresponding risk of breast cancer was 20 % (0-44 %) higher in postmenopausal women. BMI was not associated with risk of colon, kidney, other smoking related cancers, prostate cancer, or other cancers. In genetic analyses, carrying 7-10 versus 0-4 BMI increasing alleles was associated with a 3 % higher BMI (P &lt; 0.001), but not with risk of cancer. In instrumental variable analysis for a 10 kg/m(2) higher genetically determined BMI the odds ratio for any non-skin cancer was 1.16 (0.64-2.09), with a corresponding observational estimate of 0.94 (0.88-1.01). Using 108,812 individuals from the general population, we found that observationally high BMI was associated with lower risk of lung and skin cancer overall and with higher risk of breast cancer in postmenopausal women, but not with other types of cancer. BMI increasing alleles were not associated with risk of cancer, and results do not support causal associations. Power to test associations for some cancer sites was low.</style></abstract><notes><style face="normal" font="default" size="100%">Benn, Marianne&#xD;Tybjaerg-Hansen, Anne&#xD;Smith, George Davey&#xD;Nordestgaard, Borge Gronne&#xD;eng&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Netherlands&#xD;Eur J Epidemiol. 2016 Sep;31(9):879-92. doi: 10.1007/s10654-016-0147-5. Epub 2016 Apr 9.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27061578</style></url></related-urls><pdf-urls><url>internal-pdf://1436403342/Benn-2016-High body mass index and cancer risk.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s10654-016-0147-5</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>108</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">108</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bockerman, P.</style></author><author><style face="normal" font="default" size="100%">Cawley, J.</style></author><author><style face="normal" font="default" size="100%">Viinikainen, J.</style></author><author><style face="normal" font="default" size="100%">Lehtimaki, T.</style></author><author><style face="normal" font="default" size="100%">Rovio, S.</style></author><author><style face="normal" font="default" size="100%">Seppala, I.</style></author><author><style face="normal" font="default" size="100%">Pehkonen, J.</style></author><author><style face="normal" font="default" size="100%">Raitakari, O.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Labour Institute for Economic Research and IZA, Jyvaskyla University School of Business and Economics, University of Jyvaskyla, Jyvaskyla, Finland.&#xD;Department of Policy Analysis and Management, and Department of Economics, Cornell University, Ithaca, New York.&#xD;Jyvaskyla University School of Business and Economics, University of Jyvaskyla, Jyvaskyla, Finland.&#xD;Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.&#xD;Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.&#xD;Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The effect of weight on labor market outcomes: An application of genetic instrumental variables</style></title><secondary-title><style face="normal" font="default" size="100%">Health Econ</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Health Econ</style></full-title></periodical><pages><style face="normal" font="default" size="100%">65-77</style></pages><volume><style face="normal" font="default" size="100%">28</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2018/09/22</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Body Weight/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Employment/*statistics &amp; numerical data/trends</style></keyword><keyword><style face="normal" font="default" size="100%">Finland</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Income</style></keyword><keyword><style face="normal" font="default" size="100%">*Models, Economic</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Salaries and Fringe Benefits/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">*earnings</style></keyword><keyword><style face="normal" font="default" size="100%">*employment</style></keyword><keyword><style face="normal" font="default" size="100%">*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*obesity</style></keyword><keyword><style face="normal" font="default" size="100%">*overweight</style></keyword><keyword><style face="normal" font="default" size="100%">*social income transfers</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1099-1050 (Electronic)&#xD;1057-9230 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30240095</style></accession-num><abstract><style face="normal" font="default" size="100%">This paper contributes to the literature on the labor market consequences of obesity by using a novel instrument: genetic risk score, which reflects the predisposition to higher body mass index (BMI) across many genetic loci. We estimate instrumental variable models of the effect of BMI on labor market outcomes using Finnish data that have many strengths, for example, BMI that is measured rather than self-reported, and data on earnings and social income transfers that are from administrative tax records and are thus free of the problems associated with nonresponse, reporting error or top coding. The empirical results are sensitive to whether we use a narrower or broader genetic risk score, and to model specification. For example, models using the narrower genetic risk score as an instrument imply that a one-unit increase in BMI is associated with 6.9% lower wages, 1.8% fewer years employed, and a 3 percentage point higher probability of receiving any social income transfers. However, when we use a newer, broader genetic risk score, we cannot reject the null hypothesis of no effect. Future research using genetic risk scores should examine the sensitivity of their results to the risk score used.</style></abstract><notes><style face="normal" font="default" size="100%">Bockerman, Petri&#xD;Cawley, John&#xD;Viinikainen, Jutta&#xD;Lehtimaki, Terho&#xD;Rovio, Suvi&#xD;Seppala, Ilkka&#xD;Pehkonen, Jaakko&#xD;Raitakari, Olli&#xD;eng&#xD;Competitive State Research Financing of the Expert Responsibility area of Kuopio/International&#xD;Diabetes Research Foundation of Finnish Diabetes Association/International&#xD;Emil Aaltonen Foundation/International&#xD;Finnish Foundation for Cardiovascular Research/International&#xD;Juho Vainio Foundation/International&#xD;OP Group Research Foundation/International&#xD;Paavo Nurmi Foundation/International&#xD;Palkansaaja Foundation/International&#xD;Robert Wood Johnson Foundation/International&#xD;Signe and Ane Gyllenberg Foundation/International&#xD;Social Insurance Institution of Finland/International&#xD;293120/Strategic Research Council funding for the project Work, Inequality and Public Policy/International&#xD;X51001/Tampere and Turku University Hospitals/International&#xD;755320/EU Horizon 2020/International&#xD;6664/Yrjo Jahnsson Foundation/International&#xD;6646/Yrjo Jahnsson Foundation/International&#xD;Tampere Tuberculosis Foundation/International&#xD;Finnish Cultural Foundation/International&#xD;X51001/Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals/International&#xD;117787/Academy of Finland/International&#xD;121584/Academy of Finland/International&#xD;124282/Academy of Finland/International&#xD;126925/Academy of Finland/International&#xD;129378/Academy of Finland/International&#xD;134309/Academy of Finland/International&#xD;286284/Academy of Finland/International&#xD;41071/Academy of Finland/International&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Health Econ. 2019 Jan;28(1):65-77. doi: 10.1002/hec.3828. Epub 2018 Sep 21.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30240095</style></url></related-urls><pdf-urls><url>internal-pdf://3885506617/Bockerman-2019-The effect of weight on labor m.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6585973</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/hec.3828</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>93</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">93</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bonnefond, A.</style></author><author><style face="normal" font="default" size="100%">Yengo, L.</style></author><author><style face="normal" font="default" size="100%">Dechaume, A.</style></author><author><style face="normal" font="default" size="100%">Canouil, M.</style></author><author><style face="normal" font="default" size="100%">Castelain, M.</style></author><author><style face="normal" font="default" size="100%">Roger, E.</style></author><author><style face="normal" font="default" size="100%">Allegaert, F.</style></author><author><style face="normal" font="default" size="100%">Caiazzo, R.</style></author><author><style face="normal" font="default" size="100%">Raverdy, V.</style></author><author><style face="normal" font="default" size="100%">Pigeyre, M.</style></author><author><style face="normal" font="default" size="100%">Arredouani, A.</style></author><author><style face="normal" font="default" size="100%">Borys, J. M.</style></author><author><style face="normal" font="default" size="100%">Levy-Marchal, C.</style></author><author><style face="normal" font="default" size="100%">Weill, J.</style></author><author><style face="normal" font="default" size="100%">Roussel, R.</style></author><author><style face="normal" font="default" size="100%">Balkau, B.</style></author><author><style face="normal" font="default" size="100%">Marre, M.</style></author><author><style face="normal" font="default" size="100%">Pattou, F.</style></author><author><style face="normal" font="default" size="100%">Brousseau, T.</style></author><author><style face="normal" font="default" size="100%">Froguel, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">University of Lille, CNRS, Institut Pasteur de Lille, UMR 8199 - EGID, Lille, 59000, France. amelie.bonnefond@inserm.fr.&#xD;University of Lille, CNRS, Institut Pasteur de Lille, UMR 8199 - EGID, Lille, 59000, France.&#xD;Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4067, Australia.&#xD;University of Lille, Inserm, U1190 - EGID, Lille, 59000, France.&#xD;Endocrine Surgery Department, CHU of Lille, Lille, 59000, France.&#xD;Qatar Biomedical Research Institute, Qatar Foundation, Doha, 5825, Qatar.&#xD;Fleurbaix-Laventie Association, Laventie, 62840, France.&#xD;Inserm CIE 05 - Department of Clinical Epidemiology, Robert Debre Hospital, Paris, 75019, France.&#xD;Pediatric Endocrine Department, CHU of Lille, Lille, 59000, France.&#xD;Inserm, U1138, Centre de Recherche des Cordeliers, Paris, 75006, France.&#xD;Paris-Diderot University, Sorbonne Paris-Cite, Paris, 75013, France.&#xD;Department of Endocrinology-Diabetology and Nutrition, DHU-FIRE, Bichat Hospital, Assistance Publique-Hopitaux de Paris, Paris, 75018, France.&#xD;Inserm, U1018, CESP, Team 5 (EpReC, Renal and cardiovascular Epidemiology), UVSQ-UPS, Villejuif, 94807, France.&#xD;UF8832 - Biochimie Automatisee, Pole de Biologie Pathologie Genetique, CHU of Lille, Lille, 59000, France.&#xD;University of Lille, CNRS, Institut Pasteur de Lille, UMR 8199 - EGID, Lille, 59000, France. froguel@good.ibl.fr.&#xD;Department of Genomics of Common Disease, School of Public Health, Imperial College London, Hammersmith Hospital, London, W12 0NN, UK. froguel@good.ibl.fr.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Relationship between salivary/pancreatic amylase and body mass index: a systems biology approach</style></title><secondary-title><style face="normal" font="default" size="100%">BMC Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMC Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">37</style></pages><volume><style face="normal" font="default" size="100%">15</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2017/02/24</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*enzymology</style></keyword><keyword><style face="normal" font="default" size="100%">Pancreatic alpha-Amylases/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Salivary alpha-Amylases/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Systems Biology</style></keyword><keyword><style face="normal" font="default" size="100%">*amy1a/amy2a</style></keyword><keyword><style face="normal" font="default" size="100%">*Copy number variant</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*Metabonomics</style></keyword><keyword><style face="normal" font="default" size="100%">*Obesity</style></keyword><keyword><style face="normal" font="default" size="100%">*Salivary/Pancreatic amylase</style></keyword><keyword><style face="normal" font="default" size="100%">*Starch</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 23</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1741-7015 (Electronic)&#xD;1741-7015 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28228143</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Salivary (AMY1) and pancreatic (AMY2) amylases hydrolyze starch. Copy number of AMY1A (encoding AMY1) was reported to be higher in populations with a high-starch diet and reduced in obese people. These results based on quantitative PCR have been challenged recently. We aimed to re-assess the relationship between amylase and adiposity using a systems biology approach. METHODS: We assessed the association between plasma enzymatic activity of AMY1 or AMY2, and several metabolic traits in almost 4000 French individuals from D.E.S.I.R. longitudinal study. The effect of the number of copies of AMY1A (encoding AMY1) or AMY2A (encoding AMY2) measured through droplet digital PCR was then analyzed on the same parameters in the same study. A Mendelian randomization analysis was also performed. We subsequently assessed the association between AMY1A copy number and obesity risk in two case-control studies (5000 samples in total). Finally, we assessed the association between body mass index (BMI)-related plasma metabolites and AMY1 or AMY2 activity. RESULTS: We evidenced strong associations between AMY1 or AMY2 activity and lower BMI. However, we found a modest contribution of AMY1A copy number to lower BMI. Mendelian randomization identified a causal negative effect of BMI on AMY1 and AMY2 activities. Yet, we also found a significant negative contribution of AMY1 activity at baseline to the change in BMI during the 9-year follow-up, and a significant contribution of AMY1A copy number to lower obesity risk in children, suggesting a bidirectional relationship between AMY1 activity and adiposity. Metabonomics identified a BMI-independent association between AMY1 activity and lactate, a product of complex carbohydrate fermentation. CONCLUSIONS: These findings provide new insights into the involvement of amylase in adiposity and starch metabolism.</style></abstract><notes><style face="normal" font="default" size="100%">Bonnefond, Amelie&#xD;Yengo, Loic&#xD;Dechaume, Aurelie&#xD;Canouil, Mickael&#xD;Castelain, Maxime&#xD;Roger, Estelle&#xD;Allegaert, Frederic&#xD;Caiazzo, Robert&#xD;Raverdy, Violeta&#xD;Pigeyre, Marie&#xD;Arredouani, Abdelilah&#xD;Borys, Jean-Michel&#xD;Levy-Marchal, Claire&#xD;Weill, Jacques&#xD;Roussel, Ronan&#xD;Balkau, Beverley&#xD;Marre, Michel&#xD;Pattou, Francois&#xD;Brousseau, Thierry&#xD;Froguel, Philippe&#xD;eng&#xD;England&#xD;BMC Med. 2017 Feb 23;15(1):37. doi: 10.1186/s12916-017-0784-x.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28228143</style></url></related-urls><pdf-urls><url>internal-pdf://1165621500/Bonnefond-2017-Relationship between salivary_p.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5322607</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12916-017-0784-x</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>22</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">22</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Brennan, P.</style></author><author><style face="normal" font="default" size="100%">McKay, J.</style></author><author><style face="normal" font="default" size="100%">Moore, L.</style></author><author><style face="normal" font="default" size="100%">Zaridze, D.</style></author><author><style face="normal" font="default" size="100%">Mukeria, A.</style></author><author><style face="normal" font="default" size="100%">Szeszenia-Dabrowska, N.</style></author><author><style face="normal" font="default" size="100%">Lissowska, J.</style></author><author><style face="normal" font="default" size="100%">Rudnai, P.</style></author><author><style face="normal" font="default" size="100%">Fabianova, E.</style></author><author><style face="normal" font="default" size="100%">Mates, D.</style></author><author><style face="normal" font="default" size="100%">Bencko, V.</style></author><author><style face="normal" font="default" size="100%">Foretova, L.</style></author><author><style face="normal" font="default" size="100%">Janout, V.</style></author><author><style face="normal" font="default" size="100%">Chow, W. H.</style></author><author><style face="normal" font="default" size="100%">Rothman, N.</style></author><author><style face="normal" font="default" size="100%">Chabrier, A.</style></author><author><style face="normal" font="default" size="100%">Gaborieau, V.</style></author><author><style face="normal" font="default" size="100%">Timpson, N.</style></author><author><style face="normal" font="default" size="100%">Hung, R. J.</style></author><author><style face="normal" font="default" size="100%">Smith, G. D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">International Agency for Research on Cancer (IARC), Genetic Epidemiology Group, Lyon, France. brennan@iarc.fr</style></auth-address><titles><title><style face="normal" font="default" size="100%">Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">971-5</style></pages><volume><style face="normal" font="default" size="100%">38</style></volume><number><style face="normal" font="default" size="100%">4</style></number><edition><style face="normal" font="default" size="100%">2009/06/23</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Europe/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Markers</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Head and Neck Neoplasms/epidemiology/etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Kidney Neoplasms/epidemiology/etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Lung Neoplasms/epidemiology/etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasm Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasms/epidemiology/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications/epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1464-3685 (Electronic)&#xD;0300-5771 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">19542184</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Obesity is a risk factor for several cancers although appears to have an inverse association with cancers strongly related to tobacco. Studying obesity is difficult due to numerous biases and confounding. METHODS: To avoid these biases we used a Mendelian randomization approach incorporating an analysis of variants in the FTO gene that are strongly associated with BMI levels among 7000 subjects from a study of lung, kidney and upper-aerodigestive cancer. RESULTS: The FTO A allele which is linked with increased BMI was associated with a decreased risk of lung cancer (allelic odds ratio (OR) = 0.92, 95% confidence interval (CI) 0.84-1.00). It was also associated with a weak increased risk of kidney cancer, which was more apparent before the age of 50 (OR = 1.44, CI 1.09-1.90). CONCLUSION: Our results highlight the potential for genetic variation to act as an unconfounded marker of environmentally modifiable factors, and offer the potential to obtain estimates of the causal effect of obesity. However, far larger sample sizes than studied here will be required to undertake this with precision.</style></abstract><notes><style face="normal" font="default" size="100%">Brennan, Paul&#xD;McKay, James&#xD;Moore, Lee&#xD;Zaridze, David&#xD;Mukeria, Anush&#xD;Szeszenia-Dabrowska, Neonilia&#xD;Lissowska, Jolanta&#xD;Rudnai, Peter&#xD;Fabianova, Eleonora&#xD;Mates, Dana&#xD;Bencko, Vladimir&#xD;Foretova, Lenka&#xD;Janout, Vladimir&#xD;Chow, Wong-Ho&#xD;Rothman, Nathaniel&#xD;Chabrier, Amelie&#xD;Gaborieau, Valerie&#xD;Timpson, Nic&#xD;Hung, Rayjean J&#xD;Smith, George Davey&#xD;eng&#xD;G0600705/Medical Research Council/United Kingdom&#xD;CA 092039-01A2/CA/NCI NIH HHS/&#xD;Multicenter Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Int J Epidemiol. 2009 Aug;38(4):971-5. doi: 10.1093/ije/dyp162. Epub 2009 Jun 19.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/19542184</style></url></related-urls><pdf-urls><url>internal-pdf://0214433104/Brennan-2009-Obesity and cancer_ Mendelian ran.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC2734066</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/ije/dyp162</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>62</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">62</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Brower, M. A.</style></author><author><style face="normal" font="default" size="100%">Hai, Y.</style></author><author><style face="normal" font="default" size="100%">Jones, M. R.</style></author><author><style face="normal" font="default" size="100%">Guo, X.</style></author><author><style face="normal" font="default" size="100%">Chen, Y. I.</style></author><author><style face="normal" font="default" size="100%">Rotter, J. I.</style></author><author><style face="normal" font="default" size="100%">Krauss, R. M.</style></author><author><style face="normal" font="default" size="100%">Legro, R. S.</style></author><author><style face="normal" font="default" size="100%">Azziz, R.</style></author><author><style face="normal" font="default" size="100%">Goodarzi, M. O.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.&#xD;Department of Statistics, University of Auckland, Auckland, New Zealand.&#xD;Institute for Translational Genomics and Population Sciences and Department of Pediatrics, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.&#xD;Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.&#xD;Children&apos;s Hospital of Oakland Research Institute, Oakland, CA, USA.&#xD;Department of Obstetrics and Gynecology, Pennsylvania State College of Medicine, Hershey, PA, USA.&#xD;Departments of Obstetrics and Gynecology and Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome</style></title><secondary-title><style face="normal" font="default" size="100%">Hum Reprod</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Hum Reprod</style></full-title></periodical><pages><style face="normal" font="default" size="100%">127-136</style></pages><volume><style face="normal" font="default" size="100%">34</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2018/11/30</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Association Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Polycystic Ovary Syndrome/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1460-2350 (Electronic)&#xD;0268-1161 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30496407</style></accession-num><abstract><style face="normal" font="default" size="100%">STUDY QUESTION: What are the causal relationships between polycystic ovary syndrome (PCOS) and body mass index (BMI)? SUMMARY ANSWER: Bidirectional Mendelian randomization analyses suggest that increased BMI is causal for PCOS while the reverse is not the case. WHAT IS KNOWN ALREADY: The contribution of obesity to the pathogenesis of PCOS is controversial. To date, published genetic studies addressing this question have generated conflicting results and have not utilized the full extent of known single nucleotide polymorphisms associated with body mass index (BMI). STUDY DESIGN, SIZE, DURATION: This cross-sectional Mendelian randomization (MR) and genetic association study was conducted in 750 individuals of European origin and with PCOS and 1567 BMI-matched controls. PARTICIPANTS/MATERIALS, SETTING, METHODS: Cases and controls were matched for BMI as well as for distribution of weight categories (normal weight, overweight, obese). Two-sample MR using inverse variance weighting (IVW) was conducted using a 92-SNP instrument variable for BMI with PCOS as the outcome, followed by two-sample MR with a 16-SNP instrument variable for PCOS with BMI as the outcome. Sensitivity analyses included MR-Egger and maximum likelihood methods. Secondary analyses assessed associations of genetic risk scores and individual SNPs with PCOS, BMI and quantitative androgen-related and glucose homeostasis-related traits. MAIN RESULTS AND THE ROLE OF CHANCE: Each standard deviation genetically higher BMI was associated with a 4.89 (95% CI 1.46-16.32) higher odds of PCOS. Conversely, genetic risk of PCOS did not influence BMI. Sensitivity analyses yielded directionally consistent results. The genetic risk score of 92 BMI SNPs was associated with the diagnosis of PCOS (OR 1.043, 95% CI 1.009-1.078, P = 0.012). Of the 92 BMI risk variants evaluated, none were associated individually with PCOS after considering multiple testing. The association of FTO SNP rs1421085 with BMI was stronger in women with PCOS (beta = 0.071, P = 0.0006) than in controls (beta = 0.046, P = 0.065). LIMITATIONS, REASONS FOR CAUTION: The current sample size, while providing good power for MR and genetic risk score analyses, had limited power to demonstrate association of individual SNPs with PCOS. Cases and controls were not matched for age; however, this was mitigated by adjusting analyses for age. Dietary and lifestyle data, which could have been used to explore the greater association of the FTO SNP with BMI in women with PCOS, was not available. WIDER IMPLICATIONS OF THE FINDINGS: Increasing BMI appears to be causal for PCOS but having PCOS does not appear to affect BMI. This study used the most comprehensive set of SNPs for BMI currently available. Prior studies using fewer SNPs had yielded conflicting results and may have been confounded because cases and controls were not matched for weight categories. The current results highlight the potential utility of weight management in the prevention and treatment of PCOS. STUDY FUNDING/COMPETING INTEREST(S): National Institutes of Health Grants R01-HD29364 and K24-HD01346 (to R.A.), Grant R01-DK79888 (to M.O.G.), Grant U54-HD034449 (to R.S.L.), Grant U19-HL069757 (to R.M.K.). The funders had no influence on the data collection, analyses or conclusions of the study. No conflict of interests to declare. TRIAL REGISTRATION NUMBER: N/A.</style></abstract><notes><style face="normal" font="default" size="100%">Brower, M A&#xD;Hai, Y&#xD;Jones, M R&#xD;Guo, X&#xD;Chen, Y-D I&#xD;Rotter, J I&#xD;Krauss, R M&#xD;Legro, R S&#xD;Azziz, R&#xD;Goodarzi, M O&#xD;eng&#xD;N01HC95168/HL/NHLBI NIH HHS/&#xD;U54 HD044315/HD/NICHD NIH HHS/&#xD;K24 HD001346/HD/NICHD NIH HHS/&#xD;U10 HD038992/HD/NICHD NIH HHS/&#xD;N01HC95159/HL/NHLBI NIH HHS/&#xD;N01HC95169/HL/NHLBI NIH HHS/&#xD;U54 HD034449/HD/NICHD NIH HHS/&#xD;N02 HL64278/HL/NHLBI NIH HHS/&#xD;R01 HD029364/HD/NICHD NIH HHS/&#xD;N01HC95165/HL/NHLBI NIH HHS/&#xD;U19 HL069757/HL/NHLBI NIH HHS/&#xD;U10 HD038998/HD/NICHD NIH HHS/&#xD;N01HC95164/HL/NHLBI NIH HHS/&#xD;HHSN263201500003I/NH/NIH HHS/&#xD;R01 HL098077/HL/NHLBI NIH HHS/&#xD;N01HC95162/HL/NHLBI NIH HHS/&#xD;U10 HD055942/HD/NICHD NIH HHS/&#xD;P50 ES015915/ES/NIEHS NIH HHS/&#xD;R01 DK079888/DK/NIDDK NIH HHS/&#xD;U10 HD039005/HD/NICHD NIH HHS/&#xD;N01HC95160/HL/NHLBI NIH HHS/&#xD;UL1 TR000040/TR/NCATS NIH HHS/&#xD;UL1 TR001420/TR/NCATS NIH HHS/&#xD;U10 HD055944/HD/NICHD NIH HHS/&#xD;N01HC95161/HL/NHLBI NIH HHS/&#xD;UL1 TR001079/TR/NCATS NIH HHS/&#xD;M01 RR000425/RR/NCRR NIH HHS/&#xD;P30 DK063491/DK/NIDDK NIH HHS/&#xD;U10 HD055936/HD/NICHD NIH HHS/&#xD;N01HC95167/HL/NHLBI NIH HHS/&#xD;U10 HD055925/HD/NICHD NIH HHS/&#xD;U10 HD027049/HD/NICHD NIH HHS/&#xD;UL1 TR001881/TR/NCATS NIH HHS/&#xD;N01HC95163/HL/NHLBI NIH HHS/&#xD;N01HC95166/HL/NHLBI NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Hum Reprod. 2019 Jan 1;34(1):127-136. doi: 10.1093/humrep/dey343.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30496407</style></url></related-urls><pdf-urls><url>internal-pdf://3272899690/Brower-2019-Bidirectional Mendelian randomizat.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6295958</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/humrep/dey343</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>151</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">151</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Budu-Aggrey, A.</style></author><author><style face="normal" font="default" size="100%">Brumpton, B.</style></author><author><style face="normal" font="default" size="100%">Tyrrell, J.</style></author><author><style face="normal" font="default" size="100%">Watkins, S.</style></author><author><style face="normal" font="default" size="100%">Modalsli, E. H.</style></author><author><style face="normal" font="default" size="100%">Celis-Morales, C.</style></author><author><style face="normal" font="default" size="100%">Ferguson, L. D.</style></author><author><style face="normal" font="default" size="100%">Vie, G. A.</style></author><author><style face="normal" font="default" size="100%">Palmer, T.</style></author><author><style face="normal" font="default" size="100%">Fritsche, L. G.</style></author><author><style face="normal" font="default" size="100%">Loset, M.</style></author><author><style face="normal" font="default" size="100%">Nielsen, J. B.</style></author><author><style face="normal" font="default" size="100%">Zhou, W.</style></author><author><style face="normal" font="default" size="100%">Tsoi, L. C.</style></author><author><style face="normal" font="default" size="100%">Wood, A. R.</style></author><author><style face="normal" font="default" size="100%">Jones, S. E.</style></author><author><style face="normal" font="default" size="100%">Beaumont, R.</style></author><author><style face="normal" font="default" size="100%">Saunes, M.</style></author><author><style face="normal" font="default" size="100%">Romundstad, P. R.</style></author><author><style face="normal" font="default" size="100%">Siebert, S.</style></author><author><style face="normal" font="default" size="100%">McInnes, I. B.</style></author><author><style face="normal" font="default" size="100%">Elder, J. T.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Frayling, T. M.</style></author><author><style face="normal" font="default" size="100%">Asvold, B. O.</style></author><author><style face="normal" font="default" size="100%">Brown, S. J.</style></author><author><style face="normal" font="default" size="100%">Sattar, N.</style></author><author><style face="normal" font="default" size="100%">Paternoster, L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Medical Research Council (MRC) Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.&#xD;Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, United Kingdom.&#xD;K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.&#xD;Department of Thoracic Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.&#xD;Genetics of Complex Traits, Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon and Exeter Hospital, Exeter, United Kingdom.&#xD;European Centre for Environment and Human Health, University of Exeter Medical School, The Knowledge Spa, Truro, United Kingdom.&#xD;Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.&#xD;Department of Dermatology, St. Olav&apos;s Hospital, Trondheim University Hospital, Trondheim, Norway.&#xD;Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.&#xD;Department of Mathematics and Statistics, Lancaster University, Lancaster, United Kingdom.&#xD;Department of Internal Medicine, Division of Cardiology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.&#xD;Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, United States of America.&#xD;Department of Dermatology, University of Michigan, Ann Arbor, Michigan, United States of America.&#xD;Department of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan, United States of America.&#xD;Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.&#xD;Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.&#xD;Ann Arbor Veterans Affairs Hospital, Ann Arbor, Michigan, United States of America.&#xD;Department of Endocrinology, St. Olav&apos;s Hospital, Trondheim University Hospital, Trondheim, Norway.&#xD;Skin Research Group, School of Medicine, University of Dundee, Dundee, United Kingdom.&#xD;Department of Dermatology, Ninewells Hospital and Medical School, Dundee, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1002739</style></pages><volume><style face="normal" font="default" size="100%">16</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2019/02/01</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/complications/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Psoriasis/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30703100</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Psoriasis is a common inflammatory skin disease that has been reported to be associated with obesity. We aimed to investigate a possible causal relationship between body mass index (BMI) and psoriasis. METHODS AND FINDINGS: Following a review of published epidemiological evidence of the association between obesity and psoriasis, mendelian randomization (MR) was used to test for a causal relationship with BMI. We used a genetic instrument comprising 97 single-nucleotide polymorphisms (SNPs) associated with BMI as a proxy for BMI (expected to be much less confounded than measured BMI). One-sample MR was conducted using individual-level data (396,495 individuals) from the UK Biobank and the Nord-Trondelag Health Study (HUNT), Norway. Two-sample MR was performed with summary-level data (356,926 individuals) from published BMI and psoriasis genome-wide association studies (GWASs). The one-sample and two-sample MR estimates were meta-analysed using a fixed-effect model. To test for a potential reverse causal effect, MR analysis with genetic instruments comprising variants from recent genome-wide analyses for psoriasis were used to test whether genetic risk for this skin disease has a causal effect on BMI. Published observational data showed an association of higher BMI with psoriasis. A mean difference in BMI of 1.26 kg/m2 (95% CI 1.02-1.51) between psoriasis cases and controls was observed in adults, while a 1.55 kg/m2 mean difference (95% CI 1.13-1.98) was observed in children. The observational association was confirmed in UK Biobank and HUNT data sets. Overall, a 1 kg/m2 increase in BMI was associated with 4% higher odds of psoriasis (meta-analysis odds ratio [OR] = 1.04; 95% CI 1.03-1.04; P = 1.73 x 10(-60)). MR analyses provided evidence that higher BMI causally increases the odds of psoriasis (by 9% per 1 unit increase in BMI; OR = 1.09 (1.06-1.12) per 1 kg/m2; P = 4.67 x 10(-9)). In contrast, MR estimates gave little support to a possible causal effect of psoriasis genetic risk on BMI (0.004 kg/m2 change in BMI per doubling odds of psoriasis (-0.003 to 0.011). Limitations of our study include possible misreporting of psoriasis by patients, as well as potential misdiagnosis by clinicians. In addition, there is also limited ethnic variation in the cohorts studied. CONCLUSIONS: Our study, using genetic variants as instrumental variables for BMI, provides evidence that higher BMI leads to a higher risk of psoriasis. This supports the prioritization of therapies and lifestyle interventions aimed at controlling weight for the prevention or treatment of this common skin disease. Mechanistic studies are required to improve understanding of this relationship.</style></abstract><notes><style face="normal" font="default" size="100%">Budu-Aggrey, Ashley&#xD;Brumpton, Ben&#xD;Tyrrell, Jess&#xD;Watkins, Sarah&#xD;Modalsli, Ellen H&#xD;Celis-Morales, Carlos&#xD;Ferguson, Lyn D&#xD;Vie, Gunnhild Aberge&#xD;Palmer, Tom&#xD;Fritsche, Lars G&#xD;Loset, Mari&#xD;Nielsen, Jonas Bille&#xD;Zhou, Wei&#xD;Tsoi, Lam C&#xD;Wood, Andrew R&#xD;Jones, Samuel E&#xD;Beaumont, Robin&#xD;Saunes, Marit&#xD;Romundstad, Pal Richard&#xD;Siebert, Stefan&#xD;McInnes, Iain B&#xD;Elder, James T&#xD;Davey Smith, George&#xD;Frayling, Timothy M&#xD;Asvold, Bjorn Olav&#xD;Brown, Sara J&#xD;Sattar, Naveed&#xD;Paternoster, Lavinia&#xD;eng&#xD;RE/13/5/30177/BHF_/British Heart Foundation/United Kingdom&#xD;MC_UU_00011/1/MRC_/Medical Research Council/United Kingdom&#xD;MR/M005070/1/MRC_/Medical Research Council/United Kingdom&#xD;106865/Z/15/Z/WT_/Wellcome Trust/United Kingdom&#xD;MC_PC_17228/MRC_/Medical Research Council/United Kingdom&#xD;R01 AR042742/AR/NIAMS NIH HHS/&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;104150/Z/14/Z/WT_/Wellcome Trust/United Kingdom&#xD;R01 AR065183/AR/NIAMS NIH HHS/&#xD;MC_UU_00011/4/MRC_/Medical Research Council/United Kingdom&#xD;R01 AR063611/AR/NIAMS NIH HHS/&#xD;Meta-Analysis&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS Med. 2019 Jan 31;16(1):e1002739. doi: 10.1371/journal.pmed.1002739. eCollection 2019 Jan.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30703100</style></url></related-urls><pdf-urls><url>internal-pdf://3337430142/Budu-Aggrey-2019-Evidence of a causal relation.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6354959 following competing interests: IBM has received grants from Arthritis Research UK during the conduct of the study; grants and personal fees from Novartis, grants and personal fees from Janssen, grants and personal fees from Celgene, grants and personal fees from Abbvie, grants from BI, grants and personal fees from UCB, personal fees from Lilly, grants and personal fees from BMS. LP has received personal fees from Merck for Scientific Input Engagement related to MR methodology. SS has received grants from Arthritis Research UK during the conduct of the study; research grants from Janssen, BMS, Celgene, UCB, Boehringer Ingelheim and consultancy/speaker&apos;s fees from AbbVie, UCB, Celgene, Pfizer, Janssen, Boehringer Ingelheim, and Novartis. SJB has received honoraria for invited lectures at the British Association of Dermatologists&apos; annual meetings and the AAAAI annual meetings. GDS is a member of the Editorial Board of PLOS Medicine.</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1002739</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>157</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">157</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Burgess, S.</style></author><author><style face="normal" font="default" size="100%">Daniel, R. M.</style></author><author><style face="normal" font="default" size="100%">Butterworth, A. S.</style></author><author><style face="normal" font="default" size="100%">Thompson, S. G.</style></author><author><style face="normal" font="default" size="100%">E. PIC-InterAct Consortium</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK and Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK sb452@medschl.cam.ac.uk.&#xD;Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK and Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">484-95</style></pages><volume><style face="normal" font="default" size="100%">44</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2014/08/26</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Causality</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Models, Statistical</style></keyword><keyword><style face="normal" font="default" size="100%">Monte Carlo Method</style></keyword><keyword><style face="normal" font="default" size="100%">Regression Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">direct effect</style></keyword><keyword><style face="normal" font="default" size="100%">indirect effect</style></keyword><keyword><style face="normal" font="default" size="100%">instrumental variable</style></keyword><keyword><style face="normal" font="default" size="100%">mediation</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1464-3685 (Electronic)&#xD;0300-5771 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">25150977</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Mendelian randomization uses genetic variants, assumed to be instrumental variables for a particular exposure, to estimate the causal effect of that exposure on an outcome. If the instrumental variable criteria are satisfied, the resulting estimator is consistent even in the presence of unmeasured confounding and reverse causation. METHODS: We extend the Mendelian randomization paradigm to investigate more complex networks of relationships between variables, in particular where some of the effect of an exposure on the outcome may operate through an intermediate variable (a mediator). If instrumental variables for the exposure and mediator are available, direct and indirect effects of the exposure on the outcome can be estimated, for example using either a regression-based method or structural equation models. The direction of effect between the exposure and a possible mediator can also be assessed. Methods are illustrated in an applied example considering causal relationships between body mass index, C-reactive protein and uric acid. RESULTS: These estimators are consistent in the presence of unmeasured confounding if, in addition to the instrumental variable assumptions, the effects of both the exposure on the mediator and the mediator on the outcome are homogeneous across individuals and linear without interactions. Nevertheless, a simulation study demonstrates that even considerable heterogeneity in these effects does not lead to bias in the estimates. CONCLUSIONS: These methods can be used to estimate direct and indirect causal effects in a mediation setting, and have potential for the investigation of more complex networks between multiple interrelated exposures and disease outcomes.</style></abstract><notes><style face="normal" font="default" size="100%">Burgess, Stephen&#xD;Daniel, Rhian M&#xD;Butterworth, Adam S&#xD;Thompson, Simon G&#xD;eng&#xD;G0800270/Medical Research Council/United Kingdom&#xD;G1002283/Medical Research Council/United Kingdom&#xD;SP/08/007/23628/British Heart Foundation/United Kingdom&#xD;RG/08/014/24067/British Heart Foundation/United Kingdom&#xD;MR/L003120/1/Medical Research Council/United Kingdom&#xD;100114/Wellcome Trust/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Int J Epidemiol. 2015 Apr;44(2):484-95. doi: 10.1093/ije/dyu176. Epub 2014 Aug 22.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/25150977</style></url></related-urls><pdf-urls><url>internal-pdf://0977753343/Burgess-2015-Network Mendelian randomization_.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4469795</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/ije/dyu176</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>78</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">78</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cao, Y.</style></author><author><style face="normal" font="default" size="100%">Rajan, S. S.</style></author><author><style face="normal" font="default" size="100%">Wei, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Biostatistics, University of Texas School of Public Health, Houston, TX, USA.&#xD;Department of Management, Policy and Community Health, University of Texas School of Public Health, Houston, TX, USA.&#xD;Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Mendelian randomization analysis of a time-varying exposure for binary disease outcomes using functional data analysis methods</style></title><secondary-title><style face="normal" font="default" size="100%">Genet Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Genet Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">744-755</style></pages><volume><style face="normal" font="default" size="100%">40</style></volume><number><style face="normal" font="default" size="100%">8</style></number><edition><style face="normal" font="default" size="100%">2016/11/05</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular Diseases/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Variation/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Models, Genetic</style></keyword><keyword><style face="normal" font="default" size="100%">Principal Component Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Time Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*causal inference</style></keyword><keyword><style face="normal" font="default" size="100%">*functional data analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*longitudinal study</style></keyword><keyword><style face="normal" font="default" size="100%">*single nucleotide polymorphism (SNP)</style></keyword><keyword><style face="normal" font="default" size="100%">*time-varying exposure</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1098-2272 (Electronic)&#xD;0741-0395 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27813215</style></accession-num><abstract><style face="normal" font="default" size="100%">A Mendelian randomization (MR) analysis is performed to analyze the causal effect of an exposure variable on a disease outcome in observational studies, by using genetic variants that affect the disease outcome only through the exposure variable. This method has recently gained popularity among epidemiologists given the success of genetic association studies. Many exposure variables of interest in epidemiological studies are time varying, for example, body mass index (BMI). Although longitudinal data have been collected in many cohort studies, current MR studies only use one measurement of a time-varying exposure variable, which cannot adequately capture the long-term time-varying information. We propose using the functional principal component analysis method to recover the underlying individual trajectory of the time-varying exposure from the sparsely and irregularly observed longitudinal data, and then conduct MR analysis using the recovered curves. We further propose two MR analysis methods. The first assumes a cumulative effect of the time-varying exposure variable on the disease risk, while the second assumes a time-varying genetic effect and employs functional regression models. We focus on statistical testing for a causal effect. Our simulation studies mimicking the real data show that the proposed functional data analysis based methods incorporating longitudinal data have substantial power gains compared to standard MR analysis using only one measurement. We used the Framingham Heart Study data to demonstrate the promising performance of the new methods as well as inconsistent results produced by the standard MR analysis that relies on a single measurement of the exposure at some arbitrary time point.</style></abstract><notes><style face="normal" font="default" size="100%">Cao, Ying&#xD;Rajan, Suja S&#xD;Wei, Peng&#xD;eng&#xD;P30 CA016672/CA/NCI NIH HHS/&#xD;N02HL64278/HL/NHLBI NIH HHS/&#xD;R01 HL116720/HL/NHLBI NIH HHS/&#xD;R21 HL126032/HL/NHLBI NIH HHS/&#xD;R01 CA169122/CA/NCI NIH HHS/&#xD;N01HC25195/HL/NHLBI NIH HHS/&#xD;Genet Epidemiol. 2016 Dec;40(8):744-755. doi: 10.1002/gepi.22013. Epub 2016 Nov 4.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27813215</style></url></related-urls><pdf-urls><url>internal-pdf://1569057642/Cao-2016-Mendelian randomization analysis of a.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5123677</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/gepi.22013</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>71</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">71</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Carreras-Torres, R.</style></author><author><style face="normal" font="default" size="100%">Haycock, P. C.</style></author><author><style face="normal" font="default" size="100%">Relton, C. L.</style></author><author><style face="normal" font="default" size="100%">Martin, R. M.</style></author><author><style face="normal" font="default" size="100%">Smith, G. D.</style></author><author><style face="normal" font="default" size="100%">Kraft, P.</style></author><author><style face="normal" font="default" size="100%">Gao, C.</style></author><author><style face="normal" font="default" size="100%">Tworoger, S.</style></author><author><style face="normal" font="default" size="100%">Le Marchand, L.</style></author><author><style face="normal" font="default" size="100%">Wilkens, L. R.</style></author><author><style face="normal" font="default" size="100%">Park, S. L.</style></author><author><style face="normal" font="default" size="100%">Haiman, C.</style></author><author><style face="normal" font="default" size="100%">Field, J. K.</style></author><author><style face="normal" font="default" size="100%">Davies, M.</style></author><author><style face="normal" font="default" size="100%">Marcus, M.</style></author><author><style face="normal" font="default" size="100%">Liu, G.</style></author><author><style face="normal" font="default" size="100%">Caporaso, N. E.</style></author><author><style face="normal" font="default" size="100%">Christiani, D. C.</style></author><author><style face="normal" font="default" size="100%">Wei, Y.</style></author><author><style face="normal" font="default" size="100%">Chen, C.</style></author><author><style face="normal" font="default" size="100%">Doherty, J. A.</style></author><author><style face="normal" font="default" size="100%">Severi, G.</style></author><author><style face="normal" font="default" size="100%">Goodman, G. E.</style></author><author><style face="normal" font="default" size="100%">Hung, R. J.</style></author><author><style face="normal" font="default" size="100%">Amos, C. I.</style></author><author><style face="normal" font="default" size="100%">McKay, J.</style></author><author><style face="normal" font="default" size="100%">Johansson, M.</style></author><author><style face="normal" font="default" size="100%">Brennan, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France.&#xD;MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK.&#xD;National Institute for Health Research Biomedical Research Unit in Nutrition, Diet and Lifestyle at University Hospitals Bristol NHS Foundation Trust and the University of Bristol, BS2 8AE, Bristol, UK.&#xD;Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA.&#xD;Channing Division of Network Medicine, Brigham and Women&apos;s Hospital and Harvard Medical School, Boston, USA.&#xD;Epidemiology Program, University of Hawaii Cancer Center, Honolulu, USA.&#xD;Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, USA.&#xD;Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, The University of Liverpool, Liverpool, UK.&#xD;Ontario Cancer Institute, Princess Margaret Cancer Center, Toronto, ON, Canada.&#xD;Genetic Epidemiology Branch, DCEG, National Cancer Institute, NIH, Rockville, USA.&#xD;Departments of Environmental Health and Epidemiology, Harvard T. H. Chan School of Public Health and Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, USA.&#xD;Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA.&#xD;Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, USA.&#xD;Human Genetics Foundation (HuGeF), Torino, Italy.&#xD;Fred Hutchinson Cancer Research Center, Seattle, USA.&#xD;Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.&#xD;Department of Biomedical Data Science, Geisel School of medicine, Dartmouth College, Lebanon, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Sci Rep</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Sci Rep</style></full-title></periodical><pages><style face="normal" font="default" size="100%">31121</style></pages><volume><style face="normal" font="default" size="100%">6</style></volume><edition><style face="normal" font="default" size="100%">2016/08/05</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Lung Neoplasms/*pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Smoking/pathology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug 4</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2045-2322 (Electronic)&#xD;2045-2322 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27487993</style></accession-num><abstract><style face="normal" font="default" size="100%">Body mass index (BMI) is inversely associated with lung cancer risk in observational studies, even though it increases the risk of several other cancers, which could indicate confounding by tobacco smoking or reverse causality. We used the two-sample Mendelian randomization (MR) approach to circumvent these limitations of observational epidemiology by constructing a genetic instrument for BMI, based on results from the GIANT consortium, which was evaluated in relation to lung cancer risk using GWAS results on 16,572 lung cancer cases and 21,480 controls. Results were stratified by histological subtype, smoking status and sex. An increase of one standard deviation (SD) in BMI (4.65 Kg/m(2)) raised the risk for lung cancer overall (OR = 1.13; P = 0.10). This was driven by associations with squamous cell (SQ) carcinoma (OR = 1.45; P = 1.2 x 10(-3)) and small cell (SC) carcinoma (OR = 1.81; P = 0.01). An inverse trend was seen for adenocarcinoma (AD) (OR = 0.82; P = 0.06). In stratified analyses, a 1 SD increase in BMI was inversely associated with overall lung cancer in never smokers (OR = 0.50; P = 0.02). These results indicate that higher BMI may increase the risk of certain types of lung cancer, in particular SQ and SC carcinoma.</style></abstract><notes><style face="normal" font="default" size="100%">Carreras-Torres, Robert&#xD;Haycock, Philip C&#xD;Relton, Caroline L&#xD;Martin, Richard M&#xD;Smith, George Davey&#xD;Kraft, Peter&#xD;Gao, Chi&#xD;Tworoger, Shelley&#xD;Le Marchand, Loic&#xD;Wilkens, Lynne R&#xD;Park, Sungshim L&#xD;Haiman, Christopher&#xD;Field, John K&#xD;Davies, Michael&#xD;Marcus, Michael&#xD;Liu, Geoffrey&#xD;Caporaso, Neil E&#xD;Christiani, David C&#xD;Wei, Yongyue&#xD;Chen, Chu&#xD;Doherty, Jennifer A&#xD;Severi, Gianluca&#xD;Goodman, Gary E&#xD;Hung, Rayjean J&#xD;Amos, Christopher I&#xD;McKay, James&#xD;Johansson, Mattias&#xD;Brennan, Paul&#xD;eng&#xD;R35 CA197449/CA/NCI NIH HHS/&#xD;U01 CA063673/CA/NCI NIH HHS/&#xD;P01 CA087969/CA/NCI NIH HHS/&#xD;P30 CA023108/CA/NCI NIH HHS/&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;UM1 CA186107/CA/NCI NIH HHS/&#xD;UM1 CA167552/CA/NCI NIH HHS/&#xD;R01 CA049449/CA/NCI NIH HHS/&#xD;UM1 CA167462/CA/NCI NIH HHS/&#xD;P30 CA071789/CA/NCI NIH HHS/&#xD;A19169/Cancer Research UK/United Kingdom&#xD;MC_UU_12013/2/Medical Research Council/United Kingdom&#xD;Randomized Controlled Trial&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Sci Rep. 2016 Aug 4;6:31121. doi: 10.1038/srep31121.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27487993</style></url></related-urls><pdf-urls><url>internal-pdf://3733190963/Carreras-Torres-2016-The causal relevance of b.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4973233</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/srep31121</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>95</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">95</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Carreras-Torres, R.</style></author><author><style face="normal" font="default" size="100%">Johansson, M.</style></author><author><style face="normal" font="default" size="100%">Gaborieau, V.</style></author><author><style face="normal" font="default" size="100%">Haycock, P. C.</style></author><author><style face="normal" font="default" size="100%">Wade, K. H.</style></author><author><style face="normal" font="default" size="100%">Relton, C. L.</style></author><author><style face="normal" font="default" size="100%">Martin, R. M.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Brennan, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France; MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK; National Institute for Health Research Biomedical Research Unit in Nutrition, Diet and Lifestyle at University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study</style></title><secondary-title><style face="normal" font="default" size="100%">J Natl Cancer Inst</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Natl Cancer Inst</style></full-title></periodical><volume><style face="normal" font="default" size="100%">109</style></volume><number><style face="normal" font="default" size="100%">9</style></number><edition><style face="normal" font="default" size="100%">2017/09/28</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/*complications</style></keyword><keyword><style face="normal" font="default" size="100%">*Energy Metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin Resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Likelihood Functions</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Pancreatic Neoplasms/epidemiology/*etiology/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Population Surveillance</style></keyword><keyword><style face="normal" font="default" size="100%">Quantitative Trait, Heritable</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1460-2105 (Electronic)&#xD;0027-8874 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28954281</style></accession-num><abstract><style face="normal" font="default" size="100%">Background: Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging. Mendelian randomization (MR), or the use of genetic instrumental variables, may facilitate the identification of the metabolic drivers of pancreatic cancer. Methods: We identified genetic instruments for obesity, body shape, dyslipidemia, insulin resistance, and type 2 diabetes in order to evaluate their causal role in pancreatic cancer etiology. These instruments were analyzed in relation to risk using a likelihood-based MR approach within a series of 7110 pancreatic cancer patients and 7264 control subjects using genome-wide data from the Pancreatic Cancer Cohort Consortium (PanScan) and the Pancreatic Cancer Case-Control Consortium (PanC4). Potential unknown pleiotropic effects were assessed using a weighted median approach and MR-Egger sensitivity analyses. Results: Results indicated a robust causal association of increasing body mass index (BMI) with pancreatic cancer risk (odds ratio [OR] = 1.34, 95% confidence interval [CI] = 1.09 to 1.65, for each standard deviation increase in BMI [4.6 kg/m2]). There was also evidence that genetically increased fasting insulin levels were causally associated with an increased risk of pancreatic cancer (OR = 1.66, 95% CI = 1.05 to 2.63, per SD [44.4 pmol/L]). Notably, no evidence of a causal relationship was observed for type 2 diabetes, nor for dyslipidemia. Sensitivity analyses did not indicate that pleiotropy was an important source of bias. Conclusions: Our results suggest a causal role of BMI and fasting insulin in pancreatic cancer etiology.</style></abstract><notes><style face="normal" font="default" size="100%">Carreras-Torres, Robert&#xD;Johansson, Mattias&#xD;Gaborieau, Valerie&#xD;Haycock, Philip C&#xD;Wade, Kaitlin H&#xD;Relton, Caroline L&#xD;Martin, Richard M&#xD;Davey Smith, George&#xD;Brennan, Paul&#xD;eng&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;MC_UU_12013/2/Medical Research Council/United Kingdom&#xD;C18281/A19169/Cancer Research UK/United Kingdom&#xD;Meta-Analysis&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;J Natl Cancer Inst. 2017 Sep 1;109(9). pii: 3778207. doi: 10.1093/jnci/djx012.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28954281</style></url></related-urls><pdf-urls><url>internal-pdf://2941718803/Carreras-Torres-2017-The Role of Obesity, Type.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5721813</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/jnci/djx012</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>41</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">41</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Carreras-Torres, R.</style></author><author><style face="normal" font="default" size="100%">Johansson, M.</style></author><author><style face="normal" font="default" size="100%">Haycock, P. C.</style></author><author><style face="normal" font="default" size="100%">Relton, C. L.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Brennan, P.</style></author><author><style face="normal" font="default" size="100%">Martin, R. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Section of Genetics, International Agency for Research on Cancer, Lyon, France.&#xD;Medical Research Council Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK.&#xD;Section of Genetics, International Agency for Research on Cancer, Lyon, France gep@iarc.fr.&#xD;Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.&#xD;National Institute for Health Research Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Role of obesity in smoking behaviour: Mendelian randomisation study in UK Biobank</style></title><secondary-title><style face="normal" font="default" size="100%">BMJ</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMJ</style></full-title></periodical><pages><style face="normal" font="default" size="100%">k1767</style></pages><volume><style face="normal" font="default" size="100%">361</style></volume><edition><style face="normal" font="default" size="100%">2018/05/18</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Biological Specimen Banks</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/epidemiology/*genetics/psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Smoking/*genetics/psychology</style></keyword><keyword><style face="normal" font="default" size="100%">United Kingdom</style></keyword><keyword><style face="normal" font="default" size="100%">Waist Circumference</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 16</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1756-1833 (Electronic)&#xD;0959-8138 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29769355</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To determine whether body mass index, body fat percentage, and waist circumference influence smoking status and intensity. DESIGN: Mendelian randomisation study. SETTING: UK Biobank, with replication of results from the Tobacco and Genetics (TAG) consortium. PARTICIPANTS: European descent participants from the UK Biobank cohort (n=372 791) and the TAG consortium (n=74 035). MAIN OUTCOME MEASURES: Risk of current and past smoking, number of cigarettes smoked per day, age of smoking initiation. RESULTS: The Mendelian randomisation analysis indicated that each standard deviation increment in body mass index (4.6) increased the risk of being a smoker (odds ratio 1.18 (95% confidence interval 1.13 to 1.23), P&lt;0.001). This association was replicated in the TAG consortium data (1.19 (1.06 to 1.33), P=0.003). Furthermore, each standard deviation increment in body mass index was estimated to increase smoking intensity by 0.88 cigarettes per day (95% confidence interval 0.50 to 1.26, P&lt;0.001) in UK Biobank and 1.27 cigarettes per day in the TAG consortium (0.46 to 2.07, P=0.002). Similar results were also seen for body fat percentage and waist circumference in both UK Biobank and the TAG consortium data. CONCLUSIONS: These results strongly suggest that higher adiposity influences smoking behaviour and could have implications for the implementation of public health interventions aiming to reduce the prevalence of these important risk factors.</style></abstract><notes><style face="normal" font="default" size="100%">Carreras-Torres, Robert&#xD;Johansson, Mattias&#xD;Haycock, Philip C&#xD;Relton, Caroline L&#xD;Davey Smith, George&#xD;Brennan, Paul&#xD;Martin, Richard M&#xD;eng&#xD;MC_PC_17228/MRC_/Medical Research Council/United Kingdom&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/2/MRC_/Medical Research Council/United Kingdom&#xD;Validation Study&#xD;England&#xD;BMJ. 2018 May 16;361:k1767. doi: 10.1136/bmj.k1767.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29769355</style></url></related-urls><pdf-urls><url>internal-pdf://1930303429/Carreras-Torres-2018-Role of obesity in smokin.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5953237 at www.icmje.org/coi_disclosure.pdf and declare: support from Cancer Research UK and the NIHR Bristol Biomedical Research Centre for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/bmj.k1767</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>164</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">164</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Carreras-Torres, R.</style></author><author><style face="normal" font="default" size="100%">Johansson, M.</style></author><author><style face="normal" font="default" size="100%">Haycock, P. C.</style></author><author><style face="normal" font="default" size="100%">Wade, K. H.</style></author><author><style face="normal" font="default" size="100%">Relton, C. L.</style></author><author><style face="normal" font="default" size="100%">Martin, R. M.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Albanes, D.</style></author><author><style face="normal" font="default" size="100%">Aldrich, M. C.</style></author><author><style face="normal" font="default" size="100%">Andrew, A.</style></author><author><style face="normal" font="default" size="100%">Arnold, S. M.</style></author><author><style face="normal" font="default" size="100%">Bickeboller, H.</style></author><author><style face="normal" font="default" size="100%">Bojesen, S. E.</style></author><author><style face="normal" font="default" size="100%">Brunnstrom, H.</style></author><author><style face="normal" font="default" size="100%">Manjer, J.</style></author><author><style face="normal" font="default" size="100%">Bruske, I.</style></author><author><style face="normal" font="default" size="100%">Caporaso, N. E.</style></author><author><style face="normal" font="default" size="100%">Chen, C.</style></author><author><style face="normal" font="default" size="100%">Christiani, D. C.</style></author><author><style face="normal" font="default" size="100%">Christian, W. J.</style></author><author><style face="normal" font="default" size="100%">Doherty, J. A.</style></author><author><style face="normal" font="default" size="100%">Duell, E. J.</style></author><author><style face="normal" font="default" size="100%">Field, J. K.</style></author><author><style face="normal" font="default" size="100%">Davies, M. P. A.</style></author><author><style face="normal" font="default" size="100%">Marcus, M. W.</style></author><author><style face="normal" font="default" size="100%">Goodman, G. E.</style></author><author><style face="normal" font="default" size="100%">Grankvist, K.</style></author><author><style face="normal" font="default" size="100%">Haugen, A.</style></author><author><style face="normal" font="default" size="100%">Hong, Y. C.</style></author><author><style face="normal" font="default" size="100%">Kiemeney, L. A.</style></author><author><style face="normal" font="default" size="100%">van der Heijden, Ehfm</style></author><author><style face="normal" font="default" size="100%">Kraft, P.</style></author><author><style face="normal" font="default" size="100%">Johansson, M. B.</style></author><author><style face="normal" font="default" size="100%">Lam, S.</style></author><author><style face="normal" font="default" size="100%">Landi, M. T.</style></author><author><style face="normal" font="default" size="100%">Lazarus, P.</style></author><author><style face="normal" font="default" size="100%">Le Marchand, L.</style></author><author><style face="normal" font="default" size="100%">Liu, G.</style></author><author><style face="normal" font="default" size="100%">Melander, O.</style></author><author><style face="normal" font="default" size="100%">Park, S. L.</style></author><author><style face="normal" font="default" size="100%">Rennert, G.</style></author><author><style face="normal" font="default" size="100%">Risch, A.</style></author><author><style face="normal" font="default" size="100%">Haura, E. B.</style></author><author><style face="normal" font="default" size="100%">Scelo, G.</style></author><author><style face="normal" font="default" size="100%">Zaridze, D.</style></author><author><style face="normal" font="default" size="100%">Mukeriya, A.</style></author><author><style face="normal" font="default" size="100%">Savic, M.</style></author><author><style face="normal" font="default" size="100%">Lissowska, J.</style></author><author><style face="normal" font="default" size="100%">Swiatkowska, B.</style></author><author><style face="normal" font="default" size="100%">Janout, V.</style></author><author><style face="normal" font="default" size="100%">Holcatova, I.</style></author><author><style face="normal" font="default" size="100%">Mates, D.</style></author><author><style face="normal" font="default" size="100%">Schabath, M. B.</style></author><author><style face="normal" font="default" size="100%">Shen, H.</style></author><author><style face="normal" font="default" size="100%">Tardon, A.</style></author><author><style face="normal" font="default" size="100%">Teare, M. D.</style></author><author><style face="normal" font="default" size="100%">Woll, P.</style></author><author><style face="normal" font="default" size="100%">Tsao, M. S.</style></author><author><style face="normal" font="default" size="100%">Wu, X.</style></author><author><style face="normal" font="default" size="100%">Yuan, J. M.</style></author><author><style face="normal" font="default" size="100%">Hung, R. J.</style></author><author><style face="normal" font="default" size="100%">Amos, C. I.</style></author><author><style face="normal" font="default" size="100%">McKay, J.</style></author><author><style face="normal" font="default" size="100%">Brennan, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France.&#xD;MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.&#xD;National Institute for Health Research Biomedical Research Unit in Nutrition, Diet and Lifestyle at University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol, United Kingdom.&#xD;Metabolic Epidemiology Branch, DCEG, National Cancer Institute, NIH, Rockville, Maryland, United States of America.&#xD;Department of Thoracic Surgery, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.&#xD;Norris Cotton Cancer Center, Lebanon, New Hampshire, United States of America.&#xD;University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States of America.&#xD;University Medical Center Goettingen, Gottingen, Germany.&#xD;Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.&#xD;Laboratory Medicine Region Skane, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.&#xD;Helmholtz Zentrum Munchen, Munich, Germany.&#xD;Genetic Epidemiology Branch, DCEG, National Cancer Institute, NIH, Rockville, Maryland, United States of America.&#xD;Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.&#xD;Departments of Environmental Health and Epidemiology, Harvard T. H. Chan School of Public Health and Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.&#xD;Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, Kentucky, United States of America.&#xD;Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, United States of America.&#xD;Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.&#xD;Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, The University of Liverpool, Liverpool, United Kingdom.&#xD;Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.&#xD;Department of Medical Biosciences, Umea University, Umea, Sweden.&#xD;National Institute of Occupational Health, Oslo, Norway.&#xD;Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.&#xD;Radboud University Medical Center, Nijmegen, The Nederlands.&#xD;Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.&#xD;British Columbia Cancer Agency, Vancouver, British Columbia, Canada.&#xD;Washington State University College of Pharmacy, Spokane, Washington, United States of America.&#xD;Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America.&#xD;Ontario Cancer Institute, Princess Margaret Cancer Center, Toronto, Ontario, Canada.&#xD;Department of Clinical Sciences Malmo, Lund University, Lund, Sweden.&#xD;Department of Internal Medicine, Skane University Hospital, Malmo, Sweden.&#xD;Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.&#xD;Clalit National Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.&#xD;University of Salzburg and Cancer Cluster Salzburg, Salzburg, Austria.&#xD;Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.&#xD;Russian N.N. Blokhin Cancer Research Centre, Moscow, The Russian Federation.&#xD;Department of Thoracic Surgery, Clinical Center of Serbia, Belgrade, Serbia.&#xD;Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.&#xD;Nofer Institute of Occupational Medicine, Department of Environmental Epidemiology, Lodz, Poland.&#xD;Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.&#xD;Institute of Public Health and Preventive Medicine, Charles University, 2nd Faculty of Medicine, Prague, Czech Republic.&#xD;National Institute of Public Health, Bucharest, Romania.&#xD;Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.&#xD;Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China.&#xD;Instituto Universitario de Oncologia del Principado de Asturias (IUOPA), University of Oviedo and CIBERESP, Oviedo, Spain.&#xD;University of Sheffield, Sheffield, United Kingdom.&#xD;Princess Margaret Cancer Center, Toronto, Canada.&#xD;The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.&#xD;Division of Cancer Control and Population Science, University of Pittsburgh Cancer Institute; and Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America.&#xD;Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.&#xD;Department of Biomedical Data Science, Geisel School of medicine, Dartmouth College, Lebanon, New Hampshire, United States of America.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS One</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS One</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e0177875</style></pages><volume><style face="normal" font="default" size="100%">12</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2017/06/09</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Fasting</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin Resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Likelihood Functions</style></keyword><keyword><style face="normal" font="default" size="100%">Lipids/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Lung Neoplasms/blood/complications/*metabolism/*pathology</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/blood/*complications</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><isbn><style face="normal" font="default" size="100%">1932-6203 (Electronic)&#xD;1932-6203 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28594918</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Assessing the relationship between lung cancer and metabolic conditions is challenging because of the confounding effect of tobacco. Mendelian randomization (MR), or the use of genetic instrumental variables to assess causality, may help to identify the metabolic drivers of lung cancer. METHODS AND FINDINGS: We identified genetic instruments for potential metabolic risk factors and evaluated these in relation to risk using 29,266 lung cancer cases (including 11,273 adenocarcinomas, 7,426 squamous cell and 2,664 small cell cases) and 56,450 controls. The MR risk analysis suggested a causal effect of body mass index (BMI) on lung cancer risk for two of the three major histological subtypes, with evidence of a risk increase for squamous cell carcinoma (odds ratio (OR) [95% confidence interval (CI)] = 1.20 [1.01-1.43] and for small cell lung cancer (OR [95%CI] = 1.52 [1.15-2.00]) for each standard deviation (SD) increase in BMI [4.6 kg/m2]), but not for adenocarcinoma (OR [95%CI] = 0.93 [0.79-1.08]) (Pheterogeneity = 4.3x10-3). Additional analysis using a genetic instrument for BMI showed that each SD increase in BMI increased cigarette consumption by 1.27 cigarettes per day (P = 2.1x10-3), providing novel evidence that a genetic susceptibility to obesity influences smoking patterns. There was also evidence that low-density lipoprotein cholesterol was inversely associated with lung cancer overall risk (OR [95%CI] = 0.90 [0.84-0.97] per SD of 38 mg/dl), while fasting insulin was positively associated (OR [95%CI] = 1.63 [1.25-2.13] per SD of 44.4 pmol/l). Sensitivity analyses including a weighted-median approach and MR-Egger test did not detect other pleiotropic effects biasing the main results. CONCLUSIONS: Our results are consistent with a causal role of fasting insulin and low-density lipoprotein cholesterol in lung cancer etiology, as well as for BMI in squamous cell and small cell carcinoma. The latter relation may be mediated by a previously unrecognized effect of obesity on smoking behavior.</style></abstract><notes><style face="normal" font="default" size="100%">Carreras-Torres, Robert&#xD;Johansson, Mattias&#xD;Haycock, Philip C&#xD;Wade, Kaitlin H&#xD;Relton, Caroline L&#xD;Martin, Richard M&#xD;Davey Smith, George&#xD;Albanes, Demetrius&#xD;Aldrich, Melinda C&#xD;Andrew, Angeline&#xD;Arnold, Susanne M&#xD;Bickeboller, Heike&#xD;Bojesen, Stig E&#xD;Brunnstrom, Hans&#xD;Manjer, Jonas&#xD;Bruske, Irene&#xD;Caporaso, Neil E&#xD;Chen, Chu&#xD;Christiani, David C&#xD;Christian, W Jay&#xD;Doherty, Jennifer A&#xD;Duell, Eric J&#xD;Field, John K&#xD;Davies, Michael P A&#xD;Marcus, Michael W&#xD;Goodman, Gary E&#xD;Grankvist, Kjell&#xD;Haugen, Aage&#xD;Hong, Yun-Chul&#xD;Kiemeney, Lambertus A&#xD;van der Heijden, Erik H F M&#xD;Kraft, Peter&#xD;Johansson, Mikael B&#xD;Lam, Stephen&#xD;Landi, Maria Teresa&#xD;Lazarus, Philip&#xD;Le Marchand, Loic&#xD;Liu, Geoffrey&#xD;Melander, Olle&#xD;Park, Sungshim L&#xD;Rennert, Gad&#xD;Risch, Angela&#xD;Haura, Eric B&#xD;Scelo, Ghislaine&#xD;Zaridze, David&#xD;Mukeriya, Anush&#xD;Savic, Milan&#xD;Lissowska, Jolanta&#xD;Swiatkowska, Beata&#xD;Janout, Vladimir&#xD;Holcatova, Ivana&#xD;Mates, Dana&#xD;Schabath, Matthew B&#xD;Shen, Hongbing&#xD;Tardon, Adonina&#xD;Teare, M Dawn&#xD;Woll, Penella&#xD;Tsao, Ming-Sound&#xD;Wu, Xifeng&#xD;Yuan, Jian-Min&#xD;Hung, Rayjean J&#xD;Amos, Christopher I&#xD;McKay, James&#xD;Brennan, Paul&#xD;eng&#xD;R35 CA197449/CA/NCI NIH HHS/&#xD;K07 CA172294/CA/NCI NIH HHS/&#xD;P50 CA119997/CA/NCI NIH HHS/&#xD;P30 CA023108/CA/NCI NIH HHS/&#xD;P30 CA076292/CA/NCI NIH HHS/&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;R01 CA151989/CA/NCI NIH HHS/&#xD;UM1 CA167462/CA/NCI NIH HHS/&#xD;A19169/Cancer Research UK/United Kingdom&#xD;MC_UU_12013/2/Medical Research Council/United Kingdom&#xD;PLoS One. 2017 Jun 8;12(6):e0177875. doi: 10.1371/journal.pone.0177875. eCollection 2017.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28594918</style></url></related-urls><pdf-urls><url>internal-pdf://0766190989/Carreras-Torres-2017-Obesity, metabolic factor.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5464539</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pone.0177875</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>26</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">26</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Carter, Alice R.</style></author><author><style face="normal" font="default" size="100%">Borges, Maria-Carolina</style></author><author><style face="normal" font="default" size="100%">Benn, Marianne</style></author><author><style face="normal" font="default" size="100%">Tybjærg-Hansen, Anne</style></author><author><style face="normal" font="default" size="100%">Smith, George Davey</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, Børge G.</style></author><author><style face="normal" font="default" size="100%">Lawlor, Debbie A.</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><urls><pdf-urls><url>internal-pdf://2274082814/Carter-2018-Investigating the combined associa.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/303313</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>44</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">44</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Censin, Jenny C.</style></author><author><style face="normal" font="default" size="100%">Bovijn, Jonas</style></author><author><style face="normal" font="default" size="100%">Ferreira, Teresa</style></author><author><style face="normal" font="default" size="100%">Pulit, Sara L.</style></author><author><style face="normal" font="default" size="100%">Mägi, Reedik</style></author><author><style face="normal" font="default" size="100%">Mahajan, Anubha</style></author><author><style face="normal" font="default" size="100%">Holmes, Michael V.</style></author><author><style face="normal" font="default" size="100%">Lindgren, Cecilia M.</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><urls><pdf-urls><url>internal-pdf://3677110295/Censin-2019-Causal relevance of obesity on the.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/523217</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>132</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">132</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Censin, J. C.</style></author><author><style face="normal" font="default" size="100%">Nowak, C.</style></author><author><style face="normal" font="default" size="100%">Cooper, N.</style></author><author><style face="normal" font="default" size="100%">Bergsten, P.</style></author><author><style face="normal" font="default" size="100%">Todd, J. A.</style></author><author><style face="normal" font="default" size="100%">Fall, T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.&#xD;Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.&#xD;Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.&#xD;JDRF/Wellcome Trust Diabetes and Inflammation Laboratory, Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Childhood adiposity and risk of type 1 diabetes: A Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1002362</style></pages><volume><style face="normal" font="default" size="100%">14</style></volume><number><style face="normal" font="default" size="100%">8</style></number><edition><style face="normal" font="default" size="100%">2017/08/02</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 1/*epidemiology/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Europe/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Pediatric Obesity/*complications/*epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28763444</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: The incidence of type 1 diabetes (T1D) is increasing globally. One hypothesis is that increasing childhood obesity rates may explain part of this increase, but, as T1D is rare, intervention studies are challenging to perform. The aim of this study was to assess this hypothesis with a Mendelian randomization approach that uses genetic variants as instrumental variables to test for causal associations. METHODS AND FINDINGS: We created a genetic instrument of 23 single nucleotide polymorphisms (SNPs) associated with childhood adiposity in children aged 2-10 years. Summary-level association results for these 23 SNPs with childhood-onset (&lt;17 years) T1D were extracted from a meta-analysis of genome-wide association study with 5,913 T1D cases and 8,828 reference samples. Using inverse-variance weighted Mendelian randomization analysis, we found support for an effect of childhood adiposity on T1D risk (odds ratio 1.32, 95% CI 1.06-1.64 per standard deviation score in body mass index [SDS-BMI]). A sensitivity analysis provided evidence of horizontal pleiotropy bias (p = 0.04) diluting the estimates towards the null. We therefore applied Egger regression and multivariable Mendelian randomization methods to control for this type of bias and found evidence in support of a role of childhood adiposity in T1D (odds ratio in Egger regression, 2.76, 95% CI 1.40-5.44). Limitations of our study include that underlying genes and their mechanisms for most of the genetic variants included in the score are not known. Mendelian randomization requires large sample sizes, and power was limited to provide precise estimates. This research has been conducted using data from the Early Growth Genetics (EGG) Consortium, the Genetic Investigation of Anthropometric Traits (GIANT) Consortium, the Tobacco and Genetics (TAG) Consortium, and the Social Science Genetic Association Consortium (SSGAC), as well as meta-analysis results from a T1D genome-wide association study. CONCLUSIONS: This study provides genetic support for a link between childhood adiposity and T1D risk. Together with evidence from observational studies, our findings further emphasize the importance of measures to reduce the global epidemic of childhood obesity and encourage mechanistic studies.</style></abstract><notes><style face="normal" font="default" size="100%">Censin, J C&#xD;Nowak, Christoph&#xD;Cooper, Nicholas&#xD;Bergsten, Peter&#xD;Todd, John A&#xD;Fall, Tove&#xD;eng&#xD;PLoS Med. 2017 Aug 1;14(8):e1002362. doi: 10.1371/journal.pmed.1002362. eCollection 2017 Aug.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28763444</style></url></related-urls><pdf-urls><url>internal-pdf://0786974592/Censin-2017-Childhood adiposity and risk of ty.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5538636</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1002362</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>31</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">31</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Chatterjee, N. A.</style></author><author><style face="normal" font="default" size="100%">Giulianini, F.</style></author><author><style face="normal" font="default" size="100%">Geelhoed, B.</style></author><author><style face="normal" font="default" size="100%">Lunetta, K. L.</style></author><author><style face="normal" font="default" size="100%">Misialek, J. R.</style></author><author><style face="normal" font="default" size="100%">Niemeijer, M. N.</style></author><author><style face="normal" font="default" size="100%">Rienstra, M.</style></author><author><style face="normal" font="default" size="100%">Rose, L. M.</style></author><author><style face="normal" font="default" size="100%">Smith, A. V.</style></author><author><style face="normal" font="default" size="100%">Arking, D. E.</style></author><author><style face="normal" font="default" size="100%">Ellinor, P. T.</style></author><author><style face="normal" font="default" size="100%">Heeringa, J.</style></author><author><style face="normal" font="default" size="100%">Lin, H.</style></author><author><style face="normal" font="default" size="100%">Lubitz, S. A.</style></author><author><style face="normal" font="default" size="100%">Soliman, E. Z.</style></author><author><style face="normal" font="default" size="100%">Verweij, N.</style></author><author><style face="normal" font="default" size="100%">Alonso, A.</style></author><author><style face="normal" font="default" size="100%">Benjamin, E. J.</style></author><author><style face="normal" font="default" size="100%">Gudnason, V.</style></author><author><style face="normal" font="default" size="100%">Stricker, B. H. C.</style></author><author><style face="normal" font="default" size="100%">Van Der Harst, P.</style></author><author><style face="normal" font="default" size="100%">Chasman, D. I.</style></author><author><style face="normal" font="default" size="100%">Albert, C. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Preventive Medicine, Department of Medicine, Brigham and Women&apos;s Hospital, Harvard Medical School, Boston, MA, USA.&#xD;Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.&#xD;The Framingham Heart Study, Framingham, MA, USA; Cardiology and Preventive Medicine Sections, Boston University School of Medicine, Epidemiology Department, Boston University School of Public Health, Boston, MA, USA.&#xD;Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.&#xD;Department of Epidemiology, Erasmus Medical Center-University Medical Center, Rotterdam, The Netherlands.&#xD;Icelandic Heart Association, Research Institute, Kpoavogur, Iceland and University of Iceland, Reykjavik, Iceland.&#xD;McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.&#xD;Cardiovascular Research Center and Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA, USA and Program in Medical and Population Genetics, The Broad Institute of Harvard and MIT, Cambridge, MA, USA.&#xD;Computational Biomedicine Section, Boston University School of Medicine, Boston, MA, USA.&#xD;Epidemiological Cardiology Research Center (EPICARE), Wake Forest School of Medicine, Winston Salem, NC, USA.&#xD;Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.&#xD;Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women&apos;s Hospital, Harvard Medical School, Boston, MA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetic Obesity and the Risk of Atrial Fibrillation: Causal Estimates from Mendelian Randomization</style></title><secondary-title><style face="normal" font="default" size="100%">Circulation</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Circulation</style></full-title></periodical><pages><style face="normal" font="default" size="100%">741-754</style></pages><volume><style face="normal" font="default" size="100%">135</style></volume><number><style face="normal" font="default" size="100%">8</style></number><edition><style face="normal" font="default" size="100%">2016/12/16</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Alleles</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Atrial Fibrillation/epidemiology/*etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*genetics/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Proportional Hazards Models</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Random Allocation</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*atrial fibrillation</style></keyword><keyword><style face="normal" font="default" size="100%">*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*obesity</style></keyword><keyword><style face="normal" font="default" size="100%">*prevention &amp; control</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 21</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1524-4539 (Electronic)&#xD;0009-7322 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27974350</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Observational studies have identified an association between body mass index (BMI) and incident atrial fibrillation (AF). Inferring causality from observational studies, however, is subject to residual confounding, reverse causation, and bias. The primary objective of this study was to evaluate the causal association between BMI and AF by using genetic predictors of BMI. METHODS: We identified 51 646 individuals of European ancestry without AF at baseline from 7 prospective population-based cohorts initiated between 1987 and 2002 in the United States, Iceland, and the Netherlands with incident AF ascertained between 1987 and 2012. Cohort-specific mean follow-up ranged from 7.4 to 19.2 years, over which period there was a total of 4178 cases of incident AF. We performed a Mendelian randomization with instrumental variable analysis to estimate a cohort-specific causal hazard ratio for the association between BMI and AF. Two genetic instruments for BMI were used: FTO genotype (rs1558902) and a BMI gene score comprising 39 single-nucleotide polymorphisms identified by genome-wide association studies to be associated with BMI. Cohort-specific estimates were combined by random-effects, inverse variance-weighted meta-analysis. RESULTS: In age- and sex-adjusted meta-analysis, both genetic instruments were significantly associated with BMI (FTO: 0.43 [95% confidence interval, 0.32-0.54] kg/m(2) per A-allele, P&lt;0.001; BMI gene score: 1.05 [95% confidence interval, 0.90-1.20] kg/m(2) per 1-U increase, P&lt;0.001) and incident AF (FTO, hazard ratio, 1.07 [1.02-1.11] per A-allele, P=0.004; BMI gene score, hazard ratio, 1.11 [1.05-1.18] per 1-U increase, P&lt;0.001). Age- and sex-adjusted instrumental variable estimates for the causal association between BMI and incident AF were hazard ratio, 1.15 (1.04-1.26) per kg/m(2), P=0.005 (FTO) and 1.11 (1.05-1.17) per kg/m(2), P&lt;0.001 (BMI gene score). Both of these estimates were consistent with the meta-analyzed estimate between observed BMI and AF (age- and sex-adjusted hazard ratio 1.05 [1.04-1.06] per kg/m(2), P&lt;0.001). Multivariable adjustment did not significantly change findings. CONCLUSIONS: Our data are consistent with a causal relationship between BMI and incident AF. These data support the possibility that public health initiatives targeting primordial prevention of obesity may reduce the incidence of AF.</style></abstract><notes><style face="normal" font="default" size="100%">Chatterjee, Neal A&#xD;Giulianini, Franco&#xD;Geelhoed, Bastiaan&#xD;Lunetta, Kathryn L&#xD;Misialek, Jeffrey R&#xD;Niemeijer, Maartje N&#xD;Rienstra, Michiel&#xD;Rose, Lynda M&#xD;Smith, Albert V&#xD;Arking, Dan E&#xD;Ellinor, Patrick T&#xD;Heeringa, Jan&#xD;Lin, Honghuang&#xD;Lubitz, Steven A&#xD;Soliman, Elsayed Z&#xD;Verweij, Niek&#xD;Alonso, Alvaro&#xD;Benjamin, Emelia J&#xD;Gudnason, Vilmundur&#xD;Stricker, Bruno H C&#xD;Van Der Harst, Pim&#xD;Chasman, Daniel I&#xD;Albert, Christine M&#xD;eng&#xD;HHSN268201100012C/HL/NHLBI NIH HHS/&#xD;HHSN268201100009I/HL/NHLBI NIH HHS/&#xD;N01AG12100/AG/NIA NIH HHS/&#xD;HHSN268201100007C/HL/NHLBI NIH HHS/&#xD;R01 HL128914/HL/NHLBI NIH HHS/&#xD;R01 CA047988/CA/NCI NIH HHS/&#xD;R01 HL080467/HL/NHLBI NIH HHS/&#xD;HHSN268201100007I/HL/NHLBI NIH HHS/&#xD;R01 HL087641/HL/NHLBI NIH HHS/&#xD;K23 HL114724/HL/NHLBI NIH HHS/&#xD;K24 HL105780/HL/NHLBI NIH HHS/&#xD;HHSN268201100010C/HL/NHLBI NIH HHS/&#xD;UL1 RR025005/RR/NCRR NIH HHS/&#xD;HHSN268201100008C/HL/NHLBI NIH HHS/&#xD;HHSN268201500001C/HL/NHLBI NIH HHS/&#xD;HHSN268201100005G/HL/NHLBI NIH HHS/&#xD;HHSN268201100008I/HL/NHLBI NIH HHS/&#xD;R01 HL092577/HL/NHLBI NIH HHS/&#xD;R01 HL043851/HL/NHLBI NIH HHS/&#xD;R01 HL059367/HL/NHLBI NIH HHS/&#xD;16EIA26410001/AHA/American Heart Association-American Stroke Association/&#xD;T32 HL007575/HL/NHLBI NIH HHS/&#xD;HHSN268201100011I/HL/NHLBI NIH HHS/&#xD;HHSN268201100011C/HL/NHLBI NIH HHS/&#xD;R01 HL086694/HL/NHLBI NIH HHS/&#xD;U01 HG004402/HG/NHGRI NIH HHS/&#xD;RC1 HL101056/HL/NHLBI NIH HHS/&#xD;HHSN268201100006C/HL/NHLBI NIH HHS/&#xD;R01 HL116690/HL/NHLBI NIH HHS/&#xD;R01 HL102214/HL/NHLBI NIH HHS/&#xD;HHSN268201100005I/HL/NHLBI NIH HHS/&#xD;R21 HL093613/HL/NHLBI NIH HHS/&#xD;HHSN268201500001I/HL/NHLBI NIH HHS/&#xD;HHSN271201200022C/AG/NIA NIH HHS/&#xD;UM1 CA182913/CA/NCI NIH HHS/&#xD;HHSN268201100009C/HL/NHLBI NIH HHS/&#xD;HHSN268201100005C/HL/NHLBI NIH HHS/&#xD;N01HC25195/HL/NHLBI NIH HHS/&#xD;2014105/DDCF/Doris Duke Charitable Foundation/&#xD;RC1 HL099355/HL/NHLBI NIH HHS/&#xD;Meta-Analysis&#xD;Circulation. 2017 Feb 21;135(8):741-754. doi: 10.1161/CIRCULATIONAHA.116.024921. Epub 2016 Dec 14.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27974350</style></url></related-urls><pdf-urls><url>internal-pdf://0117821176/Chatterjee-2017-Genetic Obesity and the Risk o.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5322057</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1161/CIRCULATIONAHA.116.024921</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>102</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">102</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Chen, Y. C.</style></author><author><style face="normal" font="default" size="100%">Fan, H. Y.</style></author><author><style face="normal" font="default" size="100%">Huang, Y. T.</style></author><author><style face="normal" font="default" size="100%">Huang, S. Y.</style></author><author><style face="normal" font="default" size="100%">Liou, T. H.</style></author><author><style face="normal" font="default" size="100%">Lee, Y. L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Family Medicine, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.&#xD;Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.&#xD;School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan.&#xD;Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University, Taipei, Taiwan.&#xD;Institute of Statistical Science, Academia Sinica, Taipei, Taiwan.&#xD;Department of Physical Medicine and Rehabilitation, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.&#xD;Department of Physical Medicine and Rehabilitation, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.&#xD;Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan. leolee@ntu.edu.tw.&#xD;Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. leolee@ntu.edu.tw.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal relationships between adiposity and childhood asthma: bi-directional Mendelian Randomization analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Obes (Lond)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Obes (Lond)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">73-81</style></pages><volume><style face="normal" font="default" size="100%">43</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2018/07/22</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Alleles</style></keyword><keyword><style face="normal" font="default" size="100%">Asthma/epidemiology/*etiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Pediatric Obesity/*complications/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Taiwan/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-5497 (Electronic)&#xD;0307-0565 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30026589</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND/OBJECTIVES: Obesity and asthma are common chronic diseases and have been reported to be mutually causative. We investigated the causal direction of the relationship between adiposity and asthma using genetic markers as instrumental variables (IVs) in bi-directional Mendelian randomization (MR) analysis. SUBJECTS/METHODS: We used data from the Taiwan Children Health Study with 24 body mass index (BMI)-single-nucleotide polymorphisms (SNPs, combined into a weighted allelic score) and 16 asthma-SNPs (combined into two weighted allelic scores, separately for asthma inflammatory and antioxidative genes) to yield genetic IVs for adiposity and asthma, respectively. RESULTS: The weighted allele score for BMI was strongly associated with adiposity (p = 2 x 10(-16)) and active asthma (p = 0.03). The two-stage least square regression risk ratio (RR) for the effect of BMI on asthma was 1.04 (95% confidence interval: 1.00-1.07, p = 0.03). Although the weighted asthma genetic scores were significantly associated with asthma (p = 8.4 x 10(-3)), no association was seen for genetically instrumented asthma with BMI using MR. Central obesity was the most accurate predictor of asthma. Adiposity showed higher causal effects on asthma in boys and children with non-atopic asthma. Sensitivity analysis for MR revealed no directional genetic pleiotropy effects. The causal effect RRs of BMI on asthma were 1.04, 1.08, and 1.03 for inverse-variance weighted, MR-Egger regression (slope), and weighted median methods, respectively, all in accordance with the MR estimates. CONCLUSIONS: High adiposity may lead to asthma, whereas the effects of asthma on adiposity accumulation are likely to be small.</style></abstract><notes><style face="normal" font="default" size="100%">Chen, Yang-Ching&#xD;Fan, Hsien-Yu&#xD;Huang, Yen-Tsung&#xD;Huang, Shih-Yi&#xD;Liou, Tsan-Hon&#xD;Lee, Yungling L&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Int J Obes (Lond). 2019 Jan;43(1):73-81. doi: 10.1038/s41366-018-0160-8. Epub 2018 Jul 19.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30026589</style></url></related-urls><pdf-urls><url>internal-pdf://1733887062/Chen-2018-Causal relationships between adiposi.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s41366-018-0160-8</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>87</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">87</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Clifton, E. A. D.</style></author><author><style face="normal" font="default" size="100%">Perry, J. R. B.</style></author><author><style face="normal" font="default" size="100%">Imamura, F.</style></author><author><style face="normal" font="default" size="100%">Lotta, L. A.</style></author><author><style face="normal" font="default" size="100%">Brage, S.</style></author><author><style face="normal" font="default" size="100%">Forouhi, N. G.</style></author><author><style face="normal" font="default" size="100%">Griffin, S. J.</style></author><author><style face="normal" font="default" size="100%">Wareham, N. J.</style></author><author><style face="normal" font="default" size="100%">Ong, K. K.</style></author><author><style face="normal" font="default" size="100%">Day, F. R.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, CB2 0SL, UK. emma.clifton@mrc-epid.cam.ac.uk.&#xD;MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, CB2 0SL, UK.&#xD;Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, CB2 0SR, UK.&#xD;MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, CB2 0SL, UK. felix.day@mrc-epid.cam.ac.uk.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genome-wide association study for risk taking propensity indicates shared pathways with body mass index</style></title><secondary-title><style face="normal" font="default" size="100%">Commun Biol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Commun Biol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">36</style></pages><volume><style face="normal" font="default" size="100%">1</style></volume><edition><style face="normal" font="default" size="100%">2018/10/03</style></edition><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><isbn><style face="normal" font="default" size="100%">2399-3642 (Electronic)&#xD;2399-3642 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30271922</style></accession-num><abstract><style face="normal" font="default" size="100%">Risk-taking propensity is a trait of significant public health relevance but few specific genetic factors are known. Here we perform a genome-wide association study of self-reported risk-taking propensity among 436,236 white European UK Biobank study participants. We identify genome-wide associations at 26 loci (P &lt; 5 x 10(-8)), 24 of which are novel, implicating genes enriched in the GABA and GABA receptor pathways. Modelling the relationship between risk-taking propensity and body mass index (BMI) using Mendelian randomisation shows a positive association (0.25 approximate SDs of BMI (SE: 0.06); P = 6.7 x 10(-5)). The impact of individual SNPs is heterogeneous, indicating a complex relationship arising from multiple shared pathways. We identify positive genetic correlations between risk-taking and waist-hip ratio, childhood obesity, ever smoking, attention-deficit hyperactivity disorder, bipolar disorder and schizophrenia, alongside a negative correlation with women&apos;s age at first birth. These findings highlight that behavioural pathways involved in risk-taking propensity may play a role in obesity, smoking and psychiatric disorders.</style></abstract><notes><style face="normal" font="default" size="100%">Clifton, Emma A D&#xD;Perry, John R B&#xD;Imamura, Fumiaki&#xD;Lotta, Luca A&#xD;Brage, Soren&#xD;Forouhi, Nita G&#xD;Griffin, Simon J&#xD;Wareham, Nicholas J&#xD;Ong, Ken K&#xD;Day, Felix R&#xD;eng&#xD;MC_UU_12015/4/MRC_/Medical Research Council/United Kingdom&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12015/3/MRC_/Medical Research Council/United Kingdom&#xD;MC_U106179473/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12015/1/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12015/2/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12015/5/MRC_/Medical Research Council/United Kingdom&#xD;MC_PC_17228/MRC_/Medical Research Council/United Kingdom&#xD;England&#xD;Commun Biol. 2018 May 3;1:36. doi: 10.1038/s42003-018-0042-6. eCollection 2018.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30271922</style></url></related-urls><pdf-urls><url>internal-pdf://0553994172/Clifton-2018-Genome-wide association study for.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6123697</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s42003-018-0042-6</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>172</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">172</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cole, C. B.</style></author><author><style face="normal" font="default" size="100%">Nikpay, M.</style></author><author><style face="normal" font="default" size="100%">Stewart, A. F.</style></author><author><style face="normal" font="default" size="100%">McPherson, R.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.&#xD;Ruddy Canadian Cardiovascular Genetics Centre, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Increased genetic risk for obesity in premature coronary artery disease</style></title><secondary-title><style face="normal" font="default" size="100%">Eur J Hum Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur J Hum Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">587-91</style></pages><volume><style face="normal" font="default" size="100%">24</style></volume><number><style face="normal" font="default" size="100%">4</style></number><edition><style face="normal" font="default" size="100%">2015/07/30</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Artery Disease/*epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*epidemiology/genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-5438 (Electronic)&#xD;1018-4813 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26220701</style></accession-num><abstract><style face="normal" font="default" size="100%">There is ongoing controversy as to whether obesity confers risk for CAD independently of associated risk factors including diabetes mellitus. We have carried out a Mendelian randomization study using a genetic risk score (GRS) for body mass index (BMI) based on 35 risk alleles to investigate this question in a population of 5831 early onset CAD cases without diabetes mellitus and 3832 elderly healthy control subjects, all of strictly European ancestry, with adjustment for traditional risk factors (TRFs). We then estimated the genetic correlation between these BMI and CAD (rg) by relating the pairwise genetic similarity matrix to a phenotypic covariance matrix between these two traits. GRSBMI significantly (P=2.12 x 10(-12)) associated with CAD status in a multivariate model adjusted for TRFs, with a per allele odds ratio (OR) of 1.06 (95% CI 1.042-1.076). The addition of GRSBMI to TRFs explained 0.75% of CAD variance and yielded a continuous net recombination index of 16.54% (95% CI=11.82-21.26%, P&lt;0.0001). To test whether GRSBMI explained CAD status when adjusted for measured BMI, separate models were constructed in which the score and BMI were either included as covariates or not. The addition of BMI explained ~1.9% of CAD variance and GRSBMI plus BMI explained 2.65% of CAD variance. Finally, using bivariate restricted maximum likelihood analysis, we provide strong evidence of genome-wide pleiotropy between obesity and CAD. This analysis supports the hypothesis that obesity is a causal risk factor for CAD.</style></abstract><notes><style face="normal" font="default" size="100%">Cole, Christopher B&#xD;Nikpay, Majid&#xD;Stewart, Alexandre F R&#xD;McPherson, Ruth&#xD;eng&#xD;MOP2390941/Canadian Institutes of Health Research/Canada&#xD;OPB134211/Canadian Institutes of Health Research/Canada&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Eur J Hum Genet. 2016 Apr;24(4):587-91. doi: 10.1038/ejhg.2015.162. Epub 2015 Jul 29.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26220701</style></url></related-urls><pdf-urls><url>internal-pdf://2178036344/Cole-2016-Increased genetic risk for obesity i.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4929880</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/ejhg.2015.162</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>57</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">57</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Conde, S.</style></author><author><style face="normal" font="default" size="100%">Xu, X.</style></author><author><style face="normal" font="default" size="100%">Guo, H.</style></author><author><style face="normal" font="default" size="100%">Perola, M.</style></author><author><style face="normal" font="default" size="100%">Fazia, T.</style></author><author><style face="normal" font="default" size="100%">Bernardinelli, L.</style></author><author><style face="normal" font="default" size="100%">Berzuini, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Centre for Biostatistics, University of Manchester, University Place, Oxford Road, Manchester, M13 9PL, UK.&#xD;National Institute for Health and Welfare (THL), P.O. Box 30 (Mannerheimintie 166), Helsinki, FI-00271, Finland.&#xD;Department of Brain and Behavioural Sciences, University of Pavia, Via Bassi 21, Pavia, 27100, Italy.&#xD;Centre for Biostatistics, University of Manchester, University Place, Oxford Road, Manchester, M13 9PL, UK. carlo.berzuini@manchester.ac.uk.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Mendelian randomisation analysis of clustered causal effects of body mass on cardiometabolic biomarkers</style></title><secondary-title><style face="normal" font="default" size="100%">BMC Bioinformatics</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMC Bioinformatics</style></full-title></periodical><pages><style face="normal" font="default" size="100%">195</style></pages><volume><style face="normal" font="default" size="100%">19</style></volume><number><style face="normal" font="default" size="100%">Suppl 7</style></number><edition><style face="normal" font="default" size="100%">2018/08/02</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Biomarkers/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Weight</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular Diseases/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Gene Frequency/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Metabolic Diseases/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Metabolome</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Regression Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*Cardiovascular disease</style></keyword><keyword><style face="normal" font="default" size="100%">*Causal inference</style></keyword><keyword><style face="normal" font="default" size="100%">*Egger regression</style></keyword><keyword><style face="normal" font="default" size="100%">*Metabolomics</style></keyword><keyword><style face="normal" font="default" size="100%">*Multiple instrumental variables</style></keyword><keyword><style face="normal" font="default" size="100%">*Weighted median estimator</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul 9</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1471-2105 (Electronic)&#xD;1471-2105 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30066639</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Recent advances in data analysis methods based on principles of Mendelian Randomisation, such as Egger regression and the weighted median estimator, add to the researcher&apos;s ability to infer cause-effect links from observational data. Now is the time to gauge the potential of these methods within specific areas of biomedical research. In this paper, we choose a study in metabolomics as an illustrative testbed. We apply Mendelian Randomisation methods in the analysis of data from the DILGOM (Dietary, Lifestyle and Genetic determinants of Obesity and Metabolic syndrome) study, in the context of an effort to identify molecular pathways of cardiovascular disease. In particular, our illustrative analysis addresses the question whether body mass, as measured by body mass index (BMI), exerts a causal effect on the concentrations of a collection of 137 cardiometabolic markers with different degrees of atherogenic power, such as the (highly atherogenic) lipoprotein metabolites with very low density (VLDLs) and the (protective) high density lipoprotein metabolites. RESULTS: We found strongest evidence of a positive BMI effect (that is, evidence that an increase in BMI causes an increase in the metabolite concentration) on those metabolites known to represent strong risk factors for coronary artery disease, such as the VLDLs, and evidence of a negative effect on protective biomarkers. CONCLUSIONS: The methods discussed represent a useful scientific tool, although they assume the validity of conditions that are (at best) only partially verifiable. This paper provides a rigorous account of such conditions. The results of our analysis provide a proof-of-concept illustration of the potential usefulness of Mendelian Randomisation in genomic biobank studies aiming to dissect the molecular causes of disease, and to identify candidate pharmacological targets.</style></abstract><notes><style face="normal" font="default" size="100%">Conde, Susana&#xD;Xu, Xiaoguang&#xD;Guo, Hui&#xD;Perola, Markus&#xD;Fazia, Teresa&#xD;Bernardinelli, Luisa&#xD;Berzuini, Carlo&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;BMC Bioinformatics. 2018 Jul 9;19(Suppl 7):195. doi: 10.1186/s12859-018-2178-2.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30066639</style></url></related-urls><pdf-urls><url>internal-pdf://3668164670/Conde-2018-Mendelian randomisation analysis of.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6069804</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12859-018-2178-2</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>32</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">32</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Constantinescu, Andrei-Emil</style></author><author><style face="normal" font="default" size="100%">Bull, Caroline J.</style></author><author><style face="normal" font="default" size="100%">Zheng, Jie</style></author><author><style face="normal" font="default" size="100%">Elsworth, Benjamin</style></author><author><style face="normal" font="default" size="100%">Hers, Ingeborg</style></author><author><style face="normal" font="default" size="100%">Timpson, Nicholas J.</style></author><author><style face="normal" font="default" size="100%">Moore, Samantha F.</style></author><author><style face="normal" font="default" size="100%">Vincent, Emma E.</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><urls><pdf-urls><url>internal-pdf://0303407436/Constantinescu-2018-Hypothesis-free analysis o.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/476135</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>34</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">34</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Corbin, L. J.</style></author><author><style face="normal" font="default" size="100%">Richmond, R. C.</style></author><author><style face="normal" font="default" size="100%">Wade, K. H.</style></author><author><style face="normal" font="default" size="100%">Burgess, S.</style></author><author><style face="normal" font="default" size="100%">Bowden, J.</style></author><author><style face="normal" font="default" size="100%">Smith, G. D.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Integrative Epidemiology Unit, University of Bristol, Bristol, U.K.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, U.K. Department of Public Health and Primary Care, University of Cambridge, Cambridge, U.K.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, U.K. MRC Biostatistics Unit, Cambridge Institute of Public Health, Cambridge, U.K.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, U.K. n.j.timpson@bristol.ac.uk.</style></auth-address><titles><title><style face="normal" font="default" size="100%">BMI as a Modifiable Risk Factor for Type 2 Diabetes: Refining and Understanding Causal Estimates Using Mendelian Randomization</style></title><secondary-title><style face="normal" font="default" size="100%">Diabetes</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Diabetes</style></full-title></periodical><pages><style face="normal" font="default" size="100%">3002-7</style></pages><volume><style face="normal" font="default" size="100%">65</style></volume><number><style face="normal" font="default" size="100%">10</style></number><edition><style face="normal" font="default" size="100%">2016/07/13</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/*epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Pleiotropy/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Transcription Factor 7-Like 2 Protein/genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1939-327X (Electronic)&#xD;0012-1797 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27402723</style></accession-num><abstract><style face="normal" font="default" size="100%">This study focused on resolving the relationship between BMI and type 2 diabetes. The availability of multiple variants associated with BMI offers a new chance to resolve the true causal effect of BMI on type 2 diabetes; however, the properties of these associations and their validity as genetic instruments need to be considered alongside established and new methods for undertaking Mendelian randomization (MR). We explore the potential for pleiotropic genetic variants to generate bias, revise existing estimates, and illustrate value in new analysis methods. A two-sample MR approach with 96 genetic variants was used with three different analysis methods, two of which (MR-Egger and the weighted median) have been developed specifically to address problems of invalid instrumental variables. We estimate an odds ratio for type 2 diabetes per unit increase in BMI (kg/m(2)) of between 1.19 and 1.38, with the most stable estimate using all instruments and a weighted median approach (1.26 [95% CI 1.17, 1.34]). TCF7L2(rs7903146) was identified as a complex effect or pleiotropic instrument, and removal of this variant resulted in convergence of causal effect estimates from different causal analysis methods. This indicated the potential for pleiotropy to affect estimates and differences in performance of alternative analytical methods. In a real type 2 diabetes-focused example, this study demonstrates the potential impact of invalid instruments on causal effect estimates and the potential for new approaches to mitigate the bias caused.</style></abstract><notes><style face="normal" font="default" size="100%">Corbin, Laura J&#xD;Richmond, Rebecca C&#xD;Wade, Kaitlin H&#xD;Burgess, Stephen&#xD;Bowden, Jack&#xD;Smith, George Davey&#xD;Timpson, Nicholas J&#xD;eng&#xD;G0800270/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/3/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/1/MRC_/Medical Research Council/United Kingdom&#xD;100114/WT_/Wellcome Trust/United Kingdom&#xD;MC_UU_00002/3/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/2/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00002/7/MRC_/Medical Research Council/United Kingdom&#xD;C18281/A19169/CRUK_/Cancer Research UK/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Diabetes. 2016 Oct;65(10):3002-7. doi: 10.2337/db16-0418. Epub 2016 Jul 8.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27402723</style></url></related-urls><pdf-urls><url>internal-pdf://3603545169/Corbin-2016-BMI as a Modifiable Risk Factor fo.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5279886</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.2337/db16-0418</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>42</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">42</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dale, C. E.</style></author><author><style face="normal" font="default" size="100%">Fatemifar, G.</style></author><author><style face="normal" font="default" size="100%">Palmer, T. M.</style></author><author><style face="normal" font="default" size="100%">White, J.</style></author><author><style face="normal" font="default" size="100%">Prieto-Merino, D.</style></author><author><style face="normal" font="default" size="100%">Zabaneh, D.</style></author><author><style face="normal" font="default" size="100%">Engmann, J. E. L.</style></author><author><style face="normal" font="default" size="100%">Shah, T.</style></author><author><style face="normal" font="default" size="100%">Wong, A.</style></author><author><style face="normal" font="default" size="100%">Warren, H. R.</style></author><author><style face="normal" font="default" size="100%">McLachlan, S.</style></author><author><style face="normal" font="default" size="100%">Trompet, S.</style></author><author><style face="normal" font="default" size="100%">Moldovan, M.</style></author><author><style face="normal" font="default" size="100%">Morris, R. W.</style></author><author><style face="normal" font="default" size="100%">Sofat, R.</style></author><author><style face="normal" font="default" size="100%">Kumari, M.</style></author><author><style face="normal" font="default" size="100%">Hypponen, E.</style></author><author><style face="normal" font="default" size="100%">Jefferis, B. J.</style></author><author><style face="normal" font="default" size="100%">Gaunt, T. R.</style></author><author><style face="normal" font="default" size="100%">Ben-Shlomo, Y.</style></author><author><style face="normal" font="default" size="100%">Zhou, A.</style></author><author><style face="normal" font="default" size="100%">Gentry-Maharaj, A.</style></author><author><style face="normal" font="default" size="100%">Ryan, A.</style></author><author><style face="normal" font="default" size="100%">Ucleb Consortium</style></author><author><style face="normal" font="default" size="100%">Metastroke Consortium</style></author><author><style face="normal" font="default" size="100%">Mutsert, R.</style></author><author><style face="normal" font="default" size="100%">Noordam, R.</style></author><author><style face="normal" font="default" size="100%">Caulfield, M. J.</style></author><author><style face="normal" font="default" size="100%">Jukema, J. W.</style></author><author><style face="normal" font="default" size="100%">Worrall, B. B.</style></author><author><style face="normal" font="default" size="100%">Munroe, P. B.</style></author><author><style face="normal" font="default" size="100%">Menon, U.</style></author><author><style face="normal" font="default" size="100%">Power, C.</style></author><author><style face="normal" font="default" size="100%">Kuh, D.</style></author><author><style face="normal" font="default" size="100%">Lawlor, D. A.</style></author><author><style face="normal" font="default" size="100%">Humphries, S. E.</style></author><author><style face="normal" font="default" size="100%">Mook-Kanamori, D. O.</style></author><author><style face="normal" font="default" size="100%">Sattar, N.</style></author><author><style face="normal" font="default" size="100%">Kivimaki, M.</style></author><author><style face="normal" font="default" size="100%">Price, J. F.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Dudbridge, F.</style></author><author><style face="normal" font="default" size="100%">Hingorani, A. D.</style></author><author><style face="normal" font="default" size="100%">Holmes, M. V.</style></author><author><style face="normal" font="default" size="100%">Casas, J. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">From Farr Institute of Health Informatics Research, UCL Institute of Health Informatics, University College London, United Kingdom (C.E.D., G.F., D.P.-M., A.D.H., J.P.C.); Department of Mathematics and Statistics, Lancaster University, United Kingdom (T.M.P.); UCLGenetics Institute, University College London, United Kingdom (J.W.); Applied Statistical Methods in Medical Research Group, Universidad Catolica de San Antonio de Murcia, Spain (D.P.-M.); Social Genetic &amp; Developmental Psychiatry, King&apos;s College London, United Kingdom (D.Z.); Institute of Cardiovascular Science, University College London, United Kingdom (J.E.L.E., T.S., A.D.H., S.E.H.); MRC Unit for Lifelong Health &amp; Ageing at UCL, London, United Kingdom (A.W., D.K.); Clinical Pharmacology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (H.R.W., M.J.C., P.B.M.); NIHR Barts Cardiovascular Biomedical Research Unit, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (H.R.W., M.J.C., P.B.M.); Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, United Kingdom (S.M., J.F.P.); Department of Cardiology, Leiden University Medical Center, The Netherlands (S.T., W.J.); South Australian Health and Medical Research Institute, Adelaide (M.M., E.H.); EMBL Australia, Adelaide (M.M.); School of Social and Community Medicine, University of Bristol, United Kingdom (R.W.M., T.R.G., Y.B.-S., D.A.L., G.D.S.); Centre for Clinical Pharmacology, University College London, United Kingdom (R.S.); Institute for Social and Economic Research, University of Essex, Colchester, United Kingdom (M.K.); Centre for Population Health Research, School of Health Sciences and Sansom Institute, University of South Australia, Adelaide (E.H., A.Z.); Population, Policy &amp; Practice, UCL Great Ormond Street Institute of Child Health, London, United Kingdom (E.H., C.P.); Department of Primary Care &amp; Population Health, University College London, Royal Free Campus, United Kingdom (B.J.J.); MRC Integrative Epidemiology Unit, University of Bristol, United Kingdom (T.R.G., D.A.L., G.D.S.); Department of Women&apos;s Cancer, Institute for Women&apos;s Health, UCL, London, United Kingdom (A.G.-M., A.R., U.M.); Department of Clinical Epidemiology, Leiden University Medical Center, The Netherlands (R.d.M., D.O.M.-K.); Department of Internal Medicine, Section Gerontology and Geriatrics, Leiden University Medical Center, The Netherlands (R.N., S.T.); Interuniversity Cardiology Institute Netherlands, Utrecht (W.J.); Departments of Neurology and Public Health Sciences, University of Virginia, Charlottesville (B.B.W.); Department of Public Health and Primary Care, Leiden University Medical Center, The Netherlands (D.O.M.-K.); BHF Glasgow Cardiovascular Research Centre, Faculty of Medicine, United Kingdom (N.S.); Department of Epidemiology and Public Health, University College London, United Kingdom (M.K.); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom (F.D.); Department of Health Sciences, University of Leicester, United Kingdom (F.D.); Clinical Trial Service Unit &amp; Epidemiological Studies Unit, Nuffield Department of Population Health, Big Data Institute Building, University of Oxford, United Kingdom (M.V.H.); Medical Research Council Population Health Research Unit at the University of Oxford, United Kingdom (M.V.H.); and National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals, United Kingdom (M.V.H.). jp.casas@ucl.ac.uk c.dale@ucl.ac.uk.&#xD;From Farr Institute of Health Informatics Research, UCL Institute of Health Informatics, University College London, United Kingdom (C.E.D., G.F., D.P.-M., A.D.H., J.P.C.); Department of Mathematics and Statistics, Lancaster University, United Kingdom (T.M.P.); UCLGenetics Institute, University College London, United Kingdom (J.W.); Applied Statistical Methods in Medical Research Group, Universidad Catolica de San Antonio de Murcia, Spain (D.P.-M.); Social Genetic &amp; Developmental Psychiatry, King&apos;s College London, United Kingdom (D.Z.); Institute of Cardiovascular Science, University College London, United Kingdom (J.E.L.E., T.S., A.D.H., S.E.H.); MRC Unit for Lifelong Health &amp; Ageing at UCL, London, United Kingdom (A.W., D.K.); Clinical Pharmacology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (H.R.W., M.J.C., P.B.M.); NIHR Barts Cardiovascular Biomedical Research Unit, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (H.R.W., M.J.C., P.B.M.); Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, United Kingdom (S.M., J.F.P.); Department of Cardiology, Leiden University Medical Center, The Netherlands (S.T., W.J.); South Australian Health and Medical Research Institute, Adelaide (M.M., E.H.); EMBL Australia, Adelaide (M.M.); School of Social and Community Medicine, University of Bristol, United Kingdom (R.W.M., T.R.G., Y.B.-S., D.A.L., G.D.S.); Centre for Clinical Pharmacology, University College London, United Kingdom (R.S.); Institute for Social and Economic Research, University of Essex, Colchester, United Kingdom (M.K.); Centre for Population Health Research, School of Health Sciences and Sansom Institute, University of South Australia, Adelaide (E.H., A.Z.); Population, Policy &amp; Practice, UCL Great Ormond Street Institute of Child Health, London, United Kingdom (E.H., C.P.); Department of Primary Care &amp; Population Health, University College London, Royal Free Campus, United Kingdom (B.J.J.); MRC Integrative Epidemiology Unit, University of Bristol, United Kingdom (T.R.G., D.A.L., G.D.S.); Department of Women&apos;s Cancer, Institute for Women&apos;s Health, UCL, London, United Kingdom (A.G.-M., A.R., U.M.); Department of Clinical Epidemiology, Leiden University Medical Center, The Netherlands (R.d.M., D.O.M.-K.); Department of Internal Medicine, Section Gerontology and Geriatrics, Leiden University Medical Center, The Netherlands (R.N., S.T.); Interuniversity Cardiology Institute Netherlands, Utrecht (W.J.); Departments of Neurology and Public Health Sciences, University of Virginia, Charlottesville (B.B.W.); Department of Public Health and Primary Care, Leiden University Medical Center, The Netherlands (D.O.M.-K.); BHF Glasgow Cardiovascular Research Centre, Faculty of Medicine, United Kingdom (N.S.); Department of Epidemiology and Public Health, University College London, United Kingdom (M.K.); Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom (F.D.); Department of Health Sciences, University of Leicester, United Kingdom (F.D.); Clinical Trial Service Unit &amp; Epidemiological Studies Unit, Nuffield Department of Population Health, Big Data Institute Building, University of Oxford, United Kingdom (M.V.H.); Medical Research Council Population Health Research Unit at the University of Oxford, United Kingdom (M.V.H.); and National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals, United Kingdom (M.V.H.).</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Circulation</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Circulation</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2373-2388</style></pages><volume><style face="normal" font="default" size="100%">135</style></volume><number><style face="normal" font="default" size="100%">24</style></number><edition><style face="normal" font="default" size="100%">2017/05/14</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Fat Distribution/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Disease/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Observational Studies as Topic/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Stroke/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian randomization analysis</style></keyword><keyword><style face="normal" font="default" size="100%">adiposity</style></keyword><keyword><style face="normal" font="default" size="100%">body fat distribution</style></keyword><keyword><style face="normal" font="default" size="100%">body mass index</style></keyword><keyword><style face="normal" font="default" size="100%">coronary artery disease</style></keyword><keyword><style face="normal" font="default" size="100%">stroke</style></keyword><keyword><style face="normal" font="default" size="100%">waist-hip ratio</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 13</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1524-4539 (Electronic)&#xD;0009-7322 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28500271</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: The implications of different adiposity measures on cardiovascular disease etiology remain unclear. In this article, we quantify and contrast causal associations of central adiposity (waist-to-hip ratio adjusted for body mass index [WHRadjBMI]) and general adiposity (body mass index [BMI]) with cardiometabolic disease. METHODS: Ninety-seven independent single-nucleotide polymorphisms for BMI and 49 single-nucleotide polymorphisms for WHRadjBMI were used to conduct Mendelian randomization analyses in 14 prospective studies supplemented with coronary heart disease (CHD) data from CARDIoGRAMplusC4D (Coronary Artery Disease Genome-wide Replication and Meta-analysis [CARDIoGRAM] plus The Coronary Artery Disease [C4D] Genetics; combined total 66 842 cases), stroke from METASTROKE (12 389 ischemic stroke cases), type 2 diabetes mellitus from DIAGRAM (Diabetes Genetics Replication and Meta-analysis; 34 840 cases), and lipids from GLGC (Global Lipids Genetic Consortium; 213 500 participants) consortia. Primary outcomes were CHD, type 2 diabetes mellitus, and major stroke subtypes; secondary analyses included 18 cardiometabolic traits. RESULTS: Each one standard deviation (SD) higher WHRadjBMI (1 SD approximately 0.08 U) associated with a 48% excess risk of CHD (odds ratio [OR] for CHD, 1.48; 95% confidence interval [CI], 1.28-1.71), similar to findings for BMI (1 SD approximately 4.6 kg/m(2); OR for CHD, 1.36; 95% CI, 1.22-1.52). Only WHRadjBMI increased risk of ischemic stroke (OR, 1.32; 95% CI, 1.03-1.70). For type 2 diabetes mellitus, both measures had large effects: OR, 1.82 (95% CI, 1.38-2.42) and OR, 1.98 (95% CI, 1.41-2.78) per 1 SD higher WHRadjBMI and BMI, respectively. Both WHRadjBMI and BMI were associated with higher left ventricular hypertrophy, glycemic traits, interleukin 6, and circulating lipids. WHRadjBMI was also associated with higher carotid intima-media thickness (39%; 95% CI, 9%-77% per 1 SD). CONCLUSIONS: Both general and central adiposity have causal effects on CHD and type 2 diabetes mellitus. Central adiposity may have a stronger effect on stroke risk. Future estimates of the burden of adiposity on health should include measures of central and general adiposity.</style></abstract><notes><style face="normal" font="default" size="100%">Dale, Caroline E&#xD;Fatemifar, Ghazaleh&#xD;Palmer, Tom M&#xD;White, Jon&#xD;Prieto-Merino, David&#xD;Zabaneh, Delilah&#xD;Engmann, Jorgen E L&#xD;Shah, Tina&#xD;Wong, Andrew&#xD;Warren, Helen R&#xD;McLachlan, Stela&#xD;Trompet, Stella&#xD;Moldovan, Max&#xD;Morris, Richard W&#xD;Sofat, Reecha&#xD;Kumari, Meena&#xD;Hypponen, Elina&#xD;Jefferis, Barbara J&#xD;Gaunt, Tom R&#xD;Ben-Shlomo, Yoav&#xD;Zhou, Ang&#xD;Gentry-Maharaj, Aleksandra&#xD;Ryan, Andy&#xD;Mutsert, Renee de&#xD;Noordam, Raymond&#xD;Caulfield, Mark J&#xD;Jukema, J Wouter&#xD;Worrall, Bradford B&#xD;Munroe, Patricia B&#xD;Menon, Usha&#xD;Power, Chris&#xD;Kuh, Diana&#xD;Lawlor, Debbie A&#xD;Humphries, Steve E&#xD;Mook-Kanamori, Dennis O&#xD;Sattar, Naveed&#xD;Kivimaki, Mika&#xD;Price, Jacqueline F&#xD;Davey Smith, George&#xD;Dudbridge, Frank&#xD;Hingorani, Aroon D&#xD;Holmes, Michael V&#xD;Casas, Juan P&#xD;eng&#xD;G9521010/MRC_/Medical Research Council/United Kingdom&#xD;G1001799/MRC_/Medical Research Council/United Kingdom&#xD;RG/08/008/25291/BHF_/British Heart Foundation/United Kingdom&#xD;PG/13/66/30442/BHF_/British Heart Foundation/United Kingdom&#xD;G0802432/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12019/1/MRC_/Medical Research Council/United Kingdom&#xD;MR/N01104X/1/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/1/MRC_/Medical Research Council/United Kingdom&#xD;MR/K006584/1/MRC_/Medical Research Council/United Kingdom&#xD;G0600237/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/5/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/8/MRC_/Medical Research Council/United Kingdom&#xD;G0801228/MRC_/Medical Research Council/United Kingdom&#xD;MR/N01104X/2/MRC_/Medical Research Council/United Kingdom&#xD;RG/10/12/28456/BHF_/British Heart Foundation/United Kingdom&#xD;SP/13/6/30554/BHF_/British Heart Foundation/United Kingdom&#xD;Circulation. 2017 Jun 13;135(24):2373-2388. doi: 10.1161/CIRCULATIONAHA.116.026560. Epub 2017 May 12.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28500271</style></url></related-urls><pdf-urls><url>internal-pdf://0499246149/Dale-2017-Causal Associations of Adiposity and.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5515354</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1161/CIRCULATIONAHA.116.026560</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>158</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">158</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Davies, N. M.</style></author><author><style face="normal" font="default" size="100%">Gaunt, T. R.</style></author><author><style face="normal" font="default" size="100%">Lewis, S. J.</style></author><author><style face="normal" font="default" size="100%">Holly, J.</style></author><author><style face="normal" font="default" size="100%">Donovan, J. L.</style></author><author><style face="normal" font="default" size="100%">Hamdy, F. C.</style></author><author><style face="normal" font="default" size="100%">Kemp, J. P.</style></author><author><style face="normal" font="default" size="100%">Eeles, R.</style></author><author><style face="normal" font="default" size="100%">Easton, D.</style></author><author><style face="normal" font="default" size="100%">Kote-Jarai, Z.</style></author><author><style face="normal" font="default" size="100%">Al Olama, A. A.</style></author><author><style face="normal" font="default" size="100%">Benlloch, S.</style></author><author><style face="normal" font="default" size="100%">Muir, K.</style></author><author><style face="normal" font="default" size="100%">Giles, G. G.</style></author><author><style face="normal" font="default" size="100%">Wiklund, F.</style></author><author><style face="normal" font="default" size="100%">Gronberg, H.</style></author><author><style face="normal" font="default" size="100%">Haiman, C. A.</style></author><author><style face="normal" font="default" size="100%">Schleutker, J.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author><author><style face="normal" font="default" size="100%">Travis, R. C.</style></author><author><style face="normal" font="default" size="100%">Neal, D.</style></author><author><style face="normal" font="default" size="100%">Pashayan, N.</style></author><author><style face="normal" font="default" size="100%">Khaw, K. T.</style></author><author><style face="normal" font="default" size="100%">Stanford, J. L.</style></author><author><style face="normal" font="default" size="100%">Blot, W. J.</style></author><author><style face="normal" font="default" size="100%">Thibodeau, S.</style></author><author><style face="normal" font="default" size="100%">Maier, C.</style></author><author><style face="normal" font="default" size="100%">Kibel, A. S.</style></author><author><style face="normal" font="default" size="100%">Cybulski, C.</style></author><author><style face="normal" font="default" size="100%">Cannon-Albright, L.</style></author><author><style face="normal" font="default" size="100%">Brenner, H.</style></author><author><style face="normal" font="default" size="100%">Park, J.</style></author><author><style face="normal" font="default" size="100%">Kaneva, R.</style></author><author><style face="normal" font="default" size="100%">Batra, J.</style></author><author><style face="normal" font="default" size="100%">Teixeira, M. R.</style></author><author><style face="normal" font="default" size="100%">Pandha, H.</style></author><author><style face="normal" font="default" size="100%">Practical consortium</style></author><author><style face="normal" font="default" size="100%">Lathrop, M.</style></author><author><style face="normal" font="default" size="100%">Smith, G. D.</style></author><author><style face="normal" font="default" size="100%">Martin, R. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">School of Social and Community Medicine, University of Bristol, Bristol, UK. neil.davies@bristol.ac.uk.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK. neil.davies@bristol.ac.uk.&#xD;School of Social and Community Medicine, University of Bristol, Bristol, UK.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.&#xD;School of Clinical Sciences, University of Bristol, Bristol, BS10 5NB, UK.&#xD;Nuffield Department of Surgery, University of Oxford, Oxford, UK.&#xD;University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia.&#xD;The Institute of Cancer Research, London, SM2 5NG, UK.&#xD;The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.&#xD;Strangeways Laboratory, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, Cambridge, UK.&#xD;Institute of Population Health, University of Manchester, Manchester, UK.&#xD;Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, Australia.&#xD;Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.&#xD;Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.&#xD;Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.&#xD;Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland.&#xD;Institute of Biomedical Technology/BioMediTech, University of Tampere and FimLab Laboratories, Tampere, Finland.&#xD;Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark.&#xD;Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.&#xD;Surgical Oncology (Uro-Oncology: S4), University of Cambridge, Addenbrooke&apos;s Hospital, Hills Road, Box 279, Cambridge, UK.&#xD;Li Ka Shing Centre, Cancer Research UK Cambridge Research Institute, Cambridge, UK.&#xD;Strangeways Laboratory, Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Worts Causeway, Cambridge, UK.&#xD;Department of Applied Health Research, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK.&#xD;Cambridge Institute of Public Health, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0SR, UK.&#xD;Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.&#xD;Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.&#xD;International Epidemiology Institute, 1455 Research Blvd., Suite 550, Rockville, MD, 20850, USA.&#xD;Mayo Clinic, Rochester, MN, USA.&#xD;Department of Urology, University Hospital Ulm, Ulm, Germany.&#xD;Institute of Human Genetics, University Hospital Ulm, Ulm, Germany.&#xD;Brigham and Women&apos;s Hospital/Dana-Farber Cancer Institute, 45 Francis Street-ASB II-3, Boston, MA, 02115, USA.&#xD;Washington University, St. Louis, Missouri.&#xD;International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.&#xD;Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.&#xD;Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Division of Cancer Prevention and Control, H. Lee Moffitt Cancer Center, 12902 Magnolia Dr., Tampa, FL, USA.&#xD;Molecular Medicine Center and Department of Medical Chemistry and Biochemistry, Medical University Sofia, 2 Zdrave St, 1431, Sofia, Bulgaria.&#xD;Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.&#xD;Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.&#xD;Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal.&#xD;The University of Surrey, Guildford, Surrey, GU2 7XH, UK.&#xD;Commissariat a l&apos;Energie Atomique, Center National de Genotypage, Evry, France.&#xD;McGill University-Genome Quebec Innovation Centre, Montreal, Canada.&#xD;School of Social and Community Medicine, University of Bristol, Bristol, UK. richard.martin@bristol.ac.uk.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK. richard.martin@bristol.ac.uk.&#xD;Bristol Nutrition Biomedical Research Unit, National Institute for Health Research, Bristol, UK. richard.martin@bristol.ac.uk.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium</style></title><secondary-title><style face="normal" font="default" size="100%">Cancer Causes Control</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Cancer Causes Control</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1603-16</style></pages><volume><style face="normal" font="default" size="100%">26</style></volume><number><style face="normal" font="default" size="100%">11</style></number><edition><style face="normal" font="default" size="100%">2015/09/21</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Alleles</style></keyword><keyword><style face="normal" font="default" size="100%">Body Height/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/complications</style></keyword><keyword><style face="normal" font="default" size="100%">*Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Prostatic Neoplasms/*epidemiology/genetics/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Body mass index</style></keyword><keyword><style face="normal" font="default" size="100%">Height</style></keyword><keyword><style face="normal" font="default" size="100%">Instrumental variables analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">Prostate cancer</style></keyword><keyword><style face="normal" font="default" size="100%">Single nucleotide polymorphisms</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1573-7225 (Electronic)&#xD;0957-5243 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26387087</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Epidemiological studies suggest a potential role for obesity and determinants of adult stature in prostate cancer risk and mortality, but the relationships described in the literature are complex. To address uncertainty over the causal nature of previous observational findings, we investigated associations of height- and adiposity-related genetic variants with prostate cancer risk and mortality. METHODS: We conducted a case-control study based on 20,848 prostate cancers and 20,214 controls of European ancestry from 22 studies in the PRACTICAL consortium. We constructed genetic risk scores that summed each man&apos;s number of height and BMI increasing alleles across multiple single nucleotide polymorphisms robustly associated with each phenotype from published genome-wide association studies. RESULTS: The genetic risk scores explained 6.31 and 1.46% of the variability in height and BMI, respectively. There was only weak evidence that genetic variants previously associated with increased BMI were associated with a lower prostate cancer risk (odds ratio per standard deviation increase in BMI genetic score 0.98; 95% CI 0.96, 1.00; p = 0.07). Genetic variants associated with increased height were not associated with prostate cancer incidence (OR 0.99; 95% CI 0.97, 1.01; p = 0.23), but were associated with an increase (OR 1.13; 95 % CI 1.08, 1.20) in prostate cancer mortality among low-grade disease (p heterogeneity, low vs. high grade &lt;0.001). Genetic variants associated with increased BMI were associated with an increase (OR 1.08; 95 % CI 1.03, 1.14) in all-cause mortality among men with low-grade disease (p heterogeneity = 0.03). CONCLUSIONS: We found little evidence of a substantial effect of genetically elevated height or BMI on prostate cancer risk, suggesting that previously reported observational associations may reflect common environmental determinants of height or BMI and prostate cancer risk. Genetically elevated height and BMI were associated with increased mortality (prostate cancer-specific and all-cause, respectively) in men with low-grade disease, a potentially informative but novel finding that requires replication.</style></abstract><notes><style face="normal" font="default" size="100%">Davies, Neil M&#xD;Gaunt, Tom R&#xD;Lewis, Sarah J&#xD;Holly, Jeff&#xD;Donovan, Jenny L&#xD;Hamdy, Freddie C&#xD;Kemp, John P&#xD;Eeles, Rosalind&#xD;Easton, Doug&#xD;Kote-Jarai, Zsofia&#xD;Al Olama, Ali Amin&#xD;Benlloch, Sara&#xD;Muir, Kenneth&#xD;Giles, Graham G&#xD;Wiklund, Fredrik&#xD;Gronberg, Henrik&#xD;Haiman, Christopher A&#xD;Schleutker, Johanna&#xD;Nordestgaard, Borge G&#xD;Travis, Ruth C&#xD;Neal, David&#xD;Pashayan, Nora&#xD;Khaw, Kay-Tee&#xD;Stanford, Janet L&#xD;Blot, William J&#xD;Thibodeau, Stephen&#xD;Maier, Christiane&#xD;Kibel, Adam S&#xD;Cybulski, Cezary&#xD;Cannon-Albright, Lisa&#xD;Brenner, Hermann&#xD;Park, Jong&#xD;Kaneva, Radka&#xD;Batra, Jyotsna&#xD;Teixeira, Manuel R&#xD;Pandha, Hardev&#xD;Lathrop, Mark&#xD;Smith, George Davey&#xD;Martin, Richard M&#xD;eng&#xD;CA128978/CA/NCI NIH HHS/&#xD;C5047/A10692/Cancer Research UK/United Kingdom&#xD;R01 CA092447/CA/NCI NIH HHS/&#xD;1 U19 CA 148537-01/CA/NCI NIH HHS/&#xD;G1000143/Medical Research Council/United Kingdom&#xD;Department of Health/United Kingdom&#xD;1U19 CA148065/CA/NCI NIH HHS/&#xD;1U19 CA148537/CA/NCI NIH HHS/&#xD;C5047/A8384/Cancer Research UK/United Kingdom&#xD;C12292/A11174/Cancer Research UK/United Kingdom&#xD;R01 CA128978/CA/NCI NIH HHS/&#xD;G0500966/75466/Medical Research Council/United Kingdom&#xD;Canadian Institutes of Health Research/Canada&#xD;14136/Cancer Research UK/United Kingdom&#xD;U19 CA148537/CA/NCI NIH HHS/&#xD;G0401527/Medical Research Council/United Kingdom&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;C1287/A 10710/Cancer Research UK/United Kingdom&#xD;P30 CA015083/CA/NCI NIH HHS/&#xD;C18281/A19169/Cancer Research UK/United Kingdom&#xD;C5047/A7357/Cancer Research UK/United Kingdom&#xD;C5047/A3354/Cancer Research UK/United Kingdom&#xD;MC_UU_12013/9/Medical Research Council/United Kingdom&#xD;1U19 CA148112/CA/NCI NIH HHS/&#xD;C1281/A12014/Cancer Research UK/United Kingdom&#xD;U19 CA148112/CA/NCI NIH HHS/&#xD;U19 CA148065/CA/NCI NIH HHS/&#xD;C1287/A10118/Cancer Research UK/United Kingdom&#xD;C16913/A6135/Cancer Research UK/United Kingdom&#xD;A19169/Cancer Research UK/United Kingdom&#xD;MC_UU_12013/8/Medical Research Council/United Kingdom&#xD;C5047/A15007/Cancer Research UK/United Kingdom&#xD;13065/Cancer Research UK/United Kingdom&#xD;G0600705/Medical Research Council/United Kingdom&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Netherlands&#xD;Cancer Causes Control. 2015 Nov;26(11):1603-16. doi: 10.1007/s10552-015-0654-9. Epub 2015 Sep 19.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26387087</style></url></related-urls><pdf-urls><url>internal-pdf://0242672068/Davies-2015-The effects of height and BMI on p.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4596899</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s10552-015-0654-9</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>114</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">114</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Day, F.</style></author><author><style face="normal" font="default" size="100%">Karaderi, T.</style></author><author><style face="normal" font="default" size="100%">Jones, M. R.</style></author><author><style face="normal" font="default" size="100%">Meun, C.</style></author><author><style face="normal" font="default" size="100%">He, C.</style></author><author><style face="normal" font="default" size="100%">Drong, A.</style></author><author><style face="normal" font="default" size="100%">Kraft, P.</style></author><author><style face="normal" font="default" size="100%">Lin, N.</style></author><author><style face="normal" font="default" size="100%">Huang, H.</style></author><author><style face="normal" font="default" size="100%">Broer, L.</style></author><author><style face="normal" font="default" size="100%">Magi, R.</style></author><author><style face="normal" font="default" size="100%">Saxena, R.</style></author><author><style face="normal" font="default" size="100%">Laisk, T.</style></author><author><style face="normal" font="default" size="100%">Urbanek, M.</style></author><author><style face="normal" font="default" size="100%">Hayes, M. G.</style></author><author><style face="normal" font="default" size="100%">Thorleifsson, G.</style></author><author><style face="normal" font="default" size="100%">Fernandez-Tajes, J.</style></author><author><style face="normal" font="default" size="100%">Mahajan, A.</style></author><author><style face="normal" font="default" size="100%">Mullin, B. H.</style></author><author><style face="normal" font="default" size="100%">Stuckey, B. G. A.</style></author><author><style face="normal" font="default" size="100%">Spector, T. D.</style></author><author><style face="normal" font="default" size="100%">Wilson, S. G.</style></author><author><style face="normal" font="default" size="100%">Goodarzi, M. O.</style></author><author><style face="normal" font="default" size="100%">Davis, L.</style></author><author><style face="normal" font="default" size="100%">Obermayer-Pietsch, B.</style></author><author><style face="normal" font="default" size="100%">Uitterlinden, A. G.</style></author><author><style face="normal" font="default" size="100%">Anttila, V.</style></author><author><style face="normal" font="default" size="100%">Neale, B. M.</style></author><author><style face="normal" font="default" size="100%">Jarvelin, M. R.</style></author><author><style face="normal" font="default" size="100%">Fauser, B.</style></author><author><style face="normal" font="default" size="100%">Kowalska, I.</style></author><author><style face="normal" font="default" size="100%">Visser, J. A.</style></author><author><style face="normal" font="default" size="100%">Andersen, M.</style></author><author><style face="normal" font="default" size="100%">Ong, K.</style></author><author><style face="normal" font="default" size="100%">Stener-Victorin, E.</style></author><author><style face="normal" font="default" size="100%">Ehrmann, D.</style></author><author><style face="normal" font="default" size="100%">Legro, R. S.</style></author><author><style face="normal" font="default" size="100%">Salumets, A.</style></author><author><style face="normal" font="default" size="100%">McCarthy, M. I.</style></author><author><style face="normal" font="default" size="100%">Morin-Papunen, L.</style></author><author><style face="normal" font="default" size="100%">Thorsteinsdottir, U.</style></author><author><style face="normal" font="default" size="100%">Stefansson, K.</style></author><author><style face="normal" font="default" size="100%">andMe Research, Team</style></author><author><style face="normal" font="default" size="100%">Styrkarsdottir, U.</style></author><author><style face="normal" font="default" size="100%">Perry, J. R. B.</style></author><author><style face="normal" font="default" size="100%">Dunaif, A.</style></author><author><style face="normal" font="default" size="100%">Laven, J.</style></author><author><style face="normal" font="default" size="100%">Franks, S.</style></author><author><style face="normal" font="default" size="100%">Lindgren, C. M.</style></author><author><style face="normal" font="default" size="100%">Welt, C. K.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Epidemiology Unit, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.&#xD;The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.&#xD;Department of Biological Sciences, Faculty of Arts and Sciences, Eastern Mediterranean University, Famagusta, Cyprus.&#xD;Center for Bioinformatics &amp; Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.&#xD;Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.&#xD;Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America.&#xD;University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States of America.&#xD;Departments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.&#xD;Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.&#xD;Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.&#xD;Broad Institute of Harvard and MIT and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.&#xD;Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.&#xD;Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.&#xD;Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.&#xD;Department of Anthropology, Northwestern University, Evanston, Illinois, United States of America.&#xD;deCODE genetics/Amgen, Reykjavik, Iceland.&#xD;Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom.&#xD;Department of Endocrinology &amp; Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.&#xD;School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia.&#xD;Keogh Institute for Medical Research, Nedlands, Western Australia, Australia.&#xD;Department of Twin Research &amp; Genetic Epidemiology, King&apos;s College London, London, United Kingdom.&#xD;Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.&#xD;Department of Medicine, Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.&#xD;Vanderbilt Genomics Institute, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.&#xD;Division of Endocrinology and Diabetology, Department of Internal Medicine Medical University of Graz, Graz, Austria.&#xD;Stanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.&#xD;Analytic and Translational Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.&#xD;Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.&#xD;Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.&#xD;Biocenter Oulu, University of Oulu, Oulu, Finland.&#xD;Unit of Primary Care, Oulu University Hospital, Oulu, Finland.&#xD;Department of Reproductive Medicine and Gynaecology, University Medical Center, Utrecht, The Netherlands.&#xD;Department of Internal Medicine and Metabolic Diseases, Medical University of Bialystok, Bialystok, Poland.&#xD;Department of Internal Medicine, Section of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.&#xD;Odense University Hospital, University of Southern Denmark, Odense, Denmark.&#xD;Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.&#xD;Department of Medicine, Section of Adult and Paediatric Endocrinology, Diabetes, and Metabolism, The University of Chicago, Chicago, Illinois, United States of America.&#xD;Department of Obstetrics and Gynecology and Public Health Sciences, Penn State University College of Medicine, Hershey, Pennsylvania, United States of America.&#xD;Competence Centre on Health Technologies, Tartu, Estonia.&#xD;Institute of Bio- and Translational Medicine, University of Tartu, Tartu, Estonia.&#xD;Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.&#xD;Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom.&#xD;Department of Obstetrics and Gynecology, University of Oulu and Oulu University Hospital, Medical Research Center, PEDEGO Research Unit, Oulu, Finland.&#xD;Faculty of Medicine, University of Iceland, Reykjavik, Iceland.&#xD;Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.&#xD;Institute of Reproductive &amp; Developmental Biology, Department of Surgery &amp; Cancer, Imperial College London, London, United Kingdom.&#xD;Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.&#xD;Division of Endocrinology, Metabolism and Diabetes, University of Utah, Salt Lake City, Utah, United States of America.&#xD;Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1007813</style></pages><volume><style face="normal" font="default" size="100%">14</style></volume><number><style face="normal" font="default" size="100%">12</style></number><edition><style face="normal" font="default" size="100%">2018/12/20</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Asian Continental Ancestry Group/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polycystic Ovary Syndrome/*diagnosis/*genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1553-7404 (Electronic)&#xD;1553-7390 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30566500</style></accession-num><abstract><style face="normal" font="default" size="100%">Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology. Affected women frequently have metabolic disturbances including insulin resistance and dysregulation of glucose homeostasis. PCOS is diagnosed with two different sets of diagnostic criteria, resulting in a phenotypic spectrum of PCOS cases. The genetic similarities between cases diagnosed based on the two criteria have been largely unknown. Previous studies in Chinese and European subjects have identified 16 loci associated with risk of PCOS. We report a fixed-effect, inverse-weighted-variance meta-analysis from 10,074 PCOS cases and 103,164 controls of European ancestry and characterisation of PCOS related traits. We identified 3 novel loci (near PLGRKT, ZBTB16 and MAPRE1), and provide replication of 11 previously reported loci. Only one locus differed significantly in its association by diagnostic criteria; otherwise the genetic architecture was similar between PCOS diagnosed by self-report and PCOS diagnosed by NIH or non-NIH Rotterdam criteria across common variants at 13 loci. Identified variants were associated with hyperandrogenism, gonadotropin regulation and testosterone levels in affected women. Linkage disequilibrium score regression analysis revealed genetic correlations with obesity, fasting insulin, type 2 diabetes, lipid levels and coronary artery disease, indicating shared genetic architecture between metabolic traits and PCOS. Mendelian randomization analyses suggested variants associated with body mass index, fasting insulin, menopause timing, depression and male-pattern balding play a causal role in PCOS. The data thus demonstrate 3 novel loci associated with PCOS and similar genetic architecture for all diagnostic criteria. The data also provide the first genetic evidence for a male phenotype for PCOS and a causal link to depression, a previously hypothesized comorbid disease. Thus, the genetics provide a comprehensive view of PCOS that encompasses multiple diagnostic criteria, gender, reproductive potential and mental health.</style></abstract><notes><style face="normal" font="default" size="100%">Day, Felix&#xD;Karaderi, Tugce&#xD;Jones, Michelle R&#xD;Meun, Cindy&#xD;He, Chunyan&#xD;Drong, Alex&#xD;Kraft, Peter&#xD;Lin, Nan&#xD;Huang, Hongyan&#xD;Broer, Linda&#xD;Magi, Reedik&#xD;Saxena, Richa&#xD;Laisk, Triin&#xD;Urbanek, Margrit&#xD;Hayes, M Geoffrey&#xD;Thorleifsson, Gudmar&#xD;Fernandez-Tajes, Juan&#xD;Mahajan, Anubha&#xD;Mullin, Benjamin H&#xD;Stuckey, Bronwyn G A&#xD;Spector, Timothy D&#xD;Wilson, Scott G&#xD;Goodarzi, Mark O&#xD;Davis, Lea&#xD;Obermayer-Pietsch, Barbara&#xD;Uitterlinden, Andre G&#xD;Anttila, Verneri&#xD;Neale, Benjamin M&#xD;Jarvelin, Marjo-Riitta&#xD;Fauser, Bart&#xD;Kowalska, Irina&#xD;Visser, Jenny A&#xD;Andersen, Marianne&#xD;Ong, Ken&#xD;Stener-Victorin, Elisabet&#xD;Ehrmann, David&#xD;Legro, Richard S&#xD;Salumets, Andres&#xD;McCarthy, Mark I&#xD;Morin-Papunen, Laure&#xD;Thorsteinsdottir, Unnur&#xD;Stefansson, Kari&#xD;Styrkarsdottir, Unnur&#xD;Perry, John R B&#xD;Dunaif, Andrea&#xD;Laven, Joop&#xD;Franks, Steve&#xD;Lindgren, Cecilia M&#xD;Welt, Corrine K&#xD;eng&#xD;P50 HD028138/HD/NICHD NIH HHS/&#xD;MR/N015355/1/MRC_/Medical Research Council/United Kingdom&#xD;R01 HD057450/HD/NICHD NIH HHS/&#xD;R01 HD057223/HD/NICHD NIH HHS/&#xD;UM1 CA186107/CA/NCI NIH HHS/&#xD;R01 HD085227/HD/NICHD NIH HHS/&#xD;P30 CA177558/CA/NCI NIH HHS/&#xD;MR/M012638/1/MRC_/Medical Research Council/United Kingdom&#xD;U10 HD038992/HD/NICHD NIH HHS/&#xD;P50 HD044405/HD/NICHD NIH HHS/&#xD;P30 DK063491/DK/NIDDK NIH HHS/&#xD;MC_UU_12015/2/MRC_/Medical Research Council/United Kingdom&#xD;R01 HD065029/HD/NICHD NIH HHS/&#xD;G0802782/MRC_/Medical Research Council/United Kingdom&#xD;Meta-Analysis&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS Genet. 2018 Dec 19;14(12):e1007813. doi: 10.1371/journal.pgen.1007813. eCollection 2018 Dec.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30566500</style></url></related-urls><pdf-urls><url>internal-pdf://2235245805/Day-2018-Large-scale genome-wide meta-analysis.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6300389 options in 23andMe, Inc. GT, UT, KS, and US are employees of deCODE genetics/Amgen Inc. MIM serves on advisory panels for Pfizer and NovoNordisk. MIM has received honoraria from Pfizer, NovoNordisk and EliLilly, and has received research funding from Pfizer, NovoNordisk, EliLilly, AstraZeneca, Sanofi Aventis, Boehringer Ingelheim, Merck, Roche, Janssen, Takeda, and Servier. JL has received consultancy fees from Danone, Metagenics inc., Titus Healthcare, Roche and Euroscreen. CW is a consultant for Novartis and has received UptoDate royalties.</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pgen.1007813</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>72</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">72</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Day, F. R.</style></author><author><style face="normal" font="default" size="100%">Hinds, D. A.</style></author><author><style face="normal" font="default" size="100%">Tung, J. Y.</style></author><author><style face="normal" font="default" size="100%">Stolk, L.</style></author><author><style face="normal" font="default" size="100%">Styrkarsdottir, U.</style></author><author><style face="normal" font="default" size="100%">Saxena, R.</style></author><author><style face="normal" font="default" size="100%">Bjonnes, A.</style></author><author><style face="normal" font="default" size="100%">Broer, L.</style></author><author><style face="normal" font="default" size="100%">Dunger, D. B.</style></author><author><style face="normal" font="default" size="100%">Halldorsson, B. V.</style></author><author><style face="normal" font="default" size="100%">Lawlor, D. A.</style></author><author><style face="normal" font="default" size="100%">Laval, G.</style></author><author><style face="normal" font="default" size="100%">Mathieson, I.</style></author><author><style face="normal" font="default" size="100%">McCardle, W. L.</style></author><author><style face="normal" font="default" size="100%">Louwers, Y.</style></author><author><style face="normal" font="default" size="100%">Meun, C.</style></author><author><style face="normal" font="default" size="100%">Ring, S.</style></author><author><style face="normal" font="default" size="100%">Scott, R. A.</style></author><author><style face="normal" font="default" size="100%">Sulem, P.</style></author><author><style face="normal" font="default" size="100%">Uitterlinden, A. G.</style></author><author><style face="normal" font="default" size="100%">Wareham, N. J.</style></author><author><style face="normal" font="default" size="100%">Thorsteinsdottir, U.</style></author><author><style face="normal" font="default" size="100%">Welt, C.</style></author><author><style face="normal" font="default" size="100%">Stefansson, K.</style></author><author><style face="normal" font="default" size="100%">Laven, J. S. E.</style></author><author><style face="normal" font="default" size="100%">Ong, K. K.</style></author><author><style face="normal" font="default" size="100%">Perry, J. R. B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Addenbrooke&apos;s Hospital, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.&#xD;23andMe Inc., Mountain View, California 94043, USA.&#xD;Department of Internal Medicine, Erasmus MC, Rotterdam 3015 GE, The Netherlands.&#xD;deCODE Genetics/Amgen, Sturlugata 8, IS-101 Reykjavik, Iceland.&#xD;Department of Anaesthesia and Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.&#xD;Department of Paediatrics, University of Cambridge School of Clinical Medicine, Box 181, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.&#xD;Institute of Biomedical and Neural Engineering, School of Science and Engineering, Reykjavik University, Menntavegur 1, 101 Reykjavik, Iceland.&#xD;MRC Integrative Epidemiology Unit at the University of Bristol, Bristol BS8 2BN, UK.&#xD;School of Social and Community Medicine, University of Bristol, Oakfield House, Bristol BS8 2BN, UK.&#xD;Human Evolutionary Genetics, CNRS URA3012 Institut Pasteur, 28 rue du Dr. Roux, 75724 Paris Cedex 15, France.&#xD;Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.&#xD;Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Erasmus MC, Rotterdam, 3015 GE, The Netherlands.&#xD;Faculty of Medicine, University of Iceland, IS-101 Reykjavik, Iceland.&#xD;Division of Endocrinology, Metabolism and Diabetes, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome</style></title><secondary-title><style face="normal" font="default" size="100%">Nat Commun</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Nat Commun</style></full-title></periodical><pages><style face="normal" font="default" size="100%">8464</style></pages><volume><style face="normal" font="default" size="100%">6</style></volume><edition><style face="normal" font="default" size="100%">2015/09/30</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adaptor Proteins, Signal Transducing/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Aging/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">DNA Repair Enzymes/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">DNA-Binding Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">ErbB Receptors/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Follicle Stimulating Hormone, beta Subunit/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasm Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Ovary/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Phosphoproteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polycystic Ovary Syndrome/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Selection, Genetic</style></keyword><keyword><style face="normal" font="default" size="100%">Transcription Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep 29</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2041-1723 (Electronic)&#xD;2041-1723 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26416764</style></accession-num><abstract><style face="normal" font="default" size="100%">Polycystic ovary syndrome (PCOS) is the most common reproductive disorder in women, yet there is little consensus regarding its aetiology. Here we perform a genome-wide association study of PCOS in up to 5,184 self-reported cases of White European ancestry and 82,759 controls, with follow-up in a further approximately 2,000 clinically validated cases and approximately 100,000 controls. We identify six signals for PCOS at genome-wide statistical significance (P&lt;5 x 10(-8)), in/near genes ERBB4/HER4, YAP1, THADA, FSHB, RAD50 and KRR1. Variants in/near three of the four epidermal growth factor receptor genes (ERBB2/HER2, ERBB3/HER3 and ERBB4/HER4) are associated with PCOS at or near genome-wide significance. Mendelian randomization analyses indicate causal roles in PCOS aetiology for higher BMI (P=2.5 x 10(-9)), higher insulin resistance (P=6 x 10(-4)) and lower serum sex hormone binding globulin concentrations (P=5 x 10(-4)). Furthermore, genetic susceptibility to later menopause is associated with higher PCOS risk (P=1.6 x 10(-8)) and PCOS-susceptibility alleles are associated with higher serum anti-Mullerian hormone concentrations in girls (P=8.9 x 10(-5)). This large-scale study implicates an aetiological role of the epidermal growth factor receptors, infers causal mechanisms relevant to clinical management and prevention, and suggests balancing selection mechanisms involved in PCOS risk.</style></abstract><notes><style face="normal" font="default" size="100%">Day, Felix R&#xD;Hinds, David A&#xD;Tung, Joyce Y&#xD;Stolk, Lisette&#xD;Styrkarsdottir, Unnur&#xD;Saxena, Richa&#xD;Bjonnes, Andrew&#xD;Broer, Linda&#xD;Dunger, David B&#xD;Halldorsson, Bjarni V&#xD;Lawlor, Debbie A&#xD;Laval, Guillaume&#xD;Mathieson, Iain&#xD;McCardle, Wendy L&#xD;Louwers, Yvonne&#xD;Meun, Cindy&#xD;Ring, Susan&#xD;Scott, Robert A&#xD;Sulem, Patrick&#xD;Uitterlinden, Andre G&#xD;Wareham, Nicholas J&#xD;Thorsteinsdottir, Unnur&#xD;Welt, Corrine&#xD;Stefansson, Kari&#xD;Laven, Joop S E&#xD;Ong, Ken K&#xD;Perry, John R B&#xD;eng&#xD;092731/Wellcome Trust/United Kingdom&#xD;R01 DK077659/DK/NIDDK NIH HHS/&#xD;U106179472/Medical Research Council/United Kingdom&#xD;102215/Wellcome Trust/United Kingdom&#xD;MC_UU_12015/1/Medical Research Council/United Kingdom&#xD;MC_UU_12015/2/Medical Research Council/United Kingdom&#xD;MC_PC_15018/Medical Research Council/United Kingdom&#xD;U106179471/Medical Research Council/United Kingdom&#xD;R01 HD065029/HD/NICHD NIH HHS/&#xD;G0600717/Medical Research Council/United Kingdom&#xD;MC_U106179471/Medical Research Council/United Kingdom&#xD;MC_UU_12013/5/Medical Research Council/United Kingdom&#xD;R44HG006981/HG/NHGRI NIH HHS/&#xD;R44 HG006981/HG/NHGRI NIH HHS/&#xD;MC_U106179472/Medical Research Council/United Kingdom&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nat Commun. 2015 Sep 29;6:8464. doi: 10.1038/ncomms9464.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26416764</style></url></related-urls><pdf-urls><url>internal-pdf://2571637413/Day-2015-Causal mechanisms and balancing selec.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4598835</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/ncomms9464</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>139</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">139</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Debette, S.</style></author><author><style face="normal" font="default" size="100%">Wolf, C.</style></author><author><style face="normal" font="default" size="100%">Lambert, J. C.</style></author><author><style face="normal" font="default" size="100%">Crivello, F.</style></author><author><style face="normal" font="default" size="100%">Soumare, A.</style></author><author><style face="normal" font="default" size="100%">Zhu, Y. C.</style></author><author><style face="normal" font="default" size="100%">Schilling, S.</style></author><author><style face="normal" font="default" size="100%">Dufouil, C.</style></author><author><style face="normal" font="default" size="100%">Mazoyer, B.</style></author><author><style face="normal" font="default" size="100%">Amouyel, P.</style></author><author><style face="normal" font="default" size="100%">Tzourio, C.</style></author><author><style face="normal" font="default" size="100%">Elbaz, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">INSERM, Neuroepidemiology U708, Paris and Bordeaux, France; Department of Epidemiology, University of Versailles Saint-Quentin-en-Yvelines, Garches, France; Department of Neurology, Boston University School of Medicine, Boston, MA, USA; Department of Neurology, Lariboisiere Hospital, Paris 7 University, Paris, France. Electronic address: sdebette@bu.edu.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Abdominal obesity and lower gray matter volume: a Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Neurobiol Aging</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Neurobiol Aging</style></full-title></periodical><pages><style face="normal" font="default" size="100%">378-86</style></pages><volume><style face="normal" font="default" size="100%">35</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2013/09/04</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aging/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Anthropometry</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Brain/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Cerebral Infarction/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Hippocampus/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Magnetic Resonance Imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Nimodipine</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/diagnosis/*pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Organ Size</style></keyword><keyword><style face="normal" font="default" size="100%">Periaqueductal Gray/*pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Brain volume</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic</style></keyword><keyword><style face="normal" font="default" size="100%">Gray matter volume</style></keyword><keyword><style face="normal" font="default" size="100%">Mri</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity</style></keyword><keyword><style face="normal" font="default" size="100%">Population-based</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1558-1497 (Electronic)&#xD;0197-4580 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">23998998</style></accession-num><abstract><style face="normal" font="default" size="100%">We investigated the relationship of anthropometric markers of obesity with quantitative magnetic resonance imaging markers of brain aging, including measures of total brain volume (TBV), gray matter volume (GMV), hippocampal volume, white matter hyperintensity volume (WMHV), and brain infarcts, and examined causality using Mendelian randomization (MR). Analyses were performed in 1779 individuals (60.4% women, 72.8 +/- 4.1 years of age) from the 3C-Dijon population-based cohort study (N = 1555 for the MR). Larger waist-to-hip-ratio (WHR) and waist circumference (WC) were associated with lower TBV (p = 0.0001 and p = 0.005), and lower GMV (p = 0.0008 and p = 0.003), independently of age, gender, body mass index (BMI), and vascular risk factors. Higher BMI, WC, and WHR were associated with larger WMHV and WC with brain infarcts, before adjusting for vascular risk factors only. We used MR to investigate the inverse relationship between WHR and GMV. One valid instrumental variable was available in women only (rs6905288), which was associated with GMV (p = 0.015). Age and BMI-adjusted effect estimates from the MR analysis confirmed the inverse association between GMV and WHR and are in favor of a causal association.</style></abstract><notes><style face="normal" font="default" size="100%">Debette, Stephanie&#xD;Wolf, Christiane&#xD;Lambert, Jean-Charles&#xD;Crivello, Fabrice&#xD;Soumare, Aicha&#xD;Zhu, Yi-Cheng&#xD;Schilling, Sabrina&#xD;Dufouil, Carole&#xD;Mazoyer, Bernard&#xD;Amouyel, Philippe&#xD;Tzourio, Christophe&#xD;Elbaz, Alexis&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Neurobiol Aging. 2014 Feb;35(2):378-86. doi: 10.1016/j.neurobiolaging.2013.07.022. Epub 2013 Aug 31.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/23998998</style></url></related-urls><pdf-urls><url>internal-pdf://0248680197/Debette-2014-Abdominal obesity and lower gray.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.neurobiolaging.2013.07.022</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>46</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">46</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">den Hollander, W. J.</style></author><author><style face="normal" font="default" size="100%">Broer, L.</style></author><author><style face="normal" font="default" size="100%">Schurmann, C.</style></author><author><style face="normal" font="default" size="100%">Meyre, D.</style></author><author><style face="normal" font="default" size="100%">den Hoed, C. M.</style></author><author><style face="normal" font="default" size="100%">Mayerle, J.</style></author><author><style face="normal" font="default" size="100%">Hofman, A.</style></author><author><style face="normal" font="default" size="100%">Homuth, G.</style></author><author><style face="normal" font="default" size="100%">Uitterlinden, A. G.</style></author><author><style face="normal" font="default" size="100%">Lerch, M. M.</style></author><author><style face="normal" font="default" size="100%">Kuipers, E. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands. w.j.denhollander@gmail.com.&#xD;Internal Medicine, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.&#xD;The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.&#xD;The Genetics of Obesity and Related Metabolic Traits Program, Icahn School of Medicine at Mount Sinai, New York, NY, USA.&#xD;Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.&#xD;Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada.&#xD;Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.&#xD;Department of Medicine A, University Medicine Greifswald, Greifswald, Germany.&#xD;Epidemiology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.&#xD;Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.&#xD;Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Helicobacter pylori colonization and obesity - a Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Sci Rep</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Sci Rep</style></full-title></periodical><pages><style face="normal" font="default" size="100%">14467</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2017/11/02</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Germany</style></keyword><keyword><style face="normal" font="default" size="100%">Helicobacter Infections/complications</style></keyword><keyword><style face="normal" font="default" size="100%">Helicobacter pylori/*growth &amp; development/pathogenicity</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Netherlands</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*genetics/*microbiology/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Random Allocation</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct 31</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2045-2322 (Electronic)&#xD;2045-2322 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29089580</style></accession-num><abstract><style face="normal" font="default" size="100%">Obesity is associated with substantial morbidity, costs, and decreased life expectancy, and continues to rise worldwide. While etiological understanding is needed for prevention, epidemiological studies indicated that colonization with Helicobacter pylori (H. pylori) may affect body mass index (BMI), but with inconsistent results. Here, we examine the relationship between H. pylori colonization and BMI/obesity. Cross-sectional analyses were performed in two independent population-based cohorts of elderly from the Netherlands and Germany (n = 13,044). Genetic risk scores were conducted based on genetic loci associated with either H. pylori colonization or BMI/obesity. We performed a bi-directional Mendelian randomization. Meta-analysis of cross-sectional data revealed no association between anti-H. pylori IgG titer and BMI, nor of H. pylori positivity and BMI. Anti-H. pylori IgG titer was negatively associated with obesity (OR 0.99972; 95% CI 0.99946-0.99997, p = 0.03) and with obesity classes (Beta -6.91 *10(-5); 95% CI -1.38*10(-4), -5.49*10(-7), p = 0.048), but the magnitude of these effects was limited. Mendelian randomization showed no causal relation between H. pylori genetic risk score and BMI/obesity, nor between BMI or obesity genetic risk scores and H. pylori positivity. This study provides no evidence for a clinically relevant association between H. pylori and BMI/obesity.</style></abstract><notes><style face="normal" font="default" size="100%">den Hollander, Wouter J&#xD;Broer, Linda&#xD;Schurmann, Claudia&#xD;Meyre, David&#xD;den Hoed, Caroline M&#xD;Mayerle, Julia&#xD;Hofman, Albert&#xD;Homuth, Georg&#xD;Uitterlinden, Andre G&#xD;Lerch, Markus M&#xD;Kuipers, Ernst J&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Sci Rep. 2017 Oct 31;7(1):14467. doi: 10.1038/s41598-017-14106-4.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29089580</style></url></related-urls><pdf-urls><url>internal-pdf://0554836634/den Hollander-2017-Helicobacter pylori coloniz.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5663904</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s41598-017-14106-4</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>39</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">39</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Di Paola, R.</style></author><author><style face="normal" font="default" size="100%">Marucci, A.</style></author><author><style face="normal" font="default" size="100%">Fontana, A.</style></author><author><style face="normal" font="default" size="100%">Menzaghi, C.</style></author><author><style face="normal" font="default" size="100%">Salvemini, L.</style></author><author><style face="normal" font="default" size="100%">Copetti, M.</style></author><author><style face="normal" font="default" size="100%">Pellegrini, F.</style></author><author><style face="normal" font="default" size="100%">De Cosmo, S.</style></author><author><style face="normal" font="default" size="100%">Trischitta, V.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Role of obesity on all-cause mortality in whites with type 2 diabetes from Italy</style></title><secondary-title><style face="normal" font="default" size="100%">Acta Diabetol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Acta Diabetol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">971-6</style></pages><volume><style face="normal" font="default" size="100%">50</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2013/08/21</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cause of Death</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/ethnology/*mortality</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Italy/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/ethnology/*mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1432-5233 (Electronic)&#xD;0940-5429 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">23959063</style></accession-num><abstract><style face="normal" font="default" size="100%">Mortality rate of diabetic patients is twice as much that of non-diabetic individuals. The role of obesity on mortality risk in patients with type 2 diabetes is controversial. Aim of our study was to address the relationship between obesity and all-cause mortality in a real-life set of white patients with type 2 diabetes from central-southern Italy from the Gargano Mortality Study (GMS). In addition, we used genetic data from genome-wide association studies (GWAs)-derived single nucleotide polymorphisms (SNPs) firmly associated with body mass index (BMI), in order to investigate the intrinsic nature of reduced mortality rate we, in fact, observed in obese patients. Study subjects with type 2 diabetes (n = 764) are part of the GMS, which is aimed at unraveling predictors of incident all-cause mortality. Time-to-death analyses were performed by Cox regression. Association between genotype risk score and obesity was tested by logistic regression. Of the 32 SNPs firmly associated with BMI, we investigated those with BMI beta value &gt;/=0.10 kg/m(2) and allele frequency &gt;/=10 %. Genotyping was performed by KBioscience (http://www.lgcgenomics.com/). In GMS, obesity predicted a 45 % reduction in all-cause mortality. Individuals with high &quot;obesity genetic load&quot; (i.e., those carrying &gt;9 risk alleles) were 60 % more likely to be obese as compared to individuals with low &quot;obesity genetic load.&quot; Most importantly, mortality rate was not different in individuals with high and low &quot;obesity genetic load,&quot; thus indicating no role of obesity genes on all-cause mortality and speaking against a cause-effect relationship underlying the association between obesity and reduced mortality rate.</style></abstract><notes><style face="normal" font="default" size="100%">Di Paola, R&#xD;Marucci, A&#xD;Fontana, A&#xD;Menzaghi, C&#xD;Salvemini, L&#xD;Copetti, M&#xD;Pellegrini, F&#xD;De Cosmo, S&#xD;Trischitta, V&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Acta Diabetol. 2013 Dec;50(6):971-6. doi: 10.1007/s00592-013-0509-3.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/23959063</style></url></related-urls><pdf-urls><url>internal-pdf://1513321374/DiPaola-2013-Role of obesity on all-cause mort.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s00592-013-0509-3</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>153</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">153</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Disney-Hogg, L.</style></author><author><style face="normal" font="default" size="100%">Sud, A.</style></author><author><style face="normal" font="default" size="100%">Law, P. J.</style></author><author><style face="normal" font="default" size="100%">Cornish, A. J.</style></author><author><style face="normal" font="default" size="100%">Kinnersley, B.</style></author><author><style face="normal" font="default" size="100%">Ostrom, Q. T.</style></author><author><style face="normal" font="default" size="100%">Labreche, K.</style></author><author><style face="normal" font="default" size="100%">Eckel-Passow, J. E.</style></author><author><style face="normal" font="default" size="100%">Armstrong, G. N.</style></author><author><style face="normal" font="default" size="100%">Claus, E. B.</style></author><author><style face="normal" font="default" size="100%">Il&apos;yasova, D.</style></author><author><style face="normal" font="default" size="100%">Schildkraut, J.</style></author><author><style face="normal" font="default" size="100%">Barnholtz-Sloan, J. S.</style></author><author><style face="normal" font="default" size="100%">Olson, S. H.</style></author><author><style face="normal" font="default" size="100%">Bernstein, J. L.</style></author><author><style face="normal" font="default" size="100%">Lai, R. K.</style></author><author><style face="normal" font="default" size="100%">Swerdlow, A. J.</style></author><author><style face="normal" font="default" size="100%">Simon, M.</style></author><author><style face="normal" font="default" size="100%">Hoffmann, P.</style></author><author><style face="normal" font="default" size="100%">Nothen, M. M.</style></author><author><style face="normal" font="default" size="100%">Jockel, K. H.</style></author><author><style face="normal" font="default" size="100%">Chanock, S.</style></author><author><style face="normal" font="default" size="100%">Rajaraman, P.</style></author><author><style face="normal" font="default" size="100%">Johansen, C.</style></author><author><style face="normal" font="default" size="100%">Jenkins, R. B.</style></author><author><style face="normal" font="default" size="100%">Melin, B. S.</style></author><author><style face="normal" font="default" size="100%">Wrensch, M. R.</style></author><author><style face="normal" font="default" size="100%">Sanson, M.</style></author><author><style face="normal" font="default" size="100%">Bondy, M. L.</style></author><author><style face="normal" font="default" size="100%">Houlston, R. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.&#xD;Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.&#xD;Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, MI, 55905, USA.&#xD;Section of Epidemiology and Population Sciences, Department of Medicine, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.&#xD;School of Public Health, Yale University, New Haven, CT, 06510, USA.&#xD;Department of Neurosurgery, Brigham and Women&apos;s Hospital, Boston, MA, 02115, USA.&#xD;Department of Epidemiology and Biostatistics, School of Public Health, Georgia State University, Atlanta, GA, 30303, USA.&#xD;Duke Cancer Institute, Duke University Medical Center, Durham, NC, 27710, USA.&#xD;Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, 27710, USA.&#xD;Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10017, USA.&#xD;Departments of Neurology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA.&#xD;Division of Breast Cancer Research, The Institute of Cancer Research, London, SW7 3RP, UK.&#xD;Department of Neurosurgery, University of Bonn Medical Center, Sigmund-Freud-Str. 25, Bonn, 53105, Germany.&#xD;Human Genomics Research Group, Department of Biomedicine, University of Basel, Basel, 4031, Switzerland.&#xD;Department of Genomics, Life &amp; Brain Center, University of Bonn, Bonn, 53127, Germany.&#xD;Institute of Human Genetics, University of Bonn School of Medicine and University Hospital Bonn, Bonn, 53127, Germany.&#xD;Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, 45147, Germany.&#xD;Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, 20892, USA.&#xD;Danish Cancer Society Research Center, Survivorship, Danish Cancer Society, Copenhagen, 2100, Denmark.&#xD;Oncology Clinic, Finsen Centre, Rigshospitalet, University of Copenhagen, Copenhagen, 2100, Denmark.&#xD;Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MI, 55905, USA.&#xD;Department of Radiation Sciences, Umea University, Umea, 901 87, Sweden.&#xD;Department of Neurological Surgery, School of Medicine, University of California, San Francisco, CA, 94143, USA.&#xD;Institute of Human Genetics, University of California, San Franciso, CA, 94143, USA.&#xD;Sorbonne Universites UPMC Univ Paris 06 INSERM CNRS, U1127, UMR 7225, ICM, Paris, 75013, France.&#xD;AP-HP, Groupe Hospitalier Pitie-Salpetriere, Service de Neurologie 2-Mazarin, Paris, 75013, France.&#xD;Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK. richard.houlston@icr.ac.uk.&#xD;Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK. richard.houlston@icr.ac.uk.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Influence of obesity-related risk factors in the aetiology of glioma</style></title><secondary-title><style face="normal" font="default" size="100%">Br J Cancer</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Br J Cancer</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1020-1027</style></pages><volume><style face="normal" font="default" size="100%">118</style></volume><number><style face="normal" font="default" size="100%">7</style></number><edition><style face="normal" font="default" size="100%">2018/03/14</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/complications/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Linkage</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Glioma/epidemiology/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin Resistance/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Lipid Metabolism/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Waist-Hip Ratio</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1532-1827 (Electronic)&#xD;0007-0920 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29531326</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Obesity and related factors have been implicated as possible aetiological factors for the development of glioma in epidemiological observation studies. We used genetic markers in a Mendelian randomisation framework to examine whether obesity-related traits influence glioma risk. This methodology reduces bias from confounding and is not affected by reverse causation. METHODS: Genetic instruments were identified for 10 key obesity-related risk factors, and their association with glioma risk was evaluated using data from a genome-wide association study of 12,488 glioma patients and 18,169 controls. The estimated odds ratio of glioma associated with each of the genetically defined obesity-related traits was used to infer evidence for a causal relationship. RESULTS: No convincing association with glioma risk was seen for genetic instruments for body mass index, waist-to-hip ratio, lipids, type-2 diabetes, hyperglycaemia or insulin resistance. Similarly, we found no evidence to support a relationship between obesity-related traits with subtypes of glioma-glioblastoma (GBM) or non-GBM tumours. CONCLUSIONS: This study provides no evidence to implicate obesity-related factors as causes of glioma.</style></abstract><notes><style face="normal" font="default" size="100%">Disney-Hogg, Linden&#xD;Sud, Amit&#xD;Law, Philip J&#xD;Cornish, Alex J&#xD;Kinnersley, Ben&#xD;Ostrom, Quinn T&#xD;Labreche, Karim&#xD;Eckel-Passow, Jeanette E&#xD;Armstrong, Georgina N&#xD;Claus, Elizabeth B&#xD;Il&apos;yasova, Dora&#xD;Schildkraut, Joellen&#xD;Barnholtz-Sloan, Jill S&#xD;Olson, Sara H&#xD;Bernstein, Jonine L&#xD;Lai, Rose K&#xD;Swerdlow, Anthony J&#xD;Simon, Matthias&#xD;Hoffmann, Per&#xD;Nothen, Markus M&#xD;Jockel, Karl-Heinz&#xD;Chanock, Stephen&#xD;Rajaraman, Preetha&#xD;Johansen, Christoffer&#xD;Jenkins, Robert B&#xD;Melin, Beatrice S&#xD;Wrensch, Margaret R&#xD;Sanson, Marc&#xD;Bondy, Melissa L&#xD;Houlston, Richard S&#xD;eng&#xD;R01 CA139020/CA/NCI NIH HHS/&#xD;P30 CA008748/CA/NCI NIH HHS/&#xD;P30 CA125123/CA/NCI NIH HHS/&#xD;P50 CA097257/CA/NCI NIH HHS/&#xD;R01 CA207360/CA/NCI NIH HHS/&#xD;A8362/CRUK_/Cancer Research UK/United Kingdom&#xD;WT_/Wellcome Trust/United Kingdom&#xD;R01 CA052689/CA/NCI NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Br J Cancer. 2018 Apr;118(7):1020-1027. doi: 10.1038/s41416-018-0009-x. Epub 2018 Mar 13.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29531326</style></url></related-urls><pdf-urls><url>internal-pdf://1328653964/Disney-Hogg-2018-Influence of obesity-related.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5931112</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s41416-018-0009-x</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>124</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">124</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dixon, S. C.</style></author><author><style face="normal" font="default" size="100%">Nagle, C. M.</style></author><author><style face="normal" font="default" size="100%">Thrift, A. P.</style></author><author><style face="normal" font="default" size="100%">Pharoah, P. D.</style></author><author><style face="normal" font="default" size="100%">Pearce, C. L.</style></author><author><style face="normal" font="default" size="100%">Zheng, W.</style></author><author><style face="normal" font="default" size="100%">Painter, J. N.</style></author><author><style face="normal" font="default" size="100%">Aocs Group</style></author><author><style face="normal" font="default" size="100%">Australian Cancer, Study</style></author><author><style face="normal" font="default" size="100%">Chenevix-Trench, G.</style></author><author><style face="normal" font="default" size="100%">Fasching, P. A.</style></author><author><style face="normal" font="default" size="100%">Beckmann, M. W.</style></author><author><style face="normal" font="default" size="100%">Lambrechts, D.</style></author><author><style face="normal" font="default" size="100%">Vergote, I.</style></author><author><style face="normal" font="default" size="100%">Lambrechts, S.</style></author><author><style face="normal" font="default" size="100%">Van Nieuwenhuysen, E.</style></author><author><style face="normal" font="default" size="100%">Rossing, M. A.</style></author><author><style face="normal" font="default" size="100%">Doherty, J. A.</style></author><author><style face="normal" font="default" size="100%">Wicklund, K. G.</style></author><author><style face="normal" font="default" size="100%">Chang-Claude, J.</style></author><author><style face="normal" font="default" size="100%">Rudolph, A.</style></author><author><style face="normal" font="default" size="100%">Moysich, K. B.</style></author><author><style face="normal" font="default" size="100%">Odunsi, K.</style></author><author><style face="normal" font="default" size="100%">Goodman, M. T.</style></author><author><style face="normal" font="default" size="100%">Wilkens, L. R.</style></author><author><style face="normal" font="default" size="100%">Thompson, P. J.</style></author><author><style face="normal" font="default" size="100%">Shvetsov, Y. B.</style></author><author><style face="normal" font="default" size="100%">Dork, T.</style></author><author><style face="normal" font="default" size="100%">Park-Simon, T. W.</style></author><author><style face="normal" font="default" size="100%">Hillemanns, P.</style></author><author><style face="normal" font="default" size="100%">Bogdanova, N.</style></author><author><style face="normal" font="default" size="100%">Butzow, R.</style></author><author><style face="normal" font="default" size="100%">Nevanlinna, H.</style></author><author><style face="normal" font="default" size="100%">Pelttari, L. M.</style></author><author><style face="normal" font="default" size="100%">Leminen, A.</style></author><author><style face="normal" font="default" size="100%">Modugno, F.</style></author><author><style face="normal" font="default" size="100%">Ness, R. B.</style></author><author><style face="normal" font="default" size="100%">Edwards, R. P.</style></author><author><style face="normal" font="default" size="100%">Kelley, J. L.</style></author><author><style face="normal" font="default" size="100%">Heitz, F.</style></author><author><style face="normal" font="default" size="100%">Karlan, B. Y.</style></author><author><style face="normal" font="default" size="100%">Kjaer, S. K.</style></author><author><style face="normal" font="default" size="100%">Hogdall, E.</style></author><author><style face="normal" font="default" size="100%">Jensen, A.</style></author><author><style face="normal" font="default" size="100%">Goode, E. L.</style></author><author><style face="normal" font="default" size="100%">Fridley, B. L.</style></author><author><style face="normal" font="default" size="100%">Cunningham, J. M.</style></author><author><style face="normal" font="default" size="100%">Winham, S. J.</style></author><author><style face="normal" font="default" size="100%">Giles, G. G.</style></author><author><style face="normal" font="default" size="100%">Bruinsma, F.</style></author><author><style face="normal" font="default" size="100%">Milne, R. L.</style></author><author><style face="normal" font="default" size="100%">Southey, M. C.</style></author><author><style face="normal" font="default" size="100%">Hildebrandt, M. A.</style></author><author><style face="normal" font="default" size="100%">Wu, X.</style></author><author><style face="normal" font="default" size="100%">Lu, K. H.</style></author><author><style face="normal" font="default" size="100%">Liang, D.</style></author><author><style face="normal" font="default" size="100%">Levine, D. A.</style></author><author><style face="normal" font="default" size="100%">Bisogna, M.</style></author><author><style face="normal" font="default" size="100%">Schildkraut, J. M.</style></author><author><style face="normal" font="default" size="100%">Berchuck, A.</style></author><author><style face="normal" font="default" size="100%">Cramer, D. W.</style></author><author><style face="normal" font="default" size="100%">Terry, K. L.</style></author><author><style face="normal" font="default" size="100%">Bandera, E. V.</style></author><author><style face="normal" font="default" size="100%">Olson, S. H.</style></author><author><style face="normal" font="default" size="100%">Salvesen, H. B.</style></author><author><style face="normal" font="default" size="100%">Thomsen, L. C.</style></author><author><style face="normal" font="default" size="100%">Kopperud, R. K.</style></author><author><style face="normal" font="default" size="100%">Bjorge, L.</style></author><author><style face="normal" font="default" size="100%">Kiemeney, L. A.</style></author><author><style face="normal" font="default" size="100%">Massuger, L. F.</style></author><author><style face="normal" font="default" size="100%">Pejovic, T.</style></author><author><style face="normal" font="default" size="100%">Cook, L. S.</style></author><author><style face="normal" font="default" size="100%">Le, N. D.</style></author><author><style face="normal" font="default" size="100%">Swenerton, K. D.</style></author><author><style face="normal" font="default" size="100%">Brooks-Wilson, A.</style></author><author><style face="normal" font="default" size="100%">Kelemen, L. E.</style></author><author><style face="normal" font="default" size="100%">Lubinski, J.</style></author><author><style face="normal" font="default" size="100%">Huzarski, T.</style></author><author><style face="normal" font="default" size="100%">Gronwald, J.</style></author><author><style face="normal" font="default" size="100%">Menkiszak, J.</style></author><author><style face="normal" font="default" size="100%">Wentzensen, N.</style></author><author><style face="normal" font="default" size="100%">Brinton, L.</style></author><author><style face="normal" font="default" size="100%">Yang, H.</style></author><author><style face="normal" font="default" size="100%">Lissowska, J.</style></author><author><style face="normal" font="default" size="100%">Hogdall, C. K.</style></author><author><style face="normal" font="default" size="100%">Lundvall, L.</style></author><author><style face="normal" font="default" size="100%">Song, H.</style></author><author><style face="normal" font="default" size="100%">Tyrer, J. P.</style></author><author><style face="normal" font="default" size="100%">Campbell, I.</style></author><author><style face="normal" font="default" size="100%">Eccles, D.</style></author><author><style face="normal" font="default" size="100%">Paul, J.</style></author><author><style face="normal" font="default" size="100%">Glasspool, R.</style></author><author><style face="normal" font="default" size="100%">Siddiqui, N.</style></author><author><style face="normal" font="default" size="100%">Whittemore, A. S.</style></author><author><style face="normal" font="default" size="100%">Sieh, W.</style></author><author><style face="normal" font="default" size="100%">McGuire, V.</style></author><author><style face="normal" font="default" size="100%">Rothstein, J. H.</style></author><author><style face="normal" font="default" size="100%">Narod, S. A.</style></author><author><style face="normal" font="default" size="100%">Phelan, C.</style></author><author><style face="normal" font="default" size="100%">Risch, H. A.</style></author><author><style face="normal" font="default" size="100%">McLaughlin, J. R.</style></author><author><style face="normal" font="default" size="100%">Anton-Culver, H.</style></author><author><style face="normal" font="default" size="100%">Ziogas, A.</style></author><author><style face="normal" font="default" size="100%">Menon, U.</style></author><author><style face="normal" font="default" size="100%">Gayther, S. A.</style></author><author><style face="normal" font="default" size="100%">Ramus, S. J.</style></author><author><style face="normal" font="default" size="100%">Gentry-Maharaj, A.</style></author><author><style face="normal" font="default" size="100%">Wu, A. H.</style></author><author><style face="normal" font="default" size="100%">Pike, M. C.</style></author><author><style face="normal" font="default" size="100%">Tseng, C. C.</style></author><author><style face="normal" font="default" size="100%">Kupryjanczyk, J.</style></author><author><style face="normal" font="default" size="100%">Dansonka-Mieszkowska, A.</style></author><author><style face="normal" font="default" size="100%">Budzilowska, A.</style></author><author><style face="normal" font="default" size="100%">Spiewankiewicz, B.</style></author><author><style face="normal" font="default" size="100%">Webb, P. M.</style></author><author><style face="normal" font="default" size="100%">Ovarian Cancer Association, Consortium</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia The University of Queensland, School of Public Health, Brisbane, QLD, Australia Suzanne.Dixon@qimrberghofer.edu.au.&#xD;Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia The University of Queensland, School of Public Health, Brisbane, QLD, Australia.&#xD;Department of Medicine and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.&#xD;Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.&#xD;Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.&#xD;Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, TN, USA.&#xD;Molecular Cancer Epidemiology Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.&#xD;Cancer Genetics Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.&#xD;University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, Los Angeles, CA, USA University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany.&#xD;University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany.&#xD;Vesalius Research Center, VIB, Leuven, Belgium Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Belgium.&#xD;Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.&#xD;Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Department of Epidemiology, University of Washington, Seattle, WA, USA.&#xD;Department of Epidemiology, The Geisel School of Medicine at Dartmouth, Hanover, NH, USA.&#xD;Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.&#xD;German Cancer Research Center, Division of Cancer Epidemiology, Heidelberg, Germany.&#xD;Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.&#xD;Department of Gynecological Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA.&#xD;Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.&#xD;Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.&#xD;Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.&#xD;Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.&#xD;Radiation Oncology Research Unit, Hannover Medical School, Hannover, Germany.&#xD;Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.&#xD;Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.&#xD;Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA Ovarian Cancer Center of Excellence, Women&apos;s Cancer Research Program, Magee-Women&apos;s Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA.&#xD;The University of Texas School of Public Health, Houston, TX, USA.&#xD;Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA Ovarian Cancer Center of Excellence, Women&apos;s Cancer Research Program, Magee-Women&apos;s Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.&#xD;Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.&#xD;Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/ Knappschaft GmbH, Essen, Germany Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.&#xD;Women&apos;s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.&#xD;Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.&#xD;Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.&#xD;Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.&#xD;Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.&#xD;University of Kansas Medical Center, Kansas City, KS, USA.&#xD;Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.&#xD;Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.&#xD;Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.&#xD;Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia.&#xD;Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.&#xD;Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, VIC, Australia.&#xD;Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.&#xD;Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.&#xD;College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, USA.&#xD;Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.&#xD;Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA Cancer Control and Population Sciences, Duke Cancer Institute, Durham, NC, USA.&#xD;Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.&#xD;Obstetrics and Gynecology Epidemiology Center, Brigham and Women&apos;s Hospital, Boston, MA, USA.&#xD;Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.&#xD;Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.&#xD;Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway.&#xD;Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.&#xD;Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Department of Gynaecology, Nijmegen, The Netherlands.&#xD;Department of Obstetrics &amp; Gynecology, Oregon Health &amp; Science University, Portland, OR, USA Knight Cancer Institute, Oregon Health &amp; Science University, Portland, OR, USA.&#xD;Division of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA.&#xD;Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada.&#xD;Department of Medicine, University of British Columbia, Vancouver, BC, Canada.&#xD;Canada&apos;s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada.&#xD;Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.&#xD;International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.&#xD;Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland.&#xD;Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.&#xD;Department of Cancer Epidemiology and Prevention, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.&#xD;Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.&#xD;Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.&#xD;Cancer Genetics Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia Department of Pathology, University of Melbourne, Parkville, VIC, Australia.&#xD;Faculty of Medicine, University of Southampton, Southampton, UK.&#xD;The Beatson West of Scotland Cancer Centre, Glasgow, UK.&#xD;Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, UK.&#xD;Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, CA, USA.&#xD;Women&apos;s College Research Institute, University of Toronto, Toronto, ON, Canada.&#xD;Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.&#xD;Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.&#xD;Public Health Ontario, Toronto, ON, Canada.&#xD;Department of Epidemiology, University of California Irvine, Irvine, CA, USA Genetic Epidemiology Research Institute, UCI Center for Cancer Genetics Research &amp; Prevention, School of Medicine, University of California Irvine, Irvine, CA, USA.&#xD;Department of Epidemiology, University of California Irvine, Irvine, CA, USA.&#xD;Women&apos;s Cancer, Institute for Women&apos;s Health, University College London, London, UK.&#xD;Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.&#xD;Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.&#xD;Department of Gynecologic Oncology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">884-95</style></pages><volume><style face="normal" font="default" size="100%">45</style></volume><number><style face="normal" font="default" size="100%">3</style></number><edition><style face="normal" font="default" size="100%">2016/07/13</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Alleles</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Markers</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Logistic Models</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Meta-Analysis as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Multivariate Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/complications/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Ovarian Neoplasms/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*obesity</style></keyword><keyword><style face="normal" font="default" size="100%">*ovarian neoplasms</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1464-3685 (Electronic)&#xD;0300-5771 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27401727</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Observational studies have reported a positive association between body mass index (BMI) and ovarian cancer risk. However, questions remain as to whether this represents a causal effect, or holds for all histological subtypes. The lack of association observed for serous cancers may, for instance, be due to disease-associated weight loss. Mendelian randomization (MR) uses genetic markers as proxies for risk factors to overcome limitations of observational studies. We used MR to elucidate the relationship between BMI and ovarian cancer, hypothesizing that genetically predicted BMI would be associated with increased risk of non-high grade serous ovarian cancers (non-HGSC) but not HGSC. METHODS: We pooled data from 39 studies (14 047 cases, 23 003 controls) in the Ovarian Cancer Association Consortium. We constructed a weighted genetic risk score (GRS, partial F-statistic = 172), summing alleles at 87 single nucleotide polymorphisms previously associated with BMI, weighting by their published strength of association with BMI. Applying two-stage predictor-substitution MR, we used logistic regression to estimate study-specific odds ratios (OR) and 95% confidence intervals (CI) for the association between genetically predicted BMI and risk, and pooled these using random-effects meta-analysis. RESULTS: Higher genetically predicted BMI was associated with increased risk of non-HGSC (pooled OR = 1.29, 95% CI 1.03-1.61 per 5 units BMI) but not HGSC (pooled OR = 1.06, 95% CI 0.88-1.27). Secondary analyses stratified by behaviour/subtype suggested that, consistent with observational data, the association was strongest for low-grade/borderline serous cancers (OR = 1.93, 95% CI 1.33-2.81). CONCLUSIONS: Our data suggest that higher BMI increases risk of non-HGSC, but not the more common and aggressive HGSC subtype, confirming the observational evidence.</style></abstract><notes><style face="normal" font="default" size="100%">Dixon, Suzanne C&#xD;Nagle, Christina M&#xD;Thrift, Aaron P&#xD;Pharoah, Paul Dp&#xD;Pearce, Celeste Leigh&#xD;Zheng, Wei&#xD;Painter, Jodie N&#xD;(Ovarian Cancer)&#xD;Chenevix-Trench, Georgia&#xD;Fasching, Peter A&#xD;Beckmann, Matthias W&#xD;Lambrechts, Diether&#xD;Vergote, Ignace&#xD;Lambrechts, Sandrina&#xD;Van Nieuwenhuysen, Els&#xD;Rossing, Mary Anne&#xD;Doherty, Jennifer A&#xD;Wicklund, Kristine G&#xD;Chang-Claude, Jenny&#xD;Rudolph, Anja&#xD;Moysich, Kirsten B&#xD;Odunsi, Kunle&#xD;Goodman, Marc T&#xD;Wilkens, Lynne R&#xD;Thompson, Pamela J&#xD;Shvetsov, Yurii B&#xD;Dork, Thilo&#xD;Park-Simon, Tjoung-Won&#xD;Hillemanns, Peter&#xD;Bogdanova, Natalia&#xD;Butzow, Ralf&#xD;Nevanlinna, Heli&#xD;Pelttari, Liisa M&#xD;Leminen, Arto&#xD;Modugno, Francesmary&#xD;Ness, Roberta B&#xD;Edwards, Robert P&#xD;Kelley, Joseph L&#xD;Heitz, Florian&#xD;Karlan, Beth Y&#xD;Kjaer, Susanne K&#xD;Hogdall, Estrid&#xD;Jensen, Allan&#xD;Goode, Ellen L&#xD;Fridley, Brooke L&#xD;Cunningham, Julie M&#xD;Winham, Stacey J&#xD;Giles, Graham G&#xD;Bruinsma, Fiona&#xD;Milne, Roger L&#xD;Southey, Melissa C&#xD;Hildebrandt, Michelle A T&#xD;Wu, Xifeng&#xD;Lu, Karen H&#xD;Liang, Dong&#xD;Levine, Douglas A&#xD;Bisogna, Maria&#xD;Schildkraut, Joellen M&#xD;Berchuck, Andrew&#xD;Cramer, Daniel W&#xD;Terry, Kathryn L&#xD;Bandera, Elisa V&#xD;Olson, Sara H&#xD;Salvesen, Helga B&#xD;Thomsen, Liv Cecilie&#xD;Kopperud, Reidun K&#xD;Bjorge, Line&#xD;Kiemeney, Lambertus A&#xD;Massuger, Leon F A G&#xD;Pejovic, Tanja&#xD;Cook, Linda S&#xD;Le, Nhu D&#xD;Swenerton, Kenneth D&#xD;Brooks-Wilson, Angela&#xD;Kelemen, Linda E&#xD;Lubinski, Jan&#xD;Huzarski, Tomasz&#xD;Gronwald, Jacek&#xD;Menkiszak, Janusz&#xD;Wentzensen, Nicolas&#xD;Brinton, Louise&#xD;Yang, Hannah&#xD;Lissowska, Jolanta&#xD;Hogdall, Claus K&#xD;Lundvall, Lene&#xD;Song, Honglin&#xD;Tyrer, Jonathan P&#xD;Campbell, Ian&#xD;Eccles, Diana&#xD;Paul, James&#xD;Glasspool, Rosalind&#xD;Siddiqui, Nadeem&#xD;Whittemore, Alice S&#xD;Sieh, Weiva&#xD;McGuire, Valerie&#xD;Rothstein, Joseph H&#xD;Narod, Steven A&#xD;Phelan, Catherine&#xD;Risch, Harvey A&#xD;McLaughlin, John R&#xD;Anton-Culver, Hoda&#xD;Ziogas, Argyrios&#xD;Menon, Usha&#xD;Gayther, Simon A&#xD;Ramus, Susan J&#xD;Gentry-Maharaj, Aleksandra&#xD;Wu, Anna H&#xD;Pike, Malcolm C&#xD;Tseng, Chiu-Chen&#xD;Kupryjanczyk, Jolanta&#xD;Dansonka-Mieszkowska, Agnieszka&#xD;Budzilowska, Agnieszka&#xD;Spiewankiewicz, Beata&#xD;Webb, Penelope M&#xD;eng&#xD;R01 CA063682/CA/NCI NIH HHS/&#xD;UL1 TR000124/TR/NCATS NIH HHS/&#xD;P50 CA159981/CA/NCI NIH HHS/&#xD;R01 CA058860/CA/NCI NIH HHS/&#xD;C5047/A10692/Cancer Research UK/United Kingdom&#xD;K07 CA143047/CA/NCI NIH HHS/&#xD;P50 CA105009/CA/NCI NIH HHS/&#xD;R01 CA095023/CA/NCI NIH HHS/&#xD;R01 CA122443/CA/NCI NIH HHS/&#xD;M01 RR000056/RR/NCRR NIH HHS/&#xD;Department of Health/United Kingdom&#xD;P30 CA016056/CA/NCI NIH HHS/&#xD;C490/A16561/Cancer Research UK/United Kingdom&#xD;K07 CA095666/CA/NCI NIH HHS/&#xD;P30 CA008748/CA/NCI NIH HHS/&#xD;C5047/A8384/Cancer Research UK/United Kingdom&#xD;C12292/A11174/Cancer Research UK/United Kingdom&#xD;R01 CA112523/CA/NCI NIH HHS/&#xD;P30 CA072720/CA/NCI NIH HHS/&#xD;C8197/A16565/Cancer Research UK/United Kingdom&#xD;N01 CN025403/CA/NCI NIH HHS/&#xD;MOP-86727/CIHR/Canada&#xD;R01 CA063678/CA/NCI NIH HHS/&#xD;K22 CA138563/CA/NCI NIH HHS/&#xD;C1312/A15589/Cancer Research UK/United Kingdom&#xD;MSH-87734/CIHR/Canada&#xD;C1281/A12014/Cancer Research UK/United Kingdom&#xD;C536/A6689/Cancer Research UK/United Kingdom&#xD;C1287/A10710/Cancer Research UK/United Kingdom&#xD;R03 CA115195/CA/NCI NIH HHS/&#xD;C536/A13086/Cancer Research UK/United Kingdom&#xD;C1287/A10118/Cancer Research UK/United Kingdom&#xD;UM1 CA182910/CA/NCI NIH HHS/&#xD;P30 CA071789/CA/NCI NIH HHS/&#xD;P50 CA136393/CA/NCI NIH HHS/&#xD;R03 CA113148/CA/NCI NIH HHS/&#xD;C5047/A15007/Cancer Research UK/United Kingdom&#xD;10124/Cancer Research UK/United Kingdom&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Research Support, N.I.H., Intramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Int J Epidemiol. 2016 Jun;45(3):884-95. doi: 10.1093/ije/dyw158. Epub 2016 Jul 10.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27401727</style></url></related-urls><pdf-urls><url>internal-pdf://3147093454/Dixon-2016-Adult body mass index and risk of o.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5644573</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/ije/dyw158</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>122</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">122</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dongiovanni, P.</style></author><author><style face="normal" font="default" size="100%">Stender, S.</style></author><author><style face="normal" font="default" size="100%">Pietrelli, A.</style></author><author><style face="normal" font="default" size="100%">Mancina, R. M.</style></author><author><style face="normal" font="default" size="100%">Cespiati, A.</style></author><author><style face="normal" font="default" size="100%">Petta, S.</style></author><author><style face="normal" font="default" size="100%">Pelusi, S.</style></author><author><style face="normal" font="default" size="100%">Pingitore, P.</style></author><author><style face="normal" font="default" size="100%">Badiali, S.</style></author><author><style face="normal" font="default" size="100%">Maggioni, M.</style></author><author><style face="normal" font="default" size="100%">Mannisto, V.</style></author><author><style face="normal" font="default" size="100%">Grimaudo, S.</style></author><author><style face="normal" font="default" size="100%">Pipitone, R. M.</style></author><author><style face="normal" font="default" size="100%">Pihlajamaki, J.</style></author><author><style face="normal" font="default" size="100%">Craxi, A.</style></author><author><style face="normal" font="default" size="100%">Taube, M.</style></author><author><style face="normal" font="default" size="100%">Carlsson, L. M. S.</style></author><author><style face="normal" font="default" size="100%">Fargion, S.</style></author><author><style face="normal" font="default" size="100%">Romeo, S.</style></author><author><style face="normal" font="default" size="100%">Kozlitina, J.</style></author><author><style face="normal" font="default" size="100%">Valenti, L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Internal Medicine and Metabolic Diseases, Fondazione IRCCS Ca&apos; Granda Ospedale Policlinico Milano, Milan, Italy.&#xD;Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA.&#xD;Bioinformatic unit, Istituto Nazionale Genetica Molecolare, Milan, Italy.&#xD;Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.&#xD;Department of Gastroenterology, Universita di Palermo, Palermo, Italy.&#xD;Department of Surgery, Fondazione IRCCS Ca&apos; Granda Ospedale Policlinico Milano, Milan, Italy.&#xD;Department of Pathology, Fondazione IRCCS Ca&apos; Granda Ospedale Policlinico Milano, Milan, Italy.&#xD;Department of Gastroenterology, University of Eastern Finland, Kuopio University Hospital, Kuopio, Finland.&#xD;Department of Medicine, University of Eastern Finland, Kuopio University Hospital, Kuopio, Finland.&#xD;Clinical Nutrition and Obesity Center, Kuopio University Hospital, Kuopio, Finland.&#xD;Department of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.&#xD;Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.&#xD;Department of Pathophysiology and Transplantation, Universita degli Studi di Milano, Milan, Italy.&#xD;Clinical Nutrition Unit, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy.&#xD;Cardiology Department, Sahlgrenska University Hospital, Gothenburg, Sweden.&#xD;McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver</style></title><secondary-title><style face="normal" font="default" size="100%">J Intern Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Intern Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">356-370</style></pages><volume><style face="normal" font="default" size="100%">283</style></volume><number><style face="normal" font="default" size="100%">4</style></number><edition><style face="normal" font="default" size="100%">2017/12/28</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Acyltransferases/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adaptor Proteins, Signal Transducing/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adipose Tissue/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Chronic Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/complications</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Markers/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin Resistance/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Lipase/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Liver Cirrhosis/*etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Membrane Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Non-alcoholic Fatty Liver Disease/*complications</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*fibrosis</style></keyword><keyword><style face="normal" font="default" size="100%">*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*insulin resistance</style></keyword><keyword><style face="normal" font="default" size="100%">*mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*nonalcoholic fatty liver disease</style></keyword><keyword><style face="normal" font="default" size="100%">*type 2 diabetes</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1365-2796 (Electronic)&#xD;0954-6820 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29280273</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND AND AIMS: Nonalcoholic fatty liver disease is epidemiologically associated with hepatic and metabolic disorders. The aim of this study was to examine whether hepatic fat accumulation has a causal role in determining liver damage and insulin resistance. METHODS: We performed a Mendelian randomization analysis using risk alleles in PNPLA3, TM6SF2, GCKR and MBOAT7, and a polygenic risk score for hepatic fat, as instruments. We evaluated complementary cohorts of at-risk individuals and individuals from the general population: 1515 from the liver biopsy cohort (LBC), 3329 from the Swedish Obese Subjects Study (SOS) and 4570 from the population-based Dallas Heart Study (DHS). RESULTS: Hepatic fat was epidemiologically associated with liver damage, insulin resistance, dyslipidemia and hypertension. The impact of genetic variants on liver damage was proportional to their effect on hepatic fat accumulation. Genetically determined hepatic fat was associated with aminotransferases, and with inflammation, ballooning and fibrosis in the LBC. Furthermore, in the LBC, the causal association between hepatic fat and fibrosis was independent of disease activity, suggesting that a causal effect of long-term liver fat accumulation on liver disease is independent of inflammation. Genetically determined hepatic steatosis was associated with insulin resistance in the LBC and SOS. However, this association was dependent on liver damage severity. Genetically determined hepatic steatosis was associated with liver fibrosis/cirrhosis and with a small increase in risk of type 2 diabetes in publicly available databases. CONCLUSION: These data suggest that long-term hepatic fat accumulation plays a causal role in the development of chronic liver disease.</style></abstract><notes><style face="normal" font="default" size="100%">Dongiovanni, P&#xD;Stender, S&#xD;Pietrelli, A&#xD;Mancina, R M&#xD;Cespiati, A&#xD;Petta, S&#xD;Pelusi, S&#xD;Pingitore, P&#xD;Badiali, S&#xD;Maggioni, M&#xD;Mannisto, V&#xD;Grimaudo, S&#xD;Pipitone, R M&#xD;Pihlajamaki, J&#xD;Craxi, A&#xD;Taube, M&#xD;Carlsson, L M S&#xD;Fargion, S&#xD;Romeo, S&#xD;Kozlitina, J&#xD;Valenti, L&#xD;eng&#xD;UL1 TR001105/TR/NCATS NIH HHS/&#xD;R01 DK090066/DK/NIDDK NIH HHS/&#xD;P01 HL020948/HL/NHLBI NIH HHS/&#xD;Multicenter Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;J Intern Med. 2018 Apr;283(4):356-370. doi: 10.1111/joim.12719. Epub 2017 Dec 27.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29280273</style></url></related-urls><pdf-urls><url>internal-pdf://3878079093/Dongiovanni-2018-Causal relationship of hepati.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5900872</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/joim.12719</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>147</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">147</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Emdin, C. A.</style></author><author><style face="normal" font="default" size="100%">Khera, A. V.</style></author><author><style face="normal" font="default" size="100%">Natarajan, P.</style></author><author><style face="normal" font="default" size="100%">Klarin, D.</style></author><author><style face="normal" font="default" size="100%">Zekavat, S. M.</style></author><author><style face="normal" font="default" size="100%">Hsiao, A. J.</style></author><author><style face="normal" font="default" size="100%">Kathiresan, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Center for Genomic Medicine and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston2Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts.&#xD;Department of Economics, Massachusetts Institute of Technology, Cambridge.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease</style></title><secondary-title><style face="normal" font="default" size="100%">JAMA</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">JAMA</style></full-title></periodical><pages><style face="normal" font="default" size="100%">626-634</style></pages><volume><style face="normal" font="default" size="100%">317</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2017/02/15</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Blood Glucose/analysis/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Disease/blood/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/blood/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity, Abdominal/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">*Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Triglycerides/blood</style></keyword><keyword><style face="normal" font="default" size="100%">*Waist-Hip Ratio</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 14</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1538-3598 (Electronic)&#xD;0098-7484 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28196256</style></accession-num><abstract><style face="normal" font="default" size="100%">Importance: In observational studies, abdominal adiposity has been associated with type 2 diabetes and coronary heart disease (CHD). Whether these associations represent causal relationships remains uncertain. Objective: To test the association of a polygenic risk score for waist-to-hip ratio (WHR) adjusted for body mass index (BMI), a measure of abdominal adiposity, with type 2 diabetes and CHD through the potential intermediates of blood lipids, blood pressure, and glycemic phenotypes. Design, Setting, and Participants: A polygenic risk score for WHR adjusted for BMI, a measure of genetic predisposition to abdominal adiposity, was constructed with 48 single-nucleotide polymorphisms. The association of this score with cardiometabolic traits, type 2 diabetes, and CHD was tested in a mendelian randomization analysis that combined case-control and cross-sectional data sets. Estimates for cardiometabolic traits were based on a combined data set consisting of summary results from 4 genome-wide association studies conducted from 2007 to 2015, including up to 322154 participants, as well as individual-level, cross-sectional data from the UK Biobank collected from 2007-2011, including 111986 individuals. Estimates for type 2 diabetes and CHD were derived from summary statistics of 2 separate genome-wide association studies conducted from 2007 to 2015 and including 149821 individuals and 184305 individuals, respectively, combined with individual-level data from the UK Biobank. Exposures: Genetic predisposition to increased WHR adjusted for BMI. Main Outcomes and Measures: Type 2 diabetes and CHD. Results: Among 111986 individuals in the UK Biobank, the mean age was 57 (SD, 8) years, 58845 participants (52.5%) were women, and mean WHR was 0.875. Analysis of summary-level genome-wide association study results and individual-level UK Biobank data demonstrated that a 1-SD increase in WHR adjusted for BMI mediated by the polygenic risk score was associated with 27-mg/dL higher triglyceride levels, 4.1-mg/dL higher 2-hour glucose levels, and 2.1-mm Hg higher systolic blood pressure (each P &lt; .001). A 1-SD genetic increase in WHR adjusted for BMI was also associated with a higher risk of type 2 diabetes (odds ratio, 1.77 [95% CI, 1.57-2.00]; absolute risk increase per 1000 participant-years, 6.0 [95% CI, CI, 4.4-7.8]; number of participants with type 2 diabetes outcome, 40530) and CHD (odds ratio, 1.46 [95% CI, 1.32-1.62]; absolute risk increase per 1000 participant-years, 1.8 [95% CI, 1.3-2.4]; number of participants with CHD outcome, 66440). Conclusions and Relevance: A genetic predisposition to higher waist-to-hip ratio adjusted for body mass index was associated with increased risk of type 2 diabetes and coronary heart disease. These results provide evidence supportive of a causal association between abdominal adiposity and these outcomes.</style></abstract><notes><style face="normal" font="default" size="100%">Emdin, Connor A&#xD;Khera, Amit V&#xD;Natarajan, Pradeep&#xD;Klarin, Derek&#xD;Zekavat, Seyedeh M&#xD;Hsiao, Allan J&#xD;Kathiresan, Sekar&#xD;eng&#xD;KL2 TR001100/TR/NCATS NIH HHS/&#xD;MC_QA137853/Medical Research Council/United Kingdom&#xD;R01 HL127564/HL/NHLBI NIH HHS/&#xD;T32 HL007734/HL/NHLBI NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;JAMA. 2017 Feb 14;317(6):626-634. doi: 10.1001/jama.2016.21042.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28196256</style></url></related-urls><pdf-urls><url>internal-pdf://1863046895/Emdin-2017-Genetic Association of Waist-to-Hip.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5571980</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1001/jama.2016.21042</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>66</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">66</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Eriksson, J.</style></author><author><style face="normal" font="default" size="100%">Haring, R.</style></author><author><style face="normal" font="default" size="100%">Grarup, N.</style></author><author><style face="normal" font="default" size="100%">Vandenput, L.</style></author><author><style face="normal" font="default" size="100%">Wallaschofski, H.</style></author><author><style face="normal" font="default" size="100%">Lorentzen, E.</style></author><author><style face="normal" font="default" size="100%">Hansen, T.</style></author><author><style face="normal" font="default" size="100%">Mellstrom, D.</style></author><author><style face="normal" font="default" size="100%">Pedersen, O.</style></author><author><style face="normal" font="default" size="100%">Nauck, M.</style></author><author><style face="normal" font="default" size="100%">Lorentzon, M.</style></author><author><style face="normal" font="default" size="100%">Nystrup Husemoen, L. L.</style></author><author><style face="normal" font="default" size="100%">Volzke, H.</style></author><author><style face="normal" font="default" size="100%">Karlsson, M.</style></author><author><style face="normal" font="default" size="100%">Baumeister, S. E.</style></author><author><style face="normal" font="default" size="100%">Linneberg, A.</style></author><author><style face="normal" font="default" size="100%">Ohlsson, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.&#xD;University Medicine Greifswald, Institute of Clinical Chemistry and Laboratory Medicine, Greifswald, Germany.&#xD;School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.&#xD;The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.&#xD;Bioinformatics Core Facility, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.&#xD;Geriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.&#xD;Research Centre for Prevention and Health, the Capital Region, Copenhagen, Denmark.&#xD;University Medicine Greifswald, Institute for Community Medicine, Greifswald, Germany.&#xD;Clinical and Molecular Osteoporosis Research Unit, Department of Orthopaedics and Clinical Sciences, Lund University, Skane University Hospital (SUS), Malmo, Sweden.&#xD;Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.&#xD;Department of Clinical Experimental Research, Rigshospitalet, Glostrup, Denmark.&#xD;Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS One</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS One</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e0176277</style></pages><volume><style face="normal" font="default" size="100%">12</style></volume><number><style face="normal" font="default" size="100%">4</style></number><edition><style face="normal" font="default" size="100%">2017/04/28</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*blood/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Testosterone/*blood</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><isbn><style face="normal" font="default" size="100%">1932-6203 (Electronic)&#xD;1932-6203 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28448539</style></accession-num><abstract><style face="normal" font="default" size="100%">CONTEXT: Obesity in men is associated with low serum testosterone and both are associated with several diseases and increased mortality. OBJECTIVES: Examine the direction and causality of the relationship between body mass index (BMI) and serum testosterone. DESIGN: Bi-directional Mendelian randomization (MR) analysis on prospective cohorts. SETTING: Five cohorts from Denmark, Germany and Sweden (Inter99, SHIP, SHIP Trend, GOOD and MrOS Sweden). PARTICIPANTS: 7446 Caucasian men, genotyped for 97 BMI-associated SNPs and three testosterone-associated SNPs. MAIN OUTCOME MEASURES: BMI and serum testosterone adjusted for age, smoking, time of blood sampling and site. RESULTS: 1 SD genetically instrumented increase in BMI was associated with a 0.25 SD decrease in serum testosterone (IV ratio: -0.25, 95% CI: -0.42--0.09, p = 2.8*10-3). For a body weight reduction altering the BMI from 30 to 25 kg/m2, the effect would equal a 13% increase in serum testosterone. No association was seen for genetically instrumented testosterone with BMI, a finding that was confirmed using large-scale data from the GIANT consortium (n = 104349). CONCLUSIONS: Our results suggest that there is a causal effect of BMI on serum testosterone in men. Population level interventions to reduce BMI are expected to increase serum testosterone in men.</style></abstract><notes><style face="normal" font="default" size="100%">Eriksson, Joel&#xD;Haring, Robin&#xD;Grarup, Niels&#xD;Vandenput, Liesbeth&#xD;Wallaschofski, Henri&#xD;Lorentzen, Erik&#xD;Hansen, Torben&#xD;Mellstrom, Dan&#xD;Pedersen, Oluf&#xD;Nauck, Matthias&#xD;Lorentzon, Mattias&#xD;Nystrup Husemoen, Lise Lotte&#xD;Volzke, Henry&#xD;Karlsson, Magnus&#xD;Baumeister, Sebastian E&#xD;Linneberg, Allan&#xD;Ohlsson, Claes&#xD;eng&#xD;PLoS One. 2017 Apr 27;12(4):e0176277. doi: 10.1371/journal.pone.0176277. eCollection 2017.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28448539</style></url></related-urls><pdf-urls><url>internal-pdf://1743445965/Eriksson-2017-Causal relationship between obes.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5407807</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pone.0176277</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>100</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">100</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Fall, T.</style></author><author><style face="normal" font="default" size="100%">Hagg, S.</style></author><author><style face="normal" font="default" size="100%">Ploner, A.</style></author><author><style face="normal" font="default" size="100%">Magi, R.</style></author><author><style face="normal" font="default" size="100%">Fischer, K.</style></author><author><style face="normal" font="default" size="100%">Draisma, H. H.</style></author><author><style face="normal" font="default" size="100%">Sarin, A. P.</style></author><author><style face="normal" font="default" size="100%">Benyamin, B.</style></author><author><style face="normal" font="default" size="100%">Ladenvall, C.</style></author><author><style face="normal" font="default" size="100%">Akerlund, M.</style></author><author><style face="normal" font="default" size="100%">Kals, M.</style></author><author><style face="normal" font="default" size="100%">Esko, T.</style></author><author><style face="normal" font="default" size="100%">Nelson, C. P.</style></author><author><style face="normal" font="default" size="100%">Kaakinen, M.</style></author><author><style face="normal" font="default" size="100%">Huikari, V.</style></author><author><style face="normal" font="default" size="100%">Mangino, M.</style></author><author><style face="normal" font="default" size="100%">Meirhaeghe, A.</style></author><author><style face="normal" font="default" size="100%">Kristiansson, K.</style></author><author><style face="normal" font="default" size="100%">Nuotio, M. L.</style></author><author><style face="normal" font="default" size="100%">Kobl, M.</style></author><author><style face="normal" font="default" size="100%">Grallert, H.</style></author><author><style face="normal" font="default" size="100%">Dehghan, A.</style></author><author><style face="normal" font="default" size="100%">Kuningas, M.</style></author><author><style face="normal" font="default" size="100%">de Vries, P. S.</style></author><author><style face="normal" font="default" size="100%">de Bruijn, R. F.</style></author><author><style face="normal" font="default" size="100%">Willems, S. M.</style></author><author><style face="normal" font="default" size="100%">Heikkila, K.</style></author><author><style face="normal" font="default" size="100%">Silventoinen, K.</style></author><author><style face="normal" font="default" size="100%">Pietilainen, K. H.</style></author><author><style face="normal" font="default" size="100%">Legry, V.</style></author><author><style face="normal" font="default" size="100%">Giedraitis, V.</style></author><author><style face="normal" font="default" size="100%">Goumidi, L.</style></author><author><style face="normal" font="default" size="100%">Syvanen, A. C.</style></author><author><style face="normal" font="default" size="100%">Strauch, K.</style></author><author><style face="normal" font="default" size="100%">Koenig, W.</style></author><author><style face="normal" font="default" size="100%">Lichtner, P.</style></author><author><style face="normal" font="default" size="100%">Herder, C.</style></author><author><style face="normal" font="default" size="100%">Palotie, A.</style></author><author><style face="normal" font="default" size="100%">Menni, C.</style></author><author><style face="normal" font="default" size="100%">Uitterlinden, A. G.</style></author><author><style face="normal" font="default" size="100%">Kuulasmaa, K.</style></author><author><style face="normal" font="default" size="100%">Havulinna, A. S.</style></author><author><style face="normal" font="default" size="100%">Moreno, L. A.</style></author><author><style face="normal" font="default" size="100%">Gonzalez-Gross, M.</style></author><author><style face="normal" font="default" size="100%">Evans, A.</style></author><author><style face="normal" font="default" size="100%">Tregouet, D. A.</style></author><author><style face="normal" font="default" size="100%">Yarnell, J. W.</style></author><author><style face="normal" font="default" size="100%">Virtamo, J.</style></author><author><style face="normal" font="default" size="100%">Ferrieres, J.</style></author><author><style face="normal" font="default" size="100%">Veronesi, G.</style></author><author><style face="normal" font="default" size="100%">Perola, M.</style></author><author><style face="normal" font="default" size="100%">Arveiler, D.</style></author><author><style face="normal" font="default" size="100%">Brambilla, P.</style></author><author><style face="normal" font="default" size="100%">Lind, L.</style></author><author><style face="normal" font="default" size="100%">Kaprio, J.</style></author><author><style face="normal" font="default" size="100%">Hofman, A.</style></author><author><style face="normal" font="default" size="100%">Stricker, B. H.</style></author><author><style face="normal" font="default" size="100%">van Duijn, C. M.</style></author><author><style face="normal" font="default" size="100%">Ikram, M. A.</style></author><author><style face="normal" font="default" size="100%">Franco, O. H.</style></author><author><style face="normal" font="default" size="100%">Cottel, D.</style></author><author><style face="normal" font="default" size="100%">Dallongeville, J.</style></author><author><style face="normal" font="default" size="100%">Hall, A. S.</style></author><author><style face="normal" font="default" size="100%">Jula, A.</style></author><author><style face="normal" font="default" size="100%">Tobin, M. D.</style></author><author><style face="normal" font="default" size="100%">Penninx, B. W.</style></author><author><style face="normal" font="default" size="100%">Peters, A.</style></author><author><style face="normal" font="default" size="100%">Gieger, C.</style></author><author><style face="normal" font="default" size="100%">Samani, N. J.</style></author><author><style face="normal" font="default" size="100%">Montgomery, G. W.</style></author><author><style face="normal" font="default" size="100%">Whitfield, J. B.</style></author><author><style face="normal" font="default" size="100%">Martin, N. G.</style></author><author><style face="normal" font="default" size="100%">Groop, L.</style></author><author><style face="normal" font="default" size="100%">Spector, T. D.</style></author><author><style face="normal" font="default" size="100%">Magnusson, P. K.</style></author><author><style face="normal" font="default" size="100%">Amouyel, P.</style></author><author><style face="normal" font="default" size="100%">Boomsma, D. I.</style></author><author><style face="normal" font="default" size="100%">Nilsson, P. M.</style></author><author><style face="normal" font="default" size="100%">Jarvelin, M. R.</style></author><author><style face="normal" font="default" size="100%">Lyssenko, V.</style></author><author><style face="normal" font="default" size="100%">Metspalu, A.</style></author><author><style face="normal" font="default" size="100%">Strachan, D. P.</style></author><author><style face="normal" font="default" size="100%">Salomaa, V.</style></author><author><style face="normal" font="default" size="100%">Ripatti, S.</style></author><author><style face="normal" font="default" size="100%">Pedersen, N. L.</style></author><author><style face="normal" font="default" size="100%">Prokopenko, I.</style></author><author><style face="normal" font="default" size="100%">McCarthy, M. I.</style></author><author><style face="normal" font="default" size="100%">Ingelsson, E.</style></author><author><style face="normal" font="default" size="100%">Engage Consortium</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.&#xD;Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.&#xD;Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.&#xD;Estonian Genome Center, University of Tartu, Tartu, Estonia.&#xD;Department of Biological Psychology, VU University Amsterdam, Amsterdam, the Netherlands The EMGO Institute for Health and Care Research, Amsterdam, the Netherlands.&#xD;Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland Public Health Genomics Unit, National Institute for Health and Welfare, Helsinki, Finland.&#xD;Queensland Brain Institute, University of Queensland, St. Lucia, Queensland, Australia QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.&#xD;Department of Clinical Sciences, Diabetes and Endocrinology, Skane University Hospital, Lund University, Malmo, Sweden.&#xD;Estonian Genome Center, University of Tartu, Tartu, Estonia Institute of Mathematical Statistics, University of Tartu, Tartu, Estonia.&#xD;Estonian Genome Center, University of Tartu, Tartu, Estonia Division of Endocrinology, Children&apos;s Hospital Boston, Boston, MA Department of Genetics, Harvard Medical School, Boston, MA The Broad Institute, Massachusetts Institute of Technology/Harvard University, Cambridge, MA.&#xD;Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, National Institute for Health Research, Leicester, U.K. Department of Cardiovascular Sciences, University of Leicester, BHF Cardiovascular Research Centre, Glenfield Hospital, Leicester, U.K.&#xD;Institute of Health Sciences and Biocenter Oulu, University of Oulu, Oulu, Finland.&#xD;Institute of Health Sciences, University of Oulu, Oulu, Finland.&#xD;Department of Twin Research and Genetic Epidemiology, King&apos;s College London, London, U.K.&#xD;INSERM, U744, Institut Pasteur de Lille, Universite Lille Nord de France, UDSL, France.&#xD;Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.&#xD;Institute of Genetic Epidemiology, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany.&#xD;Research Unit of Molecular Epidemiology, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany Institute of Epidemiology II, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany German Center for Diabetes Research, Neuherberg, Germany.&#xD;Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.&#xD;Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands Inspectorate for Health Care, the Hague, the Netherlands.&#xD;Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands.&#xD;Department of Public Health, Hjelt Institute, University of Helsinki, Helsinki, Finland.&#xD;Department of Social Research, University of Helsinki, Helsinki, Finland.&#xD;Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland Obesity Research Unit, Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki Finland Department of Medicine, Division of Endocrinology, Helsinki University Central Hospital, Finland.&#xD;Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.&#xD;Department of Medical Sciences, Uppsala University, Uppsala, Sweden.&#xD;Institute of Genetic Epidemiology, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany Institute of Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-Universitat, Munich, Germany.&#xD;Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany.&#xD;Institut fur Humangenetik, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany.&#xD;Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Dusseldorf, Dusseldorf, Germany German Center for Diabetes Research, partner Dusseldorf, Germany.&#xD;Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland Public Health Genomics Unit, National Institute for Health and Welfare, Helsinki, Finland The Broad Institute, Massachusetts Institute of Technology/Harvard University, Cambridge, MA.&#xD;Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherland.&#xD;Growth, Exercise, Nutrition and Development Research Group, Department of Physiatry and Nursery, Faculty of Health Sciences, University of Zaragoza, Spain.&#xD;ImFine Research Group, Departamento de Salud y Rendimiento Humano, Facultad de Ciencias de la Actividad Fisica y del Deporte, Universidad Politecnica de Madrid, Madrid, Spain.&#xD;Centre for Public Health, the Queen&apos;s University of Belfast, Belfast, Northern Ireland, U.K.&#xD;Team Genomics &amp; Pathophysiology of Cardiovascular Diseases, Sorbonne Universites, Universite Pierre et Marie Curie of Paris 06, UMRS 1166, Paris, France Team Genomics &amp; Pathophysiology of Cardiovascular Diseases, INSERM, UMRS 1166, Paris, France Institute for Cardiometabolism and Nutrition, Paris, France.&#xD;Department of Cardiology, Toulouse University School of Medicine, Rangueil Hospital, Toulouse, France.&#xD;Research Center on Epidemiology and Preventive Medicine, Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy.&#xD;Department of Epidemiology and Public Health, University of Strasbourg and University Hospital of Strasbourg, Strasbourg, France.&#xD;Department of Experimental Medicine, University of Milano-Bicocca, Monza, Italy.&#xD;Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland Department of Public Health, Hjelt Institute, University of Helsinki, Helsinki, Finland National Institute for Health and Welfare, Helsinki, Finland.&#xD;Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands Inspectorate for Health Care, the Hague, the Netherlands Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherland.&#xD;Leeds Institute of Genetics, Health and Therapeutics, University of Leeds, Leeds, U.K.&#xD;Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland.&#xD;Department of Health Sciences and Genetics, University of Leicester, Leicester, U.K.&#xD;The EMGO Institute for Health and Care Research, Amsterdam, the Netherlands Department of Psychiatry, VU University Medical Center, Amsterdam, the Netherlands.&#xD;Institute of Epidemiology II, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany.&#xD;Institute of Genetic Epidemiology, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany Research Unit of Molecular Epidemiology, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany Institute of Epidemiology II, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany.&#xD;QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.&#xD;Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland Department of Clinical Sciences, Diabetes and Endocrinology, Skane University Hospital, Lund University, Malmo, Sweden.&#xD;Department of Clinical Sciences, Lund University, Malmo, Sweden.&#xD;Institute of Health Sciences and Biocenter Oulu, University of Oulu, Oulu, Finland Department of Children, Young People and Families, National Institute for Health and Welfare, Oulu, Finland Department of Epidemiology and Biostatistics, Medical Research Council Health Protection Agency, Centre for Environment &amp; Health, School of Public Health, Imperial College London, U.K. Unit of Primary Care, Oulu University Hospital, Oulu, Finland.&#xD;Department of Clinical Sciences, Diabetes and Endocrinology, Skane University Hospital, Lund University, Malmo, Sweden Steno Diabetes Center, Gentofte, Denmark.&#xD;St. George&apos;s, University of London, London, U.K.&#xD;Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland Public Health Genomics Unit, National Institute for Health and Welfare, Helsinki, Finland Department of Public Health, Hjelt Institute, University of Helsinki, Helsinki, Finland Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.&#xD;Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K. Department of Genomics of Common Disease, School of Public Health, Imperial College London, London, U.K. Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K.&#xD;Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K. Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K. Oxford National Institute for Health Research Biomedical Research Centre, Churchill Hospital, Oxford, U.K.&#xD;Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K. erik.ingelsson@medsci.uu.se.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Age- and sex-specific causal effects of adiposity on cardiovascular risk factors</style></title><secondary-title><style face="normal" font="default" size="100%">Diabetes</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Diabetes</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1841-52</style></pages><volume><style face="normal" font="default" size="100%">64</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2015/02/26</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Aging/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure</style></keyword><keyword><style face="normal" font="default" size="100%">C-Reactive Protein/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular Diseases/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol, HDL/blood/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Interleukin-6</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Sex Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Triglycerides/blood/metabolism</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1939-327X (Electronic)&#xD;0012-1797 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">25712996</style></accession-num><abstract><style face="normal" font="default" size="100%">Observational studies have reported different effects of adiposity on cardiovascular risk factors across age and sex. Since cardiovascular risk factors are enriched in obese individuals, it has not been easy to dissect the effects of adiposity from those of other risk factors. We used a Mendelian randomization approach, applying a set of 32 genetic markers to estimate the causal effect of adiposity on blood pressure, glycemic indices, circulating lipid levels, and markers of inflammation and liver disease in up to 67,553 individuals. All analyses were stratified by age (cutoff 55 years of age) and sex. The genetic score was associated with BMI in both nonstratified analysis (P = 2.8 x 10(-107)) and stratified analyses (all P &lt; 3.3 x 10(-30)). We found evidence of a causal effect of adiposity on blood pressure, fasting levels of insulin, C-reactive protein, interleukin-6, HDL cholesterol, and triglycerides in a nonstratified analysis and in the &lt;55-year stratum. Further, we found evidence of a smaller causal effect on total cholesterol (P for difference = 0.015) in the &gt;/=55-year stratum than in the &lt;55-year stratum, a finding that could be explained by biology, survival bias, or differential medication. In conclusion, this study extends previous knowledge of the effects of adiposity by providing sex- and age-specific causal estimates on cardiovascular risk factors.</style></abstract><notes><style face="normal" font="default" size="100%">Fall, Tove&#xD;Hagg, Sara&#xD;Ploner, Alexander&#xD;Magi, Reedik&#xD;Fischer, Krista&#xD;Draisma, Harmen H M&#xD;Sarin, Antti-Pekka&#xD;Benyamin, Beben&#xD;Ladenvall, Claes&#xD;Akerlund, Mikael&#xD;Kals, Mart&#xD;Esko, Tonu&#xD;Nelson, Christopher P&#xD;Kaakinen, Marika&#xD;Huikari, Ville&#xD;Mangino, Massimo&#xD;Meirhaeghe, Aline&#xD;Kristiansson, Kati&#xD;Nuotio, Marja-Liisa&#xD;Kobl, Michael&#xD;Grallert, Harald&#xD;Dehghan, Abbas&#xD;Kuningas, Maris&#xD;de Vries, Paul S&#xD;de Bruijn, Renee F A G&#xD;Willems, Sara M&#xD;Heikkila, Kauko&#xD;Silventoinen, Karri&#xD;Pietilainen, Kirsi H&#xD;Legry, Vanessa&#xD;Giedraitis, Vilmantas&#xD;Goumidi, Louisa&#xD;Syvanen, Ann-Christine&#xD;Strauch, Konstantin&#xD;Koenig, Wolfgang&#xD;Lichtner, Peter&#xD;Herder, Christian&#xD;Palotie, Aarno&#xD;Menni, Cristina&#xD;Uitterlinden, Andre G&#xD;Kuulasmaa, Kari&#xD;Havulinna, Aki S&#xD;Moreno, Luis A&#xD;Gonzalez-Gross, Marcela&#xD;Evans, Alun&#xD;Tregouet, David-Alexandre&#xD;Yarnell, John W G&#xD;Virtamo, Jarmo&#xD;Ferrieres, Jean&#xD;Veronesi, Giovanni&#xD;Perola, Markus&#xD;Arveiler, Dominique&#xD;Brambilla, Paolo&#xD;Lind, Lars&#xD;Kaprio, Jaakko&#xD;Hofman, Albert&#xD;Stricker, Bruno H&#xD;van Duijn, Cornelia M&#xD;Ikram, M Arfan&#xD;Franco, Oscar H&#xD;Cottel, Dominique&#xD;Dallongeville, Jean&#xD;Hall, Alistair S&#xD;Jula, Antti&#xD;Tobin, Martin D&#xD;Penninx, Brenda W&#xD;Peters, Annette&#xD;Gieger, Christian&#xD;Samani, Nilesh J&#xD;Montgomery, Grant W&#xD;Whitfield, John B&#xD;Martin, Nicholas G&#xD;Groop, Leif&#xD;Spector, Tim D&#xD;Magnusson, Patrik K&#xD;Amouyel, Philippe&#xD;Boomsma, Dorret I&#xD;Nilsson, Peter M&#xD;Jarvelin, Marjo-Riitta&#xD;Lyssenko, Valeriya&#xD;Metspalu, Andres&#xD;Strachan, David P&#xD;Salomaa, Veikko&#xD;Ripatti, Samuli&#xD;Pedersen, Nancy L&#xD;Prokopenko, Inga&#xD;McCarthy, Mark I&#xD;Ingelsson, Erik&#xD;eng&#xD;RC2 MH089951/MH/NIMH NIH HHS/&#xD;G1001799/Medical Research Council/United Kingdom&#xD;R01 MH063706/MH/NIMH NIH HHS/&#xD;British Heart Foundation/United Kingdom&#xD;R01 AA007535/AA/NIAAA NIH HHS/&#xD;N01-RC-45035/RC/CCR NIH HHS/&#xD;090532/Wellcome Trust/United Kingdom&#xD;R01 AA014041/AA/NIAAA NIH HHS/&#xD;R01 MH081802/MH/NIMH NIH HHS/&#xD;R01 HL087679/HL/NHLBI NIH HHS/&#xD;RC2 MH089995/MH/NIMH NIH HHS/&#xD;AA-10248/AA/NIAAA NIH HHS/&#xD;079895/Wellcome Trust/United Kingdom&#xD;MH-081802/MH/NIMH NIH HHS/&#xD;AA-07535/AA/NIAAA NIH HHS/&#xD;U01-DK-062418/DK/NIDDK NIH HHS/&#xD;1RC2-MH-089951-01/MH/NIMH NIH HHS/&#xD;G0500539/Medical Research Council/United Kingdom&#xD;R01-D0042157-01A/PHS HHS/&#xD;1RC2-MH-089995-01/MH/NIMH NIH HHS/&#xD;MR/N01104X/1/Medical Research Council/United Kingdom&#xD;5R01MH63706-02/MH/NIMH NIH HHS/&#xD;U01 DK062418/DK/NIDDK NIH HHS/&#xD;U24 MH068457/MH/NIMH NIH HHS/&#xD;G0902313/Medical Research Council/United Kingdom&#xD;N01RC37004/RC/CCR NIH HHS/&#xD;U24-MH-068457-06/MH/NIMH NIH HHS/&#xD;068545/Z/02/Wellcome Trust/United Kingdom&#xD;5R01HL087679-02/HL/NHLBI NIH HHS/&#xD;098381/Wellcome Trust/United Kingdom&#xD;RL1 MH083268/MH/NIMH NIH HHS/&#xD;N01 CN045165/CN/NCI NIH HHS/&#xD;RC2MH089951/MH/NIMH NIH HHS/&#xD;76113/B/04/Z/Wellcome Trust/United Kingdom&#xD;G0000934/Medical Research Council/United Kingdom&#xD;MR/L01629X/1/Medical Research Council/United Kingdom&#xD;AA-014041/AA/NIAAA NIH HHS/&#xD;G0600705/Medical Research Council/United Kingdom&#xD;Research Support, American Recovery and Reinvestment Act&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Diabetes. 2015 May;64(5):1841-52. doi: 10.2337/db14-0988. Epub 2015 Feb 23.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/25712996</style></url></related-urls><pdf-urls><url>internal-pdf://2320196847/Fall-2015-Age- and sex-specific causal effects.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4407863</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.2337/db14-0988</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>162</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">162</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Fan, H. Y.</style></author><author><style face="normal" font="default" size="100%">Huang, Y. T.</style></author><author><style face="normal" font="default" size="100%">Hsieh, R. H.</style></author><author><style face="normal" font="default" size="100%">Chao, J. C.</style></author><author><style face="normal" font="default" size="100%">Tung, Y. C.</style></author><author><style face="normal" font="default" size="100%">Lee, Y. L.</style></author><author><style face="normal" font="default" size="100%">Chen, Y. C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Family Medicine, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan; Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.&#xD;Institute of Statistical Science, Academia Sinica, Taiwan.&#xD;School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan.&#xD;School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan; Master Program in Global Health and Development, Taipei Medical University, Taipei, Taiwan; Nutrition Research Center, Taipei Medical University Hospital, Taipei, Taiwan.&#xD;Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.&#xD;Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. Electronic address: leolee@ntu.edu.tw.&#xD;Department of Family Medicine, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan; School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan; Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University, Taipei, Taiwan. Electronic address: melisa26@gmail.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Birthweight, time-varying adiposity growth and early menarche in girls: A Mendelian randomisation and mediation analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Obes Res Clin Pract</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Obes Res Clin Pract</style></full-title></periodical><pages><style face="normal" font="default" size="100%">445-451</style></pages><volume><style face="normal" font="default" size="100%">12</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2018/08/08</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Birth Weight/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Menarche/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Pediatric Obesity/genetics/*physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">*Adiposity growth</style></keyword><keyword><style face="normal" font="default" size="100%">*Birthweight</style></keyword><keyword><style face="normal" font="default" size="100%">*Early menarche</style></keyword><keyword><style face="normal" font="default" size="100%">*Mediation analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomisation</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep - Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1871-403X (Print)&#xD;1871-403X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30082248</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To explore the causal effect of time-varying z-BMI growth on early menarche using Mendelian randomisation (MR); to identify critical adiposity predictors of early menarche; to compare the effects of birthweight and time-varying z-BMI growth as mediators of the path from genes to early menarche using mediation analysis. METHODS: We used data from the Taiwan Children Health Study with 21 obesity-related single-nucleotide polymorphisms (SNPs) to yield genetic (instrumental variable)IVs for adiposity. Children with available data on genotyping, birthweight, adiposity, and menarcheal age were included. RESULTS: In MR analyses, results based on the time-varying z-BMI growth show more statistical power and capture more information of adiposity growth (p=0.01) than those based on single point z-BMI (p=0.02). Among adiposity measures, critical predictors of early menarche are fat free mass (RR=1.33, 95% CI 1.07-1.65) and waist/height ratio (RR=1.27, 95% CI 1.03-1.56). Other potential predictors of early menarche are sum of skinfold (RR=1.24, 95% CI 1.03-1.48) and total body fat (RR=1.20, 95% CI 1.05-1.38). In both one-mediation and multi-mediation analyses, time-varying z-BMI growth in the prepubertal years plays a crucial mediator in the pathway from the genes to early menarche. CONCLUSIONS: This study discovered that greater prepubertal adiposity growth is a crucial mediator in the path from genes to early menarche. For girls with genes positively associated with obesity; and/or of lower birthweight, a strategy to prevent childhood adiposity should be implemented in order to avoid early menarche development.</style></abstract><notes><style face="normal" font="default" size="100%">Fan, Hsien-Yu&#xD;Huang, Yen-Tsung&#xD;Hsieh, Rong-Hong&#xD;Chao, Jane C-J&#xD;Tung, Yi-Ching&#xD;Lee, Yungling L&#xD;Chen, Yang-Ching&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Netherlands&#xD;Obes Res Clin Pract. 2018 Sep - Oct;12(5):445-451. doi: 10.1016/j.orcp.2018.07.008. Epub 2018 Aug 3.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30082248</style></url></related-urls><pdf-urls><url>internal-pdf://0309773297/Fan-2018-Birthweight, time-varying adiposity g.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.orcp.2018.07.008</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>113</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">113</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gao, C.</style></author><author><style face="normal" font="default" size="100%">Patel, C. J.</style></author><author><style face="normal" font="default" size="100%">Michailidou, K.</style></author><author><style face="normal" font="default" size="100%">Peters, U.</style></author><author><style face="normal" font="default" size="100%">Gong, J.</style></author><author><style face="normal" font="default" size="100%">Schildkraut, J.</style></author><author><style face="normal" font="default" size="100%">Schumacher, F. R.</style></author><author><style face="normal" font="default" size="100%">Zheng, W.</style></author><author><style face="normal" font="default" size="100%">Boffetta, P.</style></author><author><style face="normal" font="default" size="100%">Stucker, I.</style></author><author><style face="normal" font="default" size="100%">Willett, W.</style></author><author><style face="normal" font="default" size="100%">Gruber, S.</style></author><author><style face="normal" font="default" size="100%">Easton, D. F.</style></author><author><style face="normal" font="default" size="100%">Hunter, D. J.</style></author><author><style face="normal" font="default" size="100%">Sellers, T. A.</style></author><author><style face="normal" font="default" size="100%">Haiman, C.</style></author><author><style face="normal" font="default" size="100%">Henderson, B. E.</style></author><author><style face="normal" font="default" size="100%">Hung, R. J.</style></author><author><style face="normal" font="default" size="100%">Amos, C.</style></author><author><style face="normal" font="default" size="100%">Pierce, B. L.</style></author><author><style face="normal" font="default" size="100%">Lindstrom, S.</style></author><author><style face="normal" font="default" size="100%">Kraft, P.</style></author><author><style face="normal" font="default" size="100%">the Colorectal Transdisciplinary, Study</style></author><author><style face="normal" font="default" size="100%">Discovery, Biology</style></author><author><style face="normal" font="default" size="100%">Risk of Inherited Variants in Breast, Cancer</style></author><author><style face="normal" font="default" size="100%">Elucidating Loci Involved in Prostate Cancer, Susceptibility</style></author><author><style face="normal" font="default" size="100%">Follow-up of Ovarian Cancer Genetic, Association</style></author><author><style face="normal" font="default" size="100%">Interaction, Studies</style></author><author><style face="normal" font="default" size="100%">Transdisciplinary Research in Cancer of the, Lung</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.&#xD;Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.&#xD;Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK, Department of Electron Microscopy/Molecular Pathology, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus and.&#xD;Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.&#xD;Cancer Prevention, Detection &amp; Control Research Program, Duke Cancer Institute, Durham, NC, USA, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.&#xD;Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.&#xD;Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA.&#xD;Tisch Cancer institute and Institute for Transitional Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.&#xD;Centre for Research in Epidemiology and Population Health, INSERM, Villejuif, France.&#xD;Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA, Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.&#xD;USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.&#xD;Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK, Department of Oncology, University of Cambridge, Cambridge, UK.&#xD;Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.&#xD;Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.&#xD;Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.&#xD;Center for Genomic Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.&#xD;Department of Public Health Studies, University of Chicago, Chicago, IL, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">896-908</style></pages><volume><style face="normal" font="default" size="100%">45</style></volume><number><style face="normal" font="default" size="100%">3</style></number><edition><style face="normal" font="default" size="100%">2016/07/19</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Colorectal Neoplasms/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Lung Neoplasms/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasms/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Ovarian Neoplasms/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">*Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Prostatic Neoplasms/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Regression Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*Waist-Hip Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">*Cancer risk</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*post-GWAS study</style></keyword><keyword><style face="normal" font="default" size="100%">*waist-to-hip ratio</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1464-3685 (Electronic)&#xD;0300-5771 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27427428</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Adiposity traits have been associated with risk of many cancers in observational studies, but whether these associations are causal is unclear. Mendelian randomization (MR) uses genetic predictors of risk factors as instrumental variables to eliminate reverse causation and reduce confounding bias. We performed MR analyses to assess the possible causal relationship of birthweight, childhood and adult body mass index (BMI), and waist-hip ratio (WHR) on the risks of breast, ovarian, prostate, colorectal and lung cancers. METHODS: We tested the association between genetic risk scores and each trait using summary statistics from published genome-wide association studies (GWAS) and from 51 537 cancer cases and 61 600 controls in the Genetic Associations and Mechanisms in Oncology (GAME-ON) Consortium. RESULTS: We found an inverse association between the genetic score for childhood BMI and risk of breast cancer [odds ratio (OR) = 0.71 per standard deviation (s.d.) increase in childhood BMI; 95% confidence interval (CI): 0.60, 0.80; P = 6.5 x 10(-5)). We also found the genetic score for adult BMI to be inversely associated with breast cancer risk (OR = 0.66 per s.d. increase in BMI; 95% CI: 0.57, 0.77; P = 2.5 x 10(-7)), and positively associated with ovarian cancer (OR = 1.35; 95% CI: 1.05, 1.72; P = 0.017), lung cancer (OR = 1.27; 95% CI: 1.09, 1.49; P = 2.9 x 10(-3)) and colorectal cancer (OR = 1.39; 95% CI: 1.06, 1.82, P = 0.016). The inverse association between genetically predicted adult BMI and breast cancer risk remained even after adjusting for directional pleiotropy via MR-Egger regression. CONCLUSIONS: Findings from this study provide additional understandings of the complex relationship between adiposity and cancer risks. Our results for breast and lung cancer are particularly interesting, given previous reports of effect heterogeneity by menopausal status and smoking status.</style></abstract><notes><style face="normal" font="default" size="100%">Gao, Chi&#xD;Patel, Chirag J&#xD;Michailidou, Kyriaki&#xD;Peters, Ulrike&#xD;Gong, Jian&#xD;Schildkraut, Joellen&#xD;Schumacher, Fredrick R&#xD;Zheng, Wei&#xD;Boffetta, Paolo&#xD;Stucker, Isabelle&#xD;Willett, Walter&#xD;Gruber, Stephen&#xD;Easton, Douglas F&#xD;Hunter, David J&#xD;Sellers, Thomas A&#xD;Haiman, Christopher&#xD;Henderson, Brian E&#xD;Hung, Rayjean J&#xD;Amos, Christopher&#xD;Pierce, Brandon L&#xD;Lindstrom, Sara&#xD;Kraft, Peter&#xD;(CORECT)&#xD;(DRIVE)&#xD;(ELLIPSE)&#xD;(FOCI)&#xD;(TRICL)&#xD;eng&#xD;P30 CA023108/CA/NCI NIH HHS/&#xD;R00 ES023504/ES/NIEHS NIH HHS/&#xD;R21 ES025052/ES/NIEHS NIH HHS/&#xD;U19 CA148107/CA/NCI NIH HHS/&#xD;U19 CA148065/CA/NCI NIH HHS/&#xD;U19 CA148537/CA/NCI NIH HHS/&#xD;U19 CA148112/CA/NCI NIH HHS/&#xD;U19 CA148127/CA/NCI NIH HHS/&#xD;K99 ES023504/ES/NIEHS NIH HHS/&#xD;C1287/A16563/Cancer Research UK/United Kingdom&#xD;C150/A5660/Cancer Research UK/United Kingdom&#xD;C1178/A3947/Cancer Research UK/United Kingdom&#xD;076113/Wellcome Trust/United Kingdom&#xD;085475/Wellcome Trust/United Kingdom&#xD;R01 CA114343/CA/NCI NIH HHS/&#xD;C490/A8339/Cancer Research UK/United Kingdom&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Int J Epidemiol. 2016 Jun;45(3):896-908. doi: 10.1093/ije/dyw129. Epub 2016 Jul 17.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27427428</style></url></related-urls><pdf-urls><url>internal-pdf://0800179723/Gao-2016-Mendelian randomization study of adip.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6372135</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/ije/dyw129</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>143</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">143</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Geng, T.</style></author><author><style face="normal" font="default" size="100%">Smith, C. E.</style></author><author><style face="normal" font="default" size="100%">Li, C.</style></author><author><style face="normal" font="default" size="100%">Huang, T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Epidemiology Domain, Saw Swee Hock School of Public Health, National University of Singapore, Singapore.&#xD;Nutrition and Genomics Laboratory, Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA.&#xD;Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA.&#xD;Epidemiology Domain, Saw Swee Hock School of Public Health, National University of Singapore, Singapore huangtao@bjmu.edu.cn.&#xD;Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Childhood BMI and Adult Type 2 Diabetes, Coronary Artery Diseases, Chronic Kidney Disease, and Cardiometabolic Traits: A Mendelian Randomization Analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Diabetes Care</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Diabetes Care</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1089-1096</style></pages><volume><style face="normal" font="default" size="100%">41</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2018/02/28</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Age Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child Development/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Artery Disease/epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Complications/*epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/*epidemiology/*genetics/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Insulin Resistance/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Renal Insufficiency, Chronic/epidemiology/genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1935-5548 (Electronic)&#xD;0149-5992 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29483184</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To test the causal effect of childhood BMI on adult cardiometabolic diseases using a Mendelian randomization analysis. RESEARCH DESIGN AND METHODS: We used 15 single nucleotide polymorphisms as instrumental variables for childhood BMI to test the causal effect of childhood BMI on cardiometabolic diseases using summary-level data from consortia. RESULTS: We found that a 1-SD increase in childhood BMI (kg/m(2)) was associated with an 83% increase in risk of type 2 diabetes (odds ratio [OR] 1.83 [95% CI 1.46, 2.30]; P = 2.5 x 10(-7)) and a 28% increase in risk of coronary artery disease (CAD) (OR 1.28 [95% CI 1.17, 1.39]; P = 2.1 x 10(-8)) at the Bonferroni-adjusted level of significance (P &lt; 0.017) in adults. In addition, a 1-SD increase in childhood BMI was associated with a 0.587-SD increase in adulthood BMI (kg/m(2)), a 0.062-SD increase in hip circumference (cm), a 0.602-SD increase in waist circumference (cm), a 0.111 pmol/L increase in log fasting insulin, a 0.068 increase in log-transformed HOMA of ss-cell function (%), a 0.126 increase in log-transformed HOMA of insulin resistance (%), and a 0.109-SD increase in triglyceride (mg/dL) but a 0.138-SD decrease in HDL (mg/dL) in adults at the Bonferroni-adjusted level of significance (P &lt; 0.0026). CONCLUSIONS: A genetic predisposition to higher childhood BMI was associated with increased risk of type 2 diabetes and CAD in adult life. These results provide evidence supportive of a causal association between childhood BMI and these outcomes.</style></abstract><notes><style face="normal" font="default" size="100%">Geng, Tingting&#xD;Smith, Caren E&#xD;Li, Changwei&#xD;Huang, Tao&#xD;eng&#xD;Diabetes Care. 2018 May;41(5):1089-1096. doi: 10.2337/dc17-2141. Epub 2018 Feb 26.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29483184</style></url></related-urls><pdf-urls><url>internal-pdf://4009320469/Geng-2018-Childhood BMI and Adult Type 2 Diabe.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.2337/dc17-2141</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>94</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">94</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Geng, T. T.</style></author><author><style face="normal" font="default" size="100%">Huang, T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Saw Swee Hock School of Public Health, National University of Singapore, Singapore, 117549, Singapore.&#xD;Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, 38 Xueyuan Road, Haidian District, Beijing, 100191, China. huangtao@bjmu.edu.cn.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Maternal central obesity and birth size: a Mendelian randomization analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Lipids Health Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Lipids Health Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">181</style></pages><volume><style face="normal" font="default" size="100%">17</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2018/08/02</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Birth Weight/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Height/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity, Abdominal/*genetics/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy</style></keyword><keyword><style face="normal" font="default" size="100%">Puberty/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Waist Circumference/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Waist-Hip Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Birth length</style></keyword><keyword><style face="normal" font="default" size="100%">Birth size</style></keyword><keyword><style face="normal" font="default" size="100%">Birth weight</style></keyword><keyword><style face="normal" font="default" size="100%">Maternal central obesity</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">Puberty height</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul 31</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-511X (Electronic)&#xD;1476-511X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30064420</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Observational studies have illustrated that maternal central obesity is associated with birth size, including of birth weight, birth length and head circumference, but the causal nature of these associations remains unclear. Our study aimed to test the causal effect of maternal central obesity on birth size and puberty height growth using a Mendelian randomization (MR) analysis. METHODS: We performed two-sample MR using summary-level genome-wide public data. Thirty-five single nucleotide polymorphisms (SNPs), 25 SNPs and 41 SNPs were selected as instrumental variables for waist-to-hip ratio adjusted for BMI, waist circumference adjusted for BMI and hip circumference adjusted for BMI, respectively to test the causal effects of maternal central obesity on birth size and puberty height using an inverse-variance-weighted approach. RESULTS: In this MR analysis, we found no evidence of a causal association between waist circumference or waist-to-hip ratio and the outcomes. However, we observed that one standard deviation (SD) increase in hip circumference (HIP) was associated with a 0.392 SD increase in birth length (p = 1.1 x 10(- 6)) and a 0.168 SD increase in birth weight (p = 7.1 x 10(- 5)), respectively at the Bonferroni-adjusted level of significance. In addition, higher genetically predicted maternal HIP was strongly associated with the puberty heights (0.835 SD, p = 8.4 x 10(- 10)). However, HIP was not associated with head circumference (p = 0.172). CONCLUSIONS: A genetic predisposition to higher maternal HIP was causally associated with larger offspring birth size independent of maternal BMI. However, we found no evidence of a causal association between maternal waist circumference, waist-to-hip ratio and birth size.</style></abstract><notes><style face="normal" font="default" size="100%">Geng, Ting-Ting&#xD;Huang, Tao&#xD;eng&#xD;England&#xD;Lipids Health Dis. 2018 Jul 31;17(1):181. doi: 10.1186/s12944-018-0831-4.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30064420</style></url></related-urls><pdf-urls><url>internal-pdf://2988246894/Geng-2018-Maternal central obesity and birth s.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6069873</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s12944-018-0831-4</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>70</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">70</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gharahkhani, P.</style></author><author><style face="normal" font="default" size="100%">Ong, J. S.</style></author><author><style face="normal" font="default" size="100%">An, J.</style></author><author><style face="normal" font="default" size="100%">Law, M. H.</style></author><author><style face="normal" font="default" size="100%">Whiteman, D. C.</style></author><author><style face="normal" font="default" size="100%">Neale, R. E.</style></author><author><style face="normal" font="default" size="100%">MacGregor, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. Puya.Gharahkhani@qimrberghofer.edu.au.&#xD;QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Effect of increased body mass index on risk of diagnosis or death from cancer</style></title><secondary-title><style face="normal" font="default" size="100%">Br J Cancer</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Br J Cancer</style></full-title></periodical><pages><style face="normal" font="default" size="100%">565-570</style></pages><volume><style face="normal" font="default" size="100%">120</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2019/02/09</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasms/*epidemiology/genetics/*mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Overweight/epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">United Kingdom</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1532-1827 (Electronic)&#xD;0007-0920 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30733581</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Whether body mass index (BMI) is causally associated with the risk of being diagnosed with or dying from any cancer remains unclear. Weight reduction has clinical importance for cancer control only if weight gain causes cancer development or death. We aimed to answer the question &apos;does genetically predicted BMI influence my risk of being diagnosed with or dying from any cancer&apos;. METHODS: We used a Mendelian randomisation (MR) approach to estimate causal effect of BMI in 46,155 white-British participants aged between 40 and 69 years at recruitment (median age at follow-up 61 years) from the UK Biobank, who developed any type of cancer, among whom 6998 died from cancer. To derive MR instruments for BMI, we selected up to 390,628 cancer-free participants. RESULTS: For each standard deviation (4.78 units) increase in genetically predicted BMI, we estimated a causal odds ratio (COR) of 1.07 (1.02-1.12) and 1.28 (1.16-1.41) for overall cancer risk and mortality, respectively. The corresponding estimates were similar for males and females, and smokers and non-smokers. CONCLUSIONS: Higher genetically predicted BMI increases the risk of being diagnosed with or dying from any cancer. These data suggest that increased overall weight may causally increase overall cancer incidence and mortality among Europeans.</style></abstract><notes><style face="normal" font="default" size="100%">Gharahkhani, Puya&#xD;Ong, Jue-Sheng&#xD;An, Jiyuan&#xD;Law, Matthew H&#xD;Whiteman, David C&#xD;Neale, Rachel E&#xD;MacGregor, Stuart&#xD;eng&#xD;MC_PC_17228/MRC_/Medical Research Council/United Kingdom&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Br J Cancer. 2019 Mar;120(5):565-570. doi: 10.1038/s41416-019-0386-9. Epub 2019 Feb 8.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30733581</style></url></related-urls><pdf-urls><url>internal-pdf://3258150899/Gharahkhani-2019-Effect of increased body mass.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6462026</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s41416-019-0386-9</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>17</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">17</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gianfrancesco, M. A.</style></author><author><style face="normal" font="default" size="100%">Glymour, M. M.</style></author><author><style face="normal" font="default" size="100%">Walter, S.</style></author><author><style face="normal" font="default" size="100%">Rhead, B.</style></author><author><style face="normal" font="default" size="100%">Shao, X.</style></author><author><style face="normal" font="default" size="100%">Shen, L.</style></author><author><style face="normal" font="default" size="100%">Quach, H.</style></author><author><style face="normal" font="default" size="100%">Hubbard, A.</style></author><author><style face="normal" font="default" size="100%">Jonsdottir, I.</style></author><author><style face="normal" font="default" size="100%">Stefansson, K.</style></author><author><style face="normal" font="default" size="100%">Strid, P.</style></author><author><style face="normal" font="default" size="100%">Hillert, J.</style></author><author><style face="normal" font="default" size="100%">Hedstrom, A.</style></author><author><style face="normal" font="default" size="100%">Olsson, T.</style></author><author><style face="normal" font="default" size="100%">Kockum, I.</style></author><author><style face="normal" font="default" size="100%">Schaefer, C.</style></author><author><style face="normal" font="default" size="100%">Alfredsson, L.</style></author><author><style face="normal" font="default" size="100%">Barcellos, L. F.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Genetic Epidemiology and Genomics Lab, Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.&#xD;Department of Epidemiology and Biostatistics, University of California, San Francisco, USA.&#xD;Institute of Clinical and Experimental Medicine, Division of Gastroenterology, Linkoping University, Linkoping, Sweden.&#xD;Center for Medical Image Science and Visualization (CMIV), Linkoping University, Linkoping, Sweden.&#xD;Computational Biology Graduate Group, University of California, Berkeley, CA, USA.&#xD;Centre for Reproductive Medicine, Dalian Maternal and Children&apos;s Centre, Dalian, China.&#xD;Collaborative Innovation Center on Forecast and Evaluation of Meteorological Disasters, Jiangsu Key Laboratory of Agricultural Meteorology, Department of Agricultural Resource and Environment, College of Applied Meteorology, University of Information Science and Technology, Nanjing, 210044, China.&#xD;Human Evolutionary Genetics, Institut Pasteur, 75015 Paris, France.&#xD;Centre National de la Recherche Scientifique URA3012, 75015 Paris, France.&#xD;Center of Bioinformatics, Biostatistics, and Integrative Biology, Institut Pasteur, 75015 Paris, France.&#xD;Institute of Pharmaceutical Science, King&apos;s College London, London, UK; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.&#xD;deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.&#xD;Department of Immunology, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.&#xD;Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.&#xD;Faculty of Medicine, University of Iceland, Reykjavik, Iceland.&#xD;Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.&#xD;Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden&#xD;Department of Public Health and Clinical Medicine, Umea University, Umea, Sweden.&#xD;Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden/Department of Neurology, Karolinska University Hospital Solna, Stockholm, Sweden.&#xD;Department of Soil Science, Federal University of Vicosa, Vicosa, MG, Brazil.&#xD;Centre for Occupational and Environmental Medicine, Stockholm County Council, Sweden.&#xD;Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.&#xD;Division of Epidemiology, School of Public Health, University of California, 324 Stanley Hall, Berkeley, CA, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal Effect of Genetic Variants Associated With Body Mass Index on Multiple Sclerosis Susceptibility</style></title><secondary-title><style face="normal" font="default" size="100%">Am J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Am J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">162-171</style></pages><volume><style face="normal" font="default" size="100%">185</style></volume><number><style face="normal" font="default" size="100%">3</style></number><edition><style face="normal" font="default" size="100%">2017/01/12</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Multiple Sclerosis/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*genetic instrumental variables</style></keyword><keyword><style face="normal" font="default" size="100%">*multiple sclerosis</style></keyword><keyword><style face="normal" font="default" size="100%">*obesity</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-6256 (Electronic)&#xD;0002-9262 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28073764</style></accession-num><abstract><style face="normal" font="default" size="100%">Multiple sclerosis (MS) is an autoimmune disease with both genetic and environmental risk factors. Recent studies indicate that childhood and adolescent obesity double the risk of MS, but this association may reflect unmeasured confounders rather than causal effects of obesity. We used separate-sample Mendelian randomization to estimate the causal effect of body mass index (BMI) on susceptibility to MS. Using data from non-Hispanic white members of the Kaiser Permanente Medical Care Plan of Northern California (KPNC) (2006-2014; 1,104 cases of MS and 10,536 controls) and a replication data set from Sweden (the Epidemiological Investigation of MS (EIMS) and the Genes and Environment in MS (GEMS) studies, 2005-2013; 5,133 MS cases and 4,718 controls), we constructed a weighted genetic risk score using 97 variants previously established to predict BMI. Results were adjusted for birth year, sex, education, smoking status, ancestry, and genetic predictors of MS. Estimates in KPNC and Swedish data sets suggested that higher genetically induced BMI predicted greater susceptibility to MS (odds ratio = 1.13, 95% confidence interval: 1.04, 1.22 for the KPNC sample; odds ratio = 1.09, 95% confidence interval: 1.03, 1.15 for the Swedish sample). Although the mechanism remains unclear, to our knowledge, these findings support a causal effect of increased BMI on susceptibility to MS for the first time, and they suggest a role for inflammatory pathways that characterize both obesity and the MS disease process.</style></abstract><notes><style face="normal" font="default" size="100%">Gianfrancesco, Milena A&#xD;Glymour, M Maria&#xD;Walter, Stefan&#xD;Rhead, Brooke&#xD;Shao, Xiaorong&#xD;Shen, Ling&#xD;Quach, Hong&#xD;Hubbard, Alan&#xD;Jonsdottir, Ingileif&#xD;Stefansson, Kari&#xD;Strid, Pernilla&#xD;Hillert, Jan&#xD;Hedstrom, Anna&#xD;Olsson, Tomas&#xD;Kockum, Ingrid&#xD;Schaefer, Catherine&#xD;Alfredsson, Lars&#xD;Barcellos, Lisa F&#xD;eng&#xD;RC2 AG036607/AG/NIA NIH HHS/&#xD;T32 HG000047/HG/NHGRI NIH HHS/&#xD;F31 NS093832/NS/NINDS NIH HHS/&#xD;R01 AI076544/AI/NIAID NIH HHS/&#xD;F31 NS096885/NS/NINDS NIH HHS/&#xD;R01 NS049510/NS/NINDS NIH HHS/&#xD;Am J Epidemiol. 2017 Feb 1;185(3):162-171. doi: 10.1093/aje/kww120.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28073764</style></url></related-urls><pdf-urls><url>internal-pdf://0107039564/Gianfrancesco-2017-Causal Effect of Genetic Va.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5391720</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/aje/kww120</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>54</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">54</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Granell, R.</style></author><author><style face="normal" font="default" size="100%">Henderson, A. J.</style></author><author><style face="normal" font="default" size="100%">Evans, D. M.</style></author><author><style face="normal" font="default" size="100%">Smith, G. D.</style></author><author><style face="normal" font="default" size="100%">Ness, A. R.</style></author><author><style face="normal" font="default" size="100%">Lewis, S.</style></author><author><style face="normal" font="default" size="100%">Palmer, T. M.</style></author><author><style face="normal" font="default" size="100%">Sterne, J. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.&#xD;UK National Institute for Health Research Bristol Nutrition Biomedical Research Unit in Nutrition, Diet and Lifestyle, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, United Kingdom; School of Oral and Dental Sciences, University of Bristol, Bristol, United Kingdom.&#xD;School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Effects of BMI, fat mass, and lean mass on asthma in childhood: a Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1001669</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><number><style face="normal" font="default" size="100%">7</style></number><edition><style face="normal" font="default" size="100%">2014/07/02</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Adiposity</style></keyword><keyword><style face="normal" font="default" size="100%">Alleles</style></keyword><keyword><style face="normal" font="default" size="100%">Asthma/epidemiology/etiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Weight</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">England/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*Polymorphism, Single Nucleotide</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">24983943</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Observational studies have reported associations between body mass index (BMI) and asthma, but confounding and reverse causality remain plausible explanations. We aim to investigate evidence for a causal effect of BMI on asthma using a Mendelian randomization approach. METHODS AND FINDINGS: We used Mendelian randomization to investigate causal effects of BMI, fat mass, and lean mass on current asthma at age 7(1/2) y in the Avon Longitudinal Study of Parents and Children (ALSPAC). A weighted allele score based on 32 independent BMI-related single nucleotide polymorphisms (SNPs) was derived from external data, and associations with BMI, fat mass, lean mass, and asthma were estimated. We derived instrumental variable (IV) estimates of causal risk ratios (RRs). 4,835 children had available data on BMI-associated SNPs, asthma, and BMI. The weighted allele score was strongly associated with BMI, fat mass, and lean mass (all p-values&lt;0.001) and with childhood asthma (RR 2.56, 95% CI 1.38-4.76 per unit score, p = 0.003). The estimated causal RR for the effect of BMI on asthma was 1.55 (95% CI 1.16-2.07) per kg/m2, p = 0.003. This effect appeared stronger for non-atopic (1.90, 95% CI 1.19-3.03) than for atopic asthma (1.37, 95% CI 0.89-2.11) though there was little evidence of heterogeneity (p = 0.31). The estimated causal RRs for the effects of fat mass and lean mass on asthma were 1.41 (95% CI 1.11-1.79) per 0.5 kg and 2.25 (95% CI 1.23-4.11) per kg, respectively. The possibility of genetic pleiotropy could not be discounted completely; however, additional IV analyses using FTO variant rs1558902 and the other BMI-related SNPs separately provided similar causal effects with wider confidence intervals. Loss of follow-up was unlikely to bias the estimated effects. CONCLUSIONS: Higher BMI increases the risk of asthma in mid-childhood. Higher BMI may have contributed to the increase in asthma risk toward the end of the 20th century. Please see later in the article for the Editors&apos; Summary.</style></abstract><notes><style face="normal" font="default" size="100%">Granell, Raquel&#xD;Henderson, A John&#xD;Evans, David M&#xD;Smith, George Davey&#xD;Ness, Andrew R&#xD;Lewis, Sarah&#xD;Palmer, Tom M&#xD;Sterne, Jonathan A C&#xD;eng&#xD;092731/Wellcome Trust/United Kingdom&#xD;0401540/Medical Research Council/United Kingdom&#xD;102215/Wellcome Trust/United Kingdom&#xD;MC_PC_15018/Medical Research Council/United Kingdom&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;MC_UU_12013/4/Medical Research Council/United Kingdom&#xD;G0902125/Medical Research Council/United Kingdom&#xD;G9815508/Medical Research Council/United Kingdom&#xD;G0601625/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS Med. 2014 Jul 1;11(7):e1001669. doi: 10.1371/journal.pmed.1001669. eCollection 2014 Jul.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/24983943</style></url></related-urls><pdf-urls><url>internal-pdf://2601160279/Granell-2014-Effects of BMI, fat mass, and lea.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4077660</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1001669</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>9</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">9</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Guo, Q.</style></author><author><style face="normal" font="default" size="100%">Burgess, S.</style></author><author><style face="normal" font="default" size="100%">Turman, C.</style></author><author><style face="normal" font="default" size="100%">Bolla, M. K.</style></author><author><style face="normal" font="default" size="100%">Wang, Q.</style></author><author><style face="normal" font="default" size="100%">Lush, M.</style></author><author><style face="normal" font="default" size="100%">Abraham, J.</style></author><author><style face="normal" font="default" size="100%">Aittomaki, K.</style></author><author><style face="normal" font="default" size="100%">Andrulis, I. L.</style></author><author><style face="normal" font="default" size="100%">Apicella, C.</style></author><author><style face="normal" font="default" size="100%">Arndt, V.</style></author><author><style face="normal" font="default" size="100%">Barrdahl, M.</style></author><author><style face="normal" font="default" size="100%">Benitez, J.</style></author><author><style face="normal" font="default" size="100%">Berg, C. D.</style></author><author><style face="normal" font="default" size="100%">Blomqvist, C.</style></author><author><style face="normal" font="default" size="100%">Bojesen, S. E.</style></author><author><style face="normal" font="default" size="100%">Bonanni, B.</style></author><author><style face="normal" font="default" size="100%">Brand, J. S.</style></author><author><style face="normal" font="default" size="100%">Brenner, H.</style></author><author><style face="normal" font="default" size="100%">Broeks, A.</style></author><author><style face="normal" font="default" size="100%">Burwinkel, B.</style></author><author><style face="normal" font="default" size="100%">Caldas, C.</style></author><author><style face="normal" font="default" size="100%">Campa, D.</style></author><author><style face="normal" font="default" size="100%">Canzian, F.</style></author><author><style face="normal" font="default" size="100%">Chang-Claude, J.</style></author><author><style face="normal" font="default" size="100%">Chanock, S. J.</style></author><author><style face="normal" font="default" size="100%">Chin, S. F.</style></author><author><style face="normal" font="default" size="100%">Couch, F. J.</style></author><author><style face="normal" font="default" size="100%">Cox, A.</style></author><author><style face="normal" font="default" size="100%">Cross, S. S.</style></author><author><style face="normal" font="default" size="100%">Cybulski, C.</style></author><author><style face="normal" font="default" size="100%">Czene, K.</style></author><author><style face="normal" font="default" size="100%">Darabi, H.</style></author><author><style face="normal" font="default" size="100%">Devilee, P.</style></author><author><style face="normal" font="default" size="100%">Diver, W. R.</style></author><author><style face="normal" font="default" size="100%">Dunning, A. M.</style></author><author><style face="normal" font="default" size="100%">Earl, H. M.</style></author><author><style face="normal" font="default" size="100%">Eccles, D. M.</style></author><author><style face="normal" font="default" size="100%">Ekici, A. B.</style></author><author><style face="normal" font="default" size="100%">Eriksson, M.</style></author><author><style face="normal" font="default" size="100%">Evans, D. G.</style></author><author><style face="normal" font="default" size="100%">Fasching, P. A.</style></author><author><style face="normal" font="default" size="100%">Figueroa, J.</style></author><author><style face="normal" font="default" size="100%">Flesch-Janys, D.</style></author><author><style face="normal" font="default" size="100%">Flyger, H.</style></author><author><style face="normal" font="default" size="100%">Gapstur, S. M.</style></author><author><style face="normal" font="default" size="100%">Gaudet, M. M.</style></author><author><style face="normal" font="default" size="100%">Giles, G. G.</style></author><author><style face="normal" font="default" size="100%">Glendon, G.</style></author><author><style face="normal" font="default" size="100%">Grip, M.</style></author><author><style face="normal" font="default" size="100%">Gronwald, J.</style></author><author><style face="normal" font="default" size="100%">Haeberle, L.</style></author><author><style face="normal" font="default" size="100%">Haiman, C. A.</style></author><author><style face="normal" font="default" size="100%">Hall, P.</style></author><author><style face="normal" font="default" size="100%">Hamann, U.</style></author><author><style face="normal" font="default" size="100%">Hankinson, S.</style></author><author><style face="normal" font="default" size="100%">Hartikainen, J. M.</style></author><author><style face="normal" font="default" size="100%">Hein, A.</style></author><author><style face="normal" font="default" size="100%">Hiller, L.</style></author><author><style face="normal" font="default" size="100%">Hogervorst, F. B.</style></author><author><style face="normal" font="default" size="100%">Holleczek, B.</style></author><author><style face="normal" font="default" size="100%">Hooning, M. J.</style></author><author><style face="normal" font="default" size="100%">Hoover, R. N.</style></author><author><style face="normal" font="default" size="100%">Humphreys, K.</style></author><author><style face="normal" font="default" size="100%">Hunter, D. J.</style></author><author><style face="normal" font="default" size="100%">Husing, A.</style></author><author><style face="normal" font="default" size="100%">Jakubowska, A.</style></author><author><style face="normal" font="default" size="100%">Jukkola-Vuorinen, A.</style></author><author><style face="normal" font="default" size="100%">Kaaks, R.</style></author><author><style face="normal" font="default" size="100%">Kabisch, M.</style></author><author><style face="normal" font="default" size="100%">Kataja, V.</style></author><author><style face="normal" font="default" size="100%">kConFab, Aocs Investigators</style></author><author><style face="normal" font="default" size="100%">Knight, J. A.</style></author><author><style face="normal" font="default" size="100%">Koppert, L. B.</style></author><author><style face="normal" font="default" size="100%">Kosma, V. M.</style></author><author><style face="normal" font="default" size="100%">Kristensen, V. N.</style></author><author><style face="normal" font="default" size="100%">Lambrechts, D.</style></author><author><style face="normal" font="default" size="100%">Le Marchand, L.</style></author><author><style face="normal" font="default" size="100%">Li, J.</style></author><author><style face="normal" font="default" size="100%">Lindblom, A.</style></author><author><style face="normal" font="default" size="100%">Lindstrom, S.</style></author><author><style face="normal" font="default" size="100%">Lissowska, J.</style></author><author><style face="normal" font="default" size="100%">Lubinski, J.</style></author><author><style face="normal" font="default" size="100%">Machiela, M. J.</style></author><author><style face="normal" font="default" size="100%">Mannermaa, A.</style></author><author><style face="normal" font="default" size="100%">Manoukian, S.</style></author><author><style face="normal" font="default" size="100%">Margolin, S.</style></author><author><style face="normal" font="default" size="100%">Marme, F.</style></author><author><style face="normal" font="default" size="100%">Martens, J. W. M.</style></author><author><style face="normal" font="default" size="100%">McLean, C.</style></author><author><style face="normal" font="default" size="100%">Menendez, P.</style></author><author><style face="normal" font="default" size="100%">Milne, R. L.</style></author><author><style face="normal" font="default" size="100%">Marie Mulligan, A.</style></author><author><style face="normal" font="default" size="100%">Muranen, T. A.</style></author><author><style face="normal" font="default" size="100%">Nevanlinna, H.</style></author><author><style face="normal" font="default" size="100%">Neven, P.</style></author><author><style face="normal" font="default" size="100%">Nielsen, S. F.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author><author><style face="normal" font="default" size="100%">Olson, J. E.</style></author><author><style face="normal" font="default" size="100%">Perez, J. I. A.</style></author><author><style face="normal" font="default" size="100%">Peterlongo, P.</style></author><author><style face="normal" font="default" size="100%">Phillips, K. A.</style></author><author><style face="normal" font="default" size="100%">Poole, C. J.</style></author><author><style face="normal" font="default" size="100%">Pylkas, K.</style></author><author><style face="normal" font="default" size="100%">Radice, P.</style></author><author><style face="normal" font="default" size="100%">Rahman, N.</style></author><author><style face="normal" font="default" size="100%">Rudiger, T.</style></author><author><style face="normal" font="default" size="100%">Rudolph, A.</style></author><author><style face="normal" font="default" size="100%">Sawyer, E. J.</style></author><author><style face="normal" font="default" size="100%">Schumacher, F.</style></author><author><style face="normal" font="default" size="100%">Seibold, P.</style></author><author><style face="normal" font="default" size="100%">Seynaeve, C.</style></author><author><style face="normal" font="default" size="100%">Shah, M.</style></author><author><style face="normal" font="default" size="100%">Smeets, A.</style></author><author><style face="normal" font="default" size="100%">Southey, M. C.</style></author><author><style face="normal" font="default" size="100%">Tollenaar, Raem</style></author><author><style face="normal" font="default" size="100%">Tomlinson, I.</style></author><author><style face="normal" font="default" size="100%">Tsimiklis, H.</style></author><author><style face="normal" font="default" size="100%">Ulmer, H. U.</style></author><author><style face="normal" font="default" size="100%">Vachon, C.</style></author><author><style face="normal" font="default" size="100%">van den Ouweland, A. M. W.</style></author><author><style face="normal" font="default" size="100%">Van&apos;t Veer, L. J.</style></author><author><style face="normal" font="default" size="100%">Wildiers, H.</style></author><author><style face="normal" font="default" size="100%">Willett, W.</style></author><author><style face="normal" font="default" size="100%">Winqvist, R.</style></author><author><style face="normal" font="default" size="100%">Zamora, M. P.</style></author><author><style face="normal" font="default" size="100%">Chenevix-Trench, G.</style></author><author><style face="normal" font="default" size="100%">Dork, T.</style></author><author><style face="normal" font="default" size="100%">Easton, D. F.</style></author><author><style face="normal" font="default" size="100%">Garcia-Closas, M.</style></author><author><style face="normal" font="default" size="100%">Kraft, P.</style></author><author><style face="normal" font="default" size="100%">Hopper, J. L.</style></author><author><style face="normal" font="default" size="100%">Zheng, W.</style></author><author><style face="normal" font="default" size="100%">Schmidt, M. K.</style></author><author><style face="normal" font="default" size="100%">Pharoah, P. D. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.&#xD;MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.&#xD;Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.&#xD;Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.&#xD;Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.&#xD;Cambridge Experimental Cancer Medicine Centre, Cambridge, UK.&#xD;Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.&#xD;Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.&#xD;Department of Molecular Genetics, University of Toronto, Toronto, Canada.&#xD;Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.&#xD;Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.&#xD;Centro de Investigacion en Red de Enfermedades Raras (CIBERER), Valencia, Spain.&#xD;Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.&#xD;Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.&#xD;Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.&#xD;Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.&#xD;Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.&#xD;Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.&#xD;Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.&#xD;German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.&#xD;Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.&#xD;Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, UK.&#xD;Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK.&#xD;Department of Biology, University of Pisa, Pisa, Italy.&#xD;Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.&#xD;Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.&#xD;Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.&#xD;Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK.&#xD;Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.&#xD;Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.&#xD;Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.&#xD;Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA.&#xD;Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.&#xD;Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.&#xD;Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Central Manchester Foundation Trust, St. Mary&apos;s Hospital, Manchester, UK.&#xD;Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.&#xD;David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA.&#xD;Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK.&#xD;Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.&#xD;Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.&#xD;Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.&#xD;Cancer Epidemiology &amp; Intelligence Division, Cancer Council Victoria, Melbourne, Australia.&#xD;Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland.&#xD;Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.&#xD;Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Department of Biostatistics &amp; Epidemiology, University of Massachusetts, Amherst, Amherst, MA, USA.&#xD;Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.&#xD;Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.&#xD;Warwick Clinical Trials Unit, University of Warwick, Coventry, UK.&#xD;Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.&#xD;Saarland Cancer Registry, Saarbrucken, Germany.&#xD;Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.&#xD;Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.&#xD;Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland.&#xD;Central Finland Health Care District, Jyvaskyla Central Hospital, Jyvaskyla, Finland.&#xD;Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.&#xD;Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.&#xD;Department of Surgical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.&#xD;Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.&#xD;Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.&#xD;Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway.&#xD;VIB Center for Cancer Biology, VIB, Leuven, Belgium.&#xD;Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.&#xD;University of Hawaii Cancer Center, Honolulu, HI, USA.&#xD;Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.&#xD;Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA.&#xD;Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center - Oncology Institute, Warsaw, Poland.&#xD;Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.&#xD;Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy.&#xD;Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden.&#xD;National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.&#xD;Anatomical Pathology, The Alfred Hospital, Melbourne, Australia.&#xD;Servicio de Anatomia Patologica, Hospital Monte Naranco, Oviedo, Spain.&#xD;Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.&#xD;Laboratory Medicine Program, University Health Network, Toronto, Canada.&#xD;Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.&#xD;Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.&#xD;Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.&#xD;Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.&#xD;Servicio de Cirugia General y Especialidades, Hospital Monte Naranco, Oviedo, Spain.&#xD;IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy.&#xD;Division of Cancer Medicine, Peter MacCallum Cancer Center, Melbourne, Australia.&#xD;Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.&#xD;Department of Medicine, St Vincent&apos;s Hospital, The University of Melbourne, Fitzroy, Australia.&#xD;Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.&#xD;Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland.&#xD;Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy.&#xD;Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.&#xD;Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany.&#xD;Research Oncology, Guy&apos;s Hospital, King&apos;s College London, London, UK.&#xD;Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA.&#xD;Department of Pathology, The University of Melbourne, Melbourne, Australia.&#xD;Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.&#xD;Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.&#xD;Frauenklinik der Stadtklinik Baden-Baden, Baden-Baden, Germany.&#xD;Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.&#xD;Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.&#xD;Servicio de Oncologia Medica, Hospital Universitario La Paz, Madrid, Spain.&#xD;Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.&#xD;Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.&#xD;Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.&#xD;Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Body mass index and breast cancer survival: a Mendelian randomization analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1814-1822</style></pages><volume><style face="normal" font="default" size="100%">46</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2017/12/13</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/*genetics/*mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Causality</style></keyword><keyword><style face="normal" font="default" size="100%">Europe/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Meta-Analysis as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Receptors, Estrogen/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Survival Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*breast cancer survival</style></keyword><keyword><style face="normal" font="default" size="100%">*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1464-3685 (Electronic)&#xD;0300-5771 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29232439</style></accession-num><abstract><style face="normal" font="default" size="100%">Background: There is increasing evidence that elevated body mass index (BMI) is associated with reduced survival for women with breast cancer. However, the underlying reasons remain unclear. We conducted a Mendelian randomization analysis to investigate a possible causal role of BMI in survival from breast cancer. Methods: We used individual-level data from six large breast cancer case-cohorts including a total of 36 210 individuals (2475 events) of European ancestry. We created a BMI genetic risk score (GRS) based on genotypes at 94 known BMI-associated genetic variants. Association between the BMI genetic score and breast cancer survival was analysed by Cox regression for each study separately. Study-specific hazard ratios were pooled using fixed-effect meta-analysis. Results: BMI genetic score was found to be associated with reduced breast cancer-specific survival for estrogen receptor (ER)-positive cases [hazard ratio (HR) = 1.11, per one-unit increment of GRS, 95% confidence interval (CI) 1.01-1.22, P = 0.03). We observed no association for ER-negative cases (HR = 1.00, per one-unit increment of GRS, 95% CI 0.89-1.13, P = 0.95). Conclusions: Our findings suggest a causal effect of increased BMI on reduced breast cancer survival for ER-positive breast cancer. There is no evidence of a causal effect of higher BMI on survival for ER-negative breast cancer cases.</style></abstract><notes><style face="normal" font="default" size="100%">Guo, Qi&#xD;Burgess, Stephen&#xD;Turman, Constance&#xD;Bolla, Manjeet K&#xD;Wang, Qin&#xD;Lush, Michael&#xD;Abraham, Jean&#xD;Aittomaki, Kristiina&#xD;Andrulis, Irene L&#xD;Apicella, Carmel&#xD;Arndt, Volker&#xD;Barrdahl, Myrto&#xD;Benitez, Javier&#xD;Berg, Christine D&#xD;Blomqvist, Carl&#xD;Bojesen, Stig E&#xD;Bonanni, Bernardo&#xD;Brand, Judith S&#xD;Brenner, Hermann&#xD;Broeks, Annegien&#xD;Burwinkel, Barbara&#xD;Caldas, Carlos&#xD;Campa, Daniele&#xD;Canzian, Federico&#xD;Chang-Claude, Jenny&#xD;Chanock, Stephen J&#xD;Chin, Suet-Feung&#xD;Couch, Fergus J&#xD;Cox, Angela&#xD;Cross, Simon S&#xD;Cybulski, Cezary&#xD;Czene, Kamila&#xD;Darabi, Hatef&#xD;Devilee, Peter&#xD;Diver, W Ryan&#xD;Dunning, Alison M&#xD;Earl, Helena M&#xD;Eccles, Diana M&#xD;Ekici, Arif B&#xD;Eriksson, Mikael&#xD;Evans, D Gareth&#xD;Fasching, Peter A&#xD;Figueroa, Jonine&#xD;Flesch-Janys, Dieter&#xD;Flyger, Henrik&#xD;Gapstur, Susan M&#xD;Gaudet, Mia M&#xD;Giles, Graham G&#xD;Glendon, Gord&#xD;Grip, Mervi&#xD;Gronwald, Jacek&#xD;Haeberle, Lothar&#xD;Haiman, Christopher A&#xD;Hall, Per&#xD;Hamann, Ute&#xD;Hankinson, Susan&#xD;Hartikainen, Jaana M&#xD;Hein, Alexander&#xD;Hiller, Louise&#xD;Hogervorst, Frans B&#xD;Holleczek, Bernd&#xD;Hooning, Maartje J&#xD;Hoover, Robert N&#xD;Humphreys, Keith&#xD;Hunter, David J&#xD;Husing, Anika&#xD;Jakubowska, Anna&#xD;Jukkola-Vuorinen, Arja&#xD;Kaaks, Rudolf&#xD;Kabisch, Maria&#xD;Kataja, Vesa&#xD;Knight, Julia A&#xD;Koppert, Linetta B&#xD;Kosma, Veli-Matti&#xD;Kristensen, Vessela N&#xD;Lambrechts, Diether&#xD;Le Marchand, Loic&#xD;Li, Jingmei&#xD;Lindblom, Annika&#xD;Lindstrom, Sara&#xD;Lissowska, Jolanta&#xD;Lubinski, Jan&#xD;Machiela, Mitchell J&#xD;Mannermaa, Arto&#xD;Manoukian, Siranoush&#xD;Margolin, Sara&#xD;Marme, Federik&#xD;Martens, John W M&#xD;McLean, Catriona&#xD;Menendez, Primitiva&#xD;Milne, Roger L&#xD;Marie Mulligan, Anna&#xD;Muranen, Taru A&#xD;Nevanlinna, Heli&#xD;Neven, Patrick&#xD;Nielsen, Sune F&#xD;Nordestgaard, Borge G&#xD;Olson, Janet E&#xD;Perez, Jose I A&#xD;Peterlongo, Paolo&#xD;Phillips, Kelly-Anne&#xD;Poole, Christopher J&#xD;Pylkas, Katri&#xD;Radice, Paolo&#xD;Rahman, Nazneen&#xD;Rudiger, Thomas&#xD;Rudolph, Anja&#xD;Sawyer, Elinor J&#xD;Schumacher, Fredrick&#xD;Seibold, Petra&#xD;Seynaeve, Caroline&#xD;Shah, Mitul&#xD;Smeets, Ann&#xD;Southey, Melissa C&#xD;Tollenaar, Rob A E M&#xD;Tomlinson, Ian&#xD;Tsimiklis, Helen&#xD;Ulmer, Hans-Ulrich&#xD;Vachon, Celine&#xD;van den Ouweland, Ans M W&#xD;Van&apos;t Veer, Laura J&#xD;Wildiers, Hans&#xD;Willett, Walter&#xD;Winqvist, Robert&#xD;Zamora, M Pilar&#xD;Chenevix-Trench, Georgia&#xD;Dork, Thilo&#xD;Easton, Douglas F&#xD;Garcia-Closas, Montserrat&#xD;Kraft, Peter&#xD;Hopper, John L&#xD;Zheng, Wei&#xD;Schmidt, Marjanka K&#xD;Pharoah, Paul D P&#xD;eng&#xD;100114/WT_/Wellcome Trust/United Kingdom&#xD;A11699/CRUK_/Cancer Research UK/United Kingdom&#xD;RG/08/014/24067/BHF_/British Heart Foundation/United Kingdom&#xD;A16561/CRUK_/Cancer Research UK/United Kingdom&#xD;MR/L003120/1/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00002/7/MRC_/Medical Research Council/United Kingdom&#xD;CIHR/Canada&#xD;P50 CA116201/CA/NCI NIH HHS/&#xD;C1287/A12014/CRUK_/Cancer Research UK/United Kingdom&#xD;A7572/CRUK_/Cancer Research UK/United Kingdom&#xD;C1287/A10118 /CRUK_/Cancer Research UK/United Kingdom&#xD;10124/CRUK_/Cancer Research UK/United Kingdom&#xD;Research Support, N.I.H., Intramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Int J Epidemiol. 2017 Dec 1;46(6):1814-1822. doi: 10.1093/ije/dyx131.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29232439</style></url></related-urls><pdf-urls><url>internal-pdf://1154886545/Guo-2017-Body mass index and breast cancer sur.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5837506</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/ije/dyx131</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>5</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">5</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Guo, Y.</style></author><author><style face="normal" font="default" size="100%">Warren Andersen, S.</style></author><author><style face="normal" font="default" size="100%">Shu, X. O.</style></author><author><style face="normal" font="default" size="100%">Michailidou, K.</style></author><author><style face="normal" font="default" size="100%">Bolla, M. K.</style></author><author><style face="normal" font="default" size="100%">Wang, Q.</style></author><author><style face="normal" font="default" size="100%">Garcia-Closas, M.</style></author><author><style face="normal" font="default" size="100%">Milne, R. L.</style></author><author><style face="normal" font="default" size="100%">Schmidt, M. K.</style></author><author><style face="normal" font="default" size="100%">Chang-Claude, J.</style></author><author><style face="normal" font="default" size="100%">Dunning, A.</style></author><author><style face="normal" font="default" size="100%">Bojesen, S. E.</style></author><author><style face="normal" font="default" size="100%">Ahsan, H.</style></author><author><style face="normal" font="default" size="100%">Aittomaki, K.</style></author><author><style face="normal" font="default" size="100%">Andrulis, I. L.</style></author><author><style face="normal" font="default" size="100%">Anton-Culver, H.</style></author><author><style face="normal" font="default" size="100%">Arndt, V.</style></author><author><style face="normal" font="default" size="100%">Beckmann, M. W.</style></author><author><style face="normal" font="default" size="100%">Beeghly-Fadiel, A.</style></author><author><style face="normal" font="default" size="100%">Benitez, J.</style></author><author><style face="normal" font="default" size="100%">Bogdanova, N. V.</style></author><author><style face="normal" font="default" size="100%">Bonanni, B.</style></author><author><style face="normal" font="default" size="100%">Borresen-Dale, A. L.</style></author><author><style face="normal" font="default" size="100%">Brand, J.</style></author><author><style face="normal" font="default" size="100%">Brauch, H.</style></author><author><style face="normal" font="default" size="100%">Brenner, H.</style></author><author><style face="normal" font="default" size="100%">Bruning, T.</style></author><author><style face="normal" font="default" size="100%">Burwinkel, B.</style></author><author><style face="normal" font="default" size="100%">Casey, G.</style></author><author><style face="normal" font="default" size="100%">Chenevix-Trench, G.</style></author><author><style face="normal" font="default" size="100%">Couch, F. J.</style></author><author><style face="normal" font="default" size="100%">Cox, A.</style></author><author><style face="normal" font="default" size="100%">Cross, S. S.</style></author><author><style face="normal" font="default" size="100%">Czene, K.</style></author><author><style face="normal" font="default" size="100%">Devilee, P.</style></author><author><style face="normal" font="default" size="100%">Dork, T.</style></author><author><style face="normal" font="default" size="100%">Dumont, M.</style></author><author><style face="normal" font="default" size="100%">Fasching, P. A.</style></author><author><style face="normal" font="default" size="100%">Figueroa, J.</style></author><author><style face="normal" font="default" size="100%">Flesch-Janys, D.</style></author><author><style face="normal" font="default" size="100%">Fletcher, O.</style></author><author><style face="normal" font="default" size="100%">Flyger, H.</style></author><author><style face="normal" font="default" size="100%">Fostira, F.</style></author><author><style face="normal" font="default" size="100%">Gammon, M.</style></author><author><style face="normal" font="default" size="100%">Giles, G. G.</style></author><author><style face="normal" font="default" size="100%">Guenel, P.</style></author><author><style face="normal" font="default" size="100%">Haiman, C. A.</style></author><author><style face="normal" font="default" size="100%">Hamann, U.</style></author><author><style face="normal" font="default" size="100%">Hooning, M. J.</style></author><author><style face="normal" font="default" size="100%">Hopper, J. L.</style></author><author><style face="normal" font="default" size="100%">Jakubowska, A.</style></author><author><style face="normal" font="default" size="100%">Jasmine, F.</style></author><author><style face="normal" font="default" size="100%">Jenkins, M.</style></author><author><style face="normal" font="default" size="100%">John, E. M.</style></author><author><style face="normal" font="default" size="100%">Johnson, N.</style></author><author><style face="normal" font="default" size="100%">Jones, M. E.</style></author><author><style face="normal" font="default" size="100%">Kabisch, M.</style></author><author><style face="normal" font="default" size="100%">Kibriya, M.</style></author><author><style face="normal" font="default" size="100%">Knight, J. A.</style></author><author><style face="normal" font="default" size="100%">Koppert, L. B.</style></author><author><style face="normal" font="default" size="100%">Kosma, V. M.</style></author><author><style face="normal" font="default" size="100%">Kristensen, V.</style></author><author><style face="normal" font="default" size="100%">Le Marchand, L.</style></author><author><style face="normal" font="default" size="100%">Lee, E.</style></author><author><style face="normal" font="default" size="100%">Li, J.</style></author><author><style face="normal" font="default" size="100%">Lindblom, A.</style></author><author><style face="normal" font="default" size="100%">Luben, R.</style></author><author><style face="normal" font="default" size="100%">Lubinski, J.</style></author><author><style face="normal" font="default" size="100%">Malone, K. E.</style></author><author><style face="normal" font="default" size="100%">Mannermaa, A.</style></author><author><style face="normal" font="default" size="100%">Margolin, S.</style></author><author><style face="normal" font="default" size="100%">Marme, F.</style></author><author><style face="normal" font="default" size="100%">McLean, C.</style></author><author><style face="normal" font="default" size="100%">Meijers-Heijboer, H.</style></author><author><style face="normal" font="default" size="100%">Meindl, A.</style></author><author><style face="normal" font="default" size="100%">Neuhausen, S. L.</style></author><author><style face="normal" font="default" size="100%">Nevanlinna, H.</style></author><author><style face="normal" font="default" size="100%">Neven, P.</style></author><author><style face="normal" font="default" size="100%">Olson, J. E.</style></author><author><style face="normal" font="default" size="100%">Perez, J. I.</style></author><author><style face="normal" font="default" size="100%">Perkins, B.</style></author><author><style face="normal" font="default" size="100%">Peterlongo, P.</style></author><author><style face="normal" font="default" size="100%">Phillips, K. A.</style></author><author><style face="normal" font="default" size="100%">Pylkas, K.</style></author><author><style face="normal" font="default" size="100%">Rudolph, A.</style></author><author><style face="normal" font="default" size="100%">Santella, R.</style></author><author><style face="normal" font="default" size="100%">Sawyer, E. J.</style></author><author><style face="normal" font="default" size="100%">Schmutzler, R. K.</style></author><author><style face="normal" font="default" size="100%">Seynaeve, C.</style></author><author><style face="normal" font="default" size="100%">Shah, M.</style></author><author><style face="normal" font="default" size="100%">Shrubsole, M. J.</style></author><author><style face="normal" font="default" size="100%">Southey, M. C.</style></author><author><style face="normal" font="default" size="100%">Swerdlow, A. J.</style></author><author><style face="normal" font="default" size="100%">Toland, A. E.</style></author><author><style face="normal" font="default" size="100%">Tomlinson, I.</style></author><author><style face="normal" font="default" size="100%">Torres, D.</style></author><author><style face="normal" font="default" size="100%">Truong, T.</style></author><author><style face="normal" font="default" size="100%">Ursin, G.</style></author><author><style face="normal" font="default" size="100%">Van Der Luijt, R. B.</style></author><author><style face="normal" font="default" size="100%">Verhoef, S.</style></author><author><style face="normal" font="default" size="100%">Whittemore, A. S.</style></author><author><style face="normal" font="default" size="100%">Winqvist, R.</style></author><author><style face="normal" font="default" size="100%">Zhao, H.</style></author><author><style face="normal" font="default" size="100%">Zhao, S.</style></author><author><style face="normal" font="default" size="100%">Hall, P.</style></author><author><style face="normal" font="default" size="100%">Simard, J.</style></author><author><style face="normal" font="default" size="100%">Kraft, P.</style></author><author><style face="normal" font="default" size="100%">Pharoah, P.</style></author><author><style face="normal" font="default" size="100%">Hunter, D.</style></author><author><style face="normal" font="default" size="100%">Easton, D. F.</style></author><author><style face="normal" font="default" size="100%">Zheng, W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee, United States of America.&#xD;Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.&#xD;Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.&#xD;Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.&#xD;Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.&#xD;Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.&#xD;Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Australia.&#xD;Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.&#xD;Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany.&#xD;Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom.&#xD;Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.&#xD;Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.&#xD;Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.&#xD;Department of Health Studies, The University of Chicago, Chicago, Illinois, United States of America.&#xD;Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.&#xD;Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.&#xD;Department of Molecular Genetics, University of Toronto, Toronto, Canada.&#xD;Department of Epidemiology, University of California Irvine, Irvine, California, United States of America.&#xD;Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.&#xD;Centro de Investigacion en Red de Enfermedades Raras, Valencia, Spain.&#xD;Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.&#xD;Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.&#xD;Department of Genetics, Institute for Cancer Research, Radiumhospitalet, Oslo University Hospital, Oslo University Hospital, Oslo, Norway.&#xD;Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.&#xD;Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.&#xD;German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.&#xD;University of Tubingen, Tubingen, Germany.&#xD;Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany.&#xD;Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.&#xD;Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.&#xD;Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.&#xD;Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, United Kingdom.&#xD;Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.&#xD;Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.&#xD;Centre Hospitalier Universitaire de Quebec Research Center, Laval University, Quebec City, Canada.&#xD;Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.&#xD;David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, United States of America.&#xD;Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.&#xD;Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.&#xD;Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.&#xD;Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.&#xD;Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research &quot;Demokritos&quot;, Athens, Greece.&#xD;Departments of Epidemiology, University of North Carolina Chapel-Hill, Chapel Hill, North Carolina, United States of America.&#xD;Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France.&#xD;University Paris-Sud, Villejuif, France.&#xD;Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Department of Surgical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.&#xD;Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.&#xD;Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America.&#xD;Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, United States of America.&#xD;Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.&#xD;Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.&#xD;Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.&#xD;Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.&#xD;Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.&#xD;Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway.&#xD;University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America.&#xD;Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.&#xD;Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.&#xD;Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.&#xD;Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden.&#xD;National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.&#xD;Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.&#xD;Anatomical Pathology, The Alfred Hospital, Melbourne, Australia.&#xD;Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.&#xD;Division of Gynaecology and Obstetrics, Technische Universitat Munchen, Munich, Germany.&#xD;Beckman Research Institute of City of Hope, Duarte, California, United States of America.&#xD;Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.&#xD;Department of Oncology, University Hospital Gasthuisberg, Leuven, Belgium.&#xD;Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.&#xD;Servicio de Cirugia General y Especialidades, Hospital Monte Naranco, Oviedo, Spain.&#xD;Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.&#xD;IFOM, Fondazione Istituto FIRC (Italian Foundation of Cancer Research) di Oncologia Molecolare, Milan, Italy.&#xD;Peter MacCallum Cancer Center, The University of Melbourne, Melbourne, Australia.&#xD;Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.&#xD;Department of Medicine, St Vincent&apos;s Hospital, The University of Melbourne, Fitzroy, Australia.&#xD;Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, Oulu, Finland.&#xD;Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America.&#xD;Department of Environmental Health Sciences, Mailman School of Public Health of Columbia University, New York, New York, United States of America.&#xD;Research Oncology, Guy&apos;s Hospital, King&apos;s College London, London, United Kingdom.&#xD;Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany.&#xD;Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.&#xD;Center for Molecular Medicine, University Hospital of Cologne, Cologne, Germany.&#xD;Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.&#xD;Department of Pathology, The University of Melbourne, Melbourne, Australia.&#xD;Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom.&#xD;Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.&#xD;Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.&#xD;Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.&#xD;Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.&#xD;Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland.&#xD;Vesalius Research Center, Leuven, Belgium.&#xD;Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.&#xD;Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts, United States of America.&#xD;Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1002105</style></pages><volume><style face="normal" font="default" size="100%">13</style></volume><number><style face="normal" font="default" size="100%">8</style></number><edition><style face="normal" font="default" size="100%">2016/08/24</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/etiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group/*genetics/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Menopause</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Models, Statistical</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27551723</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Observational epidemiological studies have shown that high body mass index (BMI) is associated with a reduced risk of breast cancer in premenopausal women but an increased risk in postmenopausal women. It is unclear whether this association is mediated through shared genetic or environmental factors. METHODS: We applied Mendelian randomization to evaluate the association between BMI and risk of breast cancer occurrence using data from two large breast cancer consortia. We created a weighted BMI genetic score comprising 84 BMI-associated genetic variants to predicted BMI. We evaluated genetically predicted BMI in association with breast cancer risk using individual-level data from the Breast Cancer Association Consortium (BCAC) (cases = 46,325, controls = 42,482). We further evaluated the association between genetically predicted BMI and breast cancer risk using summary statistics from 16,003 cases and 41,335 controls from the Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) Project. Because most studies measured BMI after cancer diagnosis, we could not conduct a parallel analysis to adequately evaluate the association of measured BMI with breast cancer risk prospectively. RESULTS: In the BCAC data, genetically predicted BMI was found to be inversely associated with breast cancer risk (odds ratio [OR] = 0.65 per 5 kg/m2 increase, 95% confidence interval [CI]: 0.56-0.75, p = 3.32 x 10-10). The associations were similar for both premenopausal (OR = 0.44, 95% CI:0.31-0.62, p = 9.91 x 10-8) and postmenopausal breast cancer (OR = 0.57, 95% CI: 0.46-0.71, p = 1.88 x 10-8). This association was replicated in the data from the DRIVE consortium (OR = 0.72, 95% CI: 0.60-0.84, p = 1.64 x 10-7). Single marker analyses identified 17 of the 84 BMI-associated single nucleotide polymorphisms (SNPs) in association with breast cancer risk at p &lt; 0.05; for 16 of them, the allele associated with elevated BMI was associated with reduced breast cancer risk. CONCLUSIONS: BMI predicted by genome-wide association studies (GWAS)-identified variants is inversely associated with the risk of both pre- and postmenopausal breast cancer. The reduced risk of postmenopausal breast cancer associated with genetically predicted BMI observed in this study differs from the positive association reported from studies using measured adult BMI. Understanding the reasons for this discrepancy may reveal insights into the complex relationship of genetic determinants of body weight in the etiology of breast cancer.</style></abstract><notes><style face="normal" font="default" size="100%">Guo, Yan&#xD;Warren Andersen, Shaneda&#xD;Shu, Xiao-Ou&#xD;Michailidou, Kyriaki&#xD;Bolla, Manjeet K&#xD;Wang, Qin&#xD;Garcia-Closas, Montserrat&#xD;Milne, Roger L&#xD;Schmidt, Marjanka K&#xD;Chang-Claude, Jenny&#xD;Dunning, Allison&#xD;Bojesen, Stig E&#xD;Ahsan, Habibul&#xD;Aittomaki, Kristiina&#xD;Andrulis, Irene L&#xD;Anton-Culver, Hoda&#xD;Arndt, Volker&#xD;Beckmann, Matthias W&#xD;Beeghly-Fadiel, Alicia&#xD;Benitez, Javier&#xD;Bogdanova, Natalia V&#xD;Bonanni, Bernardo&#xD;Borresen-Dale, Anne-Lise&#xD;Brand, Judith&#xD;Brauch, Hiltrud&#xD;Brenner, Hermann&#xD;Bruning, Thomas&#xD;Burwinkel, Barbara&#xD;Casey, Graham&#xD;Chenevix-Trench, Georgia&#xD;Couch, Fergus J&#xD;Cox, Angela&#xD;Cross, Simon S&#xD;Czene, Kamila&#xD;Devilee, Peter&#xD;Dork, Thilo&#xD;Dumont, Martine&#xD;Fasching, Peter A&#xD;Figueroa, Jonine&#xD;Flesch-Janys, Dieter&#xD;Fletcher, Olivia&#xD;Flyger, Henrik&#xD;Fostira, Florentia&#xD;Gammon, Marilie&#xD;Giles, Graham G&#xD;Guenel, Pascal&#xD;Haiman, Christopher A&#xD;Hamann, Ute&#xD;Hooning, Maartje J&#xD;Hopper, John L&#xD;Jakubowska, Anna&#xD;Jasmine, Farzana&#xD;Jenkins, Mark&#xD;John, Esther M&#xD;Johnson, Nichola&#xD;Jones, Michael E&#xD;Kabisch, Maria&#xD;Kibriya, Muhammad&#xD;Knight, Julia A&#xD;Koppert, Linetta B&#xD;Kosma, Veli-Matti&#xD;Kristensen, Vessela&#xD;Le Marchand, Loic&#xD;Lee, Eunjung&#xD;Li, Jingmei&#xD;Lindblom, Annika&#xD;Luben, Robert&#xD;Lubinski, Jan&#xD;Malone, Kathi E&#xD;Mannermaa, Arto&#xD;Margolin, Sara&#xD;Marme, Frederik&#xD;McLean, Catriona&#xD;Meijers-Heijboer, Hanne&#xD;Meindl, Alfons&#xD;Neuhausen, Susan L&#xD;Nevanlinna, Heli&#xD;Neven, Patrick&#xD;Olson, Janet E&#xD;Perez, Jose I A&#xD;Perkins, Barbara&#xD;Peterlongo, Paolo&#xD;Phillips, Kelly-Anne&#xD;Pylkas, Katri&#xD;Rudolph, Anja&#xD;Santella, Regina&#xD;Sawyer, Elinor J&#xD;Schmutzler, Rita K&#xD;Seynaeve, Caroline&#xD;Shah, Mitul&#xD;Shrubsole, Martha J&#xD;Southey, Melissa C&#xD;Swerdlow, Anthony J&#xD;Toland, Amanda E&#xD;Tomlinson, Ian&#xD;Torres, Diana&#xD;Truong, Therese&#xD;Ursin, Giske&#xD;Van Der Luijt, Rob B&#xD;Verhoef, Senno&#xD;Whittemore, Alice S&#xD;Winqvist, Robert&#xD;Zhao, Hui&#xD;Zhao, Shilin&#xD;Hall, Per&#xD;Simard, Jacques&#xD;Kraft, Peter&#xD;Pharoah, Paul&#xD;Hunter, David&#xD;Easton, Douglas F&#xD;Zheng, Wei&#xD;eng&#xD;R01 CA176785/CA/NCI NIH HHS/&#xD;R37 CA070867/CA/NCI NIH HHS/&#xD;U01 CA116167/CA/NCI NIH HHS/&#xD;R25 CA160056/CA/NCI NIH HHS/&#xD;P30 CA016058/CA/NCI NIH HHS/&#xD;R01 CA192393/CA/NCI NIH HHS/&#xD;10124/CRUK_/Cancer Research UK/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, N.I.H., Extramural&#xD;PLoS Med. 2016 Aug 23;13(8):e1002105. doi: 10.1371/journal.pmed.1002105. eCollection 2016 Aug.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27551723</style></url></related-urls><pdf-urls><url>internal-pdf://2317670080/Guo-2016-Genetically Predicted Body Mass Index.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4995025</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1002105</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>165</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">165</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hagenaars, S. P.</style></author><author><style face="normal" font="default" size="100%">Gale, C. R.</style></author><author><style face="normal" font="default" size="100%">Deary, I. J.</style></author><author><style face="normal" font="default" size="100%">Harris, S. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK.&#xD;Department of Psychology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK.&#xD;Division of Psychiatry, University of Edinburgh, Edinburgh, EH10 5HF, UK.&#xD;MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.&#xD;Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK. sarah.harris@igmm.ed.ac.uk.&#xD;Medical Genetics Section, University of Edinburgh Centre for Genomic and Experimental Medicine and MRC Institute of Genetics and Molecular Medicine, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK. sarah.harris@igmm.ed.ac.uk.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Cognitive ability and physical health: a Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Sci Rep</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Sci Rep</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2651</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2017/06/03</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">*Cognition</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Artery Disease/*epidemiology/genetics/psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Databases, Factual</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/*epidemiology/genetics/psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Educational Status</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Health/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Health Status</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Neuropsychological Tests</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2045-2322 (Electronic)&#xD;2045-2322 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28572633</style></accession-num><abstract><style face="normal" font="default" size="100%">Causes of the association between cognitive ability and health remain unknown, but may reflect a shared genetic aetiology. This study examines the causal genetic associations between cognitive ability and physical health. We carried out two-sample Mendelian randomization analyses using the inverse-variance weighted method to test for causality between later life cognitive ability, educational attainment (as a proxy for cognitive ability in youth), BMI, height, systolic blood pressure, coronary artery disease, and type 2 diabetes using data from six independent GWAS consortia and the UK Biobank sample (N = 112 151). BMI, systolic blood pressure, coronary artery disease and type 2 diabetes showed negative associations with cognitive ability; height was positively associated with cognitive ability. The analyses provided no evidence for casual associations from health to cognitive ability. In the other direction, higher educational attainment predicted lower BMI, systolic blood pressure, coronary artery disease, type 2 diabetes, and taller stature. The analyses indicated no causal association from educational attainment to physical health. The lack of evidence for causal associations between cognitive ability, educational attainment, and physical health could be explained by weak instrumental variables, poorly measured outcomes, or the small number of disease cases.</style></abstract><notes><style face="normal" font="default" size="100%">Hagenaars, Saskia P&#xD;Gale, Catharine R&#xD;Deary, Ian J&#xD;Harris, Sarah E&#xD;eng&#xD;MC_QA137853/Medical Research Council/United Kingdom&#xD;MC_UP_A620_1015/Medical Research Council/United Kingdom&#xD;MR/K026992/1/Medical Research Council/United Kingdom&#xD;Biotechnology and Biological Sciences Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Sci Rep. 2017 Jun 1;7(1):2651. doi: 10.1038/s41598-017-02837-3.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28572633</style></url></related-urls><pdf-urls><url>internal-pdf://3724830231/Hagenaars-2017-Cognitive ability and physical.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5453939</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s41598-017-02837-3</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>84</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">84</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hagg, S.</style></author><author><style face="normal" font="default" size="100%">Fall, T.</style></author><author><style face="normal" font="default" size="100%">Ploner, A.</style></author><author><style face="normal" font="default" size="100%">Magi, R.</style></author><author><style face="normal" font="default" size="100%">Fischer, K.</style></author><author><style face="normal" font="default" size="100%">Draisma, H. H.</style></author><author><style face="normal" font="default" size="100%">Kals, M.</style></author><author><style face="normal" font="default" size="100%">de Vries, P. S.</style></author><author><style face="normal" font="default" size="100%">Dehghan, A.</style></author><author><style face="normal" font="default" size="100%">Willems, S. M.</style></author><author><style face="normal" font="default" size="100%">Sarin, A. P.</style></author><author><style face="normal" font="default" size="100%">Kristiansson, K.</style></author><author><style face="normal" font="default" size="100%">Nuotio, M. L.</style></author><author><style face="normal" font="default" size="100%">Havulinna, A. S.</style></author><author><style face="normal" font="default" size="100%">de Bruijn, R. F.</style></author><author><style face="normal" font="default" size="100%">Ikram, M. A.</style></author><author><style face="normal" font="default" size="100%">Kuningas, M.</style></author><author><style face="normal" font="default" size="100%">Stricker, B. H.</style></author><author><style face="normal" font="default" size="100%">Franco, O. H.</style></author><author><style face="normal" font="default" size="100%">Benyamin, B.</style></author><author><style face="normal" font="default" size="100%">Gieger, C.</style></author><author><style face="normal" font="default" size="100%">Hall, A. S.</style></author><author><style face="normal" font="default" size="100%">Huikari, V.</style></author><author><style face="normal" font="default" size="100%">Jula, A.</style></author><author><style face="normal" font="default" size="100%">Jarvelin, M. R.</style></author><author><style face="normal" font="default" size="100%">Kaakinen, M.</style></author><author><style face="normal" font="default" size="100%">Kaprio, J.</style></author><author><style face="normal" font="default" size="100%">Kobl, M.</style></author><author><style face="normal" font="default" size="100%">Mangino, M.</style></author><author><style face="normal" font="default" size="100%">Nelson, C. P.</style></author><author><style face="normal" font="default" size="100%">Palotie, A.</style></author><author><style face="normal" font="default" size="100%">Samani, N. J.</style></author><author><style face="normal" font="default" size="100%">Spector, T. D.</style></author><author><style face="normal" font="default" size="100%">Strachan, D. P.</style></author><author><style face="normal" font="default" size="100%">Tobin, M. D.</style></author><author><style face="normal" font="default" size="100%">Whitfield, J. B.</style></author><author><style face="normal" font="default" size="100%">Uitterlinden, A. G.</style></author><author><style face="normal" font="default" size="100%">Salomaa, V.</style></author><author><style face="normal" font="default" size="100%">Syvanen, A. C.</style></author><author><style face="normal" font="default" size="100%">Kuulasmaa, K.</style></author><author><style face="normal" font="default" size="100%">Magnusson, P. K.</style></author><author><style face="normal" font="default" size="100%">Esko, T.</style></author><author><style face="normal" font="default" size="100%">Hofman, A.</style></author><author><style face="normal" font="default" size="100%">de Geus, E. J.</style></author><author><style face="normal" font="default" size="100%">Lind, L.</style></author><author><style face="normal" font="default" size="100%">Giedraitis, V.</style></author><author><style face="normal" font="default" size="100%">Perola, M.</style></author><author><style face="normal" font="default" size="100%">Evans, A.</style></author><author><style face="normal" font="default" size="100%">Ferrieres, J.</style></author><author><style face="normal" font="default" size="100%">Virtamo, J.</style></author><author><style face="normal" font="default" size="100%">Kee, F.</style></author><author><style face="normal" font="default" size="100%">Tregouet, D. A.</style></author><author><style face="normal" font="default" size="100%">Arveiler, D.</style></author><author><style face="normal" font="default" size="100%">Amouyel, P.</style></author><author><style face="normal" font="default" size="100%">Gianfagna, F.</style></author><author><style face="normal" font="default" size="100%">Brambilla, P.</style></author><author><style face="normal" font="default" size="100%">Ripatti, S.</style></author><author><style face="normal" font="default" size="100%">van Duijn, C. M.</style></author><author><style face="normal" font="default" size="100%">Metspalu, A.</style></author><author><style face="normal" font="default" size="100%">Prokopenko, I.</style></author><author><style face="normal" font="default" size="100%">McCarthy, M. I.</style></author><author><style face="normal" font="default" size="100%">Pedersen, N. L.</style></author><author><style face="normal" font="default" size="100%">Ingelsson, E.</style></author><author><style face="normal" font="default" size="100%">European Network for, Genetic</style></author><author><style face="normal" font="default" size="100%">Genomic Epidemiology, Consortium</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, Estonian Genome Center, University of Tartu, Tartu, Estonia, Department of Biological Psychology, VU University Amsterdam, Amsterdam, The Netherlands, EMGO Institute for Health and Care Research, Amsterdam, The Netherlands, Institute of Mathematical Statistics, University of Tartu, Tartu, Estonia, Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands, Netherlands Consortium for Healthy Ageing, Netherlands Genomics Initiative, Leiden, The Netherlands, Department of Genetic Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands, Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland, National Institute for Health and Welfare, Helsinki, Finland, Department of Neurology, and Department of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands, Inspectorate for Health Care, The Hague, The Netherlands, Queensland Brain Institute, University of Queensland, Brisbane, QLD, Australia, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia, Institute of Genetic Epidemiology, Helmholtz Zentrum Munchen - German Research Center for Environmental Health, Neuherberg, Germany, Division of Epidemiology, Leeds Institute of Genetics, Health and Therapeutics, University of Leeds, Leeds, UK, Center for Life Course and Systems Epidemiology, University of Oulu, Oulu, Finland, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland, Department of Children, Young People and Families, National Institute for Health and Welfare, Oulu, Finland, MRC Health Protection Agency (HPE) Centre for Environment and Health, Imperial College London, London, UK, Unit of Primary Care, Oulu University Hospital, Oulu, Finland, Hjelt Institute, University of Helsinki</style></auth-address><titles><title><style face="normal" font="default" size="100%">Adiposity as a cause of cardiovascular disease: a Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">578-86</style></pages><volume><style face="normal" font="default" size="100%">44</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2015/05/29</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular Diseases/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular disease</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1464-3685 (Electronic)&#xD;0300-5771 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26016847</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Adiposity, as indicated by body mass index (BMI), has been associated with risk of cardiovascular diseases in epidemiological studies. We aimed to investigate if these associations are causal, using Mendelian randomization (MR) methods. METHODS: The associations of BMI with cardiovascular outcomes [coronary heart disease (CHD), heart failure and ischaemic stroke], and associations of a genetic score (32 BMI single nucleotide polymorphisms) with BMI and cardiovascular outcomes were examined in up to 22,193 individuals with 3062 incident cardiovascular events from nine prospective follow-up studies within the ENGAGE consortium. We used random-effects meta-analysis in an MR framework to provide causal estimates of the effect of adiposity on cardiovascular outcomes. RESULTS: There was a strong association between BMI and incident CHD (HR = 1.20 per SD-increase of BMI, 95% CI, 1.12-1.28, P = 1.9.10(-7)), heart failure (HR = 1.47, 95% CI, 1.35-1.60, P = 9.10(-19)) and ischaemic stroke (HR = 1.15, 95% CI, 1.06-1.24, P = 0.0008) in observational analyses. The genetic score was robustly associated with BMI (beta = 0.030 SD-increase of BMI per additional allele, 95% CI, 0.028-0.033, P = 3.10(-107)). Analyses indicated a causal effect of adiposity on development of heart failure (HR = 1.93 per SD-increase of BMI, 95% CI, 1.12-3.30, P = 0.017) and ischaemic stroke (HR = 1.83, 95% CI, 1.05-3.20, P = 0.034). Additional cross-sectional analyses using both ENGAGE and CARDIoGRAMplusC4D data showed a causal effect of adiposity on CHD. CONCLUSIONS: Using MR methods, we provide support for the hypothesis that adiposity causes CHD, heart failure and, previously not demonstrated, ischaemic stroke.</style></abstract><notes><style face="normal" font="default" size="100%">Hagg, Sara&#xD;Fall, Tove&#xD;Ploner, Alexander&#xD;Magi, Reedik&#xD;Fischer, Krista&#xD;Draisma, Harmen H M&#xD;Kals, Mart&#xD;de Vries, Paul S&#xD;Dehghan, Abbas&#xD;Willems, Sara M&#xD;Sarin, Antti-Pekka&#xD;Kristiansson, Kati&#xD;Nuotio, Marja-Liisa&#xD;Havulinna, Aki S&#xD;de Bruijn, Renee F A G&#xD;Ikram, M Arfan&#xD;Kuningas, Maris&#xD;Stricker, Bruno H&#xD;Franco, Oscar H&#xD;Benyamin, Beben&#xD;Gieger, Christian&#xD;Hall, Alistair S&#xD;Huikari, Ville&#xD;Jula, Antti&#xD;Jarvelin, Marjo-Riitta&#xD;Kaakinen, Marika&#xD;Kaprio, Jaakko&#xD;Kobl, Michael&#xD;Mangino, Massimo&#xD;Nelson, Christopher P&#xD;Palotie, Aarno&#xD;Samani, Nilesh J&#xD;Spector, Tim D&#xD;Strachan, David P&#xD;Tobin, Martin D&#xD;Whitfield, John B&#xD;Uitterlinden, Andre G&#xD;Salomaa, Veikko&#xD;Syvanen, Ann-Christine&#xD;Kuulasmaa, Kari&#xD;Magnusson, Patrik K&#xD;Esko, Tonu&#xD;Hofman, Albert&#xD;de Geus, Eco J C&#xD;Lind, Lars&#xD;Giedraitis, Vilmantas&#xD;Perola, Markus&#xD;Evans, Alun&#xD;Ferrieres, Jean&#xD;Virtamo, Jarmo&#xD;Kee, Frank&#xD;Tregouet, David-Alexandre&#xD;Arveiler, Dominique&#xD;Amouyel, Philippe&#xD;Gianfagna, Francesco&#xD;Brambilla, Paolo&#xD;Ripatti, Samuli&#xD;van Duijn, Cornelia M&#xD;Metspalu, Andres&#xD;Prokopenko, Inga&#xD;McCarthy, Mark I&#xD;Pedersen, Nancy L&#xD;Ingelsson, Erik&#xD;eng&#xD;AG04563/AG/NIA NIH HHS/&#xD;G1001799/Medical Research Council/United Kingdom&#xD;NIH, R01D0042157-01A/PHS HHS/&#xD;G0601463/Medical Research Council/United Kingdom&#xD;N01-RC-45035/RC/CCR NIH HHS/&#xD;090532/Wellcome Trust/United Kingdom&#xD;AG10175/AG/NIA NIH HHS/&#xD;NIMH U24 MH068457-06/PHS HHS/&#xD;AG028555/AG/NIA NIH HHS/&#xD;5R01MH63706:02/MH/NIMH NIH HHS/&#xD;1RL1MH083268-01/MH/NIMH NIH HHS/&#xD;1RC2MH089951-01/MH/NIMH NIH HHS/&#xD;MC_UP_0801/1/Medical Research Council/United Kingdom&#xD;G0500539/Medical Research Council/United Kingdom&#xD;1RC2MH089995-01/MH/NIMH NIH HHS/&#xD;MR/N01104X/1/Medical Research Council/United Kingdom&#xD;N01-RC-37004/RC/CCR NIH HHS/&#xD;N01-CN-45165/CN/NCI NIH HHS/&#xD;AG08861/AG/NIA NIH HHS/&#xD;AG08724/AG/NIA NIH HHS/&#xD;G0902313/Medical Research Council/United Kingdom&#xD;5R01HL087679-02/HL/NHLBI NIH HHS/&#xD;098381/Wellcome Trust/United Kingdom&#xD;G1002319/Medical Research Council/United Kingdom&#xD;DK U01-066134/DK/NIDDK NIH HHS/&#xD;MR/L01629X/1/Medical Research Council/United Kingdom&#xD;G0600705/Medical Research Council/United Kingdom&#xD;MH081802/MH/NIMH NIH HHS/&#xD;Meta-Analysis&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Int J Epidemiol. 2015 Apr;44(2):578-86. doi: 10.1093/ije/dyv094. Epub 2015 May 27.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26016847</style></url></related-urls><pdf-urls><url>internal-pdf://3501047266/Hagg-2015-Adiposity as a cause of cardiovascul.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4553708</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/ije/dyv094</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>24</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">24</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hartwig, F. P.</style></author><author><style face="normal" font="default" size="100%">Bowden, J.</style></author><author><style face="normal" font="default" size="100%">Loret de Mola, C.</style></author><author><style face="normal" font="default" size="100%">Tovo-Rodrigues, L.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Horta, B. L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.&#xD;MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Body mass index and psychiatric disorders: a Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Sci Rep</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Sci Rep</style></full-title></periodical><pages><style face="normal" font="default" size="100%">32730</style></pages><volume><style face="normal" font="default" size="100%">6</style></volume><edition><style face="normal" font="default" size="100%">2016/09/08</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Bipolar Disorder/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Depressive Disorder, Major/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/genetics/*psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Schizophrenia/*genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep 7</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2045-2322 (Electronic)&#xD;2045-2322 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27601421</style></accession-num><abstract><style face="normal" font="default" size="100%">Obesity is a highly prevalent risk factor for cardiometabolic diseases. Observational studies suggest that obesity is associated with psychiatric traits, but causal inference from such studies has several limitations. We used two-sample Mendelian randomization methods (inverse variance weighting, weighted median and MR-Egger regression) to evaluate the association of body mass index (BMI) with three psychiatric traits using data from the Genetic Investigation of Anthropometric Traits and Psychiatric Genomics consortia. Causal odds ratio estimates per 1-standard deviation increment in BMI ranged from 0.88 (95% CI: 0.62; 1.25) to 1.23 (95% CI: 0.65; 2.31) for bipolar disorder; 0.93 (0.78; 1.11) to 1.41 (0.87; 2.27) for schizophrenia; and 1.15 (95% CI: 0.92; 1.44) to 1.40 (95% CI: 1.03; 1.90) for major depressive disorder. Analyses removing potentially influential SNPs suggested that the effect estimates for depression might be underestimated. Our findings do not support the notion that higher BMI increases risk of bipolar disorder and schizophrenia. Although the point estimates for depression were consistent in all sensitivity analyses, the overall statistical evidence was weak. However, the fact that SNP-depression associations were estimated in relatively small samples reduced power to detect causal effects. This should be re-addressed when SNP-depression associations from larger studies become available.</style></abstract><notes><style face="normal" font="default" size="100%">Hartwig, Fernando Pires&#xD;Bowden, Jack&#xD;Loret de Mola, Christian&#xD;Tovo-Rodrigues, Luciana&#xD;Davey Smith, George&#xD;Horta, Bernardo Lessa&#xD;eng&#xD;MC_EX_MR/L012286/1/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00002/3/MRC_/Medical Research Council/United Kingdom&#xD;England&#xD;Sci Rep. 2016 Sep 7;6:32730. doi: 10.1038/srep32730.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27601421</style></url></related-urls><pdf-urls><url>internal-pdf://2253700921/Hartwig-2016-Body mass index and psychiatric d.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5013405</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/srep32730</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>60</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">60</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">He, L.</style></author><author><style face="normal" font="default" size="100%">Culminskaya, I.</style></author><author><style face="normal" font="default" size="100%">Loika, Y.</style></author><author><style face="normal" font="default" size="100%">Arbeev, K. G.</style></author><author><style face="normal" font="default" size="100%">Bagley, O.</style></author><author><style face="normal" font="default" size="100%">Duan, M.</style></author><author><style face="normal" font="default" size="100%">Yashin, A. I.</style></author><author><style face="normal" font="default" size="100%">Kulminski, A. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Biodemography of Aging Research Unit, Social Science Research Institute, Duke University, Durham, NC 27708, USA. Electronic address: lianghe@mit.edu.&#xD;Biodemography of Aging Research Unit, Social Science Research Institute, Duke University, Durham, NC 27708, USA.&#xD;Biodemography of Aging Research Unit, Social Science Research Institute, Duke University, Durham, NC 27708, USA. Electronic address: kulminsk@duke.edu.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal effects of cardiovascular risk factors on onset of major age-related diseases: A time-to-event Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Exp Gerontol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Exp Gerontol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">74-86</style></pages><volume><style face="normal" font="default" size="100%">107</style></volume><edition><style face="normal" font="default" size="100%">2017/10/02</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Aging</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular Diseases/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Causality</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol, HDL/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol, LDL/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Linear Models</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Neoplasms/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Stroke/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Triglycerides/blood</style></keyword><keyword><style face="normal" font="default" size="100%">*Age-related disease</style></keyword><keyword><style face="normal" font="default" size="100%">*Body mass index</style></keyword><keyword><style face="normal" font="default" size="100%">*Causal effect</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*Time-to-event analysis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1873-6815 (Electronic)&#xD;0531-5565 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28964830</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUNDS: Elucidating the causal effects of common intermediate risk factors on the onset of age-related diseases is indispensable for developing prevention and intervention procedures. METHODS: We conducted two-stage time-to-event Mendelian randomization meta-analyses combining five large-scale longitudinal cohorts to investigate dynamic causal effects of cardiovascular disease risk factors including body mass index (BMI), systolic blood pressure (SBP), and lipids on the age-at-onset of age-related diseases. We constructed weighted polygenic scores based on genetic markers from previously reported genome-wide association studies as instrumental variables to estimate the causal effects. To avoid false positive due to potential pleiotropic effects of the genetic markers, we performed a leave-one-out sensitivity analysis and an MR-Egger sensitivity analysis that we expanded in the survival context. RESULTS: Our results show that elevated BMI increases the absolute risk of type 2 diabetes (T2D) (p=7.68e-04), heart failure (p=9.03e-03), and cardiovascular diseases (CVD) (p=1.69e-03) and the causal effects start at different ages. A significant association between BMI and the risk of stroke is observed; however, the sensitivity analyses suggest that the association is attributed to the potential pleiotropic effects of rs2867125 and rs1558902. Raised SBP levels are significantly associated with the development of atrial fibrillation (p=6.42e-03). Low-density lipoprotein cholesterol (LDL-C) levels are inversely associated with the age-at-onset of T2D (p=1.05e-02). In addition, LDL-C and triglycerides are inversely associated with the risks of cancer and T2D, respectively. Nevertheless, the sensitivity analyses suggest that these associations are probably due to pleiotropic effects of several single-nucleotide polymorphisms including rs4970834 and rs1260326. CONCLUSIONS: Our results highlight the involvement of BMI in the development of multiple age-related diseases. Some observed causal associations can attribute to pleiotropic effects of some genetic variations. These findings have important implications in unraveling causal effects of common risk factors on age-related diseases and guiding effective intervention strategies to reduce the incidence of these diseases.</style></abstract><notes><style face="normal" font="default" size="100%">He, Liang&#xD;Culminskaya, Irina&#xD;Loika, Yury&#xD;Arbeev, Konstantin G&#xD;Bagley, Olivia&#xD;Duan, Matt&#xD;Yashin, Anatoliy I&#xD;Kulminski, Alexander M&#xD;eng&#xD;HHSN268201100012C/HL/NHLBI NIH HHS/&#xD;HHSN268201100001I/HL/NHLBI NIH HHS/&#xD;HHSN268201100009I/HL/NHLBI NIH HHS/&#xD;N01HC95160/HL/NHLBI NIH HHS/&#xD;HHSN268201100010C/HL/NHLBI NIH HHS/&#xD;N01HC95163/HL/NHLBI NIH HHS/&#xD;HHSN268201100008C/HL/NHLBI NIH HHS/&#xD;U01 HL080295/HL/NHLBI NIH HHS/&#xD;HHSN268201100005G/HL/NHLBI NIH HHS/&#xD;HHSN268201100004I/HL/NHLBI NIH HHS/&#xD;HHSN268201100008I/HL/NHLBI NIH HHS/&#xD;HHSN268201100007C/HL/NHLBI NIH HHS/&#xD;N01 HC015103/HC/NHLBI NIH HHS/&#xD;N01HC95169/HL/NHLBI NIH HHS/&#xD;HHSN268201100046C/HL/NHLBI NIH HHS/&#xD;HHSN268201100011I/HL/NHLBI NIH HHS/&#xD;HHSN268201100011C/HL/NHLBI NIH HHS/&#xD;UL1 RR024156/RR/NCRR NIH HHS/&#xD;N01 HC085084/HC/NHLBI NIH HHS/&#xD;N01 HC085085/HC/NHLBI NIH HHS/&#xD;HHSN268201100003C/WH/WHI NIH HHS/&#xD;U01 HG004402/HG/NHGRI NIH HHS/&#xD;N01HC95164/HL/NHLBI NIH HHS/&#xD;N02HL64278/HL/NHLBI NIH HHS/&#xD;N01HC95162/HL/NHLBI NIH HHS/&#xD;N01HC85086/HL/NHLBI NIH HHS/&#xD;N01HC95168/HL/NHLBI NIH HHS/&#xD;N01HC55222/HL/NHLBI NIH HHS/&#xD;HHSN268201100006C/HL/NHLBI NIH HHS/&#xD;N01HC85079/HL/NHLBI NIH HHS/&#xD;HHSN268201200036C/HL/NHLBI NIH HHS/&#xD;HHSN268201100005I/HL/NHLBI NIH HHS/&#xD;HHSN271201100004C/AG/NIA NIH HHS/&#xD;N01HC95165/HL/NHLBI NIH HHS/&#xD;N01HC95159/HL/NHLBI NIH HHS/&#xD;N01HC95161/HL/NHLBI NIH HHS/&#xD;HHSN268201100002C/WH/WHI NIH HHS/&#xD;N01HC65226/HL/NHLBI NIH HHS/&#xD;P01 AG043352/AG/NIA NIH HHS/&#xD;N01HC85082/HL/NHLBI NIH HHS/&#xD;N01HC75150/HL/NHLBI NIH HHS/&#xD;N01HC95167/HL/NHLBI NIH HHS/&#xD;HHSN268201100009C/HL/NHLBI NIH HHS/&#xD;N01HC85083/HL/NHLBI NIH HHS/&#xD;HHSN268201100005C/HL/NHLBI NIH HHS/&#xD;N01HC25195/HL/NHLBI NIH HHS/&#xD;HHSN268201100007I/HL/NHLBI NIH HHS/&#xD;HHSN268201100002I/HL/NHLBI NIH HHS/&#xD;R01 AG047310/AG/NIA NIH HHS/&#xD;N01HC95166/HL/NHLBI NIH HHS/&#xD;R01 AG023629/AG/NIA NIH HHS/&#xD;N01 HC045133/HC/NHLBI NIH HHS/&#xD;N01HC85080/HL/NHLBI NIH HHS/&#xD;N01 HC035129/HC/NHLBI NIH HHS/&#xD;HHSN268201100001C/WH/WHI NIH HHS/&#xD;HHSN268201100004C/WH/WHI NIH HHS/&#xD;N01HC85081/HL/NHLBI NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Exp Gerontol. 2018 Jul 1;107:74-86. doi: 10.1016/j.exger.2017.09.019. Epub 2017 Sep 28.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28964830</style></url></related-urls><pdf-urls><url>internal-pdf://2565749100/He-2018-Causal effects of cardiovascular risk.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5874182</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.exger.2017.09.019</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>8</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">8</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Holmes, M. V.</style></author><author><style face="normal" font="default" size="100%">Lange, L. A.</style></author><author><style face="normal" font="default" size="100%">Palmer, T.</style></author><author><style face="normal" font="default" size="100%">Lanktree, M. B.</style></author><author><style face="normal" font="default" size="100%">North, K. E.</style></author><author><style face="normal" font="default" size="100%">Almoguera, B.</style></author><author><style face="normal" font="default" size="100%">Buxbaum, S.</style></author><author><style face="normal" font="default" size="100%">Chandrupatla, H. R.</style></author><author><style face="normal" font="default" size="100%">Elbers, C. C.</style></author><author><style face="normal" font="default" size="100%">Guo, Y.</style></author><author><style face="normal" font="default" size="100%">Hoogeveen, R. C.</style></author><author><style face="normal" font="default" size="100%">Li, J.</style></author><author><style face="normal" font="default" size="100%">Li, Y. R.</style></author><author><style face="normal" font="default" size="100%">Swerdlow, D. I.</style></author><author><style face="normal" font="default" size="100%">Cushman, M.</style></author><author><style face="normal" font="default" size="100%">Price, T. S.</style></author><author><style face="normal" font="default" size="100%">Curtis, S. P.</style></author><author><style face="normal" font="default" size="100%">Fornage, M.</style></author><author><style face="normal" font="default" size="100%">Hakonarson, H.</style></author><author><style face="normal" font="default" size="100%">Patel, S. R.</style></author><author><style face="normal" font="default" size="100%">Redline, S.</style></author><author><style face="normal" font="default" size="100%">Siscovick, D. S.</style></author><author><style face="normal" font="default" size="100%">Tsai, M. Y.</style></author><author><style face="normal" font="default" size="100%">Wilson, J. G.</style></author><author><style face="normal" font="default" size="100%">van der Schouw, Y. T.</style></author><author><style face="normal" font="default" size="100%">FitzGerald, G. A.</style></author><author><style face="normal" font="default" size="100%">Hingorani, A. D.</style></author><author><style face="normal" font="default" size="100%">Casas, J. P.</style></author><author><style face="normal" font="default" size="100%">de Bakker, P. I.</style></author><author><style face="normal" font="default" size="100%">Rich, S. S.</style></author><author><style face="normal" font="default" size="100%">Schadt, E. E.</style></author><author><style face="normal" font="default" size="100%">Asselbergs, F. W.</style></author><author><style face="normal" font="default" size="100%">Reiner, A. P.</style></author><author><style face="normal" font="default" size="100%">Keating, B. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Transplantation, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA; Genetic Epidemiology Group, Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, 1-19 Torrington Place, London WC1E 6BT, UK. Electronic address: michael.holmes@uphs.upenn.edu.&#xD;Department of Genetics, University of North Carolina School of Medicine at Chapel Hill, Chapel Hill, NC 27514, USA.&#xD;Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.&#xD;Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.&#xD;Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA.&#xD;Center for Applied Genomics, Abramson Research Center, The Children&apos;s Hospital of Philadelphia, Philadelphia, PA 19104, USA.&#xD;Jackson Heart Study Coordinating Center, Jackson State University, 350 West Woodrow Wilson Avenue, Suite 701, Jackson, MS 39213, USA.&#xD;Complex Genetics Section, Department of Medical Genetics, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands.&#xD;Division of Atherosclerosis &amp; Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.&#xD;Genetic Epidemiology Group, Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, 1-19 Torrington Place, London WC1E 6BT, UK.&#xD;Departments of Medicine and Pathology, University of Vermont, 208 South Park Drive, Colchester, VT 05446 USA.&#xD;The Institute for Translational Medicine and Therapeutics, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.&#xD;Merck Research Laboratories, P.O. Box 2000, Rahway, NJ 07065, USA.&#xD;The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.&#xD;Department of Medicine, Brigham and Women&apos;s Hospital, Boston, MA 02115, USA.&#xD;Cardiovascular Health Research Unit, Departments of Medicine and Epidemiology, University of Washington, Seattle, WA 98101, USA.&#xD;Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55414, USA.&#xD;Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39216, USA.&#xD;Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands.&#xD;Genetic Epidemiology Group, Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, 1-19 Torrington Place, London WC1E 6BT, UK; Faculty of Epidemiology and Public Health, London School of Hygiene &amp; Tropical Medicine, London WC1E 7HT, UK.&#xD;Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands; Brigham and Women&apos;s Hospital, 77 Avenue Louis Pasteur, New Research Building, Room 168, Boston, MA 02115, USA.&#xD;Center for Public Health Genomics, University of Virginia, Charlottesville, VA 22908, USA.&#xD;Department of Genomics, Mount Sinai School of Medicine, New York, NY 10029, USA.&#xD;Division of Heart and Lungs, Department of Cardiology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands; Durrer Center for Cardiogenetic Research, ICIN - Netherlands Heart Institute, Catharijnesingel 52, Postbus 19258, 3501 DG Utrecht, the Netherlands; Faculty of Population Health Sciences, Institute of Cardiovascular Science, University College London, London WC1E 6BT, UK.&#xD;Center for Public Health Genomics, University of Virginia, Charlottesville, VA 22908, USA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.&#xD;Division of Transplantation, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA; Center for Applied Genomics, Abramson Research Center, The Children&apos;s Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. Electronic address: bkeating@mail.med.upenn.edu.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Am J Hum Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Am J Hum Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">198-208</style></pages><volume><style face="normal" font="default" size="100%">94</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2014/01/28</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Glucose/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol, HDL/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol, LDL/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Disease/blood/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/blood/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Fasting</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Association Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Interleukin-6/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Meta-Analysis as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Selection, Genetic</style></keyword><keyword><style face="normal" font="default" size="100%">Sensitivity and Specificity</style></keyword><keyword><style face="normal" font="default" size="100%">Stroke/blood/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 6</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1537-6605 (Electronic)&#xD;0002-9297 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">24462370</style></accession-num><abstract><style face="normal" font="default" size="100%">Elevated body mass index (BMI) associates with cardiometabolic traits on observational analysis, yet the underlying causal relationships remain unclear. We conducted Mendelian randomization analyses by using a genetic score (GS) comprising 14 BMI-associated SNPs from a recent discovery analysis to investigate the causal role of BMI in cardiometabolic traits and events. We used eight population-based cohorts, including 34,538 European-descent individuals (4,407 type 2 diabetes (T2D), 6,073 coronary heart disease (CHD), and 3,813 stroke cases). A 1 kg/m(2) genetically elevated BMI increased fasting glucose (0.18 mmol/l; 95% confidence interval (CI) = 0.12-0.24), fasting insulin (8.5%; 95% CI = 5.9-11.1), interleukin-6 (7.0%; 95% CI = 4.0-10.1), and systolic blood pressure (0.70 mmHg; 95% CI = 0.24-1.16) and reduced high-density lipoprotein cholesterol (-0.02 mmol/l; 95% CI = -0.03 to -0.01) and low-density lipoprotein cholesterol (LDL-C; -0.04 mmol/l; 95% CI = -0.07 to -0.01). Observational and causal estimates were directionally concordant, except for LDL-C. A 1 kg/m(2) genetically elevated BMI increased the odds of T2D (odds ratio [OR] = 1.27; 95% CI = 1.18-1.36) but did not alter risk of CHD (OR 1.01; 95% CI = 0.94-1.08) or stroke (OR = 1.03; 95% CI = 0.95-1.12). A meta-analysis incorporating published studies reporting 27,465 CHD events in 219,423 individuals yielded a pooled OR of 1.04 (95% CI = 0.97-1.12) per 1 kg/m(2) increase in BMI. In conclusion, we identified causal effects of BMI on several cardiometabolic traits; however, whether BMI causally impacts CHD risk requires further evidence.</style></abstract><notes><style face="normal" font="default" size="100%">Holmes, Michael V&#xD;Lange, Leslie A&#xD;Palmer, Tom&#xD;Lanktree, Matthew B&#xD;North, Kari E&#xD;Almoguera, Berta&#xD;Buxbaum, Sarah&#xD;Chandrupatla, Hareesh R&#xD;Elbers, Clara C&#xD;Guo, Yiran&#xD;Hoogeveen, Ron C&#xD;Li, Jin&#xD;Li, Yun R&#xD;Swerdlow, Daniel I&#xD;Cushman, Mary&#xD;Price, Tom S&#xD;Curtis, Sean P&#xD;Fornage, Myriam&#xD;Hakonarson, Hakon&#xD;Patel, Sanjay R&#xD;Redline, Susan&#xD;Siscovick, David S&#xD;Tsai, Michael Y&#xD;Wilson, James G&#xD;van der Schouw, Yvonne T&#xD;FitzGerald, Garret A&#xD;Hingorani, Aroon D&#xD;Casas, Juan P&#xD;de Bakker, Paul I W&#xD;Rich, Stephen S&#xD;Schadt, Eric E&#xD;Asselbergs, Folkert W&#xD;Reiner, Alex P&#xD;Keating, Brendan J&#xD;eng&#xD;G0802432/Medical Research Council/United Kingdom&#xD;MR/K006584/1/Medical Research Council/United Kingdom&#xD;P20 MD006899/MD/NIMHD NIH HHS/&#xD;PG/09/022/26739/British Heart Foundation/United Kingdom&#xD;Observational Study&#xD;Am J Hum Genet. 2014 Feb 6;94(2):198-208. doi: 10.1016/j.ajhg.2013.12.014. Epub 2014 Jan 23.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/24462370</style></url></related-urls><pdf-urls><url>internal-pdf://3766777212/Holmes-2014-Causal effects of body mass index.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3928659</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.ajhg.2013.12.014</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>69</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">69</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Howe, Laura D.</style></author><author><style face="normal" font="default" size="100%">Kanayalal, Roshni</style></author><author><style face="normal" font="default" size="100%">Beaumont, Robin</style></author><author><style face="normal" font="default" size="100%">Davies, Alisha R.</style></author><author><style face="normal" font="default" size="100%">Frayling, Timothy M.</style></author><author><style face="normal" font="default" size="100%">Harrison, Sean</style></author><author><style face="normal" font="default" size="100%">Jones, Samuel Edward</style></author><author><style face="normal" font="default" size="100%">Sassi, Franco</style></author><author><style face="normal" font="default" size="100%">Wood, Andrew R.</style></author><author><style face="normal" font="default" size="100%">Tyrrell, Jess</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><urls><pdf-urls><url>internal-pdf://1087997817/Howe-2019-Effects of body mass index on relati.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/524488</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>82</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">82</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Howe, L. J.</style></author><author><style face="normal" font="default" size="100%">Trela-Larsen, L.</style></author><author><style face="normal" font="default" size="100%">Taylor, M.</style></author><author><style face="normal" font="default" size="100%">Heron, J.</style></author><author><style face="normal" font="default" size="100%">Munafo, M. R.</style></author><author><style face="normal" font="default" size="100%">Taylor, A. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK; School of Social and Community Medicine, University of Bristol, Bristol, UK. Electronic address: lh14833@bristol.ac.uk.&#xD;Musculoskeletal Research Unit, University of Bristol, Learning and Research Building (Level 1), Southmead Hospital, Bristol, BS10 5NB, UK.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK; School of Social and Community Medicine, University of Bristol, Bristol, UK.&#xD;School of Social and Community Medicine, University of Bristol, Bristol, UK.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK; UK Centre for Tobacco and Alcohol Studies, School of Experimental Psychology, University of Bristol, Bristol, BS8 1TU, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Body mass index, body dissatisfaction and adolescent smoking initiation</style></title><secondary-title><style face="normal" font="default" size="100%">Drug Alcohol Depend</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Drug Alcohol Depend</style></full-title></periodical><pages><style face="normal" font="default" size="100%">143-149</style></pages><volume><style face="normal" font="default" size="100%">178</style></volume><edition><style face="normal" font="default" size="100%">2017/06/26</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent Behavior/*psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Body Image/*psychology</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Body Weight/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Parents/psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Tobacco Smoking/*trends</style></keyword><keyword><style face="normal" font="default" size="100%">*alspac</style></keyword><keyword><style face="normal" font="default" size="100%">*Body dissatisfaction</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*Tobacco</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1879-0046 (Electronic)&#xD;0376-8716 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28647682</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Smoking influences body weight, but there is little evidence as to whether body mass index (BMI) and body dissatisfaction increase smoking initiation in adolescents. METHODS: We evaluated the association between measured BMI, body dissatisfaction and latent classes of smoking initiation (never smokers, experimenters, late onset regular smokers, early onset regular smokers) in the Avon Longitudinal Study of Parents and Children. In observational analyses we used BMI (N=3754) and body dissatisfaction at age 10.5 years (N=3349). In Mendelian randomisation (MR) analysis, we used a BMI genetic risk score of 76 single nucleotide polymorphisms (N=4017). RESULTS: In females, higher BMI was associated with increased odds of early onset regular smoking (OR: 1.11, 95% CI: 1.04, 1.18) compared to being a never smoker, but not clearly associated with experimenting with smoking (OR: 1.04, 95% CI: 0.99, 1.10) or late onset regular smoking (OR: 1.01, 95% CI: 0.94, 1.09). No clear evidence was found for associations between BMI and smoking initiation classes in males (p-value for sex interaction&lt;/=0.001). Body dissatisfaction was associated with increased odds of late-onset regular smoking (OR: 1.71, 95% CI: 1.32, 1.99) in males and females combined (P-value for sex interaction=0.32). There was no clear evidence for an association between the BMI genetic risk score and smoking latent classes in males or females but estimates were imprecise. CONCLUSIONS: BMI in females and body dissatisfaction in males and females are associated with increased odds of smoking initiation, highlighting these as potentially important factors for consideration in smoking prevention strategies.</style></abstract><notes><style face="normal" font="default" size="100%">Howe, Laurence J&#xD;Trela-Larsen, Lea&#xD;Taylor, Michelle&#xD;Heron, Jon&#xD;Munafo, Marcus R&#xD;Taylor, Amy E&#xD;eng&#xD;MC_UU_12013/6/MRC_/Medical Research Council/United Kingdom&#xD;MR/K023195/1/MRC_/Medical Research Council/United Kingdom&#xD;MC_PC_15018/MRC_/Medical Research Council/United Kingdom&#xD;WT_/Wellcome Trust/United Kingdom&#xD;G9815508/MRC_/Medical Research Council/United Kingdom&#xD;Observational Study&#xD;Ireland&#xD;Drug Alcohol Depend. 2017 Sep 1;178:143-149. doi: 10.1016/j.drugalcdep.2017.04.008. Epub 2017 Jun 8.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28647682</style></url></related-urls><pdf-urls><url>internal-pdf://0123078787/Howe-2017-Body mass index, body dissatisfactio.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5558147</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.drugalcdep.2017.04.008</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>79</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">79</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Huang, Y.</style></author><author><style face="normal" font="default" size="100%">Xu, M.</style></author><author><style face="normal" font="default" size="100%">Xie, L.</style></author><author><style face="normal" font="default" size="100%">Wang, T.</style></author><author><style face="normal" font="default" size="100%">Huang, X.</style></author><author><style face="normal" font="default" size="100%">Lv, X.</style></author><author><style face="normal" font="default" size="100%">Chen, Y.</style></author><author><style face="normal" font="default" size="100%">Ding, L.</style></author><author><style face="normal" font="default" size="100%">Lin, L.</style></author><author><style face="normal" font="default" size="100%">Wang, W.</style></author><author><style face="normal" font="default" size="100%">Bi, Y.</style></author><author><style face="normal" font="default" size="100%">Sun, Y.</style></author><author><style face="normal" font="default" size="100%">Zhang, Y.</style></author><author><style face="normal" font="default" size="100%">Ning, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">State Key Laboratory of Medical Genomics, Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health, National Clinical Research Center for Metabolic Diseases, Collaborative Innovation Center of Systems Biomedicine and Shanghai Clinical Center for Endocrine and Metabolic Diseases, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, 200025, China; Shanghai Institute of Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.&#xD;Medical Systems Biology Research Center, Tsinghua University School of Medicine, Beijing, 100084, China.&#xD;Medical Systems Biology Research Center, Tsinghua University School of Medicine, Beijing, 100084, China; National Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China. Electronic address: ymsun@capitalbio.com.&#xD;State Key Laboratory of Medical Genomics, Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health, National Clinical Research Center for Metabolic Diseases, Collaborative Innovation Center of Systems Biomedicine and Shanghai Clinical Center for Endocrine and Metabolic Diseases, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, 200025, China; Shanghai Institute of Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Electronic address: feifei-a@163.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Obesity and peripheral arterial disease: A Mendelian Randomization analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Atherosclerosis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Atherosclerosis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">218-24</style></pages><volume><style face="normal" font="default" size="100%">247</style></volume><edition><style face="normal" font="default" size="100%">2016/03/08</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Chi-Square Distribution</style></keyword><keyword><style face="normal" font="default" size="100%">China/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Association Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Linear Models</style></keyword><keyword><style face="normal" font="default" size="100%">Logistic Models</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Multivariate Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/diagnosis/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Peripheral Arterial Disease/diagnosis/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Pulse Wave Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Vascular Stiffness</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic risk score</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization</style></keyword><keyword><style face="normal" font="default" size="100%">Peripheral arterial disease</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1879-1484 (Electronic)&#xD;0021-9150 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26945778</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND AND AIMS: Observational studies showed that obesity is a major risk factor for peripheral arterial disease (PAD). However, conventional epidemiology studies are vulnerable to residual bias from confounding factors. We aimed to explore the causality of obesity in development of PAD using Mendelian Randomization (MR) approach. METHODS: A MR analysis was performed in 11,477 community-dwelling adults aged 40 years and above recruited from two nearby communities during 2011-2013 in Shanghai, China. We genotyped 14 body mass index (BMI) associated common variants identified and validated in East Asians. PAD was defined as ankle-to-brachial index (ABI) &lt;0.90 or &gt;1.40. Weighted BMI genetic risk score (GRS) was used as the Instrumental Variable (IV). RESULTS: After adjusted for confounding factors, we found that each standard deviation (SD, 2.76 points) increase in BMI-GRS was associated with 0.43 (95% confidence interval [CI]: 0.36-0.49) kg/m(2) increase in BMI (P &lt; 0.0001) and an odds ratio (OR) for PAD of 1.17 (95% CI: 1.07-1.27; P = 0.0004). Compared with the lowest quartile of BMI-GRS, the second, third and highest quartile associated with 9%, 19% and 45% increment of PAD risk, respectively (P for trend = 0.002). In the MR analysis, we demonstrated a causal relationship between obesity and PAD (OR = 1.44 per BMI-unit, 95% CI: 1.18-1.75; P = 0.0003). CONCLUSIONS: This study suggested that obesity may be causally associated with PAD after controlling for the potential intermediate factors like hypertension, dyslipidemia and hyperglycemia.</style></abstract><notes><style face="normal" font="default" size="100%">Huang, Ya&#xD;Xu, Min&#xD;Xie, Lan&#xD;Wang, Tiange&#xD;Huang, Xiaolin&#xD;Lv, Xiaofei&#xD;Chen, Ying&#xD;Ding, Lin&#xD;Lin, Lin&#xD;Wang, Weiqing&#xD;Bi, Yufang&#xD;Sun, Yimin&#xD;Zhang, Yifei&#xD;Ning, Guang&#xD;eng&#xD;Multicenter Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Ireland&#xD;Atherosclerosis. 2016 Apr;247:218-24. doi: 10.1016/j.atherosclerosis.2015.12.034. Epub 2015 Dec 29.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26945778</style></url></related-urls><pdf-urls><url>internal-pdf://2436773289/Huang-2016-Obesity and peripheral arterial dis.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.atherosclerosis.2015.12.034</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>76</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">76</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hung, C. F.</style></author><author><style face="normal" font="default" size="100%">Rivera, M.</style></author><author><style face="normal" font="default" size="100%">Craddock, N.</style></author><author><style face="normal" font="default" size="100%">Owen, M. J.</style></author><author><style face="normal" font="default" size="100%">Gill, M.</style></author><author><style face="normal" font="default" size="100%">Korszun, A.</style></author><author><style face="normal" font="default" size="100%">Maier, W.</style></author><author><style face="normal" font="default" size="100%">Mors, O.</style></author><author><style face="normal" font="default" size="100%">Preisig, M.</style></author><author><style face="normal" font="default" size="100%">Rice, J. P.</style></author><author><style face="normal" font="default" size="100%">Rietschel, M.</style></author><author><style face="normal" font="default" size="100%">Jones, L.</style></author><author><style face="normal" font="default" size="100%">Middleton, L.</style></author><author><style face="normal" font="default" size="100%">Aitchison, K. J.</style></author><author><style face="normal" font="default" size="100%">Davis, O. S.</style></author><author><style face="normal" font="default" size="100%">Breen, G.</style></author><author><style face="normal" font="default" size="100%">Lewis, C.</style></author><author><style face="normal" font="default" size="100%">Farmer, A.</style></author><author><style face="normal" font="default" size="100%">McGuffin, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Chi-Fa Hung, MD, MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry at King&apos;s College London, UK, and Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan; Margarita Rivera, PhD, MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry at King&apos;s College London, UK, and CIBERSAM, University of Granada, Section of Psychiatry, Institute of Neurosciences, Biomedical Research Centre (CIBM), Granada, Spain; Nick Craddock, PhD, FRCPsych, FMedSci, Michael J. Owen, PhD, FRCPsych, FMedSci, Department of Psychological Medicine, School of Medicine, Cardiff University, UK; Michael Gill, PhD, Department of Psychiatry, Trinity Centre for Health Sciences, St James&apos; Hospital, Dublin, Ireland; Ania Korszun, PhD, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary&apos;s University of London, UK; Wolfgang Maier, PhD, Psychiatrie und Psychotherapie, Universitatsklinikum Bonn, Bonn, Germany; Ole Mors, PhD, Research Department P, Aarhus University Hospital, Risskov, Aarhus, Denmark; Martin Preisig, MD, Department of Adult Psychiatry, University Hospital of Lausanne, Prilly-Lausanne, Switzerland; John P. Rice, PhD, Department of Psychiatry, Washington University, St Louis, Missouri, USA; Marcella Rietschel, MD, Central Institute of Mental Health, Mannheim, Germany; Lisa Jones, PhD, Department of Psychiatry, School of Clinical and Experimental Medicine, University of Birmingham, UK; Lefkos Middleton, MD,Division of Neuroscience and Mental Health, Imperial College London, UK; Kathy J. Aitchison, PhD, MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry at King&apos;s College London, UK and Department of Psychiatry, University of Alberta, Alberta, Canada; Oliver S. P. Davis, PhD, University College London Genetics Institute, Department of Genetics, Evolution and Environment, University Colleg</style></auth-address><titles><title><style face="normal" font="default" size="100%">Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study</style></title><secondary-title><style face="normal" font="default" size="100%">Br J Psychiatry</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Br J Psychiatry</style></full-title></periodical><pages><style face="normal" font="default" size="100%">24-8</style></pages><volume><style face="normal" font="default" size="100%">205</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2014/05/09</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Depressive Disorder/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1472-1465 (Electronic)&#xD;0007-1250 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">24809401</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Obesity has been shown to be associated with depression and it has been suggested that higher body mass index (BMI) increases the risk of depression and other common mental disorders. However, the causal relationship remains unclear and Mendelian randomisation, a form of instrumental variable analysis, has recently been employed to attempt to resolve this issue. AIMS: To investigate whether higher BMI increases the risk of major depression. METHOD: Two instrumental variable analyses were conducted to test the causal relationship between obesity and major depression in RADIANT, a large case-control study of major depression. We used a single nucleotide polymorphism (SNP) in FTO and a genetic risk score (GRS) based on 32 SNPs with well-established associations with BMI. RESULTS: Linear regression analysis, as expected, showed that individuals carrying more risk alleles of FTO or having higher score of GRS had a higher BMI. Probit regression suggested that higher BMI is associated with increased risk of major depression. However, our two instrumental variable analyses did not support a causal relationship between higher BMI and major depression (FTO genotype: coefficient -0.03, 95% CI -0.18 to 0.13, P = 0.73; GRS: coefficient -0.02, 95% CI -0.11 to 0.07, P = 0.62). CONCLUSIONS: Our instrumental variable analyses did not support a causal relationship between higher BMI and major depression. The positive associations of higher BMI with major depression in probit regression analyses might be explained by reverse causality and/or residual confounding.</style></abstract><notes><style face="normal" font="default" size="100%">Hung, Chi-Fa&#xD;Rivera, Margarita&#xD;Craddock, Nick&#xD;Owen, Michael J&#xD;Gill, Michael&#xD;Korszun, Ania&#xD;Maier, Wolfgang&#xD;Mors, Ole&#xD;Preisig, Martin&#xD;Rice, John P&#xD;Rietschel, Marcella&#xD;Jones, Lisa&#xD;Middleton, Lefkos&#xD;Aitchison, Kathy J&#xD;Davis, Oliver S P&#xD;Breen, Gerome&#xD;Lewis, Cathryn&#xD;Farmer, Anne&#xD;McGuffin, Peter&#xD;eng&#xD;MR/L010305/1/Medical Research Council/United Kingdom&#xD;G0701420/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Br J Psychiatry. 2014 Jul;205(1):24-8. doi: 10.1192/bjp.bp.113.130419. Epub 2014 May 8.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/24809401</style></url></related-urls><pdf-urls><url>internal-pdf://0077359515/Hung-2014-Relationship between obesity and the.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4076654</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1192/bjp.bp.113.130419</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>170</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">170</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jarvis, D.</style></author><author><style face="normal" font="default" size="100%">Mitchell, J. S.</style></author><author><style face="normal" font="default" size="100%">Law, P. J.</style></author><author><style face="normal" font="default" size="100%">Palin, K.</style></author><author><style face="normal" font="default" size="100%">Tuupanen, S.</style></author><author><style face="normal" font="default" size="100%">Gylfe, A.</style></author><author><style face="normal" font="default" size="100%">Hanninen, U. A.</style></author><author><style face="normal" font="default" size="100%">Cajuso, T.</style></author><author><style face="normal" font="default" size="100%">Tanskanen, T.</style></author><author><style face="normal" font="default" size="100%">Kondelin, J.</style></author><author><style face="normal" font="default" size="100%">Kaasinen, E.</style></author><author><style face="normal" font="default" size="100%">Sarin, A. P.</style></author><author><style face="normal" font="default" size="100%">Kaprio, J.</style></author><author><style face="normal" font="default" size="100%">Eriksson, J. G.</style></author><author><style face="normal" font="default" size="100%">Rissanen, H.</style></author><author><style face="normal" font="default" size="100%">Knekt, P.</style></author><author><style face="normal" font="default" size="100%">Pukkala, E.</style></author><author><style face="normal" font="default" size="100%">Jousilahti, P.</style></author><author><style face="normal" font="default" size="100%">Salomaa, V.</style></author><author><style face="normal" font="default" size="100%">Ripatti, S.</style></author><author><style face="normal" font="default" size="100%">Palotie, A.</style></author><author><style face="normal" font="default" size="100%">Jarvinen, H.</style></author><author><style face="normal" font="default" size="100%">Renkonen-Sinisalo, L.</style></author><author><style face="normal" font="default" size="100%">Lepisto, A.</style></author><author><style face="normal" font="default" size="100%">Bohm, J.</style></author><author><style face="normal" font="default" size="100%">Meklin, J. P.</style></author><author><style face="normal" font="default" size="100%">Al-Tassan, N. A.</style></author><author><style face="normal" font="default" size="100%">Palles, C.</style></author><author><style face="normal" font="default" size="100%">Martin, L.</style></author><author><style face="normal" font="default" size="100%">Barclay, E.</style></author><author><style face="normal" font="default" size="100%">Farrington, S. M.</style></author><author><style face="normal" font="default" size="100%">Timofeeva, M. N.</style></author><author><style face="normal" font="default" size="100%">Meyer, B. F.</style></author><author><style face="normal" font="default" size="100%">Wakil, S. M.</style></author><author><style face="normal" font="default" size="100%">Campbell, H.</style></author><author><style face="normal" font="default" size="100%">Smith, C. G.</style></author><author><style face="normal" font="default" size="100%">Idziaszczyk, S.</style></author><author><style face="normal" font="default" size="100%">Maughan, T. S.</style></author><author><style face="normal" font="default" size="100%">Kaplan, R.</style></author><author><style face="normal" font="default" size="100%">Kerr, R.</style></author><author><style face="normal" font="default" size="100%">Kerr, D.</style></author><author><style face="normal" font="default" size="100%">Buchanan, D. D.</style></author><author><style face="normal" font="default" size="100%">Win, A. K.</style></author><author><style face="normal" font="default" size="100%">Hopper, J. L.</style></author><author><style face="normal" font="default" size="100%">Jenkins, M. A.</style></author><author><style face="normal" font="default" size="100%">Lindor, N. M.</style></author><author><style face="normal" font="default" size="100%">Newcomb, P. A.</style></author><author><style face="normal" font="default" size="100%">Gallinger, S.</style></author><author><style face="normal" font="default" size="100%">Conti, D.</style></author><author><style face="normal" font="default" size="100%">Schumacher, F.</style></author><author><style face="normal" font="default" size="100%">Casey, G.</style></author><author><style face="normal" font="default" size="100%">Taipale, J.</style></author><author><style face="normal" font="default" size="100%">Aaltonen, L. A.</style></author><author><style face="normal" font="default" size="100%">Cheadle, J. P.</style></author><author><style face="normal" font="default" size="100%">Dunlop, M. G.</style></author><author><style face="normal" font="default" size="100%">Tomlinson, I. P.</style></author><author><style face="normal" font="default" size="100%">Houlston, R. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Genetics and Epidemiology, The Institute of Cancer Research, London SW7 3RP, UK.&#xD;Genome-Scale Biology Research Program, Research Programs Unit, University of Helsinki 00014, Helsinki, Finland.&#xD;Department of Medical and Clinical Genetics, Medicum, University of Helsinki, Helsinki 00014, Finland.&#xD;Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland.&#xD;National Institute for Health and Welfare, Helsinki 00271, Finland.&#xD;Folkhalsan Research Centre, Helsinki 00250, Finland.&#xD;Unit of General Practice and Primary Health Care, University of Helsinki, Helsinki University Hospital, Helsinki 00014, Finland.&#xD;Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki 00130, Finland.&#xD;School of Health Sciences, University of Tampere, Tampere 33014, Finland.&#xD;Department of Medicine, Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA 02114, USA.&#xD;Program in Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.&#xD;Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA.&#xD;Department of Surgery, Helsinki University Central Hospital, Hospital District of Helsinki and Uusimaa, Helsinki 00029, Finland.&#xD;Department of Surgery, Abdominal Center, Helsinki University Hospital Helsinki 00029, Finland.&#xD;Department of Pathology, Central Finland Central Hospital, Jyvaskyla 40620, Finland.&#xD;Department of Surgery, Jyvaskyla Central Hospital, University of Eastern Finland, Jyvaskyla 40620, Finland.&#xD;Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh 12713, Saudi Arabia.&#xD;Wellcome Trust Centre for Human Genetics, NIHR Comprehensive Biomedical Research Centre, Oxford OX3 7BN, UK.&#xD;Colon Cancer Genetics Group, MRC Human Genetics Unit, The University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK.&#xD;The Roslin Institute, University of Edinburgh, Easter Bush, Roslin, Edinburgh EH25 9RG, UK.&#xD;Centre for Population Health Sciences, University of Edinburgh, Edinburgh EH8 9AG, UK.&#xD;Institute of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.&#xD;CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK.&#xD;MRC Clinical Trials Unit, Aviation House, London WC2B 6NH, UK.&#xD;Department of Oncology, Oxford Cancer Centre, University of Oxford, Churchill Hospital, Oxford OX3 7LE, UK.&#xD;Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK.&#xD;Department of Pathology, Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, The University of Melbourne, Melbourne, VIC 3010, Australia.&#xD;Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne, VIC 3010, Australia.&#xD;Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ 85259, USA.&#xD;Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.&#xD;Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.&#xD;Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90033, USA.&#xD;Department of Biosciences and Nutrition, SciLife Center, Karolinska Institutet, Solna SE 141 83, Sweden.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer</style></title><secondary-title><style face="normal" font="default" size="100%">Br J Cancer</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Br J Cancer</style></full-title></periodical><pages><style face="normal" font="default" size="100%">266-72</style></pages><volume><style face="normal" font="default" size="100%">115</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2016/06/24</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Colorectal Neoplasms/*complications/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Random Allocation</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul 12</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1532-1827 (Electronic)&#xD;0007-0920 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27336604</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Observational studies have associated adiposity with an increased risk of colorectal cancer (CRC). However, such studies do not establish a causal relationship. To minimise bias from confounding we performed a Mendelian randomisation (MR) analysis to examine the relationship between adiposity and CRC. METHODS: We used SNPs associated with adult body mass index (BMI), waist-hip ratio (WHR), childhood obesity and birth weight as instrumental variables in a MR analysis of 9254 CRC cases and 18 386 controls. RESULTS: In the MR analysis, the odds ratios (ORs) of CRC risk per unit increase in BMI, WHR and childhood obesity were 1.23 (95% CI: 1.02-1.49, P=0.033), 1.59 (95% CI: 1.08-2.34, P=0.019) and 1.07 (95% CI: 1.03-1.13, P=0.018), respectively. There was no evidence for association between birth weight and CRC (OR=1.22, 95% CI: 0.89-1.67, P=0.22). Combining these data with a concurrent MR-based analysis for BMI and WHR with CRC risk (totalling to 18 190 cases, 27 617 controls) provided increased support, ORs for BMI and WHR were 1.26 (95% CI: 1.10-1.44, P=7.7 x 10(-4)) and 1.40 (95% CI: 1.14-1.72, P=1.2 x 10(-3)), respectively. CONCLUSIONS: These data provide further evidence for a strong causal relationship between adiposity and the risk of developing CRC highlighting the urgent need for prevention and treatment of adiposity.</style></abstract><notes><style face="normal" font="default" size="100%">Jarvis, David&#xD;Mitchell, Jonathan S&#xD;Law, Philip J&#xD;Palin, Kimmo&#xD;Tuupanen, Sari&#xD;Gylfe, Alexandra&#xD;Hanninen, Ulrika A&#xD;Cajuso, Tatiana&#xD;Tanskanen, Tomas&#xD;Kondelin, Johanna&#xD;Kaasinen, Eevi&#xD;Sarin, Antti-Pekka&#xD;Kaprio, Jaakko&#xD;Eriksson, Johan G&#xD;Rissanen, Harri&#xD;Knekt, Paul&#xD;Pukkala, Eero&#xD;Jousilahti, Pekka&#xD;Salomaa, Veikko&#xD;Ripatti, Samuli&#xD;Palotie, Aarno&#xD;Jarvinen, Heikki&#xD;Renkonen-Sinisalo, Laura&#xD;Lepisto, Anna&#xD;Bohm, Jan&#xD;Meklin, Jukka-Pekka&#xD;Al-Tassan, Nada A&#xD;Palles, Claire&#xD;Martin, Lynn&#xD;Barclay, Ella&#xD;Farrington, Susan M&#xD;Timofeeva, Maria N&#xD;Meyer, Brian F&#xD;Wakil, Salma M&#xD;Campbell, Harry&#xD;Smith, Christopher G&#xD;Idziaszczyk, Shelley&#xD;Maughan, Timothy S&#xD;Kaplan, Richard&#xD;Kerr, Rachel&#xD;Kerr, David&#xD;Buchanan, Daniel D&#xD;Win, Aung K&#xD;Hopper, John L&#xD;Jenkins, Mark A&#xD;Lindor, Noralane M&#xD;Newcomb, Polly A&#xD;Gallinger, Steve&#xD;Conti, David&#xD;Schumacher, Fred&#xD;Casey, Graham&#xD;Taipale, Jussi&#xD;Aaltonen, Lauri A&#xD;Cheadle, Jeremy P&#xD;Dunlop, Malcolm G&#xD;Tomlinson, Ian P&#xD;Houlston, Richard S&#xD;eng&#xD;HHSN261201000035C/CA/NCI NIH HHS/&#xD;MC_UU_12023/20/MRC_/Medical Research Council/United Kingdom&#xD;U24 CA074794/CA/NCI NIH HHS/&#xD;U24 CA074806/CA/NCI NIH HHS/&#xD;K05 AA000145/AA/NIAAA NIH HHS/&#xD;R01 AA012502/AA/NIAAA NIH HHS/&#xD;U01 CA074783/CA/NCI NIH HHS/&#xD;U24 CA074799/CA/NCI NIH HHS/&#xD;R37 AA012502/AA/NIAAA NIH HHS/&#xD;U01 CA074799/CA/NCI NIH HHS/&#xD;MC_PC_U127527198/MRC_/Medical Research Council/United Kingdom&#xD;U24 CA074783/CA/NCI NIH HHS/&#xD;N01 CN067009/CN/NCI NIH HHS/&#xD;12076/CRUK_/Cancer Research UK/United Kingdom&#xD;MC_U127527198/MRC_/Medical Research Council/United Kingdom&#xD;U24 CA097735/CA/NCI NIH HHS/&#xD;U01 CA074794/CA/NCI NIH HHS/&#xD;HHSN261201300011C/RC/CCR NIH HHS/&#xD;HHSN261201300012I/CA/NCI NIH HHS/&#xD;R01 CA143237/CA/NCI NIH HHS/&#xD;N01PC35142/CA/NCI NIH HHS/&#xD;MR/K018647/1/MRC_/Medical Research Council/United Kingdom&#xD;K02 AA018755/AA/NIAAA NIH HHS/&#xD;HHSN261201300021C/CA/NCI NIH HHS/&#xD;HHSN261201000035I/CA/NCI NIH HHS/&#xD;HHSN261201000034C/CA/NCI NIH HHS/&#xD;U01 CA097735/CA/NCI NIH HHS/&#xD;UM1 CA167551/CA/NCI NIH HHS/&#xD;U01 CA122839/CA/NCI NIH HHS/&#xD;U58 DP003862/DP/NCCDPHP CDC HHS/&#xD;WT_/Wellcome Trust/United Kingdom&#xD;U01 CA074806/CA/NCI NIH HHS/&#xD;U24 CA074800/CA/NCI NIH HHS/&#xD;HHSN261201000121C/CP/NCI NIH HHS/&#xD;U01 CA074800/CA/NCI NIH HHS/&#xD;Meta-Analysis&#xD;England&#xD;Br J Cancer. 2016 Jul 12;115(2):266-72. doi: 10.1038/bjc.2016.188. Epub 2016 Jun 23.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27336604</style></url></related-urls><pdf-urls><url>internal-pdf://4173908139/Jarvis-2016-Mendelian randomisation analysis s.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4947703</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/bjc.2016.188</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>21</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">21</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Johansson, M.</style></author><author><style face="normal" font="default" size="100%">Carreras-Torres, R.</style></author><author><style face="normal" font="default" size="100%">Scelo, G.</style></author><author><style face="normal" font="default" size="100%">Purdue, M. P.</style></author><author><style face="normal" font="default" size="100%">Mariosa, D.</style></author><author><style face="normal" font="default" size="100%">Muller, D. C.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Haycock, P. C.</style></author><author><style face="normal" font="default" size="100%">Brown, K. M.</style></author><author><style face="normal" font="default" size="100%">Wang, Z.</style></author><author><style face="normal" font="default" size="100%">Ye, Y.</style></author><author><style face="normal" font="default" size="100%">Hofmann, J. N.</style></author><author><style face="normal" font="default" size="100%">Foll, M.</style></author><author><style face="normal" font="default" size="100%">Gaborieau, V.</style></author><author><style face="normal" font="default" size="100%">Machiela, M. J.</style></author><author><style face="normal" font="default" size="100%">Colli, L. M.</style></author><author><style face="normal" font="default" size="100%">Li, P.</style></author><author><style face="normal" font="default" size="100%">Garnier, J. G.</style></author><author><style face="normal" font="default" size="100%">Blanche, H.</style></author><author><style face="normal" font="default" size="100%">Boland, A.</style></author><author><style face="normal" font="default" size="100%">Burdette, L.</style></author><author><style face="normal" font="default" size="100%">Prokhortchouk, E.</style></author><author><style face="normal" font="default" size="100%">Skryabin, K. G.</style></author><author><style face="normal" font="default" size="100%">Yeager, M.</style></author><author><style face="normal" font="default" size="100%">Radojevic-Skodric, S.</style></author><author><style face="normal" font="default" size="100%">Ognjanovic, S.</style></author><author><style face="normal" font="default" size="100%">Foretova, L.</style></author><author><style face="normal" font="default" size="100%">Holcatova, I.</style></author><author><style face="normal" font="default" size="100%">Janout, V.</style></author><author><style face="normal" font="default" size="100%">Mates, D.</style></author><author><style face="normal" font="default" size="100%">Mukeriya, A.</style></author><author><style face="normal" font="default" size="100%">Rascu, S.</style></author><author><style face="normal" font="default" size="100%">Zaridze, D.</style></author><author><style face="normal" font="default" size="100%">Bencko, V.</style></author><author><style face="normal" font="default" size="100%">Cybulski, C.</style></author><author><style face="normal" font="default" size="100%">Fabianova, E.</style></author><author><style face="normal" font="default" size="100%">Jinga, V.</style></author><author><style face="normal" font="default" size="100%">Lissowska, J.</style></author><author><style face="normal" font="default" size="100%">Lubinski, J.</style></author><author><style face="normal" font="default" size="100%">Navratilova, M.</style></author><author><style face="normal" font="default" size="100%">Rudnai, P.</style></author><author><style face="normal" font="default" size="100%">Benhamou, S.</style></author><author><style face="normal" font="default" size="100%">Cancel-Tassin, G.</style></author><author><style face="normal" font="default" size="100%">Cussenot, O.</style></author><author><style face="normal" font="default" size="100%">Weiderpass, E.</style></author><author><style face="normal" font="default" size="100%">Ljungberg, B.</style></author><author><style face="normal" font="default" size="100%">Tumkur Sitaram, R.</style></author><author><style face="normal" font="default" size="100%">Haggstrom, C.</style></author><author><style face="normal" font="default" size="100%">Bruinsma, F.</style></author><author><style face="normal" font="default" size="100%">Jordan, S. J.</style></author><author><style face="normal" font="default" size="100%">Severi, G.</style></author><author><style face="normal" font="default" size="100%">Winship, I.</style></author><author><style face="normal" font="default" size="100%">Hveem, K.</style></author><author><style face="normal" font="default" size="100%">Vatten, L. J.</style></author><author><style face="normal" font="default" size="100%">Fletcher, T.</style></author><author><style face="normal" font="default" size="100%">Larsson, S. C.</style></author><author><style face="normal" font="default" size="100%">Wolk, A.</style></author><author><style face="normal" font="default" size="100%">Banks, R. E.</style></author><author><style face="normal" font="default" size="100%">Selby, P. J.</style></author><author><style face="normal" font="default" size="100%">Easton, D. F.</style></author><author><style face="normal" font="default" size="100%">Andreotti, G.</style></author><author><style face="normal" font="default" size="100%">Beane Freeman, L. E.</style></author><author><style face="normal" font="default" size="100%">Koutros, S.</style></author><author><style face="normal" font="default" size="100%">Mannisto, S.</style></author><author><style face="normal" font="default" size="100%">Weinstein, S.</style></author><author><style face="normal" font="default" size="100%">Clark, P. E.</style></author><author><style face="normal" font="default" size="100%">Edwards, T. L.</style></author><author><style face="normal" font="default" size="100%">Lipworth, L.</style></author><author><style face="normal" font="default" size="100%">Gapstur, S. M.</style></author><author><style face="normal" font="default" size="100%">Stevens, V. L.</style></author><author><style face="normal" font="default" size="100%">Carol, H.</style></author><author><style face="normal" font="default" size="100%">Freedman, M. L.</style></author><author><style face="normal" font="default" size="100%">Pomerantz, M. M.</style></author><author><style face="normal" font="default" size="100%">Cho, E.</style></author><author><style face="normal" font="default" size="100%">Wilson, K. M.</style></author><author><style face="normal" font="default" size="100%">Gaziano, J. M.</style></author><author><style face="normal" font="default" size="100%">Sesso, H. D.</style></author><author><style face="normal" font="default" size="100%">Freedman, N. D.</style></author><author><style face="normal" font="default" size="100%">Parker, A. S.</style></author><author><style face="normal" font="default" size="100%">Eckel-Passow, J. E.</style></author><author><style face="normal" font="default" size="100%">Huang, W. Y.</style></author><author><style face="normal" font="default" size="100%">Kahnoski, R. J.</style></author><author><style face="normal" font="default" size="100%">Lane, B. R.</style></author><author><style face="normal" font="default" size="100%">Noyes, S. L.</style></author><author><style face="normal" font="default" size="100%">Petillo, D.</style></author><author><style face="normal" font="default" size="100%">Teh, B. T.</style></author><author><style face="normal" font="default" size="100%">Peters, U.</style></author><author><style face="normal" font="default" size="100%">White, E.</style></author><author><style face="normal" font="default" size="100%">Anderson, G. L.</style></author><author><style face="normal" font="default" size="100%">Johnson, L.</style></author><author><style face="normal" font="default" size="100%">Luo, J.</style></author><author><style face="normal" font="default" size="100%">Buring, J.</style></author><author><style face="normal" font="default" size="100%">Lee, I. M.</style></author><author><style face="normal" font="default" size="100%">Chow, W. H.</style></author><author><style face="normal" font="default" size="100%">Moore, L. E.</style></author><author><style face="normal" font="default" size="100%">Eisen, T.</style></author><author><style face="normal" font="default" size="100%">Henrion, M.</style></author><author><style face="normal" font="default" size="100%">Larkin, J.</style></author><author><style face="normal" font="default" size="100%">Barman, P.</style></author><author><style face="normal" font="default" size="100%">Leibovich, B. C.</style></author><author><style face="normal" font="default" size="100%">Choueiri, T. K.</style></author><author><style face="normal" font="default" size="100%">Lathrop, G. M.</style></author><author><style face="normal" font="default" size="100%">Deleuze, J. F.</style></author><author><style face="normal" font="default" size="100%">Gunter, M.</style></author><author><style face="normal" font="default" size="100%">McKay, J. D.</style></author><author><style face="normal" font="default" size="100%">Wu, X.</style></author><author><style face="normal" font="default" size="100%">Houlston, R. S.</style></author><author><style face="normal" font="default" size="100%">Chanock, S. J.</style></author><author><style face="normal" font="default" size="100%">Relton, C.</style></author><author><style face="normal" font="default" size="100%">Richards, J. B.</style></author><author><style face="normal" font="default" size="100%">Martin, R. M.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Brennan, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">International Agency for Research on Cancer (IARC), Lyon, France.&#xD;Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.&#xD;Imperial College, London, United Kingdom.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.&#xD;St. Jude Children&apos;s Research Hospital, Memphis, Tennessee, United States of America.&#xD;Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.&#xD;Max Planck Institute for Demographic Research, Rostock, Germany.&#xD;Centre National de Genotypage, Institut de Genomique, Centre de l&apos;Energie Atomique et aux Energies Alternatives, Evry, France.&#xD;Fondation Jean Dausset - Centre d&apos;Etude du Polymorphisme Humain, Paris, France.&#xD;Federal Research Centre &quot;Fundamentals of Biotechnology&quot; of the Russian Academy of Sciences, Moscow, Russian Federation.&#xD;Kurchatov Scientific Center, Moscow, Russian Federation.&#xD;Institute of Pathology, Medical School of Belgrade, Belgrade, Serbia.&#xD;Clinic of Urology, Clinical Center of Serbia, Belgrade, Serbia.&#xD;Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota, United States of America.&#xD;International Organization for Cancer Prevention and Research (IOCPR), Belgrade, Serbia.&#xD;Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.&#xD;Institute of Public Health and Preventive Medicine, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.&#xD;Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic.&#xD;National Institute of Public Health, Bucharest, Romania.&#xD;Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.&#xD;Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.&#xD;Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.&#xD;International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.&#xD;Regional Authority of Public Health in Banska Bystrica, Banska Bystrica, Slovakia.&#xD;The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland.&#xD;National Public Health Center, National Directorate of Environmental Health, Budapest, Hungary.&#xD;INSERM U946, Paris, France.&#xD;CNRS UMR8200, Institute Gustave Roussy, Villejuif, France.&#xD;CeRePP, Paris, France.&#xD;UPMC Univ Paris 06, GRC n degrees 5, Institut Universitaire de Cancerologie, Paris, France.&#xD;AP-HP, Department of Urology, Hopitaux Universitaires Est Parisien Tenon, Paris, France.&#xD;Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.&#xD;Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.&#xD;Genetic Epidemiology Group, Folkhalsan Research Center, Helsinki, Finland.&#xD;Department of Community Medicine, University of Tromso, The Arctic University of Norway, Tromso, Norway.&#xD;Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden.&#xD;Department of Biobank Research, Umea University, Umea, Sweden.&#xD;Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.&#xD;Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.&#xD;QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.&#xD;School of Public Health, The University of Queensland, Brisbane, Australia.&#xD;&quot;Health across generations&quot; team, CESP Inserm, Facultes de Medicine Universite Paris-Sud, UVSQ, Universite Paris-Saclay, Gustave Roussy, Villejuif, France.&#xD;Human Genetics Foundation (HuGeF), Torino, Italy.&#xD;Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia.&#xD;K. G. Jebsen Center for Genetic Epidemiology, Department of Public Health, Norwegian University of Science and Technology, Trondheim, Norway.&#xD;Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.&#xD;London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom.&#xD;Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.&#xD;Leeds Institute of Cancer and Pathology, University of Leeds, St James&apos;s University Hospital, Leeds, United Kingdom.&#xD;National Institute for Health Research Diagnostic Evidence Cooperative, Division of Surgery, Imperial College London, St Mary&apos;s Hospital, London, United Kingdom.&#xD;Department of Oncology, University of Cambridge, Cambridge, United Kingdom.&#xD;Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.&#xD;National Institute for Health and Welfare, Helsinki, Finland.&#xD;Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States of America.&#xD;Department of Medicine, Division of Epidemiology, Vanderbilt-Ingram Cancer Center, Vanderbilt Genetics Institute, Nashville, Tennessee, United States of America.&#xD;American Cancer Society, Atlanta, Georgia, United States of America.&#xD;Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.&#xD;Brown University, Providence, Rhode Island, United States of America.&#xD;Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.&#xD;Brigham and Women&apos;s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.&#xD;Department of Medicine, Brigham and Women&apos;s Hospital, Boston, Massachusetts, United States of America.&#xD;Department of Health Sciences Research, Mayo Clinic, Jacksonville, Florida, United States of America.&#xD;Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America.&#xD;Division of Urology, Spectrum Health, Grand Rapids, Michigan, United States of America.&#xD;College of Human Medicine, Michigan State University, Grand Rapids, Michigan, United States of America.&#xD;Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, Michigan, United States of America.&#xD;Spectrum Health, Grand Rapids, Michigan, United States of America.&#xD;Diagnostics Program at Ferris State University, Grand Rapids, Michigan, United States of America.&#xD;Program in Cancer and Stem Cell Biology, Duke-National, University of Singapore Medical School, Singapore, Singapore.&#xD;Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore.&#xD;Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.&#xD;Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.&#xD;Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.&#xD;WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.&#xD;Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.&#xD;Department of Epidemiology and Biostatistics, School of Public Health Indiana University Bloomington, Bloomington, Indiana, United States of America.&#xD;University of Cambridge, Cambridge, United Kingdom.&#xD;The Institute of Cancer Research, London, United Kingdom.&#xD;Dept. of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.&#xD;Royal Marsden NHS Foundation Trust, London, United Kingdom.&#xD;Department of Urology, Mayo Clinic, Rochester, Minnesota, United States of America.&#xD;McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada.&#xD;School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.&#xD;Departments of Medicine, Human Genetics, Epidemiology and Biostatistics, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.&#xD;University Hospitals Bristol NHS Foundation Trust National Institute for Health Research Bristol Nutrition Biomedical Research Unit, University of Bristol, Bristol, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1002724</style></pages><volume><style face="normal" font="default" size="100%">16</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2019/01/04</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Blood Glucose/analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Carcinoma, Renal Cell/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/complications</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Markers</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Kidney Neoplasms/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Lipids/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30605491</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Several obesity-related factors have been associated with renal cell carcinoma (RCC), but it is unclear which individual factors directly influence risk. We addressed this question using genetic markers as proxies for putative risk factors and evaluated their relation to RCC risk in a mendelian randomization (MR) framework. This methodology limits bias due to confounding and is not affected by reverse causation. METHODS AND FINDINGS: Genetic markers associated with obesity measures, blood pressure, lipids, type 2 diabetes, insulin, and glucose were initially identified as instrumental variables, and their association with RCC risk was subsequently evaluated in a genome-wide association study (GWAS) of 10,784 RCC patients and 20,406 control participants in a 2-sample MR framework. The effect on RCC risk was estimated by calculating odds ratios (ORSD) for a standard deviation (SD) increment in each risk factor. The MR analysis indicated that higher body mass index increases the risk of RCC (ORSD: 1.56, 95% confidence interval [CI] 1.44-1.70), with comparable results for waist-to-hip ratio (ORSD: 1.63, 95% CI 1.40-1.90) and body fat percentage (ORSD: 1.66, 95% CI 1.44-1.90). This analysis further indicated that higher fasting insulin (ORSD: 1.82, 95% CI 1.30-2.55) and diastolic blood pressure (DBP; ORSD: 1.28, 95% CI 1.11-1.47), but not systolic blood pressure (ORSD: 0.98, 95% CI 0.84-1.14), increase the risk for RCC. No association with RCC risk was seen for lipids, overall type 2 diabetes, or fasting glucose. CONCLUSIONS: This study provides novel evidence for an etiological role of insulin in RCC, as well as confirmatory evidence that obesity and DBP influence RCC risk.</style></abstract><notes><style face="normal" font="default" size="100%">Johansson, Mattias&#xD;Carreras-Torres, Robert&#xD;Scelo, Ghislaine&#xD;Purdue, Mark P&#xD;Mariosa, Daniela&#xD;Muller, David C&#xD;Timpson, Nicolas J&#xD;Haycock, Philip C&#xD;Brown, Kevin M&#xD;Wang, Zhaoming&#xD;Ye, Yuanqing&#xD;Hofmann, Jonathan N&#xD;Foll, Matthieu&#xD;Gaborieau, Valerie&#xD;Machiela, Mitchell J&#xD;Colli, Leandro M&#xD;Li, Peng&#xD;Garnier, Jean-Guillaume&#xD;Blanche, Helene&#xD;Boland, Anne&#xD;Burdette, Laurie&#xD;Prokhortchouk, Egor&#xD;Skryabin, Konstantin G&#xD;Yeager, Meredith&#xD;Radojevic-Skodric, Sanja&#xD;Ognjanovic, Simona&#xD;Foretova, Lenka&#xD;Holcatova, Ivana&#xD;Janout, Vladimir&#xD;Mates, Dana&#xD;Mukeriya, Anush&#xD;Rascu, Stefan&#xD;Zaridze, David&#xD;Bencko, Vladimir&#xD;Cybulski, Cezary&#xD;Fabianova, Eleonora&#xD;Jinga, Viorel&#xD;Lissowska, Jolanta&#xD;Lubinski, Jan&#xD;Navratilova, Marie&#xD;Rudnai, Peter&#xD;Benhamou, Simone&#xD;Cancel-Tassin, Geraldine&#xD;Cussenot, Olivier&#xD;Weiderpass, Elisabete&#xD;Ljungberg, Borje&#xD;Tumkur Sitaram, Raviprakash&#xD;Haggstrom, Christel&#xD;Bruinsma, Fiona&#xD;Jordan, Susan J&#xD;Severi, Gianluca&#xD;Winship, Ingrid&#xD;Hveem, Kristian&#xD;Vatten, Lars J&#xD;Fletcher, Tony&#xD;Larsson, Susanna C&#xD;Wolk, Alicja&#xD;Banks, Rosamonde E&#xD;Selby, Peter J&#xD;Easton, Douglas F&#xD;Andreotti, Gabriella&#xD;Beane Freeman, Laura E&#xD;Koutros, Stella&#xD;Mannisto, Satu&#xD;Weinstein, Stephanie&#xD;Clark, Peter E&#xD;Edwards, Todd L&#xD;Lipworth, Loren&#xD;Gapstur, Susan M&#xD;Stevens, Victoria L&#xD;Carol, Hallie&#xD;Freedman, Matthew L&#xD;Pomerantz, Mark M&#xD;Cho, Eunyoung&#xD;Wilson, Kathryn M&#xD;Gaziano, J Michael&#xD;Sesso, Howard D&#xD;Freedman, Neal D&#xD;Parker, Alexander S&#xD;Eckel-Passow, Jeanette E&#xD;Huang, Wen-Yi&#xD;Kahnoski, Richard J&#xD;Lane, Brian R&#xD;Noyes, Sabrina L&#xD;Petillo, David&#xD;Teh, Bin Tean&#xD;Peters, Ulrike&#xD;White, Emily&#xD;Anderson, Garnet L&#xD;Johnson, Lisa&#xD;Luo, Juhua&#xD;Buring, Julie&#xD;Lee, I-Min&#xD;Chow, Wong-Ho&#xD;Moore, Lee E&#xD;Eisen, Timothy&#xD;Henrion, Marc&#xD;Larkin, James&#xD;Barman, Poulami&#xD;Leibovich, Bradley C&#xD;Choueiri, Toni K&#xD;Lathrop, G Mark&#xD;Deleuze, Jean-Francois&#xD;Gunter, Marc&#xD;McKay, James D&#xD;Wu, Xifeng&#xD;Houlston, Richard S&#xD;Chanock, Stephen J&#xD;Relton, Caroline&#xD;Richards, J Brent&#xD;Martin, Richard M&#xD;Davey Smith, George&#xD;Brennan, Paul&#xD;eng&#xD;MC_UU_12013/3/MRC_/Medical Research Council/United Kingdom&#xD;CAPMC/ CIHR/Canada&#xD;R01 CA170298/CA/NCI NIH HHS/&#xD;RP-PG-0707-10101/DH_/Department of Health/United Kingdom&#xD;MC_UU_12013/2/MRC_/Medical Research Council/United Kingdom&#xD;C18281/A19169/CRUK_/Cancer Research UK/United Kingdom&#xD;U01 CA155309/CA/NCI NIH HHS/&#xD;MC_UU_12013/1/MRC_/Medical Research Council/United Kingdom&#xD;6858/CRUK_/Cancer Research UK/United Kingdom&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, N.I.H., Intramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS Med. 2019 Jan 3;16(1):e1002724. doi: 10.1371/journal.pmed.1002724. eCollection 2019 Jan.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30605491</style></url></related-urls><pdf-urls><url>internal-pdf://2370961729/Johansson-2019-The influence of obesity-relate.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6317776 following competing interests: TE declared employment, research support, and stock in AstraZeneca and research support from Bayer and Pfizer. PCH is a population health fellow of Cancer Research UK. GDS is a member of the Editorial Board of PLOS Medicine.</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1002724</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>16</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">16</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jokela, M.</style></author><author><style face="normal" font="default" size="100%">Elovainio, M.</style></author><author><style face="normal" font="default" size="100%">Keltikangas-Jarvinen, L.</style></author><author><style face="normal" font="default" size="100%">Batty, G. D.</style></author><author><style face="normal" font="default" size="100%">Hintsanen, M.</style></author><author><style face="normal" font="default" size="100%">Seppala, I.</style></author><author><style face="normal" font="default" size="100%">Kahonen, M.</style></author><author><style face="normal" font="default" size="100%">Viikari, J. S.</style></author><author><style face="normal" font="default" size="100%">Raitakari, O. T.</style></author><author><style face="normal" font="default" size="100%">Lehtimaki, T.</style></author><author><style face="normal" font="default" size="100%">Kivimaki, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute of Behavioural Sciences, University of Helsinki, Helsinki, Finland.&#xD;National Institute for Health and Welfare, Helsinki, Finland.&#xD;Department of Epidemiology and Public Health, University College London, London, UK.&#xD;Department of Psychology, Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.&#xD;Helsinki Collegium for Advanced Studies, University of Helsinki, Helsinki, Finland.&#xD;Department of Clinical Chemistry, Centre for Laboratory Medicine, Tampere University Hospital, Tampere, Finland.&#xD;Medical School, University of Tampere, Tampere, Finland.&#xD;Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland.&#xD;Department of Medicine, Turku University Hospital.&#xD;Department of Clinical Physiology, Turku University Hospital and Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Body mass index and depressive symptoms: instrumental-variables regression with genetic risk score</style></title><secondary-title><style face="normal" font="default" size="100%">Genes Brain Behav</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Genes Brain Behav</style></full-title></periodical><pages><style face="normal" font="default" size="100%">942-8</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><number><style face="normal" font="default" size="100%">8</style></number><edition><style face="normal" font="default" size="100%">2012/09/11</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Body Weight/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Depressive Disorder/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Finland</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Markers/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescence</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">adulthood</style></keyword><keyword><style face="normal" font="default" size="100%">body mass index</style></keyword><keyword><style face="normal" font="default" size="100%">depression</style></keyword><keyword><style face="normal" font="default" size="100%">genetic risk score</style></keyword><keyword><style face="normal" font="default" size="100%">instrumental variables</style></keyword><keyword><style face="normal" font="default" size="100%">obesity</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1601-183X (Electronic)&#xD;1601-183X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">22958333</style></accession-num><abstract><style face="normal" font="default" size="100%">The causal role of obesity in the development of depression remains uncertain. We applied instrumental-variables regression (Mendelian randomization) to examine the association of adolescent and adult body mass index (BMI) with adult depressive symptoms. Participants were from the Young Finns prospective cohort study (n = 1731 persons, 2844 person-observations), with repeated measurements of BMI and depressive symptoms (modified Beck&apos;s Depression Inventory). Genetic risk score of 31 single nucleotide polymorphisms previously identified as robust genetic markers of body weight was used as a proxy for variation in BMI. In standard linear regression analysis, higher adult depressive symptoms were predicted by higher adolescent BMI (B = 0.33, CI = 0.06-0.60, P = 0.017) and adult BMI (B = 0.47, CI = 0.32-0.63, P &lt; 0.001). These associations were replicated in instrumental-variables analysis with genetic risk score as instrument (B = 1.96, CI = 0.03-3.90, P = 0.047 for adolescent BMI; B = 1.08, CI = 0.11-2.04, P = 0.030 for adult BMI). The association for adolescent BMI was significantly stronger in the instrumented analysis compared to standard regression (P = 0.04). These findings provide additional evidence to support a causal role for high BMI in increasing symptoms of depression. However, the present analysis also demonstrates potential limitations of applying Mendelian randomization when using complex phenotypes.</style></abstract><notes><style face="normal" font="default" size="100%">Jokela, M&#xD;Elovainio, M&#xD;Keltikangas-Jarvinen, L&#xD;Batty, G D&#xD;Hintsanen, M&#xD;Seppala, I&#xD;Kahonen, M&#xD;Viikari, J S&#xD;Raitakari, O T&#xD;Lehtimaki, T&#xD;Kivimaki, M&#xD;eng&#xD;G19/35/Medical Research Council/United Kingdom&#xD;G0100222/Medical Research Council/United Kingdom&#xD;Biotechnology and Biological Sciences Research Council/United Kingdom&#xD;G8802774/Medical Research Council/United Kingdom&#xD;G0902037/Medical Research Council/United Kingdom&#xD;R01AG034454/AG/NIA NIH HHS/&#xD;R01HL036310/HL/NHLBI NIH HHS/&#xD;Wellcome Trust/United Kingdom&#xD;RG/07/008/23674/British Heart Foundation/United Kingdom&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Genes Brain Behav. 2012 Nov;11(8):942-8. doi: 10.1111/j.1601-183X.2012.00846.x. Epub 2012 Oct 1.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/22958333</style></url></related-urls><pdf-urls><url>internal-pdf://1128258590/Jokela-2012-Body mass index and depressive sym.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/j.1601-183X.2012.00846.x</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>148</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">148</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jones, S. E.</style></author><author><style face="normal" font="default" size="100%">Tyrrell, J.</style></author><author><style face="normal" font="default" size="100%">Wood, A. R.</style></author><author><style face="normal" font="default" size="100%">Beaumont, R. N.</style></author><author><style face="normal" font="default" size="100%">Ruth, K. S.</style></author><author><style face="normal" font="default" size="100%">Tuke, M. A.</style></author><author><style face="normal" font="default" size="100%">Yaghootkar, H.</style></author><author><style face="normal" font="default" size="100%">Hu, Y.</style></author><author><style face="normal" font="default" size="100%">Teder-Laving, M.</style></author><author><style face="normal" font="default" size="100%">Hayward, C.</style></author><author><style face="normal" font="default" size="100%">Roenneberg, T.</style></author><author><style face="normal" font="default" size="100%">Wilson, J. F.</style></author><author><style face="normal" font="default" size="100%">Del Greco, F.</style></author><author><style face="normal" font="default" size="100%">Hicks, A. A.</style></author><author><style face="normal" font="default" size="100%">Shin, C.</style></author><author><style face="normal" font="default" size="100%">Yun, C. H.</style></author><author><style face="normal" font="default" size="100%">Lee, S. K.</style></author><author><style face="normal" font="default" size="100%">Metspalu, A.</style></author><author><style face="normal" font="default" size="100%">Byrne, E. M.</style></author><author><style face="normal" font="default" size="100%">Gehrman, P. R.</style></author><author><style face="normal" font="default" size="100%">Tiemeier, H.</style></author><author><style face="normal" font="default" size="100%">Allebrandt, K. V.</style></author><author><style face="normal" font="default" size="100%">Freathy, R. M.</style></author><author><style face="normal" font="default" size="100%">Murray, A.</style></author><author><style face="normal" font="default" size="100%">Hinds, D. A.</style></author><author><style face="normal" font="default" size="100%">Frayling, T. M.</style></author><author><style face="normal" font="default" size="100%">Weedon, M. N.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Genetics of Complex Traits, University of Exeter Medical School, Exeter, United Kingdom.&#xD;23andMe Inc., Mountain View, California, United States of America.&#xD;A9.com Inc, Palo Alto, California, United States of America.&#xD;Estonian Genome Center and Institute of Molecular and Cell Biology of University of Tartu, Estonian Biocentre, Tartu, Estonia.&#xD;Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, Edinburgh, Scotland.&#xD;Institute of Medical Psychology, Ludwig-Maximilians-University, Munich, Germany.&#xD;Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland.&#xD;Center for Biomedicine, European Academy of Bolzano, Bozen, Italy-affiliated Institute of the University of Lubeck, Lubeck, Germany.&#xD;Division of Pulmonary, Sleep and Critical Care Medicine, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.&#xD;Institute of Human Genomic Study, College of Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.&#xD;Department of Neurology, Bundang Clinical Neuroscience Institute, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.&#xD;The University of Queensland, Queensland Brain Institute, Brisbane, Australia.&#xD;Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.&#xD;Department of Epidemiology, Erasmus Medical Center, Rotterdam, Netherlands.&#xD;Department of Psychiatry, Erasmus Medical Center, Rotterdam, Netherlands.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genome-Wide Association Analyses in 128,266 Individuals Identifies New Morningness and Sleep Duration Loci</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1006125</style></pages><volume><style face="normal" font="default" size="100%">12</style></volume><number><style face="normal" font="default" size="100%">8</style></number><edition><style face="normal" font="default" size="100%">2016/08/06</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Circadian Rhythm/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/*genetics/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/genetics/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">PAX8 Transcription Factor/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Protein-Serine-Threonine Kinases/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Sleep/*genetics/physiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1553-7404 (Electronic)&#xD;1553-7390 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27494321</style></accession-num><abstract><style face="normal" font="default" size="100%">Disrupted circadian rhythms and reduced sleep duration are associated with several human diseases, particularly obesity and type 2 diabetes, but until recently, little was known about the genetic factors influencing these heritable traits. We performed genome-wide association studies of self-reported chronotype (morning/evening person) and self-reported sleep duration in 128,266 white British individuals from the UK Biobank study. Sixteen variants were associated with chronotype (P&lt;5x10-8), including variants near the known circadian rhythm genes RGS16 (1.21 odds of morningness, 95% CI [1.15, 1.27], P = 3x10-12) and PER2 (1.09 odds of morningness, 95% CI [1.06, 1.12], P = 4x10-10). The PER2 signal has previously been associated with iris function. We sought replication using self-reported data from 89,283 23andMe participants; thirteen of the chronotype signals remained associated at P&lt;5x10-8 on meta-analysis and eleven of these reached P&lt;0.05 in the same direction in the 23andMe study. We also replicated 9 additional variants identified when the 23andMe study was used as a discovery GWAS of chronotype (all P&lt;0.05 and meta-analysis P&lt;5x10-8). For sleep duration, we replicated one known signal in PAX8 (2.6 minutes per allele, 95% CI [1.9, 3.2], P = 5.7x10-16) and identified and replicated two novel associations at VRK2 (2.0 minutes per allele, 95% CI [1.3, 2.7], P = 1.2x10-9; and 1.6 minutes per allele, 95% CI [1.1, 2.2], P = 7.6x10-9). Although we found genetic correlation between chronotype and BMI (rG = 0.056, P = 0.05); undersleeping and BMI (rG = 0.147, P = 1x10-5) and oversleeping and BMI (rG = 0.097, P = 0.04), Mendelian Randomisation analyses, with limited power, provided no consistent evidence of causal associations between BMI or type 2 diabetes and chronotype or sleep duration. Our study brings the total number of loci associated with chronotype to 22 and with sleep duration to three, and provides new insights into the biology of sleep and circadian rhythms in humans.</style></abstract><notes><style face="normal" font="default" size="100%">Jones, Samuel E&#xD;Tyrrell, Jessica&#xD;Wood, Andrew R&#xD;Beaumont, Robin N&#xD;Ruth, Katherine S&#xD;Tuke, Marcus A&#xD;Yaghootkar, Hanieh&#xD;Hu, Youna&#xD;Teder-Laving, Maris&#xD;Hayward, Caroline&#xD;Roenneberg, Till&#xD;Wilson, James F&#xD;Del Greco, Fabiola&#xD;Hicks, Andrew A&#xD;Shin, Chol&#xD;Yun, Chang-Ho&#xD;Lee, Seung Ku&#xD;Metspalu, Andres&#xD;Byrne, Enda M&#xD;Gehrman, Philip R&#xD;Tiemeier, Henning&#xD;Allebrandt, Karla V&#xD;Freathy, Rachel M&#xD;Murray, Anna&#xD;Hinds, David A&#xD;Frayling, Timothy M&#xD;Weedon, Michael N&#xD;eng&#xD;G0500070/Medical Research Council/United Kingdom&#xD;G0601261/Medical Research Council/United Kingdom&#xD;MC_PC_U127561128/Medical Research Council/United Kingdom&#xD;MC_QA137853/Medical Research Council/United Kingdom&#xD;Meta-Analysis&#xD;PLoS Genet. 2016 Aug 5;12(8):e1006125. doi: 10.1371/journal.pgen.1006125. eCollection 2016 Aug.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27494321</style></url></related-urls><pdf-urls><url>internal-pdf://2806823864/Jones-2016-Genome-Wide Association Analyses in.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4975467</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pgen.1006125</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>51</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">51</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kar, S. P.</style></author><author><style face="normal" font="default" size="100%">Andrulis, I. L.</style></author><author><style face="normal" font="default" size="100%">Brenner, H.</style></author><author><style face="normal" font="default" size="100%">Burgess, S.</style></author><author><style face="normal" font="default" size="100%">Chang-Claude, J.</style></author><author><style face="normal" font="default" size="100%">Considine, D.</style></author><author><style face="normal" font="default" size="100%">Dork, T.</style></author><author><style face="normal" font="default" size="100%">Evans, D. G. R.</style></author><author><style face="normal" font="default" size="100%">Gago-Dominguez, M.</style></author><author><style face="normal" font="default" size="100%">Giles, G. G.</style></author><author><style face="normal" font="default" size="100%">Hartman, M.</style></author><author><style face="normal" font="default" size="100%">Huo, D.</style></author><author><style face="normal" font="default" size="100%">Kaaks, R.</style></author><author><style face="normal" font="default" size="100%">Li, J.</style></author><author><style face="normal" font="default" size="100%">Lophatananon, A.</style></author><author><style face="normal" font="default" size="100%">Margolin, S.</style></author><author><style face="normal" font="default" size="100%">Milne, R. L.</style></author><author><style face="normal" font="default" size="100%">Muir, K. R.</style></author><author><style face="normal" font="default" size="100%">Olsson, H.</style></author><author><style face="normal" font="default" size="100%">Punie, K.</style></author><author><style face="normal" font="default" size="100%">Radice, P.</style></author><author><style face="normal" font="default" size="100%">Simard, J.</style></author><author><style face="normal" font="default" size="100%">Tamimi, R. M.</style></author><author><style face="normal" font="default" size="100%">Van Nieuwenhuysen, E.</style></author><author><style face="normal" font="default" size="100%">Wendt, C.</style></author><author><style face="normal" font="default" size="100%">Zheng, W.</style></author><author><style face="normal" font="default" size="100%">Pharoah, P. D. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. sk718@medschl.cam.ac.uk.&#xD;Homerton College, Hills Road, Cambridge, CB2 8PH, UK. sk718@medschl.cam.ac.uk.&#xD;Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.&#xD;Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.&#xD;Division of Clinical Epidemiology and Ageing Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.&#xD;Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.&#xD;MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.&#xD;Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Cancer Epidemiology, University Medical Center Hamburg-Eppendorf, University Cancer Center Hamburg (UCCH), Hamburg, Germany.&#xD;Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.&#xD;Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.&#xD;Genomic Medicine Group, Galician Foundation of Genomic Medicine, Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saude (SERGAS), Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Santiago De Compostela, Spain.&#xD;Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.&#xD;Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.&#xD;Center for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.&#xD;Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.&#xD;Department of Surgery, National University of Singapore, Singapore, Singapore.&#xD;Department of Public Health Sciences, University of Chicago, Chicago, IL, USA.&#xD;Human Genetics, Genome Institute of Singapore, Singapore, Singapore.&#xD;Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.&#xD;Department of Oncology, Sodersjukhuset and Department of Clinical Science and Education, Sodersjukhuset, Karolinska Institutet, Stockholm, Sweden.&#xD;Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.&#xD;Department of Oncology, Leuven Multidisciplinary Breast Centre, University Hospital Leuven, KU Leuven, Louvain, Belgium.&#xD;Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy.&#xD;Genomics Center, Centre Hospitalier Universitaire de Quebec - Universite Laval Research Center, Quebec City, QC, Canada.&#xD;Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.&#xD;Channing Division of Network Medicine, Department of Medicine, Brigham and Women&apos;s Hospital and Harvard Medical School, Boston, MA, USA.&#xD;Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.&#xD;Department of Oncology, University of Cambridge, Cambridge, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The association between weight at birth and breast cancer risk revisited using Mendelian randomisation</style></title><secondary-title><style face="normal" font="default" size="100%">Eur J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">591-600</style></pages><volume><style face="normal" font="default" size="100%">34</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2019/02/10</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Birth Weight/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Birth weight</style></keyword><keyword><style face="normal" font="default" size="100%">Breast cancer</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian randomisation</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1573-7284 (Electronic)&#xD;0393-2990 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30737679</style></accession-num><abstract><style face="normal" font="default" size="100%">Observational studies suggest that higher birth weight (BW) is associated with increased risk of breast cancer in adult life. We conducted a two-sample Mendelian randomisation (MR) study to assess whether this association is causal. Sixty independent single nucleotide polymorphisms (SNPs) known to be associated at P &lt; 5 x 10(-8) with BW were used to construct (1) a 41-SNP instrumental variable (IV) for univariable MR after removing SNPs with pleiotropic associations with other breast cancer risk factors and (2) a 49-SNP IV for multivariable MR after filtering SNPs for data availability. BW predicted by the 41-SNP IV was not associated with overall breast cancer risk in inverse-variance weighted (IVW) univariable MR analysis of genetic association data from 122,977 breast cancer cases and 105,974 controls (odds ratio = 0.86 per 500 g higher BW; 95% confidence interval 0.73-1.01). Sensitivity analyses using four alternative methods and three alternative IVs, including an IV with 59 of the 60 BW-associated SNPs, yielded similar results. Multivariable MR adjusting for the effects of the 49-SNP IV on birth length, adult height, adult body mass index, age at menarche, and age at menopause using IVW and MR-Egger methods provided estimates consistent with univariable analyses. Results were also similar when all analyses were repeated after restricting to estrogen receptor-positive or -negative breast cancer cases. Point estimates of the odds ratios from most analyses performed indicated an inverse relationship between genetically-predicted BW and breast cancer, but we are unable to rule out an association between the non-genetically-determined component of BW and breast cancer. Thus, genetically-predicted higher BW was not associated with an increased risk of breast cancer in adult life in our MR study.</style></abstract><notes><style face="normal" font="default" size="100%">Kar, Siddhartha P&#xD;Andrulis, Irene L&#xD;Brenner, Hermann&#xD;Burgess, Stephen&#xD;Chang-Claude, Jenny&#xD;Considine, Daniel&#xD;Dork, Thilo&#xD;Evans, Dafydd Gareth R&#xD;Gago-Dominguez, Manuela&#xD;Giles, Graham G&#xD;Hartman, Mikael&#xD;Huo, Dezheng&#xD;Kaaks, Rudolf&#xD;Li, Jingmei&#xD;Lophatananon, Artitaya&#xD;Margolin, Sara&#xD;Milne, Roger L&#xD;Muir, Kenneth R&#xD;Olsson, Hakan&#xD;Punie, Kevin&#xD;Radice, Paolo&#xD;Simard, Jacques&#xD;Tamimi, Rulla M&#xD;Van Nieuwenhuysen, Els&#xD;Wendt, Camilla&#xD;Zheng, Wei&#xD;Pharoah, Paul D P&#xD;eng&#xD;RP-PG-0707-10031/DH_/Department of Health/United Kingdom&#xD;RG/18/13/33946/BHF_/British Heart Foundation/United Kingdom&#xD;RG/13/13/30194/BHF_/British Heart Foundation/United Kingdom&#xD;RP-PG-1214-20016/DH_/Department of Health/United Kingdom&#xD;MC_UU_00002/7/MRC_/Medical Research Council/United Kingdom&#xD;10119/CRUK_/Cancer Research UK/United Kingdom&#xD;10124/CRUK_/Cancer Research UK/United Kingdom&#xD;Netherlands&#xD;Eur J Epidemiol. 2019 Jun;34(6):591-600. doi: 10.1007/s10654-019-00485-7. Epub 2019 Feb 8.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30737679</style></url></related-urls><pdf-urls><url>internal-pdf://3008444089/Kar-2019-The association between weight at bir.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6497616</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s10654-019-00485-7</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>30</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">30</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kemp, J. P.</style></author><author><style face="normal" font="default" size="100%">Sayers, A.</style></author><author><style face="normal" font="default" size="100%">Smith, G. D.</style></author><author><style face="normal" font="default" size="100%">Tobias, J. H.</style></author><author><style face="normal" font="default" size="100%">Evans, D. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia.&#xD;MRC Integrative Epidemiology Unit and.&#xD;School of Clinical Sciences, University of Bristol, Bristol, UK.&#xD;University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia d.evans1@uq.edu.au.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Using Mendelian randomization to investigate a possible causal relationship between adiposity and increased bone mineral density at different skeletal sites in children</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1560-1572</style></pages><volume><style face="normal" font="default" size="100%">45</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2016/05/25</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Absorptiometry, Photon</style></keyword><keyword><style face="normal" font="default" size="100%">Adenylyl Cyclases/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Bone Density/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Bone and Bones/*diagnostic imaging</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">England</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Multivariate Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Osteoporosis/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">*alspac</style></keyword><keyword><style face="normal" font="default" size="100%">*Bone</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*body mass index</style></keyword><keyword><style face="normal" font="default" size="100%">*genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1464-3685 (Electronic)&#xD;0300-5771 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27215616</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Lean mass is positively associated with bone mineral density (BMD). However, the relationship between adiposity and BMD is more controversial. In particular, it is unclear if the observational association between the two reflects a causal effect of fat mass on BMD. Previous Mendelian randomization (MR) studies using variants in the FTO and MC4R genes as genetic instruments for adiposity have suggested that fat mass does indeed causally influence BMD. However, it is possible that these genetic variants pleiotropically influence lean mass and affect BMD through pathways independent of adiposity, invalidating one of the core assumptions of MR and complicating interpretation of the analysis. METHODS: To investigate whether adiposity causally affects BMD, we investigated the relationship between fat mass and BMD at the skull (SK), upper limbs (UL) and lower limbs (LL), spine (SP) and pelvis (PE), using 32 body mass index (BMI)-associated SNPs, including a variant near ADCY3 that was strongly associated with fat but not lean mass in our sample. Dual-energy X-ray absorptiometry (DXA) scans and genetic data were available for 5221 subjects (mean age 9.9 years) from the Avon Longitudinal Study of Parents and Children. We performed a series of MR analyses involving single BMI-associated SNPs and allelic scores of these SNPs. We used new extensions of the MR method including MR Egger regression and multivariable MR, which are more robust to possible confounding effects due to horizontal pleiotropy and, in the case of multivariable MR, specifically account for the effect of lean mass in the analysis. Bidirectional Mendelian randomization analysis was also performed to examine whether BMD causally affected BMI and adiposity. RESULTS: Observationally, fat mass was strongly positively related to BMD at all sites, but more weakly at the skull. Instrumental variables (IV) analyses using an allelic score of BMI SNPs suggested that fat mass was causally related to LL-BMD, UL-BMD, SP-BMD and PE-BMD but not SK-BMD. Multivariable MR, Egger regression and IV analyses involving the ADCY3 variant suggested a positive causal effect of adiposity on all sites except the skull, and that an effect was present even after taking lean mass into account. Finally, IV analyses using BMD allelic scores showed no evidence of reverse causality between BMD and fat mass. CONCLUSIONS: Our results suggest that adiposity is causally related to increased BMD at all sites except the skull, perhaps reflecting positive effects of loading on bone formation at weighted but not unweighted sites. In contrast, we found no evidence for BMD causally affecting BMI or measures of adiposity. Our results illustrate how MR can be used profitably to investigate clinical questions relevant to osteoporosis.</style></abstract><notes><style face="normal" font="default" size="100%">Kemp, John P&#xD;Sayers, Adrian&#xD;Smith, George Davey&#xD;Tobias, Jonathan H&#xD;Evans, David M&#xD;eng&#xD;092731/Wellcome Trust/United Kingdom&#xD;102215/Wellcome Trust/United Kingdom&#xD;MC_PC_15018/Medical Research Council/United Kingdom&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;MC_UU_12013/4/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Int J Epidemiol. 2016 Oct;45(5):1560-1572. doi: 10.1093/ije/dyw079. Epub 2016 May 22.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27215616</style></url></related-urls><pdf-urls><url>internal-pdf://3948328121/Kemp-2016-Using Mendelian randomization to inv.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5100609</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/ije/dyw079</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>35</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">35</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kivimaki, M.</style></author><author><style face="normal" font="default" size="100%">Jokela, M.</style></author><author><style face="normal" font="default" size="100%">Hamer, M.</style></author><author><style face="normal" font="default" size="100%">Geddes, J.</style></author><author><style face="normal" font="default" size="100%">Ebmeier, K.</style></author><author><style face="normal" font="default" size="100%">Kumari, M.</style></author><author><style face="normal" font="default" size="100%">Singh-Manoux, A.</style></author><author><style face="normal" font="default" size="100%">Hingorani, A.</style></author><author><style face="normal" font="default" size="100%">Batty, G. D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Epidemiology and Public Health, Faculty of Biomedical Sciences, University College London, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Examining overweight and obesity as risk factors for common mental disorders using fat mass and obesity-associated (FTO) genotype-instrumented analysis: The Whitehall II Study, 1985-2004</style></title><secondary-title><style face="normal" font="default" size="100%">Am J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Am J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">421-9</style></pages><volume><style face="normal" font="default" size="100%">173</style></volume><number><style face="normal" font="default" size="100%">4</style></number><edition><style face="normal" font="default" size="100%">2011/01/21</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">Anxiety/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Causality</style></keyword><keyword><style face="normal" font="default" size="100%">Chi-Square Distribution</style></keyword><keyword><style face="normal" font="default" size="100%">Depression/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Follow-Up Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">London/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Overweight/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Regression Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Sex Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Surveys and Questionnaires</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 15</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-6256 (Electronic)&#xD;0002-9262 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">21248310</style></accession-num><abstract><style face="normal" font="default" size="100%">The Mendelian randomization approach exploits genetic variants to improve causal inference when using observational data. The authors examined the relation between long-term obesity and common mental disorders (CMD) by utilizing the known relation between fat mass and obesity-associated (FTO) genotype and body mass index (BMI; weight (kg)/height (m)(2)). Data collection in 2,981 men and 1,164 women (mean age at baseline = 44 years) from the Whitehall II Study (London, United Kingdom) included 4 repeated examinations of BMI and CMD over a 19-year follow-up period (1985-2004), plus an assessment of FTO polymorphism rs1421085. In men, there was an association of FTO genotype with all measures of adiposity (mean BMI, number of times obese, and, in nonobese persons, number of times overweight). FTO was also associated with CMD in men. This was independent of adiposity, thus potentially violating the exclusion restriction assumption. According to both conventional and FTO-instrumented regression analysis, measurement of obesity was associated with an increased occurrence of CMD. In the FTO-instrumented analysis only, higher BMI and overweight were also associated with CMD. In women, there was no link between FTO and adiposity. Mendelian randomization analyses supported the status of long-term obesity as a risk factor for CMD in men-a finding that should be interpreted cautiously because the function of the FTO gene is unknown.</style></abstract><notes><style face="normal" font="default" size="100%">Kivimaki, Mika&#xD;Jokela, Markus&#xD;Hamer, Mark&#xD;Geddes, John&#xD;Ebmeier, Klaus&#xD;Kumari, Meena&#xD;Singh-Manoux, Archana&#xD;Hingorani, Aroon&#xD;Batty, G David&#xD;eng&#xD;R01 HL036310/HL/NHLBI NIH HHS/&#xD;G19/35/Medical Research Council/United Kingdom&#xD;MC_U130059821/Medical Research Council/United Kingdom&#xD;G0100222/Medical Research Council/United Kingdom&#xD;AG13196/AG/NIA NIH HHS/&#xD;Biotechnology and Biological Sciences Research Council/United Kingdom&#xD;G8802774/Medical Research Council/United Kingdom&#xD;G0902037/Medical Research Council/United Kingdom&#xD;Department of Health/United Kingdom&#xD;R37 AG013196/AG/NIA NIH HHS/&#xD;HL36310/HL/NHLBI NIH HHS/&#xD;R01 AG013196/AG/NIA NIH HHS/&#xD;HS06516/HS/AHRQ HHS/&#xD;Wellcome Trust/United Kingdom&#xD;RG/07/008/23674/British Heart Foundation/United Kingdom&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;Am J Epidemiol. 2011 Feb 15;173(4):421-9. doi: 10.1093/aje/kwq444. Epub 2011 Jan 19.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/21248310</style></url></related-urls><pdf-urls><url>internal-pdf://2740901003/Kivimaki-2011-Examining overweight and obesity.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3032807</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/aje/kwq444</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>131</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">131</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kivimaki, M.</style></author><author><style face="normal" font="default" size="100%">Smith, G. D.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Lawlor, D. A.</style></author><author><style face="normal" font="default" size="100%">Batty, G. D.</style></author><author><style face="normal" font="default" size="100%">Kahonen, M.</style></author><author><style face="normal" font="default" size="100%">Juonala, M.</style></author><author><style face="normal" font="default" size="100%">Ronnemaa, T.</style></author><author><style face="normal" font="default" size="100%">Viikari, J. S.</style></author><author><style face="normal" font="default" size="100%">Lehtimaki, T.</style></author><author><style face="normal" font="default" size="100%">Raitakari, O. T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Epidemiology and Public Health, University College London, London, UK. m.kivimaki@ucl.ac.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">Lifetime body mass index and later atherosclerosis risk in young adults: examining causal links using Mendelian randomization in the Cardiovascular Risk in Young Finns study</style></title><secondary-title><style face="normal" font="default" size="100%">Eur Heart J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur Heart J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2552-60</style></pages><volume><style face="normal" font="default" size="100%">29</style></volume><number><style face="normal" font="default" size="100%">20</style></number><edition><style face="normal" font="default" size="100%">2008/06/14</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">Atherosclerosis/*genetics/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure/genetics/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Carotid Artery, Common/*pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Confounding Factors, Epidemiologic</style></keyword><keyword><style face="normal" font="default" size="100%">Epidemiologic Methods</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Finland</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Variation/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Genetic</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Socioeconomic Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Tunica Intima/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Tunica Media/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1522-9645 (Electronic)&#xD;0195-668X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">18550552</style></accession-num><abstract><style face="normal" font="default" size="100%">AIMS: Mendelian randomization uses genetic variants related to environmentally modifiable risk factors in an attempt to improve causal inference from observational data. We examined the effect of lifetime body mass index (BMI) on adult carotid intima-media thickness (CIMT) and various atherosclerotic risk factors by using both Mendelian randomization and conventional analyses. METHODS AND RESULTS: A total of 2230 individuals (1218 women), aged 3-18 at study induction, took part in clinical examinations in 1980, 1983, 1986, and, most recently, 2001 when they were aged 24-39. In these analyses we utilized the known relation between FTO polymorphism rs9939609 and BMI. The dose-response association between the number of A alleles in FTO and higher mean BMI from childhood to adulthood was confirmed, but no associations with potential confounding factors were observed. In standard regression models, lifetime BMI was associated with adult CIMT, lifetime systolic blood pressure, adult fasting glucose, and adult HOMA-index. When variation in FTO was used as an instrument for unconfounded BMI levels, similar or larger effects of lifetime BMI on all these phenotypes were found, although with wider confidence intervals. CONCLUSION: Mutually supportive results from Mendelian randomization and standard regression models strengthen the evidence of the effect of lifetime BMI on atherosclerosis risk in young adults.</style></abstract><notes><style face="normal" font="default" size="100%">Kivimaki, Mika&#xD;Smith, George Davey&#xD;Timpson, Nic J&#xD;Lawlor, Debbie A&#xD;Batty, G David&#xD;Kahonen, Mika&#xD;Juonala, Markus&#xD;Ronnemaa, Tapani&#xD;Viikari, Jorma S A&#xD;Lehtimaki, Terho&#xD;Raitakari, Olli T&#xD;eng&#xD;G0600705/Medical Research Council/United Kingdom&#xD;G19/35/Medical Research Council/United Kingdom&#xD;MC_U130059821/Medical Research Council/United Kingdom&#xD;G0100222/Medical Research Council/United Kingdom&#xD;G8802774/Medical Research Council/United Kingdom&#xD;Department of Health/United Kingdom&#xD;Wellcome Trust/United Kingdom&#xD;RG/07/008/23674/British Heart Foundation/United Kingdom&#xD;Multicenter Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Eur Heart J. 2008 Oct;29(20):2552-60. doi: 10.1093/eurheartj/ehn252. Epub 2008 Jun 10.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/18550552</style></url></related-urls><pdf-urls><url>internal-pdf://3726698103/Kivimaki-2008-Lifetime body mass index and lat.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC2567023</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/eurheartj/ehn252</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>23</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">23</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Klarin, D.</style></author><author><style face="normal" font="default" size="100%">Emdin, C. A.</style></author><author><style face="normal" font="default" size="100%">Natarajan, P.</style></author><author><style face="normal" font="default" size="100%">Conrad, M. F.</style></author><author><style face="normal" font="default" size="100%">Invent Consortium</style></author><author><style face="normal" font="default" size="100%">Kathiresan, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">From the Center for Genomic Medicine (D.K., C.A.E., P.N., S.K.), Department of Surgery (D.K.), and Division of Vascular and Endovascular Surgery (M.E.C.), Massachusetts General Hospital, Harvard Medical School, Boston; and Program in Medical and Population Genetics, Broad Institute, Cambridge, MA (D.K., C.A.E., P.N., S.K.).&#xD;From the Center for Genomic Medicine (D.K., C.A.E., P.N., S.K.), Department of Surgery (D.K.), and Division of Vascular and Endovascular Surgery (M.E.C.), Massachusetts General Hospital, Harvard Medical School, Boston; and Program in Medical and Population Genetics, Broad Institute, Cambridge, MA (D.K., C.A.E., P.N., S.K.). skathiresan1@mgh.harvard.edu.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor</style></title><secondary-title><style face="normal" font="default" size="100%">Circ Cardiovasc Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Circ Cardiovasc Genet</style></full-title></periodical><volume><style face="normal" font="default" size="100%">10</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2017/04/05</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Biological Specimen Banks</style></keyword><keyword><style face="normal" font="default" size="100%">DNA-Binding Proteins/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Loci</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Transcription Factors/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">United Kingdom</style></keyword><keyword><style face="normal" font="default" size="100%">Venous Thromboembolism/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*body mass index</style></keyword><keyword><style face="normal" font="default" size="100%">*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*venous thromboembolism</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1942-3268 (Electronic)&#xD;1942-3268 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28373160</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: UK Biobank is the world&apos;s largest repository for phenotypic and genotypic information for individuals of European ancestry. Here, we leverage UK Biobank to understand the inherited basis for venous thromboembolism (VTE), a leading cause of cardiovascular mortality. METHODS AND RESULTS: We identified 3290 VTE cases and 116 868 controls through billing code-based phenotyping. We performed a genome-wide association study for VTE with approximately 9 000 000 imputed single-nucleotide polymorphisms. We performed a phenome-wide association study for a genetic risk score of 10 VTE-associated variants. To assess whether obesity is a causal factor for VTE, we performed Mendelian randomization analysis using a genetic risk score instrument composed of 68 body mass index-associated variants. The genome-wide association study for VTE replicated previous findings at the F5, F2, ABO, F11, and FGG loci. We identified 1 new locus-ZFPM2 rs4602861-at genome-wide significance (odds ratio, 1.11; 95% confidence interval, 1.07-1.15; P=4.9x10(-10)) and a new independent variant at the F2 locus (rs3136516; odds ratio, 1.10; 95% confidence interval, 1.06-1.13; P=7.60x10(-9)). In a phenome-wide association study, a 10 single-nucleotide polymorphism VTE genetic risk score was associated with coronary artery disease (odds ratio, 1.08; 95% confidence interval, 1.05-1.10 per unit increase in VTE odds; P=1.08x10(-9)). In a Mendelian randomization analysis, genetically elevated body mass index (a 1 SD increase) was associated with 57% higher risk of VTE (odds ratio, 1.57; 95% confidence interval, 1.08-1.97; P=0.003). CONCLUSIONS: For common diseases such as VTE, biobanks provide potential to perform genetic discovery, explore the phenotypic consequences for disease-associated variants, and test causal inference.</style></abstract><notes><style face="normal" font="default" size="100%">Klarin, Derek&#xD;Emdin, Connor A&#xD;Natarajan, Pradeep&#xD;Conrad, Mark F&#xD;Kathiresan, Sekar&#xD;eng&#xD;MC_QA137853/Medical Research Council/United Kingdom&#xD;R01 HL127564/HL/NHLBI NIH HHS/&#xD;T32 HL007734/HL/NHLBI NIH HHS/&#xD;Clinical Trial&#xD;Circ Cardiovasc Genet. 2017 Apr;10(2). pii: CIRCGENETICS.116.001643. doi: 10.1161/CIRCGENETICS.116.001643.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28373160</style></url></related-urls><pdf-urls><url>internal-pdf://4126098041/Klarin-2017-Genetic Analysis of Venous Thrombo.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5395047</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1161/CIRCGENETICS.116.001643</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>38</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">38</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Klovaite, J.</style></author><author><style face="normal" font="default" size="100%">Benn, M.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">J Intern Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Intern Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">573-84</style></pages><volume><style face="normal" font="default" size="100%">277</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2014/08/28</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Denmark/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Pulmonary Embolism/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Venous Thrombosis/epidemiology/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">deep venous thrombosis</style></keyword><keyword><style face="normal" font="default" size="100%">general population</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1365-2796 (Electronic)&#xD;0954-6820 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">25161014</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To test the hypothesis that obesity is causally associated with deep venous thrombosis (DVT). DESIGN: A Mendelian randomization design. SETTING: The Copenhagen General Population Study and the Copenhagen City Heart Study combined. SUBJECTS: Body mass index (BMI) measurements were available for 87, 574 individuals of Danish descent from the adult general population. All subjects completed questionnaires and were genotyped for the FTO rs9939609 variant. MAIN OUTCOME MEASURE: First events of DVT with or without pulmonary embolism (PE). ANALYSIS: The results were assessed using Cox regression, instrumental variable analysis and Poisson regression. RESULTS: Observationally, the risk of DVT increased with increasing BMI (P-trend &lt; 0.0001). The multivariable-adjusted hazard ratio [95% confidence interval (CI)] for DVT was 1.3 (1.1-1.6) in overweight, 1.8 (1.4-2.2) in moderately obese and 3.4 (2.6-4.6) in severely obese compared with normal-weight individuals. For DVT complicated by PE, corresponding hazard ratios (95% CI) were 1.2 (0.8-1.8), 2.1 (1.3-3.5) and 5.1 (2.8-9.2). FTO AA versus TT genotype was associated with a 2.4% increase in BMI with hazard ratios (95% CI) of 1.09 (0.95-1.25) for DVT and 1.54 (1.12-2.10) for DVT complicated by PE. In instrumental variable analysis, the causal odds ratio (95% CI) for an increase in BMI of 1 kg m(-2) was 1.13 (0.92-1.39) for DVT alone and 1.86 (1.14-3.02) for DVT complicated by PE. The absolute 10-year risk of DVT in a high-risk group (i.e. those aged &gt;60 years and homozygous for Factor V Leiden) was 35% in obese individuals and 18% in normal-weight individuals. CONCLUSION: A strong observational association between obesity and DVT with or without PE, supported by a direct genetic association between the obesity-specific locus FTO and DVT with PE, implies that obesity is likely to be causally associated with DVT.</style></abstract><notes><style face="normal" font="default" size="100%">Klovaite, J&#xD;Benn, M&#xD;Nordestgaard, B G&#xD;eng&#xD;England&#xD;J Intern Med. 2015 May;277(5):573-84. doi: 10.1111/joim.12299. Epub 2014 Sep 15.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/25161014</style></url></related-urls><pdf-urls><url>internal-pdf://1948155977/Klovaite-2015-Obesity as a causal risk factor.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/joim.12299</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>67</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">67</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lang, J. E.</style></author><author><style face="normal" font="default" size="100%">Hossain, J.</style></author><author><style face="normal" font="default" size="100%">Holbrook, J. T.</style></author><author><style face="normal" font="default" size="100%">Teague, W. G.</style></author><author><style face="normal" font="default" size="100%">Gold, B. D.</style></author><author><style face="normal" font="default" size="100%">Wise, R. A.</style></author><author><style face="normal" font="default" size="100%">Lima, J. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Pulmonary &amp; Sleep Medicine, Nemours Children&apos;s Hospital, Orlando, Florida, USA.&#xD;Department of Biomedical Research, Center for Pediatric Research, Alfred I. DuPont Hospital of Children, Wilmington, Delaware, USA.&#xD;Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.&#xD;Division of Pediatric Respiratory Medicine &amp; Allergy, University of Virginia School of Medicine, Charlottesville, Virginia, USA.&#xD;GI Care for Kids, Children&apos;s Center for Digestive Healthcare, Atlanta, Georgia, USA.&#xD;Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.&#xD;Center for Pharmacogenomics &amp; Translational Research, Nemours Children&apos;s Clinic, Jacksonville, Florida, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Gastro-oesophageal reflux and worse asthma control in obese children: a case of symptom misattribution?</style></title><secondary-title><style face="normal" font="default" size="100%">Thorax</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Thorax</style></full-title></periodical><pages><style face="normal" font="default" size="100%">238-46</style></pages><volume><style face="normal" font="default" size="100%">71</style></volume><number><style face="normal" font="default" size="100%">3</style></number><edition><style face="normal" font="default" size="100%">2016/02/03</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Asthma/diagnosis/epidemiology/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Comorbidity/trends</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Disease Management</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Florida/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Follow-Up Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Forced Expiratory Flow Rates</style></keyword><keyword><style face="normal" font="default" size="100%">Gastroesophageal Reflux/diagnosis/epidemiology/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/diagnosis/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Prognosis</style></keyword><keyword><style face="normal" font="default" size="100%">Quality of Life</style></keyword><keyword><style face="normal" font="default" size="100%">Respiratory Function Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Severity of Illness Index</style></keyword><keyword><style face="normal" font="default" size="100%">Surveys and Questionnaires</style></keyword><keyword><style face="normal" font="default" size="100%">Asthma</style></keyword><keyword><style face="normal" font="default" size="100%">Asthma Epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Asthma Mechanisms</style></keyword><keyword><style face="normal" font="default" size="100%">Paediatric asthma</style></keyword><keyword><style face="normal" font="default" size="100%">Perception of Asthma/Breathlessness</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1468-3296 (Electronic)&#xD;0040-6376 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26834184</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Obese children for unknown reasons report greater asthma symptoms. Asthma and obesity both independently associate with gastro-oesophageal reflux symptoms (GORS). Determining if obesity affects the link between GORS and asthma will help elucidate the obese-asthma phenotype. OBJECTIVE: Extend our previous work to determine the degree of associations between the GORS and asthma phenotype. METHODS: We conducted a cross-sectional study of lean (20%-65% body mass index, BMI) and obese (&gt;/=95% BMI) children aged 10-17 years old with persistent, early-onset asthma. Participants contributed demographics, GORS and asthma questionnaires and lung function data. We determined associations between weight status, GORS and asthma outcomes using multivariable linear and logistic regression. Findings were replicated in a second well-characterised cohort of asthmatic children. RESULTS: Obese children had seven times higher odds of reporting multiple GORS (OR=7.7, 95% CI 1.9 to 31.0, interaction p value=.004). Asthma symptoms were closely associated with GORS scores in obese patients (r=0.815, p&lt;0.0001) but not in leans (r=0.291, p=0.200; interaction p value=0.003). Higher GORS scores associated with higher FEV1-per cent predicted (p=0.003), lower airway resistance (R10, p=0.025), improved airway reactance (X10, p=0.005) but significantly worse asthma control (Asthma Control Questionnaire, p=0.007). A significant but weaker association between GORS and asthma symptoms was seen in leans compared with obese in the replicate cohort. CONCLUSION: GORS are more likely to associate with asthma symptoms in obese children. Better lung function among children reporting gastro-oesophageal reflux and asthma symptoms suggests that misattribution of GORS to asthma may be a contributing mechanism to excess asthma symptoms in obese children.</style></abstract><notes><style face="normal" font="default" size="100%">Lang, Jason E&#xD;Hossain, Jobayer&#xD;Holbrook, Janet T&#xD;Teague, W Gerald&#xD;Gold, Benjamin D&#xD;Wise, Robert A&#xD;Lima, John J&#xD;eng&#xD;U01 HL072968/HL/NHLBI NIH HHS/&#xD;U01HL080450-01/HL/NHLBI NIH HHS/&#xD;23HL096838-06/HL/NHLBI NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Thorax. 2016 Mar;71(3):238-46. doi: 10.1136/thoraxjnl-2015-207662. Epub 2016 Feb 1.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26834184</style></url></related-urls><pdf-urls><url>internal-pdf://2627633660/Colak-2016-Obese individuals experience wheezi.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/thoraxjnl-2015-207662</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>163</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">163</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Larsson, S. C.</style></author><author><style face="normal" font="default" size="100%">Burgess, S.</style></author><author><style face="normal" font="default" size="100%">Michaelsson, K.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Unit of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.&#xD;MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.&#xD;Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.&#xD;Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetic association between adiposity and gout: a Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Rheumatology (Oxford)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Rheumatology (Oxford)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2145-2148</style></pages><volume><style face="normal" font="default" size="100%">57</style></volume><number><style face="normal" font="default" size="100%">12</style></number><edition><style face="normal" font="default" size="100%">2018/08/08</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Gout/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*blood/complications/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Uric Acid/*blood</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1462-0332 (Electronic)&#xD;1462-0324 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30085130</style></accession-num><abstract><style face="normal" font="default" size="100%">Objective: To investigate whether overall obesity (as measured by BMI) and abdominal obesity (as measured by waist-to-hip ratio adjusted for BMI) are associated with gout risk and serum urate concentrations using Mendelian randomization. Methods: Single nucleotide polymorphisms associated with BMI (n = 97) and waist-to-hip ratio adjusted for BMI (n = 49) were analysed for association with gout risk in 2115 gout cases and 67 259 controls, and with serum urate concentrations in 110 347 individuals from the Global Urate Genetics Consortium. Results: Genetically higher BMI, but not waist-to-hip ratio adjusted for BMI, was positively associated with risk of gout and serum urate concentrations. Each standard deviation (about 4.6 kg/m2) increase in genetically predicted BMI was associated with an odds ratio of gout of 2.24 (95% CI 1.70, 2.95; P = 8.4 x 10-9) and with a 0.30 mg/dl (95% CI 0.25, 0.35; P = 1.6 x 10-36) increase in serum urate concentrations. Conclusion: These findings provide support that overall obesity may be a risk factor for gout and is associated with higher serum urate concentrations.</style></abstract><notes><style face="normal" font="default" size="100%">Larsson, Susanna C&#xD;Burgess, Stephen&#xD;Michaelsson, Karl&#xD;eng&#xD;MC_UU_00002/7/MRC_/Medical Research Council/United Kingdom&#xD;MR/L003120/1/MRC_/Medical Research Council/United Kingdom&#xD;RG/13/13/30194/BHF_/British Heart Foundation/United Kingdom&#xD;England&#xD;Rheumatology (Oxford). 2018 Dec 1;57(12):2145-2148. doi: 10.1093/rheumatology/key229.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30085130</style></url></related-urls><pdf-urls><url>internal-pdf://3304683088/Larsson-2018-Genetic association between adipo.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6697177</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/rheumatology/key229</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>91</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">91</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lauridsen, B. K.</style></author><author><style face="normal" font="default" size="100%">Stender, S.</style></author><author><style face="normal" font="default" size="100%">Kristensen, T. S.</style></author><author><style face="normal" font="default" size="100%">Kofoed, K. F.</style></author><author><style face="normal" font="default" size="100%">Kober, L.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author><author><style face="normal" font="default" size="100%">Tybjaerg-Hansen, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Clinical Biochemistry, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.&#xD;Copenhagen University Hospitals and Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark.&#xD;Department of Radiology, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.&#xD;Department of Cardiology, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.&#xD;The Copenhagen General Population Study, Herlev and Gentofte Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark.&#xD;Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark.&#xD;The Copenhagen City Heart Study, Frederiksberg Hospital, Nordre Fasanvej 57, 2000 Frederiksberg, Denmark.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals</style></title><secondary-title><style face="normal" font="default" size="100%">Eur Heart J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur Heart J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">385-393</style></pages><volume><style face="normal" font="default" size="100%">39</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2017/12/12</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Denmark/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Liver/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Myocardial Ischemia/complications/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*Non-alcoholic Fatty Liver Disease/complications/epidemiology/genetics/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*Cardiovascular disease</style></keyword><keyword><style face="normal" font="default" size="100%">*Causality</style></keyword><keyword><style face="normal" font="default" size="100%">*Epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Liver disease</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1522-9645 (Electronic)&#xD;0195-668X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29228164</style></accession-num><abstract><style face="normal" font="default" size="100%">Aims: In observational studies, non-alcoholic fatty liver disease (NAFLD) is associated with high risk of ischaemic heart disease (IHD). We tested the hypothesis that a high liver fat content or a diagnosis of NAFLD is a causal risk factor for IHD. Methods and results: In a cohort study of the Danish general population (n = 94 708/IHD = 10 897), we first tested whether a high liver fat content or a diagnosis of NAFLD was associated observationally with IHD. Subsequently, using Mendelian randomization, we tested whether a genetic variant in the gene encoding the protein patatin-like phospholipase domain containing 3 protein (PNPLA3), I148M (rs738409), a strong and specific cause of high liver fat content and NAFLD, was causally associated with the risk of IHD. We found that the risk of IHD increased stepwise with increasing liver fat content (in quartiles) up to an odds ratio (OR) of 2.41 (1.28-4.51)(P-trend = 0.004). The corresponding OR for IHD in individuals with vs. without NAFLD was 1.65 (1.34-2.04)(P = 3x10-6). PNPLA3 I148M was associated with a stepwise increase in liver fat content of up to 28% in MM vs. II-homozygotes (P-trend = 0.0001) and with ORs of 2.03 (1.52-2.70) for NAFLD (P = 3x10-7), 3.28 (2.37-4.54) for cirrhosis (P = 4x10-12), and 0.95 (0.86-1.04) for IHD (P = 0.46). In agreement, in meta-analysis (N = 279 013/IHD = 71 698), the OR for IHD was 0.98 (0.96-1.00) per M-allele vs. I-allele. The OR for IHD per M-allele higher genetically determined liver fat content was 0.98 (0.94-1.03) vs. an observational estimate of 1.05 (1.02-1.09)(P for comparison = 0.02). Conclusion: Despite confirming the known observational association of liver fat content and NAFLD with IHD, lifelong, genetically high liver fat content was not causally associated with risk of IHD. These results suggest that the observational association is due to confounding or reverse causation.</style></abstract><notes><style face="normal" font="default" size="100%">Lauridsen, Bo Kobbero&#xD;Stender, Stefan&#xD;Kristensen, Thomas Skarup&#xD;Kofoed, Klaus Fuglsang&#xD;Kober, Lars&#xD;Nordestgaard, Borge G&#xD;Tybjaerg-Hansen, Anne&#xD;eng&#xD;Meta-Analysis&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Eur Heart J. 2018 Feb 1;39(5):385-393. doi: 10.1093/eurheartj/ehx662.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29228164</style></url></related-urls><pdf-urls><url>internal-pdf://2898147768/Lauridsen-2018-Liver fat content, non-alcoholi.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/eurheartj/ehx662</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>103</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">103</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lawlor, D. A.</style></author><author><style face="normal" font="default" size="100%">Harbord, R. M.</style></author><author><style face="normal" font="default" size="100%">Tybjaerg-Hansen, A.</style></author><author><style face="normal" font="default" size="100%">Palmer, T. M.</style></author><author><style face="normal" font="default" size="100%">Zacho, J.</style></author><author><style face="normal" font="default" size="100%">Benn, M.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Smith, G. D.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Centre for Causal Analyses in Translational Epidemiology, University of Bristol, UK. d.a.lawlor@bristol.ac.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">Using genetic loci to understand the relationship between adiposity and psychological distress: a Mendelian Randomization study in the Copenhagen General Population Study of 53,221 adults</style></title><secondary-title><style face="normal" font="default" size="100%">J Intern Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Intern Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">525-37</style></pages><volume><style face="normal" font="default" size="100%">269</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2011/01/08</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">Anxiety Disorders/*genetics/psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Denmark</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Loci/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Receptor, Melanocortin, Type 4/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Stress, Psychological/*genetics/psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Waist-Hip Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1365-2796 (Electronic)&#xD;0954-6820 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">21210875</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVE: We used genetic variants that are robustly associated with adiposity to examine the causal association of adiposity with psychological distress. METHODS: We examined the association of adiposity with psychological distress in a large (N = 53,221) general population cohort of 20- to 99-year-old adults from Copenhagen, Denmark. Psychological distress was assessed using four questions that asked about: feeling stressed; not accomplishing very much; wanting to give up; and regular use of antidepressants/sedatives. We used the genetic loci FTO rs9939609 and MC4R rs17782313 as instrumental variables for adiposity quantified by body mass index (BMI) and waist to hip ratio (WHR). RESULTS: In conventional multivariable analyses, BMI and WHR were positively associated with distress. For example, the odds ratio of reporting not accomplishing for each additional standard deviation increase for BMI was 1.11 (95% CI: 1.09, 1.13) and for WHR was 1.10 (95% CI: 1.08, 1.13) in the fully adjusted analyses. In contrast, instrumental variable analyses showed an inverse association of adiposity on distress; corresponding odds ratio in instrumental variable analyses was 0.64 (95% CI: 0.46, 0.89) for BMI and 0.49 (95% CI: 0.25, 0.94) for WHR (P-values for difference between the two approaches both = 0.001). CONCLUSION: The inverse associations of adiposity and psychological distress when genetic variants are used as instrumental variables could be explained by biological pathways linking adiposity and distress. The positive associations of adiposity with distress in multivariable analyses might be explained by residual confounding or reverse causality.</style></abstract><notes><style face="normal" font="default" size="100%">Lawlor, Debbie A&#xD;Harbord, Roger M&#xD;Tybjaerg-Hansen, Anne&#xD;Palmer, Tom M&#xD;Zacho, Jeppe&#xD;Benn, Marianne&#xD;Timpson, Nicholas J&#xD;Smith, George Davey&#xD;Nordestgaard, Borge G&#xD;eng&#xD;G0600705/Medical Research Council/United Kingdom&#xD;G0601625/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;J Intern Med. 2011 May;269(5):525-37. doi: 10.1111/j.1365-2796.2011.02343.x.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/21210875</style></url></related-urls><pdf-urls><url>internal-pdf://3668822487/Lawlor-2011-Using genetic loci to understand t.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/j.1365-2796.2011.02343.x</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>107</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">107</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lee, M. R.</style></author><author><style face="normal" font="default" size="100%">Lim, Y. H.</style></author><author><style face="normal" font="default" size="100%">Hong, Y. C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Preventive Medicine, Seoul National University College of Medicine.&#xD;Institute of Environmental Medicine, Seoul National University Medical Research Center.&#xD;Environmental Health Center, Seoul National University College of Medicine, Seoul, Republic of Korea.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal association of body mass index with hypertension using a Mendelian randomization design</style></title><secondary-title><style face="normal" font="default" size="100%">Medicine (Baltimore)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Medicine (Baltimore)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e11252</style></pages><volume><style face="normal" font="default" size="100%">97</style></volume><number><style face="normal" font="default" size="100%">30</style></number><edition><style face="normal" font="default" size="100%">2018/07/26</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Causality</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Confounding Factors, Epidemiologic</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Hypertension/diagnosis/epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Republic of Korea/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1536-5964 (Electronic)&#xD;0025-7974 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30045251</style></accession-num><abstract><style face="normal" font="default" size="100%">Observational studies have shown that obesity is a major risk factor for hypertension, but unmeasured confounding factors may exist. We used Mendelian randomization (MR) to assess the causal effect of obesity on hypertension.The MR analysis was performed in a well-defined community cohort study of 8832 middle-aged (40-69 years) adults in Korea enrolled from 2001 to 2013. We used baseline hypertension and newly diagnosed hypertension during the 10-year follow-up period as the outcome variable. Genetic risk score associated with body mass index (BMI GRS) was used as the instrumental variable (IV) to measure the causal relationship between obesity and hypertension. The IV estimate of causal odds ratio (OR) was derived using the Wald ratio estimator and then exponentiation to express the result as an OR.In the multivariable model adjusting for age, sex, study area, education, smoking, and current alcohol consumption, each 1 kg/m increase in BMI was associated with a 19% (OR: 1.19, 95% confidence interval [CI]: 1.17-1.21) increase in hypertension risk. We selected 6 single-nucleotide polymorphisms (P &lt; 1.0 x 10) associated with BMI by genome-wide screening using linear regression and created 6 types of GRS. We demonstrated that each standard-deviation increase in BMI GRS was associated with a 5% to 6% (OR: 1.05-1.06) increased risk of hypertension (all P &lt; .05). Using BMI GRS as the IV, we found a causal relationship between BMI and hypertension (OR: 1.13-1.26, all P &lt; .05 except weighted GRS [n = 6]).Using Mendelian randomization, we found that obesity is causally associated with hypertension. This information will have important public health implications, supporting evidence that obesity-reduction programs will reduce the incidence of hypertension.</style></abstract><notes><style face="normal" font="default" size="100%">Lee, Mee-Ri&#xD;Lim, Youn-Hee&#xD;Hong, Yun-Chul&#xD;eng&#xD;Medicine (Baltimore). 2018 Jul;97(30):e11252. doi: 10.1097/MD.0000000000011252.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30045251</style></url></related-urls><pdf-urls><url>internal-pdf://3825904752/Lee-2018-Causal association of body mass index.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6078651</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1097/MD.0000000000011252</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>55</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">55</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Levy, M.</style></author><author><style face="normal" font="default" size="100%">Hall, D.</style></author><author><style face="normal" font="default" size="100%">Sud, A.</style></author><author><style face="normal" font="default" size="100%">Law, P.</style></author><author><style face="normal" font="default" size="100%">Litchfield, K.</style></author><author><style face="normal" font="default" size="100%">Dudakia, D.</style></author><author><style face="normal" font="default" size="100%">Haugen, T. B.</style></author><author><style face="normal" font="default" size="100%">Karlsson, R.</style></author><author><style face="normal" font="default" size="100%">Reid, A.</style></author><author><style face="normal" font="default" size="100%">Huddart, R. A.</style></author><author><style face="normal" font="default" size="100%">Grotmol, T.</style></author><author><style face="normal" font="default" size="100%">Wiklund, F.</style></author><author><style face="normal" font="default" size="100%">Houlston, R. S.</style></author><author><style face="normal" font="default" size="100%">Turnbull, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Genetics &amp; Epidemiology, The Institute of Cancer Research, London, UK.&#xD;Faculty of Health Sciences, Oslo and Akershus University College of Applied Sciences, Oslo, Norway.&#xD;Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.&#xD;Academic Radiotherapy Unit, Institute of Cancer Research, Sutton, Surrey, UK.&#xD;Academic Uro-oncology Unit, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.&#xD;Department of Research, Cancer Registry of Norway, Oslo, Norway.&#xD;William Harvey Research Institute, Queen Mary University, London, UK.&#xD;Department of Clinical Genetics, Guy&apos;s and St Thomas&apos; NHS Trust, London, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Mendelian randomisation analysis provides no evidence for a relationship between adult height and testicular cancer risk</style></title><secondary-title><style face="normal" font="default" size="100%">Andrology</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Andrology</style></full-title></periodical><pages><style face="normal" font="default" size="100%">914-922</style></pages><volume><style face="normal" font="default" size="100%">5</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2017/08/15</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Height/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Models, Statistical</style></keyword><keyword><style face="normal" font="default" size="100%">*Neoplasms, Germ Cell and Embryonal/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Random Allocation</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*Testicular Neoplasms/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Waist-Hip Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">genome-wide association studies</style></keyword><keyword><style face="normal" font="default" size="100%">germ cell tumour</style></keyword><keyword><style face="normal" font="default" size="100%">growth</style></keyword><keyword><style face="normal" font="default" size="100%">height</style></keyword><keyword><style face="normal" font="default" size="100%">testicular cancer</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2047-2927 (Electronic)&#xD;2047-2919 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28804972</style></accession-num><abstract><style face="normal" font="default" size="100%">Observational studies have suggested anthropometric traits, particularly increased height are associated with an elevated risk of testicular cancer (testicular germ cell tumour). However, there is an inconsistency between study findings, suggesting the possibility of the influence of confounding factors. To examine the association between anthropometric traits and testicular germ cell tumour using an unbiased approach, we performed a Mendelian randomisation study. We used genotype data from genome wide association studies of testicular germ cell tumour totalling 5518 cases and 19,055 controls. Externally weighted polygenic risk scores were created and used to evaluate associations with testicular germ cell tumour risk per one standard deviation (s.d) increase in genetically-defined adult height, adult BMI, adult waist hip ratio adjusted for BMI (WHRadjBMI), adult hip circumference adjusted for BMI (HIPadjBMI), adult waist circumference adjusted for BMI (WCadjBMI), birth weight (BW) and childhood obesity. Mendelian randomisation analysis did not demonstrate an association between any anthropometric trait and testicular germ cell tumour risk. In particular, despite good power, there was no global evidence for association between height and testicular germ cell tumour. However, three SNPs for adult height individually showed association with testicular germ cell tumour (rs4624820: OR = 1.47, 95% CI: 1.41-1.55, p = 2.7 x 10(-57) ; rs12228415: OR = 1.17, 95% CI: 1.11-1.22, p = 3.1 x 10(-10) ; rs7568069: OR = 1.13, 95% CI: 1.07-1.18, p = 1.1 x 10(-6) ). This Mendelian randomisation analysis, based on the largest testicular germ cell tumour genome wide association dataset to date, does not support a causal etiological association between anthropometric traits and testicular germ cell tumour aetiology. Our findings are more compatible with confounding by shared environmental factors, possibly related to prenatal growth with exposure to these risk factors occurring in utero.</style></abstract><notes><style face="normal" font="default" size="100%">Levy, M&#xD;Hall, D&#xD;Sud, A&#xD;Law, P&#xD;Litchfield, K&#xD;Dudakia, D&#xD;Haugen, T B&#xD;Karlsson, R&#xD;Reid, A&#xD;Huddart, R A&#xD;Grotmol, T&#xD;Wiklund, F&#xD;Houlston, R S&#xD;Turnbull, C&#xD;eng&#xD;G0700491/Medical Research Council/United Kingdom&#xD;England&#xD;Andrology. 2017 Sep;5(5):914-922. doi: 10.1111/andr.12388. Epub 2017 Aug 13.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28804972</style></url></related-urls><pdf-urls><url>internal-pdf://3868750974/Levy-2017-Mendelian randomisation analysis pro.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/andr.12388</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>6</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">6</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lim, L. S.</style></author><author><style face="normal" font="default" size="100%">Tai, E. S.</style></author><author><style face="normal" font="default" size="100%">Aung, T.</style></author><author><style face="normal" font="default" size="100%">Tay, W. T.</style></author><author><style face="normal" font="default" size="100%">Saw, S. M.</style></author><author><style face="normal" font="default" size="100%">Seielstad, M.</style></author><author><style face="normal" font="default" size="100%">Wong, T. Y.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Singapore Eye Research Institute, Singapore.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Relation of age-related cataract with obesity and obesity genes in an Asian population</style></title><secondary-title><style face="normal" font="default" size="100%">Am J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Am J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1267-74</style></pages><volume><style face="normal" font="default" size="100%">169</style></volume><number><style face="normal" font="default" size="100%">10</style></number><edition><style face="normal" font="default" size="100%">2009/03/31</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Age Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">Asian Continental Ancestry Group/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Cataract/*epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Confidence Intervals</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Logistic Models</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Multivariate Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Singapore/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Surveys and Questionnaires</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 15</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-6256 (Electronic)&#xD;0002-9262 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">19329528</style></accession-num><abstract><style face="normal" font="default" size="100%">Obesity shows an inconsistent association with cataract. Causality has not been established. Polymorphisms at the fat mass- and obesity-associated (FTO) locus are associated with obesity and offer an opportunity to examine the obesity-cataract association using a mendelian randomization approach. The authors conducted a population-based study among Singaporean Malay adults (2004-2006) in which nuclear, cortical, and posterior subcapsular (PSC) cataracts were assessed and defined by slit-lamp examination using Lens Opacity Classification System III. Obesity was defined as body mass index (weight (kg)/height (m)(2)) &gt; or =30. The study included 3,000 subjects, of whom 1,339 (44.6%) had cataract (848 (28.3%) nuclear, 939 (31.3%) cortical, and 285 (9.5%) PSC). After multivariable adjustment for age, gender, diabetes, hypertension, smoking, and education, obesity was significantly associated with cortical (odds ratio (OR) = 1.31, 95% confidence interval (CI): 1.01, 1.71) and PSC (OR = 1.60, 95% CI: 1.10, 2.32) cataracts but not nuclear cataract. FTO single nucleotide polymorphisms known to be associated with obesity in this study population were not associated with cortical or PSC cataract but were associated with nuclear cataract (OR = 1.33, 95% CI: 1.11, 1.58), even in multivariate analyses controlling additionally for body mass index, diabetes, hypertension, and smoking (OR = 1.30, 95% CI: 1.08, 1.55). These results do not support a causal association between obesity and cortical or PSC cataract. The FTO gene may be involved in the pathogenesis of nuclear cataract.</style></abstract><notes><style face="normal" font="default" size="100%">Lim, Laurence S&#xD;Tai, E-Shyong&#xD;Aung, Tin&#xD;Tay, Wan Ting&#xD;Saw, Seang Mei&#xD;Seielstad, Mark&#xD;Wong, Tien Yin&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Am J Epidemiol. 2009 May 15;169(10):1267-74. doi: 10.1093/aje/kwp045. Epub 2009 Mar 27.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/19329528</style></url></related-urls><pdf-urls><url>internal-pdf://0511180435/Lim-2009-Relation of age-related cataract with.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/aje/kwp045</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>63</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">63</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lindstrom, S.</style></author><author><style face="normal" font="default" size="100%">Germain, M.</style></author><author><style face="normal" font="default" size="100%">Crous-Bou, M.</style></author><author><style face="normal" font="default" size="100%">Smith, E. N.</style></author><author><style face="normal" font="default" size="100%">Morange, P. E.</style></author><author><style face="normal" font="default" size="100%">van Hylckama Vlieg, A.</style></author><author><style face="normal" font="default" size="100%">de Haan, H. G.</style></author><author><style face="normal" font="default" size="100%">Chasman, D.</style></author><author><style face="normal" font="default" size="100%">Ridker, P.</style></author><author><style face="normal" font="default" size="100%">Brody, J.</style></author><author><style face="normal" font="default" size="100%">de Andrade, M.</style></author><author><style face="normal" font="default" size="100%">Heit, J. A.</style></author><author><style face="normal" font="default" size="100%">Tang, W.</style></author><author><style face="normal" font="default" size="100%">DeVivo, I.</style></author><author><style face="normal" font="default" size="100%">Grodstein, F.</style></author><author><style face="normal" font="default" size="100%">Smith, N. L.</style></author><author><style face="normal" font="default" size="100%">Tregouet, D.</style></author><author><style face="normal" font="default" size="100%">Kabrhel, C.</style></author><author><style face="normal" font="default" size="100%">Invent Consortium</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Epidemiology, University of Washington, Seattle, WA, USA. saralind@uw.edu.&#xD;Sorbonne Universites, UPMC Univ. Paris 06, INSERM, UMR_S 1166, Team Genomics and Pathophysiology of Cardiovascular Diseases, Paris, France.&#xD;ICAN Institute for Cardiometabolism and Nutrition, Paris, France.&#xD;Channing Division of Network Medicine, Department of Medicine, Brigham and Women&apos;s Hospital and Harvard Medical School, Boston, MA, USA.&#xD;Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.&#xD;Department of Pediatrics, Rady Children&apos;s Hospital, University of California, San Diego, La Jolla, CA, USA.&#xD;Department of Clinical Medicine, K.G. Jebsen Thrombosis Research and Expertise Centre (TREC), UiT The Artic University of Norway, Tromso, Norway.&#xD;INSERM, UMR_S1062, Nutrition Obesity and Risk of Thrombosis, Aix-Marseille University, Marseille, France.&#xD;Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.&#xD;Division of Preventive Medicine, Brigham and Women&apos;s Hospital, Boston, MA, USA.&#xD;Harvard Medical School, Boston, MA, USA.&#xD;Department of Medicine, University of Washington, Seattle, WA, USA.&#xD;Biomedical Statistics and Informatics, Mayo Clinic and College of Medicine, Rochester, MN, USA.&#xD;Division of Cardiovascular Diseases, Mayo Clinic and College of Medicine, Rochester, MN, USA.&#xD;Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.&#xD;Department of Epidemiology, University of Washington, Seattle, WA, USA.&#xD;Group Health Research Institute, Group Health Cooperative, Seattle, WA, USA.&#xD;Department of Veterans Affairs Office of Research and Development, Seattle Epidemiologic Research and Information Center, Seattle, WA, USA.&#xD;Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Hum Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Hum Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">897-902</style></pages><volume><style face="normal" font="default" size="100%">136</style></volume><number><style face="normal" font="default" size="100%">7</style></number><edition><style face="normal" font="default" size="100%">2017/05/22</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Logistic Models</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/complications/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Proportional Hazards Models</style></keyword><keyword><style face="normal" font="default" size="100%">Venous Thromboembolism/complications/*genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1432-1203 (Electronic)&#xD;0340-6717 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28528403</style></accession-num><abstract><style face="normal" font="default" size="100%">Observational studies have shown an association between obesity and venous thromboembolism (VTE) but it is not known if observed associations are causal, due to reverse causation or confounding bias. We conducted a Mendelian Randomization study of body mass index (BMI) and VTE. We identified 95 single nucleotide polymorphisms (SNPs) that have been previously associated with BMI and assessed the association between genetically predicted high BMI and VTE leveraging data from a previously conducted GWAS within the INVENT consortium comprising a total of 7507 VTE cases and 52,632 controls of European ancestry. Five BMI SNPs were associated with VTE at P &lt; 0.05, with the strongest association seen for the FTO SNP rs1558902 (OR 1.07, 95% CI 1.02-1.12, P = 0.005). In addition, we observed a significant association between genetically predicted BMI and VTE (OR = 1.59, 95% CI 1.30-1.93 per standard deviation increase in BMI, P = 5.8 x 10(-6)). Our study provides evidence for a causal relationship between high BMI and risk of VTE. Reducing obesity levels will likely result in lower incidence in VTE.</style></abstract><notes><style face="normal" font="default" size="100%">Lindstrom, Sara&#xD;Germain, Marine&#xD;Crous-Bou, Marta&#xD;Smith, Erin N&#xD;Morange, Pierre-Emmanuel&#xD;van Hylckama Vlieg, Astrid&#xD;de Haan, Hugoline G&#xD;Chasman, Daniel&#xD;Ridker, Paul&#xD;Brody, Jennifer&#xD;de Andrade, Mariza&#xD;Heit, John A&#xD;Tang, Weihong&#xD;DeVivo, Immaculata&#xD;Grodstein, Francine&#xD;Smith, Nicholas L&#xD;Tregouet, David&#xD;Kabrhel, Christopher&#xD;eng&#xD;R01 HL095080/HL/NHLBI NIH HHS/&#xD;R01 HL083141/HL/NHLBI NIH HHS/&#xD;R01 HL068986/HL/NHLBI NIH HHS/&#xD;R01 HL043851/HL/NHLBI NIH HHS/&#xD;UM1 CA176726/CA/NCI NIH HHS/&#xD;R01 HL059367/HL/NHLBI NIH HHS/&#xD;R01 HL116854/HL/NHLBI NIH HHS/&#xD;R01 HL085251/HL/NHLBI NIH HHS/&#xD;R01 HL066216/HL/NHLBI NIH HHS/&#xD;U01 CA167552/CA/NCI NIH HHS/&#xD;R01 HL074745/HL/NHLBI NIH HHS/&#xD;U01 HL107442/HL/NHLBI NIH HHS/&#xD;R01 HL060739/HB/NHLBI NIH HHS/&#xD;UM1 CA186107/CA/NCI NIH HHS/&#xD;UM1 CA182913/CA/NCI NIH HHS/&#xD;R01 CA047988/CA/NCI NIH HHS/&#xD;R01 HL080467/HL/NHLBI NIH HHS/&#xD;R01 HL043201/HL/NHLBI NIH HHS/&#xD;UM1 CA167552/CA/NCI NIH HHS/&#xD;R01 HL060739/HL/NHLBI NIH HHS/&#xD;U01 HG004735/HG/NHGRI NIH HHS/&#xD;R01 HL073410/HL/NHLBI NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Hum Genet. 2017 Jul;136(7):897-902. doi: 10.1007/s00439-017-1811-x. Epub 2017 May 20.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28528403</style></url></related-urls><pdf-urls><url>internal-pdf://1909708027/Lindstrom-2017-Assessing the causal relationsh.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5531049</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s00439-017-1811-x</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">1</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lv, W. Q.</style></author><author><style face="normal" font="default" size="100%">Zhang, X.</style></author><author><style face="normal" font="default" size="100%">Fan, K.</style></author><author><style face="normal" font="default" size="100%">Xia, X.</style></author><author><style face="normal" font="default" size="100%">Zhang, Q.</style></author><author><style face="normal" font="default" size="100%">Liu, H. M.</style></author><author><style face="normal" font="default" size="100%">Jiang, B. Y.</style></author><author><style face="normal" font="default" size="100%">Zhang, W. D.</style></author><author><style face="normal" font="default" size="100%">Deng, H. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">College of Public Health, Zhengzhou University, Zhengzhou, NO.100 Kexue Road, High-Tech Development Zone of States, People&apos;s Republic of China.&#xD;Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, People&apos;s Republic of China.&#xD;Henan Health Cadre College, Zhengzhou, NO.149 Huayuan Road, Jinshui District, People&apos;s Republic of China.&#xD;College of Public Health, Zhengzhou University, Zhengzhou, NO.100 Kexue Road, High-Tech Development Zone of States, People&apos;s Republic of China. imooni@163.com.&#xD;College of Public Health, Zhengzhou University, Zhengzhou, NO.100 Kexue Road, High-Tech Development Zone of States, People&apos;s Republic of China. hdeng2@tulane.edu.&#xD;Center for Genomics and Bioinformatics, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, 70112, USA. hdeng2@tulane.edu.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetically driven adiposity traits increase the risk of coronary artery disease independent of blood pressure, dyslipidaemia, glycaemic traits</style></title><secondary-title><style face="normal" font="default" size="100%">Eur J Hum Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur J Hum Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1547-1553</style></pages><volume><style face="normal" font="default" size="100%">26</style></volume><number><style face="normal" font="default" size="100%">10</style></number><edition><style face="normal" font="default" size="100%">2018/06/13</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Artery Disease/*genetics/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/*genetics/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Dyslipidemias/genetics/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*genetics/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-5438 (Electronic)&#xD;1018-4813 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29891878</style></accession-num><abstract><style face="normal" font="default" size="100%">Adiposity has been associated with the risk of coronary artery disease (CAD) in observational studies, but their association may differ according to specific characteristics of studies. In Mendelian randomization (MR) analyses, genetic variants are used as instrumental variables (IVs) of exposures to examine causal effects to overcome confounding factors and reverse causation. We performed MR analyses for adiposity (n = 322,154) on risk of CAD (60,801 cases and 123,504 controls) based on the currently largest genome-wide association studies. The estimated associations between adiposity traits and CAD were calculated by an inverse-variance weighted method with and without excluding the IVs, which are associated with the well-known risk factors of CAD. Genetic variants are identified to be associated with the well-known risk factors of CAD by a cross-phenotype meta-analysis method. Our results furnished strong evidence for a causal role of adiposity in risk of CAD, with the odds ratios (ORs) for CAD being 1.53 (95% CI 1.36-1.72) for body mass index (BMI), 1.48 (1.20-1.96) for waist-hip ratio (WHR), and 1.34 (1.07-1.59) for WHR adjusted for BMI (WHRadjBMI), respectively. After excluding mediators-associated IVs from the MR analyses, the corresponding ORs were 1.46 (1.28-1.67) for BMI, 1.39 (1.01-1.93) for WHR, and 1.38 (1.04-1.84) for WHRadjBMI, respectively. Furthermore, our results suggested that central adiposity and general adiposity might pose a similar risk for CAD. In summary, our data supported that genetically driven adiposity traits imposed the risk of CAD independent of blood pressure, dyslipidaemia, glycaemic traits, and type 2 diabetes.</style></abstract><notes><style face="normal" font="default" size="100%">Lv, Wan-Qiang&#xD;Zhang, Xue&#xD;Fan, Kun&#xD;Xia, Xin&#xD;Zhang, Qiang&#xD;Liu, Hui-Min&#xD;Jiang, Bu-Ying&#xD;Zhang, Wei-Dong&#xD;Deng, Hong-Wen&#xD;eng&#xD;R01 AR059781/AR/NIAMS NIH HHS/&#xD;R01 AR069055/AR/NIAMS NIH HHS/&#xD;U19 AG055373/AG/NIA NIH HHS/&#xD;P20 GM109036/GM/NIGMS NIH HHS/&#xD;R01 MH104680/MH/NIMH NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Eur J Hum Genet. 2018 Oct;26(10):1547-1553. doi: 10.1038/s41431-018-0180-9. Epub 2018 Jun 11.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29891878</style></url></related-urls><pdf-urls><url>internal-pdf://3645903719/Lv-2018-Genetically driven adiposity traits in.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6138729</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s41431-018-0180-9</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>120</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">120</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lyall, D. M.</style></author><author><style face="normal" font="default" size="100%">Celis-Morales, C.</style></author><author><style face="normal" font="default" size="100%">Ward, J.</style></author><author><style face="normal" font="default" size="100%">Iliodromiti, S.</style></author><author><style face="normal" font="default" size="100%">Anderson, J. J.</style></author><author><style face="normal" font="default" size="100%">Gill, J. M. R.</style></author><author><style face="normal" font="default" size="100%">Smith, D. J.</style></author><author><style face="normal" font="default" size="100%">Ntuk, U. E.</style></author><author><style face="normal" font="default" size="100%">Mackay, D. F.</style></author><author><style face="normal" font="default" size="100%">Holmes, M. V.</style></author><author><style face="normal" font="default" size="100%">Sattar, N.</style></author><author><style face="normal" font="default" size="100%">Pell, J. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute of Health &amp; Wellbeing, University of Glasgow, Glasgow, Scotland.&#xD;Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow Scotland.&#xD;Clinical Trial Service Unit &amp; Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, England.&#xD;Medical Research Council Population Health Research Unit, University of Oxford, Oxford, England.&#xD;National Institute for Health Research, Oxford Biomedical Research Centre, Oxford University Hospitals, Oxford, England.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study</style></title><secondary-title><style face="normal" font="default" size="100%">JAMA Cardiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">JAMA Cardiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">882-889</style></pages><volume><style face="normal" font="default" size="100%">2</style></volume><number><style face="normal" font="default" size="100%">8</style></number><edition><style face="normal" font="default" size="100%">2017/07/06</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Alcohol Drinking/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Biological Specimen Banks</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Disease/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Heart Rate</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Hypertension/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Multifactorial Inheritance</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Overweight/epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Smoking/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Social Class</style></keyword><keyword><style face="normal" font="default" size="100%">Stroke/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">United Kingdom/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2380-6591 (Electronic)</style></isbn><accession-num><style face="normal" font="default" size="100%">28678979</style></accession-num><abstract><style face="normal" font="default" size="100%">Importance: Higher body mass index (BMI) is a risk factor for cardiometabolic disease; however, the underlying causal associations remain unclear. Objectives: To use UK Biobank data to report causal estimates of the association between BMI and cardiometabolic disease outcomes and traits, such as pulse rate, using mendelian randomization. Design, Setting, and Participants: Cross-sectional baseline data from a population-based cohort study including 119859 UK Biobank participants with complete phenotypic (medical and sociodemographic) and genetic data. Participants attended 1 of 22 assessment centers across the United Kingdom between 2006 and 2010. The present study was conducted from May 1 to July 11, 2016. Main Outcomes and Measures: Prevalence of hypertension, coronary heart disease, and type 2 diabetes were determined at assessment, based on self-report. Blood pressure was measured clinically. Participants self-reported sociodemographic information pertaining to relevant confounders. A polygenic risk score comprising 93 single-nucleotide polymorphisms associated with BMI from previous genome-wide association studies was constructed, and the genetic risk score was applied to derive causal estimates using a mendelian randomization approach. Results: Of the 119859 individuals included in the study, 56 816 (47.4%) were men; mean (SD) age was 56.87 (7.93) years. Mendelian randomization analysis showed significant positive associations between genetically instrumented higher BMI and risk of hypertension (odds ratio [OR] per 1-SD higher BMI, 1.64; 95% CI, 1.48-1.83; P = 1.1 x 10-19), coronary heart disease (OR, 1.35; 95% CI, 1.09-1.69; P = .007) and type 2 diabetes (OR, 2.53; 95% CI, 2.04-3.13; P = 1.5 x 10-17), as well as systolic blood pressure (beta = 1.65 mm Hg; 95% CI, 0.78-2.52 mm Hg; P = 2.0 x 10-04) and diastolic blood pressure (beta = 1.37 mm Hg; 95% CI, 0.88-1.85 mm Hg; P = 3.6 x 10-08). These associations were independent of age, sex, Townsend deprivation scores, alcohol intake, and smoking history. Conclusions and Relevance: The results of this study add to the burgeoning evidence of an association between higher BMI and increased risk of cardiometabolic diseases. This finding has relevance for public health policies in many countries with increasing obesity levels.</style></abstract><notes><style face="normal" font="default" size="100%">Lyall, Donald M&#xD;Celis-Morales, Carlos&#xD;Ward, Joey&#xD;Iliodromiti, Stamatina&#xD;Anderson, Jana J&#xD;Gill, Jason M R&#xD;Smith, Daniel J&#xD;Ntuk, Uduakobong Efanga&#xD;Mackay, Daniel F&#xD;Holmes, Michael V&#xD;Sattar, Naveed&#xD;Pell, Jill P&#xD;eng&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;MR/N015177/1/MRC_/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;JAMA Cardiol. 2017 Aug 1;2(8):882-889. doi: 10.1001/jamacardio.2016.5804.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28678979</style></url></related-urls><pdf-urls><url>internal-pdf://3627383608/Lyall-2017-Association of Body Mass Index With.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5710596</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1001/jamacardio.2016.5804</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>146</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">146</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lyngdoh, T.</style></author><author><style face="normal" font="default" size="100%">Vuistiner, P.</style></author><author><style face="normal" font="default" size="100%">Marques-Vidal, P.</style></author><author><style face="normal" font="default" size="100%">Rousson, V.</style></author><author><style face="normal" font="default" size="100%">Waeber, G.</style></author><author><style face="normal" font="default" size="100%">Vollenweider, P.</style></author><author><style face="normal" font="default" size="100%">Bochud, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS One</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS One</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e39321</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2012/06/23</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">Causality</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Glucose Transport Proteins, Facilitative/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Membrane Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Random Allocation</style></keyword><keyword><style face="normal" font="default" size="100%">Receptor, Melanocortin, Type 4/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Uric Acid/*blood</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year></dates><isbn><style face="normal" font="default" size="100%">1932-6203 (Electronic)&#xD;1932-6203 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">22723994</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Although the relationship between serum uric acid (SUA) and adiposity is well established, the direction of the causality is still unclear in the presence of conflicting evidences. We used a bidirectional Mendelian randomization approach to explore the nature and direction of causality between SUA and adiposity in a population-based study of Caucasians aged 35 to 75 years. METHODS AND FINDINGS: We used, as instrumental variables, rs6855911 within the SUA gene SLC2A9 in one direction, and combinations of SNPs within the adiposity genes FTO, MC4R and TMEM18 in the other direction. Adiposity markers included weight, body mass index, waist circumference and fat mass. We applied a two-stage least squares regression: a regression of SUA/adiposity markers on our instruments in the first stage and a regression of the response of interest on the fitted values from the first stage regression in the second stage. SUA explained by the SLC2A9 instrument was not associated to fat mass (regression coefficient [95% confidence interval]: 0.05 [-0.10, 0.19] for fat mass) contrasting with the ordinary least square estimate (0.37 [0.34, 0.40]). By contrast, fat mass explained by genetic variants of the FTO, MC4R and TMEM18 genes was positively and significantly associated to SUA (0.31 [0.01, 0.62]), similar to the ordinary least square estimate (0.27 [0.25, 0.29]). Results were similar for the other adiposity markers. CONCLUSIONS: Using a bidirectional Mendelian randomization approach in adult Caucasians, our findings suggest that elevated SUA is a consequence rather than a cause of adiposity.</style></abstract><notes><style face="normal" font="default" size="100%">Lyngdoh, Tanica&#xD;Vuistiner, Philippe&#xD;Marques-Vidal, Pedro&#xD;Rousson, Valentin&#xD;Waeber, Gerard&#xD;Vollenweider, Peter&#xD;Bochud, Murielle&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS One. 2012;7(6):e39321. doi: 10.1371/journal.pone.0039321. Epub 2012 Jun 19.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/22723994</style></url></related-urls><pdf-urls><url>internal-pdf://3465104449/Lyngdoh-2012-Serum uric acid and adiposity_ de.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3378571</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pone.0039321</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>12</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">12</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mack, S.</style></author><author><style face="normal" font="default" size="100%">Coassin, S.</style></author><author><style face="normal" font="default" size="100%">Vaucher, J.</style></author><author><style face="normal" font="default" size="100%">Kronenberg, F.</style></author><author><style face="normal" font="default" size="100%">Lamina, C.</style></author><author><style face="normal" font="default" size="100%">Apo, A. I. V. Gwas Consortium</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Innsbruck, 6020, Austria.&#xD;Department of Internal Medicine, Lausanne University Hospital, Lausanne, 1015, Switzerland.&#xD;Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Innsbruck, 6020, Austria. Claudia.Lamina@i-med.ac.at.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Evaluating the Causal Relation of ApoA-IV with Disease-Related Traits - A Bidirectional Two-sample Mendelian Randomization Study</style></title><secondary-title><style face="normal" font="default" size="100%">Sci Rep</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Sci Rep</style></full-title></periodical><pages><style face="normal" font="default" size="100%">8734</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2017/08/20</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity</style></keyword><keyword><style face="normal" font="default" size="100%">Apolipoproteins A/*genetics/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Biomarkers</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Glucose</style></keyword><keyword><style face="normal" font="default" size="100%">Fasting</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Association Studies/methods</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Glomerular Filtration Rate</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Lipids/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">*Quantitative Trait, Heritable</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug 18</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2045-2322 (Electronic)&#xD;2045-2322 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28821713</style></accession-num><abstract><style face="normal" font="default" size="100%">Apolipoprotein A-IV (apoA-IV) has been observed to be associated with lipids, kidney function, adiposity- and diabetes-related parameters. To assess the causal relationship of apoA-IV with these phenotypes, we conducted bidirectional Mendelian randomization (MR) analyses using publicly available summary-level datasets from GWAS consortia on apoA-IV concentrations (n = 13,813), kidney function (estimated glomerular filtration rate (eGFR), n = 133,413), lipid traits (HDL cholesterol, LDL cholesterol, triglycerides, n = 188,577), adiposity-related traits (body-mass-index (n = 322,206), waist-hip-ratio (n = 210,088)) and fasting glucose (n = 133,010). Main analyses consisted in inverse-variance weighted and multivariable MR, whereas MR-Egger regression and weighted median estimation were used as sensitivity analyses. We found that eGFR is likely to be causal on apoA-IV concentrations (53 SNPs; causal effect estimate per 1-SD increase in eGFR = -0.39; 95% CI = [-0.54, -0.24]; p-value = 2.4e-07). Triglyceride concentrations were also causally associated with apoA-IV concentrations (40 SNPs; causal effect estimate per 1-SD increase in triglycerides = -0.06; 95% CI = [-0.08, -0.04]; p-value = 4.8e-07), independently of HDL-C and LDL-C concentrations (causal effect estimate from multivariable MR = -0.06; 95% CI = [-0.10, -0.02]; p-value = 0.0014). Evaluating the inverse direction of causality revealed a possible causal association of apoA-IV on HDL-cholesterol (2 SNPs; causal effect estimate per one percent increase in apoA-IV = -0.40; 95% CI = [-0.60, -0.21]; p-value = 5.5e-05).</style></abstract><notes><style face="normal" font="default" size="100%">Mack, Salome&#xD;Coassin, Stefan&#xD;Vaucher, Julien&#xD;Kronenberg, Florian&#xD;Lamina, Claudia&#xD;eng&#xD;P 26660/Austrian Science Fund FWF/Austria&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Sci Rep. 2017 Aug 18;7(1):8734. doi: 10.1038/s41598-017-07213-9.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28821713</style></url></related-urls><pdf-urls><url>internal-pdf://3231595377/Mack-2017-Evaluating the Causal Relation of Ap.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5562707</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s41598-017-07213-9</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>52</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">52</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mao, Y.</style></author><author><style face="normal" font="default" size="100%">Yan, C.</style></author><author><style face="normal" font="default" size="100%">Lu, Q.</style></author><author><style face="normal" font="default" size="100%">Zhu, M.</style></author><author><style face="normal" font="default" size="100%">Yu, F.</style></author><author><style face="normal" font="default" size="100%">Wang, C.</style></author><author><style face="normal" font="default" size="100%">Dai, J.</style></author><author><style face="normal" font="default" size="100%">Ma, H.</style></author><author><style face="normal" font="default" size="100%">Hu, Z.</style></author><author><style face="normal" font="default" size="100%">Shen, H.</style></author><author><style face="normal" font="default" size="100%">Jin, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.&#xD;Department of Epidemiology and Biostatistics, School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.&#xD;Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Centre For Cancer Medicine, Nanjing Medical University, Nanjing, China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetically predicted high body mass index is associated with increased gastric cancer risk</style></title><secondary-title><style face="normal" font="default" size="100%">Eur J Hum Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur J Hum Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1061-1066</style></pages><volume><style face="normal" font="default" size="100%">25</style></volume><number><style face="normal" font="default" size="100%">9</style></number><edition><style face="normal" font="default" size="100%">2017/06/22</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Body Weight/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Stomach Neoplasms/*genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-5438 (Electronic)&#xD;1018-4813 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28635950</style></accession-num><abstract><style face="normal" font="default" size="100%">Epidemiological studies have linked body mass index (BMI) with risk of gastrointestinal cancers. However, for gastric cancer, the relationship is more controversial. In particular, it is unclear whether the observed association is due to confounding or bias inherent in conventional observational studies. To investigate whether BMI is causally associated with gastric cancer risk, we applied Mendelian randomization using individual-level data from 2631 gastric cancer cases and 4373 cancer-free controls. We derived a weighted genetic risk score (wGRS) using 37 BMI-associated genetic variants as an instrumental variable. We used logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for associations between genetically predicted BMI and gastric cancer risk. We observed that higher genetically determined BMI was associated with increased gastric cancer risk (per standard deviation (SD) increase in the wGRS: OR=1.07, 95% CI: 1.02-1.13, P=4.94 x 10(-3)). Compared with individuals in the bottom tertile of the BMI wGRS, those in the top tertile had 1.14-fold (95% CI: 1.01-1.29) increased risk of developing gastric cancer. Sensitivity analyses using alternative causal inference measures demonstrated consistent association. Our study indicated that genetically high BMI was associated with increased gastric cancer risk, suggesting that high BMI may have a causal role in the etiology of gastric cancer.</style></abstract><notes><style face="normal" font="default" size="100%">Mao, Yingying&#xD;Yan, Caiwang&#xD;Lu, Qun&#xD;Zhu, Meng&#xD;Yu, Fei&#xD;Wang, Cheng&#xD;Dai, Juncheng&#xD;Ma, Hongxia&#xD;Hu, Zhibin&#xD;Shen, Hongbing&#xD;Jin, Guangfu&#xD;eng&#xD;Meta-Analysis&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Eur J Hum Genet. 2017 Sep;25(9):1061-1066. doi: 10.1038/ejhg.2017.103. Epub 2017 Jun 21.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28635950</style></url></related-urls><pdf-urls><url>internal-pdf://0054410620/Mao-2017-Genetically predicted high body mass.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5558171</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/ejhg.2017.103</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>85</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">85</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Marott, S. C.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author><author><style face="normal" font="default" size="100%">Tybjaerg-Hansen, A.</style></author><author><style face="normal" font="default" size="100%">Benn, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Clinical Biochemistry (S.C.W.M., M.B.), Herlev and Gentofte Hospital, 2900 Hellerup, Denmark; Department of Clinical Biochemistry (B.G.N.), Herlev and Gentofte Hospital, and The Copenhagen General Population Study (S.C.W.M., B.G.N., A.T.-H., M.B.), Herlev and Gentofte Hospital, 2730 Herlev, Denmark; Department of Clinical Biochemistry (A.T.-H.), Rigshospitalet, 2100 Copenhagen O, Denmark; and Copenhagen University Hospital (S.C.W.M., B.G.N., A.T.-H., M.B.), Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Components of the Metabolic Syndrome and Risk of Type 2 Diabetes</style></title><secondary-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></full-title></periodical><pages><style face="normal" font="default" size="100%">3212-21</style></pages><volume><style face="normal" font="default" size="100%">101</style></volume><number><style face="normal" font="default" size="100%">8</style></number><edition><style face="normal" font="default" size="100%">2016/06/11</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Glucose/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Denmark/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/*complications/*epidemiology/genetics/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Follow-Up Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Lipoproteins, HDL/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Metabolic Syndrome/*complications/*epidemiology/genetics/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Triglycerides/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Waist Circumference</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1945-7197 (Electronic)&#xD;0021-972X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27285293</style></accession-num><abstract><style face="normal" font="default" size="100%">CONTEXT: The metabolic syndrome (MetS) is associated with type 2 diabetes (T2D). However, whether each of the 5 components of the MetS individually is causally associated with T2D is unknown. OBJECTIVE: We tested the hypothesis that each component is causally associated with T2D. DESIGN: Mendelian randomization using genetic variations that alter levels of the MetS components are randomly assorted at gamete formation and free of confounding and reverse causation, which allows us to infer causality. SETTING: General community. STUDY PARTICIPANTS: A total of 95 756 individuals from the prospective Copenhagen General Population Study. MAIN OUTCOME MEASURE: Type 2 diabetes. RESULTS: A 1-cm larger waist circumference was associated with an observational 5% (95% confidence interval, 4%-5%) and a causal genetic 5% (1%-10%) higher risk of T2D. In contrast, although a 1-unit higher level of triglycerides and blood pressure and a 1-unit lower level of high-density lipoprotein cholesterol were associated with higher observational T2D risk, the corresponding causal genetic risks were not. As expected, a 1 mmol/L higher glucose level was associated with an observational 32% (30%-34%) and a causal genetic 82% (21%-173%) higher T2D risk. CONCLUSIONS: In conclusion, larger waist circumference and higher glucose levels were each causally associated with higher risk of T2D. Findings like these may change clinical thinking so that waist circumference control will be prioritized to the same extend as control of blood pressure, lipids, and glucose levels in T2D prevention.</style></abstract><notes><style face="normal" font="default" size="100%">Marott, Sarah C W&#xD;Nordestgaard, Borge G&#xD;Tybjaerg-Hansen, Anne&#xD;Benn, Marianne&#xD;eng&#xD;J Clin Endocrinol Metab. 2016 Aug;101(8):3212-21. doi: 10.1210/jc.2015-3777. Epub 2016 Jun 10.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27285293</style></url></related-urls><pdf-urls><url>internal-pdf://0843927404/Marott-2016-Components of the Metabolic Syndro.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1210/jc.2015-3777</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>43</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">43</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Marott, S. C. W.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author><author><style face="normal" font="default" size="100%">Tybjaerg-Hansen, A.</style></author><author><style face="normal" font="default" size="100%">Benn, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.&#xD;Copenhagen University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.&#xD;The Copenhagen General Population Study, Herlev and Gentofte Hospital, Herlev, Denmark.&#xD;Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Herlev, Denmark.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal Associations in Type 2 Diabetes Development</style></title><secondary-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1313-1324</style></pages><volume><style face="normal" font="default" size="100%">104</style></volume><number><style face="normal" font="default" size="100%">4</style></number><edition><style face="normal" font="default" size="100%">2018/12/20</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Age Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Glucose/*analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Confounding Factors, Epidemiologic</style></keyword><keyword><style face="normal" font="default" size="100%">Denmark/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/blood/*epidemiology/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Follow-Up Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">*Insulin Resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Registries/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1945-7197 (Electronic)&#xD;0021-972X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30566658</style></accession-num><abstract><style face="normal" font="default" size="100%">CONTEXT: Obesity, glucose, insulin resistance [homeostatic model assessment, version 2, for insulin resistance (HOMA2-IR)], and insulin secretion (HOMA2-beta) have been associated with type 2 diabetes (T2D) observationally. However, the causal, genetic contribution of each parameter to this risk is largely unknown and important to study because observational data are prone to confounding but genetic, causal data are free of confounding and reverse causation. OBJECTIVE: We examined the causal, genetic contribution of body mass index (BMI), glucose level, C-peptide level, HOMA2-IR, and HOMA2-beta to the risk of T2D in 95,540 individuals from the Copenhagen General Population Study and estimated the absolute 10-year risks. METHODS: Cox regression analysis, instrumental variable analysis, and Poisson regression analysis were performed to estimate the observational hazard ratios, causal, genetic ORs, and absolute 10-year risks of T2D. RESULTS: For 1-SD greater level, BMI was associated with an observational 66% (95% CI, 62% to 72%) and causal, genetic 121% (95% CI, 25% to 291%) greater risk of T2D; glucose with an observational 44% (95% CI, 41% to 46%) and causal, genetic 183% (95% CI, 56% to 416%) greater risk of T2D; and HOMA2-IR with an observational 30% (95% CI, 18% to 44%) and causal, genetic 12% (95% CI, 2% to 22%) greater risk of T2D. In contrast, for 1-SD greater level, HOMA2-beta was associated with an observational 14% (95% CI, 11% to 16%) and causal, genetic 21% (95% CI, 8% to 32%) lower risk of T2D. The upper tertiles of HOMA2-IR were associated with absolute 10-year diabetes risks of 31% and 37% in obese women and men, age &gt;60 years, and a glucose level of 6.1 to 11.0 mmol/L. CONCLUSIONS: BMI, glucose level, HOMA2-IR, and HOMA2-beta are causally associated with T2D.</style></abstract><notes><style face="normal" font="default" size="100%">Marott, Sarah C W&#xD;Nordestgaard, Borge G&#xD;Tybjaerg-Hansen, Anne&#xD;Benn, Marianne&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;J Clin Endocrinol Metab. 2019 Apr 1;104(4):1313-1324. doi: 10.1210/jc.2018-01648.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30566658</style></url></related-urls><pdf-urls><url>internal-pdf://3708606269/Marott-2018-Causal associations in type 2 diab.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1210/jc.2018-01648</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>174</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">174</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mendelson, M. M.</style></author><author><style face="normal" font="default" size="100%">Marioni, R. E.</style></author><author><style face="normal" font="default" size="100%">Joehanes, R.</style></author><author><style face="normal" font="default" size="100%">Liu, C.</style></author><author><style face="normal" font="default" size="100%">Hedman, A. K.</style></author><author><style face="normal" font="default" size="100%">Aslibekyan, S.</style></author><author><style face="normal" font="default" size="100%">Demerath, E. W.</style></author><author><style face="normal" font="default" size="100%">Guan, W.</style></author><author><style face="normal" font="default" size="100%">Zhi, D.</style></author><author><style face="normal" font="default" size="100%">Yao, C.</style></author><author><style face="normal" font="default" size="100%">Huan, T.</style></author><author><style face="normal" font="default" size="100%">Willinger, C.</style></author><author><style face="normal" font="default" size="100%">Chen, B.</style></author><author><style face="normal" font="default" size="100%">Courchesne, P.</style></author><author><style face="normal" font="default" size="100%">Multhaup, M.</style></author><author><style face="normal" font="default" size="100%">Irvin, M. R.</style></author><author><style face="normal" font="default" size="100%">Cohain, A.</style></author><author><style face="normal" font="default" size="100%">Schadt, E. E.</style></author><author><style face="normal" font="default" size="100%">Grove, M. L.</style></author><author><style face="normal" font="default" size="100%">Bressler, J.</style></author><author><style face="normal" font="default" size="100%">North, K.</style></author><author><style face="normal" font="default" size="100%">Sundstrom, J.</style></author><author><style face="normal" font="default" size="100%">Gustafsson, S.</style></author><author><style face="normal" font="default" size="100%">Shah, S.</style></author><author><style face="normal" font="default" size="100%">McRae, A. F.</style></author><author><style face="normal" font="default" size="100%">Harris, S. E.</style></author><author><style face="normal" font="default" size="100%">Gibson, J.</style></author><author><style face="normal" font="default" size="100%">Redmond, P.</style></author><author><style face="normal" font="default" size="100%">Corley, J.</style></author><author><style face="normal" font="default" size="100%">Murphy, L.</style></author><author><style face="normal" font="default" size="100%">Starr, J. M.</style></author><author><style face="normal" font="default" size="100%">Kleinbrink, E.</style></author><author><style face="normal" font="default" size="100%">Lipovich, L.</style></author><author><style face="normal" font="default" size="100%">Visscher, P. M.</style></author><author><style face="normal" font="default" size="100%">Wray, N. R.</style></author><author><style face="normal" font="default" size="100%">Krauss, R. M.</style></author><author><style face="normal" font="default" size="100%">Fallin, D.</style></author><author><style face="normal" font="default" size="100%">Feinberg, A.</style></author><author><style face="normal" font="default" size="100%">Absher, D. M.</style></author><author><style face="normal" font="default" size="100%">Fornage, M.</style></author><author><style face="normal" font="default" size="100%">Pankow, J. S.</style></author><author><style face="normal" font="default" size="100%">Lind, L.</style></author><author><style face="normal" font="default" size="100%">Fox, C.</style></author><author><style face="normal" font="default" size="100%">Ingelsson, E.</style></author><author><style face="normal" font="default" size="100%">Arnett, D. K.</style></author><author><style face="normal" font="default" size="100%">Boerwinkle, E.</style></author><author><style face="normal" font="default" size="100%">Liang, L.</style></author><author><style face="normal" font="default" size="100%">Levy, D.</style></author><author><style face="normal" font="default" size="100%">Deary, I. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Framingham Heart Study, Framingham, Massachusetts, United States of America.&#xD;Boston University School of Medicine, Boston, Massachusetts, United States of America.&#xD;Department of Cardiology, Boston Children&apos;s Hospital, Boston, Massachusetts, United States of America.&#xD;Population Sciences Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.&#xD;Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, United Kingdom.&#xD;Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.&#xD;Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.&#xD;Hebrew SeniorLife, Harvard Medical School, Boston, Massachusetts, United States of America.&#xD;Department of Biostatistics, Boston University, Boston, Massachusetts, United States of America.&#xD;Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.&#xD;Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.&#xD;Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States of America.&#xD;Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States of America.&#xD;Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.&#xD;Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.&#xD;Icahn Institute for Genomics and Multiscale Biology and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.&#xD;Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas, United States of America.&#xD;Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.&#xD;Cardiovascular Epidemiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.&#xD;Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.&#xD;Wellcome Trust Clinical Research Facility, Western General Hospital, University of Edinburgh, Edinburgh, United Kingdom.&#xD;Department of Psychology, University of Edinburgh, Edinburgh, United Kingdom.&#xD;Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, United Kingdom.&#xD;Center for Molecular Medicine and Genetics and Department of Neurology, Wayne State University, Detroit, Michigan, United States of America.&#xD;Children&apos;s Hospital Oakland Research Institute, Oakland, California, United States of America.&#xD;HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, United States of America.&#xD;Brown Foundation Institute of Molecular Medicine, University of Texas, Houston, Texas, United States of America.&#xD;Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, United States of America.&#xD;College of Public Health, University of Kentucky, Lexington, Kentucky, United States of America.&#xD;Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States of America.&#xD;Departments of Epidemiology and Biostatistics, School of Public Health, Harvard University, Boston, Massachusetts, United States of America.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1002215</style></pages><volume><style face="normal" font="default" size="100%">14</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2017/01/18</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Artery Disease/etiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*DNA Methylation</style></keyword><keyword><style face="normal" font="default" size="100%">Epigenesis, Genetic</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Gene Expression Regulation</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Leukocytes/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">*Lipid Metabolism/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/complications</style></keyword><keyword><style face="normal" font="default" size="100%">Oligonucleotide Array Sequence Analysis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28095459</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: The link between DNA methylation, obesity, and adiposity-related diseases in the general population remains uncertain. METHODS AND FINDINGS: We conducted an association study of body mass index (BMI) and differential methylation for over 400,000 CpGs assayed by microarray in whole-blood-derived DNA from 3,743 participants in the Framingham Heart Study and the Lothian Birth Cohorts, with independent replication in three external cohorts of 4,055 participants. We examined variations in whole blood gene expression and conducted Mendelian randomization analyses to investigate the functional and clinical relevance of the findings. We identified novel and previously reported BMI-related differential methylation at 83 CpGs that replicated across cohorts; BMI-related differential methylation was associated with concurrent changes in the expression of genes in lipid metabolism pathways. Genetic instrumental variable analysis of alterations in methylation at one of the 83 replicated CpGs, cg11024682 (intronic to sterol regulatory element binding transcription factor 1 [SREBF1]), demonstrated links to BMI, adiposity-related traits, and coronary artery disease. Independent genetic instruments for expression of SREBF1 supported the findings linking methylation to adiposity and cardiometabolic disease. Methylation at a substantial proportion (16 of 83) of the identified loci was found to be secondary to differences in BMI. However, the cross-sectional nature of the data limits definitive causal determination. CONCLUSIONS: We present robust associations of BMI with differential DNA methylation at numerous loci in blood cells. BMI-related DNA methylation and gene expression provide mechanistic insights into the relationship between DNA methylation, obesity, and adiposity-related diseases.</style></abstract><notes><style face="normal" font="default" size="100%">Mendelson, Michael M&#xD;Marioni, Riccardo E&#xD;Joehanes, Roby&#xD;Liu, Chunyu&#xD;Hedman, Asa K&#xD;Aslibekyan, Stella&#xD;Demerath, Ellen W&#xD;Guan, Weihua&#xD;Zhi, Degui&#xD;Yao, Chen&#xD;Huan, Tianxiao&#xD;Willinger, Christine&#xD;Chen, Brian&#xD;Courchesne, Paul&#xD;Multhaup, Michael&#xD;Irvin, Marguerite R&#xD;Cohain, Ariella&#xD;Schadt, Eric E&#xD;Grove, Megan L&#xD;Bressler, Jan&#xD;North, Kari&#xD;Sundstrom, Johan&#xD;Gustafsson, Stefan&#xD;Shah, Sonia&#xD;McRae, Allan F&#xD;Harris, Sarah E&#xD;Gibson, Jude&#xD;Redmond, Paul&#xD;Corley, Janie&#xD;Murphy, Lee&#xD;Starr, John M&#xD;Kleinbrink, Erica&#xD;Lipovich, Leonard&#xD;Visscher, Peter M&#xD;Wray, Naomi R&#xD;Krauss, Ronald M&#xD;Fallin, Daniele&#xD;Feinberg, Andrew&#xD;Absher, Devin M&#xD;Fornage, Myriam&#xD;Pankow, James S&#xD;Lind, Lars&#xD;Fox, Caroline&#xD;Ingelsson, Erik&#xD;Arnett, Donna K&#xD;Boerwinkle, Eric&#xD;Liang, Liming&#xD;Levy, Daniel&#xD;Deary, Ian J&#xD;eng&#xD;R01 HL104135/HL/NHLBI NIH HHS/&#xD;MR/K026992/1/MRC_/Medical Research Council/United Kingdom&#xD;R01 AG042187/AG/NIA NIH HHS/&#xD;U01 HL072524/HL/NHLBI NIH HHS/&#xD;DP2 CA196375/CA/NCI NIH HHS/&#xD;P30 DK020541/DK/NIDDK NIH HHS/&#xD;R01 HL135313/HL/NHLBI NIH HHS/&#xD;PLoS Med. 2017 Jan 17;14(1):e1002215. doi: 10.1371/journal.pmed.1002215. eCollection 2017 Jan.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28095459</style></url></related-urls><pdf-urls><url>internal-pdf://0880521994/Mendelson-2017-Association of Body Mass Index.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5240936 not an employee when the work was conducted. EI is a scientific advisor and consultant for Precision Wellness, Inc. and scientific advisor for Cellink for work unrelated to this paper. IJD has research grants from Age UK and the UK Medical Research Council.</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1002215</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>77</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">77</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Millard, L. A.</style></author><author><style face="normal" font="default" size="100%">Davies, N. M.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Tilling, K.</style></author><author><style face="normal" font="default" size="100%">Flach, P. A.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Integrative Epidemiology Unit (IEU) at the University of Bristol, University of Bristol, Bristol.&#xD;Intelligent Systems Laboratory, Department of Computer Science, University of Bristol, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">MR-PheWAS: hypothesis prioritization among potential causal effects of body mass index on many outcomes, using Mendelian randomization</style></title><secondary-title><style face="normal" font="default" size="100%">Sci Rep</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Sci Rep</style></full-title></periodical><pages><style face="normal" font="default" size="100%">16645</style></pages><volume><style face="normal" font="default" size="100%">5</style></volume><edition><style face="normal" font="default" size="100%">2015/11/17</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Alleles</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Leptin/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Lipids/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov 16</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2045-2322 (Electronic)&#xD;2045-2322 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26568383</style></accession-num><abstract><style face="normal" font="default" size="100%">Observational cohort studies can provide rich datasets with a diverse range of phenotypic variables. However, hypothesis-driven epidemiological analyses by definition only test particular hypotheses chosen by researchers. Furthermore, observational analyses may not provide robust evidence of causality, as they are susceptible to confounding, reverse causation and measurement error. Using body mass index (BMI) as an exemplar, we demonstrate a novel extension to the phenome-wide association study (pheWAS) approach, using automated screening with genotypic instruments to screen for causal associations amongst any number of phenotypic outcomes. We used a sample of 8,121 children from the ALSPAC dataset, and tested the linear association of a BMI-associated allele score with 172 phenotypic outcomes (with variable sample sizes). We also performed an instrumental variable analysis to estimate the causal effect of BMI on each phenotype. We found 21 of the 172 outcomes were associated with the allele score at an unadjusted p &lt; 0.05 threshold, and use Bonferroni corrections, permutation testing and estimates of the false discovery rate to consider the strength of results given the number of tests performed. The most strongly associated outcomes included leptin, lipid profile, and blood pressure. We also found novel evidence of effects of BMI on a global self-worth score.</style></abstract><notes><style face="normal" font="default" size="100%">Millard, Louise A C&#xD;Davies, Neil M&#xD;Timpson, Nic J&#xD;Tilling, Kate&#xD;Flach, Peter A&#xD;Davey Smith, George&#xD;eng&#xD;MC_UU_12013/3/Medical Research Council/United Kingdom&#xD;102215/Wellcome Trust/United Kingdom&#xD;MC_PC_15018/Medical Research Council/United Kingdom&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;MC_UU_12013/9/Medical Research Council/United Kingdom&#xD;MC_UU_12013/8/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Sci Rep. 2015 Nov 16;5:16645. doi: 10.1038/srep16645.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26568383</style></url></related-urls><pdf-urls><url>internal-pdf://3064706448/Millard-2015-MR-PheWAS_ hypothesis prioritizat.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4644974</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/srep16645</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>20</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">20</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Millard, L. A. C.</style></author><author><style face="normal" font="default" size="100%">Davies, N. M.</style></author><author><style face="normal" font="default" size="100%">Tilling, K.</style></author><author><style face="normal" font="default" size="100%">Gaunt, T. R.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.&#xD;Department of Population Health Sciences, Bristol Medical School, University of Bristol, United Kingdom.&#xD;Intelligent Systems Laboratory, Department of Computer Science, University of Bristol, Bristol, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Searching for the causal effects of body mass index in over 300 000 participants in UK Biobank, using Mendelian randomization</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1007951</style></pages><volume><style face="normal" font="default" size="100%">15</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2019/02/02</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Anxiety/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Biological Specimen Banks</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Association Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">United Kingdom</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1553-7404 (Electronic)&#xD;1553-7390 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30707692</style></accession-num><abstract><style face="normal" font="default" size="100%">Mendelian randomization (MR) has been used to estimate the causal effect of body mass index (BMI) on particular traits thought to be affected by BMI. However, BMI may also be a modifiable, causal risk factor for outcomes where there is no prior reason to suggest that a causal effect exists. We performed a MR phenome-wide association study (MR-pheWAS) to search for the causal effects of BMI in UK Biobank (n = 334 968), using the PHESANT open-source phenome scan tool. A subset of identified associations were followed up with a formal two-stage instrumental variable analysis in UK Biobank, to estimate the causal effect of BMI on these phenotypes. Of the 22 922 tests performed, our MR-pheWAS identified 587 associations below a stringent P value threshold corresponding to a 5% estimated false discovery rate. These included many previously identified causal effects, for instance, an adverse effect of higher BMI on risk of diabetes and hypertension. We also identified several novel effects, including protective effects of higher BMI on a set of psychosocial traits, identified initially in our preliminary MR-pheWAS in circa 115,000 UK Biobank participants and replicated in a different subset of circa 223,000 UK Biobank participants. Our comprehensive MR-pheWAS identified potential causal effects of BMI on a large and diverse set of phenotypes. This included both previously identified causal effects, and novel effects such as a protective effect of higher BMI on feelings of nervousness.</style></abstract><notes><style face="normal" font="default" size="100%">Millard, Louise A C&#xD;Davies, Neil M&#xD;Tilling, Kate&#xD;Gaunt, Tom R&#xD;Davey Smith, George&#xD;eng&#xD;MC_UU_12013/8/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00011/4/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00011/3/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00011/1/MRC_/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS Genet. 2019 Feb 1;15(2):e1007951. doi: 10.1371/journal.pgen.1007951. eCollection 2019 Feb.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30707692</style></url></related-urls><pdf-urls><url>internal-pdf://0985960170/Millard-2019-Searching for the causal effects.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6373977 GlaxoSmithKline and Biogen. All other authors have declared that no competing interests exist.</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pgen.1007951</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>75</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">75</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mokry, L. E.</style></author><author><style face="normal" font="default" size="100%">Ross, S.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Sawcer, S.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Richards, J. B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.&#xD;Centre for Clinical Epidemiology, Department of Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.&#xD;MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.&#xD;Department of Clinical Neurosciences, Cambridge Biomedical Campus, Cambridge, United Kingdom.&#xD;Department of Medicine, McGill University, Montreal, Quebec, Canada.&#xD;Department of Human Genetics, McGill University, Montreal, Quebec, Canada.&#xD;Department of Twin Research and Genetic Epidemiology, King&apos;s College London, London, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Obesity and Multiple Sclerosis: A Mendelian Randomization Study</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1002053</style></pages><volume><style face="normal" font="default" size="100%">13</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2016/06/29</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Multiple Sclerosis/*etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27351487</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Observational studies have reported an association between obesity, as measured by elevated body mass index (BMI), in early adulthood and risk of multiple sclerosis (MS). However, bias potentially introduced by confounding and reverse causation may have influenced these findings. Therefore, we elected to perform Mendelian randomization (MR) analyses to evaluate whether genetically increased BMI is associated with an increased risk of MS. METHODS AND FINDINGS: Employing a two-sample MR approach, we used summary statistics from the Genetic Investigation of Anthropometric Traits (GIANT) consortium and the International MS Genetics Consortium (IMSGC), the largest genome-wide association studies for BMI and MS, respectively (GIANT: n = 322,105; IMSGC: n = 14,498 cases and 24,091 controls). Seventy single nucleotide polymorphisms (SNPs) were genome-wide significant (p &lt; 5 x 10-8) for BMI in GIANT (n = 322,105) and were investigated for their association with MS risk in the IMSGC. The effect of each SNP on MS was weighted by its effect on BMI, and estimates were pooled to provide a summary measure for the effect of increased BMI upon risk of MS. Our results suggest that increased BMI influences MS susceptibility, where a 1 standard deviation increase in genetically determined BMI (kg/m2) increased odds of MS by 41% (odds ratio [OR]: 1.41, 95% CI 1.20-1.66, p = 2.7 x 10-5, I2 = 0%, 95% CI 0-29). Sensitivity analyses, including MR-Egger regression, and the weighted median approach provided no evidence of pleiotropic effects. The main study limitations are that, while these sensitivity analyses reduce the possibility that pleiotropy influenced our results, residual pleiotropy is difficult to exclude entirely. CONCLUSION: Genetically elevated BMI is associated with risk of MS, providing evidence for a causal role for obesity in MS etiology. While obesity has been associated with many late-life outcomes, these findings suggest an important consequence of childhood and/or early adulthood obesity.</style></abstract><notes><style face="normal" font="default" size="100%">Mokry, Lauren E&#xD;Ross, Stephanie&#xD;Timpson, Nicholas J&#xD;Sawcer, Stephen&#xD;Davey Smith, George&#xD;Richards, J Brent&#xD;eng&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;MC_UU_12013/3/Medical Research Council/United Kingdom&#xD;CIHR/Canada&#xD;Department of Health/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS Med. 2016 Jun 28;13(6):e1002053. doi: 10.1371/journal.pmed.1002053. eCollection 2016 Jun.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27351487</style></url></related-urls><pdf-urls><url>internal-pdf://0951600165/Mokry-2016-Obesity and Multiple Sclerosis_ A M.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4924848</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1002053</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>144</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">144</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mukherjee, S.</style></author><author><style face="normal" font="default" size="100%">Walter, S.</style></author><author><style face="normal" font="default" size="100%">Kauwe, J. S. K.</style></author><author><style face="normal" font="default" size="100%">Saykin, A. J.</style></author><author><style face="normal" font="default" size="100%">Bennett, D. A.</style></author><author><style face="normal" font="default" size="100%">Larson, E. B.</style></author><author><style face="normal" font="default" size="100%">Crane, P. K.</style></author><author><style face="normal" font="default" size="100%">Glymour, M. M.</style></author><author><style face="normal" font="default" size="100%">Adult Changes in Thought Study, Investigators</style></author><author><style face="normal" font="default" size="100%">Religious Orders, Study Memory</style></author><author><style face="normal" font="default" size="100%">Aging Project, Investigators</style></author><author><style face="normal" font="default" size="100%">Alzheimer&apos;s Disease Genetics, Consortium</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Medicine, University of Washington, Seattle, WA, USA.&#xD;Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA.&#xD;Department of Biology, Brigham Young University, Provo, UT, USA.&#xD;Department of Radiology, Indiana University, Indianapolis, IN, USA.&#xD;Department of Neurology, Rush University, Chicago, IL, USA.&#xD;Group Health Research Institute, Seattle, WA, USA.&#xD;Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA. Electronic address: mglymour@epi.ucsf.edu.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetically predicted body mass index and Alzheimer&apos;s disease-related phenotypes in three large samples: Mendelian randomization analyses</style></title><secondary-title><style face="normal" font="default" size="100%">Alzheimers Dement</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Alzheimers Dement</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1439-1451</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><number><style face="normal" font="default" size="100%">12</style></number><edition><style face="normal" font="default" size="100%">2015/06/17</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Alzheimer Disease/complications/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Linear Models</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/complications/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Alzheimer&apos;s disease</style></keyword><keyword><style face="normal" font="default" size="100%">Dementia</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1552-5279 (Electronic)&#xD;1552-5260 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26079416</style></accession-num><abstract><style face="normal" font="default" size="100%">Observational research shows that higher body mass index (BMI) increases Alzheimer&apos;s disease (AD) risk, but it is unclear whether this association is causal. We applied genetic variants that predict BMI in Mendelian randomization analyses, an approach that is not biased by reverse causation or confounding, to evaluate whether higher BMI increases AD risk. We evaluated individual-level data from the AD Genetics Consortium (ADGC: 10,079 AD cases and 9613 controls), the Health and Retirement Study (HRS: 8403 participants with algorithm-predicted dementia status), and published associations from the Genetic and Environmental Risk for AD consortium (GERAD1: 3177 AD cases and 7277 controls). No evidence from individual single-nucleotide polymorphisms or polygenic scores indicated BMI increased AD risk. Mendelian randomization effect estimates per BMI point (95% confidence intervals) were as follows: ADGC, odds ratio (OR) = 0.95 (0.90-1.01); HRS, OR = 1.00 (0.75-1.32); GERAD1, OR = 0.96 (0.87-1.07). One subscore (cellular processes not otherwise specified) unexpectedly predicted lower AD risk.</style></abstract><notes><style face="normal" font="default" size="100%">Mukherjee, Shubhabrata&#xD;Walter, Stefan&#xD;Kauwe, John S K&#xD;Saykin, Andrew J&#xD;Bennett, David A&#xD;Larson, Eric B&#xD;Crane, Paul K&#xD;Glymour, M Maria&#xD;eng&#xD;5R01AG022374/AG/NIA NIH HHS/&#xD;AG05144/AG/NIA NIH HHS/&#xD;P30 AG013854/AG/NIA NIH HHS/&#xD;RC4AG039029/AG/NIA NIH HHS/&#xD;MH60451/MH/NIMH NIH HHS/&#xD;RC4 AG039029/AG/NIA NIH HHS/&#xD;UL1 TR001445/TR/NCATS NIH HHS/&#xD;R01 AG054060/AG/NIA NIH HHS/&#xD;P30 AG010124/AG/NIA NIH HHS/&#xD;P50 AG023501/AG/NIA NIH HHS/&#xD;R01 AG17917/AG/NIA NIH HHS/&#xD;U01 HG006375/HG/NHGRI NIH HHS/&#xD;R01 AG019771/AG/NIA NIH HHS/&#xD;P30 AG028377/AG/NIA NIH HHS/&#xD;RC2 AG036528/AG/NIA NIH HHS/&#xD;AG041232/AG/NIA NIH HHS/&#xD;RF1 AG015819/AG/NIA NIH HHS/&#xD;P50 AG008671/AG/NIA NIH HHS/&#xD;P50 AG005142/AG/NIA NIH HHS/&#xD;U01 AG10483/AG/NIA NIH HHS/&#xD;P30 AG10133/AG/NIA NIH HHS/&#xD;R01 AG035137/AG/NIA NIH HHS/&#xD;P30 AG010133/AG/NIA NIH HHS/&#xD;U24 AG021886/AG/NIA NIH HHS/&#xD;R01 AG031581/AG/NIA NIH HHS/&#xD;U01 AG009740/AG/NIA NIH HHS/&#xD;P50 AG005131/AG/NIA NIH HHS/&#xD;P50 AG016574/AG/NIA NIH HHS/&#xD;P50 AG005146/AG/NIA NIH HHS/&#xD;P50 AG016577/AG/NIA NIH HHS/&#xD;R01 AG019085/AG/NIA NIH HHS/&#xD;U01 AG032984/AG/NIA NIH HHS/&#xD;R01 AG042611/AG/NIA NIH HHS/&#xD;R01 AG013616/AG/NIA NIH HHS/&#xD;R01 AG030146/AG/NIA NIH HHS/&#xD;U01 AG024904/AG/NIA NIH HHS/&#xD;P50 AG008702/AG/NIA NIH HHS/&#xD;UL1 RR029893/RR/NCRR NIH HHS/&#xD;CAPMC/ CIHR/Canada&#xD;R01 AA023416/AA/NIAAA NIH HHS/&#xD;HHMI/Howard Hughes Medical Institute/&#xD;AG05128/AG/NIA NIH HHS/&#xD;U01 AG016976/AG/NIA NIH HHS/&#xD;P50 NS039764/NS/NINDS NIH HHS/&#xD;P01 AG003991/AG/NIA NIH HHS/&#xD;P30 AG008051/AG/NIA NIH HHS/&#xD;P50 AG005681/AG/NIA NIH HHS/&#xD;P30 AG013846/AG/NIA NIH HHS/&#xD;U24 AG056270/AG/NIA NIH HHS/&#xD;RC2 AG036502/AG/NIA NIH HHS/&#xD;R01 AG017917/AG/NIA NIH HHS/&#xD;R01AG17917/AG/NIA NIH HHS/&#xD;R01 MH080295/MH/NIMH NIH HHS/&#xD;P01 AG03991/AG/NIA NIH HHS/&#xD;U01 AG 06781/AG/NIA NIH HHS/&#xD;P50 AG005136/AG/NIA NIH HHS/&#xD;AG010491/AG/NIA NIH HHS/&#xD;P30 AG08051/AG/NIA NIH HHS/&#xD;P30 AG012300/AG/NIA NIH HHS/&#xD;NS39764/NS/NINDS NIH HHS/&#xD;UL1 TR001108/TR/NCATS NIH HHS/&#xD;AG041718/AG/NIA NIH HHS/&#xD;R01 AG012101/AG/NIA NIH HHS/&#xD;P50 AG016573/AG/NIA NIH HHS/&#xD;P01 AG019724/AG/NIA NIH HHS/&#xD;P50 AG016570/AG/NIA NIH HHS/&#xD;P30 AG008017/AG/NIA NIH HHS/&#xD;R01 AG008122/AG/NIA NIH HHS/&#xD;P50 AG005134/AG/NIA NIH HHS/&#xD;P30 AG010161/AG/NIA NIH HHS/&#xD;U54 CA132378/CA/NCI NIH HHS/&#xD;R01 AG033193/AG/NIA NIH HHS/&#xD;1RC2AG036502/AG/NIA NIH HHS/&#xD;AG030653/AG/NIA NIH HHS/&#xD;R01 AG15819/AG/NIA NIH HHS/&#xD;U24 AG026390/AG/NIA NIH HHS/&#xD;AG025688/AG/NIA NIH HHS/&#xD;MRC_/Medical Research Council/United Kingdom&#xD;1R01 AG035137/AG/NIA NIH HHS/&#xD;R37 AG015473/AG/NIA NIH HHS/&#xD;U24 AG026395/AG/NIA NIH HHS/&#xD;AG027944/AG/NIA NIH HHS/&#xD;P50 AG025688/AG/NIA NIH HHS/&#xD;R01 CA129769/CA/NCI NIH HHS/&#xD;P50 AG005133/AG/NIA NIH HHS/&#xD;U01 AG010483/AG/NIA NIH HHS/&#xD;P01 AG002219/AG/NIA NIH HHS/&#xD;R01AG15819/AG/NIA NIH HHS/&#xD;U01 AG006781/AG/NIA NIH HHS/&#xD;U01 AG06781/AG/NIA NIH HHS/&#xD;R01 AG041797/AG/NIA NIH HHS/&#xD;P50 AG005144/AG/NIA NIH HHS/&#xD;P01 AG010491/AG/NIA NIH HHS/&#xD;U01AG009740/AG/NIA NIH HHS/&#xD;P50 AG005138/AG/NIA NIH HHS/&#xD;R01 AG021547/AG/NIA NIH HHS/&#xD;R01 AG041232/AG/NIA NIH HHS/&#xD;R01 AG019757/AG/NIA NIH HHS/&#xD;R01 AG020688/AG/NIA NIH HHS/&#xD;R01 AG034374/AG/NIA NIH HHS/&#xD;R43 AG051285/AG/NIA NIH HHS/&#xD;5R01AG012101/AG/NIA NIH HHS/&#xD;R01 AG030653/AG/NIA NIH HHS/&#xD;R01 AG33193/AG/NIA NIH HHS/&#xD;R01 AG027944/AG/NIA NIH HHS/&#xD;R01 AG30146/AG/NIA NIH HHS/&#xD;R01 AG017173/AG/NIA NIH HHS/&#xD;R01 AG025259/AG/NIA NIH HHS/&#xD;P30AG10161/AG/NIA NIH HHS/&#xD;R01AG34374/AG/NIA NIH HHS/&#xD;U01 HG004610/HG/NHGRI NIH HHS/&#xD;RC2 AG036495/AG/NIA NIH HHS/&#xD;P30 AG010129/AG/NIA NIH HHS/&#xD;P30 AG019610/AG/NIA NIH HHS/&#xD;P50 AG016582/AG/NIA NIH HHS/&#xD;R01 AG041718/AG/NIA NIH HHS/&#xD;5R01AG013616/AG/NIA NIH HHS/&#xD;P50 AG016576/AG/NIA NIH HHS/&#xD;P30 AG028383/AG/NIA NIH HHS/&#xD;AG019757/AG/NIA NIH HHS/&#xD;MO1RR00096/RR/NCRR NIH HHS/&#xD;R01 AG026916/AG/NIA NIH HHS/&#xD;RC2AG036495/AG/NIA NIH HHS/&#xD;R01 NS059873/NS/NINDS NIH HHS/&#xD;AG021547/AG/NIA NIH HHS/&#xD;UL1RR02777/RR/NCRR NIH HHS/&#xD;R01 AG015819/AG/NIA NIH HHS/&#xD;IK2 BX001820/BX/BLRD VA/&#xD;P50, P50 AG016575/AG/NIA NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Alzheimers Dement. 2015 Dec;11(12):1439-1451. doi: 10.1016/j.jalz.2015.05.015. Epub 2015 Jun 12.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26079416</style></url></related-urls><pdf-urls><url>internal-pdf://2301995328/Mukherjee-2015-Genetically predicted body mass.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4676945</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.jalz.2015.05.015</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>128</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">128</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mumby, H. S.</style></author><author><style face="normal" font="default" size="100%">Elks, C. E.</style></author><author><style face="normal" font="default" size="100%">Li, S.</style></author><author><style face="normal" font="default" size="100%">Sharp, S. J.</style></author><author><style face="normal" font="default" size="100%">Khaw, K. T.</style></author><author><style face="normal" font="default" size="100%">Luben, R. N.</style></author><author><style face="normal" font="default" size="100%">Wareham, N. J.</style></author><author><style face="normal" font="default" size="100%">Loos, R. J.</style></author><author><style face="normal" font="default" size="100%">Ong, K. K.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke&apos;s Hospital, P.O. Box 285, Cambridge CB2 0QQ, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Mendelian Randomisation Study of Childhood BMI and Early Menarche</style></title><secondary-title><style face="normal" font="default" size="100%">J Obes</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Obes</style></full-title></periodical><pages><style face="normal" font="default" size="100%">180729</style></pages><volume><style face="normal" font="default" size="100%">2011</style></volume><edition><style face="normal" font="default" size="100%">2011/07/21</style></edition><dates><year><style face="normal" font="default" size="100%">2011</style></year></dates><isbn><style face="normal" font="default" size="100%">2090-0716 (Electronic)&#xD;2090-0708 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">21773002</style></accession-num><abstract><style face="normal" font="default" size="100%">To infer the causal association between childhood BMI and age at menarche, we performed a mendelian randomisation analysis using twelve established &quot;BMI-increasing&quot; genetic variants as an instrumental variable (IV) for higher BMI. In 8,156 women of European descent from the EPIC-Norfolk cohort, height was measured at age 39-77 years; age at menarche was self-recalled, as was body weight at age 20 years, and BMI at 20 was calculated as a proxy for childhood BMI. DNA was genotyped for twelve BMI-associated common variants (in/near FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, ETV5, MTCH2, SEC16B, FAIM2 and SH2B1), and for each individual a &quot;BMI-increasing-allele-score&quot; was calculated by summing the number of BMI-increasing alleles across all 12 loci. Using this BMI-increasing-allele-score as an instrumental variable for BMI, each 1 kg/m(2) increase in childhood BMI was predicted to result in a 6.5% (95% CI: 4.6-8.5%) higher absolute risk of early menarche (before age 12 years). While mendelian randomisation analysis is dependent on a number of assumptions, our findings support a causal effect of BMI on early menarche and suggests that increasing prevalence of childhood obesity will lead to similar trends in the prevalence of early menarche.</style></abstract><notes><style face="normal" font="default" size="100%">Mumby, Hannah S&#xD;Elks, Cathy E&#xD;Li, Shengxu&#xD;Sharp, Stephen J&#xD;Khaw, Kay-Tee&#xD;Luben, Robert N&#xD;Wareham, Nicholas J&#xD;Loos, Ruth J F&#xD;Ong, Ken K&#xD;eng&#xD;G1000143/Medical Research Council/United Kingdom&#xD;MC_U106179471/Medical Research Council/United Kingdom&#xD;MC_U106179472/Medical Research Council/United Kingdom&#xD;G0401527/Medical Research Council/United Kingdom&#xD;MC_U106188470/Medical Research Council/United Kingdom&#xD;J Obes. 2011;2011:180729. doi: 10.1155/2011/180729. Epub 2011 May 18.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/21773002</style></url></related-urls><pdf-urls><url>internal-pdf://0625297214/Mumby-2011-Mendelian Randomisation Study of Ch.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3136158</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1155/2011/180729</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>49</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">49</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nead, K. T.</style></author><author><style face="normal" font="default" size="100%">Sharp, S. J.</style></author><author><style face="normal" font="default" size="100%">Thompson, D. J.</style></author><author><style face="normal" font="default" size="100%">Painter, J. N.</style></author><author><style face="normal" font="default" size="100%">Savage, D. B.</style></author><author><style face="normal" font="default" size="100%">Semple, R. K.</style></author><author><style face="normal" font="default" size="100%">Barker, A.</style></author><author><style face="normal" font="default" size="100%">Australian National Endometrial Cancer Study, Group</style></author><author><style face="normal" font="default" size="100%">Perry, J. R.</style></author><author><style face="normal" font="default" size="100%">Attia, J.</style></author><author><style face="normal" font="default" size="100%">Dunning, A. M.</style></author><author><style face="normal" font="default" size="100%">Easton, D. F.</style></author><author><style face="normal" font="default" size="100%">Holliday, E.</style></author><author><style face="normal" font="default" size="100%">Lotta, L. A.</style></author><author><style face="normal" font="default" size="100%">O&apos;Mara, T.</style></author><author><style face="normal" font="default" size="100%">McEvoy, M.</style></author><author><style face="normal" font="default" size="100%">Pharoah, P. D.</style></author><author><style face="normal" font="default" size="100%">Scott, R. J.</style></author><author><style face="normal" font="default" size="100%">Spurdle, A. B.</style></author><author><style face="normal" font="default" size="100%">Langenberg, C.</style></author><author><style face="normal" font="default" size="100%">Wareham, N. J.</style></author><author><style face="normal" font="default" size="100%">Scott, R. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Epidemiology Unit, University of Cambridge, Cambridge, UK (KTN, SJS, AB, JRBP, LAL, CL, NJW, RAS); Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (KTN); Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (DJT, DFE, PDPP); Queensland Institute of Medical Research, Brisbane, Australia (JNP, ANECS, TO, ABS); University of Cambridge Metabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Cambridge, UK (DBS, RKS); Hunter Medical Research Institute, John Hunter Hospital, Newcastle, Australia (JA, EH, RJS); Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, The University of Newcastle, Newcastle, Australia (JA, MM); Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (AMD, DFE, PDPP); Centre for Information Based Medicine, School of Medicine and Public Health, University of Newcastle, Australia (EH, RJS).&#xD;MRC Epidemiology Unit, University of Cambridge, Cambridge, UK (KTN, SJS, AB, JRBP, LAL, CL, NJW, RAS); Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (KTN); Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (DJT, DFE, PDPP); Queensland Institute of Medical Research, Brisbane, Australia (JNP, ANECS, TO, ABS); University of Cambridge Metabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Cambridge, UK (DBS, RKS); Hunter Medical Research Institute, John Hunter Hospital, Newcastle, Australia (JA, EH, RJS); Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, The University of Newcastle, Newcastle, Australia (JA, MM); Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK (AMD, DFE, PDPP); Centre for Information Based Medicine, School of Medicine and Public Health, University of Newcastle, Australia (EH, RJS). robert.scott@mrc-epid.cam.ac.uk.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis</style></title><secondary-title><style face="normal" font="default" size="100%">J Natl Cancer Inst</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Natl Cancer Inst</style></full-title></periodical><volume><style face="normal" font="default" size="100%">107</style></volume><number><style face="normal" font="default" size="100%">9</style></number><edition><style face="normal" font="default" size="100%">2015/07/03</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Glucose/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/blood/*complications</style></keyword><keyword><style face="normal" font="default" size="100%">Endometrial Neoplasms/*blood/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Fasting</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Hyperinsulinism/blood/*complications</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin/*blood/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">*Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1460-2105 (Electronic)&#xD;0027-8874 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26134033</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Insulinemia and type 2 diabetes (T2D) have been associated with endometrial cancer risk in numerous observational studies. However, the causality of these associations is uncertain. Here we use a Mendelian randomization (MR) approach to assess whether insulinemia and T2D are causally associated with endometrial cancer. METHODS: We used single nucleotide polymorphisms (SNPs) associated with T2D (49 variants), fasting glucose (36 variants), fasting insulin (18 variants), early insulin secretion (17 variants), and body mass index (BMI) (32 variants) as instrumental variables in MR analyses. We calculated MR estimates for each risk factor with endometrial cancer using an inverse-variance weighted method with SNP-endometrial cancer associations from 1287 case patients and 8273 control participants. RESULTS: Genetically predicted higher fasting insulin levels were associated with greater risk of endometrial cancer (odds ratio [OR] per standard deviation = 2.34, 95% confidence internal [CI] = 1.06 to 5.14, P = .03). Consistently, genetically predicted higher 30-minute postchallenge insulin levels were also associated with endometrial cancer risk (OR = 1.40, 95% CI = 1.12 to 1.76, P = .003). We observed no associations between genetic risk of type 2 diabetes (OR = 0.91, 95% CI = 0.79 to 1.04, P = .16) or higher fasting glucose (OR = 1.00, 95% CI = 0.67 to 1.50, P = .99) and endometrial cancer. In contrast, endometrial cancer risk was higher in individuals with genetically predicted higher BMI (OR = 3.86, 95% CI = 2.24 to 6.64, P = 1.2x10(-6)). CONCLUSION: This study provides evidence to support a causal association of higher insulin levels, independently of BMI, with endometrial cancer risk.</style></abstract><notes><style face="normal" font="default" size="100%">Nead, Kevin T&#xD;Sharp, Stephen J&#xD;Thompson, Deborah J&#xD;Painter, Jodie N&#xD;Savage, David B&#xD;Semple, Robert K&#xD;Barker, Adam&#xD;(ANECS)&#xD;Perry, John R B&#xD;Attia, John&#xD;Dunning, Alison M&#xD;Easton, Douglas F&#xD;Holliday, Elizabeth&#xD;Lotta, Luca A&#xD;O&apos;Mara, Tracy&#xD;McEvoy, Mark&#xD;Pharoah, Paul D P&#xD;Scott, Rodney J&#xD;Spurdle, Amanda B&#xD;Langenberg, Claudia&#xD;Wareham, Nicholas J&#xD;Scott, Robert A&#xD;eng&#xD;C490/A10124/Cancer Research UK/United Kingdom&#xD;MC_U106179471/Medical Research Council/United Kingdom&#xD;MC_UU_12015/2/Medical Research Council/United Kingdom&#xD;098498/Wellcome Trust/United Kingdom&#xD;085475/Wellcome Trust/United Kingdom&#xD;MC_U106179472/Medical Research Council/United Kingdom&#xD;MC_UU_12015/1/Medical Research Council/United Kingdom&#xD;100574/Wellcome Trust/United Kingdom&#xD;068545/Z/02/Wellcome Trust/United Kingdom&#xD;G0000934/Medical Research Council/United Kingdom&#xD;10124/Cancer Research UK/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;J Natl Cancer Inst. 2015 Jul 1;107(9). pii: djv178. doi: 10.1093/jnci/djv178. Print 2015 Sep.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26134033</style></url></related-urls><pdf-urls><url>internal-pdf://1317335267/Nead-2015-Evidence of a Causal Association Bet.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4572886</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/jnci/djv178</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>88</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">88</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author><author><style face="normal" font="default" size="100%">Palmer, T. M.</style></author><author><style face="normal" font="default" size="100%">Benn, M.</style></author><author><style face="normal" font="default" size="100%">Zacho, J.</style></author><author><style face="normal" font="default" size="100%">Tybjaerg-Hansen, A.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Denmark.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1001212</style></pages><volume><style face="normal" font="default" size="100%">9</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2012/05/09</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Alleles</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Membrane Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Myocardial Ischemia/epidemiology/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Receptor, Melanocortin, Type 4/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">22563304</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Adiposity, assessed as elevated body mass index (BMI), is associated with increased risk of ischemic heart disease (IHD); however, whether this is causal is unknown. We tested the hypothesis that positive observational associations between BMI and IHD are causal. METHODS AND FINDINGS: In 75,627 individuals taken from two population-based and one case-control study in Copenhagen, we measured BMI, ascertained 11,056 IHD events, and genotyped FTO(rs9939609), MC4R(rs17782313), and TMEM18(rs6548238). Using genotypes as a combined allele score in instrumental variable analyses, the causal odds ratio (OR) between BMI and IHD was estimated and compared with observational estimates. The allele score-BMI and the allele score-IHD associations used to estimate the causal OR were also calculated individually. In observational analyses the OR for IHD was 1.26 (95% CI 1.19-1.34) for every 4 kg/m(2) increase in BMI. A one-unit allele score increase associated with a 0.28 kg/m(2) (95 CI% 0.20-0.36) increase in BMI and an OR for IHD of 1.03 (95% CI 1.01-1.05) (corresponding to an average 1.68 kg/m(2) BMI increase and 18% increase in the odds of IHD for those carrying all six BMI increasing alleles). In instrumental variable analysis using the same allele score the causal IHD OR for a 4 kg/m(2) increase in BMI was 1.52 (95% CI 1.12-2.05). CONCLUSIONS: For every 4 kg/m(2) increase in BMI, observational estimates suggested a 26% increase in odds for IHD while causal estimates suggested a 52% increase. These data add evidence to support a causal link between increased BMI and IHD risk, though the mechanism may ultimately be through intermediate factors like hypertension, dyslipidemia, and type 2 diabetes. This work has important policy implications for public health, given the continuous nature of the BMI-IHD association and the modifiable nature of BMI. This analysis demonstrates the value of observational studies and their ability to provide unbiased results through inclusion of genetic data avoiding confounding, reverse causation, and bias.</style></abstract><notes><style face="normal" font="default" size="100%">Nordestgaard, Borge G&#xD;Palmer, Tom M&#xD;Benn, Marianne&#xD;Zacho, Jeppe&#xD;Tybjaerg-Hansen, Anne&#xD;Davey Smith, George&#xD;Timpson, Nicholas J&#xD;eng&#xD;G0600705/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS Med. 2012;9(5):e1001212. doi: 10.1371/journal.pmed.1001212. Epub 2012 May 1.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/22563304</style></url></related-urls><pdf-urls><url>internal-pdf://3481567908/Nordestgaard-2012-The effect of elevated body.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3341326</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1001212</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>150</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">150</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nordestgaard, L. T.</style></author><author><style face="normal" font="default" size="100%">Tybjaerg-Hansen, A.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author><author><style face="normal" font="default" size="100%">Frikke-Schmidt, R.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.&#xD;The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, DK-2730 Herlev, Denmark.&#xD;Department of Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2100 Copenhagen, Denmark.&#xD;The Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, DK-2730 Herlev, Denmark.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Body Mass Index and Risk of Alzheimer&apos;s Disease: A Mendelian Randomization Study of 399,536 Individuals</style></title><secondary-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2310-2320</style></pages><volume><style face="normal" font="default" size="100%">102</style></volume><number><style face="normal" font="default" size="100%">7</style></number><edition><style face="normal" font="default" size="100%">2017/06/15</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Alzheimer Disease/epidemiology/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Anthropometry/methods</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Confounding Factors, Epidemiologic</style></keyword><keyword><style face="normal" font="default" size="100%">Denmark/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Thinness/*complications/epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1945-7197 (Electronic)&#xD;0021-972X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28609829</style></accession-num><abstract><style face="normal" font="default" size="100%">Context: Recently, data on 2,000,000 people established that low body mass index (BMI) is associated with increased risk of dementia. Whether this observational association reflects a causal effect remains to be clarified. Objective: We tested the hypothesis that there is a causal association between low BMI and high risk of Alzheimer&apos;s disease. Design, Setting, and Participants: Using a Mendelian randomization approach, we studied 95,578 individuals from the Copenhagen General Population Study (CGPS) with up to 36 years of follow-up and consortia data on 303,958 individuals from the Genetic Investigation of Anthropometric Traits (GIANT) and the International Genomics of Alzheimer&apos;s Project (IGAP). Main Outcome Measure: Risk of Alzheimer&apos;s disease. Results: The causal odds ratio for a 1-kg/m2 genetically determined lower BMI was 0.98 [95% confidence interval (CI), 0.77 to 1.23] for a weighted allele score in the CGPS. Using 32 BMI-decreasing variants from GIANT and IGAP the causal odds ratio for Alzheimer&apos;s disease for a 1-standard deviation (SD) lower genetically determined BMI was 1.02 (95% CI, 0.86 to 1.22). Corresponding observational hazard ratios from the CGPS were 1.07 (95% CI, 1.05 to 1.09) and 1.32 (95% CI, 1.20 to 1.46) for a 1-kg/m2 and a 1-SD lower BMI, respectively. Conclusions: Genetic and hence lifelong low BMI is not associated with increased risk of Alzheimer&apos;s disease in the general population. These data suggest that low BMI is not a causal risk factor for Alzheimer&apos;s disease and that the corresponding observational association likely is explained by reverse causation or confounding.</style></abstract><notes><style face="normal" font="default" size="100%">Nordestgaard, Liv Tybjaerg&#xD;Tybjaerg-Hansen, Anne&#xD;Nordestgaard, Borge G&#xD;Frikke-Schmidt, Ruth&#xD;eng&#xD;N01AG12100/AG/NIA NIH HHS/&#xD;U24 AG021886/AG/NIA NIH HHS/&#xD;U01 AG032984/AG/NIA NIH HHS/&#xD;U01 AG016976/AG/NIA NIH HHS/&#xD;R01 HL105756/HL/NHLBI NIH HHS/&#xD;R01 AG033193/AG/NIA NIH HHS/&#xD;Wellcome Trust/United Kingdom&#xD;503480/Medical Research Council/United Kingdom&#xD;082604/2/07/Z/Wellcome Trust/United Kingdom&#xD;Observational Study&#xD;J Clin Endocrinol Metab. 2017 Jul 1;102(7):2310-2320. doi: 10.1210/jc.2017-00195.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28609829</style></url></related-urls><pdf-urls><url>internal-pdf://4142071309/Nordestgaard-2017-Body Mass Index and Risk of.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5505195</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1210/jc.2017-00195</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>4</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">4</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">North, Teri-Louise</style></author><author><style face="normal" font="default" size="100%">Davies, Neil M.</style></author><author><style face="normal" font="default" size="100%">Harrison, Sean</style></author><author><style face="normal" font="default" size="100%">Carter, Alice R.</style></author><author><style face="normal" font="default" size="100%">Hemani, Gibran</style></author><author><style face="normal" font="default" size="100%">Sanderson, Eleanor</style></author><author><style face="normal" font="default" size="100%">Tilling, Kate</style></author><author><style face="normal" font="default" size="100%">Howe, Laura D.</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><urls><pdf-urls><url>internal-pdf://0962653571/North-2019-Using genetic instruments to estima.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/544734</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>166</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">166</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Noyce, A. J.</style></author><author><style face="normal" font="default" size="100%">Kia, D. A.</style></author><author><style face="normal" font="default" size="100%">Hemani, G.</style></author><author><style face="normal" font="default" size="100%">Nicolas, A.</style></author><author><style face="normal" font="default" size="100%">Price, T. R.</style></author><author><style face="normal" font="default" size="100%">De Pablo-Fernandez, E.</style></author><author><style face="normal" font="default" size="100%">Haycock, P. C.</style></author><author><style face="normal" font="default" size="100%">Lewis, P. A.</style></author><author><style face="normal" font="default" size="100%">Foltynie, T.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">International Parkinson Disease Genomics, Consortium</style></author><author><style face="normal" font="default" size="100%">Schrag, A.</style></author><author><style face="normal" font="default" size="100%">Lees, A. J.</style></author><author><style face="normal" font="default" size="100%">Hardy, J.</style></author><author><style face="normal" font="default" size="100%">Singleton, A.</style></author><author><style face="normal" font="default" size="100%">Nalls, M. A.</style></author><author><style face="normal" font="default" size="100%">Pearce, N.</style></author><author><style face="normal" font="default" size="100%">Lawlor, D. A.</style></author><author><style face="normal" font="default" size="100%">Wood, N. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom.&#xD;Centre for Neuroscience and Trauma, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.&#xD;School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.&#xD;Laboratory for Neurogenetics, National Institute on Aging National Institutes of Health, Bethesda, Maryland, United States of America.&#xD;School of Pharmacy, University of Reading, Reading, United Kingdom.&#xD;Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, University College London, London, United Kingdom.&#xD;Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, United Kingdom.&#xD;Data Tecnica International, Glen Echo, Maryland, United States of America.&#xD;Department of Medical Statistics, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1002314</style></pages><volume><style face="normal" font="default" size="100%">14</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2017/06/14</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">*Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Parkinson Disease/*epidemiology/genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28609445</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Both positive and negative associations between higher body mass index (BMI) and Parkinson disease (PD) have been reported in observational studies, but it has been difficult to establish causality because of the possibility of residual confounding or reverse causation. To our knowledge, Mendelian randomisation (MR)-the use of genetic instrumental variables (IVs) to explore causal effects-has not previously been used to test the effect of BMI on PD. METHODS AND FINDINGS: Two-sample MR was undertaken using genome-wide association (GWA) study data. The associations between the genetic instruments and BMI were obtained from the GIANT consortium and consisted of the per-allele difference in mean BMI for 77 independent variants that reached genome-wide significance. The per-allele difference in log-odds of PD for each of these variants was estimated from a recent meta-analysis, which included 13,708 cases of PD and 95,282 controls. The inverse-variance weighted method was used to estimate a pooled odds ratio (OR) for the effect of a 5-kg/m2 higher BMI on PD. Evidence of directional pleiotropy averaged across all variants was sought using MR-Egger regression. Frailty simulations were used to assess whether causal associations were affected by mortality selection. A combined genetic IV expected to confer a lifetime exposure of 5-kg/m2 higher BMI was associated with a lower risk of PD (OR 0.82, 95% CI 0.69-0.98). MR-Egger regression gave similar results, suggesting that directional pleiotropy was unlikely to be biasing the result (intercept 0.002; p = 0.654). However, the apparent protective influence of higher BMI could be at least partially induced by survival bias in the PD GWA study, as demonstrated by frailty simulations. Other important limitations of this application of MR include the inability to analyse non-linear associations, to undertake subgroup analyses, and to gain mechanistic insights. CONCLUSIONS: In this large study using two-sample MR, we found that variants known to influence BMI had effects on PD in a manner consistent with higher BMI leading to lower risk of PD. The mechanism underlying this apparent protective effect warrants further study.</style></abstract><notes><style face="normal" font="default" size="100%">Noyce, Alastair J&#xD;Kia, Demis A&#xD;Hemani, Gibran&#xD;Nicolas, Aude&#xD;Price, T Ryan&#xD;De Pablo-Fernandez, Eduardo&#xD;Haycock, Philip C&#xD;Lewis, Patrick A&#xD;Foltynie, Thomas&#xD;Davey Smith, George&#xD;Schrag, Anette&#xD;Lees, Andrew J&#xD;Hardy, John&#xD;Singleton, Andrew&#xD;Nalls, Mike A&#xD;Pearce, Neil&#xD;Lawlor, Debbie A&#xD;Wood, Nicholas W&#xD;eng&#xD;J-0804/Parkinson&apos;s UK/United Kingdom&#xD;R01 CA141668/CA/NCI NIH HHS/&#xD;Z01 ES101986/Intramural NIH HHS/&#xD;MR/L501554/1/Medical Research Council/United Kingdom&#xD;Z01 AG000949/Intramural NIH HHS/&#xD;R01 NS037167/NS/NINDS NIH HHS/&#xD;MR/L010933/1/Medical Research Council/United Kingdom&#xD;F-1201/Parkinson&apos;s UK/United Kingdom&#xD;Wellcome Trust/United Kingdom&#xD;G-1107/Parkinson&apos;s UK/United Kingdom&#xD;MR/N026004/1/Medical Research Council/United Kingdom&#xD;MC_UU_12013/5/Medical Research Council/United Kingdom&#xD;MC_PC_09003/Medical Research Council/United Kingdom&#xD;P50 NS071674/NS/NINDS NIH HHS/&#xD;PLoS Med. 2017 Jun 13;14(6):e1002314. doi: 10.1371/journal.pmed.1002314. eCollection 2017 Jun.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28609445</style></url></related-urls><pdf-urls><url>internal-pdf://1754529467/Noyce-2017-Estimating the causal influence of.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5469450</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1002314</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>37</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">37</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ogawa, K.</style></author><author><style face="normal" font="default" size="100%">Stuart, P. E.</style></author><author><style face="normal" font="default" size="100%">Tsoi, L. C.</style></author><author><style face="normal" font="default" size="100%">Suzuki, K.</style></author><author><style face="normal" font="default" size="100%">Nair, R. P.</style></author><author><style face="normal" font="default" size="100%">Mochizuki, H.</style></author><author><style face="normal" font="default" size="100%">Elder, J. T.</style></author><author><style face="normal" font="default" size="100%">Okada, Y.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan; Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.&#xD;Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA.&#xD;Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA; Department of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan, USA; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.&#xD;Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan.&#xD;Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.&#xD;Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA; Ann Arbor Veterans Affairs Hospital, Ann Arbor, Michigan, USA.&#xD;Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan; Laboratory of Statistical Immunology, Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Japan. Electronic address: yokada@sg.med.osaka-u.ac.jp.</style></auth-address><titles><title><style face="normal" font="default" size="100%">A Transethnic Mendelian Randomization Study Identifies Causality of Obesity on Risk of Psoriasis</style></title><secondary-title><style face="normal" font="default" size="100%">J Invest Dermatol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Invest Dermatol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1397-1400</style></pages><volume><style face="normal" font="default" size="100%">139</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2018/12/12</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Asian Continental Ancestry Group/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Causality</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*epidemiology/genetics/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Psoriasis/*epidemiology/genetics/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1523-1747 (Electronic)&#xD;0022-202X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30528826</style></accession-num><notes><style face="normal" font="default" size="100%">Ogawa, Kotaro&#xD;Stuart, Philip E&#xD;Tsoi, Lam C&#xD;Suzuki, Ken&#xD;Nair, Rajan P&#xD;Mochizuki, Hideki&#xD;Elder, James T&#xD;Okada, Yukinori&#xD;eng&#xD;R01 AR042742/AR/NIAMS NIH HHS/&#xD;R01 AR050511/AR/NIAMS NIH HHS/&#xD;R01 AR063611/AR/NIAMS NIH HHS/&#xD;R01 AR065183/AR/NIAMS NIH HHS/&#xD;Letter&#xD;Meta-Analysis&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;J Invest Dermatol. 2019 Jun;139(6):1397-1400. doi: 10.1016/j.jid.2018.11.023. Epub 2018 Dec 5.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30528826</style></url></related-urls><pdf-urls><url>internal-pdf://2034917456/Ogawa-2018-A trans-ethnic Mendelian randomizat.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC7028352</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.jid.2018.11.023</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>105</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">105</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Oikonen, M.</style></author><author><style face="normal" font="default" size="100%">Wendelin-Saarenhovi, M.</style></author><author><style face="normal" font="default" size="100%">Lyytikainen, L. P.</style></author><author><style face="normal" font="default" size="100%">Siitonen, N.</style></author><author><style face="normal" font="default" size="100%">Loo, B. M.</style></author><author><style face="normal" font="default" size="100%">Jula, A.</style></author><author><style face="normal" font="default" size="100%">Seppala, I.</style></author><author><style face="normal" font="default" size="100%">Saarikoski, L.</style></author><author><style face="normal" font="default" size="100%">Lehtimaki, T.</style></author><author><style face="normal" font="default" size="100%">Hutri-Kahonen, N.</style></author><author><style face="normal" font="default" size="100%">Juonala, M.</style></author><author><style face="normal" font="default" size="100%">Kahonen, M.</style></author><author><style face="normal" font="default" size="100%">Huupponen, R.</style></author><author><style face="normal" font="default" size="100%">Viikari, J. S.</style></author><author><style face="normal" font="default" size="100%">Raitakari, O. T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">The Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Kiinamyllynkatu 10, P.O. Box 52, FI-20520 Turku, Finland.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study</style></title><secondary-title><style face="normal" font="default" size="100%">Atherosclerosis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Atherosclerosis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">497-503</style></pages><volume><style face="normal" font="default" size="100%">223</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2012/07/04</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Age Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Asymptomatic Diseases</style></keyword><keyword><style face="normal" font="default" size="100%">Atherosclerosis/blood/diagnosis/*epidemiology/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Biomarkers/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular Diseases/blood/*epidemiology/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Carotid Intima-Media Thickness</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Finland/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Hemodynamics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Least-Squares Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Logistic Models</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Multivariate Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Uric Acid/*blood</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1879-1484 (Electronic)&#xD;0021-9150 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">22749515</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND AND METHODS: Serum uric acid (SUA) is a suggested biomarker for established coronary artery disease, but the role of SUA in early phases of atherosclerosis is controversial. The relations of SUA with vascular markers of subclinical atherosclerosis, including carotid artery intima-media thickness (cIMT), carotid plaque, carotid distensibility (Cdist) and brachial flow-mediated dilatation (FMD) were examined in 1985 young adults aged 30-45 years. In addition to ordinary regression, we used Mendelian randomization techniques to infer causal associations. RESULTS: In women, the independent multivariate correlates of SUA included BMI, creatinine, alcohol use, triglycerides, glucose and adiponectin (inverse association) (Model R(2) = 0.30). In men, the correlates were BMI, creatinine, triglycerides, C-reactive protein, alcohol use, total cholesterol and adiponectin (inverse) (Model R(2) = 0.33). BMI alone explained most of the variation of SUA levels both in women and men (Partial R(2) approximately 0.2). When SUA was modeled as an explanatory variable for vascular markers, it directly associated with cIMT and inversely with Cdist in age- and sex-adjusted analysis. After further adjustments for BMI or glomerular filtration rate, these relations were reduced to non-significance. No associations were found between SUA and FMD or the presence of a carotid plaque. Mendelian randomization analyses using known genetic variants for BMI and SUA confirmed that BMI is causally linked to SUA and that BMI is a significant confounder in the association between SUA and cIMT. CONCLUSION: SUA is associated with cardiovascular risk markers in young adults, especially BMI, but we found no evidence that SUA would have an independent role in the pathophysiology of early atherosclerosis.</style></abstract><notes><style face="normal" font="default" size="100%">Oikonen, Mervi&#xD;Wendelin-Saarenhovi, Maria&#xD;Lyytikainen, Leo-Pekka&#xD;Siitonen, Niina&#xD;Loo, Britt-Marie&#xD;Jula, Antti&#xD;Seppala, Ilkka&#xD;Saarikoski, Liisa&#xD;Lehtimaki, Terho&#xD;Hutri-Kahonen, Nina&#xD;Juonala, Markus&#xD;Kahonen, Mika&#xD;Huupponen, Risto&#xD;Viikari, Jorma S A&#xD;Raitakari, Olli T&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Ireland&#xD;Atherosclerosis. 2012 Aug;223(2):497-503. doi: 10.1016/j.atherosclerosis.2012.05.036. Epub 2012 Jun 7.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/22749515</style></url></related-urls><pdf-urls><url>internal-pdf://0098147984/Oikonen-2012-Associations between serum uric a.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.atherosclerosis.2012.05.036</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>160</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">160</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ostergaard, S. D.</style></author><author><style face="normal" font="default" size="100%">Mukherjee, S.</style></author><author><style face="normal" font="default" size="100%">Sharp, S. J.</style></author><author><style face="normal" font="default" size="100%">Proitsi, P.</style></author><author><style face="normal" font="default" size="100%">Lotta, L. A.</style></author><author><style face="normal" font="default" size="100%">Day, F.</style></author><author><style face="normal" font="default" size="100%">Perry, J. R.</style></author><author><style face="normal" font="default" size="100%">Boehme, K. L.</style></author><author><style face="normal" font="default" size="100%">Walter, S.</style></author><author><style face="normal" font="default" size="100%">Kauwe, J. S.</style></author><author><style face="normal" font="default" size="100%">Gibbons, L. E.</style></author><author><style face="normal" font="default" size="100%">Alzheimer&apos;s Disease Genetics, Consortium</style></author><author><style face="normal" font="default" size="100%">Gerad Consortium</style></author><author><style face="normal" font="default" size="100%">E. PIC-InterAct Consortium</style></author><author><style face="normal" font="default" size="100%">Larson, E. B.</style></author><author><style face="normal" font="default" size="100%">Powell, J. F.</style></author><author><style face="normal" font="default" size="100%">Langenberg, C.</style></author><author><style face="normal" font="default" size="100%">Crane, P. K.</style></author><author><style face="normal" font="default" size="100%">Wareham, N. J.</style></author><author><style face="normal" font="default" size="100%">Scott, R. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Research Department P, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.&#xD;Department of Medicine, University of Washington, Seattle, Washington, United States of America.&#xD;MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.&#xD;Department of Basic and Clinical Neuroscience, King&apos;s College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.&#xD;Department of Biology, Brigham Young University, Provo, Utah, United States of America.&#xD;Department of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, San Francisco, California, United States of America.&#xD;Department of Medicine, University of Washington, Seattle, Washington, United States of America; Group Health Research Institute, Seattle, Washington, United States of America.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1001841; discussion e1001841</style></pages><volume><style face="normal" font="default" size="100%">12</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2015/06/17</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Alzheimer Disease/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26079503</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Potentially modifiable risk factors including obesity, diabetes, hypertension, and smoking are associated with Alzheimer disease (AD) and represent promising targets for intervention. However, the causality of these associations is unclear. We sought to assess the causal nature of these associations using Mendelian randomization (MR). METHODS AND FINDINGS: We used SNPs associated with each risk factor as instrumental variables in MR analyses. We considered type 2 diabetes (T2D, NSNPs = 49), fasting glucose (NSNPs = 36), insulin resistance (NSNPs = 10), body mass index (BMI, NSNPs = 32), total cholesterol (NSNPs = 73), HDL-cholesterol (NSNPs = 71), LDL-cholesterol (NSNPs = 57), triglycerides (NSNPs = 39), systolic blood pressure (SBP, NSNPs = 24), smoking initiation (NSNPs = 1), smoking quantity (NSNPs = 3), university completion (NSNPs = 2), and years of education (NSNPs = 1). We calculated MR estimates of associations between each exposure and AD risk using an inverse-variance weighted approach, with summary statistics of SNP-AD associations from the International Genomics of Alzheimer&apos;s Project, comprising a total of 17,008 individuals with AD and 37,154 cognitively normal elderly controls. We found that genetically predicted higher SBP was associated with lower AD risk (odds ratio [OR] per standard deviation [15.4 mm Hg] of SBP [95% CI]: 0.75 [0.62-0.91]; p = 3.4 x 10(-3)). Genetically predicted higher SBP was also associated with a higher probability of taking antihypertensive medication (p = 6.7 x 10(-8)). Genetically predicted smoking quantity was associated with lower AD risk (OR per ten cigarettes per day [95% CI]: 0.67 [0.51-0.89]; p = 6.5 x 10(-3)), although we were unable to stratify by smoking history; genetically predicted smoking initiation was not associated with AD risk (OR = 0.70 [0.37, 1.33]; p = 0.28). We saw no evidence of causal associations between glycemic traits, T2D, BMI, or educational attainment and risk of AD (all p &gt; 0.1). Potential limitations of this study include the small proportion of intermediate trait variance explained by genetic variants and other implicit limitations of MR analyses. CONCLUSIONS: Inherited lifetime exposure to higher SBP is associated with lower AD risk. These findings suggest that higher blood pressure--or some environmental exposure associated with higher blood pressure, such as use of antihypertensive medications--may reduce AD risk.</style></abstract><notes><style face="normal" font="default" size="100%">Ostergaard, Soren D&#xD;Mukherjee, Shubhabrata&#xD;Sharp, Stephen J&#xD;Proitsi, Petroula&#xD;Lotta, Luca A&#xD;Day, Felix&#xD;Perry, John R B&#xD;Boehme, Kevin L&#xD;Walter, Stefan&#xD;Kauwe, John S&#xD;Gibbons, Laura E&#xD;Larson, Eric B&#xD;Powell, John F&#xD;Langenberg, Claudia&#xD;Crane, Paul K&#xD;Wareham, Nicholas J&#xD;Scott, Robert A&#xD;eng&#xD;MH60451/MH/NIMH NIH HHS/&#xD;R01 AG025259/AG/NIA NIH HHS/&#xD;P50 AG005131/AG/NIA NIH HHS/&#xD;AG05144/AG/NIA NIH HHS/&#xD;UL1RR02777/RR/NCRR NIH HHS/&#xD;P50 AG016574/AG/NIA NIH HHS/&#xD;UL1 TR001445/TR/NCATS NIH HHS/&#xD;P50 AG008671/AG/NIA NIH HHS/&#xD;U01 HG004610/HG/NHGRI NIH HHS/&#xD;P50 AG023501/AG/NIA NIH HHS/&#xD;P30 AG010129/AG/NIA NIH HHS/&#xD;R01 AG17917/AG/NIA NIH HHS/&#xD;AG041232/AG/NIA NIH HHS/&#xD;U01 AG10483/AG/NIA NIH HHS/&#xD;P50 AG016573/AG/NIA NIH HHS/&#xD;P30 AG10133/AG/NIA NIH HHS/&#xD;MR/L501529/1/MRC_/Medical Research Council/United Kingdom&#xD;P50 AG016577/AG/NIA NIH HHS/&#xD;MC_U123160651/MRC_/Medical Research Council/United Kingdom&#xD;U01 AG032984/AG/NIA NIH HHS/&#xD;U01 HG008657/HG/NHGRI NIH HHS/&#xD;P01 AG002219/AG/NIA NIH HHS/&#xD;167/ALZS_/Alzheimer&apos;s Society/United Kingdom&#xD;R01 AG042611/AG/NIA NIH HHS/&#xD;P30 AG062421/AG/NIA NIH HHS/&#xD;R01 AG030146/AG/NIA NIH HHS/&#xD;P50 AG005146/AG/NIA NIH HHS/&#xD;R01 AG020688/AG/NIA NIH HHS/&#xD;R01 AG017173/AG/NIA NIH HHS/&#xD;P50 AG016575/AG/NIA NIH HHS/&#xD;CAPMC/ CIHR/Canada&#xD;U01 AG016976/AG/NIA NIH HHS/&#xD;P01 AG003991/AG/NIA NIH HHS/&#xD;P30 AG028377/AG/NIA NIH HHS/&#xD;HHMI/Howard Hughes Medical Institute/&#xD;G0300429/MRC_/Medical Research Council/United Kingdom&#xD;AG05128/AG/NIA NIH HHS/&#xD;P30 AG008051/AG/NIA NIH HHS/&#xD;P50 AG005681/AG/NIA NIH HHS/&#xD;P30 AG013846/AG/NIA NIH HHS/&#xD;U01 AG024904/AG/NIA NIH HHS/&#xD;1R01AG035137/AG/NIA NIH HHS/&#xD;P01 AG03991/AG/NIA NIH HHS/&#xD;U24 AG021886/AG/NIA NIH HHS/&#xD;RC2 AG036535/AG/NIA NIH HHS/&#xD;U01 AG 06781/AG/NIA NIH HHS/&#xD;G0902227/MRC_/Medical Research Council/United Kingdom&#xD;P50 AG005136/AG/NIA NIH HHS/&#xD;AG010491/AG/NIA NIH HHS/&#xD;P30 AG08051/AG/NIA NIH HHS/&#xD;R01 MH080295/MH/NIMH NIH HHS/&#xD;P30 AG012300/AG/NIA NIH HHS/&#xD;NS39764/NS/NINDS NIH HHS/&#xD;UL1 TR001108/TR/NCATS NIH HHS/&#xD;089703/WT_/Wellcome Trust/United Kingdom&#xD;MC_UU_12015/1/MRC_/Medical Research Council/United Kingdom&#xD;AG041718/AG/NIA NIH HHS/&#xD;MC_U106179471/MRC_/Medical Research Council/United Kingdom&#xD;5R01AG022374/AG/NIA NIH HHS/&#xD;P50 AG005134/AG/NIA NIH HHS/&#xD;P30 AG008017/AG/NIA NIH HHS/&#xD;MC_UU_12015/2/MRC_/Medical Research Council/United Kingdom&#xD;P01 AG019724/AG/NIA NIH HHS/&#xD;R01AG33193/AG/NIA NIH HHS/&#xD;U54 CA132378/CA/NCI NIH HHS/&#xD;MC_U106179472/MRC_/Medical Research Council/United Kingdom&#xD;1RC2AG036502/AG/NIA NIH HHS/&#xD;P30 ES013508/ES/NIEHS NIH HHS/&#xD;AG030653/AG/NIA NIH HHS/&#xD;R01 AG15819/AG/NIA NIH HHS/&#xD;U24 AG026390/AG/NIA NIH HHS/&#xD;UL1 RR029893/RR/NCRR NIH HHS/&#xD;AG025688/AG/NIA NIH HHS/&#xD;R01 AG019085/AG/NIA NIH HHS/&#xD;P50 AG016570/AG/NIA NIH HHS/&#xD;MR/L023784/1/MRC_/Medical Research Council/United Kingdom&#xD;AG027944/AG/NIA NIH HHS/&#xD;P50 AG025688/AG/NIA NIH HHS/&#xD;K01 AG030514/AG/NIA NIH HHS/&#xD;R01 CA129769/CA/NCI NIH HHS/&#xD;P50 AG005133/AG/NIA NIH HHS/&#xD;P30 AG028383/AG/NIA NIH HHS/&#xD;P50 AG008702/AG/NIA NIH HHS/&#xD;U01 AG006781/AG/NIA NIH HHS/&#xD;U01 AG06781/AG/NIA NIH HHS/&#xD;R01 AG027944/AG/NIA NIH HHS/&#xD;ImNIH/Intramural NIH HHS/&#xD;R01 AG041232/AG/NIA NIH HHS/&#xD;P30 AG010161/AG/NIA NIH HHS/&#xD;P50 AG005138/AG/NIA NIH HHS/&#xD;MR/K006584/1/MRC_/Medical Research Council/United Kingdom&#xD;5R01AG012101/AG/NIA NIH HHS/&#xD;R01 AG30146/AG/NIA NIH HHS/&#xD;R37 AG015473/AG/NIA NIH HHS/&#xD;R01 AG011101/AG/NIA NIH HHS/&#xD;RC2 AG036528/AG/NIA NIH HHS/&#xD;P30 AG019610/AG/NIA NIH HHS/&#xD;P50 AG005142/AG/NIA NIH HHS/&#xD;R01 NS059873/NS/NINDS NIH HHS/&#xD;5R01AG013616/AG/NIA NIH HHS/&#xD;U24 AG026395/AG/NIA NIH HHS/&#xD;MR/L023784/2/MRC_/Medical Research Council/United Kingdom&#xD;P30 AG013854/AG/NIA NIH HHS/&#xD;MR/L010305/1/MRC_/Medical Research Council/United Kingdom&#xD;P50 AG016576/AG/NIA NIH HHS/&#xD;AG019757/AG/NIA NIH HHS/&#xD;MO1RR00096/RR/NCRR NIH HHS/&#xD;081864/WT_/Wellcome Trust/United Kingdom&#xD;P50 AG016582/AG/NIA NIH HHS/&#xD;G0400713/MRC_/Medical Research Council/United Kingdom&#xD;AG021547/AG/NIA NIH HHS/&#xD;U01 HG006375/HG/NHGRI NIH HHS/&#xD;MC_G1000734/MRC_/Medical Research Council/United Kingdom&#xD;R01 AG031581/AG/NIA NIH HHS/&#xD;R01 AG026916/AG/NIA NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, N.I.H., Intramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;PLoS Med. 2015 Jun 16;12(6):e1001841; discussion e1001841. doi: 10.1371/journal.pmed.1001841. eCollection 2015 Jun.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26079503</style></url></related-urls><pdf-urls><url>internal-pdf://3335032576/Ostergaard-2017-Associations between potential.PDF</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4469461</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1001841</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>134</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">134</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Painter, J. N.</style></author><author><style face="normal" font="default" size="100%">O&apos;Mara, T. A.</style></author><author><style face="normal" font="default" size="100%">Marquart, L.</style></author><author><style face="normal" font="default" size="100%">Webb, P. M.</style></author><author><style face="normal" font="default" size="100%">Attia, J.</style></author><author><style face="normal" font="default" size="100%">Medland, S. E.</style></author><author><style face="normal" font="default" size="100%">Cheng, T.</style></author><author><style face="normal" font="default" size="100%">Dennis, J.</style></author><author><style face="normal" font="default" size="100%">Holliday, E. G.</style></author><author><style face="normal" font="default" size="100%">McEvoy, M.</style></author><author><style face="normal" font="default" size="100%">Scott, R. J.</style></author><author><style face="normal" font="default" size="100%">Ahmed, S.</style></author><author><style face="normal" font="default" size="100%">Healey, C. S.</style></author><author><style face="normal" font="default" size="100%">Shah, M.</style></author><author><style face="normal" font="default" size="100%">Gorman, M.</style></author><author><style face="normal" font="default" size="100%">Martin, L.</style></author><author><style face="normal" font="default" size="100%">Hodgson, S. V.</style></author><author><style face="normal" font="default" size="100%">Beckmann, M. W.</style></author><author><style face="normal" font="default" size="100%">Ekici, A. B.</style></author><author><style face="normal" font="default" size="100%">Fasching, P. A.</style></author><author><style face="normal" font="default" size="100%">Hein, A.</style></author><author><style face="normal" font="default" size="100%">Rubner, M.</style></author><author><style face="normal" font="default" size="100%">Czene, K.</style></author><author><style face="normal" font="default" size="100%">Darabi, H.</style></author><author><style face="normal" font="default" size="100%">Hall, P.</style></author><author><style face="normal" font="default" size="100%">Li, J.</style></author><author><style face="normal" font="default" size="100%">Dork, T.</style></author><author><style face="normal" font="default" size="100%">Durst, M.</style></author><author><style face="normal" font="default" size="100%">Hillemanns, P.</style></author><author><style face="normal" font="default" size="100%">Runnebaum, I. B.</style></author><author><style face="normal" font="default" size="100%">Amant, F.</style></author><author><style face="normal" font="default" size="100%">Annibali, D.</style></author><author><style face="normal" font="default" size="100%">Depreeuw, J.</style></author><author><style face="normal" font="default" size="100%">Lambrechts, D.</style></author><author><style face="normal" font="default" size="100%">Neven, P.</style></author><author><style face="normal" font="default" size="100%">Cunningham, J. M.</style></author><author><style face="normal" font="default" size="100%">Dowdy, S. C.</style></author><author><style face="normal" font="default" size="100%">Goode, E. L.</style></author><author><style face="normal" font="default" size="100%">Fridley, B. L.</style></author><author><style face="normal" font="default" size="100%">Winham, S. J.</style></author><author><style face="normal" font="default" size="100%">Njolstad, T. S.</style></author><author><style face="normal" font="default" size="100%">Salvesen, H. B.</style></author><author><style face="normal" font="default" size="100%">Trovik, J.</style></author><author><style face="normal" font="default" size="100%">Werner, H. M.</style></author><author><style face="normal" font="default" size="100%">Ashton, K. A.</style></author><author><style face="normal" font="default" size="100%">Otton, G.</style></author><author><style face="normal" font="default" size="100%">Proietto, A.</style></author><author><style face="normal" font="default" size="100%">Mints, M.</style></author><author><style face="normal" font="default" size="100%">Tham, E.</style></author><author><style face="normal" font="default" size="100%">Bolla, M. K.</style></author><author><style face="normal" font="default" size="100%">Michailidou, K.</style></author><author><style face="normal" font="default" size="100%">Wang, Q.</style></author><author><style face="normal" font="default" size="100%">Tyrer, J. P.</style></author><author><style face="normal" font="default" size="100%">Hopper, J. L.</style></author><author><style face="normal" font="default" size="100%">Peto, J.</style></author><author><style face="normal" font="default" size="100%">Swerdlow, A. J.</style></author><author><style face="normal" font="default" size="100%">Burwinkel, B.</style></author><author><style face="normal" font="default" size="100%">Brenner, H.</style></author><author><style face="normal" font="default" size="100%">Meindl, A.</style></author><author><style face="normal" font="default" size="100%">Brauch, H.</style></author><author><style face="normal" font="default" size="100%">Lindblom, A.</style></author><author><style face="normal" font="default" size="100%">Chang-Claude, J.</style></author><author><style face="normal" font="default" size="100%">Couch, F. J.</style></author><author><style face="normal" font="default" size="100%">Giles, G. G.</style></author><author><style face="normal" font="default" size="100%">Kristensen, V. N.</style></author><author><style face="normal" font="default" size="100%">Cox, A.</style></author><author><style face="normal" font="default" size="100%">Pharoah, P. D.</style></author><author><style face="normal" font="default" size="100%">Tomlinson, I.</style></author><author><style face="normal" font="default" size="100%">Dunning, A. M.</style></author><author><style face="normal" font="default" size="100%">Easton, D. F.</style></author><author><style face="normal" font="default" size="100%">Thompson, D. J.</style></author><author><style face="normal" font="default" size="100%">Spurdle, A. B.</style></author><author><style face="normal" font="default" size="100%">Aocs Group</style></author><author><style face="normal" font="default" size="100%">for, Rendocas</style></author><author><style face="normal" font="default" size="100%">National Study of Endometrial Cancer Genetics, Group</style></author><author><style face="normal" font="default" size="100%">Australian National Endometrial Cancer Study, Group</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.&#xD;Hunter Medical Research Institute, John Hunter Hospital, Newcastle, Australia.&#xD;Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Australia.&#xD;Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.&#xD;Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom.&#xD;Hunter Area Pathology Service, John Hunter Hospital, Newcastle, Australia.&#xD;Centre for Information Based Medicine, University of Newcastle, Australia.&#xD;School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia.&#xD;Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom.&#xD;Department of Clinical Genetics, St George&apos;s, University of London, London, United Kingdom.&#xD;Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.&#xD;Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.&#xD;Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.&#xD;Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.&#xD;Hannover Medical School, Gynaecology Research Unit, Hannover, Germany.&#xD;Department of Gynaecology, Jena University Hospital, Friedrich Schiller University, Jena, Germany.&#xD;Hannover Medical School, Clinics of Gynaecology and Obstetrics, Hannover, Germany.&#xD;Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals, KU Leuven - University of Leuven, Leuven, Belgium.&#xD;Vesalius Research Center, VIB, Leuven, Belgium.&#xD;Department of Oncology, Laboratory for Translational Genetics, University Hospitals Leuven, Leuven, Belgium.&#xD;Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.&#xD;Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Mayo Clinic, Rochester, Minnesota.&#xD;Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.&#xD;Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas.&#xD;Department of Clinical Science, Centre for Cancer Biomarkers, The University of Bergen, Bergen, Norway.&#xD;Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.&#xD;School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.&#xD;Department of Women&apos;s and Children&apos;s Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.&#xD;Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia.&#xD;London School of Hygiene and Tropical Medicine, London, United Kingdom.&#xD;Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom.&#xD;Division of Breast Cancer Research, Institute of Cancer Research, London, United Kingdom.&#xD;Department of Gynecology and Obstetrics, Molecular Biology of Breast Cancer, University of Heidelberg, Heidelberg, Germany.&#xD;Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.&#xD;German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Department of Obstetrics and Gynecology, Division of Tumor Genetics, Technical University of Munich, Munich, Germany.&#xD;Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.&#xD;University of Tubingen, Tubingen, Germany.&#xD;Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.&#xD;Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.&#xD;Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.&#xD;Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.&#xD;Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway.&#xD;The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.&#xD;Department of Clinical Molecular Oncology, Division of Medicine, Akershus University Hospital, Lorenskog, Norway.&#xD;Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer</style></title><secondary-title><style face="normal" font="default" size="100%">Cancer Epidemiol Biomarkers Prev</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Cancer Epidemiol Biomarkers Prev</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1503-1510</style></pages><volume><style face="normal" font="default" size="100%">25</style></volume><number><style face="normal" font="default" size="100%">11</style></number><edition><style face="normal" font="default" size="100%">2016/11/03</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Endometrial Neoplasms/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Waist-Hip Ratio</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1538-7755 (Electronic)&#xD;1055-9965 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27550749</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: The strongest known risk factor for endometrial cancer is obesity. To determine whether SNPs associated with increased body mass index (BMI) or waist-hip ratio (WHR) are associated with endometrial cancer risk, independent of measured BMI, we investigated relationships between 77 BMI and 47 WHR SNPs and endometrial cancer in 6,609 cases and 37,926 country-matched controls. METHODS: Logistic regression analysis and fixed effects meta-analysis were used to test for associations between endometrial cancer risk and (i) individual BMI or WHR SNPs, (ii) a combined weighted genetic risk score (wGRS) for BMI or WHR. Causality of BMI for endometrial cancer was assessed using Mendelian randomization, with BMIwGRS as instrumental variable. RESULTS: The BMIwGRS was significantly associated with endometrial cancer risk (P = 3.4 x 10(-17)). Scaling the effect of the BMIwGRS on endometrial cancer risk by its effect on BMI, the endometrial cancer OR per 5 kg/m(2) of genetically predicted BMI was 2.06 [95% confidence interval (CI), 1.89-2.21], larger than the observed effect of BMI on endometrial cancer risk (OR = 1.55; 95% CI, 1.44-1.68, per 5 kg/m(2)). The association attenuated but remained significant after adjusting for BMI (OR = 1.22; 95% CI, 1.10-1.39; P = 5.3 x 10(-4)). There was evidence of directional pleiotropy (P = 1.5 x 10(-4)). BMI SNP rs2075650 was associated with endometrial cancer at study-wide significance (P &lt; 4.0 x 10(-4)), independent of BMI. Endometrial cancer was not significantly associated with individual WHR SNPs or the WHRwGRS. CONCLUSIONS: BMI, but not WHR, is causally associated with endometrial cancer risk, with evidence that some BMI-associated SNPs alter endometrial cancer risk via mechanisms other than measurable BMI. IMPACT: The causal association between BMI SNPs and endometrial cancer has possible implications for endometrial cancer risk modeling. Cancer Epidemiol Biomarkers Prev; 25(11); 1503-10. (c)2016 AACR.</style></abstract><notes><style face="normal" font="default" size="100%">Painter, Jodie N&#xD;O&apos;Mara, Tracy A&#xD;Marquart, Louise&#xD;Webb, Penelope M&#xD;Attia, John&#xD;Medland, Sarah E&#xD;Cheng, Timothy&#xD;Dennis, Joe&#xD;Holliday, Elizabeth G&#xD;McEvoy, Mark&#xD;Scott, Rodney J&#xD;Ahmed, Shahana&#xD;Healey, Catherine S&#xD;Shah, Mitul&#xD;Gorman, Maggie&#xD;Martin, Lynn&#xD;Hodgson, Shirley V&#xD;Beckmann, Matthias W&#xD;Ekici, Arif B&#xD;Fasching, Peter A&#xD;Hein, Alexander&#xD;Rubner, Matthias&#xD;Czene, Kamila&#xD;Darabi, Hatef&#xD;Hall, Per&#xD;Li, Jingmei&#xD;Dork, Thilo&#xD;Durst, Matthias&#xD;Hillemanns, Peter&#xD;Runnebaum, Ingo B&#xD;Amant, Frederic&#xD;Annibali, Daniela&#xD;Depreeuw, Jeroen&#xD;Lambrechts, Diether&#xD;Neven, Patrick&#xD;Cunningham, Julie M&#xD;Dowdy, Sean C&#xD;Goode, Ellen L&#xD;Fridley, Brooke L&#xD;Winham, Stacey J&#xD;Njolstad, Tormund S&#xD;Salvesen, Helga B&#xD;Trovik, Jone&#xD;Werner, Henrica M J&#xD;Ashton, Katie A&#xD;Otton, Geoffrey&#xD;Proietto, Anthony&#xD;Mints, Miriam&#xD;Tham, Emma&#xD;Bolla, Manjeet K&#xD;Michailidou, Kyriaki&#xD;Wang, Qin&#xD;Tyrer, Jonathan P&#xD;Hopper, John L&#xD;Peto, Julian&#xD;Swerdlow, Anthony J&#xD;Burwinkel, Barbara&#xD;Brenner, Hermann&#xD;Meindl, Alfons&#xD;Brauch, Hiltrud&#xD;Lindblom, Annika&#xD;Chang-Claude, Jenny&#xD;Couch, Fergus J&#xD;Giles, Graham G&#xD;Kristensen, Vessela N&#xD;Cox, Angela&#xD;Pharoah, Paul D P&#xD;Tomlinson, Ian&#xD;Dunning, Alison M&#xD;Easton, Douglas F&#xD;Thompson, Deborah J&#xD;Spurdle, Amanda B&#xD;(NSECG)&#xD;(ANECS)&#xD;eng&#xD;R01 CA128978/CA/NCI NIH HHS/&#xD;P30 CA076292/CA/NCI NIH HHS/&#xD;U19 CA148537/CA/NCI NIH HHS/&#xD;R01 CA122443/CA/NCI NIH HHS/&#xD;P30 CA015083/CA/NCI NIH HHS/&#xD;U19 CA148112/CA/NCI NIH HHS/&#xD;U19 CA148065/CA/NCI NIH HHS/&#xD;10119/Cancer Research UK/United Kingdom&#xD;Wellcome Trust/United Kingdom&#xD;10118/Cancer Research UK/United Kingdom&#xD;P50 CA136393/CA/NCI NIH HHS/&#xD;10124/Cancer Research UK/United Kingdom&#xD;Meta-Analysis&#xD;Multicenter Study&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, N.I.H., Extramural&#xD;Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1503-1510. doi: 10.1158/1055-9965.EPI-16-0147. Epub 2016 Aug 22.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27550749</style></url></related-urls><pdf-urls><url>internal-pdf://1112907463/Painter-2016-Genetic Risk Score Mendelian Rand.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5093082</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1158/1055-9965.EPI-16-0147</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>48</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">48</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Palmer, T. M.</style></author><author><style face="normal" font="default" size="100%">Lawlor, D. A.</style></author><author><style face="normal" font="default" size="100%">Harbord, R. M.</style></author><author><style face="normal" font="default" size="100%">Sheehan, N. A.</style></author><author><style face="normal" font="default" size="100%">Tobias, J. H.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Sterne, J. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Centre for Causal Analyses in Translational Epidemiology, School of Social and Community Medicine, University of Bristol, Bristol, UK. tom.palmer@bristol.ac.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">Using multiple genetic variants as instrumental variables for modifiable risk factors</style></title><secondary-title><style face="normal" font="default" size="100%">Stat Methods Med Res</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Stat Methods Med Res</style></full-title></periodical><pages><style face="normal" font="default" size="100%">223-42</style></pages><volume><style face="normal" font="default" size="100%">21</style></volume><number><style face="normal" font="default" size="100%">3</style></number><edition><style face="normal" font="default" size="100%">2011/01/11</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1477-0334 (Electronic)&#xD;0962-2802 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">21216802</style></accession-num><abstract><style face="normal" font="default" size="100%">Mendelian randomisation analyses use genetic variants as instrumental variables (IVs) to estimate causal effects of modifiable risk factors on disease outcomes. Genetic variants typically explain a small proportion of the variability in risk factors; hence Mendelian randomisation analyses can require large sample sizes. However, an increasing number of genetic variants have been found to be robustly associated with disease-related outcomes in genome-wide association studies. Use of multiple instruments can improve the precision of IV estimates, and also permit examination of underlying IV assumptions. We discuss the use of multiple genetic variants in Mendelian randomisation analyses with continuous outcome variables where all relationships are assumed to be linear. We describe possible violations of IV assumptions, and how multiple instrument analyses can be used to identify them. We present an example using four adiposity-associated genetic variants as IVs for the causal effect of fat mass on bone density, using data on 5509 children enrolled in the ALSPAC birth cohort study. We also use simulation studies to examine the effect of different sets of IVs on precision and bias. When each instrument independently explains variability in the risk factor, use of multiple instruments increases the precision of IV estimates. However, inclusion of weak instruments could increase finite sample bias. Missing data on multiple genetic variants can diminish the available sample size, compared with single instrument analyses. In simulations with additive genotype-risk factor effects, IV estimates using a weighted allele score had similar properties to estimates using multiple instruments. Under the correct conditions, multiple instrument analyses are a promising approach for Mendelian randomisation studies. Further research is required into multiple imputation methods to address missing data issues in IV estimation.</style></abstract><notes><style face="normal" font="default" size="100%">Palmer, Tom M&#xD;Lawlor, Debbie A&#xD;Harbord, Roger M&#xD;Sheehan, Nuala A&#xD;Tobias, Jon H&#xD;Timpson, Nicholas J&#xD;Davey Smith, George&#xD;Sterne, Jonathan A C&#xD;eng&#xD;092731/Wellcome Trust/United Kingdom&#xD;G9815508/Medical Research Council/United Kingdom&#xD;G0600705/Medical Research Council/United Kingdom&#xD;G0601625/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Stat Methods Med Res. 2012 Jun;21(3):223-42. doi: 10.1177/0962280210394459. Epub 2011 Jan 7.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/21216802</style></url></related-urls><pdf-urls><url>internal-pdf://3697209778/Palmer-2012-Using multiple genetic variants as.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3917707</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1177/0962280210394459</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>115</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">115</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Palmer, T. M.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author><author><style face="normal" font="default" size="100%">Benn, M.</style></author><author><style face="normal" font="default" size="100%">Tybjaerg-Hansen, A.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Lawlor, D. A.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Health Sciences, Warwick Medical School, University of Warwick, Warwick, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts</style></title><secondary-title><style face="normal" font="default" size="100%">BMJ</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMJ</style></full-title></periodical><pages><style face="normal" font="default" size="100%">f4262</style></pages><volume><style face="normal" font="default" size="100%">347</style></volume><edition><style face="normal" font="default" size="100%">2013/07/23</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Denmark</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Hyperuricemia/etiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Myocardial Ischemia/blood/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Regression Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Uric Acid/*blood</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul 18</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1756-1833 (Electronic)&#xD;0959-8138 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">23869090</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVES: To assess the associations between both uric acid levels and hyperuricaemia, with ischaemic heart disease and blood pressure, and to explore the potentially confounding role of body mass index. DESIGN: Mendelian randomisation analysis, using variation at specific genes (SLC2A9 (rs7442295) as an instrument for uric acid; and FTO (rs9939609), MC4R (rs17782313), and TMEM18 (rs6548238) for body mass index). SETTING: Two large, prospective cohort studies in Denmark. PARTICIPANTS: We measured levels of uric acid and related covariables in 58,072 participants from the Copenhagen General Population Study and 10,602 from the Copenhagen City Heart Study, comprising 4890 and 2282 cases of ischaemic heart disease, respectively. MAIN OUTCOME: Blood pressure and prospectively assessed ischaemic heart disease. RESULTS: Estimates confirmed known observational associations between plasma uric acid and hyperuricaemia with risk of ischaemic heart disease and diastolic and systolic blood pressure. However, when using genotypic instruments for uric acid and hyperuricaemia, we saw no evidence for causal associations between uric acid, ischaemic heart disease, and blood pressure. We used genetic instruments to investigate body mass index as a potentially confounding factor in observational associations, and saw a causal effect on uric acid levels. Every four unit increase of body mass index saw a rise in uric acid of 0.03 mmol/L (95% confidence interval 0.02 to 0.04), and an increase in risk of hyperuricaemia of 7.5% (3.9% to 11.1%). CONCLUSION: By contrast with observational findings, there is no strong evidence for causal associations between uric acid and ischaemic heart disease or blood pressure. However, evidence supports a causal effect between body mass index and uric acid level and hyperuricaemia. This finding strongly suggests body mass index as a confounder in observational associations, and suggests a role for elevated body mass index or obesity in the development of uric acid related conditions.</style></abstract><notes><style face="normal" font="default" size="100%">Palmer, Tom M&#xD;Nordestgaard, Borge G&#xD;Benn, Marianne&#xD;Tybjaerg-Hansen, Anne&#xD;Davey Smith, George&#xD;Lawlor, Debbie A&#xD;Timpson, Nicholas J&#xD;eng&#xD;MC_UU_12013/3/Medical Research Council/United Kingdom&#xD;MC_UU_12013/5/Medical Research Council/United Kingdom&#xD;G0601625/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;BMJ. 2013 Jul 18;347:f4262. doi: 10.1136/bmj.f4262.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/23869090</style></url></related-urls><pdf-urls><url>internal-pdf://0111806853/Palmer-2013-Association of plasma uric acid wi.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3715134</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/bmj.f4262</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>138</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">138</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Palmer, T. M.</style></author><author><style face="normal" font="default" size="100%">Sterne, J. A.</style></author><author><style face="normal" font="default" size="100%">Harbord, R. M.</style></author><author><style face="normal" font="default" size="100%">Lawlor, D. A.</style></author><author><style face="normal" font="default" size="100%">Sheehan, N. A.</style></author><author><style face="normal" font="default" size="100%">Meng, S.</style></author><author><style face="normal" font="default" size="100%">Granell, R.</style></author><author><style face="normal" font="default" size="100%">Smith, G. D.</style></author><author><style face="normal" font="default" size="100%">Didelez, V.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Centre for Causal Analyses in Translational Epidemiology, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom. tom.palmer@bristol.ac.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses</style></title><secondary-title><style face="normal" font="default" size="100%">Am J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Am J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1392-403</style></pages><volume><style face="normal" font="default" size="100%">173</style></volume><number><style face="normal" font="default" size="100%">12</style></number><edition><style face="normal" font="default" size="100%">2011/05/11</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Asthma/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Causality</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Confounding Factors, Epidemiologic</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 15</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-6256 (Electronic)&#xD;0002-9262 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">21555716</style></accession-num><abstract><style face="normal" font="default" size="100%">In this paper, the authors describe different instrumental variable (IV) estimators of causal risk ratios and odds ratios with particular attention to methods that can handle continuously measured exposures. The authors present this discussion in the context of a Mendelian randomization analysis of the effect of body mass index (BMI; weight (kg)/height (m)(2)) on the risk of asthma at age 7 years (Avon Longitudinal Study of Parents and Children, 1991-1992). The authors show that the multiplicative structural mean model (MSMM) and the multiplicative generalized method of moments (MGMM) estimator produce identical estimates of the causal risk ratio. In the example, MSMM and MGMM estimates suggested an inverse relation between BMI and asthma but other IV estimates suggested a positive relation, although all estimates had wide confidence intervals. An interaction between the associations of BMI and fat mass and obesity-associated (FTO) genotype with asthma explained the different directions of the different estimates, and a simulation study supported the observation that MSMM/MGMM estimators are negatively correlated with the other estimators when such an interaction is present. The authors conclude that point estimates from various IV methods can differ in practical applications. Based on the theoretical properties of the estimators, structural mean models make weaker assumptions than other IV estimators and can therefore be expected to be consistent in a wider range of situations.</style></abstract><notes><style face="normal" font="default" size="100%">Palmer, Tom M&#xD;Sterne, Jonathan A C&#xD;Harbord, Roger M&#xD;Lawlor, Debbie A&#xD;Sheehan, Nuala A&#xD;Meng, Sha&#xD;Granell, Raquel&#xD;Smith, George Davey&#xD;Didelez, Vanessa&#xD;eng&#xD;092731/Wellcome Trust/United Kingdom&#xD;G9815508/Medical Research Council/United Kingdom&#xD;G0600705/Medical Research Council/United Kingdom&#xD;G0601625/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Am J Epidemiol. 2011 Jun 15;173(12):1392-403. doi: 10.1093/aje/kwr026. Epub 2011 May 9.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/21555716</style></url></related-urls><pdf-urls><url>internal-pdf://1834002395/Palmer-2011-Instrumental variable estimation o.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/aje/kwr026</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>110</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">110</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Panoutsopoulou, K.</style></author><author><style face="normal" font="default" size="100%">Metrustry, S.</style></author><author><style face="normal" font="default" size="100%">Doherty, S. A.</style></author><author><style face="normal" font="default" size="100%">Laslett, L. L.</style></author><author><style face="normal" font="default" size="100%">Maciewicz, R. A.</style></author><author><style face="normal" font="default" size="100%">Hart, D. J.</style></author><author><style face="normal" font="default" size="100%">Zhang, W.</style></author><author><style face="normal" font="default" size="100%">Muir, K. R.</style></author><author><style face="normal" font="default" size="100%">Wheeler, M.</style></author><author><style face="normal" font="default" size="100%">Cooper, C.</style></author><author><style face="normal" font="default" size="100%">Spector, T. D.</style></author><author><style face="normal" font="default" size="100%">Cicuttini, F. M.</style></author><author><style face="normal" font="default" size="100%">Jones, G.</style></author><author><style face="normal" font="default" size="100%">Arden, N. K.</style></author><author><style face="normal" font="default" size="100%">Doherty, M.</style></author><author><style face="normal" font="default" size="100%">Zeggini, E.</style></author><author><style face="normal" font="default" size="100%">Valdes, A. M.</style></author><author><style face="normal" font="default" size="100%">arc, Ogen Consortium</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.&#xD;Department of Twin Research, King&apos;s College London, St Thomas&apos; Hospital, London, UK.&#xD;Academic Rheumatology, Nottingham City Hospital, Nottingham, UK.&#xD;Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia.&#xD;Respiratory &amp; Inflammation iMed, AstraZeneca, Molndal, Sweden.&#xD;Centre for Epidemiology, Institute of Population Health, The Medical School, University of Manchester, Manchester, UK Health Sciences Research Institute, Warwick Medical School, University of Warwick, Coventry, UK.&#xD;NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.&#xD;Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Australia.&#xD;Department of Twin Research, King&apos;s College London, St Thomas&apos; Hospital, London, UK Academic Rheumatology, Nottingham City Hospital, Nottingham, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a Mendelian randomisation study</style></title><secondary-title><style face="normal" font="default" size="100%">Ann Rheum Dis</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Ann Rheum Dis</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2082-6</style></pages><volume><style face="normal" font="default" size="100%">73</style></volume><number><style face="normal" font="default" size="100%">12</style></number><edition><style face="normal" font="default" size="100%">2013/08/08</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Gene-Environment Interaction</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Osteoarthritis, Hip/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Osteoarthritis, Knee/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Overweight/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Gene Polymorphism</style></keyword><keyword><style face="normal" font="default" size="100%">Knee Osteoarthritis</style></keyword><keyword><style face="normal" font="default" size="100%">Osteoarthritis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1468-2060 (Electronic)&#xD;0003-4967 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">23921993</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVE: Variation in the fat mass and obesity-associated (FTO) gene influences susceptibility to obesity. A variant in the FTO gene has been implicated in genetic risk to osteoarthritis (OA). We examined the role of the FTO polymorphism rs8044769 in risk of knee and hip OA in cases and controls incorporating body mass index (BMI) information. METHODS: 5409 knee OA patients, 4355 hip OA patients and up to 5362 healthy controls from 7 independent cohorts from the UK and Australia were genotyped for rs8044769. The association of the FTO variant with OA was investigated in case/control analyses with and without BMI adjustment and in analyses matched for BMI category. A mendelian randomisation approach was employed using the FTO variant as the instrumental variable to evaluate the role of overweight on OA. RESULTS: In the meta-analysis of all overweight (BMI&gt;/=25) samples versus normal-weight controls irrespective of OA status the association of rs8044769 with overweight is highly significant (OR[CIs] for allele G=1.14 [01.08 to 1.19], p=7.5x10(-7)). A significant association with knee OA is present in the analysis without BMI adjustment (OR[CIs]=1.08[1.02 to 1.14], p=0.009) but the signal fully attenuates after BMI adjustment (OR[CIs]=0.99[0.93 to 1.05], p=0.666). We observe no evidence for association in the BMI-matched meta-analyses. Using mendelian randomisation approaches we confirm the causal role of overweight on OA. CONCLUSIONS: Our data highlight the contribution of genetic risk to overweight in defining risk to OA but the association is exclusively mediated by the effect on BMI. This is consistent with what is known of the biology of the FTO gene and supports the causative role of high BMI in OA.</style></abstract><notes><style face="normal" font="default" size="100%">Panoutsopoulou, Kalliope&#xD;Metrustry, Sarah&#xD;Doherty, Sally A&#xD;Laslett, Laura L&#xD;Maciewicz, Rose A&#xD;Hart, Deborah J&#xD;Zhang, Weiya&#xD;Muir, Kenneth R&#xD;Wheeler, Margaret&#xD;Cooper, Cyrus&#xD;Spector, Tim D&#xD;Cicuttini, Flavia M&#xD;Jones, Graeme&#xD;Arden, Nigel K&#xD;Doherty, Michael&#xD;Zeggini, Eleftheria&#xD;Valdes, Ana M&#xD;eng&#xD;MC_U122886349/MRC_/Medical Research Council/United Kingdom&#xD;MC_U147585819/MRC_/Medical Research Council/United Kingdom&#xD;MC_UP_A620_1014/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12023/14/MRC_/Medical Research Council/United Kingdom&#xD;19542/ARC_/Arthritis Research UK/United Kingdom&#xD;MC_UU_12011/1/MRC_/Medical Research Council/United Kingdom&#xD;19542/VAC_/Versus Arthritis/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Ann Rheum Dis. 2014 Dec;73(12):2082-6. doi: 10.1136/annrheumdis-2013-203772. Epub 2013 Aug 6.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/23921993</style></url></related-urls><pdf-urls><url>internal-pdf://3525532554/Panoutsopoulou-2013-The effect of FTO variatio.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4251538</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/annrheumdis-2013-203772</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>97</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">97</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Polimanti, R.</style></author><author><style face="normal" font="default" size="100%">Amstadter, A. B.</style></author><author><style face="normal" font="default" size="100%">Stein, M. B.</style></author><author><style face="normal" font="default" size="100%">Almli, L. M.</style></author><author><style face="normal" font="default" size="100%">Baker, D. G.</style></author><author><style face="normal" font="default" size="100%">Bierut, L. J.</style></author><author><style face="normal" font="default" size="100%">Bradley, B.</style></author><author><style face="normal" font="default" size="100%">Farrer, L. A.</style></author><author><style face="normal" font="default" size="100%">Johnson, E. O.</style></author><author><style face="normal" font="default" size="100%">King, A.</style></author><author><style face="normal" font="default" size="100%">Kranzler, H. R.</style></author><author><style face="normal" font="default" size="100%">Maihofer, A. X.</style></author><author><style face="normal" font="default" size="100%">Rice, J. P.</style></author><author><style face="normal" font="default" size="100%">Roberts, A. L.</style></author><author><style face="normal" font="default" size="100%">Saccone, N. L.</style></author><author><style face="normal" font="default" size="100%">Zhao, H.</style></author><author><style face="normal" font="default" size="100%">Liberzon, I.</style></author><author><style face="normal" font="default" size="100%">Ressler, K. J.</style></author><author><style face="normal" font="default" size="100%">Nievergelt, C. M.</style></author><author><style face="normal" font="default" size="100%">Koenen, K. C.</style></author><author><style face="normal" font="default" size="100%">Gelernter, J.</style></author><author><style face="normal" font="default" size="100%">Psychiatric Genomics Consortium Posttraumatic Stress Disorder, Workgroup</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Psychiatry, Yale University School of Medicine and VA CT Healthcare Center, 116A2, 950 Campbell Avenue, West Haven, CT, 06516, USA. renato.polimanti@yale.edu.&#xD;Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.&#xD;Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.&#xD;Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA.&#xD;Veterans Affairs San Diego Healthcare System and Veterans Affairs Center of Excellence for Stress and Mental Health, La Jolla, CA, USA.&#xD;Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA.&#xD;Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.&#xD;Atlanta VA Medical Center, Atlanta, GA, USA.&#xD;Department of Medicine, Biomedical Genetics Division, Boston University School of Medicine, Boston, MA, USA.&#xD;Fellow Program and Behavioral Health and Criminal Justice Division RTI International, Research Triangle Park, NC, USA.&#xD;Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.&#xD;Department of Psychiatry, University of Pennsylvania Perelman School of Medicine and VISN 4 MIRECC, Crescenz VAMC, Philadelphia, PA, USA.&#xD;Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA, USA.&#xD;Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA.&#xD;Department of Biostatistics, Yale University, New Haven, CT, USA.&#xD;VA Ann Arbor Health System, Ann Arbor, MI, USA.&#xD;Department of Psychiatry, Harvard University, Cambridge, MA, USA.&#xD;Department of Psychiatry, McLean Hospital, Belmont, MA, USA.&#xD;Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA.&#xD;Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.&#xD;Broad Institute of MIT and Harvard, Stanley Center for Psychiatric Research, Boston, MA, USA.&#xD;Department of Psychiatry, Yale University School of Medicine and VA CT Healthcare Center, 116A2, 950 Campbell Avenue, West Haven, CT, 06516, USA.&#xD;Departments of Neuroscience and of Genetics, Yale University School of Medicine, New Haven, CT, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">A putative causal relationship between genetically determined female body shape and posttraumatic stress disorder</style></title><secondary-title><style face="normal" font="default" size="100%">Genome Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Genome Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">99</style></pages><volume><style face="normal" font="default" size="100%">9</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2017/11/28</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Body Weights and Measures</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Reproduction</style></keyword><keyword><style face="normal" font="default" size="100%">Risk</style></keyword><keyword><style face="normal" font="default" size="100%">Sexual Behavior</style></keyword><keyword><style face="normal" font="default" size="100%">Stress Disorders, Post-Traumatic/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Anthropometric traits</style></keyword><keyword><style face="normal" font="default" size="100%">Genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Trauma</style></keyword><keyword><style face="normal" font="default" size="100%">Women</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov 27</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1756-994X (Electronic)&#xD;1756-994X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29178946</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: The nature and underlying mechanisms of the observed increased vulnerability to posttraumatic stress disorder (PTSD) in women are unclear. METHODS: We investigated the genetic overlap of PTSD with anthropometric traits and reproductive behaviors and functions in women. The analysis was conducted using female-specific summary statistics from large genome-wide association studies (GWAS) and a cohort of 3577 European American women (966 PTSD cases and 2611 trauma-exposed controls). We applied a high-resolution polygenic score approach and Mendelian randomization analysis to investigate genetic correlations and causal relationships. RESULTS: We observed an inverse association of PTSD with genetically determined anthropometric traits related to body shape, independent of body mass index (BMI). The top association was related to BMI-adjusted waist circumference (WCadj; R = -0.079, P &lt; 0.001, Q = 0.011). We estimated a relative decrease of 64.6% (95% confidence interval = 27.5-82.7) in the risk of PTSD per 1-SD increase in WCadj. MR-Egger regression intercept analysis showed no evidence of pleiotropic effects in this association (Ppleiotropy = 0.979). We also observed associations of genetically determined WCadj with age at first sexual intercourse and number of sexual partners (P = 0.013 and P &lt; 0.001, respectively). CONCLUSIONS: There is a putative causal relationship between genetically determined female body shape and PTSD, which could be mediated by evolutionary mechanisms involved in human sexual behaviors.</style></abstract><notes><style face="normal" font="default" size="100%">Polimanti, Renato&#xD;Amstadter, Ananda B&#xD;Stein, Murray B&#xD;Almli, Lynn M&#xD;Baker, Dewleen G&#xD;Bierut, Laura J&#xD;Bradley, Bekh&#xD;Farrer, Lindsay A&#xD;Johnson, Eric O&#xD;King, Anthony&#xD;Kranzler, Henry R&#xD;Maihofer, Adam X&#xD;Rice, John P&#xD;Roberts, Andrea L&#xD;Saccone, Nancy L&#xD;Zhao, Hongyu&#xD;Liberzon, Israel&#xD;Ressler, Kerry J&#xD;Nievergelt, Caroline M&#xD;Koenen, Karestan C&#xD;Gelernter, Joel&#xD;eng&#xD;UL1 TR001863/TR/NCATS NIH HHS/&#xD;R01 MH106595/National Institute of Mental Health&#xD;U01 MH109536/MH/NIMH NIH HHS/&#xD;U01 MH109514/MH/NIMH NIH HHS/&#xD;National Center for PTSD Research/U.S. Department of Veterans Affairs&#xD;U01 MH109532/MH/NIMH NIH HHS/&#xD;R01 MH106595/MH/NIMH NIH HHS/&#xD;U01 MH109532/National Institute of Mental Health&#xD;England&#xD;Genome Med. 2017 Nov 27;9(1):99. doi: 10.1186/s13073-017-0491-4.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29178946</style></url></related-urls><pdf-urls><url>internal-pdf://2955086881/Polimanti-2017-A putative causal relationship.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5702961</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s13073-017-0491-4</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>125</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">125</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Qi, Guanghao</style></author><author><style face="normal" font="default" size="100%">Chatterjee, Nilanjan</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><urls><pdf-urls><url>internal-pdf://1293530397/Qi-2018-Mendelian Randomization Analysis Using.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/367821</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>33</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">33</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Qian, F.</style></author><author><style face="normal" font="default" size="100%">Wang, S.</style></author><author><style face="normal" font="default" size="100%">Mitchell, J.</style></author><author><style face="normal" font="default" size="100%">McGuffog, L.</style></author><author><style face="normal" font="default" size="100%">Barrowdale, D.</style></author><author><style face="normal" font="default" size="100%">Leslie, G.</style></author><author><style face="normal" font="default" size="100%">Oosterwijk, J. C.</style></author><author><style face="normal" font="default" size="100%">Chung, W. K.</style></author><author><style face="normal" font="default" size="100%">Evans, D. G.</style></author><author><style face="normal" font="default" size="100%">Engel, C.</style></author><author><style face="normal" font="default" size="100%">Kast, K.</style></author><author><style face="normal" font="default" size="100%">Aalfs, C. M.</style></author><author><style face="normal" font="default" size="100%">Adank, M. A.</style></author><author><style face="normal" font="default" size="100%">Adlard, J.</style></author><author><style face="normal" font="default" size="100%">Agnarsson, B. A.</style></author><author><style face="normal" font="default" size="100%">Aittomaki, K.</style></author><author><style face="normal" font="default" size="100%">Alducci, E.</style></author><author><style face="normal" font="default" size="100%">Andrulis, I. L.</style></author><author><style face="normal" font="default" size="100%">Arun, B. K.</style></author><author><style face="normal" font="default" size="100%">Ausems, Mgem</style></author><author><style face="normal" font="default" size="100%">Azzollini, J.</style></author><author><style face="normal" font="default" size="100%">Barouk-Simonet, E.</style></author><author><style face="normal" font="default" size="100%">Barwell, J.</style></author><author><style face="normal" font="default" size="100%">Belotti, M.</style></author><author><style face="normal" font="default" size="100%">Benitez, J.</style></author><author><style face="normal" font="default" size="100%">Berger, A.</style></author><author><style face="normal" font="default" size="100%">Borg, A.</style></author><author><style face="normal" font="default" size="100%">Bradbury, A. R.</style></author><author><style face="normal" font="default" size="100%">Brunet, J.</style></author><author><style face="normal" font="default" size="100%">Buys, S. S.</style></author><author><style face="normal" font="default" size="100%">Caldes, T.</style></author><author><style face="normal" font="default" size="100%">Caligo, M. A.</style></author><author><style face="normal" font="default" size="100%">Campbell, I.</style></author><author><style face="normal" font="default" size="100%">Caputo, S. M.</style></author><author><style face="normal" font="default" size="100%">Chiquette, J.</style></author><author><style face="normal" font="default" size="100%">Claes, K. B. M.</style></author><author><style face="normal" font="default" size="100%">Margriet Collee, J.</style></author><author><style face="normal" font="default" size="100%">Couch, F. J.</style></author><author><style face="normal" font="default" size="100%">Coupier, I.</style></author><author><style face="normal" font="default" size="100%">Daly, M. B.</style></author><author><style face="normal" font="default" size="100%">Davidson, R.</style></author><author><style face="normal" font="default" size="100%">Diez, O.</style></author><author><style face="normal" font="default" size="100%">Domchek, S. M.</style></author><author><style face="normal" font="default" size="100%">Donaldson, A.</style></author><author><style face="normal" font="default" size="100%">Dorfling, C. M.</style></author><author><style face="normal" font="default" size="100%">Eeles, R.</style></author><author><style face="normal" font="default" size="100%">Feliubadalo, L.</style></author><author><style face="normal" font="default" size="100%">Foretova, L.</style></author><author><style face="normal" font="default" size="100%">Fowler, J.</style></author><author><style face="normal" font="default" size="100%">Friedman, E.</style></author><author><style face="normal" font="default" size="100%">Frost, D.</style></author><author><style face="normal" font="default" size="100%">Ganz, P. A.</style></author><author><style face="normal" font="default" size="100%">Garber, J.</style></author><author><style face="normal" font="default" size="100%">Garcia-Barberan, V.</style></author><author><style face="normal" font="default" size="100%">Glendon, G.</style></author><author><style face="normal" font="default" size="100%">Godwin, A. K.</style></author><author><style face="normal" font="default" size="100%">Gomez Garcia, E. B.</style></author><author><style face="normal" font="default" size="100%">Gronwald, J.</style></author><author><style face="normal" font="default" size="100%">Hahnen, E.</style></author><author><style face="normal" font="default" size="100%">Hamann, U.</style></author><author><style face="normal" font="default" size="100%">Henderson, A.</style></author><author><style face="normal" font="default" size="100%">Hendricks, C. B.</style></author><author><style face="normal" font="default" size="100%">Hopper, J. L.</style></author><author><style face="normal" font="default" size="100%">Hulick, P. J.</style></author><author><style face="normal" font="default" size="100%">Imyanitov, E. N.</style></author><author><style face="normal" font="default" size="100%">Isaacs, C.</style></author><author><style face="normal" font="default" size="100%">Izatt, L.</style></author><author><style face="normal" font="default" size="100%">Izquierdo, A.</style></author><author><style face="normal" font="default" size="100%">Jakubowska, A.</style></author><author><style face="normal" font="default" size="100%">Kaczmarek, K.</style></author><author><style face="normal" font="default" size="100%">Kang, E.</style></author><author><style face="normal" font="default" size="100%">Karlan, B. Y.</style></author><author><style face="normal" font="default" size="100%">Kets, C. M.</style></author><author><style face="normal" font="default" size="100%">Kim, S. W.</style></author><author><style face="normal" font="default" size="100%">Kim, Z.</style></author><author><style face="normal" font="default" size="100%">Kwong, A.</style></author><author><style face="normal" font="default" size="100%">Laitman, Y.</style></author><author><style face="normal" font="default" size="100%">Lasset, C.</style></author><author><style face="normal" font="default" size="100%">Hyuk Lee, M.</style></author><author><style face="normal" font="default" size="100%">Won Lee, J.</style></author><author><style face="normal" font="default" size="100%">Lee, J.</style></author><author><style face="normal" font="default" size="100%">Lester, J.</style></author><author><style face="normal" font="default" size="100%">Lesueur, F.</style></author><author><style face="normal" font="default" size="100%">Loud, J. T.</style></author><author><style face="normal" font="default" size="100%">Lubinski, J.</style></author><author><style face="normal" font="default" size="100%">Mebirouk, N.</style></author><author><style face="normal" font="default" size="100%">Meijers-Heijboer, H. E. J.</style></author><author><style face="normal" font="default" size="100%">Meindl, A.</style></author><author><style face="normal" font="default" size="100%">Miller, A.</style></author><author><style face="normal" font="default" size="100%">Montagna, M.</style></author><author><style face="normal" font="default" size="100%">Mooij, T. M.</style></author><author><style face="normal" font="default" size="100%">Morrison, P. J.</style></author><author><style face="normal" font="default" size="100%">Mouret-Fourme, E.</style></author><author><style face="normal" font="default" size="100%">Nathanson, K. L.</style></author><author><style face="normal" font="default" size="100%">Neuhausen, S. L.</style></author><author><style face="normal" font="default" size="100%">Nevanlinna, H.</style></author><author><style face="normal" font="default" size="100%">Niederacher, D.</style></author><author><style face="normal" font="default" size="100%">Nielsen, F. C.</style></author><author><style face="normal" font="default" size="100%">Nussbaum, R. L.</style></author><author><style face="normal" font="default" size="100%">Offit, K.</style></author><author><style face="normal" font="default" size="100%">Olah, E.</style></author><author><style face="normal" font="default" size="100%">Ong, K. R.</style></author><author><style face="normal" font="default" size="100%">Ottini, L.</style></author><author><style face="normal" font="default" size="100%">Park, S. K.</style></author><author><style face="normal" font="default" size="100%">Peterlongo, P.</style></author><author><style face="normal" font="default" size="100%">Pfeiler, G.</style></author><author><style face="normal" font="default" size="100%">Phelan, C. M.</style></author><author><style face="normal" font="default" size="100%">Poppe, B.</style></author><author><style face="normal" font="default" size="100%">Pradhan, N.</style></author><author><style face="normal" font="default" size="100%">Radice, P.</style></author><author><style face="normal" font="default" size="100%">Ramus, S. J.</style></author><author><style face="normal" font="default" size="100%">Rantala, J.</style></author><author><style face="normal" font="default" size="100%">Robson, M.</style></author><author><style face="normal" font="default" size="100%">Rodriguez, G. C.</style></author><author><style face="normal" font="default" size="100%">Schmutzler, R. K.</style></author><author><style face="normal" font="default" size="100%">Hutten Selkirk, C. G.</style></author><author><style face="normal" font="default" size="100%">Shah, P. D.</style></author><author><style face="normal" font="default" size="100%">Simard, J.</style></author><author><style face="normal" font="default" size="100%">Singer, C. F.</style></author><author><style face="normal" font="default" size="100%">Sokolowska, J.</style></author><author><style face="normal" font="default" size="100%">Stoppa-Lyonnet, D.</style></author><author><style face="normal" font="default" size="100%">Sutter, C.</style></author><author><style face="normal" font="default" size="100%">Yen Tan, Y.</style></author><author><style face="normal" font="default" size="100%">Teixeira, R. M.</style></author><author><style face="normal" font="default" size="100%">Teo, S. H.</style></author><author><style face="normal" font="default" size="100%">Terry, M. B.</style></author><author><style face="normal" font="default" size="100%">Thomassen, M.</style></author><author><style face="normal" font="default" size="100%">Tischkowitz, M.</style></author><author><style face="normal" font="default" size="100%">Toland, A. E.</style></author><author><style face="normal" font="default" size="100%">Tucker, K. M.</style></author><author><style face="normal" font="default" size="100%">Tung, N.</style></author><author><style face="normal" font="default" size="100%">van Asperen, C. J.</style></author><author><style face="normal" font="default" size="100%">van Engelen, K.</style></author><author><style face="normal" font="default" size="100%">van Rensburg, E. J.</style></author><author><style face="normal" font="default" size="100%">Wang-Gohrke, S.</style></author><author><style face="normal" font="default" size="100%">Wappenschmidt, B.</style></author><author><style face="normal" font="default" size="100%">Weitzel, J. N.</style></author><author><style face="normal" font="default" size="100%">Yannoukakos, D.</style></author><author><style face="normal" font="default" size="100%">Gemo Study Collaborators</style></author><author><style face="normal" font="default" size="100%">Hebon,</style></author><author><style face="normal" font="default" size="100%">Embrace,</style></author><author><style face="normal" font="default" size="100%">Greene, M. H.</style></author><author><style face="normal" font="default" size="100%">Rookus, M. A.</style></author><author><style face="normal" font="default" size="100%">Easton, D. F.</style></author><author><style face="normal" font="default" size="100%">Chenevix-Trench, G.</style></author><author><style face="normal" font="default" size="100%">Antoniou, A. C.</style></author><author><style face="normal" font="default" size="100%">Goldgar, D. E.</style></author><author><style face="normal" font="default" size="100%">Olopade, O. I.</style></author><author><style face="normal" font="default" size="100%">Rebbeck, T. R.</style></author><author><style face="normal" font="default" size="100%">Huo, D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Medicine, The University of Chicago, Chicago, IL.&#xD;Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL.&#xD;Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.&#xD;Division of Gastroenterology, Department of Hepatology and Nutrition, Children&apos;s Hospital of Philadelphia, Philadelphia, PA.&#xD;Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.&#xD;Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.&#xD;Departments of Pediatrics and Medicine, Columbia University, New York, NY.&#xD;Division of Evolution and Genomic Sciences, Genomic Medicine, Manchester Academic Health Sciences Centre, University of Manchester, Central Manchester University Hospitals, NHS Foundation Trust, Manchester, UK.&#xD;Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.&#xD;LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.&#xD;Department of Gynecology and Obstetrics, Technical University of Dresden, Dresden, Germany.&#xD;Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.&#xD;Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands.&#xD;Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL.&#xD;The University of Chicago Pritzker School of Medicine, Chicago, IL.&#xD;Family Cancer Clinic, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.&#xD;Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.&#xD;Department of Pathology, National Institute of Oncology, Budapest, Hungary.&#xD;School of Medicine, University of Iceland, Reykjavik, Iceland.&#xD;Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.&#xD;Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.&#xD;Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.&#xD;Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.&#xD;Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.&#xD;Department of Medical Genetics, University Medical Center, Utrecht, the Netherlands.&#xD;Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy.&#xD;Oncogenetique, Institut Bergonie, Bordeaux, France.&#xD;Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, KS.&#xD;Leicestershire Clinical Genetics Service, University Hospitals of Leicester NHS Trust, Leicester, UK.&#xD;Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d&apos;Investigacio Biomedica de Girona), Catalan Institute of Oncology, CIBERONC, Girona, Spain.&#xD;Service de Genetique, Institut Curie, Paris, France.&#xD;Schools of Medicine and Public Health, Division of Cancer Prevention &amp; Control Research, Jonsson Comprehensive Cancer Center, University of California Los Angeles, CA.&#xD;Department of Oncology, Lund University and Skane University Hospital, Lund, Sweden.&#xD;Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA.&#xD;Institute of Genetic Medicine, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.&#xD;Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.&#xD;Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.&#xD;Centro de Investigacion en Red de Enfermedades Raras (CIBERER), Valencia, Spain, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.&#xD;Department of Medicine, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.&#xD;Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, CIBERONC, Madrid, Spain.&#xD;Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa, Italy.&#xD;Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.&#xD;Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.&#xD;Unite de recherche en sante des populations, Centre des maladies du sein Deschenes-Fabia, Hopital du Saint-Sacrement, Quebec, QC, Canada.&#xD;Centre for Medical Genetics, Ghent University, Ghent, Belgium.&#xD;Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.&#xD;Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.&#xD;Unite d&apos;Oncogenetique, CHU Arnaud de Villeneuve, Montpellier, France.&#xD;Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA.&#xD;Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK.&#xD;N.N. Petrov Institute of Oncology, St. Petersburg, Russia.&#xD;Oncogenetics Group, Clinical and Molecular Genetics Area, Vall d&apos;Hebron Institute of Oncology (VHIO), University Hospital, Vall d&apos;Hebron, Barcelona, Spain (OD); Clinical Genetics Department, St Michael&apos;s Hospital, Bristol, UK.&#xD;Department of Genetics, University of Pretoria, Arcadia, South Africa.&#xD;City of Hope Clinical Cancer Genetics Community Research Network, Duarte, CA.&#xD;Ocogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.&#xD;Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.&#xD;Molecular Diagnostic Unit, Hereditary Cancer Program, ICO-IDIBELL (Catalan Institute of Oncology, Bellvitge Biomedical Research Institute), CIBERONC, Barcelona, Spain.&#xD;Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.&#xD;The Ohio State University, Columbus Cancer Council, Columbus, OH.&#xD;The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.&#xD;Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.&#xD;Centers for Hereditary Breast and Ovarian Cancer, Integrated Oncology and Molecular Medicine, University Hospital of Cologne, Cologne, Germany Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (CI).&#xD;Clinical Genetics, Guy&apos;s and St Thomas&apos; NHS Foundation Trust, London, UK.&#xD;Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.&#xD;Women&apos;s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA.&#xD;Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.&#xD;Department of Surgery, Daerim Saint Mary&apos;s Hospital, Seoul, Korea.&#xD;Department of Surgery, Soonchunhyang University Hospital Bucheon, Bucheon, Korea.&#xD;Hong Kong Hereditary Breast Cancer Family Registry, Happy Valley, Hong Kong.&#xD;Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong.&#xD;Department of Surgery, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.&#xD;Unite de Prevention et d&apos;Epidemiologie Genetique, Centre Leon Berard, Lyon, France.&#xD;Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, Korea.&#xD;Department of Surgery, Ulsan University College of Medicine and Asan Medical Center, Seoul, Korea.&#xD;Genetic Epidemiology of Cancer team, Institut Curie, Paris, France.&#xD;U900, INSERM, Paris, France.&#xD;PSL University, Paris, France.&#xD;Mines ParisTech, Fontainebleau, France.&#xD;Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD.&#xD;Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.&#xD;Division of Gynaecology and Obstetrics, Technische Universitat Munchen, Munich, Germany.&#xD;NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY.&#xD;Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.&#xD;Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.&#xD;Centre for Cancer Research and Cell Biology, Queens University Belfast, Belfast, UK.&#xD;Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA.&#xD;Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.&#xD;Department of Gynecology and Obstetrics, University Hospital Dusseldorf, Heinrich-Heine University Dusseldorf, Dusseldorf, Germany.&#xD;Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.&#xD;Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA.&#xD;Clinical Genetics Research Laboratory, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY.&#xD;Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.&#xD;Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.&#xD;West Midlands Regional Genetics Service, Birmingham Women&apos;s Hospital Healthcare NHS Trust, Birmingham, UK.&#xD;Department of Molecular Medicine, University La Sapienza, Rome, Italy.&#xD;Departments of Preventive Medicine and Biomedical Sciences, and Cancer Research Institute, Seoul National University, Seoul, Korea.&#xD;IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy.&#xD;Department of Urology, Medical University of Vienna, Vienna, Austria.&#xD;Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL.&#xD;Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy.&#xD;School of Women&apos;s and Children&apos;s Health, University of New South Wales Sydney, New South Wales, Australia.&#xD;The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.&#xD;Clinical Genetics, Karolinska Institutet, Stockholm, Sweden.&#xD;Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL.&#xD;Laboratoire de genetique medicale, Nancy Universite, Centre Hospitalier Regional et Universitaire, Vandoeuvre-les-Nancy, France.&#xD;Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.&#xD;Genomics Center, Centre Hospitalier Universitaire de Quebec Research Center, Laval University, Quebec City, QC, Canada.&#xD;Department of Tumour Biology, Institut Curie, INSERM U830, Paris, France.&#xD;Universite Paris Descartes, Paris, France.&#xD;Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.&#xD;Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.&#xD;Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.&#xD;Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.&#xD;Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia.&#xD;Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.&#xD;Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark.&#xD;Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, QC, Canada.&#xD;Department of Medical Genetics, Addenbrooke&apos;s Hospital, Cambridge, UK.&#xD;Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH.&#xD;School of Medicine, University of New South Wales, Sydney, New South Wales, Australia.&#xD;Hereditary Cancer Centre, Prince of Wales Hospital, Sydney, New South Wales, Australia.&#xD;Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA.&#xD;Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.&#xD;Department of Gynaecology and Obstetrics, University of Ulm, Ulm, Germany.&#xD;Clinical Cancer Genetics, City of Hope, Duarte, CA.&#xD;Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research &apos;Demokritos&apos;, Athens, Greece.&#xD;Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.&#xD;Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.&#xD;Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT.&#xD;Harvard T.H. Chan School of Public Health, Boston, MA.&#xD;Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.&#xD;Department of Public Health Sciences, The University of Chicago, Chicago, IL (DH).</style></auth-address><titles><title><style face="normal" font="default" size="100%">Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study</style></title><secondary-title><style face="normal" font="default" size="100%">J Natl Cancer Inst</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Natl Cancer Inst</style></full-title></periodical><pages><style face="normal" font="default" size="100%">350-364</style></pages><volume><style face="normal" font="default" size="100%">111</style></volume><number><style face="normal" font="default" size="100%">4</style></number><edition><style face="normal" font="default" size="100%">2018/10/13</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">BRCA1 Protein/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">BRCA2 Protein/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Height</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/*etiology/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*Mutation</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Prognosis</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1460-2105 (Electronic)&#xD;0027-8874 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30312457</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: BRCA1/2 mutations confer high lifetime risk of breast cancer, although other factors may modify this risk. Whether height or body mass index (BMI) modifies breast cancer risk in BRCA1/2 mutation carriers remains unclear. METHODS: We used Mendelian randomization approaches to evaluate the association of height and BMI on breast cancer risk, using data from the Consortium of Investigators of Modifiers of BRCA1/2 with 14 676 BRCA1 and 7912 BRCA2 mutation carriers, including 11 451 cases of breast cancer. We created a height genetic score using 586 height-associated variants and a BMI genetic score using 93 BMI-associated variants. We examined both observed and genetically determined height and BMI with breast cancer risk using weighted Cox models. All statistical tests were two-sided. RESULTS: Observed height was positively associated with breast cancer risk (HR = 1.09 per 10 cm increase, 95% confidence interval [CI] = 1.0 to 1.17; P = 1.17). Height genetic score was positively associated with breast cancer, although this was not statistically significant (per 10 cm increase in genetically predicted height, HR = 1.04, 95% CI = 0.93 to 1.17; P = .47). Observed BMI was inversely associated with breast cancer risk (per 5 kg/m2 increase, HR = 0.94, 95% CI = 0.90 to 0.98; P = .007). BMI genetic score was also inversely associated with breast cancer risk (per 5 kg/m2 increase in genetically predicted BMI, HR = 0.87, 95% CI = 0.76 to 0.98; P = .02). BMI was primarily associated with premenopausal breast cancer. CONCLUSION: Height is associated with overall breast cancer and BMI is associated with premenopausal breast cancer in BRCA1/2 mutation carriers. Incorporating height and BMI, particularly genetic score, into risk assessment may improve cancer management.</style></abstract><notes><style face="normal" font="default" size="100%">Qian, Frank&#xD;Wang, Shengfeng&#xD;Mitchell, Jonathan&#xD;McGuffog, Lesley&#xD;Barrowdale, Daniel&#xD;Leslie, Goska&#xD;Oosterwijk, Jan C&#xD;Chung, Wendy K&#xD;Evans, D Gareth&#xD;Engel, Christoph&#xD;Kast, Karin&#xD;Aalfs, Cora M&#xD;Adank, Muriel A&#xD;Adlard, Julian&#xD;Agnarsson, Bjarni A&#xD;Aittomaki, Kristiina&#xD;Alducci, Elisa&#xD;Andrulis, Irene L&#xD;Arun, Banu K&#xD;Ausems, Margreet G E M&#xD;Azzollini, Jacopo&#xD;Barouk-Simonet, Emmanuelle&#xD;Barwell, Julian&#xD;Belotti, Muriel&#xD;Benitez, Javier&#xD;Berger, Andreas&#xD;Borg, Ake&#xD;Bradbury, Angela R&#xD;Brunet, Joan&#xD;Buys, Saundra S&#xD;Caldes, Trinidad&#xD;Caligo, Maria A&#xD;Campbell, Ian&#xD;Caputo, Sandrine M&#xD;Chiquette, Jocelyne&#xD;Claes, Kathleen B M&#xD;Margriet Collee, J&#xD;Couch, Fergus J&#xD;Coupier, Isabelle&#xD;Daly, Mary B&#xD;Davidson, Rosemarie&#xD;Diez, Orland&#xD;Domchek, Susan M&#xD;Donaldson, Alan&#xD;Dorfling, Cecilia M&#xD;Eeles, Ros&#xD;Feliubadalo, Lidia&#xD;Foretova, Lenka&#xD;Fowler, Jeffrey&#xD;Friedman, Eitan&#xD;Frost, Debra&#xD;Ganz, Patricia A&#xD;Garber, Judy&#xD;Garcia-Barberan, Vanesa&#xD;Glendon, Gord&#xD;Godwin, Andrew K&#xD;Gomez Garcia, Encarna B&#xD;Gronwald, Jacek&#xD;Hahnen, Eric&#xD;Hamann, Ute&#xD;Henderson, Alex&#xD;Hendricks, Carolyn B&#xD;Hopper, John L&#xD;Hulick, Peter J&#xD;Imyanitov, Evgeny N&#xD;Isaacs, Claudine&#xD;Izatt, Louise&#xD;Izquierdo, Angel&#xD;Jakubowska, Anna&#xD;Kaczmarek, Katarzyna&#xD;Kang, Eunyoung&#xD;Karlan, Beth Y&#xD;Kets, Carolien M&#xD;Kim, Sung-Won&#xD;Kim, Zisun&#xD;Kwong, Ava&#xD;Laitman, Yael&#xD;Lasset, Christine&#xD;Hyuk Lee, Min&#xD;Won Lee, Jong&#xD;Lee, Jihyoun&#xD;Lester, Jenny&#xD;Lesueur, Fabienne&#xD;Loud, Jennifer T&#xD;Lubinski, Jan&#xD;Mebirouk, Noura&#xD;Meijers-Heijboer, Hanne E J&#xD;Meindl, Alfons&#xD;Miller, Austin&#xD;Montagna, Marco&#xD;Mooij, Thea M&#xD;Morrison, Patrick J&#xD;Mouret-Fourme, Emmanuelle&#xD;Nathanson, Katherine L&#xD;Neuhausen, Susan L&#xD;Nevanlinna, Heli&#xD;Niederacher, Dieter&#xD;Nielsen, Finn C&#xD;Nussbaum, Robert L&#xD;Offit, Kenneth&#xD;Olah, Edith&#xD;Ong, Kai-Ren&#xD;Ottini, Laura&#xD;Park, Sue K&#xD;Peterlongo, Paolo&#xD;Pfeiler, Georg&#xD;Phelan, Catherine M&#xD;Poppe, Bruce&#xD;Pradhan, Nisha&#xD;Radice, Paolo&#xD;Ramus, Susan J&#xD;Rantala, Johanna&#xD;Robson, Mark&#xD;Rodriguez, Gustavo C&#xD;Schmutzler, Rita K&#xD;Hutten Selkirk, Christina G&#xD;Shah, Payal D&#xD;Simard, Jacques&#xD;Singer, Christian F&#xD;Sokolowska, Johanna&#xD;Stoppa-Lyonnet, Dominique&#xD;Sutter, Christian&#xD;Yen Tan, Yen&#xD;Teixeira, R Manuel&#xD;Teo, Soo H&#xD;Terry, Mary Beth&#xD;Thomassen, Mads&#xD;Tischkowitz, Marc&#xD;Toland, Amanda E&#xD;Tucker, Katherine M&#xD;Tung, Nadine&#xD;van Asperen, Christi J&#xD;van Engelen, Klaartje&#xD;van Rensburg, Elizabeth J&#xD;Wang-Gohrke, Shan&#xD;Wappenschmidt, Barbara&#xD;Weitzel, Jeffrey N&#xD;Yannoukakos, Drakoulis&#xD;Greene, Mark H&#xD;Rookus, Matti A&#xD;Easton, Douglas F&#xD;Chenevix-Trench, Georgia&#xD;Antoniou, Antonis C&#xD;Goldgar, David E&#xD;Olopade, Olufunmilayo I&#xD;Rebbeck, Timothy R&#xD;Huo, Dezheng&#xD;eng&#xD;U10 CA180868/CA/NCI NIH HHS/&#xD;203477/Z/16/Z/WT_/Wellcome Trust/United Kingdom&#xD;UL1 TR001863/TR/NCATS NIH HHS/&#xD;P30 CA008748/CA/NCI NIH HHS/&#xD;P50 CA116201/CA/NCI NIH HHS/&#xD;UG1 CA233191/CA/NCI NIH HHS/&#xD;10118/CRUK_/Cancer Research UK/United Kingdom&#xD;UG1 CA233290/CA/NCI NIH HHS/&#xD;UG1 CA189867/CA/NCI NIH HHS/&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;J Natl Cancer Inst. 2019 Apr 1;111(4):350-364. doi: 10.1093/jnci/djy132.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30312457</style></url></related-urls><pdf-urls><url>internal-pdf://0344386460/Qian-2018-Height and Body Mass Index as Modifi.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6449171</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/jnci/djy132</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>58</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">58</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rees, Jessica M. B.</style></author><author><style face="normal" font="default" size="100%">Foley, Christopher N.</style></author><author><style face="normal" font="default" size="100%">Burgess, Stephen</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><urls><pdf-urls><url>internal-pdf://4150163058/Rees-2019-Factorial Mendelian randomization_ u.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/531228</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>92</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">92</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Richardson, Tom G.</style></author><author><style face="normal" font="default" size="100%">Harrison, Sean</style></author><author><style face="normal" font="default" size="100%">Hemani, Gibran</style></author><author><style face="normal" font="default" size="100%">Smith, George Davey</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><urls><pdf-urls><url>internal-pdf://1435856528/Richardson-2018-An atlas of polygenic risk sco.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/467910</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>65</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">65</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Richardson, Tom G.</style></author><author><style face="normal" font="default" size="100%">Haycock, Philip C.</style></author><author><style face="normal" font="default" size="100%">Zheng, Jie</style></author><author><style face="normal" font="default" size="100%">Timpson, Nicholas J.</style></author><author><style face="normal" font="default" size="100%">Gaunt, Tom R.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, George</style></author><author><style face="normal" font="default" size="100%">Relton, Caroline L.</style></author><author><style face="normal" font="default" size="100%">Hemani, Gibran</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><urls><pdf-urls><url>internal-pdf://0716313589/Richardson-2017-Systematic Mendelian randomiza.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/189076</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>50</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">50</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Richmond, R. C.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Ness, A. R.</style></author><author><style face="normal" font="default" size="100%">den Hoed, M.</style></author><author><style face="normal" font="default" size="100%">McMahon, G.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.&#xD;Department of Oral and Dental Science, University of Bristol, Bristol, United Kingdom.&#xD;Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Assessing causality in the association between child adiposity and physical activity levels: a Mendelian randomization analysis</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1001618</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><number><style face="normal" font="default" size="100%">3</style></number><edition><style face="normal" font="default" size="100%">2014/03/20</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Absorptiometry, Photon</style></keyword><keyword><style face="normal" font="default" size="100%">*Adiposity</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">England</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*Motor Activity</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">24642734</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Cross-sectional studies have shown that objectively measured physical activity is associated with childhood adiposity, and a strong inverse dose-response association with body mass index (BMI) has been found. However, few studies have explored the extent to which this association reflects reverse causation. We aimed to determine whether childhood adiposity causally influences levels of physical activity using genetic variants reliably associated with adiposity to estimate causal effects. METHODS AND FINDINGS: The Avon Longitudinal Study of Parents and Children collected data on objectively assessed activity levels of 4,296 children at age 11 y with recorded BMI and genotypic data. We used 32 established genetic correlates of BMI combined in a weighted allelic score as an instrumental variable for adiposity to estimate the causal effect of adiposity on activity. In observational analysis, a 3.3 kg/m(2) (one standard deviation) higher BMI was associated with 22.3 (95% CI, 17.0, 27.6) movement counts/min less total physical activity (p = 1.6x10(-)(1)(6)), 2.6 (2.1, 3.1) min/d less moderate-to-vigorous-intensity activity (p = 3.7x10(-)(2)(9)), and 3.5 (1.5, 5.5) min/d more sedentary time (p = 5.0x10(-)(4)). In Mendelian randomization analyses, the same difference in BMI was associated with 32.4 (0.9, 63.9) movement counts/min less total physical activity (p = 0.04) ( approximately 5.3% of the mean counts/minute), 2.8 (0.1, 5.5) min/d less moderate-to-vigorous-intensity activity (p = 0.04), and 13.2 (1.3, 25.2) min/d more sedentary time (p = 0.03). There was no strong evidence for a difference between variable estimates from observational estimates. Similar results were obtained using fat mass index. Low power and poor instrumentation of activity limited causal analysis of the influence of physical activity on BMI. CONCLUSIONS: Our results suggest that increased adiposity causes a reduction in physical activity in children and support research into the targeting of BMI in efforts to increase childhood activity levels. Importantly, this does not exclude lower physical activity also leading to increased adiposity, i.e., bidirectional causation.</style></abstract><notes><style face="normal" font="default" size="100%">Richmond, Rebecca C&#xD;Davey Smith, George&#xD;Ness, Andy R&#xD;den Hoed, Marcel&#xD;McMahon, George&#xD;Timpson, Nicholas J&#xD;eng&#xD;092731/Wellcome Trust/United Kingdom&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;102215/Wellcome Trust/United Kingdom&#xD;MC_PC_15018/Medical Research Council/United Kingdom&#xD;WT083431MF/Wellcome Trust/United Kingdom&#xD;MC_UU_12013/3/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS Med. 2014 Mar 18;11(3):e1001618. doi: 10.1371/journal.pmed.1001618. eCollection 2014 Mar.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/24642734</style></url></related-urls><pdf-urls><url>internal-pdf://3779749268/Richmond-2014-Assessing causality in the assoc.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3958348</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1001618</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>29</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">29</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Richmond, R. C.</style></author><author><style face="normal" font="default" size="100%">Sharp, G. C.</style></author><author><style face="normal" font="default" size="100%">Ward, M. E.</style></author><author><style face="normal" font="default" size="100%">Fraser, A.</style></author><author><style face="normal" font="default" size="100%">Lyttleton, O.</style></author><author><style face="normal" font="default" size="100%">McArdle, W. L.</style></author><author><style face="normal" font="default" size="100%">Ring, S. M.</style></author><author><style face="normal" font="default" size="100%">Gaunt, T. R.</style></author><author><style face="normal" font="default" size="100%">Lawlor, D. A.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Relton, C. L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, U.K. School of Social and Community Medicine, University of Bristol, Bristol, U.K.&#xD;Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, U.K. School of Social and Community Medicine, University of Bristol, Bristol, U.K. gemma.sharp@bristol.ac.uk.&#xD;School of Social and Community Medicine, University of Bristol, Bristol, U.K.&#xD;Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, U.K. School of Social and Community Medicine, University of Bristol, Bristol, U.K. Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, U.K.</style></auth-address><titles><title><style face="normal" font="default" size="100%">DNA Methylation and BMI: Investigating Identified Methylation Sites at HIF3A in a Causal Framework</style></title><secondary-title><style face="normal" font="default" size="100%">Diabetes</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Diabetes</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1231-44</style></pages><volume><style face="normal" font="default" size="100%">65</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2016/02/11</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Adiposity</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">*Adolescent Development</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Basic Helix-Loop-Helix Transcription Factors/*genetics/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Birth Weight</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Causality</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">*Child Development</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Confounding Factors, Epidemiologic</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*DNA Methylation</style></keyword><keyword><style face="normal" font="default" size="100%">England/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mothers</style></keyword><keyword><style face="normal" font="default" size="100%">Overweight/epidemiology/etiology/genetics/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Thinness/epidemiology/etiology/genetics/metabolism</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1939-327X (Electronic)&#xD;0012-1797 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26861784</style></accession-num><abstract><style face="normal" font="default" size="100%">Multiple differentially methylated sites and regions associated with adiposity have now been identified in large-scale cross-sectional studies. We tested for replication of associations between previously identified CpG sites at HIF3A and adiposity in approximately 1,000 mother-offspring pairs from the Avon Longitudinal Study of Parents and Children (ALSPAC). Availability of methylation and adiposity measures at multiple time points, as well as genetic data, allowed us to assess the temporal associations between adiposity and methylation and to make inferences regarding causality and directionality. Overall, our results were discordant with those expected if HIF3A methylation has a causal effect on BMI and provided more evidence for causality in the reverse direction (i.e., an effect of BMI on HIF3A methylation). These results are based on robust evidence from longitudinal analyses and were also partially supported by Mendelian randomization analysis, although this latter analysis was underpowered to detect a causal effect of BMI on HIF3A methylation. Our results also highlight an apparent long-lasting intergenerational influence of maternal BMI on offspring methylation at this locus, which may confound associations between own adiposity and HIF3A methylation. Further work is required to replicate and uncover the mechanisms underlying the direct and intergenerational effect of adiposity on DNA methylation.</style></abstract><notes><style face="normal" font="default" size="100%">Richmond, Rebecca C&#xD;Sharp, Gemma C&#xD;Ward, Mary E&#xD;Fraser, Abigail&#xD;Lyttleton, Oliver&#xD;McArdle, Wendy L&#xD;Ring, Susan M&#xD;Gaunt, Tom R&#xD;Lawlor, Debbie A&#xD;Davey Smith, George&#xD;Relton, Caroline L&#xD;eng&#xD;G0701594/Medical Research Council/United Kingdom&#xD;088806/Wellcome Trust/United Kingdom&#xD;102215/Wellcome Trust/United Kingdom&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;R01 DK103246/DK/NIDDK NIH HHS/&#xD;Wellcome Trust/United Kingdom&#xD;MC_UU_12013/5/Medical Research Council/United Kingdom&#xD;MR/M009351/1/Medical Research Council/United Kingdom&#xD;A19169/Cancer Research UK/United Kingdom&#xD;MC_UU_12013/8/Medical Research Council/United Kingdom&#xD;MC_UU_12013/2/Medical Research Council/United Kingdom&#xD;Diabetes. 2016 May;65(5):1231-44. doi: 10.2337/db15-0996. Epub 2016 Feb 9.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26861784</style></url></related-urls><pdf-urls><url>internal-pdf://3351296824/Richmond-2016-DNA Methylation and BMI_ Investi.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4839211</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.2337/db15-0996</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>64</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">64</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Richmond, R. C.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Felix, J. F.</style></author><author><style face="normal" font="default" size="100%">Palmer, T.</style></author><author><style face="normal" font="default" size="100%">Gaillard, R.</style></author><author><style face="normal" font="default" size="100%">McMahon, G.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Jaddoe, V. W.</style></author><author><style face="normal" font="default" size="100%">Lawlor, D. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.&#xD;School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.&#xD;The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.&#xD;Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.&#xD;Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.&#xD;Department of Mathematics and Statistics, Lancaster University, Lancaster, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Using Genetic Variation to Explore the Causal Effect of Maternal Pregnancy Adiposity on Future Offspring Adiposity: A Mendelian Randomisation Study</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1002221</style></pages><volume><style face="normal" font="default" size="100%">14</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2017/01/25</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Absorptiometry, Photon</style></keyword><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">England</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Multivariate Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy</style></keyword><keyword><style face="normal" font="default" size="100%">Regression Analysis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28118352</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: It has been suggested that greater maternal adiposity during pregnancy affects lifelong risk of offspring fatness via intrauterine mechanisms. Our aim was to use Mendelian randomisation (MR) to investigate the causal effect of intrauterine exposure to greater maternal body mass index (BMI) on offspring BMI and fat mass from childhood to early adulthood. METHODS AND FINDINGS: We used maternal genetic variants as instrumental variables (IVs) to test the causal effect of maternal BMI in pregnancy on offspring fatness (BMI and dual-energy X-ray absorptiometry [DXA] determined fat mass index [FMI]) in a MR approach. This was investigated, with repeat measurements, from ages 7 to 18 in the Avon Longitudinal Study of Parents and Children (ALSPAC; n = 2,521 to 3,720 for different ages). We then sought to replicate findings with results for BMI at age 6 in Generation R (n = 2,337 for replication sample; n = 6,057 for total pooled sample). In confounder-adjusted multivariable regression in ALSPAC, a 1 standard deviation (SD, equivalent of 3.7 kg/m2) increase in maternal BMI was associated with a 0.25 SD (95% CI 0.21-0.29) increase in offspring BMI at age 7, with similar results at later ages and when FMI was used as the outcome. A weighted genetic risk score was generated from 32 genetic variants robustly associated with BMI (minimum F-statistic = 45 in ALSPAC). The MR results using this genetic risk score as an IV in ALSPAC were close to the null at all ages (e.g., 0.04 SD (95% CI -0.21-0.30) at age 7 and 0.03 SD (95% CI -0.26-0.32) at age 18 per SD increase in maternal BMI), which was similar when a 97 variant generic risk score was used in ALSPAC. When findings from age 7 in ALSPAC were meta-analysed with those from age 6 in Generation R, the pooled confounder-adjusted multivariable regression association was 0.22 SD (95% CI 0.19-0.25) per SD increase in maternal BMI and the pooled MR effect (pooling the 97 variant score results from ALSPAC with the 32 variant score results from Generation R) was 0.05 SD (95%CI -0.11-0.21) per SD increase in maternal BMI (p-value for difference between the two results = 0.05). A number of sensitivity analyses exploring violation of the MR results supported our main findings. However, power was limited for some of the sensitivity tests and further studies with relevant data on maternal, offspring, and paternal genotype are required to obtain more precise (and unbiased) causal estimates. CONCLUSIONS: Our findings provide little evidence to support a strong causal intrauterine effect of incrementally greater maternal BMI resulting in greater offspring adiposity.</style></abstract><notes><style face="normal" font="default" size="100%">Richmond, Rebecca C&#xD;Timpson, Nicholas J&#xD;Felix, Janine F&#xD;Palmer, Tom&#xD;Gaillard, Romy&#xD;McMahon, George&#xD;Davey Smith, George&#xD;Jaddoe, Vincent W&#xD;Lawlor, Debbie A&#xD;eng&#xD;MC_PC_15018/Medical Research Council/United Kingdom&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;MC_UU_12013/5/Medical Research Council/United Kingdom&#xD;R01 DK103246/DK/NIDDK NIH HHS/&#xD;WT094529MA/Wellcome Trust/United Kingdom&#xD;MC_UU_12013/3/Medical Research Council/United Kingdom&#xD;C18281/A19169/Cancer Research UK/United Kingdom&#xD;NF-SI-0611-10196/Department of Health/United Kingdom&#xD;102215/2/13/2/Wellcome Trust/United Kingdom&#xD;WT088806/Wellcome Trust/United Kingdom&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS Med. 2017 Jan 24;14(1):e1002221. doi: 10.1371/journal.pmed.1002221. eCollection 2017 Jan.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28118352</style></url></related-urls><pdf-urls><url>internal-pdf://1700330375/Richmond-2017-Using Genetic Variation to Explo.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5261553 following competing interests: GDS is a member of the Editorial Board of PLOS Medicine. In addition to grant funding that is acknowledged in the paper and that was relevant to the conduct of the study reported in the paper, the University of Bristol has received funds from public, charity, and industry funders from grants on which DAL is the Principal applicant (UK Medical Research Council, UK Economic and Social Research Council, UK National Institute of Health Research, Wellcome Trust, British Heart Foundation, Roche Diagnostics, Ferring Pharmaceuticals, and Medtronic PLC.) These funders had no impact on any aspect of the work presented in this paper.</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1002221</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>121</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">121</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Richmond, R. C.</style></author><author><style face="normal" font="default" size="100%">Wade, K. H.</style></author><author><style face="normal" font="default" size="100%">Corbin, L.</style></author><author><style face="normal" font="default" size="100%">Bowden, J.</style></author><author><style face="normal" font="default" size="100%">Hemani, G.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><urls><pdf-urls><url>internal-pdf://1606462142/Richmond-2017-Investigating the role of insuli.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/155739</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>56</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">56</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rode, L.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author><author><style face="normal" font="default" size="100%">Weischer, M.</style></author><author><style face="normal" font="default" size="100%">Bojesen, S. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Clinical Biochemistry and The Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, DK-2730 Herlev, Denmark; and Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Increased body mass index, elevated C-reactive protein, and short telomere length</style></title><secondary-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></full-title></periodical><pages><style face="normal" font="default" size="100%">E1671-5</style></pages><volume><style face="normal" font="default" size="100%">99</style></volume><number><style face="normal" font="default" size="100%">9</style></number><edition><style face="normal" font="default" size="100%">2014/04/26</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">C-Reactive Protein/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Inflammation/genetics/immunology/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Multivariate Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/genetics/immunology/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Genetic</style></keyword><keyword><style face="normal" font="default" size="100%">Telomere/genetics/immunology/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1945-7197 (Electronic)&#xD;0021-972X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">24762112</style></accession-num><abstract><style face="normal" font="default" size="100%">CONTEXT: Obesity is associated with short telomere length. The cause of this association is unknown. OBJECTIVE: We hypothesized that genetically increased body mass index (BMI) is associated with telomere length shortening and that low-grade inflammation might contribute through elevated C-reactive protein. SETTING AND DESIGN: We studied 45,069 individuals from the Copenhagen General Population Study with measurements of leukocyte telomere length, BMI, and C-reactive protein in a Mendelian randomization study. Using the three obesity-associated polymorphisms FTO rs9939609, MC4R rs17782313, and TMEM18 rs6548238, and the CRP promoter polymorphism rs3091244 in instrumental variable analyses, we estimated the associations between genetically increased BMI and telomere length and between genetically increased C-reactive protein and telomere length. RESULTS: In multivariable-adjusted observational analyses, telomere length decreased with seven base pairs (95% confidence interval, -9--5) per unit increase in BMI, and further adjustment for C-reactive protein attenuated this association to -5 base pairs (-8--3). In accordance, instrumental variable analysis showed a non-significant telomere length shortening of six base pairs (-37-25) per unit increase in genetically determined BMI. Furthermore, in observational analyses, telomere length decreased with nine base pairs (-16--2) for a doubling in C-reactive protein, supported by the instrumental variable analyses showing a corresponding genetically determined decrease of 66 base pairs (-124--7). CONCLUSIONS: High BMI is associated with short telomere length observationally. This might possibly be mediated through elevated C-reactive protein, given that genetically elevated C-reactive protein levels are associated with short telomere length.</style></abstract><notes><style face="normal" font="default" size="100%">Rode, Line&#xD;Nordestgaard, Borge G&#xD;Weischer, Maren&#xD;Bojesen, Stig E&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;J Clin Endocrinol Metab. 2014 Sep;99(9):E1671-5. doi: 10.1210/jc.2014-1161. Epub 2014 Apr 24.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/24762112</style></url></related-urls><pdf-urls><url>internal-pdf://0556056567/Rode-2014-Increased Body Mass Index, Elevated.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1210/jc.2014-1161</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>11</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">11</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Schnurr, T. M.</style></author><author><style face="normal" font="default" size="100%">Viitasalo, A.</style></author><author><style face="normal" font="default" size="100%">Eloranta, A. M.</style></author><author><style face="normal" font="default" size="100%">Damsgaard, C. T.</style></author><author><style face="normal" font="default" size="100%">Mahendran, Y.</style></author><author><style face="normal" font="default" size="100%">Have, C. T.</style></author><author><style face="normal" font="default" size="100%">Vaisto, J.</style></author><author><style face="normal" font="default" size="100%">Hjorth, M. F.</style></author><author><style face="normal" font="default" size="100%">Christensen, L. B.</style></author><author><style face="normal" font="default" size="100%">Brage, S.</style></author><author><style face="normal" font="default" size="100%">Atalay, M.</style></author><author><style face="normal" font="default" size="100%">Lyytikainen, L. P.</style></author><author><style face="normal" font="default" size="100%">Lindi, V.</style></author><author><style face="normal" font="default" size="100%">Lakka, T.</style></author><author><style face="normal" font="default" size="100%">Michaelsen, K. F.</style></author><author><style face="normal" font="default" size="100%">Kilpelainen, T. O.</style></author><author><style face="normal" font="default" size="100%">Hansen, T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.&#xD;Institute of Biomedicine Physiology, School of Medicine, University of Eastern Finland, Kuopio, Finland.&#xD;Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.&#xD;Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, UK.&#xD;Department of Clinical Chemistry, Fimlab Laboratories and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.&#xD;Department of Clinical Physiology and Nuclear Medicine, School of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.&#xD;Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetic predisposition to adiposity is associated with increased objectively assessed sedentary time in young children</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Obes (Lond)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Obes (Lond)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">111-114</style></pages><volume><style face="normal" font="default" size="100%">42</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2017/09/28</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Denmark/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Exercise/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Finland/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease/*epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Sedentary Behavior</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-5497 (Electronic)&#xD;0307-0565 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28947836</style></accession-num><abstract><style face="normal" font="default" size="100%">Increased sedentariness has been linked to the growing prevalence of obesity in children, but some longitudinal studies suggest that sedentariness may be a consequence rather than a cause of increased adiposity. We used Mendelian randomization to examine the causal relations between body mass index (BMI) and objectively assessed sedentary time and physical activity in 3-8 year-old children from one Finnish and two Danish cohorts [NTOTAL=679]. A genetic risk score (GRS) comprised of 15 independent genetic variants associated with childhood BMI was used as the instrumental variable to test causal effects of BMI on sedentary time, total physical activity, and moderate-to-vigorous physical activity (MVPA). In fixed effects meta-analyses, the GRS was associated with 0.05 SD/allele increase in sedentary time (P=0.019), but there was no significant association with total physical activity (beta=0.011 SD/allele, P=0.58) or MVPA (beta=0.001 SD/allele, P=0.96), adjusting for age, sex, monitor wear-time and first three genome-wide principal components. In two-stage least squares regression analyses, each genetically instrumented one unit increase in BMI z-score increased sedentary time by 0.47 SD (P=0.072). Childhood BMI may have a causal influence on sedentary time but not on total physical activity or MVPA in young children. Our results provide important insights into the regulation of movement behaviour in childhood.</style></abstract><notes><style face="normal" font="default" size="100%">Schnurr, T M&#xD;Viitasalo, A&#xD;Eloranta, A-M&#xD;Damsgaard, C T&#xD;Mahendran, Y&#xD;Have, C T&#xD;Vaisto, J&#xD;Hjorth, M F&#xD;Christensen, L B&#xD;Brage, S&#xD;Atalay, M&#xD;Lyytikainen, L-P&#xD;Lindi, V&#xD;Lakka, T&#xD;Michaelsen, K F&#xD;Kilpelainen, T O&#xD;Hansen, T&#xD;eng&#xD;MC_UU_12015/3/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Int J Obes (Lond). 2018 Jan;42(1):111-114. doi: 10.1038/ijo.2017.235. Epub 2017 Sep 26.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28947836</style></url></related-urls><pdf-urls><url>internal-pdf://3370086254/Schnurr-2018-Genetic predisposition to adiposi.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5765967</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/ijo.2017.235</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>133</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">133</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shapland, C. Y.</style></author><author><style face="normal" font="default" size="100%">Thompson, J. R.</style></author><author><style face="normal" font="default" size="100%">Sheehan, N. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Health Sciences and Genetics, University of Leicester, Leicester, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">A Bayesian approach to Mendelian randomisation with dependent instruments</style></title><secondary-title><style face="normal" font="default" size="100%">Stat Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Stat Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">985-1001</style></pages><volume><style face="normal" font="default" size="100%">38</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2018/11/30</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Bayes Theorem</style></keyword><keyword><style face="normal" font="default" size="100%">Causality</style></keyword><keyword><style face="normal" font="default" size="100%">Computer Simulation</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Linkage Disequilibrium/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Models, Statistical</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*Bayesian model averaging</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomisation</style></keyword><keyword><style face="normal" font="default" size="100%">*dependent SNPs</style></keyword><keyword><style face="normal" font="default" size="100%">*many weak instruments</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar 15</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1097-0258 (Electronic)&#xD;0277-6715 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30485479</style></accession-num><abstract><style face="normal" font="default" size="100%">Mendelian randomisation (MR) is a method for establishing causality between a risk factor and an outcome by using genetic variants as instrumental variables. In practice, the association between individual genetic variants and the risk factor is often weak, which may lead to a lack of precision in the MR and even biased MR estimates. Usually, the most significant variant within a genetic region is selected to represent the association with the risk factor, but there is no guarantee that this variant will be causal or that it will capture all of the genetic association within the region. It may be advantageous to use extra variants selected from the same region in the MR. The problem is to decide which variants to select. Rather than selecting a specific set of variants, we investigate the use of Bayesian model averaging (BMA) to average the MR over all possible combinations of genetic variants. Our simulations demonstrate that the BMA version of MR outperforms classical estimation with many dependent variants and performs much better than an MR based on variants selected by penalised regression. In further simulations, we investigate robustness to violations in the model assumptions and demonstrate sensitivity to the inclusion of invalid instruments. The method is illustrated by applying it to an MR of the effect of body mass index on blood pressure using SNPs in the FTO gene.</style></abstract><notes><style face="normal" font="default" size="100%">Shapland, Chin Yang&#xD;Thompson, John R&#xD;Sheehan, Nuala A&#xD;eng&#xD;England&#xD;Stat Med. 2019 Mar 15;38(6):985-1001. doi: 10.1002/sim.8029. Epub 2018 Nov 28.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30485479</style></url></related-urls><pdf-urls><url>internal-pdf://2077942112/Shapland-2018-A Bayesian approach to Mendelian.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/sim.8029</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>98</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">98</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shu, X.</style></author><author><style face="normal" font="default" size="100%">Wu, L.</style></author><author><style face="normal" font="default" size="100%">Khankari, N. K.</style></author><author><style face="normal" font="default" size="100%">Shu, X. O.</style></author><author><style face="normal" font="default" size="100%">Wang, T. J.</style></author><author><style face="normal" font="default" size="100%">Michailidou, K.</style></author><author><style face="normal" font="default" size="100%">Bolla, M. K.</style></author><author><style face="normal" font="default" size="100%">Wang, Q.</style></author><author><style face="normal" font="default" size="100%">Dennis, J.</style></author><author><style face="normal" font="default" size="100%">Milne, R. L.</style></author><author><style face="normal" font="default" size="100%">Schmidt, M. K.</style></author><author><style face="normal" font="default" size="100%">Pharoah, P. D. P.</style></author><author><style face="normal" font="default" size="100%">Andrulis, I. L.</style></author><author><style face="normal" font="default" size="100%">Hunter, D. J.</style></author><author><style face="normal" font="default" size="100%">Simard, J.</style></author><author><style face="normal" font="default" size="100%">Easton, D. F.</style></author><author><style face="normal" font="default" size="100%">Zheng, W.</style></author><author><style face="normal" font="default" size="100%">Breast Cancer Association, Consortium</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, TN, USA.&#xD;Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.&#xD;Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.&#xD;Department of Electron Microscopy/Molecular Pathology, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.&#xD;Cancer Epidemiology &amp; Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.&#xD;Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.&#xD;Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.&#xD;Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.&#xD;Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.&#xD;Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.&#xD;Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.&#xD;Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.&#xD;Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.&#xD;Genomics Center, Centre Hospitalier Universitaire de Quebec Research Center, Laval University, Quebec City, QC, Canada.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">795-806</style></pages><volume><style face="normal" font="default" size="100%">48</style></volume><number><style face="normal" font="default" size="100%">3</style></number><edition><style face="normal" font="default" size="100%">2018/10/03</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Glucose/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Breast Neoplasms/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin/*blood/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity, Abdominal/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Waist-Hip Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">*Breast cancer</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization analysis</style></keyword><keyword><style face="normal" font="default" size="100%">*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*glucose</style></keyword><keyword><style face="normal" font="default" size="100%">*insulin</style></keyword><keyword><style face="normal" font="default" size="100%">*obesity</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1464-3685 (Electronic)&#xD;0300-5771 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30277539</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: In addition to the established association between general obesity and breast cancer risk, central obesity and circulating fasting insulin and glucose have been linked to the development of this common malignancy. Findings from previous studies, however, have been inconsistent, and the nature of the associations is unclear. METHODS: We conducted Mendelian randomization analyses to evaluate the association of breast cancer risk, using genetic instruments, with fasting insulin, fasting glucose, 2-h glucose, body mass index (BMI) and BMI-adjusted waist-hip-ratio (WHRadj BMI). We first confirmed the association of these instruments with type 2 diabetes risk in a large diabetes genome-wide association study consortium. We then investigated their associations with breast cancer risk using individual-level data obtained from 98 842 cases and 83 464 controls of European descent in the Breast Cancer Association Consortium. RESULTS: All sets of instruments were associated with risk of type 2 diabetes. Associations with breast cancer risk were found for genetically predicted fasting insulin [odds ratio (OR) = 1.71 per standard deviation (SD) increase, 95% confidence interval (CI) = 1.26-2.31, p = 5.09 x 10-4], 2-h glucose (OR = 1.80 per SD increase, 95% CI = 1.3 0-2.49, p = 4.02 x 10-4), BMI (OR = 0.70 per 5-unit increase, 95% CI = 0.65-0.76, p = 5.05 x 10-19) and WHRadj BMI (OR = 0.85, 95% CI = 0.79-0.91, p = 9.22 x 10-6). Stratified analyses showed that genetically predicted fasting insulin was more closely related to risk of estrogen-receptor [ER]-positive cancer, whereas the associations with instruments of 2-h glucose, BMI and WHRadj BMI were consistent regardless of age, menopausal status, estrogen receptor status and family history of breast cancer. CONCLUSIONS: We confirmed the previously reported inverse association of genetically predicted BMI with breast cancer risk, and showed a positive association of genetically predicted fasting insulin and 2-h glucose and an inverse association of WHRadj BMI with breast cancer risk. Our study suggests that genetically determined obesity and glucose/insulin-related traits have an important role in the aetiology of breast cancer.</style></abstract><notes><style face="normal" font="default" size="100%">Shu, Xiang&#xD;Wu, Lang&#xD;Khankari, Nikhil K&#xD;Shu, Xiao-Ou&#xD;Wang, Thomas J&#xD;Michailidou, Kyriaki&#xD;Bolla, Manjeet K&#xD;Wang, Qin&#xD;Dennis, Joe&#xD;Milne, Roger L&#xD;Schmidt, Marjanka K&#xD;Pharoah, Paul D P&#xD;Andrulis, Irene L&#xD;Hunter, David J&#xD;Simard, Jacques&#xD;Easton, Douglas F&#xD;Zheng, Wei&#xD;eng&#xD;C1287/A10710/CRUK_/Cancer Research UK/United Kingdom&#xD;PSR-SIIRI-701/CIHR/Canada&#xD;C1287/A16563/CRUK_/Cancer Research UK/United Kingdom&#xD;10118/CRUK_/Cancer Research UK/United Kingdom&#xD;C1287/A10118/CRUK_/Cancer Research UK/United Kingdom&#xD;U19 CA148065/CA/NCI NIH HHS/&#xD;R01 CA148667/CA/NCI NIH HHS/&#xD;R01 CA158473/CA/NCI NIH HHS/&#xD;10124/CRUK_/Cancer Research UK/United Kingdom&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Int J Epidemiol. 2019 Jun 1;48(3):795-806. doi: 10.1093/ije/dyy201.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30277539</style></url></related-urls><pdf-urls><url>internal-pdf://4143554191/Shu-2018-Associations of obesity and circulati.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6734940</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/ije/dyy201</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>109</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">109</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shungin, D.</style></author><author><style face="normal" font="default" size="100%">Cornelis, M. C.</style></author><author><style face="normal" font="default" size="100%">Divaris, K.</style></author><author><style face="normal" font="default" size="100%">Holtfreter, B.</style></author><author><style face="normal" font="default" size="100%">Shaffer, J. R.</style></author><author><style face="normal" font="default" size="100%">Yu, Y. H.</style></author><author><style face="normal" font="default" size="100%">Barros, S. P.</style></author><author><style face="normal" font="default" size="100%">Beck, J. D.</style></author><author><style face="normal" font="default" size="100%">Biffar, R.</style></author><author><style face="normal" font="default" size="100%">Boerwinkle, E. A.</style></author><author><style face="normal" font="default" size="100%">Crout, R. J.</style></author><author><style face="normal" font="default" size="100%">Ganna, A.</style></author><author><style face="normal" font="default" size="100%">Hallmans, G.</style></author><author><style face="normal" font="default" size="100%">Hindy, G.</style></author><author><style face="normal" font="default" size="100%">Hu, F. B.</style></author><author><style face="normal" font="default" size="100%">Kraft, P.</style></author><author><style face="normal" font="default" size="100%">McNeil, D. W.</style></author><author><style face="normal" font="default" size="100%">Melander, O.</style></author><author><style face="normal" font="default" size="100%">Moss, K. L.</style></author><author><style face="normal" font="default" size="100%">North, K. E.</style></author><author><style face="normal" font="default" size="100%">Orho-Melander, M.</style></author><author><style face="normal" font="default" size="100%">Pedersen, N. L.</style></author><author><style face="normal" font="default" size="100%">Ridker, P. M.</style></author><author><style face="normal" font="default" size="100%">Rimm, E. B.</style></author><author><style face="normal" font="default" size="100%">Rose, L. M.</style></author><author><style face="normal" font="default" size="100%">Rukh, G.</style></author><author><style face="normal" font="default" size="100%">Teumer, A.</style></author><author><style face="normal" font="default" size="100%">Weyant, R. J.</style></author><author><style face="normal" font="default" size="100%">Chasman, D. I.</style></author><author><style face="normal" font="default" size="100%">Joshipura, K.</style></author><author><style face="normal" font="default" size="100%">Kocher, T.</style></author><author><style face="normal" font="default" size="100%">Magnusson, P. K.</style></author><author><style face="normal" font="default" size="100%">Marazita, M. L.</style></author><author><style face="normal" font="default" size="100%">Nilsson, P.</style></author><author><style face="normal" font="default" size="100%">Offenbacher, S.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Lundberg, P.</style></author><author><style face="normal" font="default" size="100%">Palmer, T. M.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Johansson, I.</style></author><author><style face="normal" font="default" size="100%">Franks, P. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Public Health and Clinical Medicine, Section for Medicine, Umea University, Umea, Sweden, Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, Skane University Hospital, Lund University, Malmo, Sweden, Department of Odontology, Umea University, Umea, Sweden, Department of Nutrition, Harvard School of Public Health, Boston, MA, USA, Department of Pediatric Dentistry, School of Dentistry, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA, Department of Restorative Dentistry, Periodontology and Endodontology, University Medicine, Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany, Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA, Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, USA, Department of Periodontology, and Department of Dental Ecology, School of Dentistry, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA, Department of Prosthodontics, Gerodontology and Biomaterials, University Medicine, Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany, Human Genetics Center, and Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, TX, USA, Emeritus, Department of Periodontics, West Virginia University School of Dentistry, Morgantown, WV, USA, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, Department of Biobank Research, Umea University, Umea, Sweden, Department of Clinical Sciences, Diabetes and Cardiovascular Disease Genetic Epidemiology, Lund University Diabetes Center, Skane University Hosptial, Malmo, Sweden, Dental Practice and Rural Health, Morgantown, WV, USA, Department of Clinical Sciences, Hypertension and Cardiovascular Disease, Lund University Diabetes Center, Skane University Hospital, Malmo, Sweden, Department of</style></auth-address><titles><title><style face="normal" font="default" size="100%">Using genetics to test the causal relationship of total adiposity and periodontitis: Mendelian randomization analyses in the Gene-Lifestyle Interactions and Dental Endpoints (GLIDE) Consortium</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">638-50</style></pages><volume><style face="normal" font="default" size="100%">44</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2015/06/08</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Age Distribution</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Life Style</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Membrane Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Periodontitis/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Receptor, Melanocortin, Type 4/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Bmi</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">casual inference</style></keyword><keyword><style face="normal" font="default" size="100%">confounding</style></keyword><keyword><style face="normal" font="default" size="100%">periodontitis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1464-3685 (Electronic)&#xD;0300-5771 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26050256</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: The observational relationship between obesity and periodontitis is widely known, yet causal evidence is lacking. Our objective was to investigate causal associations between periodontitis and body mass index (BMI). METHODS: We performed Mendelian randomization analyses with BMI-associated loci combined in a genetic risk score (GRS) as the instrument for BMI. All analyses were conducted within the Gene-Lifestyle Interactions and Dental Endpoints (GLIDE) Consortium in 13 studies from Europe and the USA, including 49,066 participants with clinically assessed (seven studies, 42.1% of participants) and self-reported (six studies, 57.9% of participants) periodontitis and genotype data (17,672/31,394 with/without periodontitis); 68,761 participants with BMI and genotype data; and 57,871 participants (18,881/38,990 with/without periodontitis) with data on BMI and periodontitis. RESULTS: In the observational meta-analysis of all participants, the pooled crude observational odds ratio (OR) for periodontitis was 1.13 [95% confidence interval (CI): 1.03, 1.24] per standard deviation increase of BMI. Controlling for potential confounders attenuated this estimate (OR = 1.08; 95% CI:1.03, 1.12). For clinically assessed periodontitis, corresponding ORs were 1.25 (95% CI: 1.10, 1.42) and 1.13 (95% CI: 1.10, 1.17), respectively. In the genetic association meta-analysis, the OR for periodontitis was 1.01 (95% CI: 0.99, 1.03) per GRS unit (per one effect allele) in all participants and 1.00 (95% CI: 0.97, 1.03) in participants with clinically assessed periodontitis. The instrumental variable meta-analysis of all participants yielded an OR of 1.05 (95% CI: 0.80, 1.38) per BMI standard deviation, and 0.90 (95% CI: 0.56, 1.46) in participants with clinical data. CONCLUSIONS: Our study does not support total adiposity as a causal risk factor for periodontitis, as the point estimate is very close to the null in the causal inference analysis, with wide confidence intervals.</style></abstract><notes><style face="normal" font="default" size="100%">Shungin, Dmitry&#xD;Cornelis, Marilyn C&#xD;Divaris, Kimon&#xD;Holtfreter, Birte&#xD;Shaffer, John R&#xD;Yu, Yau-Hua&#xD;Barros, Silvana P&#xD;Beck, James D&#xD;Biffar, Reiner&#xD;Boerwinkle, Eric A&#xD;Crout, Richard J&#xD;Ganna, Andrea&#xD;Hallmans, Goran&#xD;Hindy, George&#xD;Hu, Frank B&#xD;Kraft, Peter&#xD;McNeil, Daniel W&#xD;Melander, Olle&#xD;Moss, Kevin L&#xD;North, Kari E&#xD;Orho-Melander, Marju&#xD;Pedersen, Nancy L&#xD;Ridker, Paul M&#xD;Rimm, Eric B&#xD;Rose, Lynda M&#xD;Rukh, Gull&#xD;Teumer, Alexander&#xD;Weyant, Robert J&#xD;Chasman, Daniel I&#xD;Joshipura, Kaumudi&#xD;Kocher, Thomas&#xD;Magnusson, Patrik K E&#xD;Marazita, Mary L&#xD;Nilsson, Peter&#xD;Offenbacher, Steve&#xD;Davey Smith, George&#xD;Lundberg, Pernilla&#xD;Palmer, Tom M&#xD;Timpson, Nicholas J&#xD;Johansson, Ingegerd&#xD;Franks, Paul W&#xD;eng&#xD;MC_UU_12013/3/Medical Research Council/United Kingdom&#xD;R01 DE014899/DE/NIDCR NIH HHS/&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;R01 DE023836/DE/NIDCR NIH HHS/&#xD;UM1 CA182913/CA/NCI NIH HHS/&#xD;Meta-Analysis&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Int J Epidemiol. 2015 Apr;44(2):638-50. doi: 10.1093/ije/dyv075. Epub 2015 Jun 6.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26050256</style></url></related-urls><pdf-urls><url>internal-pdf://0649958612/Shungin-2015-Using genetics to test the causal.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4817600</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/ije/dyv075</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>3</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">3</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Skaaby, T.</style></author><author><style face="normal" font="default" size="100%">Taylor, A. E.</style></author><author><style face="normal" font="default" size="100%">Thuesen, B. H.</style></author><author><style face="normal" font="default" size="100%">Jacobsen, R. K.</style></author><author><style face="normal" font="default" size="100%">Friedrich, N.</style></author><author><style face="normal" font="default" size="100%">Mollehave, L. T.</style></author><author><style face="normal" font="default" size="100%">Hansen, S.</style></author><author><style face="normal" font="default" size="100%">Larsen, S. C.</style></author><author><style face="normal" font="default" size="100%">Volker, U.</style></author><author><style face="normal" font="default" size="100%">Nauck, M.</style></author><author><style face="normal" font="default" size="100%">Volzke, H.</style></author><author><style face="normal" font="default" size="100%">Hansen, T.</style></author><author><style face="normal" font="default" size="100%">Pedersen, O.</style></author><author><style face="normal" font="default" size="100%">Jorgensen, T.</style></author><author><style face="normal" font="default" size="100%">Paternoster, L.</style></author><author><style face="normal" font="default" size="100%">Munafo, M.</style></author><author><style face="normal" font="default" size="100%">Grarup, N.</style></author><author><style face="normal" font="default" size="100%">Linneberg, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Research Centre for Prevention and Health, Centre for Health, Capital Region of Denmark, Copenhagen, Denmark.&#xD;MRC Integrative Epidemiology Unit (IEU), The University of Bristol, Bristol, UK.&#xD;UK Centre for Tobacco and Alcohol Studies, School of Experimental Psychology, University of Bristol, Bristol, UK.&#xD;Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.&#xD;Research unit for Dietary Studies, The Parker Institute, Frederiksberg and Bispebjerg Hospitals, The Capital Region, Frederiksberg, Denmark.&#xD;Interfaculty Institute for Genetics and Functional Genomics, University Medicine and Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany.&#xD;Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.&#xD;Section on Metabolic Genetics, Faculty of Health and Medical Sciences, The Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.&#xD;Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.&#xD;Faculty of Medicine, Aalborg University, Aalborg, Denmark.&#xD;Department of Clinical Experimental Research, Rigshospitalet, Glostrup, Denmark.&#xD;Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Estimating the causal effect of body mass index on hay fever, asthma and lung function using Mendelian randomization</style></title><secondary-title><style face="normal" font="default" size="100%">Allergy</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Allergy</style></full-title></periodical><pages><style face="normal" font="default" size="100%">153-164</style></pages><volume><style face="normal" font="default" size="100%">73</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2017/07/05</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Alleles</style></keyword><keyword><style face="normal" font="default" size="100%">Asthma/epidemiology/*etiology/*physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Forced Expiratory Volume</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Immunoglobulin E/immunology</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">*Respiratory Function Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Rhinitis, Allergic, Seasonal/epidemiology/*etiology/*physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">allergic disease</style></keyword><keyword><style face="normal" font="default" size="100%">allergic sensitization</style></keyword><keyword><style face="normal" font="default" size="100%">asthma</style></keyword><keyword><style face="normal" font="default" size="100%">hay fever</style></keyword><keyword><style face="normal" font="default" size="100%">serum-specific IgE</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1398-9995 (Electronic)&#xD;0105-4538 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28675761</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Observational studies have shown that body mass index (BMI) is positively associated with asthma. However, observational data are prone to confounding and reverse causation. In Mendelian randomization, genetic variants are used as unconfounded markers of exposures to examine causal effects. We examined the causal effect of BMI on asthma, hay fever, allergic sensitization, serum total immunoglobulin E (IgE), forced expiratory volume in one-second (FEV1) and forced vital capacity (FVC). METHODS: We included 490 497 participants in the observational and 162 124 participants in the genetic analyses. A genetic risk score (GRS) was created using 26 BMI-associated single nucleotide polymorphisms (SNPs). Results were pooled in meta-analyses and expressed as odds ratios (ORs) or beta-estimates with 95% confidence interval (CI). RESULTS: The GRS was significantly associated with asthma (OR=1.009; 95% CI: 1.004, 1.013), but not with hay fever (OR= 0.998; 95% CI: 0.994, 1.002) or allergic sensitization (OR=0.999; 95% CI: 0.986, 1.012) per BMI-increasing allele. The GRS was significantly associated with decrease in FEV1: beta=-0.0012 (95% CI: -0.0019, -0.0006) and FVC: beta=-0.0022 (95% CI: -0.0031, -0.0014) per BMI-increasing allele. Effect sizes estimated by instrumental variable analyses were OR=1.07 (95% CI: 1.03, 1.10) for asthma, a 9 ml decrease in FEV1 (95% CI: 2.0-15 mL decrease) and a 16 ml decrease in FVC (95% CI: 7.0-24 mL decrease) per 1 kg/m(2) higher BMI. CONCLUSIONS: The results support the conclusion that increasing BMI is causally related to higher prevalence of asthma and decreased lung function, but not with hay fever or biomarkers of allergy.</style></abstract><notes><style face="normal" font="default" size="100%">Skaaby, T&#xD;Taylor, A E&#xD;Thuesen, B H&#xD;Jacobsen, R K&#xD;Friedrich, N&#xD;Mollehave, L T&#xD;Hansen, S&#xD;Larsen, S C&#xD;Volker, U&#xD;Nauck, M&#xD;Volzke, H&#xD;Hansen, T&#xD;Pedersen, O&#xD;Jorgensen, T&#xD;Paternoster, L&#xD;Munafo, M&#xD;Grarup, N&#xD;Linneberg, A&#xD;eng&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00011/7/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/6/MRC_/Medical Research Council/United Kingdom&#xD;Denmark&#xD;Allergy. 2018 Jan;73(1):153-164. doi: 10.1111/all.13242. Epub 2017 Aug 2.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28675761</style></url></related-urls><pdf-urls><url>internal-pdf://2194563159/Skaaby-2018-Estimating the causal effect of bo.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/all.13242</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>152</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">152</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Speed, Maria S.</style></author><author><style face="normal" font="default" size="100%">Jefsen, Oskar H.</style></author><author><style face="normal" font="default" size="100%">Børglum, Anders D.</style></author><author><style face="normal" font="default" size="100%">Speed, Doug</style></author><author><style face="normal" font="default" size="100%">Østergaard, Søren D.</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><urls><pdf-urls><url>internal-pdf://2317643585/Speed-2019-Investigating the Association Betwe.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/539601</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>53</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">53</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Spiller, W.</style></author><author><style face="normal" font="default" size="100%">Slichter, D.</style></author><author><style face="normal" font="default" size="100%">Bowden, J.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Population Health Sciences, University of Bristol, Bristol, UK.&#xD;Department of Economics, Binghamton University, State University of New York, Binghamton, NY, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Detecting and correcting for bias in Mendelian randomization analyses using Gene-by-Environment interactions</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">702-712</style></pages><volume><style face="normal" font="default" size="100%">48</style></volume><number><style face="normal" font="default" size="100%">3</style></number><edition><style face="normal" font="default" size="100%">2018/11/22</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Bias</style></keyword><keyword><style face="normal" font="default" size="100%">Biological Specimen Banks</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Computer Simulation</style></keyword><keyword><style face="normal" font="default" size="100%">*Gene-Environment Interaction</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Pleiotropy</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*MRGxE</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*invalid instruments</style></keyword><keyword><style face="normal" font="default" size="100%">*pleiotropy</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1464-3685 (Electronic)&#xD;0300-5771 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30462199</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Mendelian randomization (MR) has developed into an established method for strengthening causal inference and estimating causal effects, largely due to the proliferation of genome-wide association studies. However, genetic instruments remain controversial, as horizontal pleiotropic effects can introduce bias into causal estimates. Recent work has highlighted the potential of gene-environment interactions in detecting and correcting for pleiotropic bias in MR analyses. METHODS: We introduce MR using Gene-by-Environment interactions (MRGxE) as a framework capable of identifying and correcting for pleiotropic bias. If an instrument-covariate interaction induces variation in the association between a genetic instrument and exposure, it is possible to identify and correct for pleiotropic effects. The interpretation of MRGxE is similar to conventional summary MR approaches, with a particular advantage of MRGxE being the ability to assess the validity of an individual instrument. RESULTS: We investigate the effect of adiposity, measured using body mass index (BMI), upon systolic blood pressure (SBP) using data from the UK Biobank and a single weighted allelic score informed by data from the GIANT consortium. We find MRGxE produces findings in agreement with two-sample summary MR approaches. Further, we perform simulations highlighting the utility of the approach even when the MRGxE assumptions are violated. CONCLUSIONS: By utilizing instrument-covariate interactions in MR analyses implemented within a linear-regression framework, it is possible to identify and correct for horizontal pleiotropic bias, provided the average magnitude of pleiotropy is constant across interaction-covariate subgroups.</style></abstract><notes><style face="normal" font="default" size="100%">Spiller, Wes&#xD;Slichter, David&#xD;Bowden, Jack&#xD;Davey Smith, George&#xD;eng&#xD;MC_UU_00011/2/MRC_/Medical Research Council/United Kingdom&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00011/1/MRC_/Medical Research Council/United Kingdom&#xD;MC_PC_17228/MRC_/Medical Research Council/United Kingdom&#xD;108902/B/15/Z/WT_/Wellcome Trust/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Int J Epidemiol. 2019 Jun 1;48(3):702-712. doi: 10.1093/ije/dyy204.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30462199</style></url></related-urls><pdf-urls><url>internal-pdf://3857012490/Spiller-2018-Detecting and correcting for bias.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6659360</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/ije/dyy204</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>15</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">15</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Staley, J. R.</style></author><author><style face="normal" font="default" size="100%">Burgess, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Strangeways Research Laboratory, Department of Public Health and Primary Care, Cardiovascular Epidemiology Unit, University of Cambridge, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization</style></title><secondary-title><style face="normal" font="default" size="100%">Genet Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Genet Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">341-352</style></pages><volume><style face="normal" font="default" size="100%">41</style></volume><number><style face="normal" font="default" size="100%">4</style></number><edition><style face="normal" font="default" size="100%">2017/03/21</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Blood Pressure/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Computer Simulation</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Models, Genetic</style></keyword><keyword><style face="normal" font="default" size="100%">Models, Statistical</style></keyword><keyword><style face="normal" font="default" size="100%">*Nonlinear Dynamics</style></keyword><keyword><style face="normal" font="default" size="100%">Tissue Banks</style></keyword><keyword><style face="normal" font="default" size="100%">United Kingdom</style></keyword><keyword><style face="normal" font="default" size="100%">*UK Biobank</style></keyword><keyword><style face="normal" font="default" size="100%">*causal effects</style></keyword><keyword><style face="normal" font="default" size="100%">*fractional polynomials</style></keyword><keyword><style face="normal" font="default" size="100%">*genetic variants</style></keyword><keyword><style face="normal" font="default" size="100%">*piecewise linear models</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1098-2272 (Electronic)&#xD;0741-0395 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28317167</style></accession-num><abstract><style face="normal" font="default" size="100%">Mendelian randomization, the use of genetic variants as instrumental variables (IV), can test for and estimate the causal effect of an exposure on an outcome. Most IV methods assume that the function relating the exposure to the expected value of the outcome (the exposure-outcome relationship) is linear. However, in practice, this assumption may not hold. Indeed, often the primary question of interest is to assess the shape of this relationship. We present two novel IV methods for investigating the shape of the exposure-outcome relationship: a fractional polynomial method and a piecewise linear method. We divide the population into strata using the exposure distribution, and estimate a causal effect, referred to as a localized average causal effect (LACE), in each stratum of population. The fractional polynomial method performs metaregression on these LACE estimates. The piecewise linear method estimates a continuous piecewise linear function, the gradient of which is the LACE estimate in each stratum. Both methods were demonstrated in a simulation study to estimate the true exposure-outcome relationship well, particularly when the relationship was a fractional polynomial (for the fractional polynomial method) or was piecewise linear (for the piecewise linear method). The methods were used to investigate the shape of relationship of body mass index with systolic blood pressure and diastolic blood pressure.</style></abstract><notes><style face="normal" font="default" size="100%">Staley, James R&#xD;Burgess, Stephen&#xD;eng&#xD;G0800270/MRC_/Medical Research Council/United Kingdom&#xD;RG/13/13/30194/BHF_/British Heart Foundation/United Kingdom&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;MC_UP_0801/1/MRC_/Medical Research Council/United Kingdom&#xD;MR/L003120/1/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00002/7/MRC_/Medical Research Council/United Kingdom&#xD;268834/ERC_/European Research Council/International&#xD;G66840/MRC_/Medical Research Council/United Kingdom&#xD;RG/08/014/24067/BHF_/British Heart Foundation/United Kingdom&#xD;SP/09/002/BHF_/British Heart Foundation/United Kingdom&#xD;100114/WT_/Wellcome Trust/United Kingdom&#xD;Genet Epidemiol. 2017 May;41(4):341-352. doi: 10.1002/gepi.22041. Epub 2017 Mar 20.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28317167</style></url></related-urls><pdf-urls><url>internal-pdf://2672678548/Staley-2017-Semiparametric methods for estimat.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5400068</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/gepi.22041</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>145</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">145</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Stender, S.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author><author><style face="normal" font="default" size="100%">Tybjaerg-Hansen, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Hepatology</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Hepatology</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2133-41</style></pages><volume><style face="normal" font="default" size="100%">58</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2013/06/19</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Alleles</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Confounding Factors, Epidemiologic</style></keyword><keyword><style face="normal" font="default" size="100%">Denmark</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Gallstones/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Membrane Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Random Allocation</style></keyword><keyword><style face="normal" font="default" size="100%">Receptor, Melanocortin, Type 4/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1527-3350 (Electronic)&#xD;0270-9139 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">23775818</style></accession-num><abstract><style face="normal" font="default" size="100%">UNLABELLED: Elevated body mass index (BMI) is associated with an increased risk of gallstone disease. Whether this reflects a causal association is unknown. Using a Mendelian randomization approach, we studied 77,679 individuals from the general population. Of these, 4,106 developed symptomatic gallstone disease during up to 34 years of follow-up. Subjects were genotyped for three common variants known to associate with BMI: FTO(rs9939609); MC4R(rs17782313); and TMEM18(rs6548238). The number of BMI-increasing alleles was calculated for each participant. In observational analyses, mean baseline BMI was 55% (11.6 kg/m(2) ) increased in individuals in the fifth quintile versus the first quintile, similar in women and men. The corresponding multifactorially adjusted hazard ratio (HR) for symptomatic gallstone disease was 2.84 (95% confidence interval [CI]: 2.32-3.46) overall, 3.36 (95% CI: 2.62-4.31) in women, and 1.51 (95% CI: 1.09-2.11) in men (P trend: 0.001 to &lt;0.001; P interaction: BMI*sex on risk = 0.01). In genetic analyses, carrying 6 versus 0-1 BMI-increasing alleles was associated with a 5.2% (1.3 kg/m(2) ) increase in BMI overall and with increases of 4.3% in women and 6.1% in men (all P trend: &lt;0.001). Corresponding HRs for symptomatic gallstone disease were 1.43 (95% CI: 0.99-2.05) overall, 1.54 (95% CI: 1.00-2.35) in women, and 1.19 (95% CI: 0.60-2.38) in men (P trend = 0.007, 0.02, and 0.26, respectively; P interaction allele score*sex on risk = 0.49). The estimated causal odds ratio (OR) for symptomatic gallstone disease, by instrumental variable analysis for a 1 kg/m(2) increase in genetically determined BMI, was 1.17 (95% CI: 0.99-1.37) overall and 1.20 (95% CI: 1.00-1.44) and 1.02 (95% CI: 0.90-1.16) in women and men, respectively. Corresponding observational HRs were 1.07 (95% CI: 1.06-1.08), 1.08 (95% CI: 1.07-1.10), and 1.04 (95% CI: 1.02-1.07), respectively. CONCLUSION: These results are compatible with a causal association between elevated BMI and increased risk of symptomatic gallstone disease, which is most pronounced in women.</style></abstract><notes><style face="normal" font="default" size="100%">Stender, Stefan&#xD;Nordestgaard, Borge G&#xD;Tybjaerg-Hansen, Anne&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Hepatology. 2013 Dec;58(6):2133-41. doi: 10.1002/hep.26563. Epub 2013 Oct 11.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/23775818</style></url></related-urls><pdf-urls><url>internal-pdf://3240821272/Stender-2013-Elevated body mass index as a cau.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/hep.26563</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>14</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">14</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Takahashi, H.</style></author><author><style face="normal" font="default" size="100%">Cornish, A. J.</style></author><author><style face="normal" font="default" size="100%">Sud, A.</style></author><author><style face="normal" font="default" size="100%">Law, P. J.</style></author><author><style face="normal" font="default" size="100%">Disney-Hogg, L.</style></author><author><style face="normal" font="default" size="100%">Calvocoressi, L.</style></author><author><style face="normal" font="default" size="100%">Lu, L.</style></author><author><style face="normal" font="default" size="100%">Hansen, H. M.</style></author><author><style face="normal" font="default" size="100%">Smirnov, I.</style></author><author><style face="normal" font="default" size="100%">Walsh, K. M.</style></author><author><style face="normal" font="default" size="100%">Schramm, J.</style></author><author><style face="normal" font="default" size="100%">Hoffmann, P.</style></author><author><style face="normal" font="default" size="100%">Nothen, M. M.</style></author><author><style face="normal" font="default" size="100%">Jockel, K. H.</style></author><author><style face="normal" font="default" size="100%">Schildkraut, J. M.</style></author><author><style face="normal" font="default" size="100%">Simon, M.</style></author><author><style face="normal" font="default" size="100%">Bondy, M.</style></author><author><style face="normal" font="default" size="100%">Wrensch, M.</style></author><author><style face="normal" font="default" size="100%">Wiemels, J. L.</style></author><author><style face="normal" font="default" size="100%">Claus, E. B.</style></author><author><style face="normal" font="default" size="100%">Turnbull, C.</style></author><author><style face="normal" font="default" size="100%">Houlston, R. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.&#xD;Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. alex.cornish@icr.ac.uk.&#xD;School of Public Health, Yale University, New Haven, Connecticut, USA.&#xD;Division of Neuroepidemiology, Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.&#xD;University of Bonn Medical School, Bonn, Germany.&#xD;Human Genomics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland.&#xD;Department of Genomics, Life &amp; Brain Center, University of Bonn, Bonn, Germany.&#xD;Institute of Human Genetics, University of Bonn School of Medicine &amp; University Hospital Bonn, Bonn, Germany.&#xD;Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.&#xD;Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.&#xD;Department of Neurosurgery, Bethel Clinic, Bielefeld, Germany.&#xD;Section of Epidemiology and Population Sciences, Department of Medicine and Dan L., Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.&#xD;Institute for Human Genetics, University of California San Francisco, San Francisco, California, USA.&#xD;Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.&#xD;Department of Neurosurgery, Brigham and Women&apos;s Hospital, Boston, Massachusetts, USA.&#xD;William Harvey Research Institute, Queen Mary University, London, UK.&#xD;Guys and St. Thomas Foundation NHS Trust, Great Maze Pond, London, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Mendelian randomization provides support for obesity as a risk factor for meningioma</style></title><secondary-title><style face="normal" font="default" size="100%">Sci Rep</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Sci Rep</style></full-title></periodical><pages><style face="normal" font="default" size="100%">309</style></pages><volume><style face="normal" font="default" size="100%">9</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2019/01/24</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adipose Tissue</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Meningioma/*etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan 22</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2045-2322 (Electronic)&#xD;2045-2322 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30670737</style></accession-num><abstract><style face="normal" font="default" size="100%">Little is known about the causes of meningioma. Obesity and obesity-related traits have been reported in several epidemiological observational studies to be risk factors for meningioma. We performed an analysis of genetic variants associated with obesity-related traits to assess the relationship with meningioma risk using Mendelian randomization (MR), an approach unaffected by biases from temporal variability and reverse causation that might have affected earlier investigations. We considered 11 obesity-related traits, identified genetic instruments for these factors, and assessed their association with meningioma risk using data from a genome-wide association study comprising 1,606 meningioma patients and 9,823 controls. To evaluate the causal relationship between the obesity-related traits and meningioma risk, we consider the estimated odds ratio (OR) of meningioma for each genetic instrument. We identified positive associations between body mass index (odds ratio [ORSD] = 1.27, 95% confidence interval [CI] = 1.03-1.56, P = 0.028) and body fat percentage (ORSD = 1.28, 95% CI = 1.01-1.63, P = 0.042) with meningioma risk, albeit non-significant after correction for multiple testing. Associations for basal metabolic rate, diastolic blood pressure, fasting glucose, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, systolic blood pressure, total cholesterol, triglycerides and waist circumference with risk of meningioma were non-significant. Our analysis provides additional support for obesity being associated with an increased risk of meningioma.</style></abstract><notes><style face="normal" font="default" size="100%">Takahashi, Hannah&#xD;Cornish, Alex J&#xD;Sud, Amit&#xD;Law, Philip J&#xD;Disney-Hogg, Linden&#xD;Calvocoressi, Lisa&#xD;Lu, Lingeng&#xD;Hansen, Helen M&#xD;Smirnov, Ivan&#xD;Walsh, Kyle M&#xD;Schramm, Johannes&#xD;Hoffmann, Per&#xD;Nothen, Markus M&#xD;Jockel, Karl-Heinz&#xD;Schildkraut, Joellen M&#xD;Simon, Matthias&#xD;Bondy, Melissa&#xD;Wrensch, Margaret&#xD;Wiemels, Joseph L&#xD;Claus, Elizabeth B&#xD;Turnbull, Clare&#xD;Houlston, Richard S&#xD;eng&#xD;WT_/Wellcome Trust/United Kingdom&#xD;C1298/A8362/CRUK_/Cancer Research UK/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Sci Rep. 2019 Jan 22;9(1):309. doi: 10.1038/s41598-018-36186-6.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30670737</style></url></related-urls><pdf-urls><url>internal-pdf://2538501270/Takahashi-2019-Mendelian randomization provide.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6343031</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s41598-018-36186-6</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>111</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">111</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Taylor, A. E.</style></author><author><style face="normal" font="default" size="100%">Richmond, R. C.</style></author><author><style face="normal" font="default" size="100%">Palviainen, T.</style></author><author><style face="normal" font="default" size="100%">Loukola, A.</style></author><author><style face="normal" font="default" size="100%">Wootton, R. E.</style></author><author><style face="normal" font="default" size="100%">Kaprio, J.</style></author><author><style face="normal" font="default" size="100%">Relton, C. L.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Munafo, M. R.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.&#xD;National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and the University of Bristol, UK.&#xD;MRC Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK.&#xD;Institute for Molecular Medicine Finland FIMM, Helsinki Institute for Life Science, University of Helsinki, Helsinki, Finland.&#xD;UK Centre for Tobacco and Alcohol Studies, School of Experimental Psychology, University of Bristol, Bristol, UK.&#xD;Department of Public Health, Medical Faculty, University of Helsinki, Helsinki, Finland.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The effect of body mass index on smoking behaviour and nicotine metabolism: a Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Hum Mol Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Hum Mol Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1322-1330</style></pages><volume><style face="normal" font="default" size="100%">28</style></volume><number><style face="normal" font="default" size="100%">8</style></number><edition><style face="normal" font="default" size="100%">2018/12/19</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Body Weight/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">DNA Methylation/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Nicotine/genetics/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Smoking/*genetics/*metabolism/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Smoking Cessation</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr 15</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1460-2083 (Electronic)&#xD;0964-6906 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30561638</style></accession-num><abstract><style face="normal" font="default" size="100%">Given clear evidence that smoking lowers weight, it is possible that individuals with higher body mass index (BMI) smoke in order to lose or maintain their weight. We performed Mendelian randomization (MR) analyses of the effects of BMI on smoking behaviour in UK Biobank and the Tobacco and Genetics Consortium genome-wide association study (GWAS), on cotinine levels and nicotine metabolite ratio (NMR) in published GWAS and on DNA methylation in the Avon Longitudinal Study of Parents and Children. Our results indicate that higher BMI causally influences lifetime smoking, smoking initiation, smoking heaviness and also DNA methylation at the aryl-hydrocarbon receptor repressor (AHRR) locus, but we do not see evidence for an effect on smoking cessation. While there is no strong evidence that BMI causally influences cotinine levels, suggestive evidence for a negative causal influence on NMR may explain this. There is a causal effect of BMI on smoking, but the relationship is likely to be complex due to opposing effects on behaviour and metabolism.</style></abstract><notes><style face="normal" font="default" size="100%">Taylor, Amy E&#xD;Richmond, Rebecca C&#xD;Palviainen, Teemu&#xD;Loukola, Anu&#xD;Wootton, Robyn E&#xD;Kaprio, Jaakko&#xD;Relton, Caroline L&#xD;Davey Smith, George&#xD;Munafo, Marcus R&#xD;eng&#xD;MC_UU_00011/7/MRC_/Medical Research Council/United Kingdom&#xD;MR/K023195/1/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/1/MRC_/Medical Research Council/United Kingdom&#xD;C57854/A22171/CRUK_/Cancer Research UK/United Kingdom&#xD;WT_/Wellcome Trust/United Kingdom&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/6/MRC_/Medical Research Council/United Kingdom&#xD;MC_PC_17228/MRC_/Medical Research Council/United Kingdom&#xD;C18281/A19169 /CRUK_/Cancer Research UK/United Kingdom&#xD;G9815508/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/2/MRC_/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Hum Mol Genet. 2019 Apr 15;28(8):1322-1330. doi: 10.1093/hmg/ddy434.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30561638</style></url></related-urls><pdf-urls><url>internal-pdf://0025217935/Taylor-2018-The effect of body mass index on s.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6452214</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/hmg/ddy434</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>161</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">161</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Taylor, P. N.</style></author><author><style face="normal" font="default" size="100%">Richmond, R.</style></author><author><style face="normal" font="default" size="100%">Davies, N.</style></author><author><style face="normal" font="default" size="100%">Sayers, A.</style></author><author><style face="normal" font="default" size="100%">Stevenson, K.</style></author><author><style face="normal" font="default" size="100%">Woltersdorf, W.</style></author><author><style face="normal" font="default" size="100%">Taylor, A.</style></author><author><style face="normal" font="default" size="100%">Groom, A.</style></author><author><style face="normal" font="default" size="100%">Northstone, K.</style></author><author><style face="normal" font="default" size="100%">Ring, S.</style></author><author><style face="normal" font="default" size="100%">Okosieme, O.</style></author><author><style face="normal" font="default" size="100%">Rees, A.</style></author><author><style face="normal" font="default" size="100%">Nitsch, D.</style></author><author><style face="normal" font="default" size="100%">Williams, G. R.</style></author><author><style face="normal" font="default" size="100%">Smith, G. D.</style></author><author><style face="normal" font="default" size="100%">Gregory, J. W.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Tobias, J. H.</style></author><author><style face="normal" font="default" size="100%">Dayan, C. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Thyroid Research Group (P.N.T., O.O., J.W.G., C.M.D.) and Institute of Molecular and Experimental Medicine (A.R.), Cardiff University School of Medicine, Cardiff, CF14 4XN United Kingdom; Medical Research Council Integrative Epidemiology Unit (R.R., N.D., G.D.S., N.J.T.), University of Bristol, Bristol, BS8 2BN United Kingdom; Department of Social and Community Medicine (A.S., A.G., K.N., S.R.), University of Bristol, Bristol, BS8 2BN United Kingdom; Department of Biochemistry (K.S.), Bristol Royal Infirmary University Hospitals Bristol National Health Service Foundation Trust, Bristol, BS2 8HW United Kingdom; Geschaftsleiter Medizinisches Versorgungszentrum Labor Dr. Reising-Ackermann und Kollegen (W.W.), D-04289 Leipzig, Germany; Department of Biochemistry (A.T.), Royal United Hospital, Bath, BA1 3NG United Kingdom; Department of Non-Communicable Disease Epidemiology (D.N.), Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, CF14 4XN United Kingdom; Molecular Endocrinology Group (G.R.W.), Department of Medicine, Imperial College London, London, WC1E 7HT United Kingdom; and Musculoskeletal Research Unit (J.H.T.), University of Bristol, Learning and Research Southmead Hospital, Westbury on Trym, Bristol, BS10 5NB United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Paradoxical Relationship Between Body Mass Index and Thyroid Hormone Levels: A Study Using Mendelian Randomization</style></title><secondary-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></full-title></periodical><pages><style face="normal" font="default" size="100%">730-8</style></pages><volume><style face="normal" font="default" size="100%">101</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2015/11/26</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Age Factors</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Environment</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Pediatric Obesity/epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Random Allocation</style></keyword><keyword><style face="normal" font="default" size="100%">Sex Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroid Hormones/*blood/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Thyroxine/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Triiodothyronine/blood/genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1945-7197 (Electronic)&#xD;0021-972X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26595101</style></accession-num><abstract><style face="normal" font="default" size="100%">CONTEXT: Free T3 (FT3) has been positively associated with body mass index (BMI) in cross-sectional studies in healthy individuals. This is difficult to reconcile with clinical findings in pathological thyroid dysfunction. OBJECTIVE: We aimed to investigate whether childhood adiposity influences FT3 levels. DESIGN: Mendelian randomization using genetic variants robustly associated with BMI. SETTING: Avon Longitudinal Study of Parents and Children, a population-based birth cohort. PARTICIPANTS: A total of 3014 children who had thyroid function measured at age 7, who also underwent dual x-ray absorptiometry scans at ages 9.9 and 15.5 years and have genetic data available. MAIN OUTCOME MEASURES: FT3. RESULTS: Observationally at age 7 years, BMI was positively associated with FT3: beta-standardized (beta-[std]) = 0.12 (95% confidence interval [CI]: 0.08, 0.16), P = 4.02 x 10(-10); whereas FT4 was negatively associated with BMI: beta-(std) = -0.08 (95% CI: -0.12, -0.04), P = 3.00 x 10(-5). These differences persisted after adjustment for age, sex, and early life environment. Genetic analysis indicated 1 allele change in BMI allelic score was associated with a 0.04 (95% CI: 0.03, 0.04) SD increase in BMI (P = 6.41 x 10(-17)). At age 7, a genetically determined increase in BMI of 1.89 kg/m(2) was associated with a 0.22 pmol/L (95% CI: 0.07, 0.36) increase in FT3 (P = .004) but no substantial change in FT4 0.01 mmol/L, (95% CI: -0.37, 0.40), P = .96. CONCLUSION: Our analysis shows that children with a genetically higher BMI had higher FT3 but not FT4 levels, indicating that higher BMI/fat mass has a causal role in increasing FT3 levels. This may explain the paradoxical associations observed in observational analyses. Given rising childhood obesity levels, this relationship merits closer scrutiny.</style></abstract><notes><style face="normal" font="default" size="100%">Taylor, Peter N&#xD;Richmond, Rebecca&#xD;Davies, Neil&#xD;Sayers, Adrian&#xD;Stevenson, Kirsty&#xD;Woltersdorf, Wolfram&#xD;Taylor, Andrew&#xD;Groom, Alix&#xD;Northstone, Kate&#xD;Ring, Susan&#xD;Okosieme, Onyebuchi&#xD;Rees, Aled&#xD;Nitsch, Dorothea&#xD;Williams, Graham R&#xD;Smith, George Davey&#xD;Gregory, John W&#xD;Timpson, Nicholas J&#xD;Tobias, Jonathan H&#xD;Dayan, Colin M&#xD;eng&#xD;MC_UU_12013/3/Medical Research Council/United Kingdom&#xD;102215/Wellcome Trust/United Kingdom&#xD;MC_PC_15018/Medical Research Council/United Kingdom&#xD;102215/2/13/2/Wellcome Trust/United Kingdom&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;MC_UU_12013/9/Medical Research Council/United Kingdom&#xD;Wellcome Trust/United Kingdom&#xD;Observational Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;J Clin Endocrinol Metab. 2016 Feb;101(2):730-8. doi: 10.1210/jc.2015-3505. Epub 2015 Nov 23.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26595101</style></url></related-urls><pdf-urls><url>internal-pdf://0270662615/Taylor-2016-Paradoxical Relationship Between B.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4880123</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1210/jc.2015-3505</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>13</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">13</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Thakkinstian, A.</style></author><author><style face="normal" font="default" size="100%">Chailurkit, L.</style></author><author><style face="normal" font="default" size="100%">Warodomwichit, D.</style></author><author><style face="normal" font="default" size="100%">Ratanachaiwong, W.</style></author><author><style face="normal" font="default" size="100%">Yamwong, S.</style></author><author><style face="normal" font="default" size="100%">Chanprasertyothin, S.</style></author><author><style face="normal" font="default" size="100%">Attia, J.</style></author><author><style face="normal" font="default" size="100%">Sritara, P.</style></author><author><style face="normal" font="default" size="100%">Ongphiphadhanakul, B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Section for Clinical Epidemiology and Biostatistics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal relationship between body mass index and fetuin-A level in the asian population: a bidirectional Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Clin Endocrinol (Oxf)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Clin Endocrinol (Oxf)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">197-203</style></pages><volume><style face="normal" font="default" size="100%">81</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2013/08/01</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">Asian Continental Ancestry Group</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fetuins/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/genetics/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">alpha-2-HS-Glycoprotein/*metabolism</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1365-2265 (Electronic)&#xD;0300-0664 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">23899227</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVE: Fetuin-A is associated with body mass index (BMI) as well as components of the metabolic syndrome. However, it is unclear if fetuin-A affects BMI or the other way around. We therefore assessed the causal association between fetuin-A and BMI or vice versa, utilizing a bidirectional Mendelian randomization approach. DESIGN AND METHODS: This was a study of 2558 subjects from the Electricity Generating Authority of Thailand (EGAT) cohort. Two polymorphisms, that is, rs2248690 in the alpha2-Hereman-Schmid glycoprotein (AHSG) gene and rs9939609 in the fat mass and obesity-associated (FTO) gene were genotyped. Bidirectional causal models were constructed using a two-stage least-square instrumental variable (IV) regression. First, rs2248690 locus was used as the instrumental variable for the effect of circulating fetuin-A on BMI, and then, the FTO rs9939609 locus was used as the instrumental variable for the effect of BMI on circulating fetuin-A. RESULTS: Among the 2558 subjects, the prevalence of the minor AHSG (T) and FTO (A) alleles was 17.9% and 22.1%, respectively. The AHSG rs2248690 locus was highly related to serum fetuin-A levels (P &lt; 0.001). Likewise, the FTO rs9939609 locus and BMI were highly associated (P &lt; 0.001). Mendelian randomization analyses showed that circulating fetuin-A, instrumented by the AHSG rs2248690 locus, was associated with BMI (coefficient = 2.26; 95% CI: 0.39, 4.12). In contrast, BMI, instrumented by the FTO rs9939609 locus, was not associated with circulating fetuin-A (coefficient = 0.0007; 95% CI: -0.0242, 0.0256). CONCLUSION: Our findings suggest a causal association leading from circulating fetuin-A to BMI. There was no evidence of reverse causality from BMI to fetuin-A.</style></abstract><notes><style face="normal" font="default" size="100%">Thakkinstian, Ammarin&#xD;Chailurkit, Laor&#xD;Warodomwichit, Daruneewan&#xD;Ratanachaiwong, Wipa&#xD;Yamwong, Sukit&#xD;Chanprasertyothin, Suwannee&#xD;Attia, John&#xD;Sritara, Piyamitr&#xD;Ongphiphadhanakul, Boonsong&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Clin Endocrinol (Oxf). 2014 Aug;81(2):197-203. doi: 10.1111/cen.12303. Epub 2013 Aug 28.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/23899227</style></url></related-urls><pdf-urls><url>internal-pdf://0923572148/Thakkinstian-2014-Causal relationship between.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/cen.12303</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>83</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">83</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Thrift, A. P.</style></author><author><style face="normal" font="default" size="100%">Gong, J.</style></author><author><style face="normal" font="default" size="100%">Peters, U.</style></author><author><style face="normal" font="default" size="100%">Chang-Claude, J.</style></author><author><style face="normal" font="default" size="100%">Rudolph, A.</style></author><author><style face="normal" font="default" size="100%">Slattery, M. L.</style></author><author><style face="normal" font="default" size="100%">Chan, A. T.</style></author><author><style face="normal" font="default" size="100%">Locke, A. E.</style></author><author><style face="normal" font="default" size="100%">Kahali, B.</style></author><author><style face="normal" font="default" size="100%">Justice, A. E.</style></author><author><style face="normal" font="default" size="100%">Pers, T. H.</style></author><author><style face="normal" font="default" size="100%">Gallinger, S.</style></author><author><style face="normal" font="default" size="100%">Hayes, R. B.</style></author><author><style face="normal" font="default" size="100%">Baron, J. A.</style></author><author><style face="normal" font="default" size="100%">Caan, B. J.</style></author><author><style face="normal" font="default" size="100%">Ogino, S.</style></author><author><style face="normal" font="default" size="100%">Berndt, S. I.</style></author><author><style face="normal" font="default" size="100%">Chanock, S. J.</style></author><author><style face="normal" font="default" size="100%">Casey, G.</style></author><author><style face="normal" font="default" size="100%">Haile, R. W.</style></author><author><style face="normal" font="default" size="100%">Du, M.</style></author><author><style face="normal" font="default" size="100%">Harrison, T. A.</style></author><author><style face="normal" font="default" size="100%">Thornquist, M.</style></author><author><style face="normal" font="default" size="100%">Duggan, D. J.</style></author><author><style face="normal" font="default" size="100%">Le Marchand, L.</style></author><author><style face="normal" font="default" size="100%">Lindor, N. M.</style></author><author><style face="normal" font="default" size="100%">Seminara, D.</style></author><author><style face="normal" font="default" size="100%">Song, M.</style></author><author><style face="normal" font="default" size="100%">Wu, K.</style></author><author><style face="normal" font="default" size="100%">Thibodeau, S. N.</style></author><author><style face="normal" font="default" size="100%">Cotterchio, M.</style></author><author><style face="normal" font="default" size="100%">Win, A. K.</style></author><author><style face="normal" font="default" size="100%">Jenkins, M. A.</style></author><author><style face="normal" font="default" size="100%">Hopper, J. L.</style></author><author><style face="normal" font="default" size="100%">Ulrich, C. M.</style></author><author><style face="normal" font="default" size="100%">Potter, J. D.</style></author><author><style face="normal" font="default" size="100%">Newcomb, P. A.</style></author><author><style face="normal" font="default" size="100%">Hoffmeister, M.</style></author><author><style face="normal" font="default" size="100%">Brenner, H.</style></author><author><style face="normal" font="default" size="100%">White, E.</style></author><author><style face="normal" font="default" size="100%">Hsu, L.</style></author><author><style face="normal" font="default" size="100%">Campbell, P. T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Department of Medicine and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas. aaron.thrift@bcm.edu.&#xD;Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.&#xD;Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington.&#xD;Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah.&#xD;Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Channing Division of Network Medicine, Brigham and Women&apos;s Hospital and Harvard Medical School, Boston, Massachusetts.&#xD;Center for Statistical Genetics, Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.&#xD;Department of Internal Medicine, Division of Gastroenterology, and Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan.&#xD;Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.&#xD;Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Boston Children&apos;s Hospital, Boston, Massachusetts. Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts. Department of Genetics, Harvard Medical School, Boston, Massachusetts. Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark.&#xD;Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.&#xD;Division of Epidemiology, Department of Population Health, New York University School of Medicine, New York, New York.&#xD;Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.&#xD;Division of Research, Kaiser Permanente Northern California, Oakland, California.&#xD;Department of Pathology, Brigham and Women&apos;s Hospital, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.&#xD;Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.&#xD;USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.&#xD;Department of Medicine, Division of Oncology, Stanford University, Stanford, California.&#xD;Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington. Channing Division of Network Medicine, Brigham and Women&apos;s Hospital and Harvard Medical School, Boston, Massachusetts.&#xD;Translational Genomics Research Institute, Phoenix, Arizona.&#xD;Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.&#xD;Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona.&#xD;Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, Maryland.&#xD;Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts.&#xD;Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts.&#xD;Departments of Laboratory Medicine and Pathology and Laboratory Genetics, Mayo Clinic, Rochester, Minnesota.&#xD;Prevention and Cancer Control, Cancer Care Ontario, Toronto, Canada.&#xD;Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.&#xD;Population Sciences Huntsman Cancer Institute, Salt Lake City, Utah.&#xD;Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington. Centre for Public Health Research, Massey University, Wellington, New Zealand.&#xD;Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.&#xD;Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany.&#xD;Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Department of Biostatistics, School of Public Health, University of Washington, Seattle, Washington.&#xD;Epidemiology Research Program, American Cancer Society, Atlanta, Georgia.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk</style></title><secondary-title><style face="normal" font="default" size="100%">Cancer Epidemiol Biomarkers Prev</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Cancer Epidemiol Biomarkers Prev</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1024-31</style></pages><volume><style face="normal" font="default" size="100%">24</style></volume><number><style face="normal" font="default" size="100%">7</style></number><edition><style face="normal" font="default" size="100%">2015/05/16</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Colorectal Neoplasms/*epidemiology/etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Europe/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications/epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Odds Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1538-7755 (Electronic)&#xD;1055-9965 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">25976416</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: High body mass index (BMI) is consistently linked to increased risk of colorectal cancer for men, whereas the association is less clear for women. As risk estimates from observational studies may be biased and/or confounded, we conducted a Mendelian randomization study to estimate the causal association between BMI and colorectal cancer. METHODS: We used data from 10,226 colorectal cancer cases and 10,286 controls of European ancestry. The Mendelian randomization analysis used a weighted genetic risk score, derived from 77 genome-wide association study-identified variants associated with higher BMI, as an instrumental variable (IV). We compared the IV odds ratio (IV-OR) with the OR obtained using a conventional covariate-adjusted analysis. RESULTS: Individuals carrying greater numbers of BMI-increasing alleles had higher colorectal cancer risk [per weighted allele OR, 1.31; 95% confidence interval (CI), 1.10-1.57]. Our IV estimation results support the hypothesis that genetically influenced BMI is directly associated with risk for colorectal cancer (IV-OR per 5 kg/m(2), 1.50; 95% CI, 1.13-2.01). In the sex-specific IV analyses higher BMI was associated with higher risk of colorectal cancer among women (IV-OR per 5 kg/m(2), 1.82; 95% CI, 1.26-2.61). For men, genetically influenced BMI was not associated with colorectal cancer (IV-OR per 5 kg/m(2), 1.18; 95% CI, 0.73-1.92). CONCLUSIONS: High BMI was associated with increased colorectal cancer risk for women. Whether abdominal obesity, rather than overall obesity, is a more important risk factor for men requires further investigation. IMPACT: Overall, conventional epidemiologic and Mendelian randomization studies suggest a strong association between obesity and the risk of colorectal cancer.</style></abstract><notes><style face="normal" font="default" size="100%">Thrift, Aaron P&#xD;Gong, Jian&#xD;Peters, Ulrike&#xD;Chang-Claude, Jenny&#xD;Rudolph, Anja&#xD;Slattery, Martha L&#xD;Chan, Andrew T&#xD;Locke, Adam E&#xD;Kahali, Bratati&#xD;Justice, Anne E&#xD;Pers, Tune H&#xD;Gallinger, Steven&#xD;Hayes, Richard B&#xD;Baron, John A&#xD;Caan, Bette J&#xD;Ogino, Shuji&#xD;Berndt, Sonja I&#xD;Chanock, Stephen J&#xD;Casey, Graham&#xD;Haile, Robert W&#xD;Du, Mengmeng&#xD;Harrison, Tabitha A&#xD;Thornquist, Mark&#xD;Duggan, David J&#xD;Le Marchand, Loic&#xD;Lindor, Noralane M&#xD;Seminara, Daniela&#xD;Song, Mingyang&#xD;Wu, Kana&#xD;Thibodeau, Stephen N&#xD;Cotterchio, Michelle&#xD;Win, Aung Ko&#xD;Jenkins, Mark A&#xD;Hopper, John L&#xD;Ulrich, Cornelia M&#xD;Potter, John D&#xD;Newcomb, Polly A&#xD;Hoffmeister, Michael&#xD;Brenner, Hermann&#xD;White, Emily&#xD;Hsu, Li&#xD;Campbell, Peter T&#xD;eng&#xD;U01 HG004438/HG/NHGRI NIH HHS/&#xD;P01 CA087969/CA/NCI NIH HHS/&#xD;U01 CA164930/CA/NCI NIH HHS/&#xD;HHSN268201100002C/WH/WHI NIH HHS/&#xD;U01 CA097735/CA/NCI NIH HHS/&#xD;UM1 CA167552/CA/NCI NIH HHS/&#xD;U24 CA074799/CA/NCI NIH HHS/&#xD;R01 CA059045/CA/NCI NIH HHS/&#xD;HHSN268201100001I/HL/NHLBI NIH HHS/&#xD;U01 CA074778/CA/NCI NIH HHS/&#xD;R01 CA076366/CA/NCI NIH HHS/&#xD;P01 CA 087969/CA/NCI NIH HHS/&#xD;U01 HG004446/HG/NHGRI NIH HHS/&#xD;R01 AG014358/AG/NIA NIH HHS/&#xD;U01 CA074799/CA/NCI NIH HHS/&#xD;R01 AG14358/AG/NIA NIH HHS/&#xD;P30 CA015704/CA/NCI NIH HHS/&#xD;HHSN268201100004I/HL/NHLBI NIH HHS/&#xD;P01 CA53996/CA/NCI NIH HHS/&#xD;K05 CA154337/CA/NCI NIH HHS/&#xD;U24 CA074783/CA/NCI NIH HHS/&#xD;P01 CA055075/CA/NCI NIH HHS/&#xD;P50 CA 127003/CA/NCI NIH HHS/&#xD;R01 CA151993/CA/NCI NIH HHS/&#xD;HHSN268201100046C/HL/NHLBI NIH HHS/&#xD;CAPMC/ CIHR/Canada&#xD;R01 CA048998/CA/NCI NIH HHS/&#xD;R25 CA094880/CA/NCI NIH HHS/&#xD;U01 CA137088/CA/NCI NIH HHS/&#xD;HHSN268201100003C/WH/WHI NIH HHS/&#xD;U24 CA074794/CA/NCI NIH HHS/&#xD;Z01 CP010200/ImNIH/Intramural NIH HHS/&#xD;GEI U01HG 004438/HG/NHGRI NIH HHS/&#xD;U24 CA074806/CA/NCI NIH HHS/&#xD;R01 CA 151993/CA/NCI NIH HHS/&#xD;R01 DK062370/DK/NIDDK NIH HHS/&#xD;R01 CA137178/CA/NCI NIH HHS/&#xD;U24 CA097735/CA/NCI NIH HHS/&#xD;U01 CA074794/CA/NCI NIH HHS/&#xD;1U54CA155626-01/CA/NCI NIH HHS/&#xD;U54 CA155626/CA/NCI NIH HHS/&#xD;R01CA137178/CA/NCI NIH HHS/&#xD;R01 CA047147/CA/NCI NIH HHS/&#xD;P01 CA 055075/CA/NCI NIH HHS/&#xD;R01 CA143237/CA/NCI NIH HHS/&#xD;HHSN271201100004C/AG/NIA NIH HHS/&#xD;R01 CA042182/CA/NCI NIH HHS/&#xD;U01/U24 CA074783/CA/NCI NIH HHS/&#xD;U01/U24 CA074794/CA/NCI NIH HHS/&#xD;UM1 CA167551/CA/NCI NIH HHS/&#xD;R01137178/PHS HHS/&#xD;U01 CA122839/CA/NCI NIH HHS/&#xD;(R01 CA48998/CA/NCI NIH HHS/&#xD;S10 OD020069/OD/NIH HHS/&#xD;HHSN268201100002I/HL/NHLBI NIH HHS/&#xD;U01 CA074783/CA/NCI NIH HHS/&#xD;U01/U24 CA097735/CA/NCI NIH HHS/&#xD;U01 CA074806/CA/NCI NIH HHS/&#xD;U24 CA074800/CA/NCI NIH HHS/&#xD;U01/U24 CA074806/CA/NCI NIH HHS/&#xD;P50 CA127003/CA/NCI NIH HHS/&#xD;U01 CA074800/CA/NCI NIH HHS/&#xD;HHSN268201100001C/WH/WHI NIH HHS/&#xD;HHSN268201100004C/WH/WHI NIH HHS/&#xD;U01/U24 CA074800/CA/NCI NIH HHS/&#xD;Multicenter Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1024-31. doi: 10.1158/1055-9965.EPI-14-1309. Epub 2015 May 14.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/25976416</style></url></related-urls><pdf-urls><url>internal-pdf://0440339078/Thrift-2015-Mendelian randomization study of b.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4490960</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1158/1055-9965.EPI-14-1309</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>101</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">101</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Thrift, A. P.</style></author><author><style face="normal" font="default" size="100%">Shaheen, N. J.</style></author><author><style face="normal" font="default" size="100%">Gammon, M. D.</style></author><author><style face="normal" font="default" size="100%">Bernstein, L.</style></author><author><style face="normal" font="default" size="100%">Reid, B. J.</style></author><author><style face="normal" font="default" size="100%">Onstad, L.</style></author><author><style face="normal" font="default" size="100%">Risch, H. A.</style></author><author><style face="normal" font="default" size="100%">Liu, G.</style></author><author><style face="normal" font="default" size="100%">Bird, N. C.</style></author><author><style face="normal" font="default" size="100%">Wu, A. H.</style></author><author><style face="normal" font="default" size="100%">Corley, D. A.</style></author><author><style face="normal" font="default" size="100%">Romero, Y.</style></author><author><style face="normal" font="default" size="100%">Chanock, S. J.</style></author><author><style face="normal" font="default" size="100%">Chow, W. H.</style></author><author><style face="normal" font="default" size="100%">Casson, A. G.</style></author><author><style face="normal" font="default" size="100%">Levine, D. M.</style></author><author><style face="normal" font="default" size="100%">Zhang, R.</style></author><author><style face="normal" font="default" size="100%">Ek, W. E.</style></author><author><style face="normal" font="default" size="100%">MacGregor, S.</style></author><author><style face="normal" font="default" size="100%">Ye, W.</style></author><author><style face="normal" font="default" size="100%">Hardie, L. J.</style></author><author><style face="normal" font="default" size="100%">Vaughan, T. L.</style></author><author><style face="normal" font="default" size="100%">Whiteman, D. C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Public Health Sciences (APT, LO, TLV) and Division of Human Biology (BJR), Fred Hutchinson Cancer Research Center, Seattle, WA; Cancer Control Group (APT, DCW) and Statistical Genetics (WEE, SM), QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Division of Gastroenterology and Hepatology, UNC School of Medicine (NJS) and Department of Epidemiology, School of Public Health (MDG), University of North Carolina, Chapel Hill, NC; Department of Population Sciences, Beckman Research Institute and City of Hope Comprehensive Cancer Center, Duarte, CA (LB); Yale School of Public Health, Department of Chronic Disease Epidemiology, New Haven, CT (HAR); Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre-Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada (GL); Department of Oncology, The Medical School, University of Sheffield, Sheffield, UK (NCB); Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA (AHW); Division of Research and Oakland Medical Center, Kaiser Permanente, Oakland, CA (DAC); Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN (YR), on behalf of the Mayo Clinic Esophageal Adenocarcinoma and Barrett&apos;s Esophagus Registry Consortium; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (SJC); Department of Epidemiology, MD Anderson Cancer Center, Houston, TX (WHC); Department of Surgery, University of Saskatchewan, Saskatoon SK, Canada (AGC); Department of Biostatistics, University of Washington School of Public Health, Seattle, WA (DML, RZ); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (WY); Division of Epidemiology, University of Leeds, Leeds, UK (LJH). athrift@fhcrc.org.&#xD;Division of Public Health Sciences (APT, LO, TLV) and Division of Human Biology (BJR), Fred Hutchinson Cancer Research Center, Seattle, WA; Cancer Control Group (APT, DCW) and Statistical Genetics (WEE, SM), QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Division of Gastroenterology and Hepatology, UNC School of Medicine (NJS) and Department of Epidemiology, School of Public Health (MDG), University of North Carolina, Chapel Hill, NC; Department of Population Sciences, Beckman Research Institute and City of Hope Comprehensive Cancer Center, Duarte, CA (LB); Yale School of Public Health, Department of Chronic Disease Epidemiology, New Haven, CT (HAR); Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre-Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada (GL); Department of Oncology, The Medical School, University of Sheffield, Sheffield, UK (NCB); Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA (AHW); Division of Research and Oakland Medical Center, Kaiser Permanente, Oakland, CA (DAC); Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN (YR), on behalf of the Mayo Clinic Esophageal Adenocarcinoma and Barrett&apos;s Esophagus Registry Consortium; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (SJC); Department of Epidemiology, MD Anderson Cancer Center, Houston, TX (WHC); Department of Surgery, University of Saskatchewan, Saskatoon SK, Canada (AGC); Department of Biostatistics, University of Washington School of Public Health, Seattle, WA (DML, RZ); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (WY); Division of Epidemiology, University of Leeds, Leeds, UK (LJH).</style></auth-address><titles><title><style face="normal" font="default" size="100%">Obesity and risk of esophageal adenocarcinoma and Barrett&apos;s esophagus: a Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">J Natl Cancer Inst</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Natl Cancer Inst</style></full-title></periodical><volume><style face="normal" font="default" size="100%">106</style></volume><number><style face="normal" font="default" size="100%">11</style></number><edition><style face="normal" font="default" size="100%">2014/10/02</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adenocarcinoma/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Barrett Esophagus/complications/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Esophageal Neoplasms/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/complications/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Precancerous Conditions/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1460-2105 (Electronic)&#xD;0027-8874 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">25269698</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Data from observational studies suggest that body mass index (BMI) is causally related to esophageal adenocarcinoma (EAC) and its precursor, Barrett&apos;s esophagus (BE). However, the relationships may be affected by bias and confounding. METHODS: We used data from the Barrett&apos;s and Esophageal Adenocarcinoma Genetic Susceptibility Study: 999 patients with EAC, 2061 patients with BE, and 2169 population controls. We applied the two-stage control function instrumental variable method of the Mendelian randomization approach to estimate the unbiased, unconfounded effect of BMI on risk of EAC and BE. This was performed using a genetic risk score, derived from 29 genetic variants shown to be associated with BMI, as an instrument for lifetime BMI. A higher score indicates propensity to obesity. All tests were two-sided. RESULTS: The genetic risk score was not associated with potential confounders, including gastroesophageal reflux symptoms and smoking. In the instrumental variable analyses (IV), EAC risk increased by 16% (IV-odds ratio [OR] = 1.16, 95% confidence interval [CI] = 1.01 to 1.33) and BE risk increased by 12% (IV-OR = 1.12, 95% CI = 1.00 to 1.25) per 1kg/m(2) increase in BMI. BMI was statistically significantly associated with EAC and BE in conventional epidemiologic analyses. CONCLUSIONS: People with a high genetic propensity to obesity have higher risks of esophageal metaplasia and neoplasia than people with low genetic propensity. These analyses provide the strongest evidence to date that obesity is independently associated with BE and EAC, and is not due to confounding or bias inherent in conventional epidemiologic analyses.</style></abstract><notes><style face="normal" font="default" size="100%">Thrift, Aaron P&#xD;Shaheen, Nicholas J&#xD;Gammon, Marilie D&#xD;Bernstein, Leslie&#xD;Reid, Brian J&#xD;Onstad, Lynn&#xD;Risch, Harvey A&#xD;Liu, Geoffrey&#xD;Bird, Nigel C&#xD;Wu, Anna H&#xD;Corley, Douglas A&#xD;Romero, Yvonne&#xD;Chanock, Stephen J&#xD;Chow, Wong-Ho&#xD;Casson, Alan G&#xD;Levine, David M&#xD;Zhang, Rui&#xD;Ek, Weronica E&#xD;MacGregor, Stuart&#xD;Ye, Weimin&#xD;Hardie, Laura J&#xD;Vaughan, Thomas L&#xD;Whiteman, David C&#xD;eng&#xD;U01 CA057949-03/CA/NCI NIH HHS/&#xD;U01CA57983/CA/NCI NIH HHS/&#xD;R01CA100264/CA/NCI NIH HHS/&#xD;U01CA57949/CA/NCI NIH HHS/&#xD;K05 CA124911/CA/NCI NIH HHS/&#xD;R01CA136725/CA/NCI NIH HHS/&#xD;NIDDK 02956/PHS HHS/&#xD;P30CA016672/CA/NCI NIH HHS/&#xD;P30 DK034987/DK/NIDDK NIH HHS/&#xD;P01 CA091955/CA/NCI NIH HHS/&#xD;R01 CA136725/CA/NCI NIH HHS/&#xD;P01CA091955/CA/NCI NIH HHS/&#xD;R01DK63616/DK/NIDDK NIH HHS/&#xD;R01CA133996/CA/NCI NIH HHS/&#xD;P50CA093459/CA/NCI NIH HHS/&#xD;R01CA072866/CA/NCI NIH HHS/&#xD;R01CA57947/CA/NCI NIH HHS/&#xD;U01CA57923/CA/NCI NIH HHS/&#xD;K05CA124911/CA/NCI NIH HHS/&#xD;R01 CA072866/CA/NCI NIH HHS/&#xD;R01CA59636/CA/NCI NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;J Natl Cancer Inst. 2014 Sep 30;106(11). pii: dju252. doi: 10.1093/jnci/dju252. Print 2014 Nov.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/25269698</style></url></related-urls><pdf-urls><url>internal-pdf://2867281652/Thrift-2014-Obesity and risk of esophageal ade.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4200028</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/jnci/dju252</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>126</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">126</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tikkanen, E.</style></author><author><style face="normal" font="default" size="100%">Gustafsson, S.</style></author><author><style face="normal" font="default" size="100%">Knowles, J. W.</style></author><author><style face="normal" font="default" size="100%">Perez, M.</style></author><author><style face="normal" font="default" size="100%">Burgess, S.</style></author><author><style face="normal" font="default" size="100%">Ingelsson, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, 300 Pasteur Dr, Stanford, CA, USA.&#xD;Stanford Cardiovascular Institute, Stanford University, 300 Pasteur Dr, Stanford, CA, USA.&#xD;Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, EpiHubben, MTC-huset, Uppsala, Sweden.&#xD;Stanford Diabetes Research Center, Stanford University, 300 Pasteur Dr, Stanford, CA, USA.&#xD;MRC Biostatistics Unit, Cambridge Institute of Public Health, University of Cambridge, Forvie Site, Robinson Way, Cambridge Biomedical Campus, Cambridge, UK.&#xD;Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Body composition and atrial fibrillation: a Mendelian randomization study</style></title><secondary-title><style face="normal" font="default" size="100%">Eur Heart J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur Heart J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1277-1282</style></pages><volume><style face="normal" font="default" size="100%">40</style></volume><number><style face="normal" font="default" size="100%">16</style></number><edition><style face="normal" font="default" size="100%">2019/02/06</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Atrial Fibrillation</style></keyword><keyword><style face="normal" font="default" size="100%">Biomarkers</style></keyword><keyword><style face="normal" font="default" size="100%">Body Composition</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">*Bioimpedance</style></keyword><keyword><style face="normal" font="default" size="100%">*Causal effect</style></keyword><keyword><style face="normal" font="default" size="100%">*Fat mass</style></keyword><keyword><style face="normal" font="default" size="100%">*Fat-free mass</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr 21</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1522-9645 (Electronic)&#xD;0195-668X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30721963</style></accession-num><abstract><style face="normal" font="default" size="100%">AIMS: Increases in fat-free mass and fat mass have been associated with higher risk of atrial fibrillation (AF) in observational studies. It is not known whether these associations reflect independent causal processes. Our aim was to evaluate independent causal roles of fat-free mass and fat mass on AF. METHODS AND RESULTS: We conducted a large observational study to estimate the associations between fat-free mass and fat mass on incident AF in the UK Biobank (N = 487 404, N events = 10 365). Genome-wide association analysis was performed to obtain genetic instruments for Mendelian randomization (MR). We evaluated the causal effects of fat-free mass and fat mass on AF with two-sample method by using genetic associations from AFGen consortium as outcome. Finally, we evaluated independent causal effects of fat-free mass and fat mass with multivariate MR. Both fat-free mass and fat mass had observational associations with incident AF [hazard ratio (HR) = 1.77, 95% confidence interval (CI) 1.72-1.83; HR = 1.40, 95% CI 1.37-1.43 per standard deviation increase in fat-free and fat mass, respectively]. The causal effects using the inverse-variance weighted method were 1.55 (95% CI 1.38-1.75) for fat-free mass and 1.30 (95% CI 1.17-1.45) for fat mass. Weighted median, Egger regression, and penalized methods showed similar estimates. The multivariate MR analysis suggested that the causal effects of fat-free and fat mass were independent of each other (causal risk ratios: 1.37, 95% CI 1.06-1.75; 1.28, 95% CI 1.03-1.58). CONCLUSION: Genetically programmed increases in fat-free mass and fat mass independently cause an increased risk of AF.</style></abstract><notes><style face="normal" font="default" size="100%">Tikkanen, Emmi&#xD;Gustafsson, Stefan&#xD;Knowles, Joshua W&#xD;Perez, Marco&#xD;Burgess, Stephen&#xD;Ingelsson, Erik&#xD;eng&#xD;RG/18/13/33946/BHF_/British Heart Foundation/United Kingdom&#xD;RG/13/13/30194/BHF_/British Heart Foundation/United Kingdom&#xD;R01 DK106236/DK/NIDDK NIH HHS/&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;R01 HL135313/HL/NHLBI NIH HHS/&#xD;R01 DK107437/DK/NIDDK NIH HHS/&#xD;MC_UU_00002/7/MRC_/Medical Research Council/United Kingdom&#xD;MC_PC_17228/MRC_/Medical Research Council/United Kingdom&#xD;P30 DK116074/DK/NIDDK NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Comment&#xD;England&#xD;Eur Heart J. 2019 Apr 21;40(16):1277-1282. doi: 10.1093/eurheartj/ehz003.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30721963</style></url></related-urls><pdf-urls><url>internal-pdf://4138176212/Tikkanen-2019-Body composition and atrial fibr.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6475522</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/eurheartj/ehz003</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>89</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">89</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Harbord, R.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Zacho, J.</style></author><author><style face="normal" font="default" size="100%">Tybjaerg-Hansen, A.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Medical Research Council Centre for Causal Analysis in Translational Epidemiology, Bristol University, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Does greater adiposity increase blood pressure and hypertension risk?: Mendelian randomization using the FTO/MC4R genotype</style></title><secondary-title><style face="normal" font="default" size="100%">Hypertension</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Hypertension</style></full-title></periodical><pages><style face="normal" font="default" size="100%">84-90</style></pages><volume><style face="normal" font="default" size="100%">54</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2009/05/28</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Adiposity</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Alcohol Drinking</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">*Blood Pressure</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Denmark</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Gene Frequency</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Hypertension/genetics/*physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Linear Models</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Receptor, Melanocortin, Type 4/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Smoking</style></keyword><keyword><style face="normal" font="default" size="100%">Waist-Hip Ratio</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1524-4563 (Electronic)&#xD;0194-911X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">19470880</style></accession-num><abstract><style face="normal" font="default" size="100%">Elevated blood pressure increases the risk of experiencing cardiovascular events like myocardial infarction and stroke. Current observational data suggest that body mass index may have a causal role in the etiology of hypertension, but this may be influenced by confounding and reverse causation. Through the use of instrumental variable methods, we aim to estimate the strength of the unconfounded and unbiased association between body mass index/adiposity and blood pressure. We explore these issues in the Copenhagen General Population Study. We used instrumental variable methods to obtain estimates of the causal association between body mass index and blood pressure. This was performed using both rs9939609 (FTO) and rs17782313 (MC4R) genotypes as instruments for body mass index. Avoiding the epidemiological problems of confounding, bias, and reverse causation, we confirmed observational associations between body mass index and blood pressure. In analyses including those taking antihypertensive drugs, but for whom appropriate adjustment had been made, systolic blood pressure was seen to increase by 3.85 mm Hg (95% CI: 1.88 to 5.83 mm Hg) for each 10% increase in body mass index (P=0.0002), with diastolic blood pressure showing an increase of 1.79 mm Hg (95% CI: 0.68 to 2.90 mm Hg) for each 10% increase in body mass index (P=0.002). Observed associations are large and illustrate the considerable benefits in terms of reductions in blood pressure-related morbidity that could be achieved through a reduction in body mass index.</style></abstract><notes><style face="normal" font="default" size="100%">Timpson, Nicholas J&#xD;Harbord, Roger&#xD;Davey Smith, George&#xD;Zacho, Jeppe&#xD;Tybjaerg-Hansen, Anne&#xD;Nordestgaard, Borge G&#xD;eng&#xD;G0600705/Medical Research Council/United Kingdom&#xD;G0601625/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Hypertension. 2009 Jul;54(1):84-90. doi: 10.1161/HYPERTENSIONAHA.109.130005. Epub 2009 May 26.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/19470880</style></url></related-urls><pdf-urls><url>internal-pdf://0595873983/Timpson-2009-Does greater adiposity increase b.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1161/HYPERTENSIONAHA.109.130005</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>86</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">86</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Nordestgaard, B. G.</style></author><author><style face="normal" font="default" size="100%">Harbord, R. M.</style></author><author><style face="normal" font="default" size="100%">Zacho, J.</style></author><author><style face="normal" font="default" size="100%">Frayling, T. M.</style></author><author><style face="normal" font="default" size="100%">Tybjaerg-Hansen, A.</style></author><author><style face="normal" font="default" size="100%">Smith, G. D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Centre for Causal Analysis in Translational Epidemiology, Bristol University, Bristol, UK. n.j.timpson@bris.ac.uk</style></auth-address><titles><title><style face="normal" font="default" size="100%">C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Obes (Lond)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Obes (Lond)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">300-8</style></pages><volume><style face="normal" font="default" size="100%">35</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2010/08/18</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Biomarkers/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">C-Reactive Protein/genetics/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Denmark</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Variation/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*genetics/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Sex Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">Feb</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-5497 (Electronic)&#xD;0307-0565 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">20714329</style></accession-num><abstract><style face="normal" font="default" size="100%">CONTEXT: The assignment of direction and causality within networks of observational associations is problematic outside randomized control trials, and the presence of a causal relationship between body mass index (BMI) and C-reactive protein (CRP) is disputed. OBJECTIVE: Using reciprocal Mendelian randomization, we aim to assess the direction of causality in relationships between BMI and CRP and to demonstrate this as a promising analytical technique. PARTICIPANTS AND METHODS: The study was based on a large, cross-sectional European study from Copenhagen, Denmark. Genetic associates of BMI (FTO(rs9939609)) and circulating CRP (CRP(rs3091244)) have been used to reexamine observational associations between them. RESULTS: Observational analyses showed a strong, positive association between circulating CRP and BMI (change in BMI for a doubling in log CRP of 1.03 kg m(-2) (95% confidence interval (95% CI): 1.00, 1.07), P&lt;0.0001). Analysis using CRP(rs3091244) to re-estimate the causal effect of circulating CRP on BMI yielded null effects (change in BMI for a doubling in log CRP of -0.24 kg m(-2) (95% CI: -0.58, 0.11), P=0.2). In contrast, analysis using FTO(rs9939609) to assess the causal effect of BMI on circulating CRP confirmed observational associations (ratio of geometric means of CRP per s.d. increase in BMI 1.41 (95% CI: 1.10, 1.80), P=0.006). CONCLUSIONS: Taken together, these data suggest that the observed association between circulating CRP and measured BMI is likely to be driven by BMI, with CRP being a marker of elevated adiposity. More generally, the method of reciprocal randomization has general applicability in determining the direction of causation within inter-correlated networks of metabolic components.</style></abstract><notes><style face="normal" font="default" size="100%">Timpson, N J&#xD;Nordestgaard, B G&#xD;Harbord, R M&#xD;Zacho, J&#xD;Frayling, T M&#xD;Tybjaerg-Hansen, A&#xD;Smith, G Davey&#xD;eng&#xD;G0600705/Medical Research Council/United Kingdom&#xD;G0601625/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Int J Obes (Lond). 2011 Feb;35(2):300-8. doi: 10.1038/ijo.2010.137. Epub 2010 Aug 17.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/20714329</style></url></related-urls><pdf-urls><url>internal-pdf://2763277298/Timpson-2011-C-reactive protein levels and bod.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4783860</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/ijo.2010.137</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>159</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">159</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Sayers, A.</style></author><author><style face="normal" font="default" size="100%">Davey-Smith, G.</style></author><author><style face="normal" font="default" size="100%">Tobias, J. H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Centre for Causal Analyses in Translational Epidemiology, Department of Social Medicine, University of Bristol, Bristol, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">How does body fat influence bone mass in childhood? A Mendelian randomization approach</style></title><secondary-title><style face="normal" font="default" size="100%">J Bone Miner Res</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Bone Miner Res</style></full-title></periodical><pages><style face="normal" font="default" size="100%">522-33</style></pages><volume><style face="normal" font="default" size="100%">24</style></volume><number><style face="normal" font="default" size="100%">3</style></number><edition><style face="normal" font="default" size="100%">2008/11/20</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Absorptiometry, Photon</style></keyword><keyword><style face="normal" font="default" size="100%">Adipose Tissue/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Anthropometry</style></keyword><keyword><style face="normal" font="default" size="100%">Bone and Bones/*anatomy &amp; histology</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Models, Genetic</style></keyword><keyword><style face="normal" font="default" size="100%">Organ Size</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy</style></keyword><keyword><style face="normal" font="default" size="100%">Random Allocation</style></keyword><keyword><style face="normal" font="default" size="100%">Receptor, Melanocortin, Type 4/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Spine/anatomy &amp; histology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1523-4681 (Electronic)&#xD;0884-0431 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">19016587</style></accession-num><abstract><style face="normal" font="default" size="100%">Fat mass may be a causal determinant of bone mass, but the evidence is conflicting, possibly reflecting the influence of confounding factors. The recent identification of common genetic variants related to obesity in children provides an opportunity to implement a Mendelian randomization study of obesity and bone outcomes, which is less subject to confounding and several biases than conventional approaches. Genotyping was retrieved for variants of two loci reliably associated with adiposity (the fat mass and obesity-related gene FTO and that upstream of the MC4R locus) within 7470 children from the Avon Longitudinal Study of Parents and Children (ALSPAC) who had undergone total body DXA scans at a mean of 9.9 yr. Relationships between both fat mass/genotypes and bone measures were assessed in efforts to determine evidence of causality between adiposity and bone mass. In conventional tests of association, both with and without height adjustment, total fat mass was strongly related to total body, spinal, and upper and lower limb BMC (ratio of geometric means [RGM]: 1.118 [95% CI: 1.112, 1.123], 1.110 [95% CI: 1.102, 1.119], 1.101 [95% CI: 1.093, 1.108], 1.146 [95% CI: 1.143, 1.155]; p &lt; 10(-10) [adjusted for sex, height, and sitting height]). Equivalent or larger effects were obtained from instrumental variable (IV) regression including the same covariates (1.139 [95% CI: 1.064, 1.220], 1.090 [95% CI: 1.010, 1.177], 1.142 [95% CI: 1.049, 1.243], 1.176 [95% CI: 1.099, 1.257]; p = 0.0002, 0.03, 0.002, and 2.3(-6) respectively). Similar results were obtained after adjusting for puberty, when truncal fat mass was used in place of total fat, and when bone area was used instead of bone mass. In analyses where total body BMC adjusted for bone area (BA) was the outcome (reflecting volumetric BMD), linear regression with fat mass showed evidence for association (1.004 [95% CI: 1.002, 1.007], p = 0.0001). IV regression also showed a positive effect (1.031 [95% CI: 1.000, 1.062], p = 0.05). When MC4R and FTO markers were used as instruments for fat mass, similar associations with BMC were seen to those with fat mass as measured by DXA. This suggests that fat mass is on the causal pathway for bone mass in children. In addition, both directly assessed and IV-assessed relationships between fat mass and volumetric density showed evidence for positive effects, supporting a hypothesis that fat effects on bone mass are not entirely accounted for by association with overall bone size.</style></abstract><notes><style face="normal" font="default" size="100%">Timpson, Nicholas J&#xD;Sayers, Adrian&#xD;Davey-Smith, George&#xD;Tobias, Jonathan H&#xD;eng&#xD;079960/Wellcome Trust/United Kingdom&#xD;G0600705/Medical Research Council/United Kingdom&#xD;G9815508/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;J Bone Miner Res. 2009 Mar;24(3):522-33. doi: 10.1359/jbmr.081109.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/19016587</style></url></related-urls><pdf-urls><url>internal-pdf://3481236600/Timpson-2009-How does body fat influence bone.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC2875165</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1359/jbmr.081109</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>81</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">81</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Todd, J. N.</style></author><author><style face="normal" font="default" size="100%">Dahlstrom, E. H.</style></author><author><style face="normal" font="default" size="100%">Salem, R. M.</style></author><author><style face="normal" font="default" size="100%">Sandholm, N.</style></author><author><style face="normal" font="default" size="100%">Forsblom, C.</style></author><author><style face="normal" font="default" size="100%">FinnDiane Study, Group</style></author><author><style face="normal" font="default" size="100%">McKnight, A. J.</style></author><author><style face="normal" font="default" size="100%">Maxwell, A. P.</style></author><author><style face="normal" font="default" size="100%">Brennan, E.</style></author><author><style face="normal" font="default" size="100%">Sadlier, D.</style></author><author><style face="normal" font="default" size="100%">Godson, C.</style></author><author><style face="normal" font="default" size="100%">Groop, P. H.</style></author><author><style face="normal" font="default" size="100%">Hirschhorn, J. N.</style></author><author><style face="normal" font="default" size="100%">Florez, J. C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Endocrinology, Boston Children&apos;s Hospital, Boston, MA Department of Pediatrics, Harvard Medical School, Boston, MA.&#xD;Folkhalsan Institute of Genetics, Folkhalsan Research Center, Biomedicum Helsinki, Helsinki, Finland Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland Research Programs Unit, Diabetes and Obesity Research Program, University of Helsinki, Helsinki, Finland.&#xD;Division of Endocrinology, Boston Children&apos;s Hospital, Boston, MA Department of Pediatrics, Harvard Medical School, Boston, MA Program in Medical and Population Genetics, Broad Institute, Cambridge, MA.&#xD;Folkhalsan Institute of Genetics, Folkhalsan Research Center, Biomedicum Helsinki, Helsinki, Finland Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.&#xD;Nephrology Research, Centre for Public Health, Queen&apos;s University of Belfast, Belfast, Northern Ireland.&#xD;Nephrology Research, Centre for Public Health, Queen&apos;s University of Belfast, Belfast, Northern Ireland Regional Nephrology Unit, Belfast City Hospital, Belfast, Northern Ireland.&#xD;Diabetes Complications Research Centre, Conway Institute, School of Medicine and Medical Sciences, University College Dublin, Dublin, Ireland.&#xD;Mater Misericordiae University Hospital, Dublin, Ireland.&#xD;Program in Medical and Population Genetics, Broad Institute, Cambridge, MA Department of Medicine, Harvard Medical School, Boston, MA Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA jcflorez@partners.org.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease</style></title><secondary-title><style face="normal" font="default" size="100%">Diabetes</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Diabetes</style></full-title></periodical><pages><style face="normal" font="default" size="100%">4238-46</style></pages><volume><style face="normal" font="default" size="100%">64</style></volume><number><style face="normal" font="default" size="100%">12</style></number><edition><style face="normal" font="default" size="100%">2015/08/27</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Albuminuria/epidemiology/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 1/*complications</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetic Nephropathies/epidemiology/*etiology/genetics/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Finland/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Loci</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Kidney Failure, Chronic/epidemiology/*etiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/complications/epidemiology/genetics/*physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1939-327X (Electronic)&#xD;0012-1797 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26307587</style></accession-num><abstract><style face="normal" font="default" size="100%">Obesity has been posited as an independent risk factor for diabetic kidney disease (DKD), but establishing causality from observational data is problematic. We aimed to test whether obesity is causally related to DKD using Mendelian randomization, which exploits the random assortment of genes during meiosis. In 6,049 subjects with type 1 diabetes, we used a weighted genetic risk score (GRS) comprised of 32 validated BMI loci as an instrument to test the relationship of BMI with macroalbuminuria, end-stage renal disease (ESRD), or DKD defined as presence of macroalbuminuria or ESRD. We compared these results with cross-sectional and longitudinal observational associations. Longitudinal analysis demonstrated a U-shaped relationship of BMI with development of macroalbuminuria, ESRD, or DKD over time. Cross-sectional observational analysis showed no association with overall DKD, higher odds of macroalbuminuria (for every 1 kg/m(2) higher BMI, odds ratio [OR] 1.05, 95% CI 1.03-1.07, P &lt; 0.001), and lower odds of ESRD (OR 0.95, 95% CI 0.93-0.97, P &lt; 0.001). Mendelian randomization analysis showed a 1 kg/m(2) higher BMI conferring an increased risk in macroalbuminuria (OR 1.28, 95% CI 1.11-1.45, P = 0.001), ESRD (OR 1.43, 95% CI 1.20-1.72, P &lt; 0.001), and DKD (OR 1.33, 95% CI 1.17-1.51, P &lt; 0.001). Our results provide genetic evidence for a causal link between obesity and DKD in type 1 diabetes. As obesity prevalence rises, this finding predicts an increase in DKD prevalence unless intervention should occur.</style></abstract><notes><style face="normal" font="default" size="100%">Todd, Jennifer N&#xD;Dahlstrom, Emma H&#xD;Salem, Rany M&#xD;Sandholm, Niina&#xD;Forsblom, Carol&#xD;McKnight, Amy J&#xD;Maxwell, Alexander P&#xD;Brennan, Eoin&#xD;Sadlier, Denise&#xD;Godson, Catherine&#xD;Groop, Per-Henrik&#xD;Hirschhorn, Joel N&#xD;Florez, Jose C&#xD;eng&#xD;F32-DK-103486-01/DK/NIDDK NIH HHS/&#xD;R01 DK081923/DK/NIDDK NIH HHS/&#xD;R01-DK-081923/DK/NIDDK NIH HHS/&#xD;R01 DK075787/DK/NIDDK NIH HHS/&#xD;T32-DK-007260/DK/NIDDK NIH HHS/&#xD;T32 DK007260/DK/NIDDK NIH HHS/&#xD;F32 DK103486/DK/NIDDK NIH HHS/&#xD;Observational Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Diabetes. 2015 Dec;64(12):4238-46. doi: 10.2337/db15-0254. Epub 2015 Aug 25.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26307587</style></url></related-urls><pdf-urls><url>internal-pdf://0059055088/Todd-2015-Genetic Evidence for a Causal Role o.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4657582</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.2337/db15-0254</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>25</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">25</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tyrrell, J.</style></author><author><style face="normal" font="default" size="100%">Jones, S. E.</style></author><author><style face="normal" font="default" size="100%">Beaumont, R.</style></author><author><style face="normal" font="default" size="100%">Astley, C. M.</style></author><author><style face="normal" font="default" size="100%">Lovell, R.</style></author><author><style face="normal" font="default" size="100%">Yaghootkar, H.</style></author><author><style face="normal" font="default" size="100%">Tuke, M.</style></author><author><style face="normal" font="default" size="100%">Ruth, K. S.</style></author><author><style face="normal" font="default" size="100%">Freathy, R. M.</style></author><author><style face="normal" font="default" size="100%">Hirschhorn, J. N.</style></author><author><style face="normal" font="default" size="100%">Wood, A. R.</style></author><author><style face="normal" font="default" size="100%">Murray, A.</style></author><author><style face="normal" font="default" size="100%">Weedon, M. N.</style></author><author><style face="normal" font="default" size="100%">Frayling, T. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Genetics of Complex Traits, Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon and Exeter Hospital, Exeter EX2 5DW, UK European Centre for Environment and Human Health, University of Exeter Medical School, The Knowledge Spa, Truro TR1 3HD, UK.&#xD;Genetics of Complex Traits, Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon and Exeter Hospital, Exeter EX2 5DW, UK.&#xD;Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA Center for Basic and Translational Obesity Research and Division of Endocrinology, Boston Children&apos;s Hospital, Boston, MA 02115, USA.&#xD;European Centre for Environment and Human Health, University of Exeter Medical School, The Knowledge Spa, Truro TR1 3HD, UK.&#xD;European Centre for Environment and Human Health, University of Exeter Medical School, The Knowledge Spa, Truro TR1 3HD, UK Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.&#xD;Genetics of Complex Traits, Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon and Exeter Hospital, Exeter EX2 5DW, UK T.M.Frayling@exeter.ac.uk.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Height, body mass index, and socioeconomic status: mendelian randomisation study in UK Biobank</style></title><secondary-title><style face="normal" font="default" size="100%">BMJ</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMJ</style></full-title></periodical><pages><style face="normal" font="default" size="100%">i582</style></pages><volume><style face="normal" font="default" size="100%">352</style></volume><edition><style face="normal" font="default" size="100%">2016/03/10</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Biological Specimen Banks</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Height</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">*Educational Status</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Income/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Occupations</style></keyword><keyword><style face="normal" font="default" size="100%">*Social Class</style></keyword><keyword><style face="normal" font="default" size="100%">United Kingdom/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar 8</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1756-1833 (Electronic)&#xD;0959-8138 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26956984</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To determine whether height and body mass index (BMI) have a causal role in five measures of socioeconomic status. DESIGN: Mendelian randomisation study to test for causal effects of differences in stature and BMI on five measures of socioeconomic status. Mendelian randomisation exploits the fact that genotypes are randomly assigned at conception and thus not confounded by non-genetic factors. SETTING: UK Biobank. PARTICIPANTS: 119,669 men and women of British ancestry, aged between 37 and 73 years. MAIN OUTCOME MEASURES: Age completed full time education, degree level education, job class, annual household income, and Townsend deprivation index. RESULTS: In the UK Biobank study, shorter stature and higher BMI were observationally associated with several measures of lower socioeconomic status. The associations between shorter stature and lower socioeconomic status tended to be stronger in men, and the associations between higher BMI and lower socioeconomic status tended to be stronger in women. For example, a 1 standard deviation (SD) higher BMI was associated with a pound210 (euro276; $300; 95% confidence interval pound84 to pound420; P=6 x 10(-3)) lower annual household income in men and a pound1890 ( pound1680 to pound2100; P=6 x 10(-15)) lower annual household income in women. Genetic analysis provided evidence that these associations were partly causal. A genetically determined 1 SD (6.3 cm) taller stature caused a 0.06 (0.02 to 0.09) year older age of completing full time education (P=0.01), a 1.12 (1.07 to 1.18) times higher odds of working in a skilled profession (P=6 x 10(-7)), and a pound1130 ( pound680 to pound1580) higher annual household income (P=4 x 10(-8)). Associations were stronger in men. A genetically determined 1 SD higher BMI (4.6 kg/m(2)) caused a pound2940 ( pound1680 to pound4200; P=1 x 10(-5)) lower annual household income and a 0.10 (0.04 to 0.16) SD (P=0.001) higher level of deprivation in women only. CONCLUSIONS: These data support evidence that height and BMI play an important partial role in determining several aspects of a person&apos;s socioeconomic status, especially women&apos;s BMI for income and deprivation and men&apos;s height for education, income, and job class. These findings have important social and health implications, supporting evidence that overweight people, especially women, are at a disadvantage and that taller people, especially men, are at an advantage.</style></abstract><notes><style face="normal" font="default" size="100%">Tyrrell, Jessica&#xD;Jones, Samuel E&#xD;Beaumont, Robin&#xD;Astley, Christina M&#xD;Lovell, Rebecca&#xD;Yaghootkar, Hanieh&#xD;Tuke, Marcus&#xD;Ruth, Katherine S&#xD;Freathy, Rachel M&#xD;Hirschhorn, Joel N&#xD;Wood, Andrew R&#xD;Murray, Anna&#xD;Weedon, Michael N&#xD;Frayling, Timothy M&#xD;eng&#xD;WT097835MF/Wellcome Trust/United Kingdom&#xD;G0500070/Medical Research Council/United Kingdom&#xD;104150/Z/14/Z/Wellcome Trust/United Kingdom&#xD;MC_QA137853/Medical Research Council/United Kingdom&#xD;R01 DK075787/DK/NIDDK NIH HHS/&#xD;MR/M005070/1/Medical Research Council/United Kingdom&#xD;323195/European Research Council/International&#xD;T32 DK007699/DK/NIDDK NIH HHS/&#xD;G0601261/Medical Research Council/United Kingdom&#xD;Observational Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;BMJ. 2016 Mar 8;352:i582. doi: 10.1136/bmj.i582.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26956984</style></url></related-urls><pdf-urls><url>internal-pdf://3513492379/Tyrrell-2016-Height, body mass index, and soci.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4783516</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/bmj.i582</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>167</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">167</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tyrrell, J.</style></author><author><style face="normal" font="default" size="100%">Mulugeta, A.</style></author><author><style face="normal" font="default" size="100%">Wood, A. R.</style></author><author><style face="normal" font="default" size="100%">Zhou, A.</style></author><author><style face="normal" font="default" size="100%">Beaumont, R. N.</style></author><author><style face="normal" font="default" size="100%">Tuke, M. A.</style></author><author><style face="normal" font="default" size="100%">Jones, S. E.</style></author><author><style face="normal" font="default" size="100%">Ruth, K. S.</style></author><author><style face="normal" font="default" size="100%">Yaghootkar, H.</style></author><author><style face="normal" font="default" size="100%">Sharp, S.</style></author><author><style face="normal" font="default" size="100%">Thompson, W. D.</style></author><author><style face="normal" font="default" size="100%">Ji, Y.</style></author><author><style face="normal" font="default" size="100%">Harrison, J.</style></author><author><style face="normal" font="default" size="100%">Freathy, R. M.</style></author><author><style face="normal" font="default" size="100%">Murray, A.</style></author><author><style face="normal" font="default" size="100%">Weedon, M. N.</style></author><author><style face="normal" font="default" size="100%">Lewis, C.</style></author><author><style face="normal" font="default" size="100%">Frayling, T. M.</style></author><author><style face="normal" font="default" size="100%">Hypponen, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Genetics of Complex Traits, University of Exeter Medical School, Royal Devon &amp; Exeter Hospital, Exeter, UK.&#xD;Australian Centre for Precision Health, University of South Australia Cancer Research Institute, Adelaide, SA, Australia.&#xD;Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King&apos;s College London, London, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Using genetics to understand the causal influence of higher BMI on depression</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Epidemiol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">834-848</style></pages><volume><style face="normal" font="default" size="100%">48</style></volume><number><style face="normal" font="default" size="100%">3</style></number><edition><style face="normal" font="default" size="100%">2018/11/14</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Causality</style></keyword><keyword><style face="normal" font="default" size="100%">Depressive Disorder/*epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity, Metabolically Benign/epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">United Kingdom/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*UK Biobank</style></keyword><keyword><style face="normal" font="default" size="100%">*depression</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1464-3685 (Electronic)&#xD;0300-5771 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30423117</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Depression is more common in obese than non-obese individuals, especially in women, but the causal relationship between obesity and depression is complex and uncertain. Previous studies have used genetic variants associated with BMI to provide evidence that higher body mass index (BMI) causes depression, but have not tested whether this relationship is driven by the metabolic consequences of BMI nor for differences between men and women. METHODS: We performed a Mendelian randomization study using 48 791 individuals with depression and 291 995 controls in the UK Biobank, to test for causal effects of higher BMI on depression (defined using self-report and Hospital Episode data). We used two genetic instruments, both representing higher BMI, but one with and one without its adverse metabolic consequences, in an attempt to &apos;uncouple&apos; the psychological component of obesity from the metabolic consequences. We further tested causal relationships in men and women separately, and using subsets of BMI variants from known physiological pathways. RESULTS: Higher BMI was strongly associated with higher odds of depression, especially in women. Mendelian randomization provided evidence that higher BMI partly causes depression. Using a 73-variant BMI genetic risk score, a genetically determined one standard deviation (1 SD) higher BMI (4.9 kg/m2) was associated with higher odds of depression in all individuals [odds ratio (OR): 1.18, 95% confidence interval (CI): 1.09, 1.28, P = 0.00007) and women only (OR: 1.24, 95% CI: 1.11, 1.39, P = 0.0001). Meta-analysis with 45 591 depression cases and 97 647 controls from the Psychiatric Genomics Consortium (PGC) strengthened the statistical confidence of the findings in all individuals. Similar effect size estimates were obtained using different Mendelian randomization methods, although not all reached P &lt; 0.05. Using a metabolically favourable adiposity genetic risk score, and meta-analysing data from the UK biobank and PGC, a genetically determined 1 SD higher BMI (4.9 kg/m2) was associated with higher odds of depression in all individuals (OR: 1.26, 95% CI: 1.06, 1.50], P = 0.010), but with weaker statistical confidence. CONCLUSIONS: Higher BMI, with and without its adverse metabolic consequences, is likely to have a causal role in determining the likelihood of an individual developing depression.</style></abstract><notes><style face="normal" font="default" size="100%">Tyrrell, Jessica&#xD;Mulugeta, Anwar&#xD;Wood, Andrew R&#xD;Zhou, Ang&#xD;Beaumont, Robin N&#xD;Tuke, Marcus A&#xD;Jones, Samuel E&#xD;Ruth, Katherine S&#xD;Yaghootkar, Hanieh&#xD;Sharp, Seth&#xD;Thompson, William D&#xD;Ji, Yingjie&#xD;Harrison, Jamie&#xD;Freathy, Rachel M&#xD;Murray, Anna&#xD;Weedon, Michael N&#xD;Lewis, Cathryn&#xD;Frayling, Timothy M&#xD;Hypponen, Elina&#xD;eng&#xD;DH_/Department of Health/United Kingdom&#xD;MC_PC_17228/MRC_/Medical Research Council/United Kingdom&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;104150/Z/14/Z/WT_/Wellcome Trust/United Kingdom&#xD;MR/M005070/1/MRC_/Medical Research Council/United Kingdom&#xD;WT097835MF/WT_/Wellcome Trust/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Int J Epidemiol. 2019 Jun 1;48(3):834-848. doi: 10.1093/ije/dyy223.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30423117</style></url></related-urls><pdf-urls><url>internal-pdf://3112494422/Tyrrell-2018-Using genetics to understand the.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6659462</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/ije/dyy223</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>118</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">118</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tyrrell, J.</style></author><author><style face="normal" font="default" size="100%">Richmond, R. C.</style></author><author><style face="normal" font="default" size="100%">Palmer, T. M.</style></author><author><style face="normal" font="default" size="100%">Feenstra, B.</style></author><author><style face="normal" font="default" size="100%">Rangarajan, J.</style></author><author><style face="normal" font="default" size="100%">Metrustry, S.</style></author><author><style face="normal" font="default" size="100%">Cavadino, A.</style></author><author><style face="normal" font="default" size="100%">Paternoster, L.</style></author><author><style face="normal" font="default" size="100%">Armstrong, L. L.</style></author><author><style face="normal" font="default" size="100%">De Silva, N. M.</style></author><author><style face="normal" font="default" size="100%">Wood, A. R.</style></author><author><style face="normal" font="default" size="100%">Horikoshi, M.</style></author><author><style face="normal" font="default" size="100%">Geller, F.</style></author><author><style face="normal" font="default" size="100%">Myhre, R.</style></author><author><style face="normal" font="default" size="100%">Bradfield, J. P.</style></author><author><style face="normal" font="default" size="100%">Kreiner-Moller, E.</style></author><author><style face="normal" font="default" size="100%">Huikari, V.</style></author><author><style face="normal" font="default" size="100%">Painter, J. N.</style></author><author><style face="normal" font="default" size="100%">Hottenga, J. J.</style></author><author><style face="normal" font="default" size="100%">Allard, C.</style></author><author><style face="normal" font="default" size="100%">Berry, D. J.</style></author><author><style face="normal" font="default" size="100%">Bouchard, L.</style></author><author><style face="normal" font="default" size="100%">Das, S.</style></author><author><style face="normal" font="default" size="100%">Evans, D. M.</style></author><author><style face="normal" font="default" size="100%">Hakonarson, H.</style></author><author><style face="normal" font="default" size="100%">Hayes, M. G.</style></author><author><style face="normal" font="default" size="100%">Heikkinen, J.</style></author><author><style face="normal" font="default" size="100%">Hofman, A.</style></author><author><style face="normal" font="default" size="100%">Knight, B.</style></author><author><style face="normal" font="default" size="100%">Lind, P. A.</style></author><author><style face="normal" font="default" size="100%">McCarthy, M. I.</style></author><author><style face="normal" font="default" size="100%">McMahon, G.</style></author><author><style face="normal" font="default" size="100%">Medland, S. E.</style></author><author><style face="normal" font="default" size="100%">Melbye, M.</style></author><author><style face="normal" font="default" size="100%">Morris, A. P.</style></author><author><style face="normal" font="default" size="100%">Nodzenski, M.</style></author><author><style face="normal" font="default" size="100%">Reichetzeder, C.</style></author><author><style face="normal" font="default" size="100%">Ring, S. M.</style></author><author><style face="normal" font="default" size="100%">Sebert, S.</style></author><author><style face="normal" font="default" size="100%">Sengpiel, V.</style></author><author><style face="normal" font="default" size="100%">Sorensen, T. I.</style></author><author><style face="normal" font="default" size="100%">Willemsen, G.</style></author><author><style face="normal" font="default" size="100%">de Geus, E. J.</style></author><author><style face="normal" font="default" size="100%">Martin, N. G.</style></author><author><style face="normal" font="default" size="100%">Spector, T. D.</style></author><author><style face="normal" font="default" size="100%">Power, C.</style></author><author><style face="normal" font="default" size="100%">Jarvelin, M. R.</style></author><author><style face="normal" font="default" size="100%">Bisgaard, H.</style></author><author><style face="normal" font="default" size="100%">Grant, S. F.</style></author><author><style face="normal" font="default" size="100%">Nohr, E. A.</style></author><author><style face="normal" font="default" size="100%">Jaddoe, V. W.</style></author><author><style face="normal" font="default" size="100%">Jacobsson, B.</style></author><author><style face="normal" font="default" size="100%">Murray, J. C.</style></author><author><style face="normal" font="default" size="100%">Hocher, B.</style></author><author><style face="normal" font="default" size="100%">Hattersley, A. T.</style></author><author><style face="normal" font="default" size="100%">Scholtens, D. M.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Hivert, M. F.</style></author><author><style face="normal" font="default" size="100%">Felix, J. F.</style></author><author><style face="normal" font="default" size="100%">Hypponen, E.</style></author><author><style face="normal" font="default" size="100%">Lowe, W. L., Jr.</style></author><author><style face="normal" font="default" size="100%">Frayling, T. M.</style></author><author><style face="normal" font="default" size="100%">Lawlor, D. A.</style></author><author><style face="normal" font="default" size="100%">Freathy, R. M.</style></author><author><style face="normal" font="default" size="100%">Early Growth Genetics, Consortium</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon and Exeter Hospital, Exeter, United Kingdom2European Centre for Environment and Human Health, University of Exeter, the Knowledge Spa, Truro, United Kingdom.&#xD;School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom4The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands5Medical Research Council Inte.&#xD;Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdom7Department of Mathematics and Statistics, Lancaster University, Lancaster, United Kingdom.&#xD;Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.&#xD;Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.&#xD;Department of Twin Research, King&apos;s College London, St Thomas&apos; Hospital, London, United Kingdom.&#xD;Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts, and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom12Population, Policy and Practice, UCL Institute of Child He.&#xD;Medical Research Council Integrative Epidemiology Unit at the University of Bristol, United Kingdom.&#xD;Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.&#xD;Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon and Exeter Hospital, Exeter, United Kingdom.&#xD;Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, United Kingdom15Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.&#xD;Division of Epidemiology, Department of Genes and Environment, Norwegian Institute of Public Health, Oslo, Norway.&#xD;Center for Applied Genomics, the Children&apos;s Hospital of Philadelphia, Philadelphia, Pennsylvania.&#xD;Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark, and Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark.&#xD;Institute of Health Sciences, University of Oulu, Oulu, Finland.&#xD;QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Herston, Australia.&#xD;EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands22Department of Biological Psychology, VU University Amsterdam, Amsterdam, the Netherlands.&#xD;Department of Mathematics, Universite de Sherbrooke, Quebec City, Quebec, Canada24Centre de recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec City, Quebec, Canada.&#xD;Population, Policy and Practice, UCL Institute of Child Health, University College London, United Kingdom.&#xD;Centre de recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec City, Quebec, Canada25ECOGENE-21 and Lipid Clinic, Chicoutimi Hospital, Saguenay, Quebec City, Quebec, Canada26Department of Biochemistry, Universite de Sherbrooke.&#xD;Department of Primary Care and Public Health, Imperial College London, United Kingdom.&#xD;School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom5Medical Research Council Integrative Epidemiology Unit at the University of Bristol, United Kingdom28University of Queensland Diamantin.&#xD;Center for Applied Genomics, the Children&apos;s Hospital of Philadelphia, Philadelphia, Pennsylvania29Division of Human Genetics, the Children&apos;s Hospital of Philadelphia, Philadelphia, Pennsylvania30Department of Pediatrics, Perelman School of Medicine, Unive.&#xD;FIMM Institute for Molecular Medicine Finland, Helsinki University, Helsinki, Finland.&#xD;Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, the Netherlands54Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.&#xD;Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, United Kingdom15Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom33Oxford National Institute for Health Research (NIHR) Biomedical Researc.&#xD;School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom.&#xD;Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark34Department of Medicine, Stanford University School of Medicine, Stanford, California.&#xD;Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom35Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom.&#xD;Institute of Nutritional Science, University of Potsdam, Germany37Center for Cardiovascular Research/Charite, Berlin, Germany.&#xD;School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom5Medical Research Council Integrative Epidemiology Unit at the University of Bristol, United Kingdom.&#xD;Institute of Health Sciences, University of Oulu, Oulu, Finland38Department of Epidemiology and Biostatistics, School of Public Health, Medical Research Council-Health Protection Agency Centre for Environment and Health, Faculty of Medicine, Imperial Coll.&#xD;Department of Obstetrics and Gynecology, Sahlgrenska Academy, Sahgrenska University Hospital, Gothenburg, Sweden.&#xD;Medical Research Council Integrative Epidemiology Unit at the University of Bristol, United Kingdom40Institute of Preventive Medicine, Bispebjerg and Frederiksberg University Hospital, Capital Region, Copenhagen, Denmark41Novo Nordisk Foundation Center fo.&#xD;Research Unit of Obstetrics &amp; Gynecology, Institute of Clinical Research, University of Southern Denmark, Odense.&#xD;The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands32Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, the Netherlands46Department of Pediatrics, Erasmus MC, University Medic.&#xD;Division of Epidemiology, Department of Genes and Environment, Norwegian Institute of Public Health, Oslo, Norway39Department of Obstetrics and Gynecology, Sahlgrenska Academy, Sahgrenska University Hospital, Gothenburg, Sweden.&#xD;Department of Pediatrics, University of Iowa, Iowa City.&#xD;Institute of Nutritional Science, University of Potsdam, Germany48The First Affiliated Hospital of Jinan University, Guangzhou, China.&#xD;Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts50Diabetes Center, Massachusetts General Hospital, Boston51Department of Medicine, Universite de Sherbrooke, Quebec City, Quebec, Canada.&#xD;Population, Policy and Practice, UCL Institute of Child Health, University College London, United Kingdom52Centre for Population Health Research, School of Health Sciences, and Sansom Institute, University of South Australia, Adelaide53South Australian He.&#xD;Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon and Exeter Hospital, Exeter, United Kingdom5Medical Research Council Integrative Epidemiology Unit at the University of Bristol, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetic Evidence for Causal Relationships Between Maternal Obesity-Related Traits and Birth Weight</style></title><secondary-title><style face="normal" font="default" size="100%">JAMA</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">JAMA</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1129-40</style></pages><volume><style face="normal" font="default" size="100%">315</style></volume><number><style face="normal" font="default" size="100%">11</style></number><edition><style face="normal" font="default" size="100%">2016/03/16</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Birth Weight/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Glucose/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group</style></keyword><keyword><style face="normal" font="default" size="100%">Fasting/*blood</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Newborn</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/blood/ethnology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Pregnancy</style></keyword><keyword><style face="normal" font="default" size="100%">Triglycerides/genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar 15</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1538-3598 (Electronic)&#xD;0098-7484 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">26978208</style></accession-num><abstract><style face="normal" font="default" size="100%">IMPORTANCE: Neonates born to overweight or obese women are larger and at higher risk of birth complications. Many maternal obesity-related traits are observationally associated with birth weight, but the causal nature of these associations is uncertain. OBJECTIVE: To test for genetic evidence of causal associations of maternal body mass index (BMI) and related traits with birth weight. DESIGN, SETTING, AND PARTICIPANTS: Mendelian randomization to test whether maternal BMI and obesity-related traits are potentially causally related to offspring birth weight. Data from 30,487 women in 18 studies were analyzed. Participants were of European ancestry from population- or community-based studies in Europe, North America, or Australia and were part of the Early Growth Genetics Consortium. Live, term, singleton offspring born between 1929 and 2013 were included. EXPOSURES: Genetic scores for BMI, fasting glucose level, type 2 diabetes, systolic blood pressure (SBP), triglyceride level, high-density lipoprotein cholesterol (HDL-C) level, vitamin D status, and adiponectin level. MAIN OUTCOME AND MEASURE: Offspring birth weight from 18 studies. RESULTS: Among the 30,487 newborns the mean birth weight in the various cohorts ranged from 3325 g to 3679 g. The maternal genetic score for BMI was associated with a 2-g (95% CI, 0 to 3 g) higher offspring birth weight per maternal BMI-raising allele (P = .008). The maternal genetic scores for fasting glucose and SBP were also associated with birth weight with effect sizes of 8 g (95% CI, 6 to 10 g) per glucose-raising allele (P = 7 x 10(-14)) and -4 g (95% CI, -6 to -2 g) per SBP-raising allele (P = 1x10(-5)), respectively. A 1-SD ( approximately 4 points) genetically higher maternal BMI was associated with a 55-g higher offspring birth weight (95% CI, 17 to 93 g). A 1-SD ( approximately 7.2 mg/dL) genetically higher maternal fasting glucose concentration was associated with 114-g higher offspring birth weight (95% CI, 80 to 147 g). However, a 1-SD ( approximately 10 mm Hg) genetically higher maternal SBP was associated with a 208-g lower offspring birth weight (95% CI, -394 to -21 g). For BMI and fasting glucose, genetic associations were consistent with the observational associations, but for systolic blood pressure, the genetic and observational associations were in opposite directions. CONCLUSIONS AND RELEVANCE: In this mendelian randomization study, genetically elevated maternal BMI and blood glucose levels were potentially causally associated with higher offspring birth weight, whereas genetically elevated maternal SBP was potentially causally related to lower birth weight. If replicated, these findings may have implications for counseling and managing pregnancies to avoid adverse weight-related birth outcomes.</style></abstract><notes><style face="normal" font="default" size="100%">Tyrrell, Jessica&#xD;Richmond, Rebecca C&#xD;Palmer, Tom M&#xD;Feenstra, Bjarke&#xD;Rangarajan, Janani&#xD;Metrustry, Sarah&#xD;Cavadino, Alana&#xD;Paternoster, Lavinia&#xD;Armstrong, Loren L&#xD;De Silva, N Maneka G&#xD;Wood, Andrew R&#xD;Horikoshi, Momoko&#xD;Geller, Frank&#xD;Myhre, Ronny&#xD;Bradfield, Jonathan P&#xD;Kreiner-Moller, Eskil&#xD;Huikari, Ville&#xD;Painter, Jodie N&#xD;Hottenga, Jouke-Jan&#xD;Allard, Catherine&#xD;Berry, Diane J&#xD;Bouchard, Luigi&#xD;Das, Shikta&#xD;Evans, David M&#xD;Hakonarson, Hakon&#xD;Hayes, M Geoffrey&#xD;Heikkinen, Jani&#xD;Hofman, Albert&#xD;Knight, Bridget&#xD;Lind, Penelope A&#xD;McCarthy, Mark I&#xD;McMahon, George&#xD;Medland, Sarah E&#xD;Melbye, Mads&#xD;Morris, Andrew P&#xD;Nodzenski, Michael&#xD;Reichetzeder, Christoph&#xD;Ring, Susan M&#xD;Sebert, Sylvain&#xD;Sengpiel, Verena&#xD;Sorensen, Thorkild I A&#xD;Willemsen, Gonneke&#xD;de Geus, Eco J C&#xD;Martin, Nicholas G&#xD;Spector, Tim D&#xD;Power, Christine&#xD;Jarvelin, Marjo-Riitta&#xD;Bisgaard, Hans&#xD;Grant, Struan F A&#xD;Nohr, Ellen A&#xD;Jaddoe, Vincent W&#xD;Jacobsson, Bo&#xD;Murray, Jeffrey C&#xD;Hocher, Berthold&#xD;Hattersley, Andrew T&#xD;Scholtens, Denise M&#xD;Davey Smith, George&#xD;Hivert, Marie-France&#xD;Felix, Janine F&#xD;Hypponen, Elina&#xD;Lowe, William L Jr&#xD;Frayling, Timothy M&#xD;Lawlor, Debbie A&#xD;Freathy, Rachel M&#xD;(EGG)&#xD;eng&#xD;G1001799/Medical Research Council/United Kingdom&#xD;G0701603/Medical Research Council/United Kingdom&#xD;G0500070/Medical Research Council/United Kingdom&#xD;104150/Z/14/Z/Wellcome Trust/United Kingdom&#xD;MC_UU_12013/3/Medical Research Council/United Kingdom&#xD;MC_QA137853/Medical Research Council/United Kingdom&#xD;MC_UU_1201/4/Medical Research Council/United Kingdom&#xD;MR/J012165/1/Medical Research Council/United Kingdom&#xD;MC_UU_1201/1/Medical Research Council/United Kingdom&#xD;WT094529MA/Wellcome Trust/United Kingdom&#xD;102215/Wellcome Trust/United Kingdom&#xD;104150/Wellcome Trust/United Kingdom&#xD;MR/N01104X/1/Medical Research Council/United Kingdom&#xD;MC_PC_15018/Medical Research Council/United Kingdom&#xD;Canadian Institutes of Health Research/Canada&#xD;R01 HD056465/HD/NICHD NIH HHS/&#xD;P30 ES013508/ES/NIEHS NIH HHS/&#xD;R01 DK10324/DK/NIDDK NIH HHS/&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;MC_UU_12013/4/Medical Research Council/United Kingdom&#xD;R01 DK103246/DK/NIDDK NIH HHS/&#xD;098395/Wellcome Trust/United Kingdom&#xD;MC_UU_1201/1/5/Medical Research Council/United Kingdom&#xD;WT083431MF/Wellcome Trust/United Kingdom&#xD;WT098017/Wellcome Trust/United Kingdom&#xD;323195/European Research Council/International&#xD;WT088806/Wellcome Trust/United Kingdom&#xD;G0601261/Medical Research Council/United Kingdom&#xD;MC_UU_12013/5/Medical Research Council/United Kingdom&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;JAMA. 2016 Mar 15;315(11):1129-40. doi: 10.1001/jama.2016.1975.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/26978208</style></url></related-urls><pdf-urls><url>internal-pdf://0267348373/Tyrrell-2016-Genetic evidence for causal relat.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4811305</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1001/jama.2016.1975</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>40</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">40</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">van &apos;t Hof, F. N.</style></author><author><style face="normal" font="default" size="100%">Vaucher, J.</style></author><author><style face="normal" font="default" size="100%">Holmes, M. V.</style></author><author><style face="normal" font="default" size="100%">de Wilde, A.</style></author><author><style face="normal" font="default" size="100%">Baas, A. F.</style></author><author><style face="normal" font="default" size="100%">Blankensteijn, J. D.</style></author><author><style face="normal" font="default" size="100%">Hofman, A.</style></author><author><style face="normal" font="default" size="100%">Kiemeney, L. A.</style></author><author><style face="normal" font="default" size="100%">Rivadeneira, F.</style></author><author><style face="normal" font="default" size="100%">Uitterlinden, A. G.</style></author><author><style face="normal" font="default" size="100%">Vermeulen, S. H.</style></author><author><style face="normal" font="default" size="100%">Rinkel, G. J.</style></author><author><style face="normal" font="default" size="100%">de Bakker, P. I.</style></author><author><style face="normal" font="default" size="100%">Ruigrok, Y. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Brain Center Rudolf Magnus, Department of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht, The Netherlands.&#xD;Department of Internal Medicine, Lausanne University Hospital, Switzerland, Switzerland.&#xD;Clinical Trial Service Unit &amp; Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.&#xD;Medical Research Council Population Health Research Unit at the University of Oxford, Oxford, UK.&#xD;Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.&#xD;Department of Vascular Surgery, VU Medical Center, Amsterdam, The Netherlands.&#xD;Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.&#xD;Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.&#xD;Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.&#xD;Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genetic variants associated with type 2 diabetes and adiposity and risk of intracranial and abdominal aortic aneurysms</style></title><secondary-title><style face="normal" font="default" size="100%">Eur J Hum Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Eur J Hum Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">758-762</style></pages><volume><style face="normal" font="default" size="100%">25</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2017/04/06</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aortic Aneurysm, Abdominal/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Intracranial Aneurysm/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">*Polymorphism, Single Nucleotide</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-5438 (Electronic)&#xD;1018-4813 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28378816</style></accession-num><abstract><style face="normal" font="default" size="100%">Epidemiological studies show that type 2 diabetes (T2D) is inversely associated with intracranial aneurysms (IA) and abdominal aortic aneurysms (AAA). Although adiposity has not been considered a risk factor for IA, there have been inconsistent reports relating adiposity to AAA risk. We assessed whether these observations have a genetic, causal basis. To this end, we extracted genotypes of validated single-nucleotide polymorphisms associated with T2D (n=65), body mass index (BMI) (n=97) and waist-hip ratio adjusted for BMI (WHRadjBMI) (n=47) from genotype data collected in 717 IA cases and 1988 controls, and in 818 AAA cases and 3004 controls, all of Dutch descent. For each of these three traits, we computed genetic risk scores (GRS) for each individual in these case-control data sets by summing the number of risk alleles weighted by their published effect size, and tested whether these GRS were associated with risk of aneurysm. We divided the cohorts into GRS quartiles, and compared IA and AAA risk in the highest with the lowest GRS quartile using logistic regression. We found no evidence for association in IA or AAA risk between top and bottom quartiles for the genetic risk scores for T2D, BMI and WHRadjBMI. However, additional Mendelian randomization analyses suggested a trend to potentially causal associations between BMI and WHRadjBMI and risk of AAA. Overall, our results do not support epidemiological observations relating T2D to aneurysm risk, but may indicate a potential role of adiposity in AAA that requires further investigation.</style></abstract><notes><style face="normal" font="default" size="100%">van &apos;t Hof, Femke Ng&#xD;Vaucher, Julien&#xD;Holmes, Michael V&#xD;de Wilde, Arno&#xD;Baas, Annette F&#xD;Blankensteijn, Jan D&#xD;Hofman, Albert&#xD;Kiemeney, Lambertus Alm&#xD;Rivadeneira, Fernando&#xD;Uitterlinden, Andre G&#xD;Vermeulen, Sita H&#xD;Rinkel, Gabriel Je&#xD;de Bakker, Paul Iw&#xD;Ruigrok, Ynte M&#xD;eng&#xD;G0802432/MRC_/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Eur J Hum Genet. 2017 Jun;25(6):758-762. doi: 10.1038/ejhg.2017.48. Epub 2017 Apr 5.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28378816</style></url></related-urls><pdf-urls><url>internal-pdf://1008098842/van &apos;t Hof-2017-Genetic variants associated wi.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5477373</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/ejhg.2017.48</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>112</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">112</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">van den Broek, N.</style></author><author><style face="normal" font="default" size="100%">Treur, J. L.</style></author><author><style face="normal" font="default" size="100%">Larsen, J. K.</style></author><author><style face="normal" font="default" size="100%">Verhagen, M.</style></author><author><style face="normal" font="default" size="100%">Verweij, K. J. H.</style></author><author><style face="normal" font="default" size="100%">Vink, J. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Developmental Psychopathology, Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal associations between body mass index and mental health: a Mendelian randomisation study</style></title><secondary-title><style face="normal" font="default" size="100%">J Epidemiol Community Health</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Epidemiol Community Health</style></full-title></periodical><pages><style face="normal" font="default" size="100%">708-710</style></pages><volume><style face="normal" font="default" size="100%">72</style></volume><number><style face="normal" font="default" size="100%">8</style></number><edition><style face="normal" font="default" size="100%">2018/04/19</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Mental Disorders/diagnosis/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Mental Health</style></keyword><keyword><style face="normal" font="default" size="100%">*depression</style></keyword><keyword><style face="normal" font="default" size="100%">*health behaviour</style></keyword><keyword><style face="normal" font="default" size="100%">*mendelian randomisation</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1470-2738 (Electronic)&#xD;0143-005X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29666151</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Body mass index (BMI) is correlated negatively with subjective well-being and positively with depressive symptoms. Whether these associations reflect causal effects is unclear. METHODS: We examined bidirectional, causal effects between BMI and mental health with Mendelian randomisation using summary-level data from published genome-wide association studies (BMI: n=339 224; subjective well-being: n=204 966; depressive symptoms: n=161 460). Genetic variants robustly related to the exposure variable acted as instrumental variable to estimate causal effects. We combined estimates of individual genetic variants with inverse-variance weighted meta-analysis, weighted median regression and MR-Egger regression. RESULTS: There was evidence for a causal, increasing effect of BMI on depressive symptoms and suggestive evidence for a decreasing effect of BMI on subjective well-being. We found no evidence for causality in the other direction. CONCLUSION: This study provides support for a higher BMI causing poorer mental health. Further research should corroborate these findings and explore mechanisms underlying this potential causality.</style></abstract><notes><style face="normal" font="default" size="100%">van den Broek, Nina&#xD;Treur, Jorien L&#xD;Larsen, Junilla K&#xD;Verhagen, Maaike&#xD;Verweij, Karin J H&#xD;Vink, Jacqueline M&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;J Epidemiol Community Health. 2018 Aug;72(8):708-710. doi: 10.1136/jech-2017-210000. Epub 2018 Apr 17.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29666151</style></url></related-urls><pdf-urls><url>internal-pdf://0566440739/van den Broek-2018-Causal associations between.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/jech-2017-210000</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>73</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">73</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vimaleswaran, K. S.</style></author><author><style face="normal" font="default" size="100%">Berry, D. J.</style></author><author><style face="normal" font="default" size="100%">Lu, C.</style></author><author><style face="normal" font="default" size="100%">Tikkanen, E.</style></author><author><style face="normal" font="default" size="100%">Pilz, S.</style></author><author><style face="normal" font="default" size="100%">Hiraki, L. T.</style></author><author><style face="normal" font="default" size="100%">Cooper, J. D.</style></author><author><style face="normal" font="default" size="100%">Dastani, Z.</style></author><author><style face="normal" font="default" size="100%">Li, R.</style></author><author><style face="normal" font="default" size="100%">Houston, D. K.</style></author><author><style face="normal" font="default" size="100%">Wood, A. R.</style></author><author><style face="normal" font="default" size="100%">Michaelsson, K.</style></author><author><style face="normal" font="default" size="100%">Vandenput, L.</style></author><author><style face="normal" font="default" size="100%">Zgaga, L.</style></author><author><style face="normal" font="default" size="100%">Yerges-Armstrong, L. M.</style></author><author><style face="normal" font="default" size="100%">McCarthy, M. I.</style></author><author><style face="normal" font="default" size="100%">Dupuis, J.</style></author><author><style face="normal" font="default" size="100%">Kaakinen, M.</style></author><author><style face="normal" font="default" size="100%">Kleber, M. E.</style></author><author><style face="normal" font="default" size="100%">Jameson, K.</style></author><author><style face="normal" font="default" size="100%">Arden, N.</style></author><author><style face="normal" font="default" size="100%">Raitakari, O.</style></author><author><style face="normal" font="default" size="100%">Viikari, J.</style></author><author><style face="normal" font="default" size="100%">Lohman, K. K.</style></author><author><style face="normal" font="default" size="100%">Ferrucci, L.</style></author><author><style face="normal" font="default" size="100%">Melhus, H.</style></author><author><style face="normal" font="default" size="100%">Ingelsson, E.</style></author><author><style face="normal" font="default" size="100%">Byberg, L.</style></author><author><style face="normal" font="default" size="100%">Lind, L.</style></author><author><style face="normal" font="default" size="100%">Lorentzon, M.</style></author><author><style face="normal" font="default" size="100%">Salomaa, V.</style></author><author><style face="normal" font="default" size="100%">Campbell, H.</style></author><author><style face="normal" font="default" size="100%">Dunlop, M.</style></author><author><style face="normal" font="default" size="100%">Mitchell, B. D.</style></author><author><style face="normal" font="default" size="100%">Herzig, K. H.</style></author><author><style face="normal" font="default" size="100%">Pouta, A.</style></author><author><style face="normal" font="default" size="100%">Hartikainen, A. L.</style></author><author><style face="normal" font="default" size="100%">Genetic Investigation of Anthropometric Traits, Giant Consortium</style></author><author><style face="normal" font="default" size="100%">Streeten, E. A.</style></author><author><style face="normal" font="default" size="100%">Theodoratou, E.</style></author><author><style face="normal" font="default" size="100%">Jula, A.</style></author><author><style face="normal" font="default" size="100%">Wareham, N. J.</style></author><author><style face="normal" font="default" size="100%">Ohlsson, C.</style></author><author><style face="normal" font="default" size="100%">Frayling, T. M.</style></author><author><style face="normal" font="default" size="100%">Kritchevsky, S. B.</style></author><author><style face="normal" font="default" size="100%">Spector, T. D.</style></author><author><style face="normal" font="default" size="100%">Richards, J. B.</style></author><author><style face="normal" font="default" size="100%">Lehtimaki, T.</style></author><author><style face="normal" font="default" size="100%">Ouwehand, W. H.</style></author><author><style face="normal" font="default" size="100%">Kraft, P.</style></author><author><style face="normal" font="default" size="100%">Cooper, C.</style></author><author><style face="normal" font="default" size="100%">Marz, W.</style></author><author><style face="normal" font="default" size="100%">Power, C.</style></author><author><style face="normal" font="default" size="100%">Loos, R. J.</style></author><author><style face="normal" font="default" size="100%">Wang, T. J.</style></author><author><style face="normal" font="default" size="100%">Jarvelin, M. R.</style></author><author><style face="normal" font="default" size="100%">Whittaker, J. C.</style></author><author><style face="normal" font="default" size="100%">Hingorani, A. D.</style></author><author><style face="normal" font="default" size="100%">Hypponen, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Centre for Paediatric Epidemiology and Biostatistics and MRC Centre of Epidemiology for Child Health, UCL Institute of Child Health, London, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1001383</style></pages><volume><style face="normal" font="default" size="100%">10</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2013/02/09</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Biomarkers/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Europe</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Evidence-Based Medicine</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Linear Models</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Multivariate Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">North America</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/diagnosis/ethnology/*genetics/therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">*Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Vitamin D/analogs &amp; derivatives/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Vitamin D Deficiency/diagnosis/ethnology/*genetics/prevention &amp; control</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">23393431</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Obesity is associated with vitamin D deficiency, and both are areas of active public health concern. We explored the causality and direction of the relationship between body mass index (BMI) and 25-hydroxyvitamin D [25(OH)D] using genetic markers as instrumental variables (IVs) in bi-directional Mendelian randomization (MR) analysis. METHODS AND FINDINGS: We used information from 21 adult cohorts (up to 42,024 participants) with 12 BMI-related SNPs (combined in an allelic score) to produce an instrument for BMI and four SNPs associated with 25(OH)D (combined in two allelic scores, separately for genes encoding its synthesis or metabolism) as an instrument for vitamin D. Regression estimates for the IVs (allele scores) were generated within-study and pooled by meta-analysis to generate summary effects. Associations between vitamin D scores and BMI were confirmed in the Genetic Investigation of Anthropometric Traits (GIANT) consortium (n = 123,864). Each 1 kg/m(2) higher BMI was associated with 1.15% lower 25(OH)D (p = 6.52x10(-)(2)(7)). The BMI allele score was associated both with BMI (p = 6.30x10(-)(6)(2)) and 25(OH)D (-0.06% [95% CI -0.10 to -0.02], p = 0.004) in the cohorts that underwent meta-analysis. The two vitamin D allele scores were strongly associated with 25(OH)D (p&lt;/=8.07x10(-)(5)(7) for both scores) but not with BMI (synthesis score, p = 0.88; metabolism score, p = 0.08) in the meta-analysis. A 10% higher genetically instrumented BMI was associated with 4.2% lower 25(OH)D concentrations (IV ratio: -4.2 [95% CI -7.1 to -1.3], p = 0.005). No association was seen for genetically instrumented 25(OH)D with BMI, a finding that was confirmed using data from the GIANT consortium (p&gt;/=0.57 for both vitamin D scores). CONCLUSIONS: On the basis of a bi-directional genetic approach that limits confounding, our study suggests that a higher BMI leads to lower 25(OH)D, while any effects of lower 25(OH)D increasing BMI are likely to be small. Population level interventions to reduce BMI are expected to decrease the prevalence of vitamin D deficiency.</style></abstract><notes><style face="normal" font="default" size="100%">Vimaleswaran, Karani S&#xD;Berry, Diane J&#xD;Lu, Chen&#xD;Tikkanen, Emmi&#xD;Pilz, Stefan&#xD;Hiraki, Linda T&#xD;Cooper, Jason D&#xD;Dastani, Zari&#xD;Li, Rui&#xD;Houston, Denise K&#xD;Wood, Andrew R&#xD;Michaelsson, Karl&#xD;Vandenput, Liesbeth&#xD;Zgaga, Lina&#xD;Yerges-Armstrong, Laura M&#xD;McCarthy, Mark I&#xD;Dupuis, Josee&#xD;Kaakinen, Marika&#xD;Kleber, Marcus E&#xD;Jameson, Karen&#xD;Arden, Nigel&#xD;Raitakari, Olli&#xD;Viikari, Jorma&#xD;Lohman, Kurt K&#xD;Ferrucci, Luigi&#xD;Melhus, Hakan&#xD;Ingelsson, Erik&#xD;Byberg, Liisa&#xD;Lind, Lars&#xD;Lorentzon, Mattias&#xD;Salomaa, Veikko&#xD;Campbell, Harry&#xD;Dunlop, Malcolm&#xD;Mitchell, Braxton D&#xD;Herzig, Karl-Heinz&#xD;Pouta, Anneli&#xD;Hartikainen, Anna-Liisa&#xD;Streeten, Elizabeth A&#xD;Theodoratou, Evropi&#xD;Jula, Antti&#xD;Wareham, Nicholas J&#xD;Ohlsson, Claes&#xD;Frayling, Timothy M&#xD;Kritchevsky, Stephen B&#xD;Spector, Timothy D&#xD;Richards, J Brent&#xD;Lehtimaki, Terho&#xD;Ouwehand, Willem H&#xD;Kraft, Peter&#xD;Cooper, Cyrus&#xD;Marz, Winfried&#xD;Power, Chris&#xD;Loos, Ruth J F&#xD;Wang, Thomas J&#xD;Jarvelin, Marjo-Riitta&#xD;Whittaker, John C&#xD;Hingorani, Aroon D&#xD;Hypponen, Elina&#xD;eng&#xD;G0801056/MRC_/Medical Research Council/United Kingdom&#xD;CZH/4/529/CSO_/Chief Scientist Office/United Kingdom&#xD;U.1475.00.003.00010.02(74238)/MRC_/Medical Research Council/United Kingdom&#xD;13147/ARC_/Arthritis Research UK/United Kingdom&#xD;DH_/Department of Health/United Kingdom&#xD;MC_U106179471/MRC_/Medical Research Council/United Kingdom&#xD;U.1475.00.003.00010.02(74242)/MRC_/Medical Research Council/United Kingdom&#xD;14136/CRUK_/Cancer Research UK/United Kingdom&#xD;13085/ARC_/Arthritis Research UK/United Kingdom&#xD;FS05/125/BHF_/British Heart Foundation/United Kingdom&#xD;13230/ARC_/Arthritis Research UK/United Kingdom&#xD;MC_U147574233/MRC_/Medical Research Council/United Kingdom&#xD;17265/ARC_/Arthritis Research UK/United Kingdom&#xD;G0601653/MRC_/Medical Research Council/United Kingdom&#xD;K05 AA017688/AA/NIAAA NIH HHS/&#xD;U.1475.00.002.00001.01(74218)/MRC_/Medical Research Council/United Kingdom&#xD;16349/ARC_/Arthritis Research UK/United Kingdom&#xD;MC_U147585827/MRC_/Medical Research Council/United Kingdom&#xD;13181/ARC_/Arthritis Research UK/United Kingdom&#xD;12076/CRUK_/Cancer Research UK/United Kingdom&#xD;PG/09/023/BHF_/British Heart Foundation/United Kingdom&#xD;K01 AG030506/AG/NIA NIH HHS/&#xD;MC_U147585819/MRC_/Medical Research Council/United Kingdom&#xD;G1000143/MRC_/Medical Research Council/United Kingdom&#xD;MC_U147574215/MRC_/Medical Research Council/United Kingdom&#xD;17413/ARC_/Arthritis Research UK/United Kingdom&#xD;13157/ARC_/Arthritis Research UK/United Kingdom&#xD;MC_U127527198/MRC_/Medical Research Council/United Kingdom&#xD;MC_UP_A620_1014/MRC_/Medical Research Council/United Kingdom&#xD;MC_U147574236/MRC_/Medical Research Council/United Kingdom&#xD;G0401527/MRC_/Medical Research Council/United Kingdom&#xD;090532/WT_/Wellcome Trust/United Kingdom&#xD;MC_PC_U127561128/MRC_/Medical Research Council/United Kingdom&#xD;PG/09/023/26806/BHF_/British Heart Foundation/United Kingdom&#xD;MC_U106188470/MRC_/Medical Research Council/United Kingdom&#xD;16095/ARC_/Arthritis Research UK/United Kingdom&#xD;G0400491/MRC_/Medical Research Council/United Kingdom&#xD;MC_U147574217/MRC_/Medical Research Council/United Kingdom&#xD;MC_U147585824/MRC_/Medical Research Council/United Kingdom&#xD;MC_U147574221/MRC_/Medical Research Council/United Kingdom&#xD;P30 AG021332/AG/NIA NIH HHS/&#xD;U.1475.00.003.00010.02(74237)/MRC_/Medical Research Council/United Kingdom&#xD;Meta-Analysis&#xD;Multicenter Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS Med. 2013;10(2):e1001383. doi: 10.1371/journal.pmed.1001383. Epub 2013 Feb 5.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/23393431</style></url></related-urls><pdf-urls><url>internal-pdf://0674556797/Vimaleswaran-2013-Causal relationship between.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC3564800</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1001383</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>168</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">168</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wade, K. H.</style></author><author><style face="normal" font="default" size="100%">Carslake, D.</style></author><author><style face="normal" font="default" size="100%">Sattar, N.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.&#xD;Population Health Sciences, Bristol Medical School, Faculty of Health Sciences, University of Bristol, Bristol, UK.&#xD;Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">BMI and Mortality in UK Biobank: Revised Estimates Using Mendelian Randomization</style></title><secondary-title><style face="normal" font="default" size="100%">Obesity (Silver Spring)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Obesity (Silver Spring)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1796-1806</style></pages><volume><style face="normal" font="default" size="100%">26</style></volume><number><style face="normal" font="default" size="100%">11</style></number><edition><style face="normal" font="default" size="100%">2018/10/26</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Biological Specimen Banks/*standards</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Mortality</style></keyword><keyword><style face="normal" font="default" size="100%">United Kingdom</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1930-739X (Electronic)&#xD;1930-7381 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30358150</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVE: The aim of this study was to obtain estimates of the causal relationship between BMI and mortality. METHODS: Mendelian randomization (MR) with BMI-associated genotypic variation was used to test the causal effect of BMI on all-cause and cause-specific mortality in UK Biobank participants of White British ancestry. RESULTS: MR analyses supported a causal association between higher BMI and greater risk of all-cause mortality (hazard ratio [HR] per 1 kg/m(2) : 1.03; 95% CI: 0.99-1.07) and mortality from cardiovascular diseases (HR: 1.10; 95% CI: 1.01-1.19), specifically coronary heart disease (HR: 1.12; 95% CI: 1.00-1.25) and those excluding coronary heart disease/stroke/aortic aneurysm (HR: 1.24; 95% CI: 1.03-1.48), stomach cancer (HR: 1.18; 95% CI: 0.87-1.62), and esophageal cancer (HR: 1.22; 95% CI: 0.98-1.53), and a decreased risk of lung cancer mortality (HR: 0.96; 95% CI: 0.85-1.08). Sex stratification supported the causal role of higher BMI increasing bladder cancer mortality risk (males) but decreasing respiratory disease mortality risk (males). The J-shaped observational association between BMI and mortality was visible with MR analyses, but the BMI at which mortality was minimized was lower and the association was flatter over a larger BMI range. CONCLUSIONS: Results support a causal role of higher BMI in increasing the risk of all-cause mortality and mortality from several specific causes.</style></abstract><notes><style face="normal" font="default" size="100%">Wade, Kaitlin H&#xD;Carslake, David&#xD;Sattar, Naveed&#xD;Davey Smith, George&#xD;Timpson, Nicholas J&#xD;eng&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/9/MRC_/Medical Research Council/United Kingdom&#xD;4/CRUK_/Cancer Research UK/United Kingdom&#xD;202802/Z/16/Z/WT_/Wellcome Trust/United Kingdom&#xD;2018-2023/CRUK_/Cancer Research UK/United Kingdom&#xD;1/WT_/Wellcome Trust/United Kingdom&#xD;3/CRUK_/Cancer Research UK/United Kingdom&#xD;MC_PC_12028/MRC_/Medical Research Council/United Kingdom&#xD;2013-2018/WT_/Wellcome Trust/United Kingdom&#xD;2013-2018/CRUK_/Cancer Research UK/United Kingdom&#xD;202802/WT_/Wellcome Trust/United Kingdom&#xD;9/WT_/Wellcome Trust/United Kingdom&#xD;C18281/CRUK_/Cancer Research UK/United Kingdom&#xD;2018-2023/WT_/Wellcome Trust/United Kingdom&#xD;University of Bristol/International&#xD;A19169/CRUK_/Cancer Research UK/United Kingdom&#xD;MC_UU_12013/1/MRC_/Medical Research Council/United Kingdom&#xD;1-6/CRUK_/Cancer Research UK/United Kingdom&#xD;MC_UU_12013/4/MRC_/Medical Research Council/United Kingdom&#xD;MC_PC_17228/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00011/1/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/3/MRC_/Medical Research Council/United Kingdom&#xD;1-7/CRUK_/Cancer Research UK/United Kingdom&#xD;16/WT_/Wellcome Trust/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Obesity (Silver Spring). 2018 Nov;26(11):1796-1806. doi: 10.1002/oby.22313.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30358150</style></url></related-urls><pdf-urls><url>internal-pdf://0603370138/Wade-2018-BMI and Mortality in UK Biobank_ Rev.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6334168</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/oby.22313</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>36</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">36</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wade, K. H.</style></author><author><style face="normal" font="default" size="100%">Chiesa, S. T.</style></author><author><style face="normal" font="default" size="100%">Hughes, A. D.</style></author><author><style face="normal" font="default" size="100%">Chaturvedi, N.</style></author><author><style face="normal" font="default" size="100%">Charakida, M.</style></author><author><style face="normal" font="default" size="100%">Rapala, A.</style></author><author><style face="normal" font="default" size="100%">Muthurangu, V.</style></author><author><style face="normal" font="default" size="100%">Khan, T.</style></author><author><style face="normal" font="default" size="100%">Finer, N.</style></author><author><style face="normal" font="default" size="100%">Sattar, N.</style></author><author><style face="normal" font="default" size="100%">Howe, L. D.</style></author><author><style face="normal" font="default" size="100%">Fraser, A.</style></author><author><style face="normal" font="default" size="100%">Lawlor, D. A.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Deanfield, J. E.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">MRC Integrative Epidemiology Unit (IEU) at the University of Bristol, Bristol, UK.&#xD;Population Health Sciences, Bristol Medical School, Faculty of Health Sciences, University of Bristol, Bristol, BS8 2BN.&#xD;Vascular Physiology Unit, Institute of Cardiovascular Science, University College London, 1 St. Martin&apos;s Le Grand, London, EC1A 4NP.&#xD;Cardiometabolic Phenotyping Group, Institute of Cardiovascular Science, University College London, London, W1T 7HA.&#xD;Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Assessing the causal role of body mass index on cardiovascular health in young adults: Mendelian randomization and recall-by-genotype analyses</style></title><secondary-title><style face="normal" font="default" size="100%">Circulation</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Circulation</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2187-2201</style></pages><volume><style face="normal" font="default" size="100%">138</style></volume><number><style face="normal" font="default" size="100%">20</style></number><edition><style face="normal" font="default" size="100%">2018/12/14</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Carotid Intima-Media Thickness</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Heart/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Heart Rate</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Life Style</style></keyword><keyword><style face="normal" font="default" size="100%">Longitudinal Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Phenotype</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Pulse Wave Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Vascular Resistance/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Ventricular Function, Left</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*alspac</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomization</style></keyword><keyword><style face="normal" font="default" size="100%">*cardiovascular traits</style></keyword><keyword><style face="normal" font="default" size="100%">*causality</style></keyword><keyword><style face="normal" font="default" size="100%">*recall-by-genotype</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov 13</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1524-4539 (Electronic)&#xD;0009-7322 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30524135</style></accession-num><abstract><style face="normal" font="default" size="100%">Background: Body mass index (BMI) has been suggested to be causally related to cardiovascular health in mid-to-late life, but this has not been explored systematically at younger ages - nor with detailed cardiovascular phenotyping. Recall-by-Genotype (RbG) is an approach that enables the collection of precise phenotypic measures in smaller studies, whilst maintaining statistical power and ability for causal inference. Methods: In this study, we used a combination of conventional multivariable regression analysis, Mendelian randomization (MR) and sub-sample RbG methodologies to estimate the causal effect of BMI on gross-level and detailed cardiovascular health in healthy participants from the Avon Longitudinal Study of Parents and Children at age 17 (N=1420-3108 for different outcomes) and an independent sample from the same cohort (for RbG) study at age 21 (N=386-418). Results: In both MR and RbG analyses, results suggested that higher BMI causes higher blood pressure (BP) and left ventricular mass index (LVMI) in young adults (e.g., difference in LVMI per kg/m(2) using MR: 1.07g/m(2.7); 95% CI: 0.62, 1.52; P=3.87x10(-06) and per 3.58kg/m(2) using RbG: 1.65g/m(2.7) 95% CI: 0.83, 2.47; P=0.0001). Additionally, RbG results suggested a causal role of higher BMI on higher stroke volume (SV: difference per 3.58kg/m(2): 1.49ml/m(2.04); 95% CI: 0.62, 2.35; P=0.001) and cardiac output (CO: difference per 3.58kg/m(2): 0.11l/min/m(1.83); 95% CI: 0.03, 0.19; P=0.01) but no strong evidence for a causal role on systemic vascular resistance or total arterial compliance. Neither analysis supported a causal role of higher BMI on heart rate. Conclusions: Complementary MR and RbG causal methodologies, together with a range of sensitivity analyses, suggest that higher BMI is likely to cause worse cardiovascular health, specifically higher BP and LVMI, even in youth. Higher BMI also resulted in increased CO in the RbG study, which appeared to be solely driven by SV, as neither MR nor RbG analyses suggested a causal effect of BMI on heart rate. These consistent results support efforts to reduce BMI from a young age to prevent later adverse cardiovascular health and illustrate the potential for phenotypic resolution with maintained analytical power using RbG.</style></abstract><notes><style face="normal" font="default" size="100%">Wade, Kaitlin H&#xD;Chiesa, Scott T&#xD;Hughes, Alun D&#xD;Chaturvedi, Nish&#xD;Charakida, Marietta&#xD;Rapala, Alicja&#xD;Muthurangu, Vivek&#xD;Khan, Tauseef&#xD;Finer, Nicholas&#xD;Sattar, Naveed&#xD;Howe, Laura D&#xD;Fraser, Abigail&#xD;Lawlor, Debbie A&#xD;Davey Smith, George&#xD;Deanfield, John E&#xD;Timpson, Nicholas J&#xD;eng&#xD;096989/WT_/Wellcome Trust/United Kingdom&#xD;CS/13/1/30327/BHF_/British Heart Foundation/United Kingdom&#xD;MC_UU_00011/1/MRC_/Medical Research Council/United Kingdom&#xD;202802/WT_/Wellcome Trust/United Kingdom&#xD;MR/M020894/1/MRC_/Medical Research Council/United Kingdom&#xD;RG/10/004/28240/BHF_/British Heart Foundation/United Kingdom&#xD;086676/WT_/Wellcome Trust/United Kingdom&#xD;MC_UU_12013/3/MRC_/Medical Research Council/United Kingdom&#xD;CS/15/6/31468/BHF_/British Heart Foundation/United Kingdom&#xD;PG/06/145/21955/BHF_/British Heart Foundation/United Kingdom&#xD;102215/WT_/Wellcome Trust/United Kingdom&#xD;MC_UU_12013/5/MRC_/Medical Research Council/United Kingdom&#xD;MR/M009351/1/MRC_/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Circulation. 2018 Nov 13;138(20):2187-2201. doi: 10.1161/CIRCULATIONAHA.117.033278. Epub 2018 Jul 30.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30524135</style></url></related-urls><pdf-urls><url>internal-pdf://2428815117/Wade-2018-Assessing the causal role of body ma.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6250296</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1161/CIRCULATIONAHA.117.033278</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>90</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">90</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Walter, S.</style></author><author><style face="normal" font="default" size="100%">Glymour, M. M.</style></author><author><style face="normal" font="default" size="100%">Koenen, K.</style></author><author><style face="normal" font="default" size="100%">Liang, L.</style></author><author><style face="normal" font="default" size="100%">Tchetgen Tchetgen, E. J.</style></author><author><style face="normal" font="default" size="100%">Cornelis, M.</style></author><author><style face="normal" font="default" size="100%">Chang, S. C.</style></author><author><style face="normal" font="default" size="100%">Rewak, M.</style></author><author><style face="normal" font="default" size="100%">Rimm, E.</style></author><author><style face="normal" font="default" size="100%">Kawachi, I.</style></author><author><style face="normal" font="default" size="100%">Kubzansky, L. D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Social and Behavioral Sciences,Harvard School of Public Health,Boston, MA,USA.&#xD;Mailman School of Public Health,Columbia University,New York, NY,USA.&#xD;Department of Epidemiology,Harvard School of Public Health,Boston, MA,USA.&#xD;Department of Nutrition,Harvard School of Public Health,Boston, MA,USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Do genetic risk scores for body mass index predict risk of phobic anxiety? Evidence for a shared genetic risk factor</style></title><secondary-title><style face="normal" font="default" size="100%">Psychol Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Psychol Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">181-91</style></pages><volume><style face="normal" font="default" size="100%">45</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2014/07/30</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Alpha-Ketoglutarate-Dependent Dioxygenase FTO</style></keyword><keyword><style face="normal" font="default" size="100%">Analysis of Variance</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*genetics/*psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Phobic Disorders/blood/epidemiology/*genetics/*psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Genetic</style></keyword><keyword><style face="normal" font="default" size="100%">Proteins/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Receptor, Melanocortin, Type 4/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Sex Distribution</style></keyword><keyword><style face="normal" font="default" size="100%">Surveys and Questionnaires</style></keyword><keyword><style face="normal" font="default" size="100%">United States/epidemiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1469-8978 (Electronic)&#xD;0033-2917 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">25065638</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Obesity and anxiety are often linked but the direction of effects is not clear. METHOD: Using genetic instrumental variable (IV) analyses in 5911 female participants from the Nurses&apos; Health Study (NHS, initiated 1976) and 3697 male participants from the Health Professional Follow-up Study (HPFS, initiated 1986), we aimed to determine whether obesity increases symptoms of phobic anxiety. As instrumental variables we used the fat mass and obesity-associated (FTO) gene, the melanocortin 4 receptor (MC4R) gene and a genetic risk score (GRS) based on 32 single nucleotide polymorphisms (SNPs) that significantly predict body mass index (BMI). &apos;Functional&apos; GRSs corresponding with specific biological pathways that shape BMI (adipogenesis, appetite and cardiopulmonary) were considered. The main outcome was phobic anxiety measured by the Crown Crisp Index (CCI) in 2004 in the NHS and in 2000 in the HPFS. RESULTS: In observational analysis, a 1-unit higher BMI was associated with higher phobic anxiety symptoms [women: beta = 0.05, 95% confidence interval (CI) 0.030-0.068; men: beta = 0.04, 95% CI 0.016-0.071). IV analyses showed that BMI was associated with higher phobic anxiety symptoms in the FTO-instrumented analysis (p = 0.005) but not in the GRS-instrumented analysis (p = 0.256). Functional GRSs showed heterogeneous, non-significant effects of BMI on phobic anxiety symptoms. CONCLUSIONS: Our findings do not provide conclusive evidence in favor of the hypothesis that higher BMI leads to higher levels of phobic anxiety, but rather suggest that genes that influence obesity, in particular FTO, may have direct effects on phobic anxiety, and hence that obesity and phobic anxiety may share common genetic determinants.</style></abstract><notes><style face="normal" font="default" size="100%">Walter, S&#xD;Glymour, M M&#xD;Koenen, K&#xD;Liang, L&#xD;Tchetgen Tchetgen, E J&#xD;Cornelis, M&#xD;Chang, S-C&#xD;Rewak, M&#xD;Rimm, E&#xD;Kawachi, I&#xD;Kubzansky, L D&#xD;eng&#xD;R01 ES020337/ES/NIEHS NIH HHS/&#xD;P01 CA087969/CA/NCI NIH HHS/&#xD;RC4 MH092707/MH/NIMH NIH HHS/&#xD;P01 CA87969/CA/NCI NIH HHS/&#xD;MH092707-01/MH/NIMH NIH HHS/&#xD;UM1 CA167552/CA/NCI NIH HHS/&#xD;R01 AI104459/AI/NIAID NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Psychol Med. 2015 Jan;45(1):181-91. doi: 10.1017/S0033291714001226. Epub 2014 May 28.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/25065638</style></url></related-urls><pdf-urls><url>internal-pdf://2052635376/Walter-2015-Do genetic risk scores for body ma.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4387884</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1017/S0033291714001226</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>61</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">61</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Walter, S.</style></author><author><style face="normal" font="default" size="100%">Kubzansky, L. D.</style></author><author><style face="normal" font="default" size="100%">Koenen, K. C.</style></author><author><style face="normal" font="default" size="100%">Liang, L.</style></author><author><style face="normal" font="default" size="100%">Tchetgen Tchetgen, E. J.</style></author><author><style face="normal" font="default" size="100%">Cornelis, M. C.</style></author><author><style face="normal" font="default" size="100%">Chang, S. C.</style></author><author><style face="normal" font="default" size="100%">Rimm, E.</style></author><author><style face="normal" font="default" size="100%">Kawachi, I.</style></author><author><style face="normal" font="default" size="100%">Glymour, M. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, Massachusetts; Department of Epidemiology &amp; Biostatistics, University of California, San Fransisco, California.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Revisiting Mendelian randomization studies of the effect of body mass index on depression</style></title><secondary-title><style face="normal" font="default" size="100%">Am J Med Genet B Neuropsychiatr Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Am J Med Genet B Neuropsychiatr Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">108-15</style></pages><volume><style face="normal" font="default" size="100%">168B</style></volume><number><style face="normal" font="default" size="100%">2</style></number><edition><style face="normal" font="default" size="100%">2015/02/07</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Depression/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Models, Genetic</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Fto</style></keyword><keyword><style face="normal" font="default" size="100%">adiposity</style></keyword><keyword><style face="normal" font="default" size="100%">causation</style></keyword><keyword><style face="normal" font="default" size="100%">genetic</style></keyword><keyword><style face="normal" font="default" size="100%">instrumental variable analysis</style></keyword><keyword><style face="normal" font="default" size="100%">obesity</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1552-485X (Electronic)&#xD;1552-4841 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">25656382</style></accession-num><abstract><style face="normal" font="default" size="100%">Mendelian Randomization studies, which use genetic instrumental variables (IVs) as quasi-experiments to estimate causal effects, report inconsistent findings regarding effects of body mass index (BMI) on mental health. We used genetic IV to estimate effects of BMI on depression and evaluated validity of a commonly used IV. Female Nurse&apos;s Health Study participants (n=6989, average age 56.4, [Standard Deviation 6.91] years at first depression assessment) self-reported BMI, which was averaged across eight reports prior to depression assessment (mean=24.96, SD 4.50). Genetic instruments included fat mass and obesity-associated protein (FTO) alleles, melanocortin receptor 4 (MC4R) alleles, and polygenic risk scores based on 32 established polymorphisms for BMI. Depression was assessed using multiple symptom measures, scaled to the Geriatric Depression Scale 15, averaged across up to 7 biennial waves. We used over-identification tests to assess the validity of genetic IVs. In conventional estimates, each additional BMI point predicted 0.024 (95% Confidence Interval (CI): 0.020-0.029) higher average depression scores. Genetic IV estimates were not significant when based on FTO (beta: 0.064, CI: -0.014, 0.142), MC4R (beta: 0.005, CI: -0.146, 0.156), polygenic score excluding FTO (beta=-0.003, 95%-CI -0.051, 0.045), or mechanism-specific scores. The over-identification test comparing IV estimates based on FTO to estimates based on the polygenic score excluding FTO rejected equality of estimated effects (P=0.014). Results provide no evidence against a null effect of BMI on depression and call into question validity of FTO as an instrument for BMI in Mendelian Randomization studies.</style></abstract><notes><style face="normal" font="default" size="100%">Walter, Stefan&#xD;Kubzansky, Laura D&#xD;Koenen, Karestan C&#xD;Liang, Liming&#xD;Tchetgen Tchetgen, Eric J&#xD;Cornelis, Marilyn C&#xD;Chang, Shun-Chiao&#xD;Rimm, Eric&#xD;Kawachi, Ichiro&#xD;Glymour, M Maria&#xD;eng&#xD;R01 ES020337/ES/NIEHS NIH HHS/&#xD;P01 CA087969/CA/NCI NIH HHS/&#xD;RC4 MH092707/MH/NIMH NIH HHS/&#xD;P01 CA87969/CA/NCI NIH HHS/&#xD;MH092707-01/MH/NIMH NIH HHS/&#xD;R01 AI104459/AI/NIAID NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Am J Med Genet B Neuropsychiatr Genet. 2015 Mar;168B(2):108-15. doi: 10.1002/ajmg.b.32286. Epub 2015 Feb 5.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/25656382</style></url></related-urls><pdf-urls><url>internal-pdf://3089958876/Walter-2015-Revisiting Mendelian randomization.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4387873</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/ajmg.b.32286</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>68</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">68</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wang, Heming</style></author><author><style face="normal" font="default" size="100%">Lane, Jacqueline M.</style></author><author><style face="normal" font="default" size="100%">Jones, Samuel E.</style></author><author><style face="normal" font="default" size="100%">Dashti, Hassan S.</style></author><author><style face="normal" font="default" size="100%">Ollila, Hanna</style></author><author><style face="normal" font="default" size="100%">Wood, Andrew R.</style></author><author><style face="normal" font="default" size="100%">van Hees, Vincent T.</style></author><author><style face="normal" font="default" size="100%">Brumpton, Ben</style></author><author><style face="normal" font="default" size="100%">Winsvold, Bendik S.</style></author><author><style face="normal" font="default" size="100%">Kantojärvi, Katri</style></author><author><style face="normal" font="default" size="100%">Cade, Brian E.</style></author><author><style face="normal" font="default" size="100%">Sofer, Tamar</style></author><author><style face="normal" font="default" size="100%">Song, Yanwei</style></author><author><style face="normal" font="default" size="100%">Patel, Krunal</style></author><author><style face="normal" font="default" size="100%">Anderson, Simon G.</style></author><author><style face="normal" font="default" size="100%">Bechtold, David A.</style></author><author><style face="normal" font="default" size="100%">Bowden, Jack</style></author><author><style face="normal" font="default" size="100%">Emsley, Richard</style></author><author><style face="normal" font="default" size="100%">Kyle, Simon D.</style></author><author><style face="normal" font="default" size="100%">Little, Max A.</style></author><author><style face="normal" font="default" size="100%">Loudon, Andrew S.</style></author><author><style face="normal" font="default" size="100%">Scheer, Frank A. J. L.</style></author><author><style face="normal" font="default" size="100%">Purcell, Shaun M.</style></author><author><style face="normal" font="default" size="100%">Richmond, Rebecca C.</style></author><author><style face="normal" font="default" size="100%">Spiegelhalder, Kai</style></author><author><style face="normal" font="default" size="100%">Tyrrell, Jessica</style></author><author><style face="normal" font="default" size="100%">Zhu, Xiaofeng</style></author><author><style face="normal" font="default" size="100%">Kristiansson, Kati</style></author><author><style face="normal" font="default" size="100%">Sulkava, Sonja</style></author><author><style face="normal" font="default" size="100%">Paunio, Tiina</style></author><author><style face="normal" font="default" size="100%">Hveem, Kristian</style></author><author><style face="normal" font="default" size="100%">Nielsen, Jonas B.</style></author><author><style face="normal" font="default" size="100%">Willer, Cristen J.</style></author><author><style face="normal" font="default" size="100%">Zwart, John-Anker</style></author><author><style face="normal" font="default" size="100%">Strand, Linn B.</style></author><author><style face="normal" font="default" size="100%">Frayling, Timothy M.</style></author><author><style face="normal" font="default" size="100%">Ray, David</style></author><author><style face="normal" font="default" size="100%">Lawlor, Deborah A.</style></author><author><style face="normal" font="default" size="100%">Rutter, Martin K.</style></author><author><style face="normal" font="default" size="100%">Weedon, Michael N.</style></author><author><style face="normal" font="default" size="100%">Redline, Susan</style></author><author><style face="normal" font="default" size="100%">Saxena, Richa</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><urls><pdf-urls><url>internal-pdf://0571381442/Wang-2018-Genome-wide association analysis of.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/454561</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>156</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">156</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wang, N.</style></author><author><style face="normal" font="default" size="100%">Cheng, J.</style></author><author><style face="normal" font="default" size="100%">Ning, Z.</style></author><author><style face="normal" font="default" size="100%">Chen, Y.</style></author><author><style face="normal" font="default" size="100%">Han, B.</style></author><author><style face="normal" font="default" size="100%">Li, Q.</style></author><author><style face="normal" font="default" size="100%">Chen, C.</style></author><author><style face="normal" font="default" size="100%">Zhao, L.</style></author><author><style face="normal" font="default" size="100%">Xia, F.</style></author><author><style face="normal" font="default" size="100%">Lin, D.</style></author><author><style face="normal" font="default" size="100%">Guo, L.</style></author><author><style face="normal" font="default" size="100%">Lu, Y.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute and Department of Endocrinology and Metabolism, Shanghai Ninth People&apos;s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.&#xD;Department of Endocrinology, Ministry of Health, Beijing Hospital, Beijing, China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Type 2 Diabetes and Adiposity Induce Different Lipid Profile Disorders: A Mendelian Randomization Analysis</style></title><secondary-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2016-2025</style></pages><volume><style face="normal" font="default" size="100%">103</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2018/03/06</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular Diseases/blood/epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">China/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol, HDL/blood/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol, LDL/blood/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/blood/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Association Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Lipid Metabolism Disorders/blood/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Lipids/blood/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/blood/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Triglycerides/blood/genetics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1945-7197 (Electronic)&#xD;0021-972X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29506267</style></accession-num><abstract><style face="normal" font="default" size="100%">Context: Type 2 diabetes and obesity often coexist, so it is difficult to judge whether diabetes or obesity induce certain types of hyperlipidemia due to mutual confounds and reverse causation. We used Mendelian randomization analyses to explore the causal relationships of diabetes and adiposity with lipid profiles. Design, Setting, and Main Outcome Measures: From 23 sites in East China, 9798 participants were enrolled during 2014 to 2016. We calculated two weighted genetic risk scores as instrumental variables for type 2 diabetes and body mass index (BMI). These scores were used to measure the causal relationships of diabetes and BMI with lipid profiles that included total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TGs). Results: The causal regression coefficients (betaIV) of genetically determined diabetes for the total cholesterol, LDL-C, and log10TG were 0.130 [95% confidence interval (CI): 0.020, 0.240; P = 0.014], 0.125 (96% CI: 0.041, 0.209; P = 0.001), and 0.019 (95% CI: -0.001, 0.039; P = 0.055), respectively. The betaIV for HDL-C was -0.008 (95% CI: -0.032. 0.016), which was not significant (P = 0.699). The causal regression coefficients of a genetically determined 10 kg/m2 increase in BMI for HDL-C and log10TG were -0.409 (96% CI: -0.698, -0.120; P = 0.004) and 0.227 (95% CI: 0.039, 0.415; P = 0.026), respectively. The betaIVs for TGs and LDL-C were not significant. Conclusions: This study has provided evidence for the biologically plausible causal effects of diabetes and adiposity by BMI on different elements of the lipid profile using Mendelian randomization analyses.</style></abstract><notes><style face="normal" font="default" size="100%">Wang, Ningjian&#xD;Cheng, Jing&#xD;Ning, Zhiyuan&#xD;Chen, Yi&#xD;Han, Bing&#xD;Li, Qin&#xD;Chen, Chi&#xD;Zhao, Li&#xD;Xia, Fangzhen&#xD;Lin, Dongping&#xD;Guo, Lixin&#xD;Lu, Yingli&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;J Clin Endocrinol Metab. 2018 May 1;103(5):2016-2025. doi: 10.1210/jc.2017-02789.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29506267</style></url></related-urls><pdf-urls><url>internal-pdf://1795228882/Wang-2018-Type 2 Diabetes and Adiposity Induce.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1210/jc.2017-02789</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>74</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">74</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wang, T.</style></author><author><style face="normal" font="default" size="100%">Huang, T.</style></author><author><style face="normal" font="default" size="100%">Li, Y.</style></author><author><style face="normal" font="default" size="100%">Zheng, Y.</style></author><author><style face="normal" font="default" size="100%">Manson, J. E.</style></author><author><style face="normal" font="default" size="100%">Hu, F. B.</style></author><author><style face="normal" font="default" size="100%">Qi, L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, New Orleans, LA, 70112, USA.&#xD;Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.&#xD;Shanghai Institute of Endocrine and Metabolic Diseases, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People&apos;s Republic of China.&#xD;Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.&#xD;Division of Preventive Medicine, Department of Medicine, Brigham and Women&apos;s Hospital and Harvard Medical School, Boston, MA, USA.&#xD;Channing Division of Network Medicine, Department of Medicine, Brigham and Women&apos;s Hospital and Harvard Medical School, Boston, MA, USA.&#xD;Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, New Orleans, LA, 70112, USA. lqi1@tulane.edu.&#xD;Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. lqi1@tulane.edu.&#xD;Channing Division of Network Medicine, Department of Medicine, Brigham and Women&apos;s Hospital and Harvard Medical School, Boston, MA, USA. lqi1@tulane.edu.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Low birthweight and risk of type 2 diabetes: a Mendelian randomisation study</style></title><secondary-title><style face="normal" font="default" size="100%">Diabetologia</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Diabetologia</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1920-7</style></pages><volume><style face="normal" font="default" size="100%">59</style></volume><number><style face="normal" font="default" size="100%">9</style></number><edition><style face="normal" font="default" size="100%">2016/06/24</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adenylyl Cyclases/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Birth Weight/genetics/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/*epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">European Continental Ancestry Group</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infant, Low Birth Weight</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Software</style></keyword><keyword><style face="normal" font="default" size="100%">tRNA Methyltransferases/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Birthweight</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomisation</style></keyword><keyword><style face="normal" font="default" size="100%">*Type 2 diabetes</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1432-0428 (Electronic)&#xD;0012-186X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27333884</style></accession-num><abstract><style face="normal" font="default" size="100%">AIMS/HYPOTHESIS: Low birthweight has been associated with a high risk of type 2 diabetes mellitus in observational studies. However, it remains unclear whether this relation is causal. METHODS: The present study included 3627 individuals with type 2 diabetes and 12,974 control participants of European ancestry from the Nurses&apos; Health Study and the Health Professionals Follow-Up Study. A genetic risk score (GRS) was calculated based on five low-birthweight-related single nucleotide polymorphisms (SNPs). We assessed the evidence for causality first by examining the association of the GRS and the individual SNPs with type 2 diabetes, and second by performing a Mendelian randomisation analysis to estimate the potentially causal effect size of low birthweight on type 2 diabetes. RESULTS: In a meta-analysis of the two studies, each 1 point increment in the GRS was associated with a 6% (95% CI 3%, 9%) higher risk of type 2 diabetes. CCNL1 rs900400 and 5q11.2 rs4432842 showed dose-response associations with risk of type 2 diabetes; the corresponding ORs and 95% CIs were 1.09 (1.03, 1.16) and 1.09 (1.02, 1.16), respectively. Furthermore, we observed an overall Mendelian randomisation OR of 2.94 (95% CI 1.70, 5.16; p &lt; 0.001) for type 2 diabetes per 1 SD lower genetically determined birthweight. CONCLUSIONS/INTERPRETATION: A genetically lowered birthweight was associated with increased susceptibility to type 2 diabetes. Our findings support a potential causal relation between birthweight and risk of type 2 diabetes, providing new evidence to support the role of intrauterine exposures in the pathogenesis of type 2 diabetes.</style></abstract><notes><style face="normal" font="default" size="100%">Wang, Tiange&#xD;Huang, Tao&#xD;Li, Yanping&#xD;Zheng, Yan&#xD;Manson, JoAnn E&#xD;Hu, Frank B&#xD;Qi, Lu&#xD;eng&#xD;R01 DK091718/DK/NIDDK NIH HHS/&#xD;R21 HL126024/HL/NHLBI NIH HHS/&#xD;R01 HL034594/HL/NHLBI NIH HHS/&#xD;R01 DK100383/DK/NIDDK NIH HHS/&#xD;R01 HL071981/HL/NHLBI NIH HHS/&#xD;UM1 CA186107/CA/NCI NIH HHS/&#xD;UM1 CA167552/CA/NCI NIH HHS/&#xD;R01 DK078616/DK/NIDDK NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Diabetologia. 2016 Sep;59(9):1920-7. doi: 10.1007/s00125-016-4019-z. Epub 2016 Jun 23.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27333884</style></url></related-urls><pdf-urls><url>internal-pdf://1978979924/Wang-2016-Low birthweight and risk of type 2 d.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4970938</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s00125-016-4019-z</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>136</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">136</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wang, T.</style></author><author><style face="normal" font="default" size="100%">Ma, X.</style></author><author><style face="normal" font="default" size="100%">Tang, T.</style></author><author><style face="normal" font="default" size="100%">Jin, L.</style></author><author><style face="normal" font="default" size="100%">Peng, D.</style></author><author><style face="normal" font="default" size="100%">Zhang, R.</style></author><author><style face="normal" font="default" size="100%">Chen, M.</style></author><author><style face="normal" font="default" size="100%">Yan, J.</style></author><author><style face="normal" font="default" size="100%">Wang, S.</style></author><author><style face="normal" font="default" size="100%">Yan, D.</style></author><author><style face="normal" font="default" size="100%">He, Z.</style></author><author><style face="normal" font="default" size="100%">Jiang, F.</style></author><author><style face="normal" font="default" size="100%">Cheng, X.</style></author><author><style face="normal" font="default" size="100%">Bao, Y.</style></author><author><style face="normal" font="default" size="100%">Liu, Z.</style></author><author><style face="normal" font="default" size="100%">Hu, C.</style></author><author><style face="normal" font="default" size="100%">Jia, W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Centre for Diabetes, Shanghai Jiao Tong University Affiliated Sixth People&apos;s Hospital, Shanghai, China.&#xD;Laboratory of Cardiovascular Immunology, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.&#xD;National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.&#xD;Institute for Metabolic Diseases, Shanghai Jiao Tong University Affiliated Sixth People&apos;s Hospital South Campus, Shanghai, China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Overall and central obesity with insulin sensitivity and secretion in a Han Chinese population: a Mendelian randomization analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Obes (Lond)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Obes (Lond)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1736-1741</style></pages><volume><style face="normal" font="default" size="100%">40</style></volume><number><style face="normal" font="default" size="100%">11</style></number><edition><style face="normal" font="default" size="100%">2016/08/30</style></edition><keywords><keyword><style face="normal" font="default" size="100%">*Asian Continental Ancestry Group</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Glucose/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">China/ethnology</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/etiology/*genetics/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Ethnic Groups</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin Resistance/*genetics/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Insulin Secretion</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/complications/*genetics/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Waist-Hip Ratio</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-5497 (Electronic)&#xD;0307-0565 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">27569682</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND/OBJECTIVES: Clinical heterogeneity exists in overall obesity and obesity in terms of susceptibility to type 2 diabetes, but the relationship is vulnerable to be confounded by traditional risk factors in epidemiological studies. We aimed to characterize the impact of obesity in insulin secretion and sensitivity by using Mendelian randomization (MR) approach with genetic variants. SUBJECTS/METHODS: We first constructed two genetic risk scores based on 38 established loci for body mass index (BMI; a surrogate of overall obesity) and 13 waist-to-hip ratio (WHR; a surrogate of central obesity) to assess the causal effects of BMI and WHR on several glycaemic-related traits in 2884 community-based Han Chinese individuals. RESULTS: Both of BMI and WHR were observationally correlated with insulin secretion and sensitivity indices. The MR analysis demonstrated that a genetically determined 1 s.d. (3.35 kg m(-2)) higher BMI caused a unit of 178.18 pmol l(-1) higher Stumvoll first-phase and 35.52 pmol l(-1) higher Stumvoll second-phase insulin secretion (P=0.001 and 0.002, respectively), which were even independent of central obesity (P=0.019 and 0.039, respectively). In contrast, a genetically determined 1 s.d. higher WHR (a change of 0.002 in WHR) caused a unit of 1.21 higher homeostasis model assessment of insulin resistance and 18.40 lower Gutt index (representing the insulin sensitivity) (P=0.048 and 0.028, respectively). No substantial heterogeneity existed between the observed associations and the genetic estimated associations (P for difference &gt;0.05). CONCLUSIONS: We provide new causal evidence that the impact of obesity on insulin secretion and sensitivity could vary between overall obesity and central obesity in Han Chinese populations and also identify the extent to which overall obesity affects compensatory insulin secretion and central obesity inversely links to insulin sensitivity.</style></abstract><notes><style face="normal" font="default" size="100%">Wang, T&#xD;Ma, X&#xD;Tang, T&#xD;Jin, L&#xD;Peng, D&#xD;Zhang, R&#xD;Chen, M&#xD;Yan, J&#xD;Wang, S&#xD;Yan, D&#xD;He, Z&#xD;Jiang, F&#xD;Cheng, X&#xD;Bao, Y&#xD;Liu, Z&#xD;Hu, C&#xD;Jia, W&#xD;eng&#xD;England&#xD;Int J Obes (Lond). 2016 Nov;40(11):1736-1741. doi: 10.1038/ijo.2016.155. Epub 2016 Aug 29.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/27569682</style></url></related-urls><pdf-urls><url>internal-pdf://2642736933/Wang-2016-Overall and central obesity with ins.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/ijo.2016.155</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>117</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">117</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wang, T.</style></author><author><style face="normal" font="default" size="100%">Zhang, R.</style></author><author><style face="normal" font="default" size="100%">Ma, X.</style></author><author><style face="normal" font="default" size="100%">Wang, S.</style></author><author><style face="normal" font="default" size="100%">He, Z.</style></author><author><style face="normal" font="default" size="100%">Huang, Y.</style></author><author><style face="normal" font="default" size="100%">Xu, B.</style></author><author><style face="normal" font="default" size="100%">Li, Y.</style></author><author><style face="normal" font="default" size="100%">Zhang, H.</style></author><author><style face="normal" font="default" size="100%">Jiang, F.</style></author><author><style face="normal" font="default" size="100%">Bao, Y.</style></author><author><style face="normal" font="default" size="100%">Hu, C.</style></author><author><style face="normal" font="default" size="100%">Jia, W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Centre for Diabetes, Shanghai Jiao Tong University Affiliated Sixth People&apos;s Hospital, Shanghai, China.&#xD;Institute for Metabolic Disease, Fengxian Central Hospital Affiliated to Southern Medical University, Shanghai, China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal Association of Overall Obesity and Abdominal Obesity with Type 2 Diabetes: A Mendelian Randomization Analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Obesity (Silver Spring)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Obesity (Silver Spring)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">934-942</style></pages><volume><style face="normal" font="default" size="100%">26</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2018/04/10</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/*etiology/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*complications</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity, Abdominal/*complications</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1930-739X (Electronic)&#xD;1930-7381 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29630776</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVE: This study aimed to compare the causal effect of overall obesity and abdominal obesity on type 2 diabetes among Chinese Han individuals. METHODS: The causal relationship of BMI and waist-to-hip ratio (WHR) with the risk of glucose deterioration and glycemic traits was compared using two different genetic instruments based on 30 BMI loci and 6 WHR loci with Mendelian randomization (MR) in three prospective cohorts (n = 6,476). RESULTS: Each 1-SD genetically instrumented higher WHR was associated with a 65.7% higher risk of glucose deterioration (95% CI = 1.069-2.569, P = 0.024), whereas no significant association of BMI with glucose deterioration was observed. Furthermore, a causal relationship was found only between BMI and homeostatic model assessment beta-cell function (HOMA-B) (beta = 0.143, P = 0.001), and there was a nominal association with Stumvoll second-phase insulin secretion traits (beta = 0.074, P = 0.022). The significance level did not persist in sensitivity analyses, except in the causal estimate of WHR on the Gutt index in MR-Egger (beta = -0.379, P = 0.022) and the causal estimate of BMI on homeostatic model assessment beta-cell function in weighted median MR (beta = 0.128, P = 0.017). CONCLUSIONS: The data from this study support the potential causal relationship between abdominal obesity and hyperglycemia, which may be driven by aggravated insulin resistance, in contrast with the potential causal relationship between overall obesity and insulin secretion.</style></abstract><notes><style face="normal" font="default" size="100%">Wang, Tao&#xD;Zhang, Rong&#xD;Ma, Xiaojing&#xD;Wang, Shiyun&#xD;He, Zhen&#xD;Huang, Yeping&#xD;Xu, Bo&#xD;Li, Yangyang&#xD;Zhang, Hong&#xD;Jiang, Feng&#xD;Bao, Yuqian&#xD;Hu, Cheng&#xD;Jia, Weiping&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Obesity (Silver Spring). 2018 May;26(5):934-942. doi: 10.1002/oby.22167. Epub 2018 Apr 6.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29630776</style></url></related-urls><pdf-urls><url>internal-pdf://0231103534/Wang-2018-Causal Association of Overall Obesit.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/oby.22167</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>47</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">47</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Warodomwichit, D.</style></author><author><style face="normal" font="default" size="100%">Sritara, C.</style></author><author><style face="normal" font="default" size="100%">Thakkinstian, A.</style></author><author><style face="normal" font="default" size="100%">Chailurkit, L. O.</style></author><author><style face="normal" font="default" size="100%">Yamwong, S.</style></author><author><style face="normal" font="default" size="100%">Ratanachaiwong, W.</style></author><author><style face="normal" font="default" size="100%">Ongphiphadhanakul, B.</style></author><author><style face="normal" font="default" size="100%">Sritara, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal inference of the effect of adiposity on bone mineral density in adults</style></title><secondary-title><style face="normal" font="default" size="100%">Clin Endocrinol (Oxf)</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Clin Endocrinol (Oxf)</style></full-title></periodical><pages><style face="normal" font="default" size="100%">694-9</style></pages><volume><style face="normal" font="default" size="100%">78</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2012/10/11</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Absorptiometry, Photon</style></keyword><keyword><style face="normal" font="default" size="100%">Adiposity/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Body Composition/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Bone Density/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genotype</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1365-2265 (Electronic)&#xD;0300-0664 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">23045999</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVE: The causal effect of adipose tissue on bone mass and the direction of its net influence have not been directly assessed in adult humans. Using the Mendelian randomization analysis, we assessed the causality of adiposity in measurements of bone mass in adult males and females. DESIGN AND METHODS: Subjects consisted of 2154 adults aged 25-54 years from a cross-sectional cohort of the employees of the Electricity Generating Authority of Thailand. Body composition was determined after at least 3 h of fasting using multifrequency bioelectrical impedance analysis. Bone mineral density (BMD) was assessed by dual energy X-ray absorptiometry. A polymorphism in the fat mass and obesity-associated gene (FTO rs9939609) was used as an instrument in the Mendelian randomization analysis. RESULTS: The genotype distribution of the FTO rs9939609 polymorphism was 61.1% TT, 33.9% AT and 5.0% AA. The average body mass index (BMI), body fat mass and percentage body fat were 23.9 kg/m(2) (SD = 3.6), 17.9 kg (SD = 6.6) and 26.8% (SD = 7.2), respectively. The FTO rs9939609 polymorphism was significantly correlated with BMI (coefficient = 0.673 kg/m(2) , P &lt; 0.001), body fat mass (coefficient = 0.948 kg, P &lt; 0.001) and percentage body fat (coefficient = 0.759%, P &lt; 0.01). An instrumental variable (IV) regression model, using BMI as the intermediate phenotype, suggested that FTO was a strong IV. Also, the FTO-BMI polymorphism was significantly associated with total hip and femoral neck BMD but was not correlated with total spine BMD, with estimated correlation coefficients of 0.0189 (95% CI: 0.0046, 0.0332), 0.0149 (95% CI: 0.0030, 0.0268) and 0.0025 (95% CI: -0.0131, 0.0136) g/cm(2) , respectively. The variances of BMDs explained by the FTO-BMI were 19.0%, 21.3% and 1.1%, respectively. Similar trends were also observed for the FTO-body fat mass and FTO-percentage body fat correlations. CONCLUSIONS: Mendelian randomization analysis suggests that adiposity might be causally related to BMD at the femur but not at the spine.</style></abstract><notes><style face="normal" font="default" size="100%">Warodomwichit, Daruneewan&#xD;Sritara, Chanika&#xD;Thakkinstian, Ammarin&#xD;Chailurkit, La-Or&#xD;Yamwong, Sukit&#xD;Ratanachaiwong, Wipa&#xD;Ongphiphadhanakul, Boonsong&#xD;Sritara, Piyamitr&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Clin Endocrinol (Oxf). 2013 May;78(5):694-9. doi: 10.1111/cen.12061.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/23045999</style></url></related-urls><pdf-urls><url>internal-pdf://3747275702/Warodomwichit-2013-Causal inference of the eff.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/cen.12061</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>123</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">123</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Went, M.</style></author><author><style face="normal" font="default" size="100%">Sud, A.</style></author><author><style face="normal" font="default" size="100%">Law, P. J.</style></author><author><style face="normal" font="default" size="100%">Johnson, D. C.</style></author><author><style face="normal" font="default" size="100%">Weinhold, N.</style></author><author><style face="normal" font="default" size="100%">Forsti, A.</style></author><author><style face="normal" font="default" size="100%">van Duin, M.</style></author><author><style face="normal" font="default" size="100%">Mitchell, J. S.</style></author><author><style face="normal" font="default" size="100%">Chen, B.</style></author><author><style face="normal" font="default" size="100%">Kuiper, R.</style></author><author><style face="normal" font="default" size="100%">Stephens, O. W.</style></author><author><style face="normal" font="default" size="100%">Bertsch, U.</style></author><author><style face="normal" font="default" size="100%">Campo, C.</style></author><author><style face="normal" font="default" size="100%">Einsele, H.</style></author><author><style face="normal" font="default" size="100%">Gregory, W. M.</style></author><author><style face="normal" font="default" size="100%">Henrion, M.</style></author><author><style face="normal" font="default" size="100%">Hillengass, J.</style></author><author><style face="normal" font="default" size="100%">Hoffmann, P.</style></author><author><style face="normal" font="default" size="100%">Jackson, G. H.</style></author><author><style face="normal" font="default" size="100%">Lenive, O.</style></author><author><style face="normal" font="default" size="100%">Nickel, J.</style></author><author><style face="normal" font="default" size="100%">Nothen, M. M.</style></author><author><style face="normal" font="default" size="100%">da Silva Filho, M. I.</style></author><author><style face="normal" font="default" size="100%">Thomsen, H.</style></author><author><style face="normal" font="default" size="100%">Walker, B. A.</style></author><author><style face="normal" font="default" size="100%">Broyl, A.</style></author><author><style face="normal" font="default" size="100%">Davies, F. E.</style></author><author><style face="normal" font="default" size="100%">Langer, C.</style></author><author><style face="normal" font="default" size="100%">Hansson, M.</style></author><author><style face="normal" font="default" size="100%">Kaiser, M.</style></author><author><style face="normal" font="default" size="100%">Sonneveld, P.</style></author><author><style face="normal" font="default" size="100%">Goldschmidt, H.</style></author><author><style face="normal" font="default" size="100%">Hemminki, K.</style></author><author><style face="normal" font="default" size="100%">Nilsson, B.</style></author><author><style face="normal" font="default" size="100%">Morgan, G. J.</style></author><author><style face="normal" font="default" size="100%">Houlston, R. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.&#xD;Division of Molecular Pathology, The Institute of Cancer Research, London, UK.&#xD;Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.&#xD;Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.&#xD;Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.&#xD;Center for Primary Health Care Research, Lund University, Malmo, Sweden.&#xD;Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.&#xD;National Center for Tumor Diseases, Heidelberg, Germany.&#xD;Department of Internal Medicine II, Division of Hematology and Medical Oncology, University Hospital Wurzburg, Wurzburg, Germany.&#xD;Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.&#xD;Institute of Human Genetics, University of Bonn, Bonn, Germany.&#xD;Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland.&#xD;Royal Victoria Infirmary, Newcastle upon Tyne, Newcastle, UK.&#xD;Department of Genomics, Life &amp;Brain Center, University of Bonn, Bonn, Germany.&#xD;Department of Internal Medicine III, University of Ulm, Ulm, Germany.&#xD;Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.&#xD;Hematology Clinic, Skane University Hospital, Lund, Sweden.&#xD;Clinical Immunology and Transfusion Medicine, Laboratory Medicine, Office of Medical Services, Lund, Sweden.&#xD;Broad Institute, 7 Cambridge Center, Cambridge, MA, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach</style></title><secondary-title><style face="normal" font="default" size="100%">Blood Cancer J</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Blood Cancer J</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e573</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2017/06/18</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Multiple Myeloma/*genetics/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/*genetics/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">*Quantitative Trait Loci</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 16</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2044-5385 (Electronic)&#xD;2044-5385 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28622301</style></accession-num><notes><style face="normal" font="default" size="100%">Went, M&#xD;Sud, A&#xD;Law, P J&#xD;Johnson, D C&#xD;Weinhold, N&#xD;Forsti, A&#xD;van Duin, M&#xD;Mitchell, J S&#xD;Chen, B&#xD;Kuiper, R&#xD;Stephens, O W&#xD;Bertsch, U&#xD;Campo, C&#xD;Einsele, H&#xD;Gregory, W M&#xD;Henrion, M&#xD;Hillengass, J&#xD;Hoffmann, P&#xD;Jackson, G H&#xD;Lenive, O&#xD;Nickel, J&#xD;Nothen, M M&#xD;da Silva Filho, M I&#xD;Thomsen, H&#xD;Walker, B A&#xD;Broyl, A&#xD;Davies, F E&#xD;Langer, C&#xD;Hansson, M&#xD;Kaiser, M&#xD;Sonneveld, P&#xD;Goldschmidt, H&#xD;Hemminki, K&#xD;Nilsson, B&#xD;Morgan, G J&#xD;Houlston, R S&#xD;eng&#xD;G0100132/Medical Research Council/United Kingdom&#xD;C1298/A8362/Cancer Research UK/United Kingdom&#xD;P01 CA055819/CA/NCI NIH HHS/&#xD;Letter&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Blood Cancer J. 2017 Jun 16;7(6):e573. doi: 10.1038/bcj.2017.48.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28622301</style></url></related-urls><pdf-urls><url>internal-pdf://1069643357/Went-2017-Assessing the effect of obesity-rela.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5520395</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/bcj.2017.48</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>140</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">140</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Winkler, T. W.</style></author><author><style face="normal" font="default" size="100%">Gunther, F.</style></author><author><style face="normal" font="default" size="100%">Hollerer, S.</style></author><author><style face="normal" font="default" size="100%">Zimmermann, M.</style></author><author><style face="normal" font="default" size="100%">Loos, R. J.</style></author><author><style face="normal" font="default" size="100%">Kutalik, Z.</style></author><author><style face="normal" font="default" size="100%">Heid, I. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Genetic Epidemiology, University of Regensburg, D-93051, Regensburg, Germany. thomas.winkler@ukr.de.&#xD;Department of Genetic Epidemiology, University of Regensburg, D-93051, Regensburg, Germany.&#xD;Statistical Consulting Unit StaBLab, Department of Statistics, Ludwig-Maximilians-Universitat Munich, D-80539, Munich, Germany.&#xD;The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, 10029, New York, NY, USA.&#xD;The Genetics of Obesity and Related Metabolic Traits Program, Icahn School of Medicine at Mount Sinai, 10029, New York, NY, USA.&#xD;The Mindich Child health and Development Institute, Icahn School of Medicine at Mount Sinai, 10029, New York, NY, USA.&#xD;Institute of Social and Preventive Medicine (IUMSP), Centre Hospitalier Universitaire Vaudois (CHUV), 1010, Lausanne, Switzerland.&#xD;Swiss Institute of Bioinformatics, 1015, Lausanne, Switzerland.&#xD;Department of Genetic Epidemiology, University of Regensburg, D-93051, Regensburg, Germany. iris.heid@ukr.de.</style></auth-address><titles><title><style face="normal" font="default" size="100%">A joint view on genetic variants for adiposity differentiates subtypes with distinct metabolic implications</style></title><secondary-title><style face="normal" font="default" size="100%">Nat Commun</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Nat Commun</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1946</style></pages><volume><style face="normal" font="default" size="100%">9</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2018/05/18</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adipose Tissue/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Energy Metabolism/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Meta-Analysis as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/classification/genetics/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">*Waist-Hip Ratio</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 16</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2041-1723 (Electronic)&#xD;2041-1723 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29769528</style></accession-num><abstract><style face="normal" font="default" size="100%">The problem of the genetics of related phenotypes is often addressed by analyzing adjusted-model traits, but such traits warrant cautious interpretation. Here, we adopt a joint view of adiposity traits in ~322,154 subjects (GIANT consortium). We classify 159 signals associated with body mass index (BMI), waist-to-hip ratio (WHR), or WHR adjusted for BMI (WHRadjBMI) at P &lt; 5 x 10(-8), into four classes based on the direction of their effects on BMI and WHR. Our classes help differentiate adiposity genetics with respect to anthropometry, fat depots, and metabolic health. Class-specific Mendelian randomization reveals that variants associated with both WHR-decrease and BMI increase are linked to metabolically rather favorable adiposity through beneficial hip fat. Class-specific enrichment analyses implicate digestive systems as a pathway in adiposity genetics. Our results demonstrate that WHRadjBMI variants capture relevant effects of &quot;unexpected fat distribution given the BMI&quot; and that a joint view of the genetics underlying related phenotypes can inform on important biology.</style></abstract><notes><style face="normal" font="default" size="100%">Winkler, Thomas W&#xD;Gunther, Felix&#xD;Hollerer, Simon&#xD;Zimmermann, Martina&#xD;Loos, Ruth Jf&#xD;Kutalik, Zoltan&#xD;Heid, Iris M&#xD;eng&#xD;R01 DK075787/DK/NIDDK NIH HHS/&#xD;R01 DK107786/DK/NIDDK NIH HHS/&#xD;R01 DK110113/DK/NIDDK NIH HHS/&#xD;U01 HG007417/HG/NHGRI NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nat Commun. 2018 May 16;9(1):1946. doi: 10.1038/s41467-018-04124-9.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29769528</style></url></related-urls><pdf-urls><url>internal-pdf://1148126272/Winkler-2018-A joint view on genetic variants.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5956079</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s41467-018-04124-9</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>141</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">141</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wootton, R. E.</style></author><author><style face="normal" font="default" size="100%">Lawn, R. B.</style></author><author><style face="normal" font="default" size="100%">Millard, L. A. C.</style></author><author><style face="normal" font="default" size="100%">Davies, N. M.</style></author><author><style face="normal" font="default" size="100%">Taylor, A. E.</style></author><author><style face="normal" font="default" size="100%">Munafo, M. R.</style></author><author><style face="normal" font="default" size="100%">Timpson, N. J.</style></author><author><style face="normal" font="default" size="100%">Davis, O. S. P.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Haworth, C. M. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">School of Experimental Psychology, University of Bristol, Bristol BS8 1TU, UK.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.&#xD;Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.&#xD;Intelligent Systems Laboratory, Department of Computer Science, University of Bristol, Bristol, UK.&#xD;NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol, UK.&#xD;UK Centre for Tobacco and Alcohol Studies, University of Bristol, Bristol, UK.&#xD;Avon Longitudinal Study of Parents and Children, Bristol, UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Evaluation of the causal effects between subjective wellbeing and cardiometabolic health: mendelian randomisation study</style></title><secondary-title><style face="normal" font="default" size="100%">BMJ</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMJ</style></full-title></periodical><pages><style face="normal" font="default" size="100%">k3788</style></pages><volume><style face="normal" font="default" size="100%">362</style></volume><edition><style face="normal" font="default" size="100%">2018/09/27</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adipose Tissue/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure/genetics/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular Diseases/*genetics/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol, HDL/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol, LDL/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Disease/*genetics/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Myocardial Infarction/*genetics/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Systole/physiology</style></keyword><keyword><style face="normal" font="default" size="100%">United Kingdom/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Waist Circumference/physiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep 25</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1756-1833 (Electronic)&#xD;0959-8138 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">30254091</style></accession-num><abstract><style face="normal" font="default" size="100%">OBJECTIVES: To investigate whether the association between subjective wellbeing (subjective happiness and life satisfaction) and cardiometabolic health is causal. DESIGN: Two sample, bidirectional mendelian randomisation study. SETTING: Genetic data taken from various cohorts comprised of the general population (mostly individuals of European ancestry, plus a small proportion of other ancestries); follow-up analysis included individuals from the United Kingdom. PARTICIPANTS: Summary data were used from previous genome wide association studies (number of participants ranging from 83 198 to 339 224), which investigated traits related to cardiovascular or metabolic health, had the largest sample sizes, and consisted of the most similar populations while minimising sample overlap. A follow-up analysis included 337 112 individuals from the UK Biobank (54% female (n=181 363), mean age 56.87 years (standard deviation 8.00) at recruitment). MAIN OUTCOME MEASURES: Subjective wellbeing and 11 measures of cardiometabolic health (coronary artery disease; myocardial infarction; total, high density lipoprotein, and low density lipoprotein cholesterol; diastolic and systolic blood pressure; body fat; waist to hip ratio; waist circumference; and body mass index). RESULTS: Evidence of a causal effect of body mass index on subjective wellbeing was seen; each 1 kg/m(2) increase in body mass index caused a -0.045 (95% confidence interval -0.084 to -0.006, P=0.02) standard deviation reduction in subjective wellbeing. Follow-up analysis of this association in an independent sample from the UK Biobank provided strong evidence of an effect of body mass index on satisfaction with health (beta=-0.035 unit decrease in health satisfaction (95% confidence interval -0.043 to -0.027) per standard deviation increase in body mass index, P&lt;0.001). No clear evidence of a causal effect was seen between subjective wellbeing and the other cardiometabolic health measures, in either direction. CONCLUSIONS: These results suggest that a higher body mass index is associated with a lower subjective wellbeing. A follow-up analysis confirmed this finding, suggesting that the effect in middle aged people could be driven by satisfaction with health. Body mass index is a modifiable determinant, and therefore, this study provides further motivation to tackle the obesity epidemic because of the knock-on effects of higher body mass index on subjective wellbeing.</style></abstract><notes><style face="normal" font="default" size="100%">Wootton, Robyn E&#xD;Lawn, Rebecca B&#xD;Millard, Louise A C&#xD;Davies, Neil M&#xD;Taylor, Amy E&#xD;Munafo, Marcus R&#xD;Timpson, Nicholas J&#xD;Davis, Oliver S P&#xD;Davey Smith, George&#xD;Haworth, Claire M A&#xD;eng&#xD;MC_UU_12013/3/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00011/7/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00011/1/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/1/MRC_/Medical Research Council/United Kingdom&#xD;MC_PC_17228/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/8/MRC_/Medical Research Council/United Kingdom&#xD;G9815508/MRC_/Medical Research Council/United Kingdom&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_12013/6/MRC_/Medical Research Council/United Kingdom&#xD;England&#xD;BMJ. 2018 Sep 25;362:k3788. doi: 10.1136/bmj.k3788.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/30254091</style></url></related-urls><pdf-urls><url>internal-pdf://3566080210/Wootton-2018-Evaluation of the causal effects.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6155050 at www.icmje.org/coi_disclosure.pdf and declare: main support from the NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol for the submitted work; no other financial relationships other than those detailed in the funding statement above.</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/bmj.k3788</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>59</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">59</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wurtz, P.</style></author><author><style face="normal" font="default" size="100%">Wang, Q.</style></author><author><style face="normal" font="default" size="100%">Kangas, A. J.</style></author><author><style face="normal" font="default" size="100%">Richmond, R. C.</style></author><author><style face="normal" font="default" size="100%">Skarp, J.</style></author><author><style face="normal" font="default" size="100%">Tiainen, M.</style></author><author><style face="normal" font="default" size="100%">Tynkkynen, T.</style></author><author><style face="normal" font="default" size="100%">Soininen, P.</style></author><author><style face="normal" font="default" size="100%">Havulinna, A. S.</style></author><author><style face="normal" font="default" size="100%">Kaakinen, M.</style></author><author><style face="normal" font="default" size="100%">Viikari, J. S.</style></author><author><style face="normal" font="default" size="100%">Savolainen, M. J.</style></author><author><style face="normal" font="default" size="100%">Kahonen, M.</style></author><author><style face="normal" font="default" size="100%">Lehtimaki, T.</style></author><author><style face="normal" font="default" size="100%">Mannisto, S.</style></author><author><style face="normal" font="default" size="100%">Blankenberg, S.</style></author><author><style face="normal" font="default" size="100%">Zeller, T.</style></author><author><style face="normal" font="default" size="100%">Laitinen, J.</style></author><author><style face="normal" font="default" size="100%">Pouta, A.</style></author><author><style face="normal" font="default" size="100%">Mantyselka, P.</style></author><author><style face="normal" font="default" size="100%">Vanhala, M.</style></author><author><style face="normal" font="default" size="100%">Elliott, P.</style></author><author><style face="normal" font="default" size="100%">Pietilainen, K. H.</style></author><author><style face="normal" font="default" size="100%">Ripatti, S.</style></author><author><style face="normal" font="default" size="100%">Salomaa, V.</style></author><author><style face="normal" font="default" size="100%">Raitakari, O. T.</style></author><author><style face="normal" font="default" size="100%">Jarvelin, M. R.</style></author><author><style face="normal" font="default" size="100%">Smith, G. D.</style></author><author><style face="normal" font="default" size="100%">Ala-Korpela, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.&#xD;Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland; NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.&#xD;Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland.&#xD;Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.&#xD;Institute of Health Sciences and Biocenter Oulu, University of Oulu, Oulu, Finland.&#xD;Department of Medicine, University of Turku and Turku University Hospital, Turku, Finland.&#xD;Department of Internal Medicine, Clinical Research Center and Biocenter Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.&#xD;Department of Clinical Physiology, University of Tampere and Tampere University Hospital, Tampere, Finland.&#xD;Department of Clinical Chemistry, Fimlab Laboratories, University of Tampere, Tampere, Finland.&#xD;Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.&#xD;University Heart Center Hamburg, Hamburg, Germany.&#xD;Finnish Institute of Occupational Health, Helsinki, Finland.&#xD;Department of Obstetrics and Gynecology, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland; Department of Children, Young People and Families, National Institute for Health and Welfare, Oulu, Finland.&#xD;Primary Health Care, School of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.&#xD;Primary Health Care, School of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland; Primary Health Care, Central Finland Central Hospital, Jyvaskyla, Finland.&#xD;Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, Imperial College London, London, United Kingdom.&#xD;Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland; Research Programs Unit Diabetes and Obesity, University of Helsinki, Helsinki, Finland.&#xD;Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Wellcome Trust Sanger Institute, Hinxton, United Kingdom; Hjelt Institute, Department of Public Health, University of Helsinki, Helsinki, Finland.&#xD;Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland; Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland.&#xD;Institute of Health Sciences and Biocenter Oulu, University of Oulu, Oulu, Finland; Department of Children, Young People and Families, National Institute for Health and Welfare, Oulu, Finland; Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, Imperial College London, London, United Kingdom; Oulu University Hospital, Oulu, Finland.&#xD;Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland; NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; Oulu University Hospital, Oulu, Finland; Computational Medicine, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change</style></title><secondary-title><style face="normal" font="default" size="100%">PLoS Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">PLoS Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e1001765</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><number><style face="normal" font="default" size="100%">12</style></number><edition><style face="normal" font="default" size="100%">2014/12/10</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Body Weight/*physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1549-1676 (Electronic)&#xD;1549-1277 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">25490400</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Increased adiposity is linked with higher risk for cardiometabolic diseases. We aimed to determine to what extent elevated body mass index (BMI) within the normal weight range has causal effects on the detailed systemic metabolite profile in early adulthood. METHODS AND FINDINGS: We used Mendelian randomization to estimate causal effects of BMI on 82 metabolic measures in 12,664 adolescents and young adults from four population-based cohorts in Finland (mean age 26 y, range 16-39 y; 51% women; mean +/- standard deviation BMI 24 +/- 4 kg/m(2)). Circulating metabolites were quantified by high-throughput nuclear magnetic resonance metabolomics and biochemical assays. In cross-sectional analyses, elevated BMI was adversely associated with cardiometabolic risk markers throughout the systemic metabolite profile, including lipoprotein subclasses, fatty acid composition, amino acids, inflammatory markers, and various hormones (p&lt;0.0005 for 68 measures). Metabolite associations with BMI were generally stronger for men than for women (median 136%, interquartile range 125%-183%). A gene score for predisposition to elevated BMI, composed of 32 established genetic correlates, was used as the instrument to assess causality. Causal effects of elevated BMI closely matched observational estimates (correspondence 87% +/- 3%; R(2)= 0.89), suggesting causative influences of adiposity on the levels of numerous metabolites (p&lt;0.0005 for 24 measures), including lipoprotein lipid subclasses and particle size, branched-chain and aromatic amino acids, and inflammation-related glycoprotein acetyls. Causal analyses of certain metabolites and potential sex differences warrant stronger statistical power. Metabolite changes associated with change in BMI during 6 y of follow-up were examined for 1,488 individuals. Change in BMI was accompanied by widespread metabolite changes, which had an association pattern similar to that of the cross-sectional observations, yet with greater metabolic effects (correspondence 160% +/- 2%; R(2) = 0.92). CONCLUSIONS: Mendelian randomization indicates causal adverse effects of increased adiposity with multiple cardiometabolic risk markers across the metabolite profile in adolescents and young adults within the non-obese weight range. Consistent with the causal influences of adiposity, weight changes were paralleled by extensive metabolic changes, suggesting a broadly modifiable systemic metabolite profile in early adulthood. Please see later in the article for the Editors&apos; Summary.</style></abstract><notes><style face="normal" font="default" size="100%">Wurtz, Peter&#xD;Wang, Qin&#xD;Kangas, Antti J&#xD;Richmond, Rebecca C&#xD;Skarp, Joni&#xD;Tiainen, Mika&#xD;Tynkkynen, Tuulia&#xD;Soininen, Pasi&#xD;Havulinna, Aki S&#xD;Kaakinen, Marika&#xD;Viikari, Jorma S&#xD;Savolainen, Markku J&#xD;Kahonen, Mika&#xD;Lehtimaki, Terho&#xD;Mannisto, Satu&#xD;Blankenberg, Stefan&#xD;Zeller, Tanja&#xD;Laitinen, Jaana&#xD;Pouta, Anneli&#xD;Mantyselka, Pekka&#xD;Vanhala, Mauno&#xD;Elliott, Paul&#xD;Pietilainen, Kirsi H&#xD;Ripatti, Samuli&#xD;Salomaa, Veikko&#xD;Raitakari, Olli T&#xD;Jarvelin, Marjo-Riitta&#xD;Smith, George Davey&#xD;Ala-Korpela, Mika&#xD;eng&#xD;MC_UU_12013/3/Medical Research Council/United Kingdom&#xD;MR/L01341X/1/Medical Research Council/United Kingdom&#xD;1RL1MH083268/MH/NIMH NIH HHS/&#xD;5R01HL087679/HL/NHLBI NIH HHS/&#xD;MC_UU_12013/1/Medical Research Council/United Kingdom&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;PLoS Med. 2014 Dec 9;11(12):e1001765. doi: 10.1371/journal.pmed.1001765. eCollection 2014 Dec.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/25490400</style></url></related-urls><pdf-urls><url>internal-pdf://1380507410/Wurtz-2014-Metabolic signatures of adiposity i.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4260795</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1371/journal.pmed.1001765</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>106</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">106</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Xu, L.</style></author><author><style face="normal" font="default" size="100%">Borges, M. C.</style></author><author><style face="normal" font="default" size="100%">Hemani, G.</style></author><author><style face="normal" font="default" size="100%">Lawlor, D. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">School of Public Health, Sun Yat-sen University, Guangzhou, 510080, Guangdong, People&apos;s Republic of China.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Rm OS11, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.&#xD;School of Public Health, University of Hong Kong, Hong Kong Special Administrative Region, People&apos;s Republic of China.&#xD;Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.&#xD;School of Social and Community Medicine, University of Bristol, Bristol, UK.&#xD;MRC Integrative Epidemiology Unit, University of Bristol, Rm OS11, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK. d.a.lawlor@bristol.ac.uk.&#xD;School of Social and Community Medicine, University of Bristol, Bristol, UK. d.a.lawlor@bristol.ac.uk.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study</style></title><secondary-title><style face="normal" font="default" size="100%">Diabetologia</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Diabetologia</style></full-title></periodical><pages><style face="normal" font="default" size="100%">2210-2220</style></pages><volume><style face="normal" font="default" size="100%">60</style></volume><number><style face="normal" font="default" size="100%">11</style></number><edition><style face="normal" font="default" size="100%">2017/09/11</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Blood Glucose/*metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol, HDL/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol, LDL/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Disease/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Triglycerides/blood</style></keyword><keyword><style face="normal" font="default" size="100%">*Body mass index</style></keyword><keyword><style face="normal" font="default" size="100%">*Cardiovascular disease risk factors</style></keyword><keyword><style face="normal" font="default" size="100%">*Coronary heart disease</style></keyword><keyword><style face="normal" font="default" size="100%">*Mediation</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian randomisation</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style face="normal" font="default" size="100%">Nov</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1432-0428 (Electronic)&#xD;0012-186X (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">28889241</style></accession-num><abstract><style face="normal" font="default" size="100%">AIMS/HYPOTHESIS: The extent to which effects of BMI on CHD are mediated by glycaemic and lipid risk factors is unclear. In this study we examined the effects of these traits using genetic evidence. METHODS: We used two-sample Mendelian randomisation to determine: (1) the causal effect of BMI on CHD (60,801 case vs 123,504 control participants), type 2 diabetes (34,840 case vs 114,981 control participants), fasting glucose (n = 46,186), insulin (n = 38,238), HbA1c (n = 46,368) and LDL-cholesterol, HDL-cholesterol and triacylglycerols (n = 188,577); (2) the causal effects of glycaemic and lipids traits on CHD; and (3) the extent to which these traits mediate any effect of BMI on CHD. RESULTS: One SD higher BMI (~ 4.5 kg/m(2)) was associated with higher risk of CHD (OR 1.45 [95% CI 1.27, 1.66]) and type 2 diabetes (1.96 [95% CI 1.35, 2.83]), higher levels of fasting glucose (0.07 mmol/l [95% CI 0.03, 0.11]), HbA1c (0.05% [95% CI 0.01, 0.08]), fasting insulin (0.18 log pmol/l [95% CI 0.14, 0.22]) and triacylglycerols (0.20 SD [95% CI 0.14, 0.26]) and lower levels of HDL-cholesterol (-0.23 SD [95% CI -0.32, -0.15]). There was no evidence for a causal relation between BMI and LDL-cholesterol. The causal associations of higher triacylglycerols, HbA1c and diabetes risk with CHD risk remained after performing sensitivity analyses that considered different models of horizontal pleiotropy. The BMI-CHD effect reduced from 1.45 to 1.16 (95% CI 0.99, 1.36) and to 1.36 (95% CI 1.19, 1.57) with genetic adjustment for triacylglycerols or HbA1c, respectively, and to 1.09 (95% CI 0.94, 1.27) with adjustment for both. CONCLUSIONS/INTERPRETATION: Increased triacylglycerol levels and poor glycaemic control appear to mediate much of the effect of BMI on CHD.</style></abstract><notes><style face="normal" font="default" size="100%">Xu, Lin&#xD;Borges, Maria Carolina&#xD;Hemani, Gibran&#xD;Lawlor, Debbie A&#xD;eng&#xD;MC_UU_12013/5/Medical Research Council/United Kingdom&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Diabetologia. 2017 Nov;60(11):2210-2220. doi: 10.1007/s00125-017-4396-y. Epub 2017 Sep 9.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/28889241</style></url></related-urls><pdf-urls><url>internal-pdf://3290610077/Xu-2017-The role of glycaemic and lipid risk f.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6342872</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s00125-017-4396-y</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>27</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">27</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Yarmolinsky, James</style></author><author><style face="normal" font="default" size="100%">Relton, Caroline L.</style></author><author><style face="normal" font="default" size="100%">Lophatananon, Artitaya</style></author><author><style face="normal" font="default" size="100%">Muir, Kenneth</style></author><author><style face="normal" font="default" size="100%">Menon, Usha</style></author><author><style face="normal" font="default" size="100%">Gentry-Maharaj, Aleksandra</style></author><author><style face="normal" font="default" size="100%">Walther, Axel</style></author><author><style face="normal" font="default" size="100%">Zheng, Jie</style></author><author><style face="normal" font="default" size="100%">Fasching, Peter</style></author><author><style face="normal" font="default" size="100%">Zheng, Wei</style></author><author><style face="normal" font="default" size="100%">Ling, Woo Yin</style></author><author><style face="normal" font="default" size="100%">Chang-Claude, Jenny</style></author><author><style face="normal" font="default" size="100%">Park, Sue K.</style></author><author><style face="normal" font="default" size="100%">Kim, Byoung-Gie</style></author><author><style face="normal" font="default" size="100%">Choi, Ji-Yeob</style></author><author><style face="normal" font="default" size="100%">Park, Boyoung</style></author><author><style face="normal" font="default" size="100%">Smith, George Davey</style></author><author><style face="normal" font="default" size="100%">Martin, Richard M.</style></author><author><style face="normal" font="default" size="100%">Lewis, Sarah J.</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><urls><pdf-urls><url>internal-pdf://2446244680/Yarmolinsky-2018-Evaluating causal association.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/472696</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>129</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">129</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zanetti, D.</style></author><author><style face="normal" font="default" size="100%">Tikkanen, E.</style></author><author><style face="normal" font="default" size="100%">Gustafsson, S.</style></author><author><style face="normal" font="default" size="100%">Priest, J. R.</style></author><author><style face="normal" font="default" size="100%">Burgess, S.</style></author><author><style face="normal" font="default" size="100%">Ingelsson, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Cardiovascular Medicine, Department of Medicine (D.Z., E.T., E.I.).&#xD;Division of Cardiology, Department of Pediatrics (J.R.P.).&#xD;Stanford University School of Medicine, CA. Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Sweden (S.G., E.I.).&#xD;MRC Biostatistics Unit and Department of Public Health and Primary Care, University of Cambridge, United Kingdom (S.B.).&#xD;Division of Cardiovascular Medicine, Department of Medicine (D.Z., E.T., E.I.), eriking@stanford.edu.&#xD;and Stanford Cardiovascular Institute (D.Z., E.I.).</style></auth-address><titles><title><style face="normal" font="default" size="100%">Birthweight, Type 2 Diabetes Mellitus, and Cardiovascular Disease: Addressing the Barker Hypothesis With Mendelian Randomization</style></title><secondary-title><style face="normal" font="default" size="100%">Circ Genom Precis Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Circ Genom Precis Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">e002054</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2018/06/08</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Birth Weight/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Glucose/analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Blood Pressure</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular Diseases/*epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/*epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Observational Studies as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">United States/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">*cardiovascular disease</style></keyword><keyword><style face="normal" font="default" size="100%">*diabetes mellitus, type 2</style></keyword><keyword><style face="normal" font="default" size="100%">*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*hypertension</style></keyword><keyword><style face="normal" font="default" size="100%">*obesity</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2574-8300 (Electronic)&#xD;2574-8300 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29875125</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Low birthweight has been associated with a higher risk of hypertension, type 2 diabetes mellitus (T2D), and cardiovascular disease. The Barker hypothesis posits that intrauterine growth restriction resulting in lower birthweight is causal for these diseases, but causality is difficult to infer from observational studies. METHODS: We performed regression analyses to assess associations of birthweight with cardiovascular disease and T2D in 237 631 individuals from the UK Biobank. Further, we assessed the causal relationship of such associations using Mendelian randomization. RESULTS: In the observational analyses, birthweight showed inverse associations with systolic and diastolic blood pressure (beta, -0.83 and -0.26; per raw unit in outcomes and SD change in birthweight; 95% confidence interval [CI], -0.90 to -0.75 and -0.31 to -0.22, respectively), T2D (odds ratio, 0.83; 95% CI, 0.79-0.87), lipid-lowering treatment (odds ratio, 0.84; 95% CI, 0.81-0.86), and coronary artery disease (hazard ratio, 0.85; 95% CI, 0.78-0.94), whereas the associations with adult body mass index and body fat (beta, 0.04 and 0.02; per SD change in outcomes and birthweight; 95% CI, 0.03-0.04 and 0.01-0.02, respectively) were positive. The Mendelian randomization analyses indicated inverse causal associations of birthweight with low-density lipoprotein cholesterol, 2-hour glucose, coronary artery disease, and T2D and positive causal association with body mass index but no associations with blood pressure. CONCLUSIONS: Our study indicates that lower birthweight, used as a proxy for intrauterine growth retardation, is causally related with increased susceptibility to coronary artery disease and T2D. This causal relationship is not mediated by adult obesity or hypertension.</style></abstract><notes><style face="normal" font="default" size="100%">Zanetti, Daniela&#xD;Tikkanen, Emmi&#xD;Gustafsson, Stefan&#xD;Priest, James R&#xD;Burgess, Stephen&#xD;Ingelsson, Erik&#xD;eng&#xD;RG/13/13/30194/BHF_/British Heart Foundation/United Kingdom&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;204623/WT_/Wellcome Trust/United Kingdom&#xD;MR/L003120/1/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00002/7/MRC_/Medical Research Council/United Kingdom&#xD;R01 HL135313/HL/NHLBI NIH HHS/&#xD;MC_PC_17228/MRC_/Medical Research Council/United Kingdom&#xD;P30 DK116074/DK/NIDDK NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Circ Genom Precis Med. 2018 Jun;11(6):e002054. doi: 10.1161/CIRCGEN.117.002054.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29875125</style></url></related-urls><pdf-urls><url>internal-pdf://2701730996/Zanetti-2018-Birthweight, Type 2 Diabetes Mell.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC6447084</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1161/CIRCGEN.117.002054</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>173</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">173</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zeng, Ping</style></author><author><style face="normal" font="default" size="100%">Yu, Xinghao</style></author><author><style face="normal" font="default" size="100%">Xu, Haibo</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><urls><pdf-urls><url>internal-pdf://2272193040/Zeng-2019-Association between premorbid body m.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/526186</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>2</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">2</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zeng, Ping</style></author><author><style face="normal" font="default" size="100%">Yu, Xinghao</style></author><author><style face="normal" font="default" size="100%">Zhou, Xiang</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><urls><pdf-urls><url>internal-pdf://2862306817/Zeng-2018-Birth weight is not causally associa.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/471425</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>99</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">99</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zeng, Ping</style></author><author><style face="normal" font="default" size="100%">Zhou, Xiang</style></author></authors></contributors><titles></titles><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><urls><pdf-urls><url>internal-pdf://2392311470/Zeng-2018-Causal Association between Birth Wei.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1101/447573</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>28</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">28</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zengini, E.</style></author><author><style face="normal" font="default" size="100%">Hatzikotoulas, K.</style></author><author><style face="normal" font="default" size="100%">Tachmazidou, I.</style></author><author><style face="normal" font="default" size="100%">Steinberg, J.</style></author><author><style face="normal" font="default" size="100%">Hartwig, F. P.</style></author><author><style face="normal" font="default" size="100%">Southam, L.</style></author><author><style face="normal" font="default" size="100%">Hackinger, S.</style></author><author><style face="normal" font="default" size="100%">Boer, C. G.</style></author><author><style face="normal" font="default" size="100%">Styrkarsdottir, U.</style></author><author><style face="normal" font="default" size="100%">Gilly, A.</style></author><author><style face="normal" font="default" size="100%">Suveges, D.</style></author><author><style face="normal" font="default" size="100%">Killian, B.</style></author><author><style face="normal" font="default" size="100%">Ingvarsson, T.</style></author><author><style face="normal" font="default" size="100%">Jonsson, H.</style></author><author><style face="normal" font="default" size="100%">Babis, G. C.</style></author><author><style face="normal" font="default" size="100%">McCaskie, A.</style></author><author><style face="normal" font="default" size="100%">Uitterlinden, A. G.</style></author><author><style face="normal" font="default" size="100%">van Meurs, J. B. J.</style></author><author><style face="normal" font="default" size="100%">Thorsteinsdottir, U.</style></author><author><style face="normal" font="default" size="100%">Stefansson, K.</style></author><author><style face="normal" font="default" size="100%">Davey Smith, G.</style></author><author><style face="normal" font="default" size="100%">Wilkinson, J. M.</style></author><author><style face="normal" font="default" size="100%">Zeggini, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.&#xD;5th Psychiatric Department, Dromokaiteio Psychiatric Hospital, Athens, Greece.&#xD;Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.&#xD;GSK, R&amp;D Target Sciences, Medicines Research Centre, Stevenage, UK.&#xD;Cancer Research Division, Cancer Council NSW, Sydney, New South Wales, Australia.&#xD;Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.&#xD;Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK.&#xD;Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.&#xD;Departments of Internal Medicine and Epidemiology, Erasmus MC, Rotterdam, the Netherlands.&#xD;deCODE genetics/Amgen, Reykjavik, Iceland.&#xD;Department of Orthopaedic Surgery, Akureyri Hospital, Akureyri, Iceland.&#xD;Faculty of Medicine, University of Iceland, Reykjavik, Iceland.&#xD;Institution of Health Science, University of Akureyri, Akureyri, Iceland.&#xD;Department of Medicine, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.&#xD;2nd Department of Orthopaedic Surgery, Konstantopouleio General Hospital, National and Kapodistrian University of Athens, Athens, Greece.&#xD;Division of Trauma &amp; Orthopaedic Surgery, Department of Surgery, University of Cambridge, Addenbrooke&apos;s Hospital, Cambridge, UK.&#xD;Population Health Sciences, University of Bristol, Bristol, UK.&#xD;National Institute for Health Research, Bristol Biomedical Research Centre, University Hospitals Bristol, NHS Foundation Trust and University of Bristol, Bristol, UK.&#xD;Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. eleftheria@sanger.ac.uk.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis</style></title><secondary-title><style face="normal" font="default" size="100%">Nat Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Nat Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">549-558</style></pages><volume><style face="normal" font="default" size="100%">50</style></volume><number><style face="normal" font="default" size="100%">4</style></number><edition><style face="normal" font="default" size="100%">2018/03/22</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Biological Specimen Banks/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Chromosome Mapping</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Loci</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Variation</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study/methods/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Osteoarthritis/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">RNA, Untranslated/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">United Kingdom</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1546-1718 (Electronic)&#xD;1061-4036 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29559693</style></accession-num><abstract><style face="normal" font="default" size="100%">Osteoarthritis is a common complex disease imposing a large public-health burden. Here, we performed a genome-wide association study for osteoarthritis, using data across 16.5 million variants from the UK Biobank resource. After performing replication and meta-analysis in up to 30,727 cases and 297,191 controls, we identified nine new osteoarthritis loci, in all of which the most likely causal variant was noncoding. For three loci, we detected association with biologically relevant radiographic endophenotypes, and in five signals we identified genes that were differentially expressed in degraded compared with intact articular cartilage from patients with osteoarthritis. We established causal effects on osteoarthritis for higher body mass index but not for triglyceride levels or genetic predisposition to type 2 diabetes.</style></abstract><notes><style face="normal" font="default" size="100%">Zengini, Eleni&#xD;Hatzikotoulas, Konstantinos&#xD;Tachmazidou, Ioanna&#xD;Steinberg, Julia&#xD;Hartwig, Fernando P&#xD;Southam, Lorraine&#xD;Hackinger, Sophie&#xD;Boer, Cindy G&#xD;Styrkarsdottir, Unnur&#xD;Gilly, Arthur&#xD;Suveges, Daniel&#xD;Killian, Britt&#xD;Ingvarsson, Thorvaldur&#xD;Jonsson, Helgi&#xD;Babis, George C&#xD;McCaskie, Andrew&#xD;Uitterlinden, Andre G&#xD;van Meurs, Joyce B J&#xD;Thorsteinsdottir, Unnur&#xD;Stefansson, Kari&#xD;Davey Smith, George&#xD;Wilkinson, Jeremy M&#xD;Zeggini, Eleftheria&#xD;eng&#xD;MC_QA137853/MRC_/Medical Research Council/United Kingdom&#xD;MC_UU_00011/1/MRC_/Medical Research Council/United Kingdom&#xD;WT_/Wellcome Trust/United Kingdom&#xD;MC_PC_17228/MRC_/Medical Research Council/United Kingdom&#xD;MR/P020941/1/MRC_/Medical Research Council/United Kingdom&#xD;MC_PC_12009/MRC_/Medical Research Council/United Kingdom&#xD;Meta-Analysis&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Nat Genet. 2018 Apr;50(4):549-558. doi: 10.1038/s41588-018-0079-y. Epub 2018 Mar 20.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29559693</style></url></related-urls><pdf-urls><url>internal-pdf://3070865344/Zengini-2018-Genome-wide analyses using UK Bio.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5896734</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s41588-018-0079-y</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>169</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">169</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zhang, X.</style></author><author><style face="normal" font="default" size="100%">Lv, W. Q.</style></author><author><style face="normal" font="default" size="100%">Qiu, B.</style></author><author><style face="normal" font="default" size="100%">Zhang, L. J.</style></author><author><style face="normal" font="default" size="100%">Qin, J.</style></author><author><style face="normal" font="default" size="100%">Tang, F. J.</style></author><author><style face="normal" font="default" size="100%">Wang, H. T.</style></author><author><style face="normal" font="default" size="100%">Li, H. J.</style></author><author><style face="normal" font="default" size="100%">Hao, Y. R.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, P. R. China.&#xD;Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, NO.100 Kexue Road, High-Tech Development Zone Of States, Zhengzhou, P. R. China.&#xD;Department of Orthopaedics, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, P. R. China.&#xD;Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, P. R. China.&#xD;Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, P. R. China. 984022801@qq.com.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Assessing causal estimates of the association of obesity-related traits with coronary artery disease using a Mendelian randomization approach</style></title><secondary-title><style face="normal" font="default" size="100%">Sci Rep</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Sci Rep</style></full-title></periodical><pages><style face="normal" font="default" size="100%">7146</style></pages><volume><style face="normal" font="default" size="100%">8</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2018/05/10</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Adiposity/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Coronary Artery Disease/complications/*genetics/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Obesity/complications/*genetics/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Waist Circumference/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Waist-Hip Ratio</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">May 8</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2045-2322 (Electronic)&#xD;2045-2322 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29739994</style></accession-num><abstract><style face="normal" font="default" size="100%">Obesity-related traits have been associated with coronary artery disease (CAD) in observational studies, but these associations may be biased by confounding factors and reverse causation. In this study, we specifically conducted two-sample Mendelian randomization (MR) analyses to overcome these limitations and test the associations of obesity-related traits (other than body mass index (BMI)) (n = 322,154) with CAD (22,233 cases and 64,762 controls) by using summary-level data from previous studies. The methods utilized to estimate these associations included the inverse-variance weighted method, the weighted median method and MR-Egger regression. Our results supported causal effects of BMI, hip circumference (HC), waist circumference (WC), and waist-hip ratio (WHR) on CAD. The associations of BMI-adjusted HC and WC with CAD were reversed, unlike that of WHR. In MR analyses excluding overlapping single nucleotide polymorphisms (SNPs) from obesity-related traits, the associations of these traits with CAD were preserved. The associations of BMI-adjusted HC and WC with CAD require further investigation, as collider stratification may be occurring. Additionally, central adiposity (measured by WHR) separated from general adiposity (measured by BMI) and general adiposity might pose similar risks for CAD. In clinical practice, physicians should pay attention to the potential effects of different obesity-related traits on CAD.</style></abstract><notes><style face="normal" font="default" size="100%">Zhang, Xue&#xD;Lv, Wan-Qiang&#xD;Qiu, Bo&#xD;Zhang, Li-Jun&#xD;Qin, Jian&#xD;Tang, Feng-Juan&#xD;Wang, Hai-Tao&#xD;Li, Hua-Jie&#xD;Hao, Ya-Rong&#xD;eng&#xD;England&#xD;Sci Rep. 2018 May 8;8(1):7146. doi: 10.1038/s41598-018-25305-y.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29739994</style></url></related-urls><pdf-urls><url>internal-pdf://3580435549/Zhang-2018-Assessing causal estimates of the a.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5940685</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s41598-018-25305-y</style></electronic-resource-num></record><record><database name="qualitative_synthesis.enl" path="/Users/ml16847/OneDrive - University of Bristol/001_projects/005_systematic_review/step3/qualitative_synthesis.enl">qualitative_synthesis.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>19</rec-number><foreign-keys><key app="EN" db-id="z90fpx5dewzzz3ezfr2x5rsarztwdw5zs2a9">19</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zhu, Z.</style></author><author><style face="normal" font="default" size="100%">Zheng, Z.</style></author><author><style face="normal" font="default" size="100%">Zhang, F.</style></author><author><style face="normal" font="default" size="100%">Wu, Y.</style></author><author><style face="normal" font="default" size="100%">Trzaskowski, M.</style></author><author><style face="normal" font="default" size="100%">Maier, R.</style></author><author><style face="normal" font="default" size="100%">Robinson, M. R.</style></author><author><style face="normal" font="default" size="100%">McGrath, J. J.</style></author><author><style face="normal" font="default" size="100%">Visscher, P. M.</style></author><author><style face="normal" font="default" size="100%">Wray, N. R.</style></author><author><style face="normal" font="default" size="100%">Yang, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.&#xD;The Eye Hospital, School of Ophthalmology &amp; Optometry, Wenzhou Medical University, Wenzhou, 325027, Zhejiang, China.&#xD;Queensland Brain Institute, The University of Queensland, Brisbane, QLD, 4072, Australia.&#xD;Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, QLD, 4072, Australia.&#xD;National Centre for Register-Based Research, Aarhus University, 8000, Aarhus C, Denmark.&#xD;Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia. jian.yang@uq.edu.au.&#xD;Queensland Brain Institute, The University of Queensland, Brisbane, QLD, 4072, Australia. jian.yang@uq.edu.au.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Causal associations between risk factors and common diseases inferred from GWAS summary data</style></title><secondary-title><style face="normal" font="default" size="100%">Nat Commun</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Nat Commun</style></full-title></periodical><pages><style face="normal" font="default" size="100%">224</style></pages><volume><style face="normal" font="default" size="100%">9</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2018/01/18</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Alzheimer Disease/blood/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">*Body Mass Index</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol/*blood</style></keyword><keyword><style face="normal" font="default" size="100%">Cholesterol, LDL/blood</style></keyword><keyword><style face="normal" font="default" size="100%">Diabetes Mellitus, Type 2/blood/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Disease/etiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mendelian Randomization Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan 15</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">2041-1723 (Electronic)&#xD;2041-1723 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">29335400</style></accession-num><abstract><style face="normal" font="default" size="100%">Health risk factors such as body mass index (BMI) and serum cholesterol are associated with many common diseases. It often remains unclear whether the risk factors are cause or consequence of disease, or whether the associations are the result of confounding. We develop and apply a method (called GSMR) that performs a multi-SNP Mendelian randomization analysis using summary-level data from genome-wide association studies to test the causal associations of BMI, waist-to-hip ratio, serum cholesterols, blood pressures, height, and years of schooling (EduYears) with common diseases (sample sizes of up to 405,072). We identify a number of causal associations including a protective effect of LDL-cholesterol against type-2 diabetes (T2D) that might explain the side effects of statins on T2D, a protective effect of EduYears against Alzheimer&apos;s disease, and bidirectional associations with opposite effects (e.g., higher BMI increases the risk of T2D but the effect of T2D on BMI is negative).</style></abstract><notes><style face="normal" font="default" size="100%">Zhu, Zhihong&#xD;Zheng, Zhili&#xD;Zhang, Futao&#xD;Wu, Yang&#xD;Trzaskowski, Maciej&#xD;Maier, Robert&#xD;Robinson, Matthew R&#xD;McGrath, John J&#xD;Visscher, Peter M&#xD;Wray, Naomi R&#xD;Yang, Jian&#xD;eng&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nat Commun. 2018 Jan 15;9(1):224. doi: 10.1038/s41467-017-02317-2.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/29335400</style></url></related-urls><pdf-urls><url>internal-pdf://4164781011/Zhu-2018-Causal associations between risk fact.pdf</url></pdf-urls></urls><custom2><style face="normal" font="default" size="100%">PMC5768719</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s41467-017-02317-2</style></electronic-resource-num></record></records></xml>